Final Programme - WorldPharma 2010
Final Programme - WorldPharma 2010
Final Programme - WorldPharma 2010
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
of basic and clinical pharmacology<br />
<strong>WorldPharma</strong><strong>2010</strong><br />
16th World Congress on Basic and Clinical Pharmacology<br />
17-23 July, <strong>2010</strong>, Copenhagen, Denmark<br />
<strong>Final</strong><br />
<strong>Programme</strong><br />
www.worldpharma<strong>2010</strong>.org<br />
Bridging Basic and Clinical<br />
Pharmacology
<strong>WorldPharma</strong><strong>2010</strong><br />
Welcome 3<br />
Organization 4 – 5<br />
General information 6 –10<br />
Registration 6<br />
Social programme 6<br />
Visiting Copenhagen 8<br />
Transportation 9<br />
Commercial exhibition 9<br />
Information to presenters 10<br />
Guidelines 10<br />
Information on the Internet 10<br />
Grants and sponsorships 11<br />
Map of congress venue 12 –13<br />
<strong>Programme</strong> at a glance 14 –15<br />
General events 16<br />
Day-to-day programme 17– 22<br />
Oral sessions 24 –157<br />
Sunday 18 July 24 – 29<br />
Monday 19 July 30 – 60<br />
Tuesday 20 July 61 –89<br />
Wednesday 21 July 90 –119<br />
Thursday 22 July 120 –147<br />
Friday 23 July 148 –157<br />
Poster sessions 159 – 312<br />
Monday 19 July 160 –198<br />
Tuesday 20 July 199 – 244<br />
Wednesday 21 July 245 – 279<br />
Thursday 22 July 280 – 312<br />
Index 313 – 381<br />
Notes 382 – 383<br />
The <strong>WorldPharma</strong><strong>2010</strong> scientific programme is the most<br />
comprehensive and interdisciplinary in the history of IUPHAR congresses<br />
Professor Sam Enna (USA)<br />
Secretary General of IUPHAR
Congress patron<br />
2 HRH Crown Princess Mary
Welcome to Copenhagen<br />
On behalf of the Danish Pharmacological<br />
Society and the British Pharmacological<br />
Society it is our great pleasure<br />
to welcome you to Copenhagen and<br />
the 16th World Congress on Basic and<br />
Clinical Pharmacology, or just World-<br />
Pharma<strong>2010</strong>. <strong>WorldPharma</strong><strong>2010</strong> is<br />
organized under the auspices of the<br />
International Union of Basic and Clinical<br />
Pharmacology, IUPHAR.<br />
The mission of <strong>WorldPharma</strong><strong>2010</strong> is to<br />
discuss how we can work together to<br />
meet the need for safe and effective<br />
medicines at affordable prices, and<br />
how to support the rational and wise<br />
use of drugs.<br />
<strong>WorldPharma</strong><strong>2010</strong> is the first joint<br />
world congress for both basic and clinical<br />
pharmacology, and our slogan is:<br />
“<strong>WorldPharma</strong><strong>2010</strong> – Bridging Basic<br />
and Clinical Pharmacology”. The highlevel<br />
bridge across the Oresound<br />
between Denmark and Sweden was a<br />
natural choice as logo.<br />
in the opening lecture, the 50 years<br />
IUPHAR lecture, 24 plenary lectures,<br />
18 focused conferences, 36 workshops<br />
and symposia and one sponsored<br />
symposium.<br />
We will take this opportunity to thank<br />
the members of the local organizing<br />
and scientific committees, the British<br />
Pharmacological Society, the international<br />
scientific committee as well as<br />
numerous national societies for their<br />
efforts in what seems to be the most<br />
comprehensive and interdisciplinary<br />
scientific programme in IUPHAR’s<br />
history. We also want to thank all the<br />
international focused conference<br />
leaders and invited speakers and all<br />
the congress delegates for making<br />
<strong>WorldPharma</strong><strong>2010</strong> such an outstanding<br />
event. A special thanks to Rebecca<br />
Grove-Stephensen for her enthusiasm<br />
and enormous work in handling over<br />
3000 abstracts.<br />
Once again: Welcome to Copenhagen!<br />
We will be approximately 3000 people<br />
in what most certainly is going to be<br />
one of the most spectacular events in<br />
the nearly 50-year history of IUPHAR<br />
world congresses.<br />
As you can see from the book that you<br />
are holding in your hand, the scientific<br />
programme is a cornucopia of about<br />
700 oral presentations and nearly<br />
2000 poster presentations organized<br />
Kim Brøsen<br />
President<br />
Michael J Mulvany<br />
Secretary General<br />
Welcome to Copenhagen 3
Organization<br />
Congress President<br />
Kim Brøsen<br />
Secretary General<br />
Michael J Mulvany<br />
Local Organizing Committee<br />
Kim Brøsen (chairman)<br />
Kevin Kearns (for BPS)<br />
Michael J Mulvany (vice-chairman)<br />
Hans Bräuner-Osborne<br />
Ian Ahnfelt-Rønne<br />
Jørgen Matz<br />
Jørgen Søberg Petersen<br />
Local Scientific Committee<br />
Kim Brøsen (chairman)<br />
Michael J Mulvany (vice-chairman)<br />
Ingolf Cascorbi<br />
Ulrik Gether<br />
Jesper Hallas<br />
Edward Högestatt<br />
Susanne Mandrup<br />
Helle Birgitte Mengel<br />
Anders Rane<br />
Ulf Simonsen<br />
Donald Singer (for BPS)<br />
Steffen Thirstrup<br />
Host Organizations*<br />
Jointly with<br />
Under the auspices of<br />
of basic and clinical pharmacology<br />
*<br />
The Danish Society for Pharmacology comprises<br />
the five Danish pharmacological societies:<br />
■ Danish Society of Pharmacology, Toxicology<br />
and Medicinal Chemistry<br />
■ Danish Society of Clinical Pharmacology<br />
■ Danish Society of Pharmaco-epidemiology<br />
■ Danish Society of Clinical Chemical<br />
Pharmacology<br />
■ Pharmaceutical Society of Denmark<br />
4 Organization
British Pharmacological Society<br />
Art Weston<br />
Chris Garland<br />
Ian McFadzean<br />
Jon Peters<br />
Kevin Park<br />
Munir Pirmohamed<br />
Venue<br />
International Scientific Committee<br />
Sue P Duckles, USA<br />
Patrik du Souich, Canada<br />
Sam Enna, USA<br />
Masa Mishina, Japan<br />
Paul M Vanhoutte, Hong Kong<br />
Bella Center<br />
Center Boulevard 5<br />
DK-2300 Copenhagen S<br />
Phone +45 3252 8811<br />
E-mail: bc@bellacenter.dk<br />
Website: www.bellacenter.dk<br />
Congress Secretariat<br />
ICS - International Conference Services<br />
P.O. Box 41<br />
Strandvejen 169–171<br />
DK-2900 Hellerup, Copenhagen<br />
Denmark<br />
Phone +45 7023 7823<br />
Fax +45 7023 7888<br />
E-mail: <strong>WorldPharma</strong><strong>2010</strong>@ics.dk<br />
Website: www.ics.dk<br />
Organization 5
General information<br />
Registration & information desk<br />
Opening hours:<br />
Sunday 18 July: 09:00 - 18:30<br />
Monday 19 July: 07:30 - 18:30<br />
Tuesday 20 July: 08:00 - 18:30<br />
Wednesday 21 July: 08:00 - 18:30<br />
Thursday 22 July: 08:00 - 18:30<br />
Friday 23 July: 08:00 - 13:00<br />
Registration fees on-site:<br />
Regular participants: € 800<br />
PhD and research students: € 400<br />
Accompanying persons: € 150<br />
Hotel accomodation<br />
The Registration desk will handle all<br />
enquiries related to hotel accommodation.<br />
Entitlements participants<br />
Delegates’ registration includes:<br />
■ Participation in the scientific<br />
programme<br />
■ One copy of final programme<br />
■ One copy of abstracts<br />
(on USB-stick)<br />
■ Refreshment breaks according to<br />
the programme<br />
■ Opening reception at the congress<br />
venue<br />
■ Reception at City Hall – on<br />
availability basis<br />
Entitlements accompanying<br />
persons<br />
Accompanying persons’<br />
registration includes:<br />
■ Opening reception at the congress<br />
venue<br />
■ Reception at City Hall<br />
– on availability basis<br />
■ Sightseeing tour of Copenhagen<br />
Registration cancellation &<br />
refund policy<br />
Credit cannot be given for unattended<br />
events, late arrivals or early departure.<br />
All reimbursements will only be processed<br />
after the congress.<br />
Social programme<br />
Sunday 18 July 17:30 - 20:00<br />
Opening ceremony, lecture and<br />
reception at the congress venue<br />
Attendance is free of charge, but<br />
enrolment is required, which you can<br />
do when you register.<br />
Monday 19 July 19:30 - 21:00<br />
Reception at Copenhagen City Hall<br />
The Municipality of the City of Copenhagen<br />
has invited the congress participants<br />
and their accompanying persons<br />
to a reception at the City Hall. The<br />
guests will be welcomed by one of the<br />
mayors of Copenhagen and a buffet<br />
will be served.<br />
6 General information
Fully booked – but returned invitations<br />
may be available at the registration<br />
desk.<br />
Wednesday 21 July 19:00 - 23:30<br />
Congress Dinner at the Tivoli<br />
Gardens<br />
Choose between a casual dinner or a<br />
gourmet dinner.<br />
A memorable highlight of the congress<br />
will be the congress dinner that provides<br />
an ideal opportunity to mingle and<br />
meet other colleagues at restaurants in<br />
the Tivoli Gardens. There will be two<br />
choices of menus at restaurants next<br />
to each other: Casual or gourmet.<br />
Tickets must be purchased at the registration<br />
desk in advance.<br />
Price: Casual dinner: € 60 includes a<br />
welcome drink, three-course dinner and<br />
2 glasses of wine.<br />
Gourmet dinner: € 90 includes a glass<br />
of Crement, a three-course dinner and<br />
wine ad libitum, coffee and avec.<br />
Excursions<br />
Tickets for tourist excursions will be<br />
sold from the Registration & information<br />
desk.<br />
Congress language<br />
The official language of the congress is<br />
English. No translation services will be<br />
provided.<br />
Name badges<br />
Entrance to the congress area and to<br />
the various social events will be limited<br />
to badge holders only. If the badge is<br />
lost, please contact the registration<br />
desk. A fee of DKK 50 (€ 7) will be<br />
charged for each new badge.<br />
Voltage and plugs<br />
Electricity in Denmark is 220-volt<br />
current. Plugs are European standard<br />
with two round pins.<br />
Insurance<br />
You are requested to arrange your own<br />
health and travel insurance. Neither the<br />
congress nor the congress organizers<br />
are able to take responsibility for any<br />
injuries or damages that may occur<br />
during the congress.<br />
General information 7
Banks, currency & credit cards<br />
The currency in Denmark is Danish<br />
Kroner (DKK). Most hotels and shops<br />
accept all major credit cards. Larger<br />
shops do also accept Euro. Automated<br />
cash machines, which you can use with<br />
your credit card, are available all over<br />
the city. Banks are open Monday to<br />
Friday from 10:00 to 16:00, Thursday<br />
to 18:00.<br />
Tipping<br />
Service charges are always included in<br />
the bill and extra gratuities are not<br />
necessary.<br />
Weather and dress<br />
Denmark has a maritime climate, which<br />
means that the weather is temperate,<br />
no extreme heat or cold. In July the<br />
weather is usually dry and pleasant<br />
with daytime temperatures around<br />
18 –22°C. However, rain may occur,<br />
so please bring a light raincoat or an<br />
umbrella.<br />
Visiting Copenhagen<br />
Copenhagen is at the cross-roads between<br />
continental Europe and Scandinavia<br />
and the Baltic area. The sea and<br />
waterfront dominates the city that has<br />
kept an old-world charm. The city’s old<br />
streets and architecture blends in with<br />
modern design symbolising its rapid<br />
growth. The modest size of the city is<br />
a great advantage for visitors. The best<br />
sights are within the centre which has a<br />
bustling pedestrian shopping area<br />
called “Strøget”. Most roads have a<br />
bike lane, and compared with other<br />
European cities the traffic is not too<br />
bad. Visitors may enjoy a leisurely stroll<br />
in a relaxed and safe environment – or<br />
a bicycle ride using the ubiquitous “free<br />
of charge” city bikes.<br />
8 General information
Transportation<br />
Copenhagen has an extensive and reliable<br />
network of public transportation.<br />
It includes buses, sailing harbour<br />
buses, trains and metro.<br />
Kastrup airport – Bella Center<br />
(congress venue)<br />
The Bella Center is situated between<br />
the airport and the city centre. By combining<br />
the train and the metro the Bella<br />
Center can be reached within 15<br />
minutes. Take the Øresundstog (leaving<br />
every 10 minutes) direction Helsingør/<br />
Nivå to Ørestad station (5 minutes).<br />
Change to the metro (leaving every 4<br />
minutes) direction Vanløse and get off<br />
at Bella Center station (2 minutes). The<br />
fare is DKK 23.00 (€ 3.09).<br />
Kastrup airport – City centre<br />
Trains run every 10 minutes between<br />
the airport and the Copenhagen Central<br />
Station (Hovedbanegården). The train<br />
fare is DKK 34.50 (€ 4.65). The metro<br />
operates at 3–6 minute intervals from<br />
05:00 until midnight and every 15–20<br />
minutes during the night. The travel<br />
time from the airport to central Copenhagen<br />
is approximately 15 minutes. A<br />
typical taxi fare between the airport<br />
and the city centre is approximately<br />
DKK 200 (€ 26).<br />
City centre – congress venue<br />
The taxi fare from central Copenhagen<br />
to the congress venue comes to about<br />
DKK 200 (€ 26). Taxis accept credit<br />
cards. A metro service is available between<br />
the city centre and the Bella<br />
Center every 3–6 minutes (duration<br />
10 minutes). The fare is DKK 23.00<br />
(€ 3.09). Bus 30 runs between Vesterport<br />
Station (via Central Station) and the<br />
airport and stops at the Bella Center.<br />
Congress venue – Kastrup airport<br />
The Bella Center is situated between<br />
the airport and the city centre. By combining<br />
the metro and the train the airport<br />
can be reached within 15 minutes.<br />
The fare is DKK 23.00 (€ 3.09).<br />
Commercial exhibition<br />
Exhibition opening hours:<br />
Sunday 18 July: 18:30 – 21:00<br />
Monday 19 July: 08:00 – 18:30<br />
Tuesday 20 July: 08:00 – 18:30<br />
Wednesday 21 July: 08:00 – 18:30<br />
Thursday 22 July: 08:00 – 18:30<br />
Friday 23 July: 08:00 – 13:00<br />
General information 9
Information to presenters<br />
■ The auditoria will be equipped with<br />
PCs with Windows 7 and PowerPoint<br />
<strong>2010</strong> software and data projectors.<br />
If your presentation is in another<br />
format (e.g. Mac) we cannot ensure<br />
compatibility<br />
■ Please bring your slides in Power-<br />
Point format on a USB-stick, and<br />
deliver it to the Speakers Preview<br />
Room (Room 16) at the congress at<br />
least 3 hours prior to the session<br />
start. For morning sessions leave<br />
them the day before, please<br />
■ Prepare your oral presentation so<br />
you have 5 minutes for discussion<br />
■ If your presentation includes video<br />
clips, remember to load them separately<br />
onto your USB-stik, please<br />
■ Speakers are requested to present<br />
themselves to the chair in the<br />
lecture room 15 minutes before<br />
session start<br />
Guidelines for posters<br />
■ The size at your disposal on the<br />
poster board is: 90 cm width x 120<br />
cm height. Only pins can be used to<br />
mount your poster. Pins will be supplied<br />
at the poster exhibition area<br />
■ The poster exhibition will take place<br />
in the Poster Area<br />
■ Posters should be mounted before<br />
10:00 on the day of your presentation<br />
and taken down by 18:00 hours<br />
the same day. You have been assigned<br />
a poster board number and date<br />
and you are expected to be at your<br />
assigned space 13:00 - 14:00 on<br />
the day of your presentation.<br />
Information on the internet<br />
About the congress:<br />
www.worldpharma<strong>2010</strong>.org<br />
What to see and do in<br />
Copenhagen:<br />
www.aok.dk<br />
Copenhagen Airport:<br />
www.cph.dk<br />
The weather in Denmark:<br />
www.dmi.dk<br />
The metro:<br />
www.m.dk<br />
Information about buses, harbour<br />
buses and trains:<br />
www.movia.dk<br />
www.dsb.dk/s-tog<br />
To find the easiest way to get<br />
around:<br />
www.rejseplanen.dk<br />
10 General information
Grants and sponsorships<br />
Major grant for bursaries<br />
Diamond sponsors<br />
Bronze sponsors<br />
ADIS A Wolthers Kluwer Business<br />
Sponsors<br />
American Society of Pharmacology and Experimental Therapeutics (ASPET)<br />
AstraZeneca (Italy)<br />
Danish Cardiovascular Research Academy<br />
European Association for Clinical Pharmacology and Therapeutics (EACPT)<br />
The Federation of European Pharmacological Societies (EPHAR)<br />
Hoffmann La Roche Switzerland<br />
Novo Nordisk Foundation<br />
Servier<br />
Grants and sponsorships 11
Bella Center Copenhagen<br />
Ground floor<br />
Mart<br />
B-halls<br />
Cloak room<br />
Stairs to<br />
1st floor<br />
Hall A2<br />
Hall A3<br />
Internet<br />
Stairs to<br />
1st floor<br />
Center hall<br />
Hotel<br />
Hall A1<br />
Stairs<br />
to 1st<br />
floor<br />
Bag out<br />
Aud.<br />
15<br />
Stairs to<br />
1st floor<br />
Registration<br />
Poster Area<br />
Bus<br />
stop<br />
<br />
Congress<br />
entrance<br />
<br />
West entrance<br />
Taxi<br />
12 Bella Center Copenhagen
Meeting rooms<br />
1st floor<br />
Restaurant<br />
BV1 BV2 BV3 Bella Vista BV5<br />
BV4<br />
Office<br />
congress dept.<br />
14<br />
16 17<br />
16 Speaker prep. room<br />
<br />
Scandinavian Trade Mart<br />
7<br />
6<br />
18 A<br />
18 19 20<br />
23 24 25<br />
21 22<br />
26<br />
5<br />
18 B<br />
Aud. 15<br />
Balcony<br />
Auditorium<br />
10 11 12<br />
Congress lobby<br />
(Ground floor)<br />
<br />
Congress<br />
entrance<br />
<br />
West entrance<br />
Bella Center Copenhagen 13
<strong>Programme</strong> at a glance<br />
Time Hall A2 Hall A3 Aud. 15 Aud. 10 Aud. 11<br />
Sunday 18 July<br />
09:45 - 12:45<br />
12:45 - 14:15<br />
14:15 - 16:15<br />
17:30 - 18:45 Opening ceremony – Hall A2<br />
18:45 - 20:00 Welcome reception – Hall A1<br />
Monday 19 July<br />
08:30 - 09:15 PL01 PL02 PL03<br />
09:30 - 12:15 FC09 FC02 FC05 FC01 FC04<br />
12:45 - 14:15 SS01 W05 W06 W07 W08<br />
14:30 - 17:15 FC09 FC02 FC05 FC01 FC04<br />
17:30 - 18:15 PL04 PL05 PL06<br />
Tuesday 20 July<br />
08:30 - 09:15 PL07 PL08 PL09<br />
09:30 - 12:15 FC09 FC02 FC05 FC01 FC04<br />
12:45 - 14:15 W12 W13 W14 W15 W16<br />
14:30 - 17:15 FC09 FC02 FC05 FC01 FC04<br />
17:30 - 18:15 IUPHAR Plenary lecture – Hall A2<br />
18:30 IUPHAR general assembly – Auditorium 15<br />
Wednesday 21 July<br />
08:30 - 09:15 PL10 PL11 PL12<br />
09:30 - 12:15 FC13 FC09 FC16 FC11 FC17<br />
12:45 - 14:15 W20 W21 W22 W23 W24<br />
14:30 - 17:15 FC13 FC15 FC16 FC11 FC17<br />
17:30 - 18:15 PL13 PL14 PL15<br />
Thursday 22 July<br />
08:30 - 09:15 PL16 PL17 PL18<br />
09:30 - 12:15 FC13 FC15 FC16 FC11 FC17<br />
12:45 - 14:15 W28 W29 W30 W31 W32<br />
14:30 - 17:15 FC13 FC15 FC16 FC11 FC17<br />
17:30 - 18:15 PL19 PL20 PL21<br />
Friday 23 July<br />
08:30 - 09:15 PL22 PL23 PL24<br />
09:30 - 12:15 FC13 FC15 FC16 FC11 FC17<br />
12:30 - 13:00 Closing ceremony & prize awards – Hall A2<br />
14 <strong>Programme</strong> at a glance
Aud. 12 Room 18/19 Room 20 Room BV 1/2/3 Room BV 5 Room 17<br />
W01<br />
W04 W02 W03<br />
W36<br />
FC06 FC07 FC03 W02<br />
W09 W10 W11 W02<br />
FC06 FC07 FC03 FC08<br />
FC06 FC07 FC03 FC08<br />
W17 W04 W19 W18<br />
FC06 FC07 FC03 FC08<br />
FC14 FC10 FC12 YI<br />
W25 W04 W27 W26<br />
FC14 FC10 FC12 FC18<br />
FC14 FC10 FC12 FC18<br />
W33 W34 W35 EPHAR CM<br />
FC14 FC10 FC12 FC18<br />
FC14 FC10 FC12 FC18<br />
<strong>Programme</strong> at a glance 15
General events<br />
Opening ceremony & opening lecture<br />
Sunday 18 July 17:30 - 18:45 ■ Hall A2<br />
Chair: Michael J Mulvany, (Denmark)<br />
17:30 - 17:45 Opening address<br />
Kim Brøsen, (Congress President)<br />
17:45 - 17:50 IUPHAR welcome<br />
Sue P Duckles, (President of IUPHAR)<br />
17:55 - 18:15 The Hans Christian Andersen Parade<br />
18:15 - 18:45 OL Opening lecture<br />
Found in translation: Human pharmacology and applied pharmacology come of age<br />
Jeffrey K Aronson, (UK)<br />
Welcome reception<br />
Sunday 18 July 18:45 - 20:00 ■ Hall A1<br />
IUPHAR general assembly<br />
Tuesday 20 July 18:30 ■ Auditorium 15<br />
Supported by the ASPET Division for Drug Discovery, Drug Development, and Regulatory Affairs<br />
Young Investigator Award competition<br />
Wednesday 21 July 09:15 - 12:15 ■ Room BV 1/2/3<br />
EPHAR council meeting<br />
Thursday 22 July 12:45 - 14:15 ■ Room BV 1/2/3<br />
Closing ceremony & prize awards<br />
Friday 23 July 12:30 - 13.00 ■ Hall A2<br />
Presentations to the winners of the Young Investigator Award<br />
Sue P Duckles and Sam J Ennea<br />
Information about coming meetings (EACPT2011, <strong>WorldPharma</strong> 2014)<br />
Remarks from the new president of IUPHAR<br />
Closing remarks<br />
Kim Brøsen<br />
16 General events
Day-to-day programme<br />
■ Plenary lectures<br />
■ Focused conference sessions<br />
■ Sponsored symposium<br />
■ Workshop sessions<br />
Listed in the order in which they are held and are indexed on pages 18 –22<br />
■ Posters for each day are listed after the oral programme<br />
Poster sections are indexed on page 159<br />
Focused Conferences represent a new and important concept.<br />
Professor Sue P Duckles (USA)<br />
President of IUPHAR and president of the 14th World Congress on<br />
Pharmacology (San Francisco, 2002)<br />
Day-to-day programme 17
<strong>Programme</strong> outline<br />
Plenary lectures<br />
Tue 17:30 IUL Paul M Vanhoutte The 50-Years IUPHAR Anniversary Lecture: Regenerate to be old.<br />
Sun 17:30 OL Jeffrey K Aronson Found in translation: Human pharmacology and applied<br />
pharmacology come of age.<br />
Mon 08:30 PL01 Salvador Moncada Vascular endothelium: Physiology, pharmacology and vascular<br />
disease.<br />
Mon 08:30 PL02 Klaus Cichutek Regulatory aspects of biomedicines.<br />
Mon 08:30 PL03 Trevor Sharp Pharmacological control of central serotonin neurons.<br />
Mon 17:30 PL04 Emmanuel Canet The challenges of the pharmaceutical industry in the 21st centure.<br />
Mon 17:30 PL05 Stefanie Dimmeler Cell therapy.<br />
Mon 17:30 PL06 Carlos Villalon The complex effects of 5-hydroxytryptamine in the cardiovascular<br />
system.<br />
Tue 08:30 PL07 Matthias Schwab Personalized medicine beyond pharmacogenetics.<br />
Tue 08:30 PL08 Thomas Pogge The Health Impact Fund: Making new medicines more accessible<br />
also for the poor<br />
Tue 08:30 PL09 Barry Halliwell Antioxidants & free radicals, good or bad<br />
Wed 08:30 PL10 Brian K Kobilka Structural insights into GPCR activation.<br />
Wed 08:30 PL11 Masamitsu Iino Calcium and cell functions.<br />
Wed 08:30 PL12 Otto Cars Meeting the challenge of antibiotic resistance.<br />
Wed 17:30 PL13 Jes Olesen New drug targets for headache.<br />
Wed 17:30 PL14 Shizuo Akira Toll-like receptor and innate immunity.<br />
Wed 17:30 PL15 Sue P Duckles Understanding the neuroprotective effect of estrogen; inflammation,<br />
age and mitochondria.<br />
Thu 08:30 PL16 Olavi Pelkonen Drug metabolism – past, present and future.<br />
Thu 08:30 PL17 Morris J Brown Therapeutic potential of vaccines in the management of<br />
hypertension.<br />
Thu 08:30 PL18 Ian E Hughes Teaching pharmacology in 2020.<br />
Thu 17:30 PL19 Peter J Barnes Reversal of corticosteroid resistance in severe inflammatory<br />
diseases: A novel therapeutic strategy.<br />
Thu 17:30 PL20 Ernesto Schiffrin Renin-angiotensin system and vascular inflammation.<br />
Thu 17:30 PL21 Thomas Lönngren Successes and challenges in drug development – a regulatory<br />
perspective.<br />
Fri 08:30 PL22 Ding-Feng Su New strategies for stroke prevention.<br />
Fri 08:30 PL23 Elisabeth Bock New molecular targets in Alzheimer’s disease.<br />
Fri 08:30 PL24 Bernd Mayer Pharmacology of organic nitrates: From 19th century homeopathy<br />
to genetic mouse models.<br />
Focused conferences<br />
FC01 Clinical pharmacology in the emerging countries<br />
Mon 09:30 FC01.1 Clinical pharmacology and promotion of rational use of medicines in emerging and<br />
developing countries<br />
Mon 14:30 FC01.2 Clinical pharmacology and drug regulation in resource limited settings<br />
Tue 09:30 FC01.3 Clinical trials in countries with developing and emerging economies<br />
Tue 14:30 FC01.4 Pharmacovigilance in emerging and developing countries: A luxury or a must<br />
18 <strong>Programme</strong> outline
FC02 Transmembrane transport: Perspectives for disease and drug discovery<br />
Mon 09:30 FC02.1 Molecular structure and pharmacology of membrane transporters<br />
Mon 14:30 FC02.2 Membrane transporters and disease<br />
Tue 09:30 FC02.3 Intestinal and hepatic transporters<br />
Tue 14:30 FC02.4 Membrane transporters: Molecular genetics and pharmacogenetics<br />
FC03 Ion channels in analgesia and anaesthesia<br />
Mon 09:30 FC03.1 Ion channel drug targets in the sensory nerve<br />
Mon 14:30 FC03.2 Voltage-operated calcium channels as targets for analgesic action<br />
Tue 09:30 FC03.3 Synaptic plasticity in analgesia-related pathways<br />
Tue 14:30 FC03.4 Ion channels as molecular targets for general anaesthetics<br />
FC04 Pharmacoepidemiology, current controversies and opportunities<br />
Mon 09:30 FC04.1 Methodological issues in pharmacoepidemiology<br />
Mon 14:30 FC04.2 Approaches to screening electronic medical records and claims data<br />
Tue 09:30 FC04.3 Regulatory challenges in managing risk of medicinal products<br />
Tue 14:30 FC04.4 In utero exposure to drugs<br />
FC05 Translational science in the metabolic syndrome:<br />
Basic and clinical pharmacology<br />
Mon 09:30 FC05.1 New molecular targets in metabolic syndrome<br />
Mon 14:30 FC05.2 Translational science in the metabolic syndrome: Basic and clinical pharmacology<br />
Tue 09:30 FC05.3 Normalizing blood glucose in metabolic syndrome I: GLP-1 analogues and DPP IV<br />
inhibitors<br />
Tue 14:30 FC05.4 Normalizing blood glucose in metabolic syndrome II: Glitazones and metformin<br />
FC06 The heart gone wrong; stabilization of cardiac function<br />
Mon 09:30 FC06.1 Molecular mechanisms of arrhythmia<br />
Mon 14:30 FC06.2 Novel anti-arrhythmics<br />
Tue 09:30 FC06.3 Novel treatments for systolic heart failure<br />
Tue 14:30 FC06.4 Treatment options for diastolic heart failure<br />
FC07 Simulation and data modelling in drug development. Better drugs faster<br />
Mon 09:30 FC07.1 Modelling and simulation – how and why<br />
Mon 14:30 FC07.2 Disease models – using virtual organs and patient populations<br />
Tue 09:30 FC07.3 Modelling and simulation in clinical drug development<br />
Tue 14:30 FC07.4 Modelling and simulation – A regulator’s view<br />
FC08 Developments in the treatment of sexual dysfunction and diseases of the lower<br />
urinary tract<br />
Mon 14:30 FC08.1 Treatment of sexual dysfunction associated with cardiovascular disease<br />
Tue 09:30 FC08.2 Pharmacological treatment of lower urinary tract syndrome/benign prostatic hyperplasia<br />
Tue 14:30 FC08.3 Pharmacological treatment of bladder dysfunction<br />
FC09 Inflammation and immunopharmacology: New tools for old diseases<br />
Mon 09:30 FC09.1 Steroids and beyond: Novel treatments for asthma and allergy<br />
Mon 14:30 FC09.2 Biologicals in inflammatory diseases – successes, promises and problems<br />
Tue 09:30 FC09.3 iNOS – nitric oxide pathway in inflammation and as a target of anti-inflammatory<br />
treatment<br />
Tue 14:30 FC09.4 NSAIDs and COX-2 inhibitors. Current strategies and future directions<br />
Wed 09:30 FC09.5 Novel anti-inflammatory targets and mechanism<br />
<strong>Programme</strong> outline 19
FC10 Drugs for half the world: Paediatric clinical pharmacology<br />
Wed 09:30 FC10.1 Innovative methodological approaches in drug development in children<br />
Wed 14:30 FC10.2 WHO and medicines in developing countries<br />
Thu 09:30 FC10.3 Formulation issues<br />
Thu 14:30 FC10.4 Pain in children<br />
Fri 09:30 FC10.5 Recent advance in paediatric clinical pharmacology<br />
FC11 G protein-coupled 7TM receptors: From molecular to physiological function<br />
Wed 09:30 FC11.1 7TM receptor structure<br />
Wed 14:30 FC11.2 7TM receptors: Activation, inactivation and allosteric modulation<br />
Thu 09:30 FC11.3 7TM receptors: Scaffolding and signalling mechanisms<br />
Thu 14:30 FC11.4 7TM receptors: Genetic mouse models and disease<br />
Fri 09:30 FC11.5 7TM receptors: Drug discovery and new physiological functions<br />
FC12 Ion channelopathies: New windows on complex disease and therapy<br />
Wed 09:30 FC12.1 Ion channelopathies in the brain: Inherited epilepsy and migraine<br />
Wed 14:30 FC12.2 Ion channelopathies of peripheral nerve and muscle: Inherited pain and periodic paralysis<br />
Thu 09.30 FC12.3 Ion channelopathies in the cardiovascular system: Inherited arrhythmia and hypertension<br />
Thu 14:30 FC12.4 Ion channelopathies in endocrine systems<br />
Fri 09:30 FC12.5 Ion channelopathies in lymphocytes: Severe combined immunodeficiency and<br />
store-operated calcium channels<br />
FC13 Maximising benefits and minimizing harms from drugs<br />
Wed 09:30 FC13.1 Drug safety: The epidemiology<br />
Wed 14:30 FC13.2 Drug metabolism and drug toxicity<br />
Thu 09:30 FC13.3 Pharmacogenomics and adverse drug reactions<br />
Thu 14:30 FC13.4 New technologies – will they help in developing safer drugs<br />
Fri 09:30 FC13.5 New insights in the genetics of drug metabolism and action<br />
FC14 Addiction and doping: Neurobiological and clinical basis of emerging<br />
treatments<br />
Wed 09:30 FC14.1 Pharmacological treatment of opiate dependence – much achieved, much left to do<br />
Wed 14:30 FC14.2 Pharmacological treatments of alcohol dependence – illusion or opportunity<br />
Thu 09:30 FC14.3 Craving and relapse to drug seeking: Lessons from animal models and human brain<br />
imaging<br />
Thu 14:30 FC14.4 The role of stress in the addictive process<br />
Fri 09:30 FC14.5 Doping – an underestimated problem with many unknowns<br />
FC15 Endothelium in health and disease<br />
Wed 14:30 FC15.1 Nitric oxide and oxidative stress<br />
Thu 09:30 FC15.2 Endothelium-dependent hyperpolarization<br />
Thu 14:30 FC15.3 Endothelium-mediated control of vascular tone<br />
Fri 09:30 FC15.4 Drug development and novet therapeutic targets and approaches<br />
FC16 Natural products: Past and future<br />
Wed 09:30 FC16.1 Cardioprotection by natural products<br />
Wed 14:30 FC16.2 Products derived from one single plant with convincing pharmacological data in<br />
explaining their mechanism of action<br />
Thu 09:30 FC16.3 Multiple plant products: A matter of synergy<br />
Thu 14:30 FC16.4 East meets west: From prevention to therapy<br />
Fri 09:30 FC16.5 Globalization of natural/traditional products<br />
20 <strong>Programme</strong> outline
FC17 New approaches and targets in psychiatry<br />
Wed 09:30 FC17.1 The pathophysiological basis for psychosis<br />
Wed 14:30 FC17.2 Exploring new targets in schizophrenia using translation science<br />
Thu 09:30 FC17.3 Clinical aspects of treatment with antipsychotics<br />
Thu 14:30 FC17.4 Exploring new targets in affective disorders using translational science<br />
Fri 09:30 FC17.5 New pharmacological approaches for treatment of stress induced mood disorders<br />
FC18 Nuclear receptor targets for treatment of diseases<br />
Wed 14:30 FC18.1 Nuclear receptors and metabolic control<br />
Thu 09:30 FC18.2 Nuclear receptors, vascular function and Inflammation<br />
Thu 14:30 FC18.3 Nuclear receptors in the CNS<br />
Fri 09:30 FC18.4 The molecular basis of NR pharmacology<br />
Sponsored symposium<br />
Mon 12:45 SS01 Benefit/risk ratio of antipsychotics: How to improve the effectiveness of our therapeutic<br />
armamentarium<br />
Sponsored by AstraZeneca Italy<br />
Workshops<br />
W01 Symposium: Pharmacology of adrenoceptors: Eighth satellite meeting<br />
Sun 09:45 W01.1 Part I – Molecular structure<br />
Sun 12:45 W01.2 Part II – Pharmacology<br />
Sun 15:00 W01.3 Part III – Therapeutics<br />
W02 Symposium: Advances in GI pharmacology<br />
Sun 12:45 W02.1 Part I – Gastrointestinal nutrient chemosensing and the gut-brain axis<br />
Mon 9:30 W02.2 Part II – From functional to structural disease targets<br />
Mon 12:45 W02.3 Part III – From functional to structural disease targets, continued<br />
Sun 12:45 W03 Workshop: Targeting TRP channels for pain relief (and more)<br />
W04 Symposium: Antioxidants as therapeutic targets<br />
Sun 12:45 W04.1 Part I – Systems biology<br />
Tue 12:45 W04.2 Part II – Cardiovascular health<br />
Wed 12:45 W04.3 Part III – Antioxidants as therapeutic targets<br />
Mon 12:45 W05 Workshop: Clinical trials across Europe and the role of pharmacologists<br />
Mon 12:45 W06 Workshop: Effect of disease on cytochrome p450 and membrane transporters<br />
Mon 12:45 W07 Workshop: Circadian clocks for drug development and therapeutics<br />
Mon 12:45 W08 Workshop: Identifying targets for treating vascular diseases associated to metabolic<br />
disorders<br />
Mon 12:45 W09 Workshop: Blood cells and cytokines as emerging targets for cardiovascular<br />
pharmacology<br />
Mon 12:45 W10 Workshop: Innovative Medicines Initiative: A new approach to education & training in<br />
medicines research in Europe<br />
Mon 12:45 W11 Workshop: New opportunities in the pharmacology of neuro-immune interactions<br />
Tue 12:45 W12 Workshop: Experimental pain methods in development and validation of analgesics<br />
<strong>Programme</strong> outline 21
Tue 12:45 W13 Workshop: Novel peripheral mechanisms modulating the cardiovascular system:<br />
Pathophysiological, pharmacological and therapeutic relevance<br />
Tue 12:45 W14 Workshop: Translating the human genome: From orphan G-protein coupled<br />
receptors to novel therapeutic targets<br />
Tue 12:45 W15 Workshop: The IUPHAR initiative in integrative and organ systems pharmacology<br />
Tue 12:45 W16 Workshop: Implementation and obstacles of pharmacogenetics in clinical practice<br />
Tue 12:45 W17 Workshop: Standards for PhD education in pharmacology<br />
Tue 12:45 W18 Workshop: Low-dose aspirin, COXIBs and other NSAIDs: A clinical mosaic emerges<br />
Tue 12:45 W19 Workshop: Influence of degeneration and repair in the CNS and periphery<br />
Wed 12:45 W20 Workshop: Pharmacology education for a sustainable future<br />
Wed 12:45 W21 Workshop: Inflammation – here, there and everywhere<br />
Wed 12:45 W22 Workshop: The Pfizer senior investigator award in pharmacology<br />
Wed 12:45 W23 Workshop: Applying pharmacogenomics (PGX) from research into clinical practice:<br />
Present and future<br />
Wed 12:45 W24 Workshop: EU Innovative Medicines Initiative: Better and safer drugs faster for the<br />
public<br />
Wed 12:45 W25 Workshop: High science in the lowlands<br />
Wed 12:45 W26 Workshop: Translational human bio-markers for pain and disease severity in drug<br />
development<br />
Wed 12:45 W27 Workshop: Approaches to medicinal plant research in africa: Strategy towards<br />
2014 and beyond<br />
Thu 12:45 W28 Workshop: The Boehringer-Ingelheim post-doctoral award<br />
Thu 12:45 W29 Workshop: New horizons in therapeutic drug management (TDM)<br />
Thu 12:45 W30 Workshop: Is eNOS Still a valid therapeutic target – The era after the discovery of<br />
eNOS uncoupling<br />
Thu 12:45 W31 Workshop: Developing new drugs for neglected infections<br />
Thu 12:45 W32 Workshop: The good, the bad and the ugly: When medicines cure most, harm some<br />
and confuse many<br />
Thu 12:45 W33 Workshop: Synaptic events in brain function<br />
Thu 12:45 W34 Workshop: State-of-the-art of basic and clinical pharmacology in Serbia<br />
Thu 12:45 W35 Workshop: Bridging pharmacovigilance and patient safety – experiences from<br />
regional pharmacovigilance units<br />
Sun 14:15 W36 Workshop: Challenges in the conduct of clinical trials in low and middle income<br />
settings<br />
Posters will be held on the following days<br />
Monday, 19 July Mon 001 – 500<br />
Tuesday, 20 July Tue 001 – 500<br />
Wednesday, 21 July Wed 001 – 500<br />
Thursday, 22 July Thu 001 – 500<br />
Posters will be displayed each day from 10:00 to 17:30. Presenters are asked to be by their poster<br />
from 13:00 to 14:00. For “on-site” abstracts please refer to material given out at registration.<br />
22 <strong>Programme</strong> outline
YOU’VE ONLY JUST<br />
ARRIVED & ALREADY<br />
WE’RE THINKING OF<br />
YOUR NEXT TRIP<br />
As the official airline network for the World Pharma <strong>2010</strong>, we’d like<br />
to thank you for choosing the Star Alliance network and hope<br />
that all goes really well for you here today.<br />
Whilst you concentrate on the day’s events, we hope you’ll<br />
consider us the next time you need to attend a conference.<br />
With over 21,050 flights a day to 1,167 airports across 181 countries,<br />
our 27 member airlines will extend a wide choice of flights to any<br />
future conference you’re planning to attend. And no matter which<br />
of those airline’s frequent flyer programmes you belong to, you<br />
can earn and redeem miles across all of them.<br />
So the next time you want to concentrate all your energies<br />
on your conference, we hope you’ll decide to leave the travel<br />
arrangements to us.<br />
www.staralliance.com<br />
Information correct as at 05/<strong>2010</strong>
W01<br />
Pharmacology of adrenoceptors:<br />
Eighth satellite meeting<br />
Leaders: John Ian McGrath, (UK) & Mika Scheinin, (Finland)<br />
Part I – Molecular Structure<br />
Chair: Roger Summers (Australia)<br />
09:45 - 10:00 W01.1.1 Pharmacology of adrenoceptors – convergence of molecular and integrative and<br />
systems pharmacology<br />
Roger J Summers, (Australia)<br />
10:00 - 11:00 W01.1.2 Crystal structure of β2-adrenoceptors – how we got there and what we learned<br />
Brian K Kobilka, (USA)<br />
11:00 - 11:30 W01.1.3 Molecular mechanisms of ligand-regulated receptor activation and oligomerization<br />
Leonardo Pardo, (Spain)<br />
11:30 - 12:00 W01.1.4 Agonist-specific conformational changes in α2a-adrenoceptors revealed by<br />
fluorescence resonance energy transfer<br />
Carsten Hoffmann, (Germany)<br />
12:00 - 12:45 LUNCH BREAK<br />
Part II – Pharmacology<br />
Chair: John Ian McGrath, (UK)<br />
12:45 - 13:15 W01.2.1 Pre- versus postsynaptic α2-adrenoceptors<br />
Ralf Gilsbach, (Germany), J Schneider, J Albarran-Juarez, L Hein<br />
13:15 - 13:45 W01.2.2 Localisation of adrenoceptors in live native tissue<br />
John Ian McGrath, (UK)<br />
13:45 - 14:15 W01.2.3 α1-adrenoceptors in the lower urinary tract<br />
Ikunobu Muramatsu, (Japan), A Nishimune<br />
14:15 - 14:40 W01.2.4 α2-adrenoceptors blockade accelerates the neurogenic, neurotrophic, and behavioural<br />
effects of chronic antidepressant treatment<br />
Vidita A Vaidya(India), S Yanpallewar, K Fernandes, S Marathe, K Vadodaria, D Jhaveri,<br />
K Rommelfanger, S Jha, V Muthig, L Hein, P Bartlett, D Weinshenker<br />
24 Sunday 18 July ■ 09:45 - 14:40 ■ Meeting Room 20
W01<br />
Pharmacology of adrenoceptors:<br />
Eighth satellite meeting<br />
Leaders: John Ian McGrath, (UK) & Mika Scheinin, (Finland)<br />
Part III – Therapeutics<br />
Chair: Mika Scheinin, (Finland)<br />
15:00 - 15:20 W01.3.1 Possible therapeutic uses of release-modifying drugs acting on autoreceptors and<br />
neuronal transporters<br />
Salomon Z Langer, (Israel)<br />
15:20 - 15:40 W01.3.2 β3-adrenoceptor agonists in control of overactive bladder function – translational aspects<br />
Cees Korstanje, (The Netherlands)<br />
15:40 - 16:00 W01.3.3 The α2C-adrenoceptor as a neuropsychiatric target<br />
Jukka Sallinen, (Finland)<br />
16:00 - 16:15 W01.3.4 Concluding remarks: adrenoceptors – what's next<br />
Mika Scheinin, (Finland)<br />
Sunday 18 July ■ 15:00 - 16:15 ■ Meeting Room 20 25
Kunio Torii, (Japan)
W03<br />
Targeting TRP channels for pain relief (and more)<br />
Leaders: Arpad Szallasi (USA) & Kevin S Thorneloe (USA)<br />
Targeting TRP channels for pain relief (and more)<br />
Chairs: Pierangelo Geppetti, (Italy) & Riccardo Patacchin, (Italy)<br />
12:45 - 13:15 W03.1 TRPV1 antagonists for pain relief, cough, and incontinence<br />
Marcello Trevisani, (Italy)<br />
13:15 - 13:45 W03.2 TRPV3 receptor as a pain target: a therapeutic promise or just some more new biology<br />
Neelima Khairatkar Joshi, (India), A Thomas, S Choudhary, PRVS Lingam, V Kattige,<br />
S Gullapalli, G Gudi<br />
13:45 - 14:15 W03.3 Identification of novel TRPV4 modulators<br />
Fabien Vincent, (USA)<br />
14:15 - 14:45 COFFEE BREAK<br />
14:45 - 15:15 W03.4 The rising role of TRPA1 in asthma<br />
Riccardo Patacchini, (Italy)<br />
15:15 - 15:45 W03.5 Genetic polymorphisms in TRP channels are associated with the somatosensory function<br />
in neuropathic pain patients<br />
Denisa May, (Germany), A Binder, R Baron, C Maier, TR Tölle, R-D Treede, G Wasner,<br />
H Flor, S Haenisch, C Maihöfner, A Scherens, I Cascorbi<br />
15:45 - 16:00 W03.6 TRPV4 mutations produce familial digital arthropathy brachydactyly (FDAB)<br />
Peter McIntyre, (Australia), Y Yuan, I Gresshoff, C Little, D Armor, R Savarirayan,<br />
E Botzenhart, W Cole, J Bateman, S Lamandé<br />
Sunday 18 July ■ 12:45 - 16:15 ■ Meeting Room 17 27
W04<br />
Symposium: Antioxidants as therapeutic targets<br />
Organized by: Canadian Society of Pharmacology and Therapeutics<br />
Leader: Issy Laher, (Canada)<br />
Part I – Systems biology<br />
Chairs: Issy Laher, (Canada) & Christopher M Rembold, (USA)<br />
12:45 - 13:25 W04.1.1 Free radical biology: what is new<br />
Barry Halliwell, (Singapore)<br />
13:25 - 14:00 W04.1.2 Anti-oxidants and stroke<br />
Ding-Feng Su, (PR China)<br />
14:00 - 14:35 W04.1.3 Effect of an extract of Mangifera indica L. in patients with spinocerebellar ataxia type 2<br />
Mariela Guevara-García, (Cuba), L Velázquez, R Aguilera, R Rodríguez, O Ramírez,<br />
D Almaguer, G Sánchez, JC Rodríguez<br />
15:05 - 15:40 W04.1.4 Antioxidant therapy in sepsis<br />
John X Wilson, (USA)<br />
15:40 - 16:15 W04.1.5 Different facets of microparticles in the metabolic syndrome<br />
Ramaroson Andriantsitohaina, (France)<br />
28 Sunday 18 July ■ 12:45 - 16:15 ■ Meeting Room 18/19
W36<br />
Workshop. Challenges in the conduct of clinical<br />
trials in low and middle income settings<br />
Organized by: Centre for International Child Health, University of<br />
British Columbia, Vancouver, Canada<br />
Leader: Stuart MacLeod, (Canada)<br />
Challenges in the conduct of clinical trials in low and middle income<br />
settings<br />
Chair: Stuart MacLeod, (Canada)<br />
14:15 - 14:35 W36.1 Current context for international pediatric clinical trials<br />
Stuart MacLeod, (Canada)<br />
14:35 - 14:55 W36.2 WHO Better Medicines for Children Program: objectives<br />
Suzanne R Hill, (Switzerland)<br />
14:55 - 15:15 W36.3 Design challenges and methodological innovation<br />
Martin Offringa, (The Netherlands)<br />
15:15 - 15:35 W36.4 EMEA perspective on international pediatric clinical trials<br />
Agnes Saint-Raymond, (UK)<br />
15:35 - 15:55 W36.5 A viewpoint from Africa<br />
David Ofori-Adjei, (Ghana)<br />
15:55 - 16:15 W36.6 A viewpoint from Southeast Asia<br />
Krisantha Weerasuriya, (India)<br />
Opening ceremony and opening lecture in Hall A2<br />
Sunday 18 July 17:30 - 18:45<br />
Welcome reception in Hall A1<br />
Sunday 18 July 18·45 - 20:00<br />
Sunday 18 July ■ 14:15 - 16:15 ■ Meeting Room BV5 29
Plenary lectures<br />
PL01<br />
Plenary lecture, Hall A2<br />
Chair: Paul M Vanhoutte, (PR China)<br />
08:30 - 09:15 PL01 Vascular endothelium: physiology, pharmacology and vascular disease<br />
Salvador Moncada, (UK)<br />
PL02<br />
Plenary lecture, Hall A3<br />
Chair: Steffen Thirstrup, (Denmark)<br />
08:30 - 09:15 PL02 Regulatory aspects of biomedicines<br />
Klaus Cichutek, (Germany)<br />
PL03 Plenary lecture, Auditorium 15<br />
Chair: Sam Enna, (USA)<br />
08:30 - 09:15 PL03 Pharmacological control of central serotonin neurons<br />
Trevor Sharp, (UK)<br />
30 Monday 19 July ■ 08:30 - 9:15
FC01<br />
Clinical pharmacology in the emerging countries<br />
Leader: Lembit Rägo, (Switzerland)<br />
FC01.1<br />
Clinical pharmacology and promotion of rational use of medicines in<br />
emerging and developing countries<br />
Chair: Suzanne R Hill, (Switzerland)<br />
09:30 - 09:55 FC01.1.1 Clinical pharmacology in developing countries: overview of current status and future<br />
trends.<br />
Andrew Walubo, (South Africa)<br />
09:55 - 10:20 FC01.1.2 Promoting clinical pharmacology in developing countries through education and research<br />
training<br />
Folke Sjöqvist, (Sweden)<br />
10:20 - 10:45 FC01.1.3 Update of the WHO publication on clinical pharmacology 1970:<br />
what we learned from the process and main outcomes<br />
Simon RJ Maxwell, (UK)<br />
10:45 - 11:15 COFFEE BREAK<br />
11:15 - 11:40 FC01.1.4 Is WHO’s Essential Medicines List contributing to rational medicines use in developing<br />
countries<br />
Andrew L Gray, (South Africa), K Holloway<br />
11:40 - 11:55 FC01.1.5 Free Communication Presentation:<br />
Lamivudine trial in hepatitis B surface antigen carriers with persistence hepatitis B core<br />
IgM antibody<br />
Husham Ali Alsinde, (Iraq)<br />
11:55 - 12:10 FC01.1.6 Free Communication Presentation:<br />
Comparison of efficacy of ORS + Zn verses ORS + Zn + Saccharomyces Boulardii strain<br />
in treatment of acute non infective diarrhea in Indian children<br />
Meeta Burande, (India)<br />
Monday 19 July ■ 09:30 - 12:15 ■ Auditorium 10 31
FC02<br />
Transmembrane transport:<br />
Perspectives for disease and drug discovery<br />
Supported by an unrestricted grant from Novo Nordisk Foundation<br />
Leaders: Randy Blakely, (USA) & Richard Kim, (Canada)<br />
FC02.1<br />
Molecular structure and pharmacology of membrane transporters<br />
Chairs: Jonathan A Javitch, (USA) & Ulrik Gether, (Denmark)<br />
09:30 - 09:55 FC02.1.1 The dopamine transporter: new insights into the molecular actions of cocaine and<br />
amphetamine<br />
Ulrik Gether, (Denmark)<br />
09:55 - 10:20 FC02.1.2 Mechanisms of sodium-coupled transport<br />
Jonathan A Javitch, (USA), Y Zhao, D Terry, L Shi, M Quick, H Weinstein, SC Blanchard<br />
10:20 - 10:45 FC02.1.3 Molecular pharmacology of the breast cancer resistance protein (ABCG2)<br />
Hendrik W van Veen, (UK)<br />
10:45 - 11:15 COFFEE BREAK<br />
11:15 - 11:40 FC02.1.4 Structure and function of ABC transporters in health and disease<br />
Michael M Gottesman, (USA)<br />
11:40 - 11:55 FC02.1.5 Free Communication Presentation:<br />
A comparative genomics approach identifies the xenobiotic responsive enhancer as a<br />
crucial MDR1 upstream regulatory element<br />
Oliver Burk, (Germany), H Qiu, L Wojnowski, M Schwab<br />
11:55 - 12:10 FC02.1.6 Free Communication Presentation:<br />
The influence of drug transporter polymorphisms on atorvastatin and rousvastatin<br />
plasma concentrations in a patient population<br />
Marianne DeGorter, (Canada), R Hegele, U Schwarz, R Tirona, R Kim<br />
32 Monday 19 July ■ 09:30 - 12:15 ■ Hall A3
FC03<br />
Ion channels in analgesia and anaesthesia<br />
Organized by the British Pharmacological Society<br />
Leaders: Clifford J Wolf, (USA) & Nicholas Franks, (UK)<br />
FC03.1<br />
Ion channel drug targets in the sensory nerve<br />
Chairs: Peter McNaughton, (UK) & Sulayman D Dib-Hajj, (USA)<br />
09:30 - 09:55 FC03.1.1 Acid sensing ion channels in sensory perception<br />
Eric Lingueglia, (France)<br />
09:55 - 10:20 FC03.1.2 The role of TRP ion channels in pain and temperature sensation<br />
Ardem Patapoutian, (USA)<br />
10:20 - 10:45 FC03.1.3 Modulation of TRP channels: impact on pain sensation<br />
Peter A McNaughton, (UK)<br />
10:45 - 11:15 COFFEE BREAK<br />
11:15 - 11:40 FC03.1.4 Voltage sensitive sodium channels in chronic pain states<br />
Sulayman D Dib-Hajj, (USA)<br />
11:40 - 11:55 FC03.1.5 Free Communication Presentation:<br />
Molecular basis of peripheral blockade of inflammatory pain by opioids.<br />
Thiago Cunha, (Brazil), D Roman-Campos, C Lotufo, H Duarte, G Souza, W Verri Jr,<br />
S Chiavegatto, J Cruz, M Teixeira, J Hotershall, F Cunha, S Ferreira<br />
11:55 - 12:10 FC03.1.6 Free Communication Presentation:<br />
Analgesic actions of a potent sodium channel blocker, HFI-1, in a rat model of<br />
neuropathic pain due to spinal cord injury<br />
Bevyn Jarrott, (Australia), R Weston<br />
Monday 19 July ■ 09:30 - 12:15 ■ Meeting Room 20 33
FC04<br />
Pharmacoepidemiology, current controversies and<br />
opportunities<br />
Leaders: Bert Leufkens, (The Netherlands) & Jesper Hallas, (Denmark)<br />
FC04.1<br />
Methodological issues in pharmacoepidemiology<br />
Chairs: Til Stürmer, (USA) & Jesper Hallas, (Denmark)<br />
09:30 - 09:55 FC04.1.1 Immortal and immeasurable time biases in pharmacoepidemiology<br />
Samy Suissa, (Canada)<br />
09:55 - 10:20 FC04.1.2 Natural experiments in pharmacoepidemiology<br />
Olaf H Klungel, (The Netherlands)<br />
10:20 - 10:45 FC04.1.3 Treatment decisions and propensity scores<br />
Til Stürmer, (USA)<br />
10:45 - 11:15 COFFEE BREAK<br />
11:15 - 11:40 FC04.1.4 Healthy starters, sick stoppers, and the value of new user designs with active referents<br />
in pharmacoepidemiology<br />
Robert J Glynn, (USA), S Schneeweiss, T Sturmer<br />
11:40 - 11:55 FC04.1.5 Free Communication Presentation:<br />
Improved measure of patient's adherence based of prescription claims data<br />
Lucie Blais, (Canada), M-F Beauchesne, C Lemière, A Forget<br />
11:55 - 12:10 FC04.1.6 Free Communication Presentation:<br />
EU-ADR: Opportunities for large-scale drug safety monitoring using multiple healthcare<br />
databases<br />
Preciosa Coloma, (The Netherlands), M Schuemie, G Trifirò, R Gini, R Herings,<br />
J Hippisley-Cox, G Mazzaglia, C Giaquinto, G Corrao, L Pedersen, J van der Lei,<br />
M Sturkenboom<br />
34 Monday 19 July ■ 09:30 - 12:15 ■ Auditorium 11
FC05<br />
Translational science in the metabolic syndrome:<br />
Basic and clinical pharmacology<br />
Supported by an unrestricted grant from Novo Nordisk A/S, Denmark<br />
Leaders: Leif Groop, (Sweden), Henning Beck-Nielsen, (Denmark) &<br />
Jan-Erik Henriksen, (Denmark)<br />
FC05.1<br />
New molecular targets in metabolic syndrome<br />
Chairs: Anna Krook, (Sweden) & Jørgen Rungby, (Denmark)<br />
09:30 - 09:55 FC05.1.1 Adipose tissue, reducing inflammation as a means of targeting the metabolic syndrome<br />
Bjørn Richelsen, (Denmark), J Bruun, S Pedersen<br />
09:55 - 10:20 FC05.1.2 The muscle as a target for treatment of the metabolic syndrome<br />
Anna Krook, (Sweden)<br />
10:20 - 10:45 FC05.1.3 Sodium glucose co-transporter 2 inhibitors in the treatment of hyperglycaemia<br />
John PH Wilding, (UK)<br />
10:45 - 11:15 COFFEE BREAK<br />
11:15 - 11:40 FC05.1.4 Solute carrier family 30 proteins as targets for beta-cell stimulation<br />
Fabrice Chimienti, (France)<br />
11:40 - 11:55 FC05.1.5 Free Communication Presentation:<br />
Effect of tempol on insulin sensitivity and renal responses to angiotensin II and<br />
adrenergic agonists in fructose-fed rats<br />
Nor A Abdullah, (Malaysia), MH Abdulla, MZ Abdul Sattar, MAH Khan, EJ Johns<br />
11:55 - 12:10 FC05.1.6 Free Communication Presentation:<br />
Mitochondria mediated vasodilation and insulin resistance<br />
David Busija, (USA), P Katakam, A Institoris<br />
Monday 19 July ■ 09:30 - 12:15 ■ Auditorium 15 35
FC06<br />
The heart gone wrong:<br />
Stabilization of cardiac function<br />
Leaders: Michael C Sanguinetti, (USA) & Lionel H Opie, (South Africa)<br />
FC06.1<br />
Molecular mechanisms of arrhythmia<br />
Chairs: Michael Sanguinetti, (USA) & Søren-Peter Olesen, (Denmark)<br />
09:30 - 09:55 FC06.1.1 The cardiac hERG channel and arrhythmogenesis<br />
Michael Sanguinetti, (USA), M Perry, V Garg<br />
09:55 - 10:20 FC06.1.2 Would modulating intracellular Ca be antiarrhythmic<br />
Penelope A Boyden, (USA)<br />
10:20 - 10:45 FC06.1.3 Cardiac electrical remodeling in health and disease<br />
David S Rosenbaum, (USA)<br />
10:45 - 11:15 COFFEE BREAK<br />
11:15 - 11:40 FC06.1.4 Pharmacological modulation of cardiac potassium channels<br />
Søren-Peter Olesen, (Denmark), BH Bentzen, K Calloe, J Diness, M Grunnet, RS Hansen<br />
11:40 - 11:55 FC06.1.5 Free Communication Presentation:<br />
The B1-kinin receptor antagonism reduces the hypertrophic effects of angiotensin II in<br />
the cardiovascular system of rats<br />
Graziela S Ceravolo, (Brazil), TJ Costa, EH Akamine, R Tostes, ZB Fortes, MHC Carvalho<br />
11:55 - 12:10 FC06.1.6 Free Communication Presentation:<br />
Quercetin ameliorated isoproterenol-induced and post-infarction remodeling of rat heart:<br />
haemodynamic, genetic and morphological aspects<br />
Victor Dosenko, (Ukraine), M Kuzmenko, L Tumanovskaya, V Pavlyuchenko, S Kaplinskiy,<br />
V Gurianova, A Shalamai, A Moibenko<br />
36 Monday 19 July ■ 09:30 - 12:15 ■ Auditorium 12
FC07<br />
Simulation and data modelling in drug development.<br />
Better drugs faster<br />
Leaders: Hartmut Derendorf, (USA)<br />
FC07.1<br />
Modelling and simulation – how and why<br />
Chairs: Hans V Westerhoff, (The Netherlands) & Erik Mosekilde, (Denmark)<br />
09:30 - 09:55 FC07.1.1 Multiscale modelling of living systems: towards drugs and therapy<br />
Erik Mosekilde, (Denmark)<br />
09:55 - 10:20 FC07.1.2 Hitting robustness<br />
Hiroaki Kitano, (Japan)<br />
10:20 - 10:45 FC07.1.3 Identifying mechanisms of chronotolerance and chronoefficacy for anticancer drugs<br />
Albert Goldbeter, (Belgium), A Altinok, F Lévi<br />
10:45 - 11:15 COFFEE BREAK<br />
11:15 - 11:40 FC07.1.4 Using systems biology to develop better oncology drugs<br />
Birgit Schoeberl, (USA)<br />
11:40 - 11:55 FC07.1.5 Free Communication Presentation:<br />
Modelling and simulation of data from allostery at a simple pharmaco-dynamic level<br />
Niels Bindslev, (Denmark)<br />
Adis Journals are proud to be a<br />
Bronze Sponsor of <strong>WorldPharma</strong> <strong>2010</strong><br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
Visit us<br />
at Stand A-006<br />
Monday 19 July ■ 09:30 - 12:15 ■ Meeting Room 18/19 37
FC09<br />
Inflammation and immunopharmacology:<br />
New tools for old diseases<br />
Leaders: Salvador Moncada, (UK), Eeva Moilanen, (Finland),<br />
Ian Adcock,(UK) & Frans Nijkamp, (The Netherlands)<br />
FC09.1<br />
Steroids and beyond: novel treatments for asthma and allergy<br />
Chairs: Ian Adcock, (UK) & Hiromasa Inoue, (Japan)<br />
09:30 - 09:55 FC09.1.1 Improving current steroids<br />
Ian M Adcock, (UK)<br />
09:55 - 10:20 FC09.1.2 The mast cell as a target for anti-asthma drugs<br />
Christian Taube, (Germany)<br />
10:20 - 10:45 FC09.1.3 Effector and regulatory T cells in asthma<br />
Cezmi A Akdis, (Switzerland)<br />
10:45 - 11:15 COFFEE BREAK<br />
11:15 - 11:40 FC09.1.4 Suppressor of cytokine signaling in asthma<br />
Hiromasa Inoue, (Japan)<br />
11:40 - 11:55 FC09.1.5 Free Communication Presentation:<br />
MAP kinase phosphatase-1 as a novel anti-inflammatory target<br />
Riku Korhonen, (Finland), R Nieminen, T Turpeinen, V Taimi, AR Clark, E Moilanen<br />
11:55 - 12:10 FC09.1.6 Free Communication Presentation:<br />
Pitavastatin improves lung inflammation and survival in septic mice: prevention of<br />
reduced lung glucocorticoid receptors.<br />
Ken-ichi Takano, (Japan), S Yamamoto, K Tomita, H Yamazaki, H Yokoo, Y Takano,<br />
Y Hattori<br />
38 Monday 19 July ■ 09:30 - 12:15 ■ Hall A2
IN PHARMACOLOGY<br />
<br />
ACADEMIC PUBLISHING IN THE 21 ST CENTURY<br />
<br />
<br />
<br />
<br />
<br />
<br />
FRONTIERS IN ANALYTICAL<br />
AND EXPERIMENTAL<br />
PHARMACOLOGY<br />
Martin Michel and<br />
Salvatore Salomone<br />
FRONTIERS IN BIOPHARMACY<br />
AND DRUG DELIVERY SYSTEMS<br />
Véronique Préat<br />
FRONTIERS IN CLINICAL TRIALS<br />
AND PHARMACOTHERAPY<br />
Filippo Drago<br />
FRONTIERS IN DRUG DISCOVERY<br />
Markus Follmann<br />
FRONTIERS IN DRUG<br />
METABOLISM AND TRANSPORT<br />
Jaime Kapitulnik<br />
FRONTIERS IN<br />
ETHNOPHARMACOLOGY<br />
Michael Heinrich<br />
FRONTIERS IN<br />
G PROTEIN-COUPLED<br />
RECEPTOR PHARMACOLOGY<br />
R A John Challiss<br />
FRONTIERS IN<br />
GASTROINTESTINAL<br />
PHARMACOLOGY<br />
Gareth J Sanger<br />
FRONTIERS IN INTEGRATIVE<br />
PHARMACOLOGY<br />
Jerry Buccafusco †<br />
FRONTIERS IN<br />
NEUROPHARMACOLOGY<br />
Nicholas M Barnes<br />
FRONTIERS IN<br />
PAIN PHARMACOLOGY<br />
Giustino Varrassi<br />
FRONTIERS IN PEDIATRIC<br />
CLINICAL PHARMACOLOGY<br />
Gérard Pons<br />
FRONTIERS IN<br />
PHARMACOECONOMICS<br />
AND HEALTH OUTCOMES<br />
Dominique Dubois<br />
FRONTIERS IN<br />
PHARMACOGENETICS<br />
Ulrich Zanger<br />
FRONTIERS IN PHARMACOLOGY<br />
OF ION CHANNEL AND<br />
CHANNELOPATHIES<br />
Philippe Lory and Diana Conte<br />
FRONTIERS IN PHARMACOLOGY<br />
OF NATURAL PRODUCTS<br />
Ding-Feng Su<br />
www.frontiersin.org<br />
FRONTIERS IN<br />
PHARMACOLOGY OF<br />
THROMBOSIS<br />
Bianca Rocca<br />
FRONTIERS IN<br />
PHARMACOTHERAPY<br />
OF CARDIOVASCULAR<br />
DISORDERS<br />
Eliot Ohlstein<br />
FRONTIERS IN<br />
PHARMACOTHERAPY OF<br />
INFLAMMATION<br />
Paola Patrignani<br />
FRONTIERS IN<br />
PHARMACOTHERAPY OF<br />
NEOPLASTIC DISEASES<br />
Olivier Feron<br />
FRONTIERS IN<br />
PREDICTIVE TOXICITY<br />
Olavi Pelkonen<br />
FRONTIERS IN<br />
SIGNAL TRANSDUCTION<br />
PHARMACOLOGY<br />
Vincent Laudet
W02<br />
Symposium on advances in GI pharmacology<br />
Organized by: IUPHAR Gastrointestinal Pharmacology Section<br />
Leader: Sando Szabo, (USA)<br />
Part II – Advances in GI pharmacology: From functional to structural<br />
disease targets<br />
Chairs: Sandor Szabo, (USA) & Koji Takeuchi, (Japan)<br />
09:30 - 09:35 W02.2.1 GI pharmacology: the importance of bench-to-bedside-and-back concept<br />
Duan Chen, (Norway)<br />
09:35 - 10:00 W02.2.2 The changing organ/disease targets & new molecular mechanisms in GI pharmacology<br />
Sandor Szabo, (USA)<br />
10:00 - 10:25 W02.2.3 The evolution of proton pump inhibitors: lansoprazole protects the gastrointestinal<br />
mucosa by a mechanism unrelated to antisecretory action<br />
Hiroshi Satoh, (Japan), K Amagase, K Takeuchi<br />
10:25 - 10:50 COFFEE BREAK<br />
10:50 - 11:15 W02.2.4 Prostaglandin EP receptors and their roles in mucosal protection and ulcer healing in<br />
gastrointestinal tract<br />
Koji Takeuchi, (Japan)<br />
11:15 - 11:40 W02.2.5 Glucocorticoids ARE gastroprotective – in physiologic conditions<br />
Ludmila Filaretova, (Russian Federation)<br />
11:40 - 11:55 W02.2.6 CYP2C9*3 is a potent risk factor for NSAID induced gastrointestinal bleeding<br />
Laurent Becquemont, (France), N Carbonell, C Verstuyft, J Massard, A Letierce,<br />
C Cellier, L Deforges, F Saliba, JC Delchier<br />
11:55 - 12:10 W02.2.7 New pharmacologic approach to ulcerative colitis (UC): novel use of D2 dopamine<br />
receptor (D2R) agonists<br />
Ganna Tolstanova, (Ukraine), X Deng, T Kaplan, B Paunovic, S Szabo, Z Sandor<br />
12:15 - 12:45 LUNCH BREAK<br />
40 Monday 19 July ■ 09:30 - 12:15 ■ Meeting Room BV 1/2/3
W02<br />
Symposium on advances in GI pharmacology<br />
Organized by: IUPHAR Gastrointestinal Pharmacology Section<br />
Leader: Sando Szabo, (USA)<br />
Part III – Advances in GI pharmacology: from functional to structural<br />
disease targets<br />
Chairs: Sandor Szabo, (USA) & Koji Takeuchi, (Japan)<br />
12:45 - 13:10 W02.3.1 The pentadecapeptide BPC 157 is the new drug effective both in the upper & lower GI<br />
tract<br />
Predrag Sikiric, (Croatia), S Seiwerth, R Rucman, B Turkovic<br />
13:10 - 13:35 W02.3.2 Modern pharmacologic approaches to IBS<br />
Yvett Taché, (USA)<br />
13:35 - 14:00 W02.3.3 Recent developments in IBD therapy<br />
Gaetano Iaquinto, (Italy)<br />
Monday 19 July ■ 12:45 - 14:15 ■ Meeting Room BV 1/2/3 41
SS01<br />
Sponsored symposium<br />
Sponsored by AstraZeneca Italy<br />
Benefit/risk ratio of antipsychotics: How to improve the effectiveness of<br />
our therapeutic armamentarium<br />
Chairs: Charles Marsden, (UK) & Filippo Drago, (Italy<br />
12:45 - 13:10 SS01.1 Benefit/risk ratio: The mirror of their clinical value<br />
Michael Davidson, (Israel)<br />
13:10 - 13:20 SS01.2 Safety of antipsychotics:pharmacovigilance and regulatory commitments<br />
Christina Sampaio, (Portugal)<br />
13:20 - 13:40 SS01.3 Receptor occupancy as a criterion for the assessmentof antipsychotics benefit/risk ratio<br />
Marco A Riva, (Italy)<br />
13:40 - 14:00 SS01.4 New drug delivery models: how do they improve antipsychotics benefit/risk ratio<br />
Luca Pani, (Italy)<br />
42 Monday 19 July ■ 12:45 - 14:15 ■ Hall A2
W05<br />
Workshop. Clinical trials across Europe and the role<br />
of pharmacologists<br />
Organized by: Turkish Pharmacological Society<br />
Leader: Hakki Zafer Güney, (Turkey)<br />
Clinical trials across Europe and the role of pharmacologists<br />
Chair: H Zafer Güney, (Turkey)<br />
12:45 - 13:05 W05.1 Clinical trials across Europe and the role of pharmacologists<br />
Hakki Zafer Güney, (Turkey)<br />
13:05 - 13:25 W05.2 Role of pharmacologists in pharmaceutical companies in drug development and<br />
utilisation<br />
Ugur Özkutlu, (Switzerland)<br />
13:25 - 13:45 W05.3 Alternative strategies and trial design for early drug development in oncology – do we<br />
know what we are doing<br />
Volker Wacheck, (Austria)<br />
13:45 - 14:05 W05.4 The role of clinical pharmacologists in expertorganizations recommending drugs for the<br />
greater Stockholm area<br />
Carl-Olav Stiller, (Sweden)<br />
Monday 19 July ■ 12:45 - 14:15 ■ Hall A3 43
W06<br />
Workshop. Effect of disease on cytochrome p450<br />
and membrane transporters<br />
Organized by: Canadian Society of Pharmacology and Therapeutics<br />
Leader: Patrick du Souich, (Canada)<br />
Effect of disease on cytochrome p450 and membrane transporters<br />
Chairs: Patrick du Souich, (Canada) & Micheline Piquette-Miller, (Canada)<br />
12:45 - 13:00 W06.1 Regulation of cytochrome P450s in inflammation<br />
Edward T Morgan, (USA)<br />
13:00 - 13:15 W06.2 Inflammation-mediated alterations on drug transporters; implications on therapeutic drug<br />
response<br />
Micheline Piquette-Miller, (Canada)<br />
13:15 - 13:30 W06.3 Altered drug metabolism and transport in cancer and cachexia<br />
Graham R Robertson, (Australia), A Painter, L Jankova, J Chick, M Kacevska, M Tsoli,<br />
R Taylor, M Baker, C Liddle, M Molloy, S Clarke<br />
13:30 - 13:45 W06.4 Evidence of the impact of kidney disease on drug metabolism and transport<br />
Vincent Pichette, (Canada)<br />
13:45 - 14:00 W06.5 Clinical and therapeutic repercussions of disease-induced down-regulation of the<br />
cytochrome P450 and of membrane transporters<br />
Patrick du Souich, (Canada)<br />
44 Monday 19 July ■ 12:45 - 14:15 ■ Auditorium 15
W07<br />
Workshop. Circadian clocks for drug development<br />
and therapeutics<br />
Organized by: Institut National de la Santé et de la Recherche<br />
Médicale (INSERM), (France)<br />
Leader: Francis Lévi, (France)<br />
Circadian clocks for drug development and therapeutics<br />
Chairs: Francis Lévi, (France) & Francesco Scaglione, (Italy)<br />
12:45 - 13:00 W07.1 Chronopharmacology of cardiovascular agents<br />
Bjoern Lemmer, (Germany)<br />
13:00 - 13:15 W07.2 The circadian timing system: implications for the personalization of anticancer drug<br />
delivery<br />
Francis Lévi, (France)<br />
13:15 - 13:30 W07.3 Relevance of circadian timing for the development of cyclin dependent kinase inhibitors<br />
Moustapha Hassan, (Sweden)<br />
13:30 - 13:45 W07.4 Mathematical modelling of cell proliferation, circadian rhythm and pharmacokineticspharmacodynamics<br />
to optimise cancer treatments<br />
Jean Clairambault, (France)<br />
13:45 - 14:15 W07.5 Mathematical chronoPK-PD models for tailoring chronotherapeutics –<br />
Round Table Discussion<br />
Francesco Scaglione, (Italy)<br />
Monday 19 July ■ 12:45 - 14:15 ■ Auditorium 10 45
W08<br />
Workshop. Identifying targets for treating vascular<br />
diseases associated to metabolic disorders<br />
Organized under the auspices of Universidad Autónoma de Madrid<br />
Leader: Concepción Peiró, (Spain)<br />
Identifying targets for treating vascular diseases associated to metabolic<br />
disorders<br />
Chairs: Carlos F Sánchez-Ferrer, (Spain) & Ramaronson Andriantsitahoina, (France)<br />
12:45 - 13:00 W08.1 Adipokines as regulators of vascular function<br />
Concepción Peiró, (Spain)<br />
13:00 - 13:15 W08.2 Different facets of microparticles in the metabolic syndrome<br />
Ramaronson Andriantsitahoina, (France)<br />
13:15 - 13:30 W08.3 Which role for high glucose in vascular inflammation<br />
Carlos F Sánchez-Ferrer, (Spain)<br />
13:30 - 13:45 W08.4 Vascular actions of insulin<br />
Monica Montagnani, (Italy)<br />
13:45 - 14:00 W08.5 Statins as vascular anti-inflammatory drugs<br />
Maria-Jesus Sanz, (Spain)<br />
46 Monday 19 July ■ 12:45 - 14:15 ■ Auditorium 11
W09<br />
Workshop. Blood cells and cytokines as emerging<br />
targets for cardiovascular pharmacology<br />
Organized by: Spanish Pharmacology Society (SPS)<br />
Leader: Teresa Tejerina, (Spain)<br />
Blood cells and cytokines as emerging targets for cardiovascular<br />
pharmacology<br />
Chairs: Maria José Alcaraz, (Spain) & Santiago Redondo, (Spain)<br />
12:45 - 13:00 W09.1 Cytokines and inflammatory disease<br />
Maria José Alcaraz, (Spain)<br />
13:00 - 13:15 W09.2 Chemokines as therapeutic targets in atherosclerosis<br />
Christian Weber, (Germany)<br />
13:15 - 13:30 W09.3 Cell response of TGF-beta takes central stage in therapeutical design<br />
Santiago Redondo, (Spain)<br />
13:30 - 13:45 W09.4 Tumour suppressor genes and cardiovascular diseases<br />
Vincente Andrés, (Spain), H González-Navarro, JJ Fuster, Y Naim Abu Nabah, A Vinué,<br />
KI Nakayama, K Nakayama, A Díez-Juan, C Rodríguez, J Martínez-González, M Collado,<br />
M Serrano<br />
13:45 - 14:00 W09.5 Stem cell therapy for myocardial repair<br />
Francisco Fernandez-Aviles, (Spain)<br />
Monday 19 July ■ 12:45 - 14:15 ■ Auditorium 12 47
W10<br />
Workshop. Innovative Medicines Initiative:<br />
A new approach to education & training in<br />
medicines research in Europe<br />
Organized by: Austrian Pharmacological Society (APHAR)<br />
Leader: Michael Wolzt, (Austria)<br />
Innovative Medicines Initiative: a new approach to education & training in<br />
medicines research in Europe<br />
Chairs: Michael Wolzt, (Austria) & Michel Goldman, (Belgium)<br />
12:45 - 13:05 W10.1 EMTRAIN – European Medicines Research Training Network<br />
Michael Hardman, (UK), J Demotes, I Steneker, M Wolzt on behalf of the EMTRAIN<br />
Consortium<br />
13:05 - 13:25 W10.2 SafeSciMET – European modular education and training programme in Safety Sciences<br />
for Medicine<br />
Theodor Guentert, (Switzerland), N Vermeulen, L Cornes, L Dencker, P Detilleux,<br />
D Dietrich, J Dierach, A Hartmann, H Linden, DR Newal, S Price, C Vos on behalf of the<br />
SafeSciMET Consortium<br />
13:25 - 13:45 W10.3 PharmaTrain – pharmaceutical medicines training programme<br />
Fritz R Bühler, (Switzerland), M Hardman, R Bass, J-M Boeynaems, A Chan, S Daniel,<br />
K Donaldson, M Gottwald, R Hargreaves, J-M Husson, S Kerpel-Fronius, I Klingmann,<br />
J Lahuerta, A Mollet, G Nell on behalf of the PharmaTrain Consortium<br />
13:45 - 14:05 W10.4 EU2P – European programme for pharmacovigilance & pharmacoepidemiology<br />
Deborah Szafir, (France), A Fourrier-Réglat on behalf of the Eu2P Consortium<br />
48 Monday 19 July ■ 12:45 - 14:15 ■ Meeting Room 18/19
W11<br />
Workshop. New opportunities in the pharmacology<br />
of neuro-immune interactions<br />
Organized by: The Federation of European Pharmacological Societies<br />
(EPHAR)<br />
Leaders: Ulrich Förstermann, (Germany) & Aletta D Kraneveld,<br />
(The Netherlands)<br />
New opportunities in the pharmacology of neuro-immune interactions<br />
Chairs: Aletta D. Kraneveld, (The Netherlands) & Thomas Griesbacher, (Austria)<br />
12:45 - 13:10 W11.1 Cytokine-induced sickness behaviour: mechanisms and implications<br />
Jan-Pieter Konsman, (France)<br />
13:10 - 13:35 W11.2 Neuropeptide receptors in the control of pain and inflammation: focus on migraine<br />
Pierangelo Geppetti, (Italy)<br />
13:35 - 14:00 W11.3 Gut-brain and brain-gut axis revisited: possible implications in IBD and food allergy<br />
Aletta D Kraneveld, (The Netherlands)<br />
Monday 19 July ■ 12:45 - 14:15 ■ Meeting Room 20 49
FC01<br />
Clinical pharmacology in the emerging countries<br />
Leader: Lembit Rägo, (Switzerland)<br />
FC01.2<br />
Clinical pharmacology and drug regulation in resource limited settings<br />
Chair: Alar Irs, (Estonia)<br />
14:30 - 14:55 FC01.2.1 Regulatory clinical pharmacologist – an ambassador of sanity<br />
Alar Irs, (Estonia)<br />
14:55 - 15:20 FC01.2.2 Objective drug information versus advertising<br />
Krisantha Weerasuriya, (India)<br />
15:20 - 15:45 FC01.2.3 Drug utilisation monitoring: Planning interventions and guiding selection<br />
Vera Vlahovic-Palèevski, (Croatia)<br />
15:45 - 16:15 COFFEE BREAK<br />
16:15 - 16:40 FC01.2.4 Advise on drug reimbursement issues: A developing country perspective<br />
Victor Zarate, (UK)<br />
16:40 - 16:55 FC01.2.5 Free Communication Presentation:<br />
Pharmacokinetics of isoniazid in Ethiopian Children with tuberculosis in relation to the<br />
N-acetyltransferase genotype<br />
Ephrem Engidawork, (Ethiopia), M Ibrahim, G Yimer, K Babosha, A Assefa<br />
16:55 - 17:10 FC01.2.6 Free Communication Presentation:<br />
Beneficial effects of ispaghula husk in newly diagnosed patients of type 2 diabetes<br />
mellitus<br />
Jaspal Singh Gill, (India), J Rai, PK Gill, S Singh<br />
50 Monday 19 July ■ 14:30 - 17:15 ■ Auditorium 10
FC02<br />
Transmembrane Transport:<br />
Perspectives for disease and drug discovery<br />
Supported by an unrestricted grant from Novo Nordisk Foundation<br />
Leaders: Randy Blakely, (USA) & Richard Kim, (Canada)<br />
FC02.2<br />
Membrane transporters and disease<br />
Chairs: Heidrun Potschka, (Germany) & Søren Nielsen, (Denmark)<br />
14:30 - 14:55 FC02.2.1 ABC transporters in adaptive immunity<br />
Robert Tampé, (Germany)<br />
14:55 - 15:20 FC02.2.2 Aquaporines and disease<br />
Søren Nielsen, (Denmark)<br />
15:20 - 15:45 FC02.2.3 Multidrug resistance in human epilepsy<br />
Heidrun Potschka, (Germany)<br />
15:45 - 16:15 COFFEE BREAK<br />
16:15 - 16:40 FC02.2.4 The regulation and dysregulation of neurotransmitter transport into synaptic vesicles<br />
Robert H Edwards, (USA), T Hnasko, G Goh<br />
16:40 - 16:55 FC02.2.5 Free Communication Presentation:<br />
Gemfibrozil inhibits epithelial cAMP transport<br />
Gerda Majgaard Jensen, (Denmark), J Meyer, K Kleberg, N Bindslev<br />
16:55 - 17:10 FC02.2.6 Free Communication Presentation:<br />
Transport of mycophenolic acid (MPA) and its glucuronides by OATP1B1*1a and its<br />
variant OATP1B1*5<br />
Joerg Koenig, (Germany), H Michelon, L Becquemont, MF Fromm<br />
Monday 19 July ■ 14:30 - 17:15 ■ Hall A3 51
FC03<br />
Ion channels in analgesia and anaesthesia<br />
Organized by the British Pharmacological Society<br />
Leaders: Clifford J Wolf, (USA) & Nicholas Franks, (UK)<br />
FC03.2<br />
Voltage-operated calcium channels as targets for analgesic action<br />
Chairs: Annette Dolphin, (UK) & Terrance P Snutch, (Canada)<br />
14:30 - 14:55 FC03.2.1 The slow-inactivation modulation of selective sodium and calcium channel isoforms<br />
attenuates neuropathic and acute pain signalling by reducing excitability of both<br />
peripheral nociceptors and dorsal horn spinal cord neurons<br />
Terrance P Snutch, (Canada)<br />
14:55 - 15:20 FC03.2.2 Pharmacological regulation of T-type calcium channels in peripheral pain pathways<br />
Slobodan M Todorovic, (USA)<br />
15:20 - 15:45 FC03.2.3 Identification of T-type calcium channel blockers<br />
Emmanuel Bourinet, (France)<br />
15:45 - 16:15 COFFEE BREAK<br />
16:15 - 16:40 FC03.2.4 Calcium channel α2δ subunits, dysregulation in disease and therapeutic target<br />
Annette Dolphin, (UK), C Bauer, A Tran-Van-Minh, J Hendrich, I Kadurin, A Alvarez-Laviada<br />
16:40 - 16:55 FC03.2.5 Free Communication Presentation:<br />
Peripheral hyperalgesia via the cyclic AMP/protein kinase A pathway involves activation<br />
of T-type calcium channels in rats<br />
Atsufumi Kawabata, (Japan), Y Aoki, F Sekiguchi, M Nakagawa, D Kanaoka, S Yoshida<br />
16:55 - 17:10 FC03.2.6 Free Communication Presentation:<br />
Innovative approaches for screening TRPV1 antagonists using noxious heat as a stimulus<br />
for opening the channel<br />
Marianthi Papakosta, (UK), J De Cock, R Lane, A Alderton, A Dunlop, A Haythornthwaite,<br />
R Ward, R Russell<br />
52 Monday 19 July ■ 14:30 - 17:15 ■ Meeting Room 20
FC04<br />
Pharmacoepidemiology, current controversies and<br />
opportunities<br />
Leaders: Bert Leufkens, (The Netherlands) & Jesper Hallas, (Denmark)<br />
FC04.2<br />
Approaches to screening electronic medical records and claims data<br />
Chair: Andrew Bate, (USA)<br />
14:30 - 14:55 FC04.2.1 Approaches to screening electronic medical records and claims data<br />
Andrew Bate, (USA), RF Reynolds<br />
14:55 - 15:20 FC04.2.2 The Observational Medical Outcome Partnership (OMOP) initiative. What it is, its<br />
importance and results so far<br />
Abraham G Hartzema, (USA)<br />
15:20 - 15:45 FC04.2.3 An international perspective on screening for adverse effects of drugs and vaccines –<br />
how far can and should active surveillance go<br />
Stephen JW Evans, (UK)<br />
15:45 - 16:15 COFFEE BREAK<br />
16:15 - 16:30 FC04.2.4 Free Communication Presentation:<br />
Ethnic disparities in initiation and persistence to statin treatment in patients with<br />
diabetes: A nationwide 10-year follow-up study<br />
Helena Dominguez, (Denmark), TK Schramm, GH Gislason, ML Nørgaard, J Raunsø,<br />
SZ Abildstrøm, L Køber, HE Poulsen, C Torp-Pedersen<br />
16:30 - 16:45 FC04.2.5 Free Communication Presentation:<br />
First trimester exposure to tramadol: a prospective comparative study<br />
Aurore Gouraud, (France), MN Beyens, M Boyer, P Carlier, MA Thompson, C Garayt,<br />
N Bernard, T Vial<br />
16:45 - 17:00 FC04.2.6 Free Communication Presentation:<br />
SALT-I (Study of Acute Liver Transplant): A study of NSAID-exposed acute liver failure in<br />
European transplant centres<br />
Sinem Ezgi Gulmez, (France), S Lignot-Maleyran, C de Vries, MCJM Sturkenboom,<br />
S Perez-Gutthann, J Bénichou, F Bissoli, D Larrey, GP Pageaux, Y Horsmans, J Bernuau,<br />
B Stricker, D Thorburn, P Blin, N Moore, on behalf of SALT-I team<br />
17:00 - 17:15 FC04.2.7 Free Communication Presentation:<br />
Preadmission antidiabetic treatments and mortality after ischemic stroke in patients with<br />
diabetes mellitus: a nationwide population-based follow-up study<br />
Henriette Thisted Horsdal, (Denmark), F Mehnert, J Rungby, SP Johnsen<br />
Monday 19 July ■ 14:30 - 17:15 ■ Auditorium 11 53
FC05<br />
Translational science in the metabolic syndrome:<br />
Basic and clinical pharmacology<br />
Supported by an unrestricted grant from Novo Nordisk A/S, Denmark<br />
Leaders: Leif Groop, (Sweden), Henning Beck-Nielsen, (Denmark) &<br />
Jan-Erik Henriksen, (Denmark)<br />
FC05.2<br />
Translational science in the metabolic syndrome: Basic and clinical<br />
pharmacology<br />
Chairs: Patricia Iozzo, (Finland) & Hans Erik Bøtker, (Denmark)<br />
14:30 - 14:55 FC05.2.1 Insulin resistance: Marker or mediator of increased cardiovascular risk<br />
Heinrich Taegtmeyer, (USA)<br />
14:55 - 15:20 FC05.2.2 Pathophysiology and treatment of heart failure in patients with type 2 DM<br />
Paolo G Camici, (UK)<br />
15:20 - 15:45 FC05.2.3 Antithrombotic treatment in patients with type 2 DM<br />
Steen Dalby Kristensen, (Denmark)<br />
15:45 - 16:15 COFFEE BREAK<br />
16:15 - 16:40 FC05.2.4 Polypharmacy in type 2 diabetes: significance of drug interactions<br />
Janne T Backman, (Finland)<br />
16:40 - 16:55 FC05.2.5 Free Communication Presentation:<br />
Effect of GLP-1 agonist exendin-4 on pharmacological effects of morphine<br />
Anil Gulati, (USA), M Lavhale, S Briyal, G Matwyshyn, S Sharma<br />
16:55 - 17:10 FC05.2.6 Free Communication Presentation:<br />
Muscle specific ablation of LKB1 impairs cardiac function<br />
Niels Jessen, (Denmark), Ho-Jin Koh, CD Folmes, C Wagg, N Fujii, MF Hirshman,<br />
GD Lopaschuk, LJ Goodyear<br />
54 Monday 19 July ■ 14:30 - 17:15 ■ Auditorium 15
R&D at a glance<br />
engineering<br />
proteins into<br />
superior therapies<br />
World-class competence within<br />
recombinant protein technology<br />
Leader within insulin therapies for<br />
diabetes<br />
Discoverer of recombinant human<br />
factor VIIa used as haemostatic<br />
agent, NovoSeven ®<br />
<br />
pre-mixed human growth hormone<br />
delivered in a dedicated pen system,<br />
Norditropin SimpleXx ®<br />
1,003<br />
DKK 8<br />
15%<br />
5,200<br />
160,000 L<br />
active patent<br />
families<br />
billion is our<br />
R&D spend<br />
of revenues are<br />
invested in R&D<br />
4,600 people<br />
work with R&D<br />
is the scale up to which<br />
we express proteins<br />
Novo Nordisk is a healthcare company and a world leader in diabetes care. In<br />
addition, Novo Nordisk has a leading position within areas such as haemostasis<br />
management, growth hormone therapy and hormone replacement therapy.<br />
Novo Nordisk manufactures and markets pharmaceutical products and<br />
services that make a significant difference to patients, the medical profession<br />
and society. With headquarters in Denmark, Novo Nordisk employs more than<br />
29,300 employees in 76 countries, and markets its products in 179 countries.<br />
Novo Nordisk’s B shares are listed on the stock exchanges in Copenhagen and<br />
London. Its ADRs are listed on the New York Stock Exchange under the symbol<br />
‘NVO’. For more information, visit:<br />
www.novonordisk.com/rd
FC06<br />
The heart gone wrong:<br />
Stabilization of cardiac function<br />
Leaders: Michael C Sanguinetti, (USA) & Lionel H Opie, (South Africa)<br />
FC06.2<br />
Novel anti-arrhythmics<br />
Chairs: Leif Carlsson, (Sweden) & Søren Peter Olesen (Denmark)<br />
14:30 - 15:15 FC06.2.1 Novel principles for pharmacological treatment of atrial fibrillation<br />
Leif Carlsson, (Sweden)<br />
15:15 - 15:45 FC06.2.2 Effect of dronedarone at rest and on exercise in patients with permanent atrial fibrillation<br />
Jean-Marc Davy, (France)<br />
15:45 - 16:15 COFFEE BREAK<br />
16:15 - 16:40 FC06.2.4 Kv1.5 blockers for atrial fibrillation<br />
Eva Delpón, (Spain)<br />
16:40 - 16:55 FC06.2.5 Free Communication Presentation:<br />
Hypertension induced microRNA changes in the rat heart<br />
Tilde Eskildsen, (Denmark), AY Nossent, M Schneider, D Andersen, M Sandberg,<br />
H Jensen, P Jeppesen, B Jensen, P Bie, S Sheikh<br />
16:55 - 17:10 FC06.2.6 Free Communication Presentation:<br />
Association of DDAH2 gene polymorphism with cardiovascular disease in Egyptian<br />
patients<br />
Mohamed Gad, (Egypt), S Hassanein, S Abdel-Maksoud, G Shaban, H Elgabarty<br />
56 Monday 19 July ■ 14:30 - 17:15 ■ Auditorium 12
FC07<br />
Simulation and data modelling in drug development.<br />
Better drugs faster<br />
Leaders: Hartmut Derendorf, (USA)<br />
FC07.2<br />
Disease models – using virtual organs and patient populations<br />
Chairs: Hartmut Derendorf, (USA) & Amin Rostami-Hodjegan, (UK)<br />
14:30 - 14:55 FC07.2.1 Can we predict pharmacokinetics (PK) in disease populations<br />
Amin Rostami-Hodjegan, (UK)<br />
14:55 - 15:20 FC07.2.2 Integrated models for the glucose – insulin system<br />
Mats O Karlsson, (Sweden)<br />
15:20 - 15:45 FC07.2.3 Heart modelling in drug development<br />
Blanca Rodriguez, (UK)<br />
15:45 - 16:15 COFFEE BREAK<br />
16:15 - 16:40 FC07.2.4 From circadian control of PK/PD to personalized cancer chemotherapy and<br />
chronotherapeutics<br />
Francis Lévi, (France)<br />
16:40 - 16:55 FC07.2.5 Free Communication Presentation:<br />
Target mediated disposition – the central clearance mechanism for anti-IL13R huMAb<br />
clinical pharmacokinetics<br />
Yue Huang, (USA), P Lu, J-E Charoin<br />
Monday 19 July ■ 14:30 - 17:15 ■ Meeting Room 18/19 57
FC08<br />
Development in the treatment of sexual dysfunction<br />
and diseases of the lower urinary tract<br />
Leaders: Karl-Erik Andersson, (USA) & Francois Giuliano, (France)<br />
FC08.1<br />
Treatment of sexual dysfunction associated with cardiovascular disease<br />
Chairs: Graham Jackson, (UK) & Ulf Simonsen, (Denmark)<br />
14:30 - 14:55 FC08.1.1 Animal models for sexual dysfunction and cardiovascular disease<br />
Delphine Behr-Roussel, (France)<br />
14:55 - 15:20 FC08.1.2 The promise of Rho kinase inhibitors in the treatment of cardiovascular and sexual<br />
dysfunction<br />
Kanchan Chitaley, (USA)<br />
15:20 - 15:45 FC08.1.3 Treatment of sexual dysfunction associated with cardiovascular disease<br />
Graham Jackson, (UK)<br />
15:45 - 16:15 COFFEE BREAK<br />
16:15 - 16:40 FC08.1.4 Effects of cardiovascular drugs on sexual function<br />
Javier Angulo, (Spain)<br />
16:40 - 17:00 FC08.1.5 Phosphodiesterase type 5 and inhibitors – an update<br />
Jackie D Corbin, (USA)<br />
17:00 - 17:15 FC08.1.6 Free Communication Presentation:<br />
Expression of connexins and neurochemical receptors in human detrusor: differences in<br />
gender and in multiple sclerosis<br />
Elizabeth Burcher, (Australia), F Shang, L Liu, K Vaux, R Millard<br />
58 Monday 19 July ■ 14:30 - 17:15 ■ Meeting Room BV 1/2/3
FC09<br />
Inflammation and immunopharmacology:<br />
New tools for old diseases<br />
Leaders: Salvador Moncada, (UK), Eeva Moilanen, (Finland),<br />
Ian Adcock, (UK) & Frans Nijkamp, (The Netherlands)<br />
FC09.2<br />
Biologicals in inflammatory diseases – successes, promises and problems<br />
Chair: Marc Feldmann, (UK) & Ian Ahnfelt-Rønne, (Denmark)<br />
14:30 - 14:55 FC09.2.1 TNF-α antagonists – translating molecular insights in autoimmunity into effective therapy<br />
Marc Feldmann, (UK)<br />
14:55 - 15:20 FC09.2.2 Immunomodulatory drugs in multiple sclerosis – from interferon β to specific monoclonal<br />
antibodies<br />
Roland Martin, (Germany)<br />
15:20 - 15:45 FC09.2.3 Immunogenicity and other problems in the use of biologicals<br />
Michael G Tovey, (France), C Lallemand<br />
15:45 - 16:15 COFFEE BREAK<br />
16:15 - 16:30 FC09.2.4 Free Communication Presentation:<br />
Similar effects of disease modifying anti rheumatic drugs, glucocorticoids and biologics<br />
on radiographic progression in rheumatoid arthritis. Meta-analysis of 70 randomised<br />
placebo or drug controlled studies including 112 comparisons<br />
Niels Graudal, (Denmark), G Jürgens<br />
16:30 - 16:45 FC09.2.5 Free Communication Presentation:<br />
Predictive value of pretreatment adipocytokine levels for remission rates in early RA<br />
treated with DMARDs and infliximab<br />
Katriina Vuolteenaho (Finland), P Hannonen, M Kauppi, M Korpela, T Möttönen,<br />
O Kaipiainen-Seppänen, H Kautiainen, R Nieminen, T Levälampi, M Leirisalo-Repo<br />
16:45 - 17:00 FC09.2.6 Test for neutralising antibodies in hemophilia<br />
Matthias Germer, (Germany)<br />
17:00 - 17:15 FC09.2.7 Free Communication Presentation:<br />
Adverse effects of rituximab in non oncological patients<br />
Aurore Gouraud, (France), L Moachon, G Miremont, MJ Pastor, C Villier, J Descotes,<br />
T Vial<br />
Monday 19 July ■ 14:30 - 17:15 ■ Hall A2 59
Plenary lectures<br />
PL04<br />
Plenary lecture, Hall A2<br />
Chair: Jørgen Matz, (Denmark)<br />
17:30 - 18:15 PL04 The challenges of the pharmaceutical industry in the 21st centure<br />
Emmanuel Canet, (France)<br />
PL05<br />
Plenary lecture, Hall A3<br />
Chair: Jørgen Søberg Petersen, (Denmark)<br />
17:30 - 18:15 PL05 Cell therapy<br />
Stefanie Dimmeler, (Germany<br />
PL06 Plenary lecture, Auditorium 15<br />
Chair: Ulf Simonsen, (Denmark<br />
17:30 - 18:15 PL06 The complex effects of 5-hydroxytryptamine in the cardiovascular system<br />
Carlos Villalon, (Mexico)<br />
Reception at Copenhagen City Hall<br />
Monday 19 July 19:30 - 21:00<br />
60 Monday 19 July ■ 17:30 - 18:15
FC01<br />
Clinical Plenary pharmacology lectures in the emerging countries<br />
Leader: Lembit Rägo (Switzerland)<br />
PL07<br />
EACPT plenary lecture, Hall A2<br />
Chair: Ingolf Cascorbi, (Germany)<br />
08:30 - 09:15 PL07 Personalized medicine beyond pharmacogenetics<br />
Matthias Schwab, (Germany<br />
PL08<br />
Plenary lecture, Hall A3<br />
Chair: Mohammed T Khayyal, (Egypt)<br />
08:30 - 09:15 PL08 The Health Impact Fund: Making new medicines more accessible also for the poor<br />
Thomas Pogge, (USA)<br />
PL09 Plenary lecture, Auditorium 15<br />
Chair: Gabriella Hawksworth, (UK)<br />
08:30 - 09:15 PL09 Antioxidants & free radicals, good or bad<br />
Barry Halliwell, (Singapore)<br />
Tuesday 20 July ■ 08:30 - 09:15 61
FC01<br />
Clinical pharmacology in the emerging countries<br />
Leader: Lembit Rägo, (Switzerland)<br />
FC01.3<br />
Clinical trials in countries with developing and emerging economies<br />
Chair: Lembit Rägo, (Switzerland)<br />
09:30 - 09:55 FC01.3.1 Global drug development in Singapore: regulatory perspective<br />
Yang-Tong Foo, (Singapore)<br />
09:55 - 10:20 FC01.3.2 Ethical issues related to the clinical trials outside ICH regions.<br />
Juntra Karbwang-Laothavorn, (Switzerland)<br />
10:20 - 10:45 FC01.3.3 Clinical trials registries in countries with emerging and developing economies<br />
Davina Ghersi, (Switzerland)<br />
10:45 - 11:15 COFFEE BREAK<br />
11:15 - 11:30 FC01.3.4 Free Communication Presentation:<br />
The role of CYP2B6 genetic polymorphisms in predicting toxicity from cyclophosphamide<br />
based therapy in Lebanese patients with breast cancer or Non-Hodgkin’s Lymphoma<br />
F Haroun, H Hatoum, A Bazarbachi, A Shamseddin, Z Salem, A Taher, N El Saghir,<br />
A Tfayli, Nathalie Zgheib, (Lebanon)<br />
11:30 - 11:45 FC01.3.5 Free Communication Presentation:<br />
Evaluation of the effect of intramuscular dexamethasone injection on the duration of<br />
labor and its adverse effects<br />
Maryam Kashanian, (Iran), F Dadkhah, F Mokhtari<br />
11:45 - 12:00 FC01.3.6 Free Communication Presentation:<br />
Randomized, double blind, placebo controlled, evaluation of albendazole in patients with<br />
single enhancing lesions (SELs)<br />
Sandeep Kaushal, (India), S Kaur, S Tandon, SC Chopra, G Singh<br />
12:00 - 12:15 FC01.3.7 Free Communication Presentation:<br />
Zagreb medical students’ attitudes towards online learning resources on medical<br />
therapeutics<br />
Robert Likic, (Croatia), L Bielen, V Erdeljic, KM Ausperger, MR Aumiler, D Juricic,<br />
I Francetic, S Maxwell<br />
62 Tuesday 20 July ■ 09:30 - 12:15 ■ Auditorium 10
FC02<br />
Transmembrane transport:<br />
Perspectives for disease and drug discovery<br />
Supported by an unrestricted grant from Novo Nordisk Foundation<br />
Leaders: Randy Blakely, (USA) & Richard Kim, (Canada)<br />
FC02.3<br />
Intestinal and hepatic transporters<br />
Chairs: Richard B Kim, (Canada) & Martin F Fromm, (Germany)<br />
09:30 - 09:55 FC02.3.1 Organic anion transporting polypeptide (OATP) transporters<br />
Richard B Kim, (Canada)<br />
09:55 - 10:20 FC02.3.2 Transporter-mediated drug-interactions<br />
Martin F Fromm, (Germany)<br />
10:20 - 10:45 FC02.3.3 Peptide transporters<br />
Hannelore Daniel, (Germany)<br />
10:45 - 11:15 COFFEE BREAK<br />
11:15 - 11:40 FC02.3.4 SLC6 amino acid transporters<br />
Stefan Broer, (Australia)<br />
11:40 - 11:55 FC02.3.5 Free Communication Presentation:<br />
Mapping of the allosteric binding site in the serotonin transporter<br />
Claus J Loland, (Denmark), P Plenge, L Shi, P Zhang, JA Javitch, AH Newman,<br />
H Weinstein, U Gether<br />
11:55 - 12:10 FC02.3.6 Free Communication Presentation:<br />
A subtle C-terminus mutation of the dopamine transporter results in impaired synaptic<br />
targeting and an attenuated psychostimulant response, possibly attributable to disrupted<br />
PDZ-mediated protein-protein interactions<br />
Mattias Rickhag, (Denmark), G Sørensen, K Nørgaard-Strandfelt, P Weikop, B Andresen,<br />
EM Füchtbauer, J Gomeza, G Wörtwein, D Woldbye, U Gether<br />
Tuesday 20 July ■ 09:30 - 12:15 ■ Hall A3 63
FC03<br />
Ion channels in analgesia and anaesthesia<br />
Organized by the British Pharmacological Society<br />
Leaders: Clifford J Wolf, (USA) & Nicholas Franks, (UK)<br />
FC03.3<br />
Synaptic plasticity in analgesia-related pathways<br />
Chairs: Clifford J Woolf, (USA) & MacDonald J Christie, (Australia)<br />
09:30 - 09:55 FC03.3.1 Cellular neuroadaptations to chronic opioids<br />
MacDonald J Christie, (Australia), E Bagley, J Hacker, G McNally, V Chefer,<br />
T Shippenberg<br />
09:55 - 10:20 FC03.3.2 NMDA receptors and chronic pain hypersensitivity<br />
Mike Salter, (Canada)<br />
10:20 - 10:45 FC03.3.3 Synaptic dis-inhibition in chronic pain states<br />
Hans Ulrich Zeilhofer, (Switzerland), A Di Lio, R Witschi, Z-J Wang, RV Edwankar,<br />
JM Cook<br />
10:45 - 11:15 COFFEE BREAK<br />
11:15 - 11:40 FC03.3.4 Selectively targeting ion channels for analgesia<br />
Clifford J Woolf, (USA)<br />
11:40 - 11:55 FC03.3.5 Free Communication Presentation:<br />
D113 of the human 5-HT3A receptor is a major determinant of ion permeation<br />
John A Peters, (UK), MR Livesey, M Cooper, JJ Lambert<br />
11:55 - 12:10 FC03.3.6 Free Communication Presentation:<br />
Stimulation of heteromeric TASK channel trafficking by 14-3-3 protein<br />
Kathryn Rees, (UK), E Veale, A Mathie<br />
64 Sunday 20 July ■ 09:30 - 12:15 ■ Meeting Room 20
FC04<br />
Pharmacoepidemiology, current controversies and<br />
opportunities<br />
Leaders: Bert Leufkens, (The Netherlands) & Jesper Hallas, (Denmark)<br />
FC04.3<br />
Regulatory challenges in managing risk of medicinal products<br />
Leaders: Bert Leufkens, (The Netherlands) & Jesper Hallas, (Denmark)<br />
09:30 - 09:55 FC04.3.1 What are the issues driving the regulatory agenda on drug safety and risk management<br />
June M Raine, (UK)<br />
09:55 - 10:20 FC04.3.2 Are the available research methods sufficiently valid to address current benefit-risk<br />
issues on medicinal products<br />
Stephen JW Evans, (UK)<br />
10:20 - 10:45 FC04.3.3 New approaches to fill the methods gap in pharmacovigilance<br />
Marieke de Bruin, (The Netherlands)<br />
10:45 - 11:15 COFFEE BREAK<br />
11:15 - 11:30 FC04.3.4 Free Communication Presentation:<br />
Prescription drug use during pregnancy in Estonia<br />
Alar Irs, (Estonia), J Iljuhhina, O Laius, J Lass<br />
11:30 - 11:45 FC04.3.5 Free Communication Presentation:<br />
Cannabis-related adverse events: A hospitalization-based pharmacoepidemiological study<br />
Émilie Jouanjus, (France), F Leymarie, M Tubéry, M Lapeyre-Mestre<br />
11:45 - 12:00 FC04.3.6 Free Communication Presentation:<br />
Bisphosphonates Effectiveness Safety Tradeoff (BEST)<br />
Francesco Lapi, (Italy), G Corrao, N Montanaro, M Sturkenboom, P Geppetti, D Gregori,<br />
F Carle, A Menna, A Caputi, A Vestri, M Valenti, G Mazzaglia<br />
12:00 - 12:15 FC04.3.7 Free Communication Presentation:<br />
A model for prediction of adverse drug reactions in hospitalized patients<br />
Thiyagu Rajakannan, (India), V Guddattu, SR Mallayasamy, R Vilakkthala, S Kamath,<br />
LK Bairy, PGM Rao<br />
Tuesday 20 July ■ 09:30 - 12:15 ■ Auditorium 11 65
FC05<br />
Translational science in the metabolic syndrome:<br />
Basic and clinical pharmacology<br />
Supported by an unrestricted grant from Novo Nordisk A/S, Denmark<br />
Leaders: Leif Groop, (Sweden), Henning Beck-Nielsen, (Denmark) &<br />
Jan-Erik Henriksen, (Denmark)<br />
FC05.3<br />
Normalizing blood glucose in metabolic syndrome I: GLP-1 analogues and<br />
DPP IV inhibitors<br />
Chairs: Michael A Nauck, (Germany) & Jens Juul-Holst, (Denmark)<br />
09:30 - 09:55 FC05.3.1 Incretin mimetics <strong>2010</strong>: the safety experience<br />
Wolfgang E Schmidt, (Germany)<br />
09:55 - 10:20 FC05.3.2 GLP-1 secretion as a prerequisite for the antidiabetic activity of DPP-4 inhibitors:<br />
Can it be modified<br />
Fiona M Gribble, (UK)<br />
10:20 - 10:45 FC05.3.3 Incretin-based medication and cardiovascular disease<br />
Baptist Gallwitz, (Germany)<br />
10:45 - 11:15 COFFEE BREAK<br />
11:15 - 11:40 FC05.3.4 The GlP-1 receptor as a target for treatment of diabetes<br />
Lotte Bjerre Knudsen, (Denmark)<br />
11:40 - 11:55 FC05.3.5 Free Communication Presentation:<br />
Metformin and WIN55212 increases FGF21 expression in primary rat and<br />
humanhepatocytes<br />
Eva Byskov Nygaard, (Denmark), S Vienberg, C Ørskov, H Hansen, B Andersen<br />
11:55 - 12:10 FC05.3.6 Free Communication Presentation:<br />
Metabolic syndrome associates with resistance to aspirin in patients with coronary artery<br />
disease<br />
John Oates, (USA), J Smith, E Haddad, O Boutaud, D Oram, D Blakemore, C Chen,<br />
M Taylor<br />
66 Tuesday 20 July ■ 09:30 - 12:15 ■ Auditorium 15
FC06<br />
The heart gone wrong:<br />
Stabilization of cardiac function<br />
Supported by an unrestricted grant from Danish Cardiovascular<br />
Research Academy<br />
Leaders: Michael C Sanguinetti, (USA) & Lionel H Opie, (South Africa)<br />
FC06.3<br />
Novel treatments for systolic heart failure<br />
Chair: Juan Tamargo, (Spain)<br />
09:30 - 09:55 FC06.3.1 Metabolic therapy for heart failure<br />
Lionel Opie, (South Africa)<br />
09:55 - 10:20 FC06.3.2 New therapeutic targets in heart failure<br />
Juan Tamargo, (Spain)<br />
10:20 - 10:45 FC06.3.3 Effects of serotonin in the failing cardiac ventricle: potential therapeutic implications<br />
Finn Olav Levy, (Norway)<br />
10:45 - 11:15 COFFEE BREAK<br />
11:15 - 11:40 FC06.3.4 Metabolic perturbations, modulators and cardiac function<br />
Kieran Clarke, (UK)<br />
11:40 - 11:55 FC06.3.5 Free Communication Presentation:<br />
Pharmacologic inhibition of SK channels terminates and prevents atrial fibrillation in rat<br />
and guinea pig ex vivo and in vivo models<br />
Rie Hansen, (Denmark), J Diness, M Grunnet, T Jespersen, U Sørensen<br />
11:55 - 12:10 FC06.3.6 Free Communication Presentation:<br />
Effect of Rho kinase inhibitor Y-27632 on the cardiac proteome in ischemia/reperfusion<br />
injury<br />
J Sawicka, V Cadete, D Polewicz, A Doroszko, Grzegorz Sawicki, (Canada)<br />
Tuesday 20 July ■ 09:30 - 12:15 ■ Auditorium 12 67
FC07<br />
Simulation and data modelling in drug development.<br />
Better drugs faster<br />
Leaders: Hartmut Derendorf, (USA)<br />
FC07.3<br />
Modelling and simulation in clinical drug development<br />
Chairs: Hans-Günter Schäfer, (Germany) & Hartmut Derendorf, (USA)<br />
09:30 - 09:55 FC07.3.1 Modelling and simulation in clinical drug development at Boehringer Ingelheim<br />
Hans-Günter Schäfer, (Germany), A Staab<br />
09:55 - 10:20 FC07.3.2 Modeling and simulation in clinical drug development at Bristol-Myers Squibb<br />
Amit Roy, (USA), M Pfister<br />
10:20 - 10:45 FC07.3.3 Modelling and simulation in clinical drug development at Pfizer<br />
Sriram Krishnaswami, (USA)<br />
10:45 - 11:15 COFFEE BREAK<br />
11:15 - 11:40 FC07.3.4 Modelling and simulation in clinical drug development at Eli Lilly<br />
Sandra RB Allerheiligen, (USA)<br />
11:40 - 11:55 FC07.3.5 Free Communication Presentation:<br />
Therapeutic drug monitoring and population pharmacokinetic modelling of topiramate in<br />
patients with epilepsy<br />
Mihajlo Jakovljevic, (Republic of Serbia), T Vovk, M Keres Kos, S Jankovic, A Mrhar,<br />
I Grabnar<br />
11:55 - 12:10 FC07.3.6 Free Communication Presentation:<br />
A population pharmacokinetic study of methotrexate in children with acute lymphoblastic<br />
leukemia<br />
N Jebabli, E Gaïes, I Salouage, S Trabelsi, H El jebari, M Lakhal, Anis Klouz, (Tunisia)<br />
68 Tuesday 20 July ■ 09:30 - 12:15 ■ Meeting Room 18/19
FC08<br />
Development in the treatment of sexual dysfunction<br />
and diseases of the lower urinary tract<br />
Leaders: Karl-Erik Andersson, (USA) & Francois Giuliano, (France)<br />
FC08.2<br />
Pharmacological treatment of lower urinary tract syndrome/benign<br />
prostatic hyperplasia<br />
Chairs: Karl-Erik Andersson, (USA) & Francois Giuliano, (France)<br />
09:30 - 09:55 FC08.2.1 Central pharmacological targets for the treatment of ejaculatory disorders<br />
Francois Giuliano, (France)<br />
09:55 - 10:20 FC08.2.2 Sensory functions as a basis for symptoms and therapy in the overactive bladder<br />
Karl-Erik Andersson, (USA)<br />
10:20 - 10:45 FC08.2.3 GnRH antagonists – from basic science to the clinic in BPH and lower urinary tract<br />
symptoms (LUTS)<br />
Enrico Colli, (Denmark)<br />
10:45 - 11:15 COFFEE BREAK<br />
11:15 - 11:40 FC08.2.4 BPH – beyond alpha-adrenoceptors and 5a-reductase<br />
Christian Gratzke, (Germany)<br />
11:40 - 11:55 FC08.2.5 Free Communication Presentation:<br />
Hypoxic vasodilatation of penile arteries: involvement of nitric oxide (NO) and modulation<br />
by reactive oxygen species (ROS)<br />
Dolores Prieto, (Spain), P Kaminski, M Ahmad, MS Wolin<br />
11:55 - 12:10 FC08.2.6 Free Communication Presentation:<br />
Loss of balance between excitatory P2X3 and inhibitory A1 receptors contribute to<br />
cholinergic hyperactivity in the obstructed human bladder<br />
Miguel Silva-Ramos, (Portugal), I Silva, M Duarte-Araújo, T Magalhães-Cardoso,<br />
J Lafuente-de-carvalho, P Correia-de-Sá<br />
Tuesday 20 July ■ 09:30 - 12:15 ■ Meeting Room BV 1/2/3 69
FC09<br />
Inflammation and immunopharmacology:<br />
New tools for old diseases<br />
Leaders: Salvador Moncada, (UK), Eeva Moilanen, (Finland),<br />
Ian Adcock, (UK) & Frans Nijkamp, (The Netherlands)<br />
FC09.3<br />
iNOS – nitric oxide pathway in inflammation and as a target of<br />
anti-inflammatory treatment<br />
Chairs: Salvador Moncada, (UK) & Eeva Moilanen, (Finland)<br />
09:30 - 09:55 FC09.3.1 NO as a factor in inflammation<br />
Eeva Moilanan, (Finland)<br />
09:55 - 10:20 FC09.3.2 Exhaled NO in the diagnosis and therapy monitoring of inflammatory airway disease<br />
Kjell Alving, (Sweden)<br />
10:20 - 10:45 FC09.3.3 Nitric oxide and nitrosative stress in inflammation<br />
David A Wink, (USA), C Switzer, W Flores-Santana, S Glynn, R Cheng<br />
10:45 - 11:15 COFFEE BREAK<br />
11:15 - 11:40 FC09.3.4 iNOS inhibitors in inflammatory diseases: Lessons from animal and human studies<br />
Richard G Knowles, (UK)<br />
11:40 - 12:20 FC09.3.5 NO, mitochondrial function and tissue injury in inflammation and septic shock<br />
Salvador Moncada, (UK)<br />
70 Tuesday 20 July ■ 09:30 - 12:20 ■ Hall A2
W04<br />
Symposium: Antioxidants as therapeutic targets<br />
Organized by: Canadian Society of Pharmacology and Therapeutics<br />
Leader: Issy Laher, (Canada)<br />
Part II – Cardiovascular health<br />
Chairs: Issy Laher, (Canada) & Christopher M Rembold, (USA)<br />
12:45 - 13:05 W04.2.1 Anti-oxidants and cardiovascular health<br />
Ernesto Schiffrin, (Canada)<br />
13:05 - 13:25 W04.2.2 Anti-oxidants and endothelial progenitor cells<br />
Alex F Chen, (USA)<br />
13:25 - 13:45 W04.2.3 Anti-oxidant potential of polyphenols<br />
Valerie Schini-Kerth, (France)<br />
13:45 - 14:05 W04.2.4 Future strategies for therapeutic use of antioxidants<br />
Andreas Daiber, (Germany)<br />
Tuesday 20 July ■ 12:45 - 14:15 ■ Meeting Room 18/19 71
W12<br />
Workshop. Experimental pain methods in<br />
development and validation of analgesics<br />
Organized by: Mech-Sense, Aalborg Hospital & Center for<br />
Sensory-Motor Interaction (SMI), Aalborg University<br />
Leader: Asbjørn Mohr Drewes, (Denmark)<br />
Experimental pain methods in development and validation of analgesics<br />
Chair: Lona Christrup, (Denmark)<br />
12:45 - 13:00 W12.1 Experimental pain and analgesics – introduction<br />
Asbjørn Mohr Drewes, (Denmark)<br />
13:00 - 13:15 W12.2 Translational human pain biomarkers in drug development<br />
Lars Arendt-Nielsen, (Denmark)<br />
13:15 - 13:30 W12.3 Back-translating human pain biomarkers to animals<br />
Parisa Gazerani, (Denmark), BE Cairns, L Arendt-Nielsen<br />
13:30 - 13:45 W12.4 Ketamine: Acute and chronic pain relief and its influence on diffuse noxious inhibitory<br />
control<br />
Marieke Niesters, (The Netherlands), A Dahan<br />
13:45 - 14:00 W12.5 Tissue differentiated effects of transdermal buprenorphine and fentanyl<br />
Trine Andresen, (Denmark), C Staahl, L Arendt-Nielsen, A Mohr Drewes<br />
14:00 - 14:15 W12.6 Experimental pain: The role of descending inhibition and implications for drug research<br />
Christina Brock, (Denmark)<br />
72 Tuesday 20 July ■ 12:45 - 14:15 ■ Hall A2
W13<br />
Workshop. Novel peripheral mechanisms<br />
modulating the cardiovascular system:<br />
Pathophysiological, pharmacological and<br />
therapeutic relevance<br />
Organized by: Mexican Pharmacological Society<br />
Leader: Carlos Villalón, (Mexico)<br />
Novel peripheral mechanisms modulating the cardiovascular system:<br />
pathophysiological, pharmacological and therapeutic relevance<br />
Chair: Carlos M. Villalón, (Mexico)<br />
12:45 - 13:05 W13.1 Female sex hormones mediating neurovascular mechanisms involved in the<br />
pathophysiology of migraine<br />
Antoinette Maassen van den Brink, (The Netherlands)<br />
13:05 - 13:25 W13.2 Role of proteinase receptor-2 (PAR2), a novel class of GPCR, in the cranial vasculature<br />
Saurabh Gupta, (Denmark)<br />
13:25 - 13:45 W13.3 Comparative pharmacological analysis of the moxonidine-induced cardiac sympathoinhibition<br />
in rats suffering from spontaneous hypertension<br />
David Centurión, (Mexico), LE Cobos-Puc, A Sánchez-López, MB Ramírez-Rosas,<br />
CM Villalón<br />
13:45 - 14:05 W13.4 The role of α2C-adrenoceptors in UK14304-induced vasoconstrictor responses in rat tail<br />
arteries: potential relevance in Raynaud’s phenomenon<br />
Heinz H Pertz, (Germany), F Jantschak<br />
Tuesday 20 July ■ 12:45 - 14:15 ■ Hall A3 73
W14<br />
Workshop. Translating the human genome:<br />
From orphan G-protein coupled receptors to novel<br />
therapeutic targets<br />
Organized by: International Union of Basic and Clinical Pharmacology<br />
Committee on Receptor Nomenclature and Drug Classification<br />
(NC-IUPHAR)<br />
Leader: Anthony Davenport, (UK)<br />
Translating the human genome: From orphan G-protein coupled receptors<br />
to novel therapeutic targets<br />
Chairs: Anthony Davenport, (UK) & Tony Harmar, (UK)<br />
12:45 - 13:05 W14.1 Apelins and the APJ receptor<br />
Anthony P Davenport, (UK)<br />
13:05 - 13:25 W14.2 Relaxin family peptides and their receptors: Realising the therapeutic potential<br />
Roger J Summers, (Australia), M Halls, E van der Westhuizen, M Kocan, R Bathgate<br />
13:25 - 13:45 W14.3 Trace amines and TA1 receptors<br />
Janet J Maguire, (UK)<br />
13:45 - 14:05 W14.4 Discovery of GPCR ligands for GPR3, a GPCR modulating amyloid secretion in<br />
Alzheimer’s disease<br />
David F Fischer, (The Netherlands)<br />
74 Tuesday 20 July ■ 12:45 - 14:15 ■ Auditorium 15
-DB<br />
The IUPHAR Database of Receptors and Channels<br />
The official database of the IUPHAR committee on<br />
receptor nomenclature and drug classification<br />
Features include:<br />
• Comprehensive ligand lists<br />
• Links to genomic and structural data<br />
• Tissue distribution<br />
• Functional and pathophysiological data<br />
Fully curated data, submitted by world experts<br />
www.iuphar-db.org
W15<br />
Workshop. The IUPHAR initiative in integrative and<br />
organ systems pharmacology<br />
Organized by: IUPHAR Integrative and Organ Systems Pharmacology<br />
Committee<br />
Leader: David B Bylund, (USA)<br />
The IUPHAR initiative in integrative and organ systems pharmacology<br />
Chair: Sam J Enna, (USA)<br />
12:45 - 13:10 W15.1 Integrative and organ systems pharmacology<br />
David B Bylund, (USA)<br />
13:10 - 13:35 W15.2 Initiatives to support integrative (in vivo) pharmacology and physiology research and<br />
training in the UK<br />
Michael Collis, (UK)<br />
13:35 - 14:00 W15.3 IOSP in Africa<br />
Christiaan B Brink, (South Africa)<br />
76 Tuesday 20 July ■ 12:45 - 14:15 ■ Auditorium 10
W16<br />
Workshop. Implementation and obstacles of<br />
pharmacogenetics in clinical practice<br />
Organized by: IUPHAR Subcommittee of Pharmacogenetics<br />
Leader: Ingolf Cascorbi, (Germany)<br />
Implementation and obstacles of pharmacogenetics in clinical practice<br />
Chairs: Ingolf Cascorbi, (Germany) & Magnus Ingelmann-Sundberg, (Sweden)<br />
12:45 - 13:00 W16.1 Challenges in bringing pharmacogenetics into practice: the US perspective<br />
Deanna Kroetz, (USA)<br />
13:00 - 13:15 W16.2 Challenges of global implementation of pharmacogenetics into clinical practice<br />
Guilherme Suarez-Kurtz, (Brazil)<br />
13:15 - 13:30 W16.3 Present use and limitations of pharmacogenetics in clinical psychiatry<br />
Adrián Llerana, (Spain)<br />
13:30 - 13:45 W16.4 Obstacles to the implementation of pharmacogenetic testing in Australia<br />
Andrew Somogyi, (Australia)<br />
13:45 - 14:00 W16.5 Imaging pharmacogenetics – brain fMRI for visualizing intermediate phenotypes of drug<br />
response<br />
Angela Seeringer, (Germany)<br />
14:00 - 14:15 W16.6 Postgenomics medicine, empiricism and ethics of bioethics: Preventing both<br />
underprotection of subjects and misdirected precaution<br />
Vural Özdemir, (Canada), S Samper<br />
Tuesday 20 July ■ 12:45 - 14:15 ■ Auditorium 11 77
W17<br />
Workshop. Standards for PhD Education in<br />
Pharmacology<br />
Organized by: Danish Society of Pharmacology, Toxicology and<br />
Medicinal Chemistry<br />
Leader: Michael J Mulvany, (Denmark)<br />
Standards for PhD Education in Pharmacology<br />
Chair: Zdravko Lackovic, (Croatia)<br />
12:45 - 13:05 W17.1 ORPHEUS: Towards standards for PHd education in biomedicine and health sciences in<br />
Europe<br />
Michael J Mulvany, (Denmark), Z Lackovic<br />
13:05 - 13:25 W17.2 Working towards PhD standardization in the UK<br />
Nicolas Goulding, (UK)<br />
13:25 - 13:45 W17.3 Standards for PhD education in the United States<br />
Joey W Barnett, (USA)<br />
13:45 - 14:05 W17.4 Setting the standards for PhD education in Turkey, keeping up with dynamisim, giving up<br />
the nonsense<br />
Hakan S Orer, (Turkey)<br />
78 Tuesday 20 July ■ 12:45 - 14:15 ■ Auditorium 12
W18<br />
Workshop. Low-dose aspirin, coxibs and other<br />
NSAIDs: A clinical mosaic emerges<br />
Organized by: Italian Society of Pharmacology (SIF)<br />
Leader: Carlo Riccardi, (Italy)<br />
Low-dose aspirin, coxibs and other NSAIDs: a clinical mosaic emerges<br />
Chairs: Carlo Riccardi, (Italy) & Filippo Drago, (Italy)<br />
12:45 - 13:05 W18.1 Aspirin as an antiplatelet agent: From COX-1 acetylation to randomized clinical trials and<br />
back<br />
Carlo Patrono, (Italy)<br />
13:05 - 13:25 W18.2 Recommendations on aspirin in the primary prevention in diabetic patients: how the same<br />
data can generate divergent conclusions<br />
Antonio Nicolucci, (Italy)<br />
13:25 - 13:45 W18.3 Insights into the efficacy and risk management of COX-2 inhibitors: an example of<br />
translational medicine<br />
Paola Patrignani, (Italy)<br />
13:45 - 14:05 W18.4 Selective COX-2 inhibitors: Where do we go from here<br />
Colin N Baigent, (UK), N Bhala, C Patrono<br />
Tuesday 20 July ■ 12:45 - 14:15 ■ Meeting Room BV 1/2/3 79
W19<br />
Workshop. Influence of degeneration and repair in<br />
the CNS and periphery<br />
Organized by: Hungarian Society for Experimental and Clinical<br />
Pharmacology<br />
Leader: Beáta Sperlágh, (Hungary)<br />
Influence of degeneration and repair in the CNS and periphery<br />
Chair: Zsuzsanna Fürst, (Hungary)<br />
12:45 - 13:05 W19.1 Analysis of central regulation of gastric mucosal defence in rat<br />
Klara Gyires, (Hungary), N Shujaa, Z Zádori<br />
13:05 - 13:25 W19.2 P2X and P2Y receptors in neurodegenerative diseases and neuropathic pain: An update<br />
Beáta Sperlágh, (Hungary), A Heinrich, R Andó, Z Hracskó, M Baranyi<br />
13:25 - 13:45 W19.3 Role of the transient receptor potential vanilloid 1 (TRPV1) receptor and sensory<br />
neuropeptides in airway inflammation and hyperresponsiveness<br />
Zsuzsanna Helyes, (Hungary), K Elekes, K Sándor, A Kemény, A Markovics,<br />
E Szöke, E Pintér, M Mester, L Kereskai, JP Quinn, PC Emson, J Szolcsányi<br />
13:45 - 14:05 W19.4 Cardiac ion channels as therapeutic targets<br />
András Varró, (Hungary)<br />
80 Tuesday 20 July ■ 12:45 - 14:15 ■ Meeting Room 20
FC01<br />
Clinical pharmacology in the emerging countries<br />
Leader: Lembit Rägo, (Switzerland)<br />
FC01.4<br />
Pharmacovigilance in emerging and developing countries:<br />
A luxury or a must<br />
Chairs: Ambrose O Isah, (Nigeria) & Lembit Rägo, (Switzerland)<br />
14:30 - 14:55 FC01.4.1 Specific features of medicines safety and pharmacovigilance in Africa<br />
Ambrose O Isah, (Nigeria)<br />
14:55 - 15:20 FC01.4.2 Pharmacovigilance as part of regulatory framework: Brazilan experience<br />
Murilo Freitas Dias, (Brazil)<br />
15:20 - 15:45 FC01.4.3 WHO <strong>Programme</strong> for International Drug Monitoring as an effective framework for<br />
strengthening national pharmacovigilance systems<br />
Lembit Rägo, (Switzerland)<br />
15:45 - 16:15 COFFEE BREAK<br />
16:15 - 16:30 FC01.4.4 Free Communication Presentation:<br />
Pilot study examining the frequency of several gene polymorphisms involved in morphine<br />
pharmacodynamics and pharmacokinetics in a morbidly obese population<br />
C Lloret Linares, A Hajj, C Poitou, JL Laplanche, JP Lepine, JF Bergmann,<br />
Stephane Mouly, (France), K Peoc’h<br />
16:30 - 16:45 FC01.4.5 Free Communication Presentation:<br />
Self self-reported adherence may be a factor for emergence of drug resistance to<br />
antiretroviral therapy in resource limited settings<br />
Celestino Obua, (Uganda), R Balikuddembe, M Ntale, J Kayiwa, S Baveewo, P Waako<br />
16:45 - 17:00 FC01.4.6 Free Communication Presentation:<br />
Obesity, diabetes and hypertension associated with antipsychotic use in schizophrenia<br />
Sahoo Saddichha, (India), N Manjunatha, S Akhtar<br />
17:00 - 17:15 FC01.4.7 Free Communication Presentation:<br />
Risk factors for efavirenz-based ART associated hepatotoxicity in treatment naïve HIV<br />
patients from Ethiopia<br />
Getnet Yimer, (Ethiopia), W Amogne, A Habtewold, E Makonnen, A Worku, G Aderaye,<br />
L Lindquist, E Aklillu<br />
Tuesday 20 July ■ 14:30 - 17:15 ■ Auditorium 10 81
FC02<br />
Transmembrane transport:<br />
Perspectives for disease and drug discovery<br />
Supported by an unrestricted grant from Novo Nordisk Foundation<br />
Leaders: Randy Blakely, (USA) & Richard Kim, (Canada)<br />
FC02.4<br />
Membrane transporters: Molecular genetics and pharmacogenetics<br />
Chairs: Randy Blakely, (USA) & Ingolf Cascorbi, (Germany)<br />
14:30 - 14:55 FC02.4.1 SLC6 Neurotransmitter transporters<br />
Randy Blakely, (USA)<br />
14:55 - 15:20 FC02.4.2 Clinical significance of ABCC4<br />
Heyo K Kroemer, (Germany), G Jedlitschky<br />
15:20 - 15:45 FC02.4.3 Clinical consequences of transporter variants<br />
Ingolf Cascorbi, (Germany)<br />
15:45 - 16:15 COFFEE BREAK<br />
16:15 - 16:40 FC02.4.4 Regulation of drug transporters<br />
Gerd A Kullak-Ublick, (Switzerland))<br />
16:40 - 16:55 FC02.4.5 Free Communication Presentation:<br />
Functional expression of ATP-binding cassette (ABC) transporters in a mouse Sertoli cell<br />
line system (TM4): Relevance to antiretroviral drug (ARV) permeability<br />
Kevin Robillard, (Canada), R Bendayan<br />
16:55 - 17:10 FC02.4.6 Free Communication Presentation:<br />
Polymorphisms in drug transporters rather than drug metabolizing enzymes influence the<br />
pharmacokinetics but not adverse effects with clonazepam<br />
Brian Tomlinson, (PR China), BSP Fok, OQP Yin, TTW Chu, M Hu, VHL Lee<br />
82 Tuesday 20 July ■ 14:30 - 17:15 ■ Hall A3
FC03<br />
Ion channels in analgesia and anaesthesia<br />
Organized by the British Pharmacological Society<br />
Leaders: Clifford J Wolf, (USA) & Nicholas Franks, (UK)<br />
FC03.4<br />
Ion channels as molecular targets for general anaesthetics<br />
Chairs: Nicholas Franks, (UK) & Michel Lazdunski, (France)<br />
14:30 - 14:55 FC03.4.1 Ion channels as targets for general anaesthetics<br />
Nicholas Franks, (UK)<br />
14:55 - 15:20 FC03.4.2 Two pore domain potassium channels as targets for general anaesthetics<br />
Michel Lazdunski, (France)<br />
15:20 - 15:45 FC03.4.3 GABAA receptors as targets for general anaesthetics<br />
Neil L Harrison, (USA)<br />
15:45 - 16:15 COFFEE BREAK<br />
16:15 - 16:40 FC03.4.4 HCN channel subunit specific effects of general anaesthetics<br />
Douglas A Bayliss, (USA)<br />
16:40 - 16:55 FC03.4.5 Free Communication Presentation:<br />
Searching for downstream molecules of N-type voltage-dependent calcium channels<br />
(Cav2.2) contributing to the neuropathic pain<br />
Tsutomu Tanabe, (Japan), E Sakurai, T Kurihara, K Kouchi, H Saegusa, S Zong<br />
Tuesday 20 July ■ 14:30 - 17:15 ■ Meeting Room 20 83
FC04<br />
Pharmacoepidemiology, current controversies and<br />
opportunities<br />
Leaders: Bert Leufkens, (The Netherlands) & Jesper Hallas, (Denmark)<br />
FC04.4<br />
In utero exposure to drugs<br />
Chairs: Lolkje TW de Jong-van den Berg, (The Netherlands) &<br />
Corinne de Vries, (The Netherlands)<br />
14:30 - 14:55 FC04.4.1 The impact of thalidomide and its revival as a vital medicine.<br />
Lessons learned from history<br />
Trent D Stephens, (USA)<br />
14:55 - 15:20 FC04.4.2 Pharmacological considerations of drug teratogenicity – why animal studies are not<br />
sufficient<br />
Per Damkier, (Denmark)<br />
15:20 - 15:45 FC04.4.3 Unique methodological features in the pharmacoepidemiology of birth defects<br />
Corinne de Vries, (UK)<br />
15:45 - 16:15 COFFEE BREAK<br />
16:15 - 16:40 FC04.4.4 Determining drug effects – clinical considerations when establishing birth outcomes<br />
Lolkje TW de Jong-van den Berg, (UK)<br />
16:40 - 16:55 FC04.4.5 Free Communication Presentation:<br />
Risk of ischemic stroke associated with antidepressant drug use in elderly persons<br />
Gianluca Trifiro, (Italy), J Dieleman, A Caputi, G Gambassi, M Sturkenboom<br />
16:55 - 17:10 FC04.4.6 Free Communication Presentation:<br />
Drug safety signal detection and substantiation by integrative mining of electronic healthcare<br />
records and biomedical knowledge: preliminary results from the EU-ADR project<br />
Gianluca Trifiro, (Italy), M Sturkenboom, C Diaz Acedo, A Fourrie Reglat, F Sanz,<br />
JL Oliveira, E Molero, J van der Lei, on behalf of the EU-ADR Consortium<br />
84 Tuesday 20 July ■ 14:30 - 17:15 ■ Auditorium 11
FC05<br />
Translational science in the metabolic syndrome:<br />
Basic and clinical pharmacology<br />
Supported by an unrestricted grant from Novo Nordisk A/S, Denmark<br />
Leaders: Leif Groop, (Sweden), Henning Beck-Nielsen, (Denmark) &<br />
Jan-Erik Henriksen, (Denmark)<br />
FC05.4<br />
Normalizing blood glucose in metabolic syndrome II: Glitazones and<br />
metformin<br />
Chairs: Philip Home, (UK) & Henning Beck-Nielsen, (Denmark)<br />
14:30 - 14:55 FC05.4.1 The role of metformin and glitazones in the regulation on hepatic glucose metabolism<br />
Michael Roden, (Germany)<br />
14:55 - 15:20 FC05.4.2 Rosiglitazone: Lessons from the RECORD study<br />
Philip Home, (UK)<br />
15:20 - 15:45 FC05.4.3 Metformin: Lessons from UKPDS<br />
Amanda Adler, (UK)<br />
15:45 - 16:15 COFFEE BREAK<br />
16:15 - 16:40 FC05.4.4 Translational science in metabolic syndrome – future directions<br />
Henning Beck-Nielsen, (Denmark)<br />
16:40 - 16:55 FC05.4.5 Free Communication Presentation:<br />
PPAR γ agonist pioglitazone provides comparable renoprotection to an ACE inhibitor<br />
against normotensive nondiabetic nephropathy in rat<br />
Peter Ochodnicky, (Slovak Republic), J Klimas, L Mesarosova, P Krenek, J Kyselovic<br />
16:55 - 17:10 FC05.4.6 Free Communication Presentation:<br />
Zinc Transporter 3, a pharmacological target for the treatment of beta-cell failure<br />
Kamille Smidt, (Denmark), A Pedersen, B Brock, J Rungby<br />
Tuesday 20 July ■ 14:30 - 17:15 ■ Auditorium 15 85
FC06<br />
The heart gone wrong:<br />
Stabilization of cardiac function<br />
Leaders: Michael C Sanguinetti, (USA) & Lionel H Opie, (South Africa)<br />
FC06.4<br />
Treatment options for diastolic heart failure<br />
Chairs: Douglas L Mann, (USA) & Ulf Simonsen, (Denmark)<br />
14:30 - 15:00 FC06.4.1 Clinical applications of microRNAs in cardiac remodeling and heart failure<br />
Douglas L Mann, (USA)<br />
15:00 - 15:30 FC06.4.3 Autophagy and apoptosis in heart failure<br />
Kinya Otsu, (Japan)<br />
15:30 - 16:00 COFFEE BREAK<br />
16:00 - 16:30 FC06.4.4 Rescuing a failing heart<br />
Mark E Anderson, (USA)<br />
16:30 - 16:45 FC06.4.5 Free Communication Presentation:<br />
Hypoxic preconditioning improves survival of human adipose-derived stem cells for<br />
cardiac tissue engineering<br />
Samantha Stubbs, (Australia), R Dilley, H Peshavariya, G Dusting<br />
16:45 - 17:00 FC06.4.6 Free Communication Presentation:<br />
The interaction of 14-3-3eta and PKCepsilon in cardiocyte protection induced by IPC<br />
Lei Tang, (PR China), Z Liao, D Yin, Y Luo, Y Liu, M He<br />
17:00 - 17:15 General discussion<br />
86 Tuesday 20 July ■ 14:30 - 17:15 ■ Auditorium 12
FC07<br />
Simulation and data modelling in drug development.<br />
Better drugs faster<br />
Leaders: Hartmut Derendorf, (USA)<br />
FC07.4<br />
Modelling and simulation – a regulator’s view<br />
Jogarao VS Gobburu, (USA) & Hartmut Derendorf, (USA)<br />
14:30 - 14:55 FC07.4.1 Role of modelling and simulation at the FDA<br />
Jogarao VS Gobburu, (USA)<br />
14:55 - 15:20 FC07.4.2 Role of modelling and simulation at the European Medicines Agency<br />
Franz König, (UK)<br />
15:20 - 15:45 FC07.4.3 Role of modelling and simulation for drug approval in Asia<br />
Yuki Ando, (Japan)<br />
15:45 - 16:15 COFFEE BREAK<br />
16:15 - 16:40 FC07.4.4 Exposure-response and disease modelling from a regulatory view<br />
Siv Jönsson, (Sweden), A Henningsson<br />
16:40 - 16:55 FC07.4.5 Free Communication Presentation:<br />
Bridging preclinical and clinical data using a population-based simulation software<br />
Frank Larsen, (Denmark), KG Jensen, KB Petersen<br />
16:55 - 17:10 General discussion<br />
Tuesday 20 July ■ 14:30 - 17:15 ■ Meeting Room 18/19 87
FC08<br />
Development in the treatment of sexual dysfunction<br />
and diseases of the lower urinary tract<br />
Leaders: Karl-Erik Andersson, (USA) & Francois Giuliano, (France)<br />
FC08.3<br />
Pharmacological treatment of bladder dysfunction<br />
Chairs: Karl Erik Andersson, (USA) & Mark T Nelson, (USA)<br />
14:30 - 14:55 FC08.3.1 Molecular mechanisms of bladder dysfunction<br />
George J Christ, (USA)<br />
14:55 - 15:20 FC08.3.2 Modulation of electromechanical coupling in the bladder<br />
Christopher H Fry, (UK)<br />
15:20 - 15:45 FC08.3.3 K channel modulation of bladder contractility<br />
Mark T Nelson, (USA)<br />
15:45 - 16:15 COFFEE BREAK<br />
16:15 - 16:40 FC08.3.4 Botulinum toxin treatment for overactive bladder<br />
Marcus John Drake, (UK)<br />
16:40 - 16:55 FC08.3.5 Free Communication Presentation:<br />
Is there a functional significance of the cyclic AMP-mediated signalling pathway in the<br />
control of the human prostate<br />
Eginhard Waldkirch, (Germany), S Uckert, CG Stief, MA Kuczyk, P Hedlund<br />
16:55 - 17:10 General discussion<br />
88 Tuesday 20 July ■ 14:30 - 17:15 ■ Meeting Room BV 1/2/3
FC09<br />
Inflammation and immunopharmacology:<br />
New tools for old diseases<br />
Leaders: Salvador Moncada, (UK), Eeva Moilanen, (Finland),<br />
Ian Adcock, (UK) & Frans Nijkamp, (The Netherlands)<br />
FC09.4<br />
NSAIDs and COX-2 inhibitors. Current strategies and future directions<br />
Chairs: Jane A Mitchell, (UK) & Per-Johan Jakobsson, (Sweden)<br />
14:30 - 14:55 FC09.4.1 Pharmacology of COX-1 and COX-2: Is there still a place for COX-2 selective NSAIDs<br />
Jane A Mitchell, (UK)<br />
14:55 - 15:20 FC09.4.2 Anti-inflammatory benefits and cardiovascular toxicity of NSAIDs and COX-2 inhibitors<br />
Paola Patrignani, (Italy)<br />
15:20 - 15:45 FC09.4.3 COX-2 and gastric carcinogenesis<br />
Ari Ristimäki, (Finland)<br />
15:45 - 16:15 COFFEE BREAK<br />
16:15 - 16:40 FC09.4.4 Inhibitors of microsomal PGE synthase-1<br />
Per-Johan Jakobsson, (Sweden)<br />
16:40 - 17:05 FC09.4.5 Endocannabinoids and beyond. Paracetamol, NSAIDs and novel mechanisms to treat<br />
inflammatory pain<br />
Peter Zygmunt, (Sweden), E Högestätt<br />
17:05 - 17:20 FC09.4.6 Free Communication Presentation:<br />
The role of formyl peptide receptor 2 (Fpr2) in leukocytes trafficking<br />
Vincenzo Brancaleone, (UK), N Dufton, J Dalli, RJ Flower, M Perretti<br />
IUL<br />
IUPHAR Plenary Lecture<br />
Chair: Sue P Duckles, (USA)<br />
17:30 - 18:15 IUL The 50-Years IUPHAR Anniversary Lecture: Regenerate to be old<br />
Paul M Vanhoutte, (PR China)<br />
IUPHAR general assembly in Auditorium 15<br />
Tuesday 20 July 18:30<br />
Supported by the ASPET Division for Drug Discovery, Drug Development, and Regulatory Affairs<br />
Tuesday 20 July ■ 14:30 - 18:15 ■ Hall A2 89
PL10<br />
ASPET Plenary Lecture<br />
Chair: Thue W Schwartz, (Denmark)<br />
PL10<br />
Structural insights into GPCR activation<br />
Brian Kobilka, (USA)<br />
Wednesday 21 July ■ 08:30 - 09:15 ■ Hall A2<br />
PL11<br />
Plenary Lecture<br />
Chair: Urs T Ruegg, (Switzerland)<br />
PL11<br />
Calcium and cell functions<br />
Masamitsu Iino, (Japan)<br />
Wednesday 21 July ■ 08:30 - 09:15 ■ Hall A3<br />
P12<br />
Plenary Lecture<br />
Chair: Petra Thürmann, (Germany)<br />
PL12<br />
PL12 Meeting the challenge of antibiotic resistance<br />
Otto Cars, (Sweden)<br />
Wednesday 21 July ■ 08:30 - 09:15 ■ Auditorium 15<br />
90 Wednesday 21 July ■ 08:30 - 09:15
FC09<br />
Inflammation and immunopharmacology:<br />
New tools for old diseases<br />
Leaders: Salvador Moncada, (UK), Eeva Moilanen, (Finland),<br />
Ian Adcock, (UK) & Frans Nijkamp, (The Netherlands)<br />
FC09.5<br />
Novel anti-inflammatory targets and mechanisms<br />
Chairs: Frans P Nijkamp, (The Netherlands) & J Edwin Blalock, (USA)<br />
09:30 - 09:55 FC09.5.1 Dendritic cells as targets for immunomodulation in asthma and COPD<br />
Guy G Brusselle, (Belgium)<br />
09:55 - 10:20 FC09.5.2 CXC chemokines and antagonists in chronic airway inflammation<br />
Gert Folkerts, (The Netherlands), E Blalock, S Braber, A Kraneveld, F Nijkamp<br />
10:20 - 10:45 FC09.5.3 Neuro-immune interactions in health and disease<br />
J Edwin Blalock, (USA)<br />
10:45 - 11:15 COFFEE BREAK<br />
11:15 - 11:30 FC09.5.4 Free Communication Presentation:<br />
Inhibition of protein kinase C down-regulates the expression of tristetraprolin in activated<br />
macrophages in an isoenzyme-specific manner<br />
Tiina Leppänen, (Finland), R Korhonen, RK Tuominen, E Moilanen<br />
11:30 - 11:45 FC09.5.5 Free Communication Presentation:<br />
Role of AGEs inhibitors in inflammation and rheumatoid arthritis<br />
Prem Chand Goel, (India), R Jindal, TG Singh, S Sharma, P Sharma, H Kaur, K Vohra<br />
11:45 - 12:00 FC09.5.6 Free Communication Presentation:<br />
Endogenous glucocorticoids inhibit myocardial inflammation induced by<br />
lipopolysaccharide in rats<br />
Jian-Dong Luo, (PR China)), H-N Zhang, M-S Chen<br />
12:00 - 12:15 FC09.5.7 Free Communication Presentation:<br />
Calcitonin and glucocorticoids – a novel approach to anti-inflammatory co-therapy<br />
Adam Al-Kashi, (UK), N Moradi, J Dalli, J Gilligan, N Mehta, M Perretti<br />
Wednesday 21 July ■ 09:30 - 12:15 ■ Hall A3 91
FC10<br />
Drugs for half the world:<br />
Paediatric clinical pharmacology<br />
Leader: John N van den Anker, (USA)<br />
FC10.1<br />
Innovative methodological approaches in drug development in children<br />
Chair: Gérard Pons, (France)<br />
09:30 - 09:55 FC10.1.1 Place of the innovative methodological approaches in the development of medicinal<br />
products in children<br />
Gérard Pons, (France)<br />
09:55 - 10:20 FC10.1.2 Increasing role of the observational approaches in the assessment of safety and efficacy<br />
of medicinal products in children<br />
Emilio J Sanz, (Spain)<br />
10:20 - 10:45 FC10.1.3 A collaborative approach to improving the treatment of malaria:<br />
The Worldwide Antimalarial Resistance Network<br />
Karen I Barnes, (South Africa)<br />
10:45 - 11:15 COFFEE BREAK<br />
11:15 - 11:40 FC10.1.4 Specificities of clinical trials in adolescent girls: contraception and abortion<br />
Viveca Odlind, (Sweden)<br />
11:40 - 11:55 FC10.1.5 Free Communication Presentation:<br />
Determinants of 6-mercaptopurine metabolites concentrations variability during<br />
maintenance therapy for children with acute lymphoblastic leukemia and occurrence of<br />
hepatotoxicity<br />
Tiphaine Adam de Beaumais, (France), M Fakhoury, Y Medard, S Azougagh, D Zhang,<br />
K Yakouben, E Jacqz-Aigrain<br />
11:55 - 12:10 FC10.1.6 Free Communication Presentation:<br />
Large differences in the availability of oral formulations labeled for use in young children<br />
in Serbia, Germany and the USA<br />
Milca Bajcetic, (Republic of Serbia), I Jovanovic, M Brajovic, J van den Anker<br />
92 Wednesday 21 July ■ 09:30 - 12:15 ■ Meeting Room 18/19
FC11<br />
G protein-coupled 7TM receptors:<br />
From molecular to physiological function<br />
Supported by an unrestricted grant from Novo Nordisk Foundation<br />
Leaders: Brian K Kobilka, (USA) & Jean-Philippe Pin, (France)<br />
FC11.1<br />
7TM receptor structure<br />
Chair: Gebhard FX Schertler, (UK)<br />
09:30 - 09:55 FC11.1.1 New G-protein-coupled receptor crystal structures: Insights and limitations.<br />
Gebhard FX Schertler, (UK)<br />
09:55 - 10:20 FC11.1.2 Ligand binding and micro-swicthes in 7TM receptor structures<br />
Thue W Schwartz, (Denmark)<br />
10:20 - 10:45 FC11.1.3 Signalling state of a G protein coupled 7TM receptor: Insights from spectroscopic and<br />
structural studies on rhodopsin<br />
Klaus Peter Hofmann, (Germany)<br />
10:45 - 11:15 COFFEE BREAK<br />
11:15 - 11:40 FC11.1.4 Structural views of the extracellular domains of class C GPCRs<br />
Hisato Jingami, (Japan)<br />
11:40 - 11:55 FC11.1.5 Free Communication Presentation:<br />
The selectivity of β-adrenoceptor agonists at the human β1, β2 and β3 adrenoceptors<br />
Jillian Baker, (UK)<br />
11:55 - 12:10 FC11.1.6 Free Communication Presentation:<br />
GPR55; signaling pathways and functions<br />
Maria Waldhoer, (Austria), NAB Balenga, R Schröder, J Kargl, W Platzer, S Blättermann,<br />
A Heinemann, E Kostenis<br />
Wednesday 21 July ■ 09:30 - 12:15 ■ Auditorium 10 93
FC12<br />
Ion channelopathies:<br />
New windows on complex disease and therapy<br />
Leader: William A Catterall, (USA)<br />
FC12.1<br />
Ion channelopathies in the brain: inherited epilepsy and migraine<br />
Chairs: William A Catterall, (USA) & Daniela Pietrobon, (Italy)<br />
09:30 - 09:55 FC12.1.1 Sodium channelopathies and epilepsy<br />
Ingrid Scheffer, (Australia)<br />
09:55 - 10:20 FC12.1.2 Mechanisms of hyperexcitability, febrile seizure, and ataxia in a mouse model of severe<br />
myoclonic epilepsy of infancy<br />
William A Catterall, (USA)<br />
10:20 - 10:45 FC12.1.3 Functional effects of sodium channel mutations in inherited epilepsy and migraine<br />
Massimo Mantegazza, (Italy)<br />
10:45 - 11:15 COFFEE BREAK<br />
11:15 - 11:40 FC12.1.4 Gain-of-function mutations of calcium channels in familial hemiplegic migraine<br />
Daniela Pietrobon, (Italy)<br />
11:40 - 11:55 FC12.1.5 Free Communication Presentation:<br />
Tyrosine nitration of voltage-dependent calcium channels in experimental colitis.<br />
Hamid Akbarali, (USA), G Ross, M Kang<br />
11:55 - 12:10 FC12.1.6 Free Communication Presentation:<br />
L-type calcium channels dominate the quantal catecholamine release in rat embryo<br />
cromafín cells stimulated with potassium or hypoxia<br />
Antonio MG de Diego, (Spain), JC Fernandez-Morales, AG Garcia<br />
94 Wednesday 21 July ■ 09:30 - 12:15 ■ Meeting Room 20
FC13<br />
Maximising benefits and minimising harms from<br />
drugs<br />
Organized by the British Pharmacological Society<br />
Leaders: Munir Pirmohamed, (UK) & Brian Kevin Park, (UK)<br />
FC13.1<br />
Drug safety: The epidemiology<br />
Chairs: Kees van Grootheest, (The Netherlands) & Alasdair Breckenridge, (UK)<br />
09:30 - 09:55 FC13.1.1 Adverse drug reactions in hospitals<br />
Kees van Grootheest, (The Netherlands)<br />
09:55 - 10:20 FC13.1.2 An industry perspective of drug safety<br />
Michael A Ibara, (USA)<br />
10:20 - 10:45 FC13.1.3 Drug regulation and drug safety<br />
Alasdair Breckenridge, (UK)<br />
10:45 - 11:15 COFFEE BREAK<br />
11:15 - 11:40 FC13.1.4 Clinical toxicology perspective of drug safety<br />
Simon Thomas, (UK)<br />
11:40 - 11:55 FC13.1.5 Free Communication Presentation:<br />
Health alliance for prudent prescribing, yield and use of antimicrobial drugs in the<br />
treatment of respiratory tract infection (HAPPY AUDIT)<br />
Lars Bjerrum, (Denmark), MP Hansen, JM Cots, C Llor, A Munck, B Gahrn-Hansen<br />
11:55 - 12:10 FC13.1.6 Free Communication Presentation:<br />
A drug burden index (DBI) to improve quality use of medicines in Australian war veterans<br />
and widows<br />
Danijela Gnjidic, (Australia), S Hilmer, E Roughead, A Gilbert, D Le Couteur, D Abernethy<br />
Wednesday 21 July ■ 09:30 - 12:15 ■ Hall A2 95
FC14<br />
Addiction and doping: Neurobiological and clinical<br />
basis of emerging treatments<br />
Leaders: Markus Heilig, (USA) & Yavin Shaham, (USA)<br />
FC14.1<br />
Pharmacological treatment of opiate dependence – much achieved,<br />
much left to do<br />
Chairs: Sharon Walsh, (USA) & Yasmin L Hurd, (USA)<br />
09:30 - 09:55 FC14.1.1 Efficacy of current pharmacotherapies for opioid dependence: What challenges remain<br />
Sharon Walsh, (USA)<br />
09:55 - 10:20 FC14.1.2 Neurobiological consequences of opioid exposure: Implications for pharmacotherapy<br />
development<br />
Yasmin L Hurd, (USA)<br />
10:20 - 10:45 FC14.1.3 Implication of agonist-selective receptor complexes for opioid dependence<br />
Christopher Evans, (USA)<br />
10:45 - 11:15 COFFEE BREAK<br />
11:15 - 11:40 FC14.1.4 Global impact of opioid pharmacotherapy: Beyond heroin dependence<br />
Nicolas C Clark, (Switzerland)<br />
11:40 - 11:55 FC14.1.5 Free Communication Presentation:<br />
Different Alcohol exposures induce selective alterations on the expression of the<br />
endogenous opioid system genes: possible epigenetic mechanisms<br />
Claudio D'Addario, (Italy), F Caputi, R Rimondini, S Candeletti, P Romualdi<br />
11:55 - 12:10 FC14.1.6 Free Communication Presentation:<br />
NSAIDs may confound results of urinary testosterone doping tests<br />
Jonas Lundmark, (Sweden), L Ekström, J-O Thörngren, M Garle, A Rane<br />
96 Wednesday 21 July ■ 09:30 - 12:15 ■ Auditorium 12
FC16<br />
Natural products: Past and future<br />
Organized by the IUPHAR Section on the Pharmacology of Natural<br />
Products<br />
Leaders: Ricky Ying-Keung Man, (PR China), Tai-Ping Fan, (UK) &<br />
Zhi-bin Lin, (PR China)<br />
FC16.1<br />
Cardioprotection by natural products<br />
Chairs: Roberto Soares de Moura, (Brazil) & David D Ku, (USA)<br />
09:30 - 09:55 FC16.1.1 Red wine polyphenols<br />
Valerie Schini-Kerth, (France)<br />
09:55 - 10:20 FC16.1.2 Cardioprotection by natural products: Dark chocolate<br />
Thomas F Lüscher, (Switzerland), I Sudano, A Flammer, FT Ruschitzka, G Noll<br />
10:20 - 10:45 FC16.1.3 Garlic, allicin and NO protection against pulmonary hypertension and right ventricular<br />
hypertrophy<br />
David D Ku, (USA)<br />
10:45 - 11:15 COFFEE BREAK<br />
11:15 - 11:40 FC16.1.4 Fish oil and ω3-unsaturated omega fatty acids<br />
Hiroaki Shimokawa, (Japan)<br />
11:40 - 11:55 FC16.1.5 Free Communication Presentation:<br />
The Crataegus extract WS® 1442 protects against endothelial hyperpermeability –<br />
insights into the underlying dual mechanism<br />
Robert Fürst, (Germany), MF Bubik, P Bihari, G Jürgenliemk, H Ammer, F Krombach,<br />
S Zahler, AM Vollmar<br />
11:55 - 12:10 FC16.1.6 Free Communication Presentation:<br />
Modulation of nuclear transcription factor (NF)-κB as a potential mechanism of Punica<br />
granatum in inflammatory bowel disease<br />
Tejal Gandhi, (India), T Shah, K Patel, C Joshi<br />
Wednesday 21 July ■ 09:30 - 12:15 ■ Auditorium 15 97
FC17<br />
New approaches and targets in psychiatry<br />
Supported by an unrestricted grant from H Lundbeck A/S, Denmark<br />
Leaders: David J Nutt, (UK) & Birte Glenthøj, (Denmark)<br />
FC17.1<br />
The pathophysiological basis for psychosis<br />
Chairs: Anthony A Grace, (USA) & Albert Gjedde, (Denmark)<br />
09:30 - 09:55 FC17.1.1 Hippocampal hyperactivity drives dopamine hyper-responsivity in an animal model of<br />
schizophrenia<br />
Anthony A Grace, (USA)<br />
09:55 - 10:20 FC17.1.2 Cortical and subcortical dopamine receptor interactions in sensation-seeking<br />
Albert Gjedde, (Denmark)<br />
10:20 - 10:45 FC17.1.3 Imaging the dopamine system in schizophrenia: Imbalance between cortical and<br />
subcortical dopamine regulation<br />
Anissa Abi-Dargham, (USA)<br />
10:45 - 11:15 COFFEE BREAK<br />
11:15 - 11:40 FC17.1.4 Glutamate dysfunction in schizophrenia: From prefrontal cortex to disrupted networks<br />
Judith Pratt, (UK), N Dawson, B Morris<br />
11:40 - 11:55 FC17.1.5 Free Communication Presentation:<br />
Contribution of glycogen synthase kinase-3 to the psychotomimetic effects of ketamine<br />
Hwei-Hsien Chen, (Taiwan), P-H Chiu, M-H Chan, C-Y Lin<br />
11:55 - 12:10 FC17.1.6 Free Communication Presentation:<br />
Molecular imaging in Alzheimer’s disease: From basic to clinical.<br />
Kazuhiko Yanai, (Japan), S Furumoto, T Yoshikawa, R Iwata, M Tashiro, N Okamura<br />
98 Wednesday 21 July ■ 09:30 - 12:15 ■ Auditorium 11
YI<br />
Young investigators’ session<br />
Chairs: Sue Piper Duckles, (USA) and SJ Enna, (USA)<br />
09:30 - 09:45 YI.01 Free Communication Presentation: Reversible allosteric inhibition of RGS GAP activity by<br />
small molecules reveals a general mechanism for inhibition of protein-protein interactions<br />
Levi Blazer, (USA), B Greedy, S Husbands, R Neubig<br />
09:45 - 10:00 YI.02 Free Communication Presentation: Intranasal delivery of mesenchymal stem cells to the<br />
brain<br />
Lusine Danielyan, (Germany), R Schäfer, A von Ameln-Mayerhofer, F Bernhard,<br />
S Verleysdonk, M Buadze, B Proksch, GH Buniatian, M Schwab, WH Frey II, CH Gleiter<br />
10:00 - 10:15 YI.03 Free Communication Presentation: Functional and structural analysis of NO production by<br />
equine and naturally occurring estrogens<br />
Ana Paula Dantas, (Spain), L Novensa, J Selent, M Pastor, K Sandberg, M Heras<br />
10:15 - 10:30 YI.04 Free Communication Presentation: The impact of TCF7L2 variants on antidiabetic<br />
treatment regime selection: a Malaysian perspective<br />
Muhammad H Haron, (Malaysia), R Pendek, Z Mohamed, VL Raj, NA Abdullah<br />
10:30 - 10:45 YI.05 Free Communication Presentation: The ryanodine receptor – BKCa channel signaling in<br />
erectile function<br />
Shreena Joshi, (UK), M Werner, M Nelson<br />
10:45 - 11:15 COFFEE BREAK<br />
11:15 - 11:30 YI.06 Free Communication Presentation: Lipocalin-2, an inflammatory adipokine, uncouples<br />
endothelial nitric-oxide synthase and enhances endothelial dysfunction caused by dietary<br />
obesity<br />
Jacky TC Liu, (PR China), A Xu, TW Mak, CF Liang, IKM Law, RYK Man, PM Vanhoutte,<br />
Y Wang<br />
11:30 - 11:45 YI.07 Free Communication Presentation: Association between Pro12Ala polymorphism of the<br />
PPAR-gamma2 gene and insulin sensitivity in Iranian patients with type II diabetes mellitus<br />
Azadeh Motavallian Naeini, (Iran), H Mirmohammad Sadeghi, M Amini, F Moazen<br />
11:45 - 12:00 YI.08 Free Communication Presentation: Co-administration of ondansetron reduces the<br />
analgesic efficacy of tramadol in postoperative pain in humans<br />
Ana Carolina Pereira do Vale, (Portugal), MFSC Oliveira, JPFC Assunção, CF Ribeiro,<br />
FC Pereira<br />
12:00 - 12:15 YI.09 Free Communication Presentation: Molecular predictors in dhfr and dhps genes and in<br />
vivo response to antifolate in Plasmodium falciparum malaria in Nigerian children<br />
Ernest Tambo, (Benin), CT Happi, GO Gbotosho, OA Folarin, A Sowunmi, MJ Oduola<br />
12:15 - 12:30 YI.10 Free Communication Presentation: Identification of a small molecule inhibitor of the<br />
PICK1 PDZ domain that inhibits hippocampal LTP and LTD<br />
Thor S Thorsen, (Denmark), KL Madsen, N Rebola, MA Rathje, V Anggono, A Bach,<br />
IS Moreira, N Stuhr-Hansen, T Dyhring, D Peters, T Beuming<br />
Wednesday 21 July ■ 09:30 - 12:30 ■ Meeting Room BV 1/2/3 99
W04<br />
Symposium: Antioxidants as therapeutic targets<br />
Organized by: Canadian Society of Pharmacology and Therapeutics<br />
Leader: Issy Laher, (Canada)<br />
Part III – Antioxidants as therapeutic targets<br />
Chairs: Issy Laher, (Canada) & Christopher M Rembold, (USA)<br />
12:45 - 13:05 W04.3.1 Molecular aspects of ROS generation by Noxes – (patho)physiological implications<br />
Rhian Touyz, (Canada)<br />
13:05 - 13:25 W04.3.2 Investigations of green tea polyphenols using the mouse model of Duchenne muscular<br />
dystrophy<br />
Urs T Ruegg, (Switzerland), C Gallo, J Patte-Reutenauer, E Gayi, O Dorchies<br />
13:25 - 13:45 W04.3.3 Sirtuin1 is a molecular switch for cardiovascular oxidative stress<br />
Huige Li, (Germany)<br />
13:45 - 14:05 W04.3.4 Success and failures in the use of anti-oxidants<br />
Christopher M Rembold, (USA)<br />
100 Wednesday 21 July ■ 12:45 - 14:15 ■ Meeting Room 18/19
W20<br />
Workshop. Pharmacology education for a<br />
sustainable future<br />
Organized by: IUPHAR Teaching Section<br />
Leaders: Christiaan B Brink, (South Africa) & Patangi K Rangachari,<br />
(Canada)<br />
Pharmacology education for a sustainable future<br />
Chair: Joan M Lakoski, (USA)<br />
12:45 - 13:05 W20.1 E-learning and e-assessment in pharmacology<br />
Paul White, D Dewhurst<br />
13:05 - 13:25 W20.2 Teaching pharmacology in a global arena<br />
Christiaan B Brink, (South Africa)<br />
13:25 - 13:45 W20.3 Active teachers/ engaged students: A status report<br />
Patangi K Rangachari, (Canada)<br />
13:45 - 14:05 W20.4 Pharmacology education for clinical students<br />
Simon Maxwell, (UK)<br />
Wednesday 21 July ■ 12:45 - 14:15 ■ Hall A2 101
W21<br />
Workshop. Inflammation – here, there and<br />
everywhere<br />
Organized by: Finnish Pharmacological Society<br />
Leaders: Heikki Vapaatalo, (Finland) & Eeva Moilanen, (Finland)<br />
Inflammation – here, there and everywhere<br />
Award Winners’ Symposium – Young Investigators from Finland<br />
Chairs: Heikki Vapaatalo, (Finland) & Eeva Moilanan, (Finland)<br />
12:45 - 13:00 W21.1 Inflammation in vasculature – could it be affected by nutrition<br />
Pauliina Jäkälä, (Finland)<br />
13:00 - 13:15 W21.2 Novel immunomodulatory factors in cardiac hypertrophy and heart failure<br />
Jaana Rysä, (Finland)<br />
13:15 - 13:30 W21.3 Neuroinflammation – Stem-cell derived neural progenitors and inflammatory response in<br />
a mouse model of cerebral stroke<br />
Katja A Puttonen, (Finland), K Savolainen, M Ruponen, T Malm, J Koponen,<br />
S Ylä-Herttuala, J Koistinaho, O Hovatta, A Muona<br />
13:30 - 13:45 W21.4 Inflammation and obesity – neuropeptide Y in pathogenesis of metabolic syndrome<br />
Suvi Ruohonen, (Finland), L Toukola, S Ruohonen, M Röyttä, E Savontaus<br />
13:45 - 14:00 W21.5 Novel treatments of arthritis – MAP kinase pathways in the focus<br />
Riina Nieminen, (Finland), R Korhonen, T Moilanen, AR Clark, E Moilanen<br />
102 Wednesday 21 July ■ 12:45 - 14:15 ■ Hall A3
W22<br />
Workshop. The Pfizer senior investigator award in<br />
pharmacology<br />
Organized by: Canadian Society of Pharmacology and Therapeutics<br />
Leader: Kathryn Gaebel, (Canada)<br />
The Pfizer senior investigator award in pharmacology<br />
Chair: Richard Kim, (Canada)<br />
13:00 - 14:00 W22 From Peroxynitrite to Tetracyclines: Targeting intracellular matrix metalloproteinase-2 in<br />
heart disease<br />
Richard Schulz, (Canada)<br />
Wednesday 21 July ■ 12:45 - 14:15 ■ Auditorium 15 103
W23<br />
Workshop. Applying pharmacogenomics (PGX) from<br />
research into clinical practice: Present and future<br />
Organized by: The Japanese Society of Clinical Pharmacology and<br />
Therapeutics<br />
Leader: Hiroshi Watanabe, (Japan)<br />
Applying pharmacogenomics (PGX) from research into clinical practice:<br />
Present and future<br />
Chairs: Shinichi Kawai, (Japan) & Kyoichi Ohashi, (Japan)<br />
12:45 - 13:00 W23.1 PGx from research into clinical practice (overview)<br />
Hiroshi Watanabe, (Japan), K Takeuchi, N Inui<br />
13:00 - 13:15 W23.2 GWAS and PGx in rheumatological treatment<br />
Naoyuki Kamatani, (Japan)<br />
13:15 - 13:30 W23.3 Pharmacogenetics and cardiovascular treatment<br />
Dan M Roden, (USA)<br />
13:30 - 13:45 W23.4 PGx and treatment of upper GI disorders<br />
Takahisa Furuta, (Japan), M Sugimoto, C Kodaira, M Nishino, M Yamade, T Uotani,<br />
K Umemura, H Watanabe<br />
13:45 - 14:00 W23.5 PGx and cancer treatment<br />
Magnus Ingelman-Sundberg, (Sweden)<br />
104 Wednesday 21 July ■ 12:45 - 14:15 ■ Auditorium 10
W24<br />
Workshop. EU Innovative Medicines Initiative:<br />
Better and safer drugs faster for the public<br />
Organized by: EU IMI<br />
Leader: Adam Vas, (Hungary)<br />
EU Innovative Medicines Initiative: Better and safer drugs faster for the<br />
public<br />
Chairs: Adam Vas, (Hungary) & Michel Goldman, (Belgium)<br />
12:45 - 13:05 W24.1 Innovative Medicines Initiative: The EU at the forefront of novel R&D partnerships<br />
Michel Goldman, (Belgium)<br />
13:05 - 13:25 W24.2 Challenges and opportunities in drug research<br />
Christian Noe, (Austria)<br />
13:25 - 13:45 W24.3 IMI and the Hungarian answer: National platform on drug research<br />
Adam Vas, (Hungary)<br />
13:45 - 14:05 W24.5 Stem cells and microRNA in drug discovery<br />
Jozef Dulak, (Poland)<br />
Wednesday 21 July ■ 12:45 - 14:15 ■ Auditorium 11 105
W25<br />
Workshop. High science in the lowlands<br />
Organized by: NVF – Dutch Pharmacological Society<br />
Leaders: AE Alewijnse, (The Netherlands) & Aletta K Kraneveld,<br />
(The Netherlands)<br />
High science in the lowlands<br />
Chairs: Astrid E Alewijnse, (The Netherlands) & Martina Schmidt,<br />
(The Netherlands)<br />
12:45 - 13:10 W25.1 GPCR crystal structures: She is beautiful<br />
Adriaan P IJzerman, (The Netherlands)<br />
13:10 - 13:35 W25.2 Love for opium and beyond<br />
Jan Marius van Ree, (The Netherlands)<br />
13:35 - 14:00 W25.3 Endothelial pharmacology in the Dutch Top Institute Pharma<br />
Jo GR de Mey, (The Netherlands)<br />
106 Wednesday 21 July ■ 12:45 - 14:15 ■ Auditorium 12
W26<br />
Workshop. Translational human bio-markers for<br />
pain and disease severity in drug development<br />
Organized by: Center for Sensory-Motor Interaction (SMI) Aalborg<br />
University and Nordic Bioscience a/s, Denmark<br />
Leader: Lars Arendt-Nielsen, (Denmark)<br />
Translational human bio-markers for pain and disease severity in drug<br />
development<br />
Chair: Lars Arendt-Nielsen, (Denmark)<br />
12:45 - 13:00 W26.1 Translational human pain bio-markers in early drug development<br />
Lars Arendt-Nielsen, (Denmark)<br />
13:00 - 13:15 W26.2 Biochemical markers of tissue remodelling: translational science and the FDA critical<br />
path – marker of prognosis and drug efficacy in arthritis<br />
Morten A Karsdal, (Denmark), A-C Bay-Jensen, K Henriksen, C Christiansen<br />
13:15 - 13:30 W26.3 Inflammatory pain-biomarkers assessed by microdialysis: A new method for target<br />
validation of new compounds<br />
Lars J Petersen, (Denmark)<br />
13:30 - 13:45 W26.4 Bio-markers related to cartilage degradation and pain in arthritic diseases: Combining<br />
MRI and biochemical marker based techniques<br />
Anne Christine Bay-Jensen, (Denmark), K Henriksen, C Christiansen, E Dam, M Karsdal<br />
13:45 - 14:00 W26.5 The impact of combining different biochemical markers in the evaluation of drugs within<br />
pain in early clinical development<br />
Hans Christian Hoeck, (Denmark)<br />
Wednesday 21 July ■ 12:45 - 14:15 ■ Meeting Room BV 1/2/3 107
W27<br />
Workshop. Approaches to medicinal plant research<br />
in Africa: Strategy towards 2014 and beyond<br />
Organized by: Pharmacology for Africa (PharfA) Initiative<br />
Leader: Christiaan B Brink, (South Africa)<br />
Approaches to medicinal plant research in Africa: Strategy towards 2014<br />
and beyond<br />
Chair: Douglas W Oliver, (South Africa)<br />
12:45 - 13:00 W27.1 Purified plant extracts as lead compounds in pharmacology research<br />
Anis Klouz, (Tunisia)<br />
13:00 - 13:15 W27.2 The utilization of crude plant extracts to investigate pharmacological effects: Potential<br />
and pitfalls<br />
Badiaa Lyoussi, (Morocco)<br />
13:15 - 13:30 W27.3 The utilization of crude plant extracts to investigate toxicity: Potential and pitfalls<br />
Anastasia Guantai, (Kenya)<br />
13:30 - 13:45 W27.4 Clinical testing and pharmacovigilance data for scientific evaluation of medicinal plants<br />
used in traditional medicine<br />
Alexander Dodoo, (Ghana)<br />
13:45 - 14:00 W27.5 Cultural-ethical dilemmas in medicinal plant research<br />
Guata Yoro Sy, (Senegal)<br />
14:00 - 14:15 Approaches to medicinal plant research – What works best in Africa Opportunities in<br />
Africa, pitfalls, capacity building strategies, way forward towards 2014 and beyond<br />
Panel Discussion led by Douglas W Oliver, (South Africa)<br />
108 Wednesday 21 July ■ 12:45 - 14:15 ■ Meeting Room 20
FC10<br />
Drugs for half the world:<br />
Paediatric clinical pharmacology<br />
Leader: John N van den Anker, (USA)<br />
FC10.2<br />
WHO and medicines in developing countries<br />
Chair: Kalle Hoppu, (Finland)<br />
14:30 - 14:55 FC10.2.1 Introduction & background : Why and how was the resolution WHA 60.20 better<br />
medicines for children born<br />
Kalle Hoppu, (Finland)<br />
14:55 - 15:20 FC10.2.2 Essential Medicines List for children and other activities related to paediatric medicines<br />
by the WHO<br />
Suzanne R Hill, (Switzerland)<br />
15:20 - 1545 FC10.2.3 Essential medicines list for children, what it means for the developing countries<br />
Shalini Sri Ranganathan, (Sri Lanka)<br />
15:45 - 16:15 COFFEE BREAK<br />
16:15 - 16:40 FC10.2.4 Case: Use of old data and modern scientific methods to provide more rational dosing<br />
and FDC formulations of TB medicines for children<br />
Gregory L Kearns, (USA), SM Abdel-Rahman<br />
16:40 - 16:55 FC10.2.5 Free Communication Presentation:<br />
Homocysteine as a biomarker for vascular disease in children and adolescents with<br />
epilepsy<br />
Laura S Cheng, (Canada), DJ Freeman, FH Mahmud, AN Prasad, MJ Rieder<br />
16:55 - 17:10 FC10.2.6 Free Communication Presentation:<br />
Antibiotic resistance of E.coli urinary tract isolates in pediatric patients hospitalized in a<br />
University Pediatric Hospital in Novi Sad, Serbia<br />
Emil Jakovljevic, (Republic of Serbia), K Ilic, G Kostantinidis<br />
Wednesday 21 July ■ 14:30 - 17:15 ■ Meeting Room 18/19 109
FC11<br />
G protein-coupled 7TM receptors:<br />
From molecular to physiological function<br />
Supported by an unrestricted grant from Novo Nordisk Foundation<br />
Leaders: Brian K Kobilka, (USA) & Jean-Philippe Pin, (France)<br />
FC11.2<br />
7TM receptors: Activation, inactivation and allosteric modulation<br />
Chairs: Jean Philippe R Pin, (France) & Thue W Schwartz, (Denmark)<br />
14:30 - 14:55 FC11.2.1 Molecular dynamics of metabotropic glutamate and GABA receptors<br />
Jean Philippe R Pin, (France), L Comps-Agrar, C Monnier, E Trinquet, J Kniazeff,<br />
P Rondard, L Prezeau<br />
14:55 - 15:20 FC11.2.2 Allosteric GPCR modulators: taking advantage of permissive receptor pharmacology<br />
Arthur Christopoulos, (Australia)<br />
15:20 - 15:45 FC11.2.3 Allosteric modulation of adenosine receptors<br />
Adriaan P IJzerman, (The Netherlands)<br />
15:45 - 16:15 COFFEE BREAK<br />
16:15 - 16:40 FC11.2.4 Activation and inactivation of chemokine 7TM receptors<br />
Mette M Rosenkilde, (Denmark)<br />
16:40 - 16:55 FC11.2.5 Free Communication Presentation:<br />
Towards pharmacological tissue selectivity: screening for novel nicotinic acid receptor<br />
ligands that avoid on-target adverse effects<br />
Clara C Blad, (The Netherlands), JP van Veldhoven, MR van Winsen, J Brussee, JR Lane,<br />
AP Ijzerman<br />
16:55 - 17:10 FC11.2.6 Free Communication Presentation:<br />
Serotonin 2A receptor interaction with the microtubule-associated protein 1A:<br />
Implications for Alzheimer’s disease<br />
Christoffer Clemmensen, (Denmark), AB Klein, GM Knudsen, S Aznar<br />
110 Wednesday 21 July ■ 14:30 - 17:15 ■ Auditorium 10
FC12<br />
Ion channelopathies:<br />
New windows on complex disease and therapy<br />
Leader: William A Catterall, (USA)<br />
FC12.2<br />
Ion channelopathies of peripheral nerve and muscle: Inherited pain and<br />
periodic paralysis<br />
Chairs: Sulayman D Dib-Hajj, (USA) & Karin Jurkat-Rott, (Germany)<br />
14:30 - 14:55 FC12.2.1 Functional effects of sodium channel mutations in inherited chronic pain syndromes<br />
Sulayman D Dib-Hajj, (USA), SG Waxman<br />
14:55 - 15:20 FC12.2.2 Selective inhibition of voltage-gated sodium channels by gating modifier toxins<br />
Theodore R Cummins, (USA), Y Xiao<br />
15:20 - 15:45 FC12.2.3 Leak-induced pathogenesis and treatment of periodic paralysis<br />
Karin Jurkat-Rott, (Germany), M-A Weber, M Fauler, F Lehmann-Horn<br />
15:45 - 16:15 COFFEE BREAK<br />
16:15 - 16:40 FC12.2.4 Gating pore cation currents in hypokalemic and normokalemic periodic paralysis<br />
Todd Scheuer, (USA)<br />
16:40 - 16:55 FC12.2.5 Free Communication Presentation:<br />
Ca 2+ release-activated Ca 2+ channel is a promising target for vascular proliferative<br />
diseases<br />
Jing Li, (PR China), Y Yu, T Wang, Y Wang, G He, X Zheng, J Soboloff, D Gill, X Tang<br />
Wednesday 21 July ■ 14:30 - 17:15 ■ Meeting Room 20 111
FC13<br />
Maximising benefits and minimising harms from<br />
drugs<br />
Organized by the British Pharmacological Society<br />
Leaders: Munir Pirmohamed, (UK) & Brian Kevin Park, (UK)<br />
FC13.2<br />
Drug metabolism and drug toxicity<br />
Chairs: Frank J Gonzalez, (USA) & B Kevin Park, (UK)<br />
14:30 - 14:55 FC13.2.1 Use of human pregnane X receptor and CYP3A4 double-humanized mice in the study of<br />
drug toxicity and efficacy<br />
Frank J Gonzalez, (USA), X Ma, J Cheng<br />
14:55 - 15:20 FC13.2.2 Chemically reactive metabolites: Separating fiction from facts<br />
Brian Kevin Park, (UK)<br />
15:20 - 15:45 FC13.2.3 The importance of studying mechanisms of cell death in toxicology<br />
Sten Orrenius, (Sweden)<br />
15:45 - 16:15 COFFEE BREAK<br />
16:15 - 16:40 FC13.2.4 Pharmacogenetics of drug metabolism – TPMT as a paradigm<br />
William E Evans, (USA)<br />
16:40 - 16:55 FC13.2.5 Free Communication Presentation:<br />
In vitro preclinical cardiac safety pharmacology: Development of drug proarrhythmic<br />
measurement with human embryonic stem cell derived cardiomyocyts network<br />
Tetsuo Kitamura, (Japan), F Nomura, T Kaneko, P Sartipy, K Fukuda, A Sugiyama,<br />
M Sekijima, K Yasuda<br />
16:55 - 17:10 FC13.2.6 Free Communication Presentation:<br />
The hepatic extraction of paracetamol is reduced in old age following a single pass<br />
through the isolated perfused rat liver<br />
Sarah Mitchell, (Australia), A Huizer-Pajkos, D Le Couteur, A McLachlan, S Hilmer<br />
112 Wednesday 21 July ■ 14:30 - 17:15 ■ Hall A2
FC14<br />
Addiction and doping: Neurobiological and clinical<br />
basis of emerging treatments<br />
Leaders: Markus Heilig, (USA) & Yavin Shaham, (USA)<br />
FC14.2<br />
Pharmacological treatments of alcohol dependence – illusion or<br />
opportunity<br />
Chairs: Rainer Spanagel, (Germany) & Barbara J Mason, (USA)<br />
14:30 - 14:55 FC14.2.1 Targeting glutamate receptors – preclinical and clinical studies<br />
Rainer Spanagel, (Germany)<br />
14:55 - 15:20 FC14.2.2 Targeting GABA system: Role of GABABergic drugs<br />
Giovanni Addolorato, (Italy)<br />
15:20 - 15:45 FC14.2.3 The α3β4* neuronal nicotinic acetylcholine receptor plays an important role in ethanol<br />
consumption and seeking<br />
Selena E Bartlett, (USA), S Chatterjee, P Steensland, J Simms, J Holgate, JW Coe,<br />
RS Hurst, C Schaffer, H Rollema<br />
15:45 - 16:15 COFFEE BREAK<br />
16:15 - 16:40 FC14.2.4 Gabapentin in alcoholism: from laboratory study to clinical trial<br />
Barbara J Mason, (USA)<br />
16:40 - 16:55 FC14.2.5 Free Communication Presentation:<br />
The effects of the opiate neutral antagonist 6beta-naltrexol in opiate dependent subjects<br />
John Mendelson, (USA), K Flower, CW Harris, W Sadee, W Snape, GP Galloway<br />
16:55 - 17:10 FC14.2.6 Free Communication Presentation:<br />
The influence of a cysteinyl leukotriene receptor (CysLT-R) antagonist on experimental<br />
morphine-induced physical dependence<br />
Mihai Nechifor, (Romania), M Cuciureanu, D Chelarescu<br />
Wednesday 21 July ■ 14:30 - 17:15 ■ Auditorium 12 113
FC15<br />
Endothelium in Health and disease<br />
Organized by the British Pharmacological Society<br />
Leaders: Christopher J Garland, (UK) & Arthur Weston, (UK)<br />
FC15.1<br />
Nitric oxide and oxidative stress<br />
Chairs: Alex F Chen, (USA) & Christopher G Sobey, (Australia)<br />
14:30 - 15:00 FC15.1.1 Interaction of NOS and ROS in vascular disease<br />
Ralph P Brandes, (Germany)<br />
15:00 - 15:30 FC15.1.2 eNOS uncoupling and vascular disease<br />
Alex F Chen, (USA)<br />
15:30 - 15:45 FC15.1.3 Free Communication Presentation:<br />
Exercise in type 2 diabetes: some mechanistic insights<br />
Ismail Laher, (Canada)<br />
15:45 - 16:15 COFFEE BREAK<br />
16:15 - 16:45 FC15.1.4 NADPH oxidase and therapeutic targeting<br />
Christopher G Sobey, (Australia), S Selemidis, G Drummond<br />
16:45 - 17:00 FC15.1.5 Free Communication Presentation:<br />
Role of Annexin A1 at the blood brain barrier level in mediating the brain response to<br />
inflammation<br />
Enrico Cristante, (UK), S McArthur, G Gillies, E Solito<br />
17:00 - 17:15 FC15.1.6 Free Communication Presentation:<br />
Xanthine oxidase inhibition for the treatment of cardiovascular disease: A systematic<br />
review and meta-analysis<br />
Peter Higgins, (UK), J Dawson, KR Lees, K McArthur, TJ Quinn, MR Walters<br />
114 Wednesday 21 July ■ 14:30 - 17:15 ■ Hall A3
FC16<br />
Natural products: Past and future<br />
Organized by the IUPHAR Section on the Pharmacology of Natural<br />
Products<br />
Leaders: Ricky Ying-Keung Man, (PR China), Tai-Ping Fan, (UK) &<br />
Zhi-bin Lin, (PR China)<br />
FC16.2<br />
Products derived from one single plant with convincing pharmacological<br />
data in explaining their mechanism of action<br />
Chairs: Yong-Xiang Zhang, (PR China) & Rudolf Bauer, (Austria)<br />
14:30 - 14:55 FC16.2.1 Pharmacological and clinical research on Ganoderma lucidum (Lingzhi) in China<br />
Zhi-Bin Lin, (PR China)<br />
14:55 - 15:20 FC16.2.2 Molecular actions of alkamides from Echinacea explaining their immunomodulatory<br />
activity<br />
Rudolf Bauer, (Austria)<br />
15:20 - 15:45 FC16.2.3 Memory retrieval improvement by Ptychopetalum olacoides, a traditional Amazonian<br />
medicine<br />
Elaine Elisabetsky, (Brazil), AL da Silva, M Figueiró<br />
15:45 - 16:15 COFFEE BREAK<br />
16:15 - 16:40 FC16.2.4 Novel synergistic and/or side-effects neutralizing combinations of activities in natural<br />
products<br />
Anwar-ul-Hassan Gilani, (Pakistan)<br />
16:40 - 16:55 FC16.2.5 Free Communication Presentation:<br />
Blockade by nanomolar resveratrol of exocytosis, but not fusion pore formation in<br />
chromaffin cells<br />
Antonio G Garcia, (Spain), JC Fernandez-Morales, AMG De Diego, JC Gonzalez, L Cortes,<br />
M Yañez, F Orallo, J Hernández-Guijo<br />
16:55 - 17:10 FC16.2.6 Free Communication Presentation:<br />
Lutein inhibits the function of transient receptor potential A1 in different in vitro and in<br />
vivo models<br />
Zsuzsanna Helyes, (Hungary), E Szoke, A Kemeny, P Molnar, J Deli, L Szente, T Bozo,<br />
A Pal, A Devay, M Simonyi, J Szolcsanyi, G Horvath<br />
Wednesday 21 July ■ 14:30 - 17:15 ■ Auditorium 15 115
FC17<br />
New approaches and targets in psychiatry<br />
Supported by an unrestricted grant from H Lundbeck A/S, Denmark<br />
Leaders: David J Nutt, (UK) & Birte Glenthøj, (Denmark)<br />
FC17.2<br />
Exploring new targets in schizophrenia using translation science<br />
Chairs: P Jeffrey Conn, (USA) & Torgny H Svensson, (Sweden)<br />
14:30 - 14:55 FC17.2.1 Mutants in translation: Can new models of schizophrenia provide new insight & targets<br />
John L Waddington, (Ireland), C O'Tuathaigh<br />
14:55 - 15:20 FC17.2.2 Neural synchrony as a pathophysiological mechanism in schizophrenia<br />
Peter J Uhlhaas, (Germany), C Gruetzner, M Wibral, M Leweke, W Singer<br />
15:20 - 15:45 FC17.2.3 Allosteric modulators of GPCRs for treatment of schizophrenia<br />
P Jeffrey Conn, (USA)<br />
15:45 - 16:15 COFFEE BREAK<br />
16:15 - 16:40 FC17.2.4 What can we learn from the existing drugs with atypical profiles<br />
Torgny H Svensson, (Sweden)<br />
16:40 - 16:55 FC17.2.5 Free Communication Presentation:<br />
Spadin: A new concept in the antidepressant drug design<br />
Catherine Heurteaux, (France), J Mazella, O Petrrault, G Lucas, E Deval,<br />
S Beraud-Dufour, M El-Yacoubi, A Guyon, C Widmann, E Chevet, J-L Nahon, M Borsotto<br />
16:55 - 17:10 FC17.2.6 Free Communication Presentation:<br />
Antidepressant-like effects of Commiphora Mukul resin and involvement of serotonergic<br />
system in forced swimming test in mice<br />
Mahsa Hadipour Jahromy, (Iran), SH Khakpour, M Faal, MH Jahromy<br />
116 Wednesday 21 July ■ 14:30 - 17:15 ■ Auditorium 11
BRAINMATES<br />
Got world-class professional skills That’s a good start<br />
At Lundbeck,<br />
we are connected in<br />
a<br />
very special way.<br />
Something beyond<br />
words,<br />
formulas, and procedures<br />
binds<br />
us together.<br />
In everything we do–<br />
from our everyday interaction to<br />
our<br />
greatest scientific discoveries – we are<br />
united by a passion and responsibility<br />
for helping the people who rely on<br />
our CNS solutions.<br />
Creating successful medicine depends<br />
on uniting many different processes<br />
ses<br />
and specialist skills. We<br />
cover the<br />
entire value chain from discovering an<br />
interesting molecule through<br />
testing,<br />
regulatory approval and marketing,<br />
to distributing and selling the<br />
tab-<br />
lets worldwide.<br />
This takes a highly<br />
developed and innovative culture of<br />
cooperation.<br />
Our solution is an interpeople<br />
national network of talented exchanging knowledge<br />
and developing<br />
ideas.<br />
We call them Brainmates.<br />
Our researchers,<br />
for instance,<br />
are not<br />
only highly specialized.<br />
They also mas-<br />
ter the art of cross-functional nal communication<br />
and collaboration. That<br />
is howwe we turn a linear step-by-step<br />
R&D process into a flowofof knowledge<br />
that achieves better results. s.<br />
So if you<br />
have high-level skills in your field and<br />
value cooperation,<br />
you could be one<br />
of our new wBrainmates.<br />
Pursue Brainmate opportunities at www.lundbeck.com/careers
FC18<br />
Nuclear receptor targets for treatment of diseases<br />
Supported by an unrestricted grant from Novo Nordisk Foundation<br />
Leaders: Bart Staels, (France) & Vincent Laudet, (France)<br />
Local coordinator: Susanne Mandrup, (Denmark)<br />
FC18.1<br />
Nuclear receptors and metabolic control<br />
Chairs: David J Mangelsdorf, (USA) & Susanne Mandrup, (Denmark)<br />
14:30 - 14:55 FC18.1.1 Control of cholesterol homeostasis by LXRs<br />
Peter Tontonoz, (USA)<br />
14:55 - 15:20 FC18.1.2 From metabolism to development via nuclear receptors<br />
Béatrice Desvergne, (Switzerland)<br />
15:20 - 15:45 FC18.1.3 Nuclear Receptor Regulation of Feeding and Fasting<br />
David J Mangelsdorf, (USA), SA Kliewer<br />
15:45 - 16:15 COFFEE BREAK<br />
16:15 - 16:40 FC18.1.4 PPAR γ in adipocyte differentiation and metabolic control<br />
Susanne Mandrup, (Denmark)<br />
16:40 - 16:55 FC18.1.5 Free Communication Presentation:<br />
Activation of peroxisome proliferator-activated receptor-beta/delta reduced splanchnic<br />
ischemia and reperfusion injury<br />
Salvatore Cuzzocrea, (Italy), R Di Paola, E Esposito, E Mazzon, I Paterniti, M Galuppo,<br />
T Genovese, P Bramanti<br />
16:55 - 17:10 FC18.1.6 Free Communication Presentation:<br />
Central PPAR-α activation reduces pain and hyperalgia in mice via NF-kB inhibition<br />
Giuseppe D'Agostino, (Italy), G La Rana, R Russo, O Sasso, A Iacono, R Meli,<br />
A Calignano<br />
118 Wednesday 21 July ■ 14:30 - 17:15 ■ Meeting Room BV 1/2/3
PL13<br />
Plenary Lecture<br />
Chair: Sergio H Ferreira, (Brazil)<br />
PL13<br />
New drug targets for headache<br />
Jes Olesen, (Denmark)<br />
Wednesday 21 July ■ 17:30 - 18:15 ■ Hall A2<br />
PL14<br />
Plenary Lecture<br />
Chair: Patrick du Souich, (Canada)<br />
PL14<br />
Toll-like receptor and innate immunity<br />
Shizuo Akira, (Japan), K Matsushita, O Takeuchi<br />
Wednesday 21 July ■ 17:30 - 18:15 ■ Hall A3<br />
PL15<br />
Plenary Lecture<br />
Chair: Kim Brøsen, (Denmark)<br />
PL15<br />
Understanding the neuroprotective effect of estrogen; inflammation, age<br />
and mitochondria<br />
Sue P Duckles, (USA)<br />
Wednesday 21 July ■ 17:30 - 18:15 ■ Auditorium 15<br />
Congress dinner in the Tivoli Gardens<br />
Wednesday 21 July 19:30<br />
Wednesday 21 July ■ 17:30 - 18:15 119
PL16<br />
Plenary Lecture<br />
Supported by an unrestricted grant from ADIS<br />
Chair: Munir Pirmohamed, (UK)<br />
PL16<br />
Drug metabolism – past, present and future<br />
Olavi Pelkonen, (Finland)<br />
Thursday 22 July ■ 08:30 - 09:15 ■ Hall A2<br />
PL17<br />
Plenary Lecture<br />
Chair: Edward Högestätt, (Sweden)<br />
PL17<br />
Therapeutic potential of vaccines in the management of hypertension<br />
Morris J Brown, (UK)<br />
Thursday 22 July ■ 08:30 - 09:15 ■ Hall A3<br />
PL18<br />
Plenary Lecture<br />
Chair: Christiaan B Brink, (South Africa)<br />
PL18 Teaching pharmacology in 2020<br />
Ian E Hughes, (UK)<br />
Thursday 22 July ■ 08:30 - 09:15 ■ Auditorium 15<br />
120 Thursday 22 July ■ 08:30 - 09:15
FC10<br />
Drugs for half the world:<br />
Paediatric clinical pharmacology<br />
Supported by an unrestricted grant from Hoffmann La Roche,<br />
Switzerland<br />
Leader: John N van den Anker, (USA)<br />
FC10.3<br />
Formulation issues<br />
Chairs: Jörg Breitkreutz, (Germany) & Klaus Rose, (Switzerland)<br />
09:30 - 09:55 FC10.3.1 End-user specifications for optimal paediatric formulations<br />
Atieno Ojoo, (Denmark), K Hoppu<br />
09:55 - 10:20 FC10.3.2 Novel drug formulations for children<br />
Jörg Breitkreutz, (Germany)<br />
10:20 - 10:45 FC10.3.3 Adapting formulations for children<br />
Anthony J Nunn, (UK)<br />
10:45 - 11:15 COFFEE BREAK<br />
11:15 - 11:40 FC10.3.4 Taste assessment and taste masking<br />
Catherine Tuleu, (UK)<br />
11:40 - 11:55 FC10.3.5 Free Communication Presentation:<br />
Drug interactions in the paediatric population<br />
Trevor Johnson, (UK), A Rostami-Hodjegan<br />
11:55 - 12:10 FC10.3.6 Free Communication Presentation:<br />
According to Summaries of Product Characteristics (SPC) most medicines in neonates<br />
are used off-label<br />
Jana Lass, (Estonia), K Jõgi, R Käär, T Metsvaht, H Varendi, I Lutsar<br />
Thursday 22 July ■ 09:30 - 12:15 ■ Meeting Room 18/19 121
FC11<br />
G protein-coupled 7TM receptors:<br />
From molecular to physiological function<br />
Supported by an unrestricted grant from Novo Nordisk Foundation<br />
Leaders: Brian K Kobilka, (USA) & Jean-Philippe Pin, (France)<br />
FC11.3<br />
7TM receptors: Scaffolding and signalling mechanisms<br />
Chairs: Michel Bouvier, (Canada) & Heidi E Hamm, (USA)<br />
09:30 - 09:55 FC11.3.1 G-Protein-Coupled Receptors as Oligomeric Signaling Machines<br />
Michel Bouvier, (Canada)<br />
09:55 - 10:20 FC11.3.2 New insights into mechanisms of receptor-mediated G protein activation<br />
Heidi E Hamm, (USA), A Preininger, N Van Eps, A Kaya, T Thacker, SM Meier,<br />
N Alexander, J Meiler, JL Vey, AI Kaya, LS Busenlehner, RN Armstrong, TM Iverson,<br />
WL Hubbell<br />
10:20 - 10:45 FC11.3.3 Scaffolding of G protein coupled receptors<br />
Laurant Fagni, (France), J Perroy, F Raynaud, E Moutin<br />
10:45 - 11:15 COFFEE BREAK<br />
11:15 - 11:40 FC11.3.4 Recent methodological advances in the discovery of GPCR-associated protein complexes<br />
Ralf Jockers, (France)<br />
11:40 - 11:55 FC11.3.5 Free Communication Presentation:<br />
The GABAB dimer of heterodimers: A physiological reality<br />
Laëtitia Comps-Agrar, (France), J Kniazeff, M Gassmann, M Laget, T Durroux, B Bettler,<br />
E Trinquet, J-P Pin<br />
11:55 - 12:10 FC11.3.6 Free Communication Presentation:<br />
A new family of mGluRs agonists identified by virtual screening binds in an extended<br />
glutamate binding pocket opening perspectives to develop potent and selective ligands<br />
Cyril Goudet, (France), B Vilar, C Selvam, I Lemasson, I Brabet, N Oueslati,<br />
H-O Bertrand, F Acher, J-P Pin<br />
122 Thursday 22 July ■ 09:30 - 12:15 ■ Auditorium 10
FC12<br />
Ion channelopathies:<br />
New windows on complex disease and therapy<br />
Leader: William A Catterall, (USA)<br />
FC12.3<br />
Ion channelopathies in the cardiovascular system: Inherited arrhythmia<br />
and hypertension<br />
Chairs: Michael C Sanguinetti, (USA) & Bernard C Rossier, (Switzerland)<br />
09:30 - 09:55 FC12.3.1 Molecular mechanisms of potassium channel dysfunction in long- and short-QT<br />
syndromes<br />
Michael C Sanguinetti, (USA)<br />
09:55 - 10:20 FC12.3.2 Sodium channelopathies in cardiac arrhythmia<br />
Alfred L George, (USA)<br />
10:20 - 10:45 FC12.3.3 Molecular mechanism of ryanodine receptor dysfunction in cardiac arrhythmia<br />
Andrew R Marks, (USA)<br />
10:45 - 11:15 COFFEE BREAK<br />
11:15 - 11:40 FC12.3.4 Liddle’s disease and salt-dependent hypertension<br />
Bernard C Rossier, (Switzerland)<br />
11:40 - 11:55 FC12.3.5 Free Communication Presentation:<br />
Different sodium channel currents and responses to class I antiarrhythmic drugs in rat<br />
atrial and ventricular myocytes<br />
Xiao-Hui Xu, (PR China), K-H Chen, G-R Li, M-W Jin<br />
11:55 - 12:10 General discussion<br />
Thursday 22 July ■ 09:30 - 12:15 ■ Meeting Room 20 123
FC13<br />
Maximising benefits and minimising harms from<br />
drugs<br />
Organized by the British Pharmacological Society<br />
Leaders: Munir Pirmohamed, (UK) & Brian Kevin Park, (UK)<br />
FC13.3<br />
Pharmacogenomics and adverse drug reactions<br />
Chairs: Steven J Leeder, (USA) & Munir Pirmohamed, (UK)<br />
09:30 - 09:55 FC13.3.1 The pharmacogenetics of drug hypersensitivity<br />
Simon Mallal, (Australia)<br />
09:55 - 10:20 FC13.3.2 Genetic predisposition to drug-induced liver toxicity<br />
Ann K Daly, (UK)<br />
10:20 - 10:45 FC13.3.3 Developmental considerations for severe adverse drug reactions in children<br />
Steven J Leeder, (USA)<br />
10:45 - 11:15 COFFEE BREAK<br />
11:15 - 11:40 FC13.3.4 Variability in response to anticoagulants<br />
Munir Pirmohamed, (UK)<br />
11:40 - 11:55 FC13.3.5 Free Communication Presentation:<br />
Pharmacokinetic (PK) modeling of factor V activity accurately predicts factor V levels<br />
after treatment with fresh frozen plasma<br />
Kathleen Neville, (USA), G Kearns, J Daniel, W Andrews, B Wicklund<br />
11:55 - 12:10 FC13.3.6 Free Communication Presentation:<br />
Association of beta-adrenergic receptor polymorphisms and mortality in carvedilol-treated<br />
chronic heart failure patients<br />
Morten Petersen, (Denmark), J Andersen, K Broedbaek, B Hjelvang, S Afzal,<br />
M Nyegaard, A Børglum, S Stender, L Køber, C Torp-Pedersen, H Poulsen<br />
124 Thursday 22 July ■ 09:30 - 12:15 ■ Hall A2
FC14<br />
Addiction and doping: Neurobiological and clinical<br />
basis of emerging treatments<br />
Leaders: Markus Heilig, (USA) & Yavin Shaham, (USA)<br />
FC14.3<br />
Craving and relapse to drug seeking: Lessons from animal models and<br />
human brain imaging<br />
Chair: Yavin Shaham, (USA)<br />
09:30 - 09:55 FC14.3.1 Synaptic plasticity in the mesolimbic system: therapeutic implications for substance<br />
abuse<br />
Antonello Bonci, (USA)<br />
09:55 - 10:20 FC14.3.2 The role of the drug environment in relapse to drug seeking: Lessons from rat studies<br />
Yavin Shaham, (USA), J Bossert<br />
10:20 - 10:45 FC14.3.3 Imaging craving in human addicts: Does it predict drug relapse<br />
Rajita Sinha, (USA), D Seo, C Lacadie, T Constable, K Bergquist<br />
10:45 - 11:15 COFFEE BREAK<br />
11:15 - 11:40 FC14.3.4 Incubation of craving in cigarette smokers<br />
Harriet de Wit, (USA)<br />
11:40 - 11:55 FC14.3.5 Free Communication Presentation:<br />
Targeting the delta opioid receptor effectively modulates ethanol consumption and<br />
seeking and represents a novel target for new therapies for alcohol use disorders<br />
Carsten Nielsen, (USA), J Simms, R Li, J Holgate, J Richards, S Ananthan, S Bartlett<br />
11:55 - 12:10 FC14.3.6 Free Communication Presentation:<br />
Histamine H3 receptor in the modulation of alcohol-related behaviors<br />
Saara Nuutinen, (Finland), Y Ojala, J Vanhanen, P Panula<br />
Thursday 22 July ■ 09:30 - 12:15 ■ Auditorium 12 125
FC15<br />
Endothelium in Health and disease<br />
Organized by the British Pharmacological Society<br />
Leaders: Christopher J Garland, (UK) & Arthur Weston, (UK)<br />
FC15.2<br />
Endothelium-dependent hyperpolarization<br />
Chairs: Chris J Garland, (UK) & Arthur Weston, (UK)<br />
09:30 - 09:55 FC15.2.1 SKCa and IKCa channels in myoendothelial signalling<br />
Arthur Weston, (UK), G Edwards<br />
09:55 - 10:20 FC15.2.2 Endothelial microdomains and integration of arterial dilatation<br />
Christopher J Garland, (UK), KA Dora<br />
10:20 - 10:45 FC15.2.3 The calcium-sensing receptor in blood pressure modula<br />
Jacob Tfelt-Hansen, (Denmark)<br />
10:45 - 11:15 COFFEE BREAK<br />
11:15 - 11:40 FC15.2.4 The function of calcium pulsars in endothelial cells<br />
Mark T Nelson, (USA)<br />
11:40 - 11:55 FC15.2.5 Free Communication Presentation:<br />
Nox4 NADPH oxidase is a transforming growth factor target gene in human vascular<br />
endothelial cells<br />
Jaing Fan, (PR China), H Peshavariya, C Chang, G Dusting<br />
11:55 - 12:10 FC15.2.6 Free Communication Presentation:<br />
Female apolipoprotein E-deficient mice are protected against the development of<br />
endothelial dysfunction with ageing<br />
Wing CB Kong, (PR China), RYK Man, PMV Vanhoutte, SWS Leung<br />
126 Thursday 22 July ■ 09:30 - 12:15 ■ Hall A3
FC16<br />
Natural products: Past and future<br />
Organized by the IUPHAR Section on the Pharmacology of Natural<br />
Products<br />
Leaders: Ricky Ying-Keung Man, (PR China), Tai-Ping Fan, (UK) &<br />
Zhi-bin Lin, (PR China)<br />
FC16.3<br />
Multiple plant products: A matter of synergy<br />
Chairs: Zhi-Bin Lin, (PR China) & Tai-Ping Fan, (UK)<br />
09:30 - 09:55 FC16.3.1 Defining the mechanism of action of Liuwei Dihuang decoction with nuclear-magneticresonance-spectroscopy-based<br />
metabonomic analysis<br />
Yong-Xiang Zhang, (PR China), N Jiang, W-X Zhou, X-Z Yan, Q Zhang<br />
09:55 - 10:20 FC16.3.2 Danshen diwan<br />
Henry Sun, (PR China)<br />
10:20 - 10:45 FC16.3.3 Choto-san and recognition behaviour<br />
Kinzo Matsumoto, (Japan)<br />
10:45 - 11:15 COFFEE BREAK<br />
11:15 - 11:30 FC16.3.4 Free Communication Presentation:<br />
Anti-inflammatory activity of extracts from Orthosiphon stamineus leaves<br />
Mirka Laavola, (Finland), R Nieminen, J Welling, H Vapaatalo, MF Yam, A Sadikun,<br />
Z Asmawi, R Basir, E Moilanen<br />
11:30 - 11:45 FC16.3.5 Free Communication Presentation:<br />
Development of an in vitro model for the assessment of pyrrolizidine alkaloids-induced<br />
hepatotoxicity<br />
Yanhong Li, (PR China), N Li, G Lin<br />
11:45 - 12:00 FC16.3.6 Free Communication Presentation:<br />
Composite anti-melanoma action of dry olive leaf extract<br />
Sanja Mijatovic, (Serbia), G Timotijevic, D Miljkovic, J Radovic, M Mojic,<br />
D Maksimovic-Ivanic, D Dekanski, S Stosic-Grujicic<br />
12:00 - 12:15 FC16.3.7 Free Communication Presentation:<br />
The green tea polyphenol (-)-epigallocatechin-3-gallate inhibits beta-amyloid-evoked fibril<br />
formation and neuronal toxicity in vitro<br />
Scott Smid, (Australia), B Harvey, U Musgrave<br />
Thursday 22 July ■ 09:30 - 12:15 ■ Auditorium 15 127
FC17<br />
New approaches and targets in psychiatry<br />
Supported by an unrestricted grant from H Lundbeck A/S, Denmark<br />
Leaders: David J Nutt, (UK) & Birte Glenthøj, (Denmark)<br />
FC17.3<br />
Clinical aspects of treatment with antipsychotics<br />
Chairs: Shitij Kapur, (UK) & Birte Glenthøj, (Denmark)<br />
09:30 - 10:00 FC17.3.1 The speed and onset of antipsychotic response – implications for theory and practise<br />
Shitij Kapur, (UK)<br />
10:00 - 10:30 FC17.3.2 Changes in cortical and subcortical dopamine D2 receptor binding in schizophrenia:<br />
Relation to psychopathology and treatment repsonse<br />
Birte Glenthøj, (Denmark)<br />
10:30 - 11:00 FC17.3.3 Personalized procognitive pharmacotherapy in schizophrenia<br />
Andreas Meyer-Lindenberg, (Germany)<br />
11:00 - 11:30 COFFEE BREAK<br />
11:30 - 12:00 FC17.3.4 Prospects for boosting cognition and treating cognitive decline<br />
Verity Brown, (UK)<br />
12:00 - 12:15 FC17.3.5 Free Communication Presentation:<br />
The inhibitory effect of olanzapine on psychotomimetic symptoms of<br />
tetrahydrocannabinol<br />
Hendrik Daniel Kleinloog, (The Netherlands), M Liem-Moolenaar, GE Jacobs, M de Kam,<br />
JMA van Gerven<br />
128 Thursday 22 July ■ 09:30 - 12:15 ■ Auditorium 11
FC18<br />
Nuclear receptor targets for treatment of diseases<br />
Supported by an unrestricted grant from Novo Nordisk Foundation<br />
Leaders: Bart Staels, (France) & Vincent Laudet, (France)<br />
Local coordinator: Susanne Mandrup, (Denmark)<br />
FC18.2<br />
Nuclear receptors, vascular function and inflammation<br />
Chairs: Christopher K Glass, (USA) & Bart Staels, (France)<br />
09:30 - 09:55 FC18.2.1 Nuclear receptor-dependent repression mechanisms that regulate inflammation<br />
Christopher K Glass, (USA)<br />
09:55 - 10:20 FC18.2.2 PPARa and residual cardiovascular risk<br />
Bart Staels, (France)<br />
10:20 - 10:45 FC18.2.3 Mineralocorticoid receptor and vascular function<br />
Peter Fuller, (Australia)<br />
10:45 - 11:15 COFFEE BREAK<br />
11:15 - 11:40 FC18.2.4 NR4A nuclear receptors and vascular function<br />
Carlie JM DeVries, (The Netherlands), C van Tiel, P Bonta, T Pols<br />
11:40 - 11:55 FC18.2.5 Free Communication Presentation:<br />
Induction of cardiac Angptl4 by dietary fatty acids is mediated by PPARδ and protects<br />
against oxidative stress<br />
Anastasia Georgiadi, (The Netherlands), L Lichtenstein, T Degenhardt, M Boekschoten,<br />
M Bilsen, B Desvergne, M Möller, S Kersten<br />
11:55 - 12:10 FC18.2.6 Free Communication Presentation:<br />
FXR agonists as novel medication for metabolic syndrome and NASH<br />
Claus Kremoser, (Germany), E Hambruch, U Abel, A Schulz, T Schlueter, B Birk,<br />
M Burnet, U Deuschle<br />
EPHAR council meeting<br />
in Meeting Room BV 1/2/3<br />
Thursday 22 July 12:45 - 14:15<br />
Thursday 22 July ■ 09:30 - 12:15 ■ Meeting Room BV 1/2/3 129
W28<br />
Workshop. The Boehringer-Ingelheim post-doctoral<br />
award<br />
Organized by: Canadian Society of Pharmacology and Therapeutics<br />
Leader: James Hammond, (Canada)<br />
The Boehringer-Ingelheim post-doctoral award<br />
Chair: James Hammond, (Canada)<br />
13:00 - 14:00 W28.1 The role of ion channels in neuroprotection against cerebral ischemia<br />
Hong-Shuo Sun, (Canada)<br />
130 Thursday 22 July ■ 12:45 - 14:15 ■ Hall A2
W29<br />
Workshop. New horizons in therapeutic drug<br />
management (TDM)<br />
Organized by: DSK2F, Danish Society of Clinical Chemical<br />
Pharmacology<br />
Leader: Helle R Angelo, (Denmark)<br />
New horizons in therapeutic drug management (TDM)<br />
Chairs: Per Hartvig Honore, (Denmark) & Helle Riis Angelo, (Denmark)<br />
12:45 - 13:05 W29.1 Improved psychotropic therapy using TDM<br />
Finn Bengtsson, (Sweden)<br />
13:05 - 13:25 W29.2 Prediction of individual antibiotic dose in the clinic<br />
Inga Odenholt, (Sweden)<br />
13:25 - 13:45 W29.3 Antibiotic dose prediction from in vitro and in vivo population data<br />
Elisabet Nielsen, (Sweden), A Mohamed, L Friberg<br />
13:45 - 14:05 W29.4 Therapeutic drug monitoring, a practical application<br />
C Kees Neef, (The Netherlands), DJ Touw<br />
Thursday 22 July ■ 12:45 - 14:15 ■ Hall A3 131
W30<br />
Workshop. Is eNOS still a valid therapeutic target<br />
– the era after the discovery of eNOS uncoupling<br />
Supported by unrestricted grants from<br />
Sanofi-Aventis Deutschland GmbH and Actavis Deutschland GmbH<br />
Leader: Huige Li, (Germany)<br />
Is eNOS still a valid therapeutic target – the era after the discovery of<br />
eNOS uncoupling<br />
Chair: Huige Li, (Germany)<br />
12:45 - 13:00 Introduction: All roads lead to eNOS<br />
Huige Li, (Germany)<br />
13:00 - 13:15 W30.1 Molecular mechanisms of eNOS uncoupling<br />
Yong Xia, (USA)<br />
13:15 - 13:30 W30.2 Pharmacological approaches to recouple eNOS<br />
Andreas Daiber, (Germany)<br />
13:30 - 13:45 W30.3 Posttranslational regulation of eNOS activity<br />
Valerie Schini-Kerth, (France)<br />
13:45 - 14:00 W30.4 Multiple ways to target eNOS: Killing n birds with one stone<br />
Huige Li, (Germany)<br />
132 Thursday 22 July ■ 12:45 - 14:15 ■ Auditorium 15
W31<br />
Workshop. Developing new drugs for neglected<br />
infections<br />
Organized by: Brazilian Society of Pharmacology and Experimental<br />
Therapeutics (SBFTE)<br />
Leader: Mauro M Teixeira, (Brazil)<br />
Developing new drugs for neglected infections<br />
Chair: Mauro M Teixeira, (Brazil)<br />
12:45 - 13:05 W31.1 New medicines to improve control and contribute to the eradication of malaria<br />
Timothy NC Wells, (Switzerland)<br />
13:05 - 13:25 W31.2 Development of antiviral compounds against Flavivirus<br />
Wouter Schul, (Singapore)<br />
13:25 - 13:45 W31.3 New perspectives to treat Trypanosome infection using NO donors<br />
Joao Santana da Silva, (Brazil), PMM Guedes, R Sesti-Costa, JJN Silva, JCM Pereira,<br />
DW Franco<br />
13:45 - 14:05 W31.4 Anti-inflammatory strategies to treat severe infections<br />
Mauro M Teixeira, (Brazil), D Souza, F Amaral, C Fagundes, V Vasconcelos<br />
Thursday 22 July ■ 12:45 - 14:15 ■ Auditorium 10 133
W32<br />
Workshop. The good, the bad and the ugly:<br />
When medicines cure most, harm some and<br />
confuse many<br />
Organized by: International Society of Pharmacovigilance (ISoP)<br />
Leader: Giampaolo Velo, (Italy)<br />
The good, the bad and the ugly: When medicines cure most, harm some<br />
and confuse many<br />
Chairs: Alex Dodoo, (Ghana) & Giampaolo Velo, (Italy)<br />
12:45 - 13:05 W32.1 The H1N1 story: The black and the white<br />
Pia Caduff-Janosa, (Switzerland)<br />
13:00 - 13:15 W32.2 From signals to therapy<br />
Nicholas Moore, (France)<br />
13:15 - 13:30 W32.3 New safety approaches towards advanced therapies<br />
Brian Edwards, (UK)<br />
13:30 - 13:45 W32.4 Between the rock and a hard place – safety monitoring of medicines for neglected<br />
diseases<br />
Alex Dodoo, (Ghana)<br />
13:45 - 14:00 W32.5 Drug information Drug promotion<br />
Giampaolo Velo, (Italy)<br />
134 Thursday 22 July ■ 12:45 - 14:15 ■ Auditorium 11
W33<br />
Workshop: Synaptic events in brain function<br />
Organized by: Hellenic Society of Pharmacology<br />
Leaders: Athineos Philippu, (Austria) & Charis Liapi, (Greece)<br />
Synaptic events in brain function<br />
Chairs: Athineos Philippu, (Austria) & Charis Liapi, (Greece)<br />
12:45 - 12:50 W33.1 Approaches to synaptic events in vivo under physiological and pathological conditions:<br />
State of the art<br />
Athineos Philippu, (Austria)<br />
12:50 - 13:10 W33.2 Synaptic events in the living brain, new approaches: Pharmaco magnetic resonance<br />
imaging in parallel with high performance neurochemical monitoring<br />
Alexander Rauch, (Germany), X Zhang, N Logothetis<br />
13:10 - 13:30 W33.3 Synaptic events in sleep and waking<br />
Helmut L Haas, (Germany), O Selbach, O Sergeeva<br />
13:30 - 13:50 W33.4 Sex differences in animal models of depression: focus on behavioural and neurochemical<br />
manifestation<br />
Christina Dalla, (Greece), P Pitychoutis, Z Papadopoulou-Daifoti<br />
13:50 - 14:10 W33.5 Synaptic events in stress and depression<br />
Karl Ebner, (Austria), N Singewald<br />
Thursday 22 July ■ 12:45 - 14:15 ■ Auditorium 12 135
W34<br />
Workshop. State-of-the-art of basic and clinical<br />
pharmacology in Serbia<br />
Leader: Milos P Stojiljkovic, (Republic of Serbia)<br />
State-of-the-art of basic and clinical pharmacology in Serbia<br />
Chairs: Milos P Stojiljkovic, (Republic of Serbia), Milica Prostran-Veselinovic,<br />
(Republic of Serbia) & Violeta Stanimirovic, (Republic of Serbia)<br />
12:45 - 13:00 W34.1 Bioethical principles in pharmacology: teaching of animal bioethics at the School of<br />
Medicine, University of Belgrade<br />
Zoran Todorovic, (Republic of Serbia), M Prostran-Veselinovic<br />
13:00 - 13:15 W34.2 Undergraduate and postgraduate education in basic and clinical pharmacology in Serbia<br />
Milica Prostran-Veselinovic, (Republic of Serbia)<br />
13:15 - 13:30 W34.3 Importance of pharmaco-toxicological evaluation of increased drug impurities and<br />
preserving drug quality and patient’s safety<br />
Violeta Stanimirovic, (Republic of Serbia), T Sipetic, D Nikolic, M Stojiljkovic,<br />
B Stanimirovic, V Dragojevic-Simic<br />
13:30 - 13:45 W34.4 Clinical pharmacologist in the healthcare system of Serbia: Where we are and where to<br />
go<br />
Momir M Mikov, (Republic of Serbia), S Golocorbin-Kon, Z Tomic, A Sabo<br />
13:45 - 14:00 W34.5 Ethical committees of healthcare institutions in Serbia: Who guards patient safety<br />
Viktorija Dragojevic-Simic, (Republic of Serbia), MP Stojiljkovic, V Stanimirovic<br />
136 Thursday 22 July ■ 12:45 - 14:15 ■ Meeting Room 18/19
W35<br />
Workshop. Bridging pharmacovigilance and<br />
patient safety – experiences from regional<br />
pharmacovigilance units<br />
Leader: Ulf Bergman, (Sweden)<br />
Bridging pharmacovigilance and patient safety – experiences from<br />
regional pharmacovigilance units<br />
Chair: Ulf Bergman, (Sweden)<br />
12:45 - 13:05 W35.1 From pharmacovigilance to patient safety: Prevention of adverse drug events<br />
Petra A Thürmann, (Germany)<br />
13:05 - 13:25 W35.2 Is case-based pharmacovigilance still needed in an era of computerized data bank based<br />
drug risk assessment<br />
Jörg Hasford, (Germany)<br />
13:25 - 13:45 W35.3 Pharmacovigilance in Africa – necessary, frivolous or essential<br />
Alex Dodoo, (Ghana)<br />
13:45 - 14:05 W35.4 Pharmacovigilance and patient safety – experiences from a regional pharmacovigilance<br />
centre in Sweden<br />
Ulf Bergman, (Sweden)<br />
Thursday 22 July ■ 12:45 - 14:15 ■ Auditorium 20 137
FC10<br />
Drugs for half the world:<br />
Pediatric clinical pharmacology<br />
Leader: John N van den Anker, (USA)<br />
FC10.4<br />
Pain in children<br />
Chair: Dick Tibboel, (The Netherlands)<br />
14:30 - 14:55 FC10.4.1 Postoperative pain in children; do we really need morphine<br />
Dick Tibboel, (The Netherlands)<br />
14:55 - 15:20 FC10.4.2 Developmental pharmacology of immature organs<br />
John N van den Anker, (USA)<br />
15:20 - 15:45 FC10.4.3 Neonatal analgesia: Still in search of a balanced approach<br />
Karel Allegaert, (Belgium)<br />
15:45 - 16:15 COFFEE BREAK<br />
16:15 - 16:40 FC10.4.4 Pain assessment methods in the newborn<br />
Lena Hellström-Westas, (Sweden)<br />
16:40 - 16:55 FC10.4.5 Free Communication Presentation:<br />
Therapeutic drug monitoring within the ALL-BFM trials<br />
Dominik Schrey, (Germany), C Lanvers-Kaminsky, G Hempel, J Boos<br />
16:55 - 17:10 FC10.4.6 Free Communication Presentation:<br />
Effects of caffeine on central and autonomous nervous system parameters in<br />
adolescents<br />
L Schrier, (The Netherlands), JK Burggraaf, W van Es, M Bosch, M de Kam,<br />
JMA van Gerven, AF Cohen<br />
138 Thursday 22 July ■ 14:30 - 17:15 ■ Meeting Room 18/19
FC11<br />
G protein-coupled 7TM receptors:<br />
From molecular to physiological function<br />
Supported by an unrestricted grant from Novo Nordisk Foundation<br />
Leaders: Brian K Kobilka, (USA) & Jean-Philippe Pin, (France)<br />
FC11.4<br />
7TM receptors: Genetic mouse models and disease<br />
Chairs: Marc G Caron, (USA) & Brigitte L Kieffer, (France)<br />
14:30 - 14:55 FC11.4.1 Akt/GSK3 Signaling in the Action of Psychotropic Drugs.<br />
Marc G Caron, (USA)<br />
14:55 - 15:20 FC11.4.2 Pharmacology of pre- versus postsynaptic alpha2-adrenoceptors<br />
Lutz Hein, (Germany), R Gilsbach, M Haubold, J Albarran-Juarez, J Schneider<br />
15:20 - 15:45 FC11.4.3 Mutations in ligands and receptors of the leptin-melanocortin pathway that lead to<br />
obesity<br />
Sadaf Farooqi, (UK)<br />
15:45 - 16:15 COFFEE BREAK<br />
16:15 - 16:40 FC11.4.4 Opioid receptors: Genetic approaches to study G protein coupled receptor function in<br />
vivo<br />
Brigitte L Kieffer, (France)<br />
16:40 - 16:55 FC11.4.5 Free Communication Presentation:<br />
The protein interactome of GPCRs: molecular sites for novel drugs<br />
Christian Gruber, (Austria), M Freissmuth<br />
16:55 - 17:10 FC11.4.6 Free Communication Presentation:<br />
An essential role for the first extracelullar loop in activating the adenosine A2B receptor<br />
Miriam Peeters, (The Netherlands), GJP van Westen, D Guo, MW Beukers, AP Ijzerman<br />
Thursday 22 July ■ 14:30 - 17:15 ■ Auditorium 10 139
FC12<br />
Ion channelopathies:<br />
New windows on complex disease and therapy<br />
Leader: William A Catterall, (USA)<br />
FC12.4<br />
Ion channelopathies in endocrine systems<br />
Chairs: Louis J Ptacek, (USA) & Per-Olof Berggren, (Sweden)<br />
14:30 - 14:55 FC12.4.1 Physiological and pathophysiological Ca2+ signalling in the pancreatic β-Cell<br />
Per-Olof Berggren, (Sweden), S-N Yang<br />
14:55 - 15:20 FC12.4.2 Channelopathies of ATP-gated potassium channels and insulin release<br />
Frances Ashcroft, (UK)<br />
15:20 - 15:45 FC12.4.3 ATP-sensitive potassium channels in different tissues: recent insights and surprises<br />
Colin G Nichols, (USA)<br />
15:45 - 16:15 COFFEE BREAK<br />
16:15 - 16:40 FC12.4.4 Channels in muscle disease<br />
Louis J Ptacek, (USA)<br />
16:40 - 16:55 FC12.4.5 Free Communication Presentation:<br />
Functional role of volume-Regulated chloride channel complex in cardioprotection against<br />
heart failure<br />
Linda Ye, (USA), M Zhang, G Wang, L Liu, K Schegg, DJ Burkin, JR Hume, DD Duan<br />
16:55 - 17:10 General discussion<br />
140 Thursday 22 July ■ 14:30 - 17:15 ■ Meeting Room 20
FC13<br />
Maximising benefits and minimising harms from<br />
drugs<br />
Organized by the British Pharmacological Society<br />
Leaders: Munir Pirmohamed, (UK) & Brian Kevin Park, (UK)<br />
FC13.4<br />
New technologies – will they help in developing safer drugs<br />
Chairs: David B Goldstein, (USA) & Roy Goodacre, (UK)<br />
14:30 - 14:55 FC13.4.1 Safety pharmacogenomics<br />
David B Goldstein, (USA)<br />
14:55 - 15:20 FC13.4.2 Metabolomics and its role in predicting ADRs<br />
Roy Goodacre, (UK)<br />
15:20 - 15:45 FC13.4.3 Use of Omics in understanding mechanisms of ADRs<br />
Richard S Paules, (USA), Y Cui<br />
15:45 - 16:15 COFFEE BREAK<br />
16:15 - 16:40 FC13.4.4 Systems biology approaches to drug metabolism and personalized medicine<br />
Urich M Zanger, (Germany)<br />
16:40 - 16:55 FC13.4.5 Free Communication Presentation:<br />
Noscapine is a potent CYP2C inhibitor<br />
Staffan Rosenborg, (Sweden), S Otto, J Östervall, Q-Y Yue, E Eliasson<br />
16:55 - 17:10 FC13.4.6 Free Communication Presentation:<br />
Safety of long-term treatment by piribedil in patients with chronic heart failure and<br />
cognitive disorders.<br />
Zhanna Sizova, (Russian Federation), N Lapidus<br />
Thursday 22 July ■ 14:30 - 17:15 ■ Hall A2 141
FC14<br />
Addiction and doping: Neurobiological and clinical<br />
basis of emerging treatments<br />
Leaders: Markus Heilig, (USA) & Yavin Shaham, (USA)<br />
FC14.4<br />
The role of stress in the addictive process<br />
Chairs: George F Koob, (USA) & Markus Heilig, (USA)<br />
14:30 - 14:55 FC14.4.1 The role of stress systems and the amygdale in addictive disorders<br />
George F Koob, (USA)<br />
14:55 - 15:20 FC14.4.2 Stress related neuropeptides: Candidate treatment targets in alcoholism<br />
Markus Heilig, (USA)<br />
15:20 - 15:45 FC14.4.3 Alcohol induced aggression: The role of CRH systems<br />
Klaus A Miczek, (USA)<br />
15:45 - 16:15 COFFEE BREAK<br />
16:15 - 16:40 FC14.4.4 The role of kappa-opioid transmission in dysphoric states related to stress and addiction<br />
Charles Chavkin, (USA)<br />
16:40 - 16:55 FC14.4.5 Free Communication Presentation:<br />
Safety of indirect dopamine agonists (IDA) for psychostimulant dependence. A systematic<br />
review and meta-analysis of randomized controlled trials<br />
Clara Pérez-Mañá, (Spain), X Castells, X Vidal, M Casas, D Capellà<br />
16:55 - 17:10 FC14.4.6 Free Communication Presentation:<br />
Inhibitory effects of Dendrobium alkaloids on memory impairment induced by<br />
lipopolysaccharide in rats<br />
Jing-Shan Shi, (PR China), Y-F Li, F Li, Q-H Gong, Q Wu<br />
142 Thursday 22 July ■ 14:30 - 17:15 ■ Auditorium 12
FC15<br />
Endothelium in health and disease<br />
Organized by the British Pharmacological Society<br />
Leaders: Christopher J Garland, (UK) & Arthur Weston, (UK)<br />
FC15.3<br />
Endothelium-mediated control of vascular tone<br />
Chairs: William B Campbell, (USA) & David J Webb, (UK)<br />
14:30 - 14:55 FC15.3.1 Endothelium-mediated control of vascular tone: COX-1 products<br />
Michel Félétou, (France)<br />
14:55 - 15:20 FC15.3.2 COX-2 products<br />
Yu Huang, (PR China)<br />
15:20 - 15:45 FC15.3.3 Dinucleoside polyphosphates and the purinergic system<br />
Joachim Jankowski, (Germany)<br />
15:45 - 16:10 COFFEE BREAK<br />
16:10 - 16:35 FC15.3.4 Endothelial 15-lipoxygenase eicosanoids<br />
William B Campbell, (USA)<br />
16:35 - 17:00 FC15.3.5 Endothelins<br />
David J Webb, (UK)<br />
17:00 - 17:15 FC15.3.6 Free Communication Presentation:<br />
Hydrogen sulfide stimulates angiogenesis<br />
Andreas Papapetropoulos, (Greece), A Pyriochou, Z Altaany, A Marazioti, G Yang,<br />
R Wang, C Szabo<br />
Thursday 22 July ■ 14:30 - 17:15 ■ Hall A3 143
FC16<br />
Natural products: Past and future<br />
Organized by the IUPHAR Section on the Pharmacology of Natural<br />
Products<br />
Leaders: Ricky Ying-Keung Man, (PR China), Tai-Ping Fan, (UK) &<br />
Zhi-bin Lin, (PR China)<br />
FC16.4<br />
East meets West: From prevention to therapy<br />
Chairs: Paul M Vanhoutte, (PR China) & Arnold G Herman, (Belgium)<br />
14:30 - 14:55 FC16.4.1 Holistic treatment by traditional Chinese medicine<br />
Tai-Ping Fan, (UK)<br />
14:55 - 15:20 FC16.4.2 The philosophy of Ayurvedic medicine and beyond<br />
Arunabha Ray, (India), K Gulati<br />
15:20 - 15:45 FC16.4.3 Contributions of plant-derived products to Western medicine<br />
Arnold G Herman, (Belgium)<br />
15:45 - 16:15 COFFEE BREAK<br />
16:15 - 16:40 FC16.4.4 Systems biology and the future of traditional medicine<br />
Guoan Luo, (PR China)<br />
16:40 - 16:55 FC16.4.5 Free Communication Presentation:<br />
Marine compound Xyloketal B regulates nitric oxide signaling in endothelial cells<br />
Hong-Mei Tan, (PR China), G-L Wang, W-L Chen, T-T Yan, Q Li, J Liu<br />
16:55 - 17:10 FC16.4.6 Free Communication Presentation:<br />
Dietary intake of sulforaphane glucosinolate suppresses Japanese cedar pollen-induced<br />
allergic responses via modulating Th1/Th2 balance in mice<br />
Akinori Yanaka, (Japan), M Irie, A Fukumoto, S Ishikawa, H Mori, T Inakuma<br />
144 Thursday 22 July ■ 14:30 - 17:15 ■ Auditorium 15
FC17<br />
New approaches and targets in psychiatry<br />
Supported by an unrestricted grant from H Lundbeck A/S, Denmark<br />
Leaders: David J Nutt, (UK) & Birte Glenthøj, (Denmark)<br />
FC17.4<br />
Exploring new targets in affective disorders using translational science<br />
Chairs: Christopher A Lowry, (USA) & David J Nutt, (UK)<br />
14:30 - 14:55 FC17.4.1 Can we target specific neuronal populations to improve the efficacy and safety of<br />
antidepressants<br />
Christopher A Lowry, (USA)<br />
14:55 - 15:20 FC17.4.2 In vivo approaches in preclinical models<br />
Arne Mørk, (Denmark), M Kreilgaard, LT Brennum, N Plath<br />
15:20 - 15:45 FC17.4.3 Using imaging as a translational tool for studying depression in humans<br />
Susannah E Murphy, (UK), C Harmer<br />
15:45 - 16:15 COFFEE BREAK<br />
16:15 - 16:40 FC17.4.4 Understanding current antidepressants’ action as a way to develop improved therapies<br />
David J Nutt, (UK)<br />
16:40 - 16:55 FC17.4.5 Free Communication Presentation:<br />
Acute vagal nerve stimulation promotes noradrenaline release in minipig brain<br />
Anne M Landau, (Denmark), S Dyve, AKO Alstrup, S Jakobsen, A Gjedde, DJ Doudet<br />
16:55 - 17:10 FC17.4.6 Free Communication Presentation:<br />
Glutamate receptors mediate striatal Nur77 expression induced by antipsychotic drugs<br />
Daniel Levesque, (Canada), J Maheux, E Tirotta, E Borrelli, C Rouillard, P-P Rompré<br />
Thursday 22 July ■ 14:30 - 17:15 ■ Auditorium 11 145
FC18<br />
Nuclear receptor targets for treatment of diseases<br />
Supported by an unrestricted grant from Novo Nordisk Foundation<br />
Leaders: Bart Staels, (France) & Vincent Laudet, (France)<br />
Local coordinator: Susanne Mandrup, (Denmark)<br />
FC18.3<br />
Nuclear receptors in the CNS<br />
Chairs: Michael T Heneka, (Germany) & Gary E Landreth, (USA)<br />
14:30 - 14:55 FC18.3.1 Glucocorticoid actions in the brain<br />
Osborne F Almeida, (Germany)<br />
14:55 - 15:20 FC18.3.2 Roles of PPAR in stroke<br />
Jaroslaw Aronowski, (USA)<br />
15:20 - 15:45 FC18.3.3 PPAR γ modulation in neurodegenerative disease<br />
Michael T Heneka, (Germany)<br />
15:45 - 16:15 COFFEE BREAK<br />
16:15 - 16:40 FC18.3.4 Liver X receptors as therapeutic targets in Alzheimer’s Disease<br />
Gary E Landreth, (USA)<br />
16:40 - 16:55 FC18.3.5 Free Communication Presentation:<br />
Structural basis for ligand-dependent and -independent gene repression by nuclear<br />
receptors<br />
A le Maire, C Teyssier, C Erb, M Grimaldi, S Alvarez, A de Lera, P Balaguer,<br />
H Gronemeyer, C Royer, P Germain, William Bourguet, (France)<br />
16:55 - 17:10 FC18.3.6 Free Communication Presentation:<br />
Evidence for the role of PPAR-beta/delta in the development of spinal cord injury<br />
Irene Paterniti, (Italy), E Mazzon, E Esposito, T Genovese, M Galuppo, R Di Paola,<br />
P Bramanti, A Kapoor, C Thiemermann, S Cuzzocrea<br />
146 Thursday 22 July ■ 14:30 - 17:15 ■ Meeting Room BV 1/2/3
PL19<br />
Plenary Lecture<br />
Chair: Ian Ahnfelt-Rønne, (Denmark)<br />
PL19<br />
Reversal of corticosteroid resistance in severe inflammatory diseases:<br />
A novel therapeutic strategy<br />
Peter J Barnes, (UK)<br />
Thursday 22 July ■ 17:30 - 18:15 ■ Hall A2<br />
PL20<br />
Plenary Lecture<br />
Chair: Donald R Singer, (UK)<br />
PL20<br />
Renin-angiotensin system and vascular inflammation<br />
Ernesto Schiffrin, (Canada)<br />
Thursday 22 July ■ 17:30 - 18:15 ■ Hall A3<br />
PL21<br />
EPHAR Plenary Lecture<br />
Chair: Eeva Moilanen, (Finland)<br />
PL21<br />
Successes and challenges in drug development – a regulatory<br />
perspective<br />
Thomas Lönngren, (UK)<br />
Thursday 22 July ■ 17:30 - 18:15 ■ Auditorium 15<br />
Thursday 22 July ■ 17:30 - 18:15 147
PL22<br />
Plenary Lecture<br />
Chair: Zhi-Bin Lin, (PR China)<br />
PL22<br />
New strategies for stroke prevention<br />
Ding-Feng Su, (PR China), A-J Liu<br />
Friday 23 July ■ 08:30 - 09:15 ■ Hall A2<br />
PL23<br />
Plenary Lecture<br />
Chair: Masayashi Mishina, (Japan)<br />
PL23<br />
New molecular targets in Alzheimer’s disease<br />
Elisabeth Bock, (Denmark)<br />
Friday 23 July ■ 08:30 - 09:15 ■ Hall A3<br />
PL24<br />
Plenary Lecture<br />
Chair: David J Webb, (UK)<br />
PL24<br />
Pharmacology of organic nitrates: From 19th century homeopathy to<br />
genetic mouse models<br />
Bernd Mayer, (Austria)<br />
Friday 23 July ■ 08:30 - 09:15 ■ Auditorium 15<br />
148 Friday 23 July ■ 08:30 - 09:15
FC10<br />
Drugs for half the world:<br />
Paediatric clinical pharmacology<br />
Leader: John N van den Anker, (USA)<br />
FC10.5<br />
Recent advance in paediatric clinical pharmacology<br />
Chair: Shinya Ito, (Canada)<br />
09:30 - 09:55 FC10.5.1 Post-genomics pharmacogenetics in children<br />
Evelyne Jacqz-Aigrain, (France)<br />
09:55 - 10:20 FC10.5.2 National active surveillance network for serious adverse drug reactions in children:<br />
Past and current pharmacogenomic targets<br />
Bruce Carleton, (Canada)<br />
10:20 - 10:45 FC10.5.3 Population PK-guided simulation study in children exposed to drugs in human milk<br />
Shinya Ito, (Canada), F Garcia-Bournissen, A Panchaud, C Csajka, J Kristensen,<br />
A Taddio, K Ilett, E Begg, G Tomlinson<br />
10:45 - 11:15 COFFEE BREAK<br />
11:15 - 11:40 FC10.5.4 Use of biopharmaceuticals in pediatric field: Tocilizumab, an anti-IL-6 receptor<br />
monoclonal antibody, for children with systemic juvenile idiopathic arthritis<br />
Shumpei Yokota, (Japan)<br />
11:40 - 11:55 FC10.5.5 Free Communication Presentation:<br />
Population pharmacokinetics and bayesian estimator of mycophenolic acid in children<br />
with idiopathic nephrotic syndrome<br />
Wei Zhao, (France), V Elie, V Baudouin, A Bensman, JL Andre, K Brochard, F Broux,<br />
M Cailliez, C Loirat, E Jacqz-Aigrain<br />
Friday 23 July ■ 09:30 - 12:15 ■ Meeting Room 18/19 149
FC11<br />
G protein-coupled 7TM receptors:<br />
From molecular to physiological function<br />
Supported by an unrestricted grant from Novo Nordisk Foundation<br />
Leaders: Brian K Kobilka, (USA) & Jean-Philippe Pin, (France)<br />
FC11.5<br />
7TM receptors: drug discovery and new physiological functions<br />
Chairs: Hans Bräuner-Osborne, (Denmark) & P Jeffrey Conn, (USA)<br />
09:30 - 09:55 FC11.5.1 Characterization of GPRC6A – a promiscuous 7TM receptor activated by basic L-amino<br />
acids<br />
Hans Bräuner-Osborne, (Denmark), BK Hansen, B Christiansen, C Clemmensen,<br />
LD Johansen, DS Pedersen, DE Gloriam, S Smajilovic, P Wellendorph<br />
09:55 - 10:20 FC11.5.2 Allosteric modulators of GPCRs as a novel approach to treatment of CNS disorders<br />
P Jeffrey Conn, (USA)<br />
10:20 - 10:45 FC11.5.3 GPCRs as metabolite receptors<br />
Stefan Offermanns, (Germany)<br />
10:45 - 11:15 COFFEE BREAK<br />
11:15 - 11:40 FC11.5.4 The ghrelin and the GPR39 receptors as regulators of metabolic functions.<br />
Birgitte Holst, (Denmark)<br />
11:40 - 11:55 FC11.5.5 Free Communication Presentation:<br />
Allosteric and orthosteric sites for ligands in the chemokine receptor CCR5<br />
Stefanie Thiele, (Denmark), M Rosenkilde<br />
11:55 - 12:10 FC11.5.6 Free Communication Presentation:<br />
Studies on the specific gamma-hydroxybutyric acid (GHB) binding site in the mammalian<br />
brain using novel radioiodinated ligands<br />
Petrine Wellendorph, (Denmark), S Høg, P Sabbatini, MFH Pedersen, L Martiny,<br />
GM Knudsen, B Frølund, RP Clausen, H Bräuner-Osborne<br />
150 Friday 23 July ■ 09:30 - 12:15 ■ Auditorium 10
FC12<br />
Ion channelopathies:<br />
New windows on complex disease and therapy<br />
Leader: William A Catterall, (USA)<br />
FC12.5<br />
Ion channelopathies in lymphocytes: Severe combined immunodeficiency<br />
and store-operated calcium channels<br />
Chair: Michael D Cahalan, (USA)<br />
09:30 - 09:55 FC12.5.1 Orai and stim in store-operated calcium release<br />
Michael D Cahalan, (USA)<br />
09:55 - 10:20 FC12.5.2 Diverse functions of STIM in store- operated calcium entry<br />
Richard S Lewis, (USA)<br />
10:20 - 10:45 FC12.5.3 Roles of store-operated Ca2+ entry mediated by STIM1 and ORAI1 in immunity<br />
Stefan Feske, (USA)<br />
10:45 - 11:15 COFFEE BREAK<br />
11:15 - 11:40 FC12.5.4 Store-operated calcium entry: Pore architecture of the ORAI1 calcium channel and<br />
evidence that STIM1 gates ORAI1 channels in vitro<br />
Patrick G Hogan, (USA), Y Zhou, P Meraner, A Rao<br />
11:40 - 11:55 FC12.5.5 Free Communication Presentation:<br />
Computational structural pharmacology of L-type calcium channel<br />
Boris S Zhorov, (Canada)<br />
11:55 - 12:10 General discussion<br />
Friday 23 July ■ 09:30 - 12:15 ■ Meeting Room 20 151
FC13<br />
Maximising benefits and minimising harms from<br />
drugs<br />
Organized by the British Pharmacological Society<br />
Leaders: Munir Pirmohamed, (UK) & Brian Kevin Park, (UK)<br />
FC13.5<br />
New insights in the genetics of drug metabolism and action<br />
Chairs: Magnus Ingelman-Sundberg, (Sweden) & Richard M Weinshilboum, (USA)<br />
09:30 - 09:55 FC13.5.1 Molecular mechanisms of altered drug response<br />
Magnus Ingelman-Sundberg, (Sweden)<br />
09:55 - 10:20 FC13.5.2 Genetic variability of adrenergic receptors<br />
Ian P Hall, (UK)<br />
10:20 - 10:45 FC13.5.3 Genetic variability of pain perception and treatment<br />
Jörn Lötsch, (Germany)<br />
10:45 - 11:15 COFFEE BREAK<br />
11:15 - 11:40 FC13.5.4 Pharmacogenetics to pharmacogenomics<br />
Richard M Weinshilboum, (USA)<br />
11:40 - 11:55 FC13.5.5 Free Communication Presentation:<br />
The analgesic effect of oxycodone in relation to genetic variations in the OPRM1 and<br />
ABCB1 genes<br />
Stine T Zwisler, (Denmark), TP Enggaard, L Noehr-Jensen, S Mikkelsen, C Verstuyft,<br />
L Becquemont, S Sindrup, K Brøsen<br />
11:55 - 12:10 General discussion<br />
152 Friday 23 July ■ 09:30 - 12:15 ■ Hall A2
FC14<br />
Addiction and doping: Neurobiological and clinical<br />
basis of emerging treatments<br />
Leaders: Markus Heilig, (USA) & Yavin Shaham, (USA)<br />
FC14.5<br />
Doping – an underestimated problem with many unknowns<br />
Chairs: Harrison G Pope, (USA) & Anders Rane, (Sweden)<br />
09:30 - 09:55 FC14.5.1 Societal aspects of doping<br />
Harrison G Pope, (USA)<br />
09:55 - 10:20 FC14.5.2 Morbidity and mortality in users of anabolic androgenic steroids<br />
Ingmar Thiblin, (Sweden), G Ågren, H Mobini<br />
10:20 - 10:45 FC14.5.3 Anabolic-androgenic steroid addiction Insights from animal<br />
Ruth I Wood, (USA)<br />
10:45 - 11:15 COFFEE BREAK<br />
11:15 - 11:30 FC14.5.4 Free Communication Presentation:<br />
Discovery of new drugs for anti-relapse based on dopamine D3 receptors<br />
Rui-Bin Su, (PR China), R Song, H-Y Gou, Y Liu, N Wu, X-Q Lu, R-F Yang, S-Q Zhang,<br />
Z-Q Zhang, J Li<br />
11:30 - 11:45 FC14.5.5 Free Communication Presentation:<br />
A framework for the integration of pharmacotherapy in the treatment of alcohol<br />
dependence in the Free State province, South Africa<br />
Paulina van Zyl, (South Africa), C Gagiano, W Mollentze, J Snyman<br />
11:45 - 12:00 General discussion<br />
Friday 23 July ■ 09:30 - 12:15 ■ Auditorium 12 153
FC15<br />
Endothelium in health and disease<br />
Organized by the British Pharmacological Society<br />
Leaders: Christopher J Garland, (UK) & Arthur Weston, (UK)<br />
FC15.4<br />
Drug development and novel therapeutic targets and approaches<br />
Chairs: Johannes-Peter Stasch, (Germany) & Harald Schmidt, (The Netherlands)<br />
09:30 - 09:55 FC15.4.1 Stimulators and activators of soluble guanylate cyclase: From bench to bedside<br />
Johannes-Peter Stasch, (Germany)<br />
09:55 - 10:20 FC15.4.2 Gaseous signalling molecules: the biological effects of hydrogen sulfide – comparison<br />
with nitric oxide<br />
Csaba Szabó, (USA)<br />
10:20 - 10:45 FC15.4.3 Therapeutic effects of enhancing endothelial nitric-oxide synthase (eNOS) expression and<br />
preventing eNOS uncoupling<br />
Ulrich Förstermann, (Germany), H Li<br />
10:45 - 11:15 COFFEE BREAK<br />
11:15 - 11:40 FC15.4.4 NOX 1, 2, 3 and counting: targeting oxidative stress<br />
Harald Schmidt, (The Netherlands), K Wingler, C Kleinschnitz<br />
11:40 - 11:55 FC15.4.5 Free Communication Presentation:<br />
Effects of K + channel blockers on the relaxation induced by nitric oxide (NO) donors in<br />
basilar artery from renal hypertensive 2K-1C rats<br />
Michele Paulo, (Brazil), J Vercesi, J Biazzotto, R da Silva, L Bendhack<br />
11:55 - 12:10 FC15.4.6 Free Communication Presentation:<br />
MicroRNA-27b rescues impaired endothelial progenitor cell-induced angiogenesis and<br />
wound healing via suppressing thrombospondin-1 in type 2 diabetes<br />
Alex Chen, (USA), J Wang,<br />
12:10 - 12:25 FC15.4.7 Free Communication Presentation:<br />
Co-activation of PKCdelta/ERK1/2 and p38 MAPK mediates angiotensin II-induced<br />
cyclooxygenase-2 up-regulation in endothelial cells and the clinical implications<br />
Siu Ling Wong, (PR China), CW Lau, WT Wong, A Xu, CL Au, X Yao, Y Huang<br />
154 Friday 23 July ■ 09:30 - 12:30 ■ Hall A3
FC16<br />
Natural products: Past and future<br />
Organized by the IUPHAR Section on the Pharmacology of Natural<br />
Products<br />
Leaders: Ricky Ying-Keung Man, (PR China), Tai-Ping Fan, (UK) &<br />
Zhi-bin Lin, (PR China)<br />
FC16.5<br />
Globalization of natural/traditional products<br />
Chairs: Ricky Ying-Keung Man, (PR China) & Monique Simmonds, (UK)<br />
09:30 - 09:55 FC16.5.1 Geographical sustainability of natural products: As modelled by the Araliaceae family<br />
Yuri N Zhuravlev, (Russian Federation)<br />
09:55 - 10:20 FC16.5.2 Authentication of natural products<br />
Monique Simmonds, (UK)<br />
10:20 - 10:45 FC16.5.3 Standardization of natural products (chemical and biological finger printing)<br />
Y-C Cheng, Robert Tilton, (USA)<br />
10:45 - 11:15 COFFEE BREAK<br />
11:15 - 11:40 FC16.5.4 Challenges in research on natural products and dietary supplements<br />
Josephine P Briggs, (USA)<br />
11:40 - 11:55 FC16.5.5 Free Communication Presentation:<br />
Studies on the ADME/Tox characteristics of Xiao Chai Hu Tang in Caco-2 cell model<br />
Jun-Ning Zhao, (PR China), L-C Yan, Q-C Liu, Y-Q Bi, J-H Yi<br />
11:55 - 12:10 General discussion<br />
Friday 23 July ■ 09:30 - 12:15 ■ Auditorium 15 155
FC17<br />
New approaches and targets in psychiatry<br />
Supported by an unrestricted grant from H Lundbeck A/S, Denmark<br />
Leaders: David J Nutt, (UK) & Birte Glenthøj, (Denmark)<br />
FC17.5<br />
New pharmacological approaches for treatment of stress induced mood<br />
disorders<br />
Chairs: Elisabeth B Binder, (Germany) & Rosanio Leopardi, (Switzerland)<br />
09:30 - 09:55 FC17.5.1 Using gene x environment interactions to target personalised treatment in mood<br />
disorder.<br />
Elisabeth B Binder, (Germany)<br />
09:55 - 10:20 FC17.5.2 Epigenomic effects of stress: Novel targets for treatment of mood disorders<br />
Johannes MHM Reul, (UK)<br />
10:20 - 10:45 FC17.5.3 Can brain mechanism in PTSD help direct treatment advances<br />
Eric Vermetten, (The Netherlands)<br />
10:45 - 11:15 COFFEE BREAK<br />
11:15 - 11:40 FC17.5.4 Treatment needs in psychosocial stress, exhaustion and depression<br />
Rosanio Leopardi, (Sweden)<br />
11:40 - 11:55 FC17.5.5 Free Communication Presentation:<br />
Cannabinoid CB1 and vanilloid TRPV1 receptors: Contrary functions in an animal model<br />
of panic attack<br />
Fabricio Moreira, (Brazil), P Casarotto, D Aguiar, A Terzian, H Zangrossi, F Guimaraes,<br />
C Wotjak<br />
11:55 - 12:10 FC17.5.6 General discussion<br />
156 Friday 23 July ■ 09:30 - 12:15 ■ Auditorium 11
FC18<br />
Nuclear receptor targets for treatment of diseases<br />
Supported by an unrestricted grant from Novo Nordisk Foundation<br />
Leaders: Bart Staels, (France) & Vincent Laudet, (France)<br />
Local coordinator: Susanne Mandrup, (Denmark)<br />
FC18.4<br />
The molecular basis of NR pharmacology<br />
Chairs: Shigeaki Kato, (Japan) & Vincent Laudet, (France)<br />
09:30 - 09:55 FC18.4.1 Structural studies of intact nuclear receptor complexes in their functionally revealing<br />
complexes<br />
Fraydoon Rastinejad, (USA)<br />
09:55 - 10:20 FC18.4.2 The global organization of nuclear receptor regulatory elements<br />
Gordon Hager, (USA), TC Voss, RL Schiltz, M-H Sung, S Baek, M Wiench, SC Biddie,<br />
TA Johnson, D Stavreva, S John<br />
10:20 - 10:45 FC18.4.3 The role of co-regulators/co-regulator complexes in NR function<br />
Shigeaki Kato, (Japan)<br />
10:45 - 11:15 COFFEE BREAK<br />
11:15 - 11:40 FC18.4.4 Nuclear hormone receptor superfamily: From comparative genomics to evolution<br />
Vincent Laudet, (France)<br />
11:40 - 11:55 FC18.4.5 Free Communication Presentation:<br />
Functional characterization of the semi-synthetic bile acid derivative INT-767, a dual FXR<br />
and TGR5 agonist<br />
Giovanni Rizzo, (Italy), D Passeri, F De Franco, G Ciaccioli, L Donadio, G Rizzo,<br />
S Orlandi, B Sadeghpour, XX Wang, T Jiang, M Lev, M Pruzanski, L Adorini<br />
11:55 - 12:10 FC18.4.6 Free Communication Presentation:<br />
Anti-inflammatory/neuroprotective properties of palmitoylethanolamide in a model of beta<br />
amyloid neurotoxicity<br />
Caterina Scuderi, (Italy), G Esposito, A Blasio, M Valenza, P Arietti, D De Filippis,<br />
T Iuvone, L Steardo<br />
Closing ceremony & prize awards in Hall A2<br />
Friday 23 July 12:30 - 13.00<br />
Friday 23 July ■ 09:30 - 12:15 ■ Meeting Room BV 1/2/3 157
158
Poster sessions<br />
Focused Conferences Workshops General section<br />
FC01<br />
Mon 001 - 039<br />
Tue 001 - 036<br />
FC02<br />
Mon 040 - 080<br />
Tue 037 - 076<br />
FC03<br />
Mon 081 - 089<br />
Tue 077 - 085<br />
FC04<br />
Mon 116 - 146<br />
Tue 086 - 115<br />
FC05<br />
Mon 147 - 187<br />
Tue 116 - 156<br />
FC06<br />
Mon 188 - 221<br />
Tue 157 - 189<br />
FC07<br />
Mon 222 - 230<br />
Tue 190 - 198<br />
FC08<br />
Mon 231 - 251<br />
Tue 199 - 218<br />
FC09<br />
Mon 252 - 332<br />
Tue 219 - 300<br />
FC10<br />
Wed 001 - 019<br />
Thu 001 - 020<br />
FC11<br />
Wed 020 - 095<br />
Thu 021 - 096<br />
FC12<br />
Wed 096 - 108<br />
Thu 097 - 109<br />
FC13<br />
Mon 333 - 392<br />
Tue 301 - 359<br />
Wed 109 - 167<br />
Thu 110 - 168<br />
FC14<br />
Wed 168 - 193<br />
Thu 171 - 196<br />
FC15<br />
Wed 194 - 292<br />
Thu 197 - 294<br />
FC16<br />
Wed 294 - 392<br />
Thu 295 - 393<br />
FC17<br />
Wed 393 - 433<br />
Thu 394 - 432<br />
FC18<br />
Wed 437 - 449<br />
Thu 433 - 445<br />
W01<br />
Mon 393 - 397<br />
W02<br />
Tue 460 - 476<br />
W03<br />
Mon 398 - 402<br />
W04<br />
Mon 403 - 416<br />
W11<br />
Tue 477 - 478<br />
W12<br />
Mon 090 - 115<br />
W14<br />
Tue 479<br />
W18<br />
Tue 360<br />
W19<br />
Mon 417 - 470<br />
W20<br />
Mon 471 - 481<br />
W23<br />
Tue 480 - 494<br />
W29<br />
Thu 169 - 170<br />
W30<br />
Wed 293<br />
W33<br />
Wed 434<br />
Miscellaneous<br />
Tue 361 - 371<br />
Airway<br />
Tue 372 - 373<br />
Biologics<br />
Tue 374 - 378<br />
Cell Biology<br />
Tue 379 - 380<br />
Haematology<br />
Tue 381 - 382<br />
Hepatology<br />
Tue 383 - 393<br />
Oncology<br />
Tue 394 - 442<br />
Toxicology<br />
Tue 443 - 459<br />
W34<br />
Wed 435 - 436<br />
<strong>WorldPharma</strong><strong>2010</strong> combines and integrates basic<br />
and clinical pharmacology exactly the way I had hoped<br />
Professor Paul M Vanhoutte (Hong Kong)<br />
Past President of IUPHAR (2002–6)<br />
Poster sessions 159
FC01<br />
Clinical pharmacology in the emerging countries<br />
Mon 001<br />
Mon 002<br />
Mon 003<br />
Mon 004<br />
Mon 005<br />
Mon 006<br />
Mon 007<br />
Mon 008<br />
Mon 009<br />
Mon 010<br />
Mon 011<br />
Mon 012<br />
Mon 013<br />
Mon 014<br />
Mon 015<br />
Mon 016<br />
Mon 017<br />
Patterns of influenza infection in Sylhet division of Bangladesh<br />
Salim Ahmed, (Bangladesh), ATMA Jalil, SS Ahmed, MM Siddika<br />
Comparative study of initial and aquired drug resistance in pulmonary tuberculosis<br />
Seyed Yousef Agha Alaie, (Iran), SD Mansoori, S Khazali, AA Hashtroodi, S Arami<br />
Adverse events of benznidazole in children with Chagas disease – a cohort study<br />
Jaime Altcheh, (Canada), G Moscatelli, S Moroni, F Garcia-Bournissen, H Freilij<br />
Antioxidant activity of phenolic extracts of Tunisian plants and their effect on mitochondrial respiration<br />
in vitro<br />
S Bacha, H Ferchichi, I Salouage, L Ouanes, M Boussaïd, M Lakhal, Anis Klouz, (Tunisia)<br />
Efficacy and safety of add-on mirtazapine in depression<br />
Dinesh K Badyal, (India), P Matreja, R Deswal<br />
Glutathione S-transferase M1 and Glutathione S-transferase T1 polymorphisms and lung cancer risk in<br />
Tunisian men<br />
Majda-Noura Belkhiria, (Tunisia), MA Jebali, I Harrabi, J Knani<br />
Piroxicam provides adequate analgesia after impacted lower third molar removal regardless of the<br />
surgeon’s experience<br />
Adriana Calvo, (Brazil), T Dionísio, F Giglio, P Gonçalves, C Santos<br />
Investigation of the relationship between plasma L-carnitine concentration and its antioxidant activity<br />
after single oral administration of L-carnitine in healthy volunteers<br />
Yu Cao, (PR China), Z-W Han, HJ Qu, C-B Wang<br />
Oral pharmacokinetics of three fluoroquinolones in Mexicans: Evidence for interethnic differences<br />
Miriam Carrasco-Portugal, (Mexico), G Lozoya-Moreno, S Patiño-Camacho, F Flores-Murrieta<br />
Patient’s access to antiretroviral medicines: how do they view themselves<br />
DM Carvalho, MH Magalhães, AMR Felix, ECA Costa, WA Souza, Marcia HMC Podestá, (Brazil)<br />
Inequivalence of doxorubicin liposomal formulations commercialized in Latin America<br />
Gilberto Castañeda-Hernández, (Mexico), L Villafaña-Godínez, MA Valdés, L González-Flores<br />
In vitro antiplasmodial activity of 8-hydroxyquinoline derivatives<br />
Chien-Teng Chen, (South Africa), R van Zyl<br />
Association of the ABCB1 3435C>T polymorphism and adverse events of cilostazole in healthy<br />
subjects<br />
Sung Kweon Cho, (South Korea), LA Lim, SB Jang, YJ Lee, DH Lee, HK Son, JY Chung, K Park<br />
Pharmapoly, game as a teaching strategy in pharmacology classes<br />
Luis Cifuentes, (Colombia)<br />
Summary of PK and PD in a practical way<br />
Luis Cifuentes, (Colombia),<br />
Pharmacokinetics of florfenicol (water soluble formulation) in health and Pasteurella infected broiler<br />
chickens<br />
Hesham Elzorba, (Egypt), H El-Banna<br />
Antibiotic activity against urinary pathogens in hospitalized medical patients in eastern Nigeria<br />
Oguamanam Enwere, (Nigeria), K Duruewuru, V Okwara<br />
160 Monday 19 July ■ 13:00 - 14:00 ■ Poster Area
FC01<br />
Clinical pharmacology in the emerging countries<br />
Mon 018<br />
Mon 019<br />
Mon 020<br />
Mon 021<br />
Mon 022<br />
Mon 023<br />
Mon 024<br />
Mon 025<br />
Mon 026<br />
Mon 027<br />
Mon 028<br />
Mon 029<br />
Mon 030<br />
Mon 031<br />
Can steady state plasma concentration of efavirenz predict virologic outcomes in treatment naïve HIV<br />
Ethiopian patients<br />
Abiy H Eyakem, (Ethiopia), W Amogne, G Yimer, E Makonnen, G Aderaye, A Worku, L Lindquist,<br />
L Bertilsson, J Burhenne, E Aklillu<br />
Population pharmacokinetics of oseltamivir carboxylate in Mexican patients with influenza A(H1N1)<br />
Francisco Flores-Murrieta, (Mexico), M Barranco-Garduño, M Carrasco-Portugal, H León-Molina,<br />
A Cervantes-Nevárez, G Castañeda-Hernández<br />
Analysis of n-acetyltransferase 2 phenotype and genotype in a Tunisian population<br />
E Gaïes, Anis Klouz, (Tunisia), I Salouage, S Trabelsi, I Hamza, N Jebabli, M Aouichri, M Lakhal<br />
Tunisian clinical pharmacology experience<br />
E Gaïes, R Sahnoun, D Bensaid, N Jebabli, I Salouage, S Trabelsi, I Hamza, M Aouichri,<br />
Anis Klouz,(Tunisia), M Lakhal<br />
Estimation of transfer of nifurtimox, for Chagas disease, into breastmilk. Population pharmacokinetics<br />
and simulation analysis<br />
Facundo Garcia-Bournissen, (Canada), J Altcheh, A Panchaud, S Ito<br />
Evaluation of the effect of an extract of Mangifera indica L. in patients with spinocerebellar ataxia<br />
type 2<br />
Mariela Guevara-García, (Cuba), L Velázquez, R Aguilera, R Rodríguez, O Ramírez, D Almaguer,<br />
JC Rodríguez<br />
Cost analysis of antibacterial drugs in a developing country, India<br />
Devi D Gupta, (India), M Gupta<br />
Characterization of resistance to cytosine arabinoside (ARA-C) IN NALM-6 human B leukemia cells<br />
Masaaki Ishikawa, (Japan), S-I Kanno<br />
Potential drug-drug interactions of lopinavir/ritonavir in antiretroviral prescriptions with prescribed daily<br />
doses not according to the recommended antiretroviral doses in South Africa<br />
Norah Lucky Katende-Kyenda, (South Africa), M Lubbe, J Serfontein, I Truter<br />
Complete overhaul of the authorization and single-central ethical committee approval procedure of<br />
clinical trials in Hungary<br />
Peter Kovacs, (Hungary), A Vas<br />
Effect of mastitis on disposition kinetics of levofloxacin following single dose i.v. administration in goats<br />
Birendra Kumar, (India), M Ram, V Singh, R Prasad, K Singh<br />
A phase I clincical study of CKD-732 in combination with capecitabine and oxaliplatin in patients with<br />
metastatic colorectal cancer<br />
Yoon Jung Lee, (South Korea), S Shin, HC Chung, K Park<br />
Latin America a successful emerging market for clinical research<br />
Federico Lerner, (Argentina)<br />
Effect on the expression of CYP450 enzyme in rat liver induced by total panax notoginsenoside and the<br />
potential drug-drug interaction study<br />
Xiao-yu Li, (PR China), G-L Liu, J-C Zhou, G Qian, B Sun, Y-K Guo, J-W Gao<br />
Monday 19 July ■ 13:00 - 14:00 ■ Poster Area 161
FC01<br />
Clinical pharmacology in the emerging countries<br />
Mon 032<br />
Mon 033<br />
Mon 034<br />
Mon 035<br />
Mon 036<br />
Mon 037<br />
Mon 038<br />
Mon 039<br />
Pharmacokinetic study of recombinant humanized anti-VEGF monoclonal antibody (Bevacizumab) in<br />
Chinese subjects with advanced malignancies<br />
Yang Li, (PR China), X Hu, G Cheng, YL Nie, YB Zhao, JY Wu, KX Li, C Qi<br />
Pharmacokinetics and pharmacodynamics of pegylated interferon-α2a in healthy male volunteers<br />
Lay Ahyoung Lim, (South Korea), H Son, S Jang, Y Lee, JY Chung, K Park<br />
Discovery of novel influenza neuraminidase inhibitors from natural products<br />
Ailin Liu, (PR China), S Lee, Y Wang, G Du<br />
Disruption of BBB in rat MCAO and a protective effect of anti-HMGB1 antibody<br />
Keyue Liu, (Japan), J Zhang, HK Takahashi, Y Tomono, H Wake, T Maruo, A Otsuka, S Mori,<br />
M Nishibori<br />
Evaluation of the effect of increasing hydration to premedication treatments of chemotherapy with<br />
cisplatin in decreasing renal side effects of it in patients of Air force and Buali hospitals in Tehran from<br />
2007 to 2009<br />
Artin Mardirosian, (Iran), MH Lashkari, F Nejad Dadgar, H Molana, M Fotouhi<br />
The attitude of medical students towards traditional medicine<br />
Ortrun Meissner-Kirch, (South Africa), EN Kwizera<br />
Safety and efficacy of granulocyte colony-stimulating factor (ior-LeukoCIM) in oncohematology patients.<br />
Phase IV<br />
Ivis Cristina Mendoza Hernandez, (Cuba), EG Lopez, MW de Leon, AM Veitia, JDF Aguila, EV Olazabal,<br />
MR Garcia, PP Sierra, GS Martinez, Y Barrese Pérez<br />
Clinical pharmacology service rationalized use of costly drug in academic hospital of a country in<br />
socio-economic transition<br />
Dragan Milovanovic, (Republic of Serbia), S Jankovic, D Ruzic Zecevic<br />
162 Monday 19 July ■ 13:00 - 14:00 ■ Poster Area
FC02<br />
Transmembrane transport: Perspectives for disease<br />
and drug discovery<br />
Mon 040<br />
Mon 041<br />
Mon 042<br />
Mon 043<br />
Mon 044<br />
Mon 045<br />
Mon 046<br />
Mon 047<br />
Mon 048<br />
Mon 049<br />
Mon 050<br />
Mon 051<br />
Mon 052<br />
Mon 053<br />
Mon 054<br />
Consequences of chronic postnatal stress on glutamatergic transporter and on behavioural test in the<br />
rat<br />
Gabriela Acosta, (Argentina), MM Odeon, ML Orta, A Salatino<br />
Cyclosporine A, but not tacrolimus, show relevant inhibition of OATP1B1 mediated transport of<br />
atorvastatin<br />
Rune Amundsen, (Norway), H Christensen, B Zabihyan, A Åsberg<br />
Uptake of folic acid and methyltetrafolic acid by rat and human blood-brain barrier endothelial cell lines<br />
João R Araújo, (Portugal), P Goncalves, F Martel<br />
Interactions between verapamil and digoxin in Langendorff - perfused rat hearts: the role of inhibition of<br />
P-glycoprotein in heart<br />
M Aylin Arýcý, (Turkey), E Kilinc, O Demir, M Ates, A Yesilyurt, A Gelal<br />
Impacts of EGFR-antisense and carbenoxolone on cancer cell lines<br />
Masoud Asadi, (Iran), H Hamzeiy, J Barar, Y Omidi, S Mohammadi<br />
Rho kinase inhibitor Fasudil modifies the actin cytoskeleton of astrocytes up-regulating glutamate<br />
transport and anti-inflammatory mechanisms<br />
Philip Beart, (Australia), C Lau, V Perreau, N Cheung, M Chen, L Bischof, R O'Shea<br />
New naphthalene derivatives of citalopram discriminate between the primary and the allosteric binding<br />
sites at the human serotonin transporter<br />
Klaus Bøgesø, (Denmark), P Bregnedal, K Juhl, H Zhong, O Wiborg<br />
A fast and sensitive LC-MS/MS assay for quantification of nortriptyline and its active metabolites E- and<br />
Z-10-hydroxynortriptyline in human plasma<br />
Gitte Bonke, (Denmark), BP Jensen<br />
SLCO1B1 variants as pharmacogenetic predisposition for hepatotoxicity induced by HMGCoA<br />
reductase inhibitors<br />
Nada Božina, (Croatia), I Mercep, V Miroševic, T Božina, J Sertic, Z Reiner<br />
Pharmacokinetic interactions of cimetidine and pramipexole in relation to OCT2<br />
Chang-Ik Choi, (South Korea), S-M, Moon, J-W Bae, M-J Kim, C-G Jang, S-Y Lee<br />
Pharmacogenetics of metformin<br />
Mette Marie Hougaard Christensen, (Denmark), CB Andersen, P Damkier, HB Nielsen, K Brøsen<br />
The role of p-glycoprotein in bacterial attachment to intestinal cells<br />
Andrew Crowe, (Australia)<br />
Extracellular loops 2 and 4 of GLYT2 are required for N-arachidonyl-glycine inhibition of glycine<br />
transport<br />
Amelia Edington, (Australia), R Ryan, R Vandenberg<br />
The effect of loperamide and fentanyl on the distribution kinetics of verapamil in the lung and brain in<br />
Sprague Dawley rats<br />
Iman El-Kiweri, (Saudi Arabia), MT van Patot, YL Zhang, U Christians, T Henthorn<br />
Cannabidiol inhibits BCRP and P-gp in human placental trophoblast cell lines BeWo and Jar<br />
Valeria Feinshtein, (Israel), G Holcberg, Z Ben-Zvi<br />
Monday 19 July ■ 13:00 - 14:00 ■ Poster Area 163
FC02<br />
Transmembrane transport: Perspectives for disease<br />
and drug discovery<br />
Mon 055<br />
Mon 056<br />
Mon 057<br />
Mon 058<br />
Mon 059<br />
Mon 060<br />
Mon 061<br />
Mon 062<br />
Mon 063<br />
Mon 064<br />
Mon 065<br />
Mon 066<br />
Mon 067<br />
Mon 068<br />
Mon 069<br />
Gene expression and comparative genomic hybridization profiles of 6-mercaptopurine- and<br />
6-thioguanine-resistant human leukaemia cells<br />
Alan Fotoohi, (Sweden), J Hashemi, A Moshfegh, C Larsson, F Albertioni<br />
Pharmacokinetic interaction between puerarin and edaravone and effect of borneol on the brain<br />
distribution kinetics of puerarin in rats<br />
C Gao, X Li, T Li, L Wang, Ming Xue, (PR China)<br />
Influence of polyphenols in a colon tumoral cell line: effect on butyrate uptake and on proliferation,<br />
differentiation, viability and apoptosis<br />
Pedro Gonçalves, (Portugal), JR Araújo, MJ Pinho, F Martel<br />
Characterization of LeuT, a bacterial member of the neurotransmitter:sodium symporter family, in an<br />
inward-facing conformation<br />
Kamil Gotfryd, (Denmark), D Kruger, J Kniazeff, J Javitch, C Loland, U Gether<br />
IL1β-mediates time and concentration dependent induction of ABCC2 gene expression via p38 MAPK<br />
and Akt pathway in Sk-Hep1 cells<br />
Sierk Haenisch, (Germany), S Lächelt, A Schmall, I Cascorbi<br />
Confounding factors in quantifying the concentration dependent P-glycoprotein mediated transport in in<br />
vitro cell permeation experiments<br />
Aki T Heikkinen, (Finland), T Korjamo, V Lepikkö, J Mönkkönen<br />
Modulating the dopamine transporter expression through changes in the proteostasis environment<br />
Freja Henriksen, (Denmark), I Ammendrup-Johnsen, U Gether<br />
Regulation of microglial immune fuction by store-operated calcium channels(SOCs)<br />
Dae Keon Heo, (South Korea), MG Lee, JY Kim<br />
Toxicokinetics of the food-toxin IQ in human placental perfusion is not affected by ABCG2 or xenobiotic<br />
metabolism<br />
Elina Immonen, (Finland), M Kummu, A Petsalo, T Pihlaja, K Vàhàkangas, P Myllynen<br />
Influence of P-glycoprotein polymorphism on nortriptyline-induced postural hypotension<br />
Berit P Jensen, (New Zealand), R Vyas, G Bonke, RR Roberts, D Jardine, EJ Begg<br />
Significant pharmacokinetic interaction between pitavastatin and clarithromycin in healthy subjects<br />
Kyeong-Joo Jeon, (Republic Of South Korea), C-I Choi, J-W Bae, M-J Kim, C-G Jang, S-Y Lee<br />
Evaluation of the pharmacokinetic profile of ezetimibe in healthy Koreans with different SLCO1B1<br />
genotype<br />
Kyeong-Joo Jeon, (Republic Of South Korea), C-I Choi, J-W Bae, M-J Kim, C-G Jang, S-Y Lee<br />
Identification of kinases regulating monoamine transporter function by kinome-wide siRNA screening<br />
Trine Nygaard Jørgensen, (Denmark), I Ammendrup-Johnsen, U Gether<br />
Characterization of TMEM16 family and its functional implications in human pancreatic acinar cells<br />
Jinsei Jung, (South Korea), JH Nam, JS Yoon, MG Lee<br />
Influence of MRP2 C-24T polymorphism on the disposition of orally administered ezetimibe in healthy<br />
subjects<br />
Seul-Ki Keum, (South Korea), C-I Choi, J-W Bae, M-J Kim, C-G Jang, S-Y Lee<br />
164 Monday 19 July ■ 13:00 - 14:00 ■ Poster Area
FC02<br />
Transmembrane transport: Perspectives for disease<br />
and drug discovery<br />
Mon 070<br />
Mon 071<br />
Mon 072<br />
Mon 073<br />
Mon 074<br />
Mon 075<br />
Mon 076<br />
Mon 077<br />
Mon 078<br />
Mon 079<br />
Mon 080<br />
Interactions of atazanavir (ATV) with solute carrier (SLC) transporters in Caco-2 cells, an in vitro model<br />
of human intestinal epithelium<br />
O Kis, J Zastre, M Ramaswamy, Kevin Robillard, (Canada), R Bendayan<br />
Transport of cyclic nucleotides in human colonic epithelium<br />
Karen Kleberg, (Denmark), GM Jensen, JG Meyer, S Knuhtsen, MB Hansen, N Bindslev<br />
Tissue expression and function of organic anion transporting polypeptide 2B1 splice variants<br />
Michael Knauer, (Canada), R Kim, R Tirona<br />
Application of fluorescence spectroscopy to study conformational dynamics of LeuT, a bacterial<br />
homologue of mammalian neurotransmitter transporters<br />
Dinna B Krüger, (Denmark), J Kniazeff, L Shi, K Gotfryd, CC Billesbølle, CJ Loland, JA Javitch,<br />
H Weinstein, U Gether<br />
Histamine transport into neonatal rat astrocytes: an experimental and computational study<br />
Mojca Krzan, (Slovenia), K Perdan-Pirkmajer, J Mavri<br />
Acetylcholinesterase reactivators – in vitro prediction of passive drug transport through the blood-brain<br />
barrier<br />
Kamil Kuca, (Czech Republic), J Zdarova-Karasova, P Stodulka, K Musilek, M Pohanka<br />
ABC transporters and heavy metals in BeWo human choriocarcinoma cells<br />
Maria Kummu, (Finland), A Rautio, K Vähäkangas, P Myllynen<br />
Quantification, pharmacokinetics and brian distribution kinetics of thiencynonate and its optical isomers<br />
in rat<br />
Y Liu, Y Xu, Ming Xue, (PR China), J Ruan, K Liu<br />
Structural elucidation of in vivo metabolites of phencynonate and its analogue thiencynonate in rats by<br />
liquid chromatography-tandem mass spectrometry<br />
Y Liu, Ming Xue, (PR China), Y Ku, Y Xu, J Ruan, K Liu<br />
ITH12233, a new multifunctional compound, reduces infarct volume after focal cerebral ischemia in<br />
mice<br />
Silvia Lorrio, (Spain), P Negredo, MI Rodríguez-Franco, S Conde, MP Arce, M Villarroya, JM Roda,<br />
MG López, AG García<br />
In vitro evaluation of drug interaction with P-glycoprotein and permeability of F-80002-RR in early stages<br />
of development<br />
Maria Luisa Lucero, (Spain), A Gonzalo, I Soengas, M Rodriguez<br />
Monday 19 July ■ 13:00 - 14:00 ■ Poster Area 165
FC03<br />
Ion channels in analgesia and anaesthesia<br />
Mon 081<br />
Mon 082<br />
Mon 083<br />
Mon 084<br />
Mon 085<br />
Mon 086<br />
Mon 087<br />
Mon 088<br />
Mon 089<br />
Rocuronium interferes with cytochrome P450 in vitro<br />
Pavel Anzenbacher, (Czech Republic), E Anzenbacherova, A Tunkova, M Adamus<br />
Potentiating effect of diltiazem on pentobarbital hypnosis may be related to the 5-HT1A and 5-HT2A/2C<br />
receptors: the DRN, TMN and VLPO as key elements in the pathway<br />
Su-Ying Cui, (PR China), Y-H Zhang, X Zhao, X-Q Zhang<br />
Effects of ketamine on nociception, learning and memory in rats<br />
Damianka Getova, (Bulgaria), N Doncheva<br />
N-methyl-D-aspartate channel blocking properties of dual reuptake inhibitors<br />
Peter Heusler, (France), A Tourette, C Cathala, D Cussac<br />
The effect of tramadol on concentration of noradrenaline in the locus coeruleus of rats during the<br />
formalin test<br />
Akram Jamshidzadeh, (Iran), MA Mobasher, J Sajedianfard<br />
Time course of changes in TRPV1 channel function in rat urinary bladder following streptozotocin<br />
induced diabetes<br />
Teeraporn Katisart, (UK), M Parsons, C Benham<br />
Features of Meloxicam antinociceptive potential under experimental equivalent of Parkinson’s disease<br />
on a background of Amantadine therapy<br />
Olga Makarenko, (Ukraine)<br />
The effects of gabapentin on norepinephrine, serotonin and their metabolites in Raphe magnus in<br />
formalin test by the method of microdialysis in male rats<br />
Mohammad M Namvaran, (Iran), A Jamshidzadeh, J Sajedianfard, MA Mobasher<br />
The GTP-cyclohydrolase deficient mouse shows reduced acute pain perception<br />
Arafat Nasser, (Denmark), OJ Bjerrum, A-M Heedaard, LB Møller<br />
166 Monday 19 July ■ 13:00 - 14:00 ■ Poster Area
W12<br />
Experimental pain methods in development and<br />
validation of analgesics<br />
Mon 090<br />
Mon 091<br />
Mon 092<br />
Mon 093<br />
Mon 094<br />
Mon 095<br />
Mon 096<br />
Mon 097<br />
Mon 098<br />
Mon 099<br />
Mon 100<br />
Mon 101<br />
Mon 102<br />
Mon 103<br />
Mon 104<br />
The pharmacogenomics of escitalopram in the treatment of neuropathic pain<br />
Charlotte Brasch-Andersen, (Denmark), MU Møller, SH Sindrup, K Brøsen, M Otto<br />
Single dose of tramadol on neurotransmitter systems in target and non-target areas of rat brain without<br />
nociception<br />
Pandanaboina Chetan, (USA), S Rajbanshi, R Wudayagiri<br />
Comparison of the PD/PK of Rotundine crystal form A and C in mice<br />
Lida Du, (PR China), X Li, J Ying, X Bai, S Yang, H Zhang, G Wang, Y Lu<br />
Neurotropin relieves the oxaliplatin-induced peripheral neuropathy by inhibiting neurodegeneration<br />
Nobuaki Egashira, (Japan), T Kawashiri, H Watanabe, Y Ikegami, T Yano, H Ikesue, R Oishi<br />
Characterization of the antinociceptive and anti-inflammatory activities of nicotinamide and its isomers<br />
in different experimental models<br />
Wallace Ferreira, (Brazil), A Godin, L Rocha, R Vieira, E Nascimento, J Seniuk, M Coelho<br />
Characterization of the antinociceptive and anti-inflammatory activities of nicotinic acid and its isomers<br />
in different experimental models<br />
Wallace Ferreira, (Brazil), A Godin, L Rocha, R Vieira, E Nascimento, J Seniuk, M Coelho<br />
Botulinum toxin type A reduces migraine symptoms in rats: bilateral allodynia and dural extravasation<br />
after infraorbital nerve constriction injury<br />
B Filipovic, I Matak, L Bach-Rojecky, Zdravko Lackovic, (Croatia)<br />
Evatuation of the effects induced by nicorandil and its immediate precursor in the models of<br />
formaldehyde-induced nociceptive response and carrageenan-induced edema in mice<br />
Adriana Godin, (Brazil), W Ferreira, F Oliveira, L Rocha, R Vieira, E Nascimento Jr, J Seniuk,<br />
A de Fátima, M Coelho<br />
Lack of correlation between plasma asymmetric dimethylarginine (ADMA) levels and pain-related<br />
behaviors in neuropathic rats<br />
E Hafizoglu, (Turkey), Ahmet Ulugol<br />
Evidence for CGRP uptake in rat dura mater encephali: Relevance to migraine<br />
Inger Jansen-Olesen, (Denmark), D Amrutkar, A Mataji, H Salmasi, M Sheykhzade, K Messlinger,<br />
J Olesen, S Gupta<br />
Effects of Diclofenac on the repolarization in dog ventricular muscle<br />
Norbert Jost, (Hungary), A Kristof, I Koncz, T Szell, P Biliczki, J Papp, A Varro, L Virag<br />
Inhibitory effects of dopamine on spinal reflex potentials of rat<br />
K Kawamoto, Ken-ichi Otsuguro, (Japan), S Ito<br />
Local anaesthetic infused at the incision site for post-operative pain management following abdominal<br />
surgery<br />
Sumithra Krishnan, (Australia), R Morris, P Hewett, A Karatassas, J Tonkin, J Field<br />
Investigation of antinociceptive activity of mirtazepine and its mechanism<br />
Fatma Sultan Kýlýç, (Turkey), AE Doan, K Erol<br />
Does pheny-N-tert-butylnitrone (ROS scavenger) has the antinociceptive effect through spinal<br />
mechanism in formalin rat<br />
Won Hyung Lee, (South Korea), YK Ko<br />
Monday 19 July ■ 13:00 - 14:00 ■ Poster Area 167
W12<br />
Experimental pain methods in development and<br />
validation of analgesics<br />
Mon 105 Antinociceptive effects of biphalin and its analog AM 94<br />
Sheila Leone, (Italy), L Brunetti, G Orlando, A Mollica, L Recinella, C Ferrante, A Chiavaroli, C Di Nisio,<br />
P Di Michele, R Shohreh, M Vacca<br />
Mon 106<br />
Mon 107<br />
Mon 108<br />
Mon 109<br />
Mon 110<br />
Mon 111<br />
Mon 112<br />
Mon 113<br />
Mon 114<br />
Mon 115<br />
Role of pituitary adenylate cyclase activating polypeptide in the nitroglycerin-induced migraine model of<br />
the mouse<br />
Adrienn Markovics, (Hungary), K Sándor, E Szõke, V Kormos, B Botz, A Imreh, B Gaszner, D Reglõdi,<br />
A Baba, J Tajti, J Szolcsányi, Z Helyes<br />
The influence of intravenous promethazine on intravenous morphine for the treatment of acute severe<br />
pain: a randomised clinical trial<br />
Nasir Mohamad, (Malaysia), AH Saim, NH Abu Bakar, KA Baharuddin, R Ismail<br />
Antinociceptive effect of Endomorphin 1 administered using polybutylcyanoacrylate nanoparticulate<br />
delivery systems<br />
Ostin Mungiu, (Romania), D Geta, I Jaba, B Tamba, C Bohotin, X Patras<br />
Systematic review and meta-analysis of tryptans in the acute treatment of cluster headache<br />
C Mustata, Ricardo Pardo, (Spain), E Papaseit, M Farre<br />
Role of pituitary adenylate cyclase activating polypeptide in nocifensive behaviours, inflammatory and<br />
neuropathic hyperalgesia<br />
Katalin Sándor, (Hungary), V Kormos, B Botz, A Imreh, K Bölcskei, B Gaszner, D Reglõdi, J Szolcsányi,<br />
N Shintani, H Hashimoto, A Baba, Z Helyes<br />
Experimental research on the interactions of diethylamine with opioid and non-opioid analgesics<br />
Ana Segarceanu, (Romania), I Ghita, O Coman, I Fulga<br />
SA14867 ((+)-3-acetyl-6-chloro-2-[2-(3-(N-(2-ethoxyethyl)-N-isopropylamino)propoxy)-5-me<br />
thoxyphenyl]benzothiazoline O,Oκ f-diacetyl-L-tartarate), a newly synthesized κ-opioid agonist, shows<br />
anti-nociceptive and anti-pruritic effects<br />
Fumio Tsuji, (Japan), Y Tsukahara, M Niwa, M Nakamura, M Sasano, H Aono<br />
Acetyl-L-Carnitine increases artemin level and prevents neurotrophic factor alterations in neuropathic<br />
pain state<br />
Elisa Vivoli, (Italy), L Di Cesare Mannelli, A Salvicchi, A Bartolini, C Ghelardini<br />
Structure-activity relationship study of novel fentanyl analogues<br />
S Vuckovic, Z Nesic, K Savic Vujovic, M Milovanovic, Milica Prostran-Veselinovic, (Republic of Serbia)<br />
Influence of bile acid derivates on morphine analgesic effect in mice<br />
Sasa Vukmirovic, (Republic of Serbia), V Vasovic, D Lendak, M Mikov, M Vukmirovic Papuga,<br />
N Stilinovic<br />
168 Monday 19 July ■ 13:00 - 14:00 ■ Poster Area
FC04<br />
Pharmacoepidemiology, current controversies and<br />
opportunities<br />
Mon 116<br />
Mon 117<br />
Mon 118<br />
Mon 119<br />
Mon 120<br />
Mon 121<br />
Mon 122<br />
Mon 123<br />
Mon 124<br />
The effect of adverse drug reactions (adr) on drug prescriptions during acute hospital admissions<br />
Paul Acheampong, (UK), M Doshi, C Doig<br />
Prescription patterns of controlled medicines in Istanbul<br />
Ahmet Akici, (Turkey), D Demircan, I Topcu, H Yilmaz, B Donertas, K Berkman<br />
Drug use during pregnancy: a register-based nationwide cohort study of FDA's drug classification of<br />
fetal risks<br />
Jon T Andersen, (Denmark), M Petersen, N Andersen, S Afzal, K Broedbaek, B Hjelvang,<br />
C Torp-Pedersen, HE Poulsen<br />
Association between FDA drug classification of fetal risks and the risk of major congenital<br />
malformations: a register-based nationwide cohort study<br />
Jon T Andersen, (Denmark), M Petersen, NL Andersen, S Afzal, K Broedbaek, B Hjelvang,<br />
C Torp-Pedersen, HE Poulsen<br />
Adherence to antihypertensive medications and all-cause mortality and cardiovascular events:<br />
A population-based study based on administrative data<br />
Silvia Benemei, (Italy), S Saragoni, P Batacchi, P Geppetti, M Di Bari, N Marchionni, S Buda,<br />
ED Esposti, LD Esposti<br />
Consumption of drugs against ADHD in Denmark more than ten doubled in ten years<br />
Bine Kjøller Bjerregaard, (Denmark)<br />
Statin treatment reduces mortality in severe infections – a systematic review and meta-analysis<br />
Linda Björkhem-Bergman, (Sweden), P Bergman, J Andersson, J Lindh<br />
Off-label vs compassionate drug use: Level of evidence for applications<br />
Encarnación Blanco, (Spain), A Muñoz, I Bellido, M Salazar, EI Márquez<br />
Gender difference in the impact of long-term psychoactive drug use on cognitive functioning:<br />
The VISAT cohort<br />
O Boeuf-Cazou, B Bongue, D Ansiau, J-C Marquié, Maryse Lapeyre-Mestre, (France)<br />
Mon 125 Monitoring of adverse reaction by classical antipsychotics in older patient, Cuba 2003–2008<br />
Ashley Lázaro Chao Cardeso, (Cuba), GJ López, IA Orta, JA Pérez, ID Mato<br />
Mon 126<br />
Mon 127<br />
Management of cardiovascular medication in surgical patients: Indications in summary of product<br />
characteristics and substitution for intravenous forms<br />
Liliana Castanheira, (Portugal), P Fresco, AF Macedo<br />
Adherence to treatment: feasibility of a specific self-reported questionnaire to assess medication taking<br />
behaviour<br />
Josip Culig, (Croatia), M Leppee, J Boskovic<br />
Mon 128 Emergence of H274Y mutation and oseltamivir resistance during treatment in two patients in the 2009<br />
epidemics of swine flu in Argentina<br />
Roberto Diez, (Argentina), ML Valinotto, P Barrero, M Viegas, MC Alvarez López, E López,<br />
AS Mistchenko<br />
Mon 129<br />
A community pharmacy multinational project to investigate the prescription drug abuse<br />
Paola D’Incau, (Italy), M Lapeyre-Mestre, A Carvajal, U Bergman, ER Heerdink, RV Stichele, D Macias,<br />
L Pourcel, A Conforti<br />
Monday 19 July ■ 13:00 - 14:00 ■ Poster Area 169
FC04<br />
Pharmacoepidemiology, current controversies and<br />
opportunities<br />
Mon 130<br />
Mon 131<br />
Mon 132<br />
Mon 133<br />
Mon 134<br />
Mon 135<br />
Mon 136<br />
Mon 137<br />
Mon 138<br />
Mon 139<br />
Mon 140<br />
Mon 141<br />
Mon 142<br />
Mon 143<br />
Gender differences of ADRs related to psychotropic drug use: A survey from France, Italy and Spain<br />
Paola D'Incau, (Italy), M Lapeyre-Mestre, M Sáinz, M Donati, A Carvajal<br />
Aluminium phosphide poisoning – a retrospective study<br />
Nandlal Disania, (India), L Sharma, S Janani, BM Gupta<br />
Management of acute myocardial infarction in France: Results from inclusion of a national cohort<br />
Cécile Droz-Perroteau, (France), C Dureau-Pournin, D Thomas, N Danchin, J Tricoire, J Bénichou,<br />
F Paillard, P Ducimetière, S Hercberg, H Maïzi, E Guiard, M-A Bernard, P Blin, N Moore<br />
Analysis of pharmacotherapy for pregnant women in Primorye Region<br />
Ekaterina Eliseeva, (Russian Federation), Y Feoktistova, L Lozinskaya<br />
Medical prognosis of perioperative prophylaxis efficiency in cholecystectomy<br />
Ekaterina Eliseeva, (Russian Federation), V Shevtsov<br />
Clinical pharmacology outpatient clinic: outcomes and maternal characteristics associated with pregnancy<br />
exposure to FDA category X drugs<br />
Viktorija Erdeljic, (Croatia), I Francetic, K Makar-Ausperger, R Likic, M Radacic-Aumiler, D Juricic,<br />
L Bielen<br />
Prescription of potentially inappropriate medications: Comparison between internal medicine service<br />
and geriatric unit<br />
Leslie Escobar, (Chile), P Jara, M Jirón, M Rain, G Martinez, C Dechent<br />
Mini-cases as a method to dynamize lectures of autonomic nervous system pharmacology in a medical<br />
school<br />
Magi Farre, (Spain), J-E Baños<br />
Macro-study on-line of searching in internet for health and drug products: A social pharmacology<br />
approach<br />
Juan Antonio Formigos, (Spain), M Palmero, JL Alloza,<br />
Quality of antibiotic prescribing in infant in ambulatory care<br />
Kristina Garuoliene, (Lithuania), J Gulbinovic<br />
Administrative complexities for a European observational study<br />
Sinem Ezgi Gulmez, (France), S Lignot-Maleyran, S Micon, F Hamoud, C De Vries, M Sturkenboom,<br />
P Blin, N Moore<br />
SALOME: A pilot study to test causality assessment of drug-exposed acute liver failure cases using different<br />
scales<br />
Sinem Ezgi Gulmez, (France), GP Pageaux, D Larrey, S Lignot-Maleyran, F Hamoud, S Micon,<br />
R Lassalle, J Jové, F Bissoli, Y Horsmans, J Bernuau, B Stricker, D Thorburn, P Blin, N Moore on<br />
behalf of SALT-I team<br />
Methods for improving compliance with medicine intake(MICMI): Pilot project to evaluate the ’Personal<br />
Electronic Medicine profile’[PEM]<br />
Philipp Harbig, (Denmark), I Barat, P Lund Nielsen, EM Damsgaard<br />
Do vasodilating properties of amiodarone contribute to its antiarrthythmic action in clinical practice<br />
Apostolos Hatzitolios, (Greece), N Katsiki, G Ntaios, C Savopoulos, A Spiliopoulos, C Papadopoulos,<br />
V Mirtsou-Fidani<br />
170 Monday 19 July ■ 13:00 - 14:00 ■ Poster Area
FC04<br />
Pharmacoepidemiology, current controversies and<br />
opportunities<br />
Mon 144<br />
Mon 145<br />
Mon 146<br />
The effect of co-administration of CYP1A2 and P-glycoprotein inducers or inhibitors on serum<br />
theophylline concentration<br />
Milka Hauta-aho, (Finland), T Laurikainen, T Katiskalahti, T Tirkkonen, K Laine<br />
Factors associated with short-term adherence to dietary and lifestyle guidelines in secondary<br />
prevention of acute myocardial infarction in real life practice in France<br />
S Hercberg, D Thomas, Cécile Droz-Perroteau, (France), C Dureau-Pournin, P Ducimetière, F Paillard,<br />
J Tricoire, M-A Bernard, J Bénichou, N Danchin, L Guize, P Blin, N Moore<br />
Influence of nurses’ attitudes on adverse drug reaction reporting: a pilot study in Portugal<br />
Maria T Herdeiro, (Portugal), S Pernas, O da Cruz e Silva, A Figueiras<br />
Monday 19 July ■ 13:00 - 14:00 ■ Poster Area 171
FC05<br />
Translational science in the metabolic syndrome:<br />
Basic and clinical pharmacology<br />
Mon 147<br />
Mon 148<br />
Mon 149<br />
Mon 150<br />
Mon 151<br />
Mon 152<br />
Mon 153<br />
Mon 154<br />
Mon 155<br />
Mon 156<br />
Mon 157<br />
Mon 158<br />
Mon 159<br />
The blood glucose levels in healthy volunteers administered with repaglinide and genetic<br />
polymorphisms of CYP3A4 and CYP2C8<br />
Ruzilawati Abu Bakar, (Malaysia), MS Ab Wahab, G Siew Hua<br />
Microparticles from patients with metabolic syndrome induce vascular hypo-reactivity via Fas/Fas-<br />
Ligand pathway in mice<br />
A Agouni, P-H Ducluzeau, T Benameur, M Sladkova, G Leftheriotis, O Pechanova,<br />
Carmen Martinez, (France), R Andriantsitohaina<br />
A lineal mathematical model based on HbA1c levels follow up may predict the years of evolution of<br />
type 2 diabetes mellitus starting from a single HbA1c level quantification<br />
Inmaculada Bellido, (Spain), AE Santos, L García-Carrascal, JJ Sanchez-Luque, E-I Marquez, E Blanco,<br />
A Gomez-Luque<br />
Toxicity of cytostatic agents to granulocyte-macrophage progenitors (CFU-GM) increased in Zucker<br />
obese rats<br />
I Benkõ, Krisztina Géresi, (Hungary), K Benkõ, B Szabó, A Megyeri, E Ungvári, B Peitl, Z Szilvássy<br />
Angiotensin-(1-7) prevents diabetes-induced attenuation in PPAR-γ and catalase activities<br />
Ibrahim Benter, (Kuwait), G Dhaunsi, M Yousif, S Akhtar, M Chappell, D Diz<br />
PKCβ/HuR/VEGF a new pathway in diabetic retinopathy<br />
Claudio Bucolo, (Italy), A Pascale, M Amadio, S Govoni, F Drago<br />
Evaluation of guideline-conformity of initiation of oral hypoglycemic treatment for incident diabetes<br />
mellitus type 2 in Austria<br />
Anna Bucsics, (Austria), M Asslaber, R Bauer, T Burkhardt, M Pogantsch, A Schautzer, PR Wieninger,<br />
WC Winkelmayer<br />
TNFα does not inhibit insulin-stimulated 2-deoxy-glucose uptake in in situ skeletal muscle, but does<br />
increase lipolysis and lower total glucose utilization<br />
Christian Selmer Buhl, (Denmark), CN Petersen, N Jessen, O Schmitz, S Lund, ES Buhl<br />
Alterations in aromatase enzyme levels of ovary, testis, uterus and vas deferens tissues of diabetic rats<br />
Nihan Burul-Bozkurt, (Turkey), C Pekiner, P Kelicen<br />
Central injection of CDP-Choline suppresses serum ghrelin levels while it increases serum leptin levels<br />
in rats<br />
Sinan Cavun, (Turkey), S Kýyýcý, NF Basaran, V Savci, S Imamoglu<br />
α-linolenic acid protects renal cells against palmitic acid lipotoxicity via reduction of endoplasmic<br />
reticulum stress<br />
Prabal Chatterjee, (UK), E Katsoulieris, J Mabley, M Samai, I Green<br />
Discovery of a novel dipeptidyl peptidase-IV inhibitor BPR1G462<br />
Chiung-Tong Chen, (Taiwan), K-C Yeh, C-Y Huang, W-T Jiaang, C-B Hu, Y-W Huang,T Hsu, J-S Song,<br />
T-K Yeh, C-H Chien, S Chen, Y-S Chao<br />
A genetic variant in the gene encoding adrenomedullin predicts the development of dysglycaemia over<br />
6.4 years in Chinese<br />
Bernard MY Cheung, (PR China), AWK Tso, KL Ong, RYH Leung, SS Cherny, PC Sham, TH Lam,<br />
KSL Lam<br />
172 Monday 19 July ■ 13:00 - 14:00 ■ Poster Area
FC05<br />
Translational science in the metabolic syndrome:<br />
Basic and clinical pharmacology<br />
Mon 160<br />
Mon 161<br />
Mon 162<br />
Mon 163<br />
Mon 164<br />
Mon 165<br />
Mon 166<br />
Mon 167<br />
Mon 168<br />
Mon 169<br />
Mon 170<br />
Mon 171<br />
Mon 172<br />
Mon 173<br />
Pharmacogenetic study on metabolic syndrome induced by atypical antipsychotics and mood<br />
stabilizers<br />
Eva Choong, (Switzerland), M Etter, B Oneda, H Tayebi, G Bondolfi, CB Eap<br />
Type 2 diabetes-associated non-synonymous mutations in the gene coding for the melatonin MT2<br />
receptor impair melatonin signalling<br />
Nathalie Clement, (France), A Bonnefond, K Fawcett, E Vaillant, J-L Guillaume, B Balkau (the MAGIC<br />
consortium), M Marre, G Charpentier, M Vaxillaire, I Barroso, R Jockers, P Froguel<br />
Results about the influence of Metformin on the concentrations of magnesium,zinc and cooper in<br />
NIDDM patients.<br />
Monica Daniela Dosa, (Romania), LC Petcu, C Gales, M Nechifor<br />
Interaction between cicletanine and preconditioning in concious rabbits with insulin resistance<br />
László Drimba, (Hungary), B Peitl, T Patonay, Z Szilvássy<br />
Tumor necrosis factor α inhibition by pentoxifylline protects from the impairment in vascular reactivity<br />
associated with insulin resistance<br />
Hany El-Bassossy, (Egypt), M El-Moselhy, M Fouad<br />
Protein kinase C inhibition protects from the impairment in vascular responsiveness associated with<br />
insulin deficiency but not insulin resistance<br />
Hany El-Bassossy, (Egypt), A Fahmy, W Barakat, N Dsokey<br />
Effect of taurine, pyridoxine and α lipoic acid on cafeteria diet fed rats<br />
Priya Ganpathy, (India), R Ghosh, S Pitre, V Kadam<br />
Carboplatin-induced toxicity increased to granulocyte-macrophage progenitors (CFU-GM) in<br />
Otsuka-Long-Evans-Tokushima Fatty (OLETF) rats<br />
Krisztina Géresi, (Hungary), K Benkõ, B Szabó, A Megyeri, B Peitl, Z Szilvássy, I Benkõ<br />
Effect of bis-1-4-dihydropyridine in kidneys of diabetic rats<br />
Raquel Gómez-Pliego, (Mexico), R Villalobos-Molina, M Ibarra-Barajas, B Velasco-Bejarano,<br />
J Gómez-Zamudio<br />
Effect of atorvastatin on pancreatic β-cell function and insulin resistance in type 2 diabetes mellitus<br />
patients<br />
Aman Goyal, (India), S Singh, N Tandon, N Gupta, YK Gupta<br />
Does HGF/c-Met signalling exert its effects on vascular dysfunction by small GTPases in diabetic rats<br />
Mukaddes Gumustekin, (Turkey), A Arici, F Arslan, M Karaman, M Ates, E Guneli<br />
Transcriptome profiling reveals involvement of PKC in the development of insulin resistance in liver of<br />
HFD+STZ fed rats via Rho kinase pathway<br />
Jeena Gupta, (India), K Tikoo<br />
The interaction of human urotensin II and vasodilator agents in human internal thoracic artery: Clinical<br />
implications<br />
Guo-Wei He, (PR China), X-Y Bai, X-C Liu, W-B Jing, Q Yang<br />
Fish oil affects clock gene and clock-controlled metabolism-related gene expression in the mouse liver<br />
Akiko Hirao, (Japan), H Nagahama, M Itokawa, M Shimoda, Y Tahara, S Shibata<br />
Monday 19 July ■ 13:00 - 14:00 ■ Poster Area 173
FC05<br />
Translational science in the metabolic syndrome:<br />
Basic and clinical pharmacology<br />
Mon 174<br />
Mon 175<br />
Mon 176<br />
Mon 177<br />
Mon 178<br />
Mon 179<br />
Mon 180<br />
Mon 181<br />
Mon 182<br />
Mon 183<br />
Mon 184<br />
Mon 185<br />
Mon 186<br />
Mon 187<br />
Angiotensin II type 2 receptor activation modulates insulin receptor signalling pathways in adult sensory<br />
neurons<br />
Narumi Hobara, (Japan), N Hashikawa, Y Zamami, H Kawasaki, C Yutani<br />
Early indications for clinical efficacy of diabetes drugs in development in phase 1 studies: How<br />
Marcus Hompesch, (USA), L Morrow<br />
Modification of perivascular adipose tissue (PVAT) by diabetes mellitus<br />
Enrique Hong, (Mexico), O Echeverría<br />
Anti-obesity and anti-diabetic effects of acacia polyphenol<br />
Nobutomo Ikarashi, (Japan), T Toda, T Okaniwa, K Ito, W Ochiai<br />
Effects of polyphenolic compounds on glutathione level and endothelial NO production in<br />
hypercholesterolemic rats<br />
Akira Ishihata, (Japan), Y Igarashi, Y Shimizu, Y Kobayashi, A Yamada, S Hishinuma, T Hosoda,<br />
Y Katano<br />
Dysfunction of presynaptic regulation of norepinephrine release from adrenergic nerves of caudal artery<br />
in type 2 diabetic Goto-Kakizaki rats<br />
Reiko Ishii-Nozawa, (Japan), M Mita, M Shoji, K Takeuchi<br />
Basic fibroblast growth factor upregulates hypoxia inducible factor 1α and glucose transporter 1 in<br />
adipose cells<br />
Yoshitaka Kihira, (Japan), S Tomita, Y Ikeda, K Ishizawa, K Tsuchiya, T Tamaki<br />
Antiplatelet action of statins in diabetic rabbits: Interaction with leptin<br />
Ivan Kocic, (Poland), B Racek-Król, I Rusiecka, I Pawlowska, R Wasilewski, M Bitel<br />
Differences in the pharmacokinetics of Cyp3a substrates in TSOD mice and streptozotocin-induced<br />
diabetic mice<br />
T Kudo, T Toda, T Ushiki, K Ohi, N Ikarashi, W Ochiai, Kiyoshi Sugiyama (Japan)<br />
Suppression of NF- κB signalling pathway by epigallocatechin gallate can prevent diabetes associated<br />
cognitive deficits<br />
Anurag Kuhad, (India), M Bishnoi, V Tiwari, K Chopra<br />
Cardiovascular dysfunction and the role of COX-2 in two rat models of diabetes<br />
Joanne YT Leung, (Canada), SL Lim, CCY Pang<br />
Effect of bicyclol on high fat diet (HFD)-induced fatty liver in rats<br />
Yan Li, (PR China), H Yu, H Chen<br />
Leptin induces hypertrophy via activating PPARα pathway in cultured neonatal rat cardiomyocytes<br />
Jian-Dong Luo, (PR China), N Hou, M-S Chen<br />
Association of VKORC1 -1639 G>A polymorphism with intima-media thickness of common carotid<br />
artery in subjects with type 2 diabetes mellitus<br />
Vangelis G Manolopoulos, (Greece), I Petridis, G Ragia, M Vassileiadis, I Heliopoulos, D Christakidis,<br />
A Tavridou<br />
174 Monday 19 July ■ 13:00 - 14:00 ■ Poster Area
FC06<br />
The heart gone wrong; stabilization of cardiac<br />
function<br />
Mon 188<br />
Mon 189<br />
Mon 190<br />
Mon 191<br />
Mon 192<br />
Mon 193<br />
Mon 194<br />
Mon 195<br />
Mon 196<br />
Mon 197<br />
Mon 198<br />
Mon 199<br />
Mon 200<br />
Mon 201<br />
Mon 202<br />
Mon 203<br />
Effect of vitamin E on renal ischemic preconditioning in male and female rats<br />
Nahid Abotaleb, (Iran), S Aryamanesh, SM Ebrahimi, M Nobakht<br />
Modulatory effects of zinc supplementation on cardiovascular complications in streptozotocin-induced<br />
diabetes in rats<br />
Nouf MI AL-Rasheed, (Saudi Arabia), NMI AL-Rasheed, HA Attia, LM Faddah<br />
Cardioprotective mechanism of telmisartan through the PPAR-γ pathway against isoproterenol-induced<br />
myocardial infarction in experimental diabetes<br />
Dharamvir S Arya, (India), S Goyal<br />
Mechanical and structural characteristics of carotid plaques: Analysis by multi-array echotracking<br />
system and MRI.<br />
Hélène Beaussier, (France), O Naggara, D Calvet, R Joannides, B Laloux, E Bozec,<br />
E Guegan-Massardier, E Gerardin, I Masson, C Oppenheim, P Boutouyrie, S Laurent<br />
Rational drug correction of the systemic inflammatory response syndrome in patients with congestive<br />
heart failure<br />
Tamar Bochorishvili, (Georgia), MA Rogava, ET Tsiwtsiwadze<br />
Relevance of free MPA monitoring in early period following heart transplantation<br />
Roselyne Boulieu, (France), X Cussonneau, M Larger, O Bastien<br />
Prostacyclin IP receptor activation, transforming growth factor signalling and cardiac fibrosis in<br />
hyperlipidemic mice<br />
Elsa Chan, (Australia), G Dusting, N Guo, H Peshavariya, R Dilley, S Narumiya, F Jiang<br />
Effect of pre-ischaemic conditioning on anoxic dopamine efflux in the mouse caudate.<br />
Nikky Kanti Chauhan, (UK), AMJ Young, CL Gibson, C Davidson<br />
Cardioprotective effects of exogenous and endogenous hydrocortisone in the rabbit model of<br />
ischemia-reperfusion<br />
Ali Davarian, (Iran), V Khori, O Shirinbeik Mohajer<br />
Engagement of imidazoline receptors in effects of imidazoline drugs on isolated rat heart atria<br />
Justyna Dlugokecka, (Poland), A Radwanska, R Kaliszan, A Nasal<br />
Effects of ultra-low doses of peroral antibodies to angiotensin II receptor in non-invasive and invasive rat<br />
models of heart failure<br />
Julia Dugina, (Russian Federation), IA Kheyfets, SA Sergeeva, OI Epstein<br />
Effect of atorvastatin addition to cardioplegic solution on myocardial protection in isolated rat heart<br />
Deniz Kaleli Durman, (Turkey), M Agirgol, M Kucur, F Basinoglu, O Ozdemir, BS Uydes-Dogan<br />
Disproportionally impaired microvascular structure in patients with very mild essential hypertension<br />
Ashkan Eftekhari, (Denmark), ON Mathiassen, NH Buus, O Gotzsche, MJ Mulvany, KL Christensen<br />
Effect of grapefruit juice on dronedarone pharmacokinetics in healthy subjects<br />
Christine Gaud, (France), A Brunet, E Sultan, J Galleyrand, T Duvauchelle<br />
Effects of dronedarone on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects<br />
Christine Gaud, (France), J-P Duret, A Brunet, E Sultan, R Ebrahimi<br />
Effects of dronedarone on the pharmacokinetics of digoxin in healthy subjects<br />
Christine Gaud, (France), F Hurbin, A Brunet, E Sultan, J Galleyrand, E Guénolé<br />
Monday 19 July ■ 13:00 - 14:00 ■ Poster Area 175
FC06<br />
The heart gone wrong; stabilization of cardiac<br />
function<br />
Mon 204<br />
Mon 205<br />
Mon 206<br />
Mon 207<br />
Mon 208<br />
Mon 209<br />
Mon 210<br />
Mon 211<br />
Mon 212<br />
Mon 213<br />
Mon 214<br />
Mon 215<br />
Mon 216<br />
Mon 217<br />
Mon 218<br />
Pharmacokinetic and pharmacodynamic interaction of dronedarone and verapamil in healthy subjects<br />
Christine Gaud, (France), S Doroumian, A Brunet, E Sultan, J Galleyrand<br />
Pharmacokinetics and tolerability of dronedarone in patients with moderate hepatic impairment<br />
Christine Gaud, (France), A Brunet, E Sultan, J Galleyrand, K Lasseter, T Marbury<br />
The oxidative stress predicts a higher coronary risk<br />
Jose Antonio González Correa, (Spain), M Carnero, J Muñoz-Marin, F Reguillo, M Ramajo, J Navarro-<br />
Dorado, S Redondo, JP De la Cruz, T Tejerina<br />
Ambulatory control of arterial pressure in patients with isolated systolic hypertension and associated<br />
ischemic heart disease<br />
Jose Ernesto Groning, (Cuba), R Garcia, D Garcia-Barreto, A Hernandez-Cañero<br />
Potentiation of uterus-relaxing effects of nifedipine with β-adrenergic agonists: Studies on rats and<br />
human myometrium<br />
Judit Hajagos-Tóth, (Hungary), Z Kormányos, G Falkay, R Gáspár<br />
Ginsenoside Rg-1 and salvianolic acid B mediated autophagy and apoptosis in nutrient starvation<br />
cardiac myocytes<br />
Xiao Han, (PR China), J-X Liu, X-Z Li<br />
The role of voltage-dependent anion channel in ischemia/reperfusion injury mediated by chloride<br />
Ming He, (PR China), Z Liao, L Tang, D Yin, F Zou, S Yin<br />
The effects of cannabidiol and the CB1 antagonist AM251 on the depressor responses to ACEA in vivo<br />
Claire Hepburn, (UK), O Keown, S Watt, I Megson, S Leslie, K Kane, C Wainwright<br />
Continuous infusion of a tiny dose of corticosterone improves ageing and hypertension related heart<br />
function impairment and reduces cardiac fibrosis<br />
JJ Rob Hermans, (The Netherlands), M Minnaard-Huiban, IPE Beugels, H van Essen, JJ Debets,<br />
H AJ Struijker-Boudier, JFM Smits<br />
Effects of calcitonin gene-related peptide(CGRP) on the underperfusion with norepinephrine injuries in<br />
diabetic rat hearts<br />
Makie Higuchi, (Japan), T Akamine<br />
Targeting antioxidants to sites of oxidative stress using dual action drugs<br />
Nitya Jani, (Australia), J Ziogas, C Schiesser, C Wright<br />
Fetal de novo cholesterol synthesis is required for neuroectodermal survival and cardiovascular<br />
differentiation in early mouse embryos<br />
Heli Jokela, (Finland), P Rantakari, T Lamminen, L Strauss, R Ola, A-L Mutka, H Gylling, T Miettinen,<br />
P Pakarinen, K Sainio, M Poutanen<br />
Phapmacotherapy of patients with ischemic heart disease and left ventricle dysfunction targeting to<br />
restore inotropic action and bionergetic reserve of myocardium<br />
Ketevan T Kapanadze, (Georgia), GV Sukoyan, MA Rogava<br />
Strategies to induce cardiac electrophysiological properties in C2C12 skeletal myoblasts<br />
X Koenig, E Zebedin-Brandl, M Mille, M Schnuerch, M Koley, MD Mihovilovic, R Cervenka, P Lukacs,<br />
H Todt, Karlheinz Hilber (Austria)<br />
Disrupted ion channel function in dystrophic cardiomyocytes<br />
Xaver Koenig, (Austria), M Mille, S Kimbacher, R Cervenka, P Lukacs, H Todt, RE Bittner, K Hilber<br />
176 Monday 19 July ■ 13:00 - 14:00 ■ Poster Area
FC06<br />
The heart gone wrong; stabilization of cardiac<br />
function<br />
Mon 219<br />
Mon 220<br />
Mon 221<br />
Cardiotrophin-1 is upregulated, but left ventricular function is not affected after acute daunorubicin<br />
treatment in the spontaneously hypertensive rats<br />
Peter Krenek, (Slovak Republic), K Turcekova, H Cernecka, L Mesarosova, M Snopkova,<br />
P Ochodnicky, P Musil, J Kyselovic, J Klimas<br />
DPP IV deficiency preserves cardiac function of endotoxemic rats via GLP signaling<br />
Hui Chun Ku, (Taiwan), MJ Su<br />
Fast aorta reModelling following the administration and withdrawal of calcium antagonists in<br />
spontaneously hypertensive rats<br />
Jan Kyselovic, (Slovak Republic), V Vaja, P Krenek, J Klimas, P Ochodnicky<br />
Monday 19 July ■ 13:00 - 14:00 ■ Poster Area 177
FC07<br />
Simulation and data modelling in drug development.<br />
Better drugs faster<br />
Mon 222<br />
Mon 223<br />
Mon 224<br />
Mon 225<br />
Mon 226<br />
Mon 227<br />
Mon 228<br />
Mon 229<br />
Mon 230<br />
Protective effect of aqueous saffron extract (Crocus sativus L.) on carbon tetrachloride-induced<br />
hepatotoxicity in rats<br />
Amir Ashna, (Iran), H Najafzadeh<br />
Modelling outcomes of antibiotic therapy by discrete event simulation (DES) or multi-agent-based<br />
simulation (MABS) of nosocomial pneumonia<br />
Mario Eandi, (Italy), P De Luca, L Pradelli, S Iannazzo<br />
Molecular dynamics simulations of serotonin and S-citalopram in serotonin transporter<br />
Mari Gabrielsen, (Norway), AW Ravna, K Kristiansen, I Sylte<br />
A new dimeric linear dipeptide mimetic of NGF active on animal models of Parkinson’s disease<br />
Tatiana Gudasheva, (Russian Federation), P Povarnina, T Antipova, S Seredenin<br />
The use of truncated area under the curve as a measure of relative extent in bioequivalence studies<br />
Seong Bok Jang, (South Korea), YJ Lee, LA Lim, K Park<br />
PK/PD model for pegylated, long-acting human growth hormone in adults with growth hormone<br />
deficiency<br />
Thomas Klitgaard, (Denmark), J Madsen, BS Hansen, MH Rasmussen<br />
Mechanistic Modelling of antigen-sink effect for therapeutic monoclonal antibodies: a case study<br />
YY Lau, L Roskos, M Liang, H Lu, M Zusmanovich, Bing Wang, (USA)<br />
Modelling and literature analysis to evaluate the pharmacokinetics of new fast release Ibuprofen based<br />
on a comparison of studies performed in India and Europe<br />
John C Lukas, (Spain), M Rodriguez, A Knapp, P Kraahs<br />
Preparation of artificial receptors for clozapine and study of their binding properties<br />
Seyed Ahmad Mohajeri, (Iran), G Karimi, M Rajabnia<br />
178 Monday 19 July ■ 13:00 - 14:00 ■ Poster Area
FC08<br />
Developments in the treatment of sexual<br />
dysfunction and diseases of the lower urinary tract<br />
Mon 231<br />
Mon 232<br />
Mon 233<br />
Mon 234<br />
Mon 235<br />
Mon 236<br />
Mon 237<br />
Mon 238<br />
Mon 239<br />
Mon 240<br />
Mon 241<br />
Mon 242<br />
Mon 243<br />
Mon 244<br />
Mon 245<br />
Mon 246<br />
Mon 247<br />
Finasteride and Prazosin mixed therapy in patient with bening prostatic hyperplasia<br />
Seyed Yousef Agha Alaie, (Iran), SS Kashaf, B Najafian, P Musavi<br />
Rho-kinase inhibition impacts neurogenic detrusor overactivity in chronic spinalized rats<br />
Delphine Behr-Roussel, (France), D Broquères-You, S Oger, S Compagnie, A Caisey, P Denys,<br />
E Chartier-Kastler, F Giuliano<br />
Rho-kinase inhibition relaxes detrusor from neurogenic patients<br />
Delphine Behr-Roussel, (France), S Oger, D Gorny, J Bernabé, E Chartier-Kastler, P Denys, F Giuliano<br />
Prevention of urinary tract infections in Norwegian nursing homes<br />
Jenny Bergman, (Norway), H Salvesen Blix, J Schjøtt<br />
Innervated myofibroblasts in the urinary bladder Functional and ultrastructural evidence<br />
Elizabeth Burcher, (Australia), P Sadananda, S Sandow<br />
Comparison of central nervous system penetration of antimuscarinic drugs for overactive bladder<br />
E Callegari, R Webster, K Fenner, J LaPerle, B Malhotra, Peter Bungay (USA)<br />
Role of rasayan herbs on reproductive parameters of male rats<br />
Nagendra Chauhan, (India), VK Dixit<br />
Fractionation of saw palmetto extracts and bioassay fractions in isolated rat prostate<br />
Thiam Chua, (Australia), J Simpson, S Ventura<br />
Vascular insulin resistance in penile arteries from a rat model of metabolic syndrome<br />
C Contreras, A Sánchez, B Climent, A García-Sacristán, S Benedito, Dolores Prieto, (Spain)<br />
Role of CX43 in the maintenance of spontaneous activity in the guinea pig prostate<br />
Anupa Dey, (Australia), S Kusljic, RJ Lang, B Exintaris<br />
Developments in the treatment of sexual dysfunction and diseases of the lower urinary tract<br />
Saintmoses Eromosele, (Nigeria), V Eruanga, PA Francis<br />
Pacemaker cells and contractility in the prostate gland<br />
Betty Exintaris, (Australia), A Dey, S Kusljic, M Lam, D-T Nguyen, R Lang<br />
Hydrogen sulfide promotes function of T-type calcium channels and secretion of prostatic acid<br />
phosphatase in neuroendocrine-like prostate cancer cells from the androgen-sensitive LNCaP cell line<br />
Kazuki Fukami, (Japan), R Kasamatsu, S Yoshida, F Sekiguchi, A Kawabata<br />
Effects of duloxetine on bladder and external urethral sphincter in anesthetized female guinea-pigs with<br />
intravesical acetic acid<br />
Véronique Guilloteau, (France), S Palea, M Guerard, T Westfall, P Lluel<br />
On pharmaco-toxicological approaches to vesical dysfunction<br />
Ulrich Härlin, (Germany), E Neu, A Hofstetter, G Staehler, S Magour, G Ernst, W Seidenbusch,<br />
MC Michailov, D Hüting, U Welscher, J Foltinova<br />
To investigate the effects of 5-HT and electrical field stimulation (EFS) in the bladder of Suncus murinus<br />
Farideh A Javid, (UK)<br />
Effects of potassium channel openers on parameters of ureteral function – an in vivo animal study<br />
Carsten Krahtz, (Germany), AJ Becker, ME Mayer, MA Kuczyk, CG Stief<br />
Monday 19 July ■ 13:00 - 14:00 ■ Poster Area 179
FC08<br />
Developments in the treatment of sexual<br />
dysfunction and diseases of the lower urinary tract<br />
Mon 248<br />
Mon 249<br />
Mon 250<br />
Mon 251<br />
The effect of imatinib mesylate on spontaneous activity in the guinea-pig prostate<br />
Michelle Lam, (Australia), A Dey, B Exintaris<br />
Golgi activation of cdc2 kinase in paclitaxel-inuced apoptosis in human androgen-independent prostate<br />
cancers<br />
Pin Hsuan Lu, (Taiwan), JH Guh<br />
Analysis of cellular signalling for epidermal growth factor-mediated suppression of androgen-induced<br />
expression of prostate-specific antigen gene in human prostate cancer LNCaP cells<br />
Yuma Maeda, (Japan), R Yamanaka, F Sekiguchi, A Kawabata<br />
Effects of fesoterodine 8 mg once daily on the pharmacokinetics and pharmacodynamics of a single<br />
supratherapeutic dose of warfarin in healthy subjects<br />
Bimal Malhotra, (USA), G Duczynski, C Alvey, J Gong, X Li, K Gandelman<br />
180 Monday 19 July ■ 13:00 - 14:00 ■ Poster Area
FC09<br />
Inflammation and immunopharmacology:<br />
New tools for old diseases<br />
Mon 252<br />
Mon 253<br />
Mon 254<br />
Mon 255<br />
Effect of chronic mild stress ‘CMS’ on CYP1A2 enzyme activity and inducibility in Wistar rats<br />
Ahmed M-D Abdel-tawab, (Egypt), AM Hassan, AN-E Hassan<br />
Inhibitory effect of carbon monoxide-releasing molecule CORM-2 on TNF-α release from activated-RBL-<br />
2H3 cells<br />
Masaaki Akagi, (Japan), Y Yasui, M Watanabe, A Maruyama, N Matsui, R Akagi<br />
5-(4-Methanesulphonyl-phenyl)-thyazole derivatives: new tools for chronic inflammatory disease<br />
biotherapy<br />
Melchor Alvarez de Mon, (Spain)F Ledo, E SanAntonio, E Sanz, R Corcostegui, A Berisa, V Rubio,<br />
ML Lucero, A Muñoz, A de-la-Hera<br />
Roles of COX/PGE/EP4 receptors in healing of indomethacin- induced small intestinal lesions in rats:<br />
Relation to VEGF expression<br />
Kikuko Amagase, (Japan), A Kojo, N Abe, R Hatazawa, M Tanigami, K Takeuchi<br />
Mon 256 Whole-body distribution and pharmacokinetics of radioiodinated fully humanized anti-VAP-1 antibody –<br />
a PET imaging study of rabbits<br />
Anu Autio, (Finland), PJ Vainio, A Mali, J Vainio, S Suilamo, V Oikonen, P Luoto, M Teräs, T Karhi,<br />
A Roivainen<br />
Mon 257<br />
Mon 258<br />
Mon 259<br />
Mon 260<br />
Mon 261<br />
Mon 262<br />
Mon 263<br />
Mon 264<br />
Mon 265<br />
Mon 266<br />
Analbuminemia: Cardiovascular function of endotoxemic rats<br />
Hermes Vieira Barbeiro, (Brazil), CB Lorigados, DF Barbeiro, S Catanozi, E Nakarandake, IT Velasco,<br />
FB Fusco, A dos Santos Filho, FG Soriano<br />
The effect of acute and chronic administration of Nevirapine on interleukin-2 in a rat model<br />
Zanelle Bekker, (South Africa), A Walubo, JB Du Plessis<br />
Apparent differences in pharmacokinetic performance between generic mycophenolate mofetil tablet<br />
formulations<br />
Darren Bentley, (UK), L Banken, R Robson<br />
Anti-inflammatory and antioxidant activities of an Indian medicinal plant, Emblica officinalis, in rodent<br />
models of inflammation<br />
Jagriti Bhatia, (India), M Golechha, DS Arya, F Tabassum<br />
Age-dependent effects of dexamethasone on hypoxic-ischemic brain edema<br />
Gábor Blazsó, (Hungary), M Pásztor, A Balogh, A Márki, G Dombi, G Falkay<br />
The differences of antiulcer activity of proton pump inhibitor (PPI) and H2-antagonist in diabetic rats<br />
Teresa Bobkiewicz-Kozlowska, (Poland), R Forjasz, M Nowaczyk<br />
Monitoring of azathioprine metabolites in pediatric patients with autoimmune hepatitis<br />
Roselyne Boulieu, (France), TMH Nguyen, C Le Gall, A Lachaux<br />
Searching for novel analgesic and anti-inflammatory analogs of anandamide<br />
Sumner Burstein, (USA), G Li, R Salmonsen, C McQuain, T Al, V Kattamuri<br />
Mitigation effect of esculentic acid on radiation-induced pneumonia and pulmonary fibrosis<br />
Yong-Bing Cao, (PR China), S-M Yang, Y-P Tian, M Zhang, L Zhang, K-Z Zhang, L-J Yin, B-R Zhang,<br />
R Howell, Y-Y Jiang, P Okunieff, L Zhang<br />
Remicade alleviates airway inflammation and hyperreactivity in asthmatic E3 rats<br />
Yong-Xiao Cao, (PR China), Y Cai, SM Lu, CB Xu, LO Cardell<br />
Monday 19 July ■ 13:00 - 14:00 ■ Poster Area 181
FC09<br />
Inflammation and immunopharmacology:<br />
New tools for old diseases<br />
Mon 267<br />
Mon 268<br />
Mon 269<br />
Mon 270<br />
Mon 271<br />
Mon 272<br />
Mon 273<br />
Mon 274<br />
Mon 275<br />
Mon 276<br />
Mon 277<br />
Mon 278<br />
Mon 279<br />
Mon 280<br />
Dosage regimen of vancomycin in NICU/PICU patients<br />
Oleg Cerná, (Czech Republic), Pavla Pokorná, J Sedivý<br />
The adjuvant effects of specific phytocompounds on tumor cell lysate-pulsed dendritic cell-based<br />
vaccine via induction of immunogenic tumor cell death<br />
Hui-Ming Chen, (Taiwan), S-S Chen, N-S Yang<br />
Theophylline-substituted KMUP-1 inhibits allergen-induced pulmonary vascular and bronchial<br />
inflammation: eNOS-enhancement and MMP-9-suppression<br />
Ing-Jun Chen, (Taiwan)<br />
Oxytocin injected on ovariectomized female rats can ameliorate heatstroke via increasing circulating<br />
endothelial progenitor cells<br />
Sheng-Hsien Chen, (Taiwan), W-T Huang, CY Kang<br />
Relationship of plasma interleukin-6 and its genetic variants with hypertension in Hong Kong Chinese<br />
Bernard MY Cheung, (PR China), AWK Tso, KL Ong, RYH Leung, SS Cherny, PC Sham, GN Thomas,<br />
TH Lam, KSL Lam<br />
Inhibitory effect of AS1517499, a novel STAT6 inhibitor, on antigen-induced airway<br />
hyperresponsiveness in mice<br />
Yoshihiko Chiba, (Japan), M Todoroki, Y Nishida, M Tanabe, M Misawa<br />
Effect of crotoxin, the main toxin of the rattlesnake C.d.terrificus venom, on secretory activity of<br />
peritoneal macrophages during tumor progression<br />
ES Costa, AMSC Francisco, OJ Faiad, Y Cury, Sandra Sampaio, (Brazil)<br />
Possible role of the endocannabinoid system in the analgesic effect of paracetamol-ibuprofen<br />
association – an experimental study<br />
Mihnea Costescu, (Romania), H Paunescu, OA Coman, I Fulga<br />
Hydrogen sulfide improves neutrophil migration and surival in sepsis via K+ATP channel activation<br />
Fernando Cunha, (Brazil), F Spiller, M Orrico, F Souto, J Alves-Filho, S Ferreira, J Hothersall, A Freitas<br />
Opioid receptor activation and expression is regulated by peripheral injury in both dorsal root ganglia<br />
(DRG) and nerve paw (NP) of rats<br />
Yara Cury, (Brazil), V Zambelli, AC Fernandes, V Gutierrez, C Parada<br />
PD98059, a specific mitogen-activated protein kinase inhibitor, attenuates the development of<br />
bleomycin-induced lung injury<br />
Salvatore Cuzzocrea, (Italy), M Galuppo, E Mazzon, E Esposito, R Di Paola, T Genovese, P Bramanti<br />
Influence of prolonged-release aspirin on platelet function in patients with chronic coronary disease<br />
Jose P de la Cortes, (Spain), A Guerrero, E Rueda, J Muñoz-Marín, JA Lopez-Villodres,<br />
JA Gonzalez-Correa<br />
The anti-inflammatory and anti-hypernociceptive activities of LASSBio-1141: The role of adenosine<br />
receptors<br />
Cleverton KF de Lima, (Brazil), RB Lacerda, LL da Silva, CAM Fraga, E de Jesus Barreiro,<br />
ALP de Miranda<br />
Analysis of the immunogenicity of an interferon β1a biosimilar<br />
Roberto Diez, (Argentina), M Kauffman, A Sterin-Prync, M Papouchado, E Gonzalez, A Grossberg,<br />
S Chuppa, B Odoriz, C Vrech, H Ferro<br />
182 Monday 19 July ■ 13:00 - 14:00 ■ Poster Area
FC09<br />
Inflammation and immunopharmacology:<br />
New tools for old diseases<br />
Mon 281<br />
Mon 282<br />
Mon 283<br />
Mon 284<br />
Mon 285<br />
Mon 286<br />
Mon 287<br />
Mon 288<br />
Mon 289<br />
Mon 290<br />
Mon 291<br />
Mon 292<br />
Mon 293<br />
Mon 294<br />
Mon 295<br />
NCX4040, a nitric oxide-donating aspirin, exerts anti-inflammatory effects through inhibition of IκB-α<br />
degradation in human monocytes<br />
Melania Dovizio, (Italy), E Ricciotti, L Di Francesco, P Anzellotti, T Salvatore, A Di Francesco,<br />
MG Sciulli, G Pistritto, A Monopoli, P Patrignani<br />
Cannabinoids and calcium mobilisation in microglia cells<br />
Khalil El Deeb, (UK), SPH Alexander, D Pritchard, DA Kendall<br />
Peripheral effects of the marijuana smoke in the lung of mice<br />
Krisztian Elekes, (Hungary), K Sandor, E Szoke, D Toth, A Markovics, I Szitter, L Jakab, B Szakacs,<br />
L Kereskai, J Szolcsanyi, T Molnar, Z Helyes<br />
Antiviral activity of anaferon for children in pandemic A/H1N1 in mice<br />
Oleg Epstein, (Russian Federation), JL Dugina, SA Tarasov, SA Sergeeva<br />
Substance P interacting proteins: Potential mechanisms for non-receptor mediated effects<br />
Nuray Erin, (Turkey), V Bui, G Clawson<br />
The absence of a functional peroxisome proliferator-activated receptor-α gene in mice enhances<br />
dopaminergic neuron sensitivity to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine<br />
Emanuela Esposito, (Italy), E Mazzon, I Paterniti, T Genovese, S Cuzzocrea<br />
TRPA1 plays an important role in TNFα-induced mechanical hyperalgesia<br />
Elizabeth S Fernandes, (UK), FA Russell, D Spina, R Graepel, C Gentry, J Keeble, S Bevan, SD Brain<br />
Meropenem controlled-release system<br />
Gonzalo Fernández Govantes, (Spain), JJT Durán, ST Durán<br />
Modulation of Th2-cytokines production and adhesion molecule expression on bone marrow and<br />
peripheral blood eosinophils in allergic mice by inducible nitric oxide synthase<br />
Heloisa HA Ferreira, (Brazil), EH Pellaquini, LR Benetti, LGR Fernandes, WMSC Tamashiro<br />
The sweet syndrome: two cases induced by amoxicillin- clavulanic acid<br />
Houda Filali, (Morocco), I Rahmoun, A Elgharbi, F Hakkou<br />
Inhibition of NF-κB activation by Cymbopogon citratus leaves and their polyphenols in human<br />
macrophages: a potential natural source of anti-inflammatory drugs<br />
Vera Francisco, (Portugal), A Figueirinha, BM Neves, C Garcia-Rodriguez, MC Lopes, MT Cruz,<br />
MT Batista<br />
Estrogen minimizes cell death caused by H2O2 in cells of rat glioma<br />
Lucas AM Franco, (Brazil), L Yshii, E Kawamoto, L Lima, C Scavone, C Munhoz<br />
Effect of red-wine polyphenolic compounds on allergen induced hyperreactivity of the airways<br />
Sona Franova, (Slovak Republic), M Joskova, E Novakova, K Adamicova, G Nosalova, O Pechanova<br />
The protective effect of atorvastatin against proliferative alterations produced by croton oil on mouse<br />
epidermis<br />
Alireza Garjani, (Iran), Y Doustar, H Rezazadeh, S Andalib, N Maleki-Dizaji<br />
Effect of AT1 receptor blockade on the antioxidants enzymes activities in an experimental model of<br />
periodontal disease induced by lipopolysaccharide in the rat<br />
Maria del Rosario Garrido, (Venezuela), MG Matos, JA Silva, Y Mathison, A Israel<br />
Monday 19 July ■ 13:00 - 14:00 ■ Poster Area 183
FC09<br />
Inflammation and immunopharmacology:<br />
New tools for old diseases<br />
Mon 296<br />
Mon 297<br />
Mon 298<br />
Mon 299<br />
Mon 300<br />
Mon 301<br />
Mon 302<br />
Mon 303<br />
Mon 304<br />
Mon 305<br />
Mon 306<br />
Mon 307<br />
Mon 308<br />
Mon 309<br />
Mon 310<br />
Novel small molecular weight CCL2 inhibitors reduce inflammatory response in mice<br />
Beatrice Garrone, (Italy), A di Matteo, G Mangano, C Bartella, C Apicella, N Cazzolla, G Furlotti,<br />
A Guglielmotti<br />
Diclofenac sodium suppresses rat calvarial bone defect regeneration<br />
T Georgopoulou-Karanikola, Stergios Tsartsalis, (Greece), H Kalekou, AA Veis, B Kokkas, AT Tsirlis<br />
M Mironidou-Tzouveleki<br />
Biomembrane with laticifers proteins from Calotropis procera induces tissue neoformation in mice<br />
Danilo Gonçalves, (Brazil), I Figueiredo, I Calou, R Oliveira, L Freitas, R Pinheiro, T Andrade, M Frade,<br />
GA Brito, R Leitão, M Ramos, N Alencar<br />
Comparative study of the effects of lovastatin and sinvastatin in models of acute inflammation in<br />
rodents and human neutrophils<br />
Danilo Gonçalves, (Brazil), I Calou, A Araújo, I Figueiredo, T Olinda, LK Leal, G Viana<br />
Effect of rupatadine on histamine-induced rat paw oedema formation and the concomitant upregulation<br />
of H1R and PAFR gene expression<br />
Antonis Goulas, (Greece), K Kalokasidis, D Molyva, E Varsamidou, B Kokkas, K Varsamidis<br />
CANCELLED<br />
Inhibition of iNOS, COX-2 and mPGES-1 expression, and NO and PGE2 production by flavonoids in<br />
activated macrophages<br />
Mari Hämäläinen, (Finland), R Nieminen, MZ Asmawi, P Vuorela, H Vapaatalo, E Moilanen<br />
Rho-kinase inhibitors augment anesthetics-induced relaxation in rat airway smooth muscle<br />
Motohiko Hanazaki, (Japan), A Kohjitani, S Mizobuchi, K Morita, H Sakai, Y Chiba, M Misawa<br />
Elevation of the venodilatatory responsiveness to nitric oxide in nasal mucosae of rats with allergic<br />
rhinitis<br />
Tatsuya Hara, (Japan), J Enzaka, M Sakai-Oshita, H Sakai, Y Chiba, M Misawa<br />
Expression of a novel truncated variant of Nox2 in macrophages<br />
Craig Harrison, (Australia), GR Drummond, CG Sobey, S Selemidis<br />
Relation of HSPs expression and formation of atherosclerotic lesions in the aorta of ApoE-deficient<br />
mice<br />
Naoya Hashikawa, (Japan), N Hobara, C Yutani<br />
Comparison of positive reaction of Tuberculin skin test and QuantiFERON among Healthy adult males in<br />
Japan<br />
Tomoko Hasunuma, (Japan), M Kuwamata, M Takatsuki, N Kobayashi, A Aoki, Y Monuki, M Morikawa,<br />
T Fukushima, M Nishiwaki, H Iijima, Y Kumagai<br />
Endogenous heparin levels in the controlled asthmatic patients<br />
Ivan Havlik, (South Africa), A Ahmed, M Mer, H Davids<br />
Role of nitric oxide in methotrexate-induced abnormal 5-hydroxytryptamine metabolism and damage in<br />
the rat small intestine<br />
Masahiko Hirafuji, (Japan), Y Takano, M Hirano, A Kamiya, T Machida, N Hamaue, K Iizuka<br />
Inhibition of ovalbumin-induced asthma-like reactions in BALB/c mice by the anti-inflammatory<br />
compound amurensin H<br />
Qi Hou, (PR China), L Yang, S Yuan, Z Wu, M Wen, J Bai, C Yao, Y Li, M Lin, G Cheng<br />
184 Monday 19 July ■ 13:00 - 14:00 ■ Poster Area
FC09<br />
Inflammation and immunopharmacology:<br />
New tools for old diseases<br />
Mon 311<br />
Mon 312<br />
Mon 313<br />
Mon 314<br />
Mon 315<br />
Mon 316<br />
Mon 317<br />
Mon 318<br />
Mon 319<br />
Mon 320<br />
Mon 321<br />
Mon 322<br />
Mon 323<br />
Mon 324<br />
Mon 325<br />
ROS-dependent c-Fos/AP-1 induction up-regulates heme oxygenase-1 expression by bradykinin in brain<br />
astrocytes<br />
Hsi-Lung Hsieh, (Taiwan), C-M Yang<br />
CANCELLED<br />
Microsomal prostaglandin E synthase-1 and COX-2 are coordinately contribute to ischemic excitotoxicity<br />
through EP3 receptors<br />
Yuri Ikeda-Matsuo, (Japan), H Tanji, Y Hirayama, S Uematsu, S Akira, Y Sasaki<br />
Comparative mechanisms underlying the healing effects of captopril and ranitidine on aspirin-induced<br />
gastric lesions<br />
Nafeeza Ismail, (Malaysia), N Basri<br />
Therapeutic targeting of CCL17 via the systemic administration of a monoclonal antibody ameliorates<br />
experimental fungal asthma<br />
Ugur Ismailoglu, (USA), A-P Moreira, M Ryan, A Das, AL Coelho, CM Hogaboam<br />
Are there differences in the activities of CYP3A, CYP2D6 and P-glycoprotein between therapy-naïve HIVinfected<br />
patients and healthy volunteers<br />
Alexander Jetter, (Switzerland), G Fätkenheuer, D Frank, T Klaassen, A Seeringer, O Doroshyenko,<br />
J Kirchheiner, W Hein, E Schömig, U Fuhr, C Wyen<br />
Whole blood challenge tests as translational tools for early assessment of anti-inflammatory/ immunosuppressive<br />
effects of drugs<br />
Andrea J Kales, (The Netherlands), J Burggraaf, C Kluft, M Moerland<br />
Influence of STW 11, a fixed combination medicinal product, on cytokine production of human<br />
macrophages<br />
Careen Katryniok, (Germany), G Bonaterra, D Weiser, O Kelber, R Kinscherf<br />
PACAP deficiency enhances oxazolone-induced allergic contact dermatitis in mice<br />
A Kemeny, R Cseharovszky, D Reglodi, N Shintani, H Hashimoto, A Baba, Erika Pintér, (Hungary),<br />
J Szolcsányi, Z Helyes<br />
The role of adhesive molecules in experimental sabacachnoid hemorrhage<br />
Aij-Lie Kwan, (Taiwan), C-Z Chang, C-L Lin, S-L Howng<br />
Effects of bio-liberated gold ions on human mononuclear cells. An in vitro study of dissolucytotic gold<br />
liberation from metallic gold implants<br />
Agnete Larsen, (Denmark), T Christensen, C Høst, M Stoltenberg, G Danscher, AM Larsen<br />
Adenosine A2B receptor mediated inhibition of anti-IgE induced human mast cell activation<br />
Hang Yung Alaster Lau, (PR China), KH Yip, H Wise<br />
Dysfunction of cholinergic anti-inflammatory pathways mediates organ damage in hypertension<br />
DJ Li, Fu-ming Shen, (PR China)<br />
The expression of five cytokines(IFN-α ,IFN-γ,IL-18,IL-10,IL-12) in PAM212 cell line and L929 cell line<br />
influenced by rHu IFN-α 2b cream<br />
Jin Li, (PR China), Q Zhu, J Liu, J Hu<br />
Toll-like Receptor 4 mediates the vasoconstrictor response initiated by adipose tissue in mice arteries<br />
Chao Fan Liang, (PR China), A Xu, PM Vanhoutte<br />
Monday 19 July ■ 13:00 - 14:00 ■ Poster Area 185
FC09<br />
Inflammation and immunopharmacology:<br />
New tools for old diseases<br />
Mon 326<br />
Mon 327<br />
Mon 328<br />
Mon 329<br />
Mon 330<br />
Mon 331<br />
Mon 332<br />
Neuroprotective effect of pioglitazone on iron-induced neurodegeneration: α-synuclein aggregation<br />
Anya Maan-Yuh Lin, (Taiwan), HJ Yu, SF Fang, PL Chao<br />
Thrombin-induced connective tissue growth factor expression requires c-Src/JAK2/STAT3 signalling<br />
pathway in human lung fibroblasts<br />
Chien-Huang Lin, (Taiwan), H-C Pai, B-C Chen<br />
Molecular mechanisms for ER stress mediated anti-inflammatory actions in macrophages<br />
Wan-Wan Lin, (Taiwan), HR Ho<br />
Inhaled glucocorticoids decrease rapidly bronchial NO flux in childhood asthma<br />
Laura Linkosalo, (Finland), L Lehtimäki, K Holm, M Kaila, J Laitinen, E Moilanen<br />
Establishment of in vitro binding assay of HMGB1 and S100A12 to RAGE: Effects of heparin and<br />
domain peptides on the binding<br />
Rui Liu, (Japan), S Mori, H Wake, J Zhang, K Liu, Y Izushi, M Okamura, HK Takahashi, M Nishibori<br />
Anisodamine augments its cholinergic anti-inflammatory role through potentializing stimulation effect of<br />
IL10 on α7nAChR in sepsis<br />
X Liu, Q Li, A-J Liu, Ding-Feng Su, (PR China)<br />
Effects of anti-TCR antibody on collagen-induced arthritis in DBA/1 mice<br />
Yongxue Liu, (PR China), C Han, Q Wang, Z Gao, M Peng, J Cheng<br />
186 Monday 19 July ■ 13:00 - 14:00 ■ Poster Area
FC13<br />
Maximising benefits and minimizing harms from<br />
drugs<br />
Mon 333<br />
Mon 334<br />
Mon 335<br />
Mon 336<br />
Mon 337<br />
Mon 338<br />
Population pharmacokinetics of repaglinide in healthy Malaysian subjects and genetic polymorphisms of<br />
CYP3A4 and CYP2C8<br />
Ruzilawati Abu Bakar, (Malaysia), G Siew Hua, MS Ab Wahab<br />
Bioequivalence study of 1500 mg glucosamine sulfate in Thai healthy volunteers<br />
Pravit Akarasereenont, (Thailand), S Chatsiricharoenkul, P Pongnarin, K Sathirakul, A Wongkajornsilp,<br />
S Kongpatanakul<br />
Protective effect of lafutidine against loxoprofen-induced small intestinal lesions in rats<br />
Kikuko Amagase, (Japan), R Kawahara, S Takayama, T Sugihara, A Ochi, S Kato, K Takeuchi<br />
Cynodon dactylon – a potent, economic, natural anti-diarrhoeal herb in developing countries<br />
Manoj Amrutkar, (India), V Undale, D Bharti, A Bhosale<br />
In vitro characterisation of the clopidogrel bioactivation pathways by cytochromes P450 and potential<br />
drug-drug interactions<br />
Virginie Ancrenaz, (Switzerland), Y Daali, C Samer, M Besson, P Fontana, P Dayer, J Desmeules<br />
Hepatoprotective effect of pistacia lentiscus against isoniazide induced liver toxicity in rats<br />
M Aouichri, M Haouari, L Sfaxi, R Zermani, M Ben-Attia, M Lakhal, Anis Klouz, (Tunisia)<br />
Mon 339 Publication trends of the cytochromes p450 research: 1977–2008<br />
Charles-Daniel Arreto, (France), C Wilson, C Robert<br />
Mon 340<br />
Mon 341<br />
Mon 342<br />
Single-dose pharmacokinetics of cefepime in healthy Egyptian buffalo calves<br />
Taha A Attia, (Egypt), MA Tohamy, AAM El-Gendy<br />
Striatal delivery of CDNF by AAV2 vector is neuroprotective in a rat partial lesion model of Parkinson’s<br />
disease<br />
Susanne Bäck, (Finland), J Peränen, L Lonka, T Tamminen, MH Voutilainen, A Raasmaja, M Saarma,<br />
PT Männistö, RK Tuominen<br />
Cutaneous adverse drug reactions: Analysis of spontaneous reports from healthcare professionals in<br />
Croatia<br />
Ana Balazin, (Croatia), V Macolic-Sarinic, S Arapovic, D Krnic, M Banovac, S Tomic<br />
Mon 343 Serious psychiatric adverse drug reactions spontaneously reported in Croatia from 2006 till 2009<br />
Ana Balazin, (Croatia), V Macolic-Sarinic, S Arapovic, D Krnic, M Banovac, S Tomic<br />
Mon 344<br />
Mon 345<br />
Mon 346<br />
Mon 347<br />
Mon 348<br />
The study of response to bronchodilators according to polymorphism B2-adrenergic receptors<br />
Nadyia Berdnikova, (Russian Federation)<br />
Publication rate among investigator-initiated clinical drug trials in Denmark<br />
Louise Berendt, (Denmark), KF Bach, T Callreus, LG Petersen, HE Poulsen, K Dalhoff<br />
Both heavy and light smoking reduces serum estradiol and estrone in postmenopausal women during<br />
estrogen-progestogen therapy<br />
Nina Hannover Bjarnason, H Jorgensen, C Christiansen<br />
Simvastatin decreases malondialdehyde level in plasma and tissues of rats<br />
Vlasta Bradamante, (Croatia), M Marija, L Jasna, K Marijan, K Pasko<br />
Inhibitory effects of Origanum onites essential oil against contractions of isolated rat vas deferens<br />
induced by Androctonus crassicauda venom<br />
A Cakmak, F Caliskan, Suleyman Aydin, (Turkey)<br />
Monday 19 July ■ 13:00 - 14:00 ■ Poster Area 187
FC13<br />
Maximising benefits and minimizing harms from<br />
drugs<br />
Mon 349<br />
Mon 350<br />
Mon 351<br />
Mon 352<br />
Mon 353<br />
Mon 354<br />
Mon 355<br />
Mon 356<br />
Mon 357<br />
Mon 358<br />
Mon 359<br />
Mon 360<br />
Mon 361<br />
Mon 362<br />
Mon 363<br />
Mon 364<br />
An overview on attenuation of drug-induced nephrotoxicity<br />
Guoying Cao, (PR China), X Hu<br />
Pharmacological treatment of poststroke depression<br />
Margarida Caramona, (Portugal), E Silva, B Oliveiros, E Ponciano<br />
Thiopurine methyltransferase phenotype-genotype concordance in children with acute lymphoblastic<br />
leukaemia<br />
Cher Cartwright, (UK), C Mitchell, N Goulden, A Vora, L Lennard<br />
A chemical genomics approach to cardiovascular therapeutics<br />
Katherine Casey-Green, (UK), A Marsh, P Taylor, S Ladwa, W Dimitri, J Zhang, D Singer<br />
Personalised therapies using a chemical genomics approach<br />
Katherine Casey-Green, (UK), A Marsh, P Taylor, S Ladwa, W Dimitri, D Singer<br />
Calcium channel is involved in neomycin-induced hair cell toxicity in the zebrafish lateral line<br />
Ming-Huan Chan, (Taiwan), C-F Liu, H-H Chen<br />
Bioequivalence study of two formulations of 35mg trimetazidine modified release tablets in Thai healthy<br />
volunteers under fasting and fed conditions<br />
Weerawadee Chandranipapongse, (Thailand), T Ruangnapa, S Ngokpol, K Sathirakul, P Pongnarin,<br />
S Kongpatanakul<br />
The effect of C825T polymorphism of the GNB3 gene on valproate-induced metabolic abnormalities in<br />
bipolar disorder patients<br />
Hui Hua Chang, (Taiwan), W Gean, YK Yang, HC Huang, HC Wang, RB Lu, PS Chen<br />
Bioequivalence study of 10 mg ramipril tablets in healthy Thai volunteers<br />
Somruedee Chatsiricharoenkul, (Thailand), W Thangboonjit, K Sathirakul, P Pongnarin, K Konhan,<br />
S Kongpattanakul<br />
Effects of CYP2D6*10 allele on the pharmacokinetics of atomoxetine in healthy Koreans<br />
Chang-Ik Choi, (South Korea), J-W Bae, M-J Kim, C-G Jang, S-Y Lee<br />
Dose adjustment of omeprazole based on CYP2C19 genotype<br />
Chang-Ik Choi, (South Korea), S-M Moon, J-W Bae, M-J Kim, C-G Jang, S-Y Lee<br />
Changing doctors prescription behaviour. A Drug Committee perspective: TNF inhibitors<br />
Hanne R Christensen, (Denmark), H Thomsen<br />
HPLC method development & validation for the determination of Warfarin in human plasma<br />
Yung An Chua, (Malaysia), WZW Abdullah, SH Gan<br />
High level of blood zolpidem concentrations in the morning and in the early afternoon after a single<br />
dose of a hypnotic drug followed by a night of sleep in healthy elderly subjects: potential link with<br />
impaired driving<br />
Antoine Coquerel, (France), M Loilier, S Marie, F Bertran, V Lelong-Boulouard, P Denise, M-L Bocca<br />
An enzyme-linked immunosorbent assay for therapeutic drug monitoring of trastuzumab<br />
François Darrouzain, (France), I Teulon, T Ternant, D David, D Degenne, H Watier, P Gilles<br />
Menatetrone and Nigella Sativa: a prophylactic role in corticosteroid induced osteoporosis in the rat<br />
Suzan A Darwish, (Egypt), HM Khalifa, IE Darwish, EI Anwar<br />
188 Monday 19 July ■ 13:00 - 14:00 ■ Poster Area
FC13<br />
Maximising benefits and minimizing harms from<br />
drugs<br />
Mon 365<br />
Mon 366<br />
Mon 367<br />
Mon 368<br />
Mon 369<br />
Vancomycin dosing and monitoring in children: compliance with guidelines in a Belgian teaching hospital<br />
Pieter De Cock, (Belgium), E Haegeman, N Goerlandt, P Vanhaesebrouck, V Stove, A Verstraete,<br />
P Schelstraete, H Robays<br />
The relaxant effect of hydrogen sulfide is potentiated while that of acetylcholine is not altered in<br />
pulmonary and mesenteric arteries isolated from streptozotocin-induced diabetic rats<br />
Merve Denizalti, (Turkey), TE Bozkurt, I Sahin-Erdemli, N Abacioglu<br />
Bisphosphonate-related osteonecrosis of the jaw (BONJ)<br />
G Dimosiari, Konstantinos Imprialos, (Greece), M Mironidou-Tzouveleki<br />
CYP2D6 and CYP2C19: a comparison of direct versus predicted phenotyping in a South African<br />
population<br />
Tyren Dodgen, (South Africa), D Cromarty, H Fickl, M Pepper<br />
Thyroxine medication and CYP 3A4 activity as measured by the urinary 6β-hydroxycortisol/cortisol<br />
ratio: a pilot study<br />
Josef Donnerer, (Austria), J-P Siest, E Beubler<br />
Mon 370 Statins consumption in the Republic of Croatia in 2005, 2006, 2007 and 2008<br />
Pero Draganic, (Croatia), S Zezelic, V Macolic-Sairinic, S Tomic<br />
Mon 371<br />
Mon 372<br />
Mon 373<br />
Mon 374<br />
Mon 375<br />
Mon 376<br />
Mon 377<br />
Mon 378<br />
Mon 379<br />
Mon 380<br />
Usage of and attitudes towards the drug-drug interaction database SFINX – a questionnaire study within<br />
Sweden<br />
Birgit Eiermann, (Sweden), M Andersson, M-L Ovesjö, P Bastholm, A Veg, M Edlert, Y Böttiger<br />
Comparative efficacy and bioavailability of different praziquantel brands<br />
Naglaa El-Lakkany, (Egypt), S Seif el-Din, AN Sabra, M Ibrahim, S Botros<br />
Resistance of Escherichia coli and Klebsiella pneumoniae isolates in three tertiary intensive care units:<br />
A result of insufficient employment of infection control measures or inadequate antibiotic consumption<br />
Viktorija Erdeljic, (Croatia), I Francetic, Z Bosnjak, A Budimir, S Kalenic, L Bielen, R Likic,<br />
K Makar-Ausperger<br />
Does missense mutation in the SMPD3 gene increase the risk of pulmonary hypertension<br />
Lucía Escolano, (Spain), MA Nieto, L Moreno, A Cogolludo, A Roman, JL Alvarez-Sala, F Perez-Vizcaino<br />
Distribution of methylphenidate and ritalinic acid in oral fluid<br />
Magi Farre, (Spain), R Pardo, E Marchei, O Garcia-Algar, M Pellegrini, R Pacifici, S Pichini<br />
Central nervous system pathology during pregnancy. Study of 25 clinical cases using an<br />
evidence-based approach<br />
Isabel Vitória Figueiredo, (Portugal), AC Rama, O Isabel, F Tavares, T Santos, F Fernández-Llimós,<br />
MM Castel-Branco, A Cabral, M Caramona,<br />
Adverse drug reactions in infants and children<br />
Houda Filali, (Morocco), A Elgharbi, F Hakkou<br />
Causes of therapeutic errors in older adults<br />
Houda Filali, (Morocco), H Elkarimi, D Mzah, A Miftah, F Hakkou<br />
CANCELLED<br />
Contribution of CYP2C8 to the metabolism of montelukast in vitro<br />
Anne Filppula, (Finland), J Laitila, PJ Neuvonen, JT Backman<br />
Monday 19 July ■ 13:00 - 14:00 ■ Poster Area 189
FC13<br />
Maximising benefits and minimizing harms from<br />
drugs<br />
Mon 381<br />
Mon 382<br />
Mon 383<br />
Mon 384<br />
Mon 385<br />
Mon 386<br />
Mon 387<br />
Mon 388<br />
Mon 389<br />
Mon 390<br />
Mon 391<br />
Mon 392<br />
Multi-target drugs for cognitive impairment therapy: In vitro inhibition of histamine H3 receptors and<br />
cholinesterase by original Donepezil hybrids<br />
L Flammini, S Bertoni, C Giorgio, M Tognolini, Vigilio Ballabeni, (Italy), G Morini, M Incerti, E Barocelli<br />
Montelukast reverses albuterol-induced β2-adrenoceptor tolerance in airway smooth muscle<br />
Stefano Fogli, (Italy), F Stefanelli, L Picchianti, MC Breschi<br />
Lack of interference of carbamazepine and its metabolites in the enantioselective therapeutic drug<br />
monitoring of eslicarbazepine acetate<br />
Ana Fortuna, (Portugal), G Alves, J Sousa, R Direito, M Rocha, A Falcão, P Soares-da-Silva<br />
Activity assessment of individual CYP2D6 variants using population pharmacokinetics of<br />
dextromethorphan<br />
Uwe Fuhr, (Germany), D Frank, A Gaedigk, T Klaassen, D Tomalik-Scharte, A Jetter, U Jaehde,<br />
R Süverkrüp, J Kirchheiner, K Abduljalil<br />
Pharmacovigilance between science and craft<br />
Giovanni Furlan, (Italy)<br />
Bioequivalence study of two formulations of desmopressin nasal spray: a comparison between the<br />
novel KW-8008RTS to be stored at room temperature and the conventional KW-8008 to be stored in<br />
refrigeration<br />
Hidetoshi Furuie, (Japan), M Yagi, T Yajima, N Sakoda, K Matsumoto, H Ando, Y Amano, T Sakurai<br />
The effect of resveratrol on ileal smooth muscle: functional investigation in a rat sepsis model<br />
N Gacar, SS Gocmez, G Gacar, IK Celikyurt, Oguz Mutlu, (Turkey), T Utkan<br />
A simple, novel method for assessing medication adherence: Capsule photographs taken with cellular<br />
telephones<br />
GP Galloway, JE Guillén, JR Coyle, K Flower, John Mendelson, (USA)<br />
Correlation of cytochrome P450 3A4*18 genetic polymorphisms with postoperative fentanyl<br />
requirements<br />
Siew Hua Gan, (Malaysia), PCS Tan, SK Hassan, N Abdullah<br />
Potentially inappropriate medications in elderly attended at primary care<br />
Jose Luis Garcia Fuentes, (Chile), M Jiron, I Ruiz, M Santibañez<br />
Oxaliplatin-induced neuropathy: glial activation in spinal cord and brain<br />
Carla Ghelardini, (Italy), L Di Cesare Mannelli, L Bonaccini, A Pacini, A Bartolini<br />
A randomized clinical trial utilizing the drug burden index to reduce exposure to anticholinergic and<br />
sedative medications in older people<br />
Danijela Gnjidic, (Australia), S Hilmer, D Le Couteur, D Abernethy<br />
190 Monday 19 July ■ 13:00 - 14:00 ■ Poster Area
W01<br />
Pharmacology of adrenoceptors: Eighth satellite<br />
meeting<br />
Mon 393<br />
Mon 394<br />
Mon 395<br />
Mon 396<br />
Mon 397<br />
In vivo and Ex vivoreceptor occupancy assays for the rat α2A/D receptor<br />
Sarah Able, (UK), R Fish, C Powell, S Katugampola<br />
Virtual screening using α1–adrenergic receptor pharmacophores identifies a novel structural framework<br />
for α1A/D-adrenergic receptor selective ligands<br />
Angela M Finch, (Australia), ES Stoddart, IJA MacDougall, R Griffith<br />
Ligand-directed signalling by β-adrenoceptor antagonists at the human β1- and β3-adrenoceptors<br />
Dana Hutchinson, (Australia), M Sarwar, E Stancic, M Sato, B Evans, R Summers<br />
CANCELLED<br />
What is the functional role of the hydrophobic domain in the N-terminal tail of the α2C-adrenoceptor<br />
Staffan Uhlen, (Norway), JA Jahnsen<br />
Monday 19 July ■ 13:00 - 14:00 ■ Poster Area 191
W03<br />
Targeting TRP channels for pain relief (and more)<br />
Mon 398<br />
Mon 399<br />
Mon 400<br />
Mon 401<br />
Mon 402<br />
LASSBio-881: An n-acylhydrazone TRPV1 antagonist orally effective against capsaicin- and partial<br />
sciatic ligation-induced hypernociception<br />
Marilia Guimaraes, (Brazil), J Tributino, M Santos, C Mesquita, C Lima, L Silva, C Duarte, E Barreiro,<br />
C Fraga, N Castro, AL Miranda<br />
Molecular mechanism of ETAR-operated Ca2+ entry via TRPC channels and visualization of homo- and<br />
heteromeric TRPC3/6 interaction in living cells using BiFC<br />
Takahiro Horinouchi, (Japan), T Higa, H Aoyagi, H Asano, T Nishiya, A Nishimoto, S Miwa<br />
Pharmacological resting state-fmri study using THC<br />
Linda E Klumpers, (The Netherlands), RP Soeter, N Khalili-Mahani, SARB Rombouts, MA van Buchem,<br />
JMA van Gerven<br />
Creating TRPV1 knock down mice by tentiviral transgenesis<br />
Éva Szõke, (Hungary), DM Tóth, K Kvell, B Bender, Z Bõsze, Z Sándor, J Szolcsányi<br />
SA13353, a transient receptor potential vanilloid 1 agonist, attenuates leukocyte infiltration in<br />
LPS-induced acute lung injury and ovalbumin-induced allergic airway inflammation<br />
Fumio Tsuji, (Japan), M Murai, K Oki, H Inoue, M Sasano, H Aono<br />
192 Monday 19 July ■ 13:00 - 14:00 ■ Poster Area
W04<br />
Antioxidants as therapeutic targets<br />
Mon 403<br />
Mon 404<br />
Mon 405<br />
Mon 406<br />
Mon 407<br />
Mon 408<br />
Mon 409<br />
Mon 410<br />
Mon 411<br />
Mon 412<br />
Mon 413<br />
Mon 414<br />
Mon 415<br />
Mon 416<br />
Effect of β2-glucans on photodynamic therapy of Lewis lung carcinoma<br />
Dalia Akramiene, (Denmark), C Aleksandraviciene, K Suziedelis, U Simonsen, E Stankevicius<br />
Hydrogen sulphide generation in porcine tissues<br />
Stephen Alexander, (UK), M Doe, M Garle<br />
Aggravation by selective serotonin re-uptake inhibitor of antral ulcers induced by indomethacin in rats:<br />
Pathogenic importance of impaired anti-oxidative system<br />
Kikuko Amagase, (Japan), A Kojo, C Izuhara, K Nukui, A Tanaka, K Takeuchi<br />
Nucleic acid oxidation is predominantly determined by non-genetic factors in elderly Danish twins<br />
Kasper Brødbæk, (Denmark), R Ribel-Madsen, T Henriksen, A Weimann, M Petersen, J T Andersen,<br />
S Afzal, B Hjelvang, A Vaag, P Poulsen, H E Poulsen,<br />
Melatonin modulates oxidative stress and prevents cell death in human leukocytes. Effect of<br />
intracellular calcium overload and age<br />
Javier Espino, (Spain), I Bejarano, SD Paredes, D González, RJ Reiter, JA Pariente, AB Rodríguez<br />
Involvement of EGFR/AKT / Cyclin D1 / CDK4 signalling pathway in inhibiting UVA-induced apoptosis of<br />
HaCaT cells by polypeptide from Chlamys farreri<br />
Zhiwu Han, (PR China), L Zhu, J Tong, P Li, L Yan, C Wang<br />
The effect of captopril on the activity of selenoenzymes thioredoxin reductase and glutathione<br />
peroxidase, redox homeostasis and trace element level in rat liver<br />
Anna Hodková, (Czech Republic), D Kotyzová, V Eybl<br />
Drugs with known pharmacological profiles, such as monensin, disulfiram and salinomycin, show<br />
cancer-selective inhibition of prostate cancer cell growth by increasing oxidative stress<br />
Kirsi Ketola, (Finland), P Vainio, P Halonen, P Kohonen, V Fey, RC Grafström, M Perälä, O Kallioniemi,<br />
K Iljin<br />
Role of Na+-K+ ATP-ase in the nitric oxide independent relaxation in pig urinary bladder neck<br />
Ana Martínez-Saénz, (Spain), LM Orensanz, P Recio, S Bustamante, S Benedito, A García-Sacristán,<br />
D Prieto, M Hernández<br />
Ozone attenuates imipramine-induced anti-immobility effects in the rat, while imipramine protects<br />
against ozone-induced oxidative damage in the rat hippocampus<br />
Mmalebuso Mokoena, (South Africa), CB Brink, BH Harvey, DW Oliver<br />
Upregulation of endogenous antioxidant and phase 2 enzymes by dietary supplementation of<br />
scopoletin, a plant derived coumarin, in rat liver: Possible role in protection against chronic diseases<br />
with an underlying oxidative stress<br />
Sudhakar Raja Subramaniam, (UK), EM Ellis<br />
Protective effect of L-carnitine against H2O2-induced neurotoxicity in neuroblastoma (SH-SY5Y) cells<br />
Chunbo Wang, (PR China), Z Han, L Zhu, J Yu, J Ye, J Tong<br />
CANCELLED<br />
Noradrenaline attenuates hydrogen peroxide-induced cell death of astrocyte through the increase in the<br />
level of intracellular glutathione<br />
Yasuhiro Yoshioka, (Japan), H Kadoi, A Yamamuro, A Kasai, A Maeda<br />
Monday 19 July ■ 13:00 - 14:00 ■ Poster Area 193
W19<br />
Influence of degeneration and repair in the CNS<br />
and periphery<br />
Mon 417<br />
Mon 418<br />
Mon 419<br />
Mon 420<br />
Mon 421<br />
Mon 422<br />
Mon 423<br />
Mon 424<br />
Mon 425<br />
Mon 426<br />
Mon 427<br />
Mon 428<br />
Mon 429<br />
Mon 430<br />
Mon 431<br />
The study of ABCB1 polymorphisms in Romanian epileptic patients<br />
Ioana Corina Bocsan, (Romania), AD Buzoianu, FC Militaru, R Popp, A Trifa, LP Dumbrava,<br />
E Brusturean<br />
The effect of chemical absence model on the progression of kindling in wistar rats<br />
Nihan Carcak, (Turkey), M Sahiner, E Sakallý, K Tezcan, R Gülhan, F Onat<br />
Calcium antagonistic effects of some antimigraine drugs in rat isolated basilar artery<br />
Edip Guvenc Cekic, (Turkey), M Tuncer<br />
Comparison of GABA-A in vivo occupancy in rat brain and spinal cord<br />
Rebecca Fish, (UK), S Able, C Powell, L Booth<br />
Pinocembrin prevents glutamate-induced apoptosis in SH-SY5Y neuronal cells via decrease of bax/bcl-2<br />
ratio<br />
Mei Gao, (PR China), W-C Zhang, J-J Hu, G-H Du<br />
Neuroprotective effect of dimebon in rats with intracerebral post-traumatic hematoma (hemorrhagic<br />
stroke)<br />
TL Garibova, TA Voronina, SA Litvinova, VV Grigoriev, SO Bachurin, Tatiana S Kalinina, (Russian<br />
Federation)<br />
P53 in amyloid-β peptide-induced apoptosis in cerebral endothelial cell<br />
Ming-Jen Hsu, (Taiwan), Y-F Chuang, P-T Chiu, C-Y Wang, J-R Sheu<br />
Paraquat activates Nrf2-ARE pathway: implication of decrease in proteasome activity in dopaminemediated<br />
cytotoxicity<br />
Yasuhiko Izumi, (Japan), S Matsushima, N Yamamoto, T Kume, H Sawada, A Akaike<br />
The effect of KYP-2047, a prolyl oligopeptidase inhibitor, on extracellular neurotensin- and substance<br />
P-like-immunoreactivity in the rat brain<br />
Aaro Jalkanen, (Finland), K Savolainen, M Forsberg<br />
Nephroprotective activity of the low-esterified pectins<br />
Maxim Khotimchenko, (Russian Federation), A Kropotov, Y Khotimchenko<br />
Association study of single nucleotide polymorphisms in the COMT gene and Korean autism spectrum<br />
disorders<br />
Soon Ae Kim, (South Korea), HJ Yoo, IH Cho, M Park<br />
Genome-wide association scan of Korean autism spectrum disorders with language delay<br />
Soon Ae Kim, (South Korea), SY Yang<br />
Neuroprotective effect of mildronate, a mitochondria-targeted drug, in Parkinson’s disease model in<br />
rats<br />
Vija Klusa, (Latvia), J Pupure, S Isajevs, D Svirina, U Beitnere, B Jansone, J Rumaks, S Svirskis,<br />
R Vilskersts, I Kalvinsh<br />
Acute Allopregnanolone administration may exacerbate, rather than attenuate, striatal damage during<br />
ischaemia in vitro<br />
Steve Knight, (UK), C Davidson, A Young, C Gibson<br />
Study of time dependence of afobazol and mexidol protective activity in itracerebral posttraumatic<br />
hematoma model<br />
Valentina Krayneva, (Russian Federation), A Fedorenko, S Seredenin<br />
194 Monday 19 July ■ 13:00 - 14:00 ■ Poster Area
W19<br />
Influence of degeneration and repair in the CNS<br />
and periphery<br />
Mon 432<br />
Mon 433<br />
Mon 434<br />
Mon 435<br />
Mon 436<br />
Mon 437<br />
Mon 438<br />
Mon 439<br />
Mon 440<br />
Mon 441<br />
Mon 442<br />
Mon 443<br />
Mon 444<br />
Mon 445<br />
Mon 446<br />
Mon 447<br />
Neuroprotective effect of serofendic acid on in vitro and in vivo neuronal injury<br />
Toshiaki Kume, (Japan), Y Izumi, A Akaike<br />
Quercetin protects cortical neurovascular unit against amyloid β25-35 peptide-induced amnesia in mice<br />
Rui Liu, (PR China), GF Qiang, Y Jian, X Lan, HG Yang, GH Du<br />
Efficacy of Panax notoginseng saponins on patients with intracerebral hemorrhage<br />
Yumin Luo, (PR China), Q Liu, J Song, P Liu, L Gao<br />
Dopamine inhibits NO production by LPS-activated microglia through the formation of quinoprotein<br />
Sadaaki Maeda, (Japan), A Tozawa, T Kitamoto, A Yamamuro, A Kasai, Y Yoshioka<br />
The seizures and status epilepticus in emergency department of pediatrics.The clinical and<br />
pharmacological implications of some benzodiazepines<br />
Ioan Magyar, (Romania)<br />
Ventral tegmental area NMDA receptors play a role in the effect of scopolamine on inhibitory avoidance<br />
memory in rats<br />
Gelavizh Mahmoudi, (Iran), M-R Zarrindast, A Pourmotabbed<br />
Distribution of the CYP2C9*2, CYP2C9*3 gene variants in a Romanian epileptic patients group<br />
Florentina Claudia Militaru, (Romania), A Buzoianu, C Bocsan, A Trifa, R Popp, LP Dumbrava,<br />
E Brusturean<br />
Angiotensin II type 1 (AT1) receptor blocker, telmisartan, protects brain damage induced by ischemia<br />
and amyloid-β injection partly due to PPAR-γ activation<br />
Masaki Mogi, (Japan), J Iwanami, K Tsukuda, M Horiuchi<br />
Noradrenaline protects neurons against hydrogen peroxide toxicity by increasing the release of<br />
glutathione from astrocytes<br />
Toshiki Motegi, (Japan), Y Yoshioka, A Yamamuro, A Kasai, S Maeda<br />
Functional analysis of Transferrin receptor-1 expressed in brain<br />
Yukary Nakamura, (Japan), T Takarada, Y Yoneda<br />
Pentacycloundecane conjugates of aminoguanidine and tryptamine: Nitric oxide synthase inhibition<br />
Douglas W Oliver, (South Africa), SF Malan, DK Wilkes, A de Vries<br />
Modulation of cognition and neuronal function in the age-accelerated mouse (SAMP8) by pterostilbene<br />
and resveratrol<br />
Merce Pallas, (Spain), J Chang, K Bryan, J Reeves, MA Smith, A Camins, A Rimando, B Shukitt-Hale,<br />
J Joseph, G Casadesus<br />
Prolyl oligopeptidase is not located in the long projection neurons of the rat brain<br />
Iida Peltonen, (Finland), TT Myöhänen, PT Männistö<br />
L-3-n-butylphthalide suppressed Lipopolysaccharide-induced inflammation through Nrf2 dependent<br />
pathway<br />
Ying Peng, (PR China), Y Hu, L Lu, S Xu, L Wang, X Wang<br />
Silvergold-cyankali methods for staned glial cells<br />
Bojana Petrovic, (Republic of Serbia), Z Zoric, D Drekic<br />
Spontaneous and amphetamine –induced locomotor activity in A30P -transgenic mice<br />
Marjo Piltonen, (Finland), S Patrikainen, PT Männistö<br />
Monday 19 July ■ 13:00 - 14:00 ■ Poster Area 195
W19<br />
Influence of degeneration and repair in the CNS<br />
and periphery<br />
Mon 448<br />
Mon 449<br />
Mon 450<br />
Mon 451<br />
Mon 452<br />
Mon 453<br />
Mon 454<br />
Mon 455<br />
Mon 456<br />
Mon 457<br />
Mon 458<br />
Mon 459<br />
Mon 460<br />
Mon 461<br />
Mon 462<br />
Mon 463<br />
Elderly patients with migraine: An open-label study on prophylaxis therapy with Levetiracetam<br />
V Pizza, V Busillo, A Agresta, A Bisogno, Anna Capasso, (Italy)<br />
Factor XIII Val 34 Leu polymorphism in migraine and cardiovascular disease<br />
V Pizza, F Infante, G Schiavo, E Lamaida, C Colucci d'Amato, A Bisogno, Anna Capasso, (Italy)<br />
MEK1/2 inhibition improves neurological outcome and abolishes cerebrovascular ETB and 5-HT1B<br />
receptor upregulation after subarachnoid hemorrhage in the rat<br />
Gro Klitgaard Povlsen, (Denmark), C Larsen, M Rasmussen, L Edvinsson<br />
Incidence of severe hyponatremia drug-induced and other causes in a terciary care hospital<br />
Elena Ramirez, (Spain), AM Borobia, SL Lei, R Muñoz, A Campos, C Zegarra, AJ Carcas, J Frias<br />
Interaction of phenytoin with melatonin and α-lipoic acid in experimental seizures in rats<br />
KH Reeta, (India), J Mehla, YK Gupta<br />
Disruptive effects of systemically administered angiotensin II on cerebral perfusion and learning in the<br />
rat<br />
Michael Rowan, (Ireland), W Cullen, B Ryan<br />
The protective effect of low dose of SNP on L-DOPA induced apoptosis<br />
Mousa Sahebgharani, (Iran), Z Sepehrizadeh, M Talebi, Saboori, J Esmaeili, E Jaberi<br />
Changes in hippocampal connexin 36 mRNA and protein levels during acquisition of seizures in the<br />
kindling model of epileptogenesis<br />
Mohammad Sayyah, (Iran), S Beheshti, S Majzoob Zanjani, M Golkar, H Sepehri, J Babaie, B Vaziri<br />
Lateral somatosensory cortex in spontaneous and PTZ-induced spike-wave discharges of the rat<br />
evaluated by ethosuximide<br />
Fu-Zen Shaw, (Taiwan), K-H Yeh<br />
ER stress is involved in hyperphosphorylated tau-induced cytotoxicity<br />
Yuxian Shen, (PR China), L Feng, A Sun, Y Shen, S Fang, J Li<br />
Hrd1 expression is associated with neuronal survival and tau degradation in Alzheimer's disease<br />
Yuxian Shen, (PR China), L Feng, A Sun, Q Li, H Hou, H Wang, H Fang, S Fang<br />
Contribution of CYP3A5 isozyme to the in vivo metabolism of cortisol to 6β-hydroxycortisol in humans<br />
Hiromi Shibasaki-Hirano, (Japan), S Okamoto, T Furuta<br />
The effect of anti-Parkinsonian drugs on oxidative stress induced pathological [3H]dopamine efflux after<br />
in vitro rotenone exposure in rat striatal slices<br />
Beata Sperlagh, (Hungary), E Milusheva, M Baranyi, Z Hracsko, S Vizi<br />
Activation of JNK signal by NO in cochlear spiral ligament fibrocytes following intense noise exposure<br />
Hajime Tanaka, (Japan), R Nagashima, T Yamaguchi, A Matsushita, K Ogita<br />
Effects of mexidol and hemantane in animal models of parkinsonism<br />
Elena Valdman, (Russian Federation), L Nerobkova, I Kapitsa, T Voronina, O Popova, N Zolotov<br />
Anti-Parkinsonian effects of MDMA in the rat: Contributions of 5-HT1A-receptors and serotonin<br />
transporters and role of chirality<br />
Andreas von Ameln-Mayerhofer, (Germany), M Hüpkes, C Riegel, S Seeger-Armbruster, NY Lettfuss<br />
196 Monday 19 July ■ 13:00 - 14:00 ■ Poster Area
W19<br />
Influence of degeneration and repair in the CNS<br />
and periphery<br />
Mon 464<br />
Mon 465<br />
Mon 466<br />
Mon 467<br />
Mon 468<br />
Mon 469<br />
Mon 470<br />
Reconstruction of the nigrostriatal projections in dissociated primary cultures: A role of striatal cells in<br />
dopaminergic neurite outgrowth<br />
Seiko Wakita, (Japan), Y Izumi, T Kume, H Sawada, A Akaike<br />
Microenvironment improving effect of octacosanol in 6-hydroxydopamine-induced parkinsonian models<br />
in rats<br />
Tao Wang, (China), P Zuo, P Chan<br />
Development of 2-(1-Hydroxypentyl)-benzoate, a pro-drug for treatment of cerebral ischemia and<br />
dementia<br />
Xiaoliang Wang, (PR China), J Li, S Xu, N Feng, L Wang, Y Hu, Y Peng<br />
Protective effect of rolipram on memory impairments in rats injected with amyloid-(25¨C35)<br />
Jiangping Xu, (PR China), C Wang, Y Cheng, H Zhang<br />
Polypeptide from Chlamys farreri protect neuroblastoma (SH-SY5Y) cells from oxidative stress by<br />
endoplasmic reticulum stress and JNK activation<br />
Junli Ye, (PR China), X Liu, J Yu, J Tong, C Wang<br />
Glycosaminoglycans mimetics regulation of lysosomal disturbances and tau hyperphosphorylation<br />
induced by oxidative stress<br />
Ganlin Zhang, (PR China), S Lehri, XX Zhu, MB Huynh, L Sissoeff, YJ Li, X Liu, R Raisman, C Morin,<br />
P Li, D Papy-Garcia<br />
Preliminary studies on the relationship between STUB1 and the key pathological proteins in AD animal<br />
model SAMP8<br />
Gui-Rong Zhang, (PR China), X-R Cheng, W-X Zhou, Y-X Zhang, D-L Gao, X-D Xia, X-P Jiang, L-Y Nie, Y Ji,<br />
S-P Zhou<br />
Monday 19 July ■ 13:00 - 14:00 ■ Poster Area 197
W20<br />
Pharmacology education for a sustainable future<br />
Mon 471<br />
Mon 472<br />
Mon 473<br />
Mon 474<br />
Mon 475<br />
Mon 476<br />
Mon 477<br />
Mon 478<br />
The use of e-learning improved the pharmacology learning in chiropodist’s pharmacology training<br />
Inmaculada Bellido, (Spain), E-I Marquez, JA Garcia-Arnes, E Blanco, A Gomez-Luque<br />
Self-assessment with Moodle from activities proposed by students.<br />
Juan Formigós, (Spain), MM Palmero, V Maneu, NC García-Cabanes<br />
Favorable student attitudes towards hospital training in pharmacology in nursing degree<br />
Cristina García-Cabanes, (Spain), V Maneu, MM Palmero, J Formigós<br />
Short term impacts of rational pharmacotherapy course on the rational prescribing skils of fourth-year<br />
medical students<br />
Nil Hocaoglu, (Turkey), H Guven, S Gidener, Y Tuncok, S Kalkan, M Guneli, A Gelal<br />
Pharmacotherapeutics skills training design: a case study of Medical Faculty – Andalas University<br />
Laila Isrona, (Indonesia)<br />
Six years’ experience of using an interactive voting device in teaching basic pharmacology to students<br />
of pharmacy and medicine<br />
Ewen MacDonald, (Finland)<br />
Building themes together: Student's involvement in pharmacology subjects<br />
Victoria Maneu, (Spain), J Formigós, MC García-Cabanes, MM Palmero<br />
Developing rational prescribing competence in medical school: The relation between student<br />
perceptions and examination performance<br />
Shirra Moch, (South Africa), D Naidoo, L Green-Thompson,<br />
Mon 479 Pharmacology in UNO-agenda 21<br />
Eva Neu, (Germany), U Welscher, B Schubert, MC Michailov, M Holler, M Schratz, W Seidenbusch,<br />
G Weber, I Ivanova, V Foltin, U Härlin, Y Zebuhr<br />
Mon 480<br />
Mon 481<br />
Interactive 3D encyclopedia for the teaching of pharmacology to medical students<br />
Evelyn P Obando, (Colombia), MP Usta, T Escobar, R Escobar, J Estupiñan, DA Ospina<br />
Problem-based–learning in pharmacology subjects: Prons and some cons<br />
Mercedes Palmero, (Spain), MC García-Cabanes, J Formigós, V Maneu<br />
198 Monday 19 July ■ 13:00 - 14:00 ■ Poster Area
FC01<br />
Clinical pharmacology in the emerging countries<br />
Tue 001<br />
Tue 002<br />
Tue 003<br />
Tue 004<br />
Tue 005<br />
Tue 006<br />
Tue 007<br />
Tue 008<br />
Tue 009<br />
Tue 010<br />
Tue 011<br />
Tue 012<br />
Tue 013<br />
Tue 014<br />
Tue 015<br />
Tue 016<br />
Tue 017<br />
Amitriptyline in the management of distal sensory neuropathy in South African patients with HIV<br />
Shirra Moch, (South Africa), N Dinat, P Kamerman, E Marinda, N Hatta, N Zwane<br />
The antimalarial properties of metronidazole thiosemicarbazone analogues<br />
Emma Moseley, (South Africa), R van Zyl, M Abid, I Havlik, A Azam<br />
The chemotherapeutic action of synthetic dyes against Plasmodium falciparum<br />
Harold Motau, (South Africa), R Van Zyl, L Harmse<br />
Clinical toxicities of first-line antiretroviral therapy in a resource limited setting<br />
Tinashe Mudzviti, (Zimbabwe), C Maponga, S Khoza, Q Ma, D Tagwireyi<br />
Genetic variations in ABCB1 and CYP3A5 as well as sex influence quinine disposition among Ugandans<br />
Jackson K Mukonzo, (Uganda), P Waako, J Ogwal-Okeng, L Gustafsson, E Aklillu<br />
Determination of trimetazidine in human plasma for assessing bioequivalence study<br />
Suthatip Ngokpol, (Thailand)<br />
Development and validation of a sensitive liquid chromatography/tandem mass spectrometry<br />
(LC-MS/MS) method for quantification of olanzapine in human plasma<br />
Suthatip Ngokpol, (Thailand), P Pongnarin, A Kongsiang, J Jantaka, U Panich, S Chatsiricharoenkul,<br />
S Kongpatanakul<br />
Quality of life of colorectal cancer patients in post-surgery recovery period after being supplemented<br />
with Agaricus Sylvaticus fungus: a randomized, double-blind, placebo-controlled clinical study<br />
Maria Rita Novaes, (Brazil), R Fortes<br />
Influence of rifampicin on nevirapine level in HIV patient with TB<br />
Agus W Nugroho, (Indonesia), Nafrialdi, A Simatupang<br />
Adverse reactions to medicines experienced in a Nigerian hypertension clinic<br />
Abimbola Olowofela, (Nigeria), AO Isah<br />
Artemether may affect the analgesic activity of piroxicam in malaria<br />
Temidayo Olurishe, (Nigeria), S Ado, I Adamu<br />
Excretion of the antiparasitic moxidectin into the breast milk of lactating non-breastfeeding women<br />
Virginia Parks, (France), J Korth-Bradley, S Chalon, I Gourley, K Matschke, L Fleckenstein, P Bryson,<br />
S Gossart<br />
Teaching clinical pharmacology and pharmaceutical medicine in Serbia: Postgraduate studies<br />
Milica Prostran-Veselinovic, (Republic of Serbia), Z Todorovic, R Stojanovic<br />
Effect of Citrullus colocynthis on serum glucose, lipidemic profile and c-peptide changes in patients<br />
with type II diabetes mellitus<br />
Alireza Rahbar, (Iran), I Nabipoor<br />
Treatment of sheep by hypertonic dextrose after experimental salinomycin poisoning<br />
Hamid Rajaian, (Iran), S Nazifi, R Hosseini, A Hajmohammadi, J Jalaei, K Nayeri<br />
Anti-inflammatory effect of an extract of Mangifera indica L. (Vimang®) in patients with chronic<br />
dermatitis<br />
Lorena Safonts, (Cuba), M Guevara, T Pérez, C Morales<br />
Enzymatic analysis of the venom of Hemiscorpius lepturus, an Iranian scorpion<br />
Ramin Seyedian, (Iran), K Euikyung, A Zare<br />
Tuesday 20 July ■ 13:00 - 14:00 ■ Poster Area 199
FC01<br />
Clinical pharmacology in the emerging countries<br />
Tue 018<br />
Tue 019<br />
Tue 020<br />
Tue 021<br />
Tue 022<br />
Tue 023<br />
Tue 024<br />
Tue 025<br />
Tue 026<br />
Tue 027<br />
Tue 028<br />
Tue 029<br />
Tue 030<br />
Tue 031<br />
Tue 032<br />
Tue 033<br />
Tue 034<br />
Evaluation of bioequivalency/bioavailability trials in our clinic<br />
Zafer Sezer, (Turkey), A Inal, N Küçük, Ö Soydan, A Erenmemisoglu<br />
Gatifloxacin induced hypoglycemia in Type 2 DM patient with UTI.-A case report<br />
K Sharma, Lokendra K Sharma, (India), K Sharma<br />
Cost effective drug distribution system in Rajasthan (India)<br />
Lokendra K Sharma, (India), K Sharma, M Mathur, J Chaudhary, R Mandia<br />
Lypodystrophy due to antiretrovirals. Case presentation from resource-poor health care country<br />
Abraham Simatupang, (Indonesia), F Suling<br />
Combined treatment with sertindole and clozapine – reports of cases of patients with drug-resistant<br />
schizophrenia<br />
Bozena Spila, (Poland), A Grzywa-Celiñska, A Urbañska<br />
Development and validation of bioanalytical method of amlodipine besylate in human plasma<br />
Ganesh P Subedi, (Nepal), GM Khan<br />
Drugs with both anxiolytic and psychostimulating action: New opportunities for anxiety disorders<br />
treatment<br />
Sergey Syunyakov, (Russian Federation), D Chumakov, E Teleshova, G Neznamov<br />
Environmental risk factors and occurrence of gastritis and colitis in a mestizo population of<br />
Chabeklumil, state of Chiapas, México<br />
Diana C Tapia-Pancardo, (Mexico), R Jesus-Sandoval, L Aburto-Cortes, M Angeles-Gamiño,<br />
XE Nolasco-Velazquez, MM Valera-Mota, R Villalobos-Molina<br />
Clinical pharmacology for undergraduate medical students in Serbia<br />
Zoran Todorovic, (Republic of Serbia), M Prostran-Veselinovic<br />
Developing a model checklist for the evaluation of the dispensing scores in the pharmacy<br />
HZ Toklu, GA Dulger, Bulent Gumsel, (Turkey), E Yaris, NI Klayoncu, A Akici<br />
The bidirectional regulation of vitamin D3 on calcification in human joints and ligaments<br />
Xinglong Tong, (PR China), Y Xu, Y Xu<br />
Prescription audit as an important tool in the analysis of the prescriptions for the children<br />
Canan Uluoglu, (Turkey), Z Güney, T Ercanlý<br />
The impact of a ‘Groningen Model’ of pharmacotherapy training for general practitioners in Kayseri,<br />
Turkey<br />
Hasan Basri Ulusoy, (Turkey), T Sumak, S Þahin, H Gültekin<br />
Evaluation of the rational pharmacotherapy clerkship at Erciyes University Faculty of Medicine, Kayseri,<br />
Turkey<br />
Hasan Basri Ulusoy, (Turkey), T Sumak, E Eroglu, H Gultekin<br />
New times, new trends for ethionamide<br />
Nuno Vale, (Portugal), HA Santos, E Mäkilä, J Salonen, J Hirvonen, P Gomes<br />
Effect of CTOL on the Proliferation of AF by BrdU<br />
Chunxia Wang, (PR China), L Hou<br />
Analysis on quality control of drug clinical trials<br />
Shaohua Wang, (PR China)<br />
200 Tuesday 20 July ■ 13:00 - 14:00 ■ Poster Area
FC01<br />
Clinical pharmacology in the emerging countries<br />
Tue 035<br />
Tue 036<br />
Study on protection effect of erythropoietin on newborn rats with hypoxic-ischemic brain damage<br />
Yunxiao Wang, (PR China), W Liu, Y Cao, Y Meng<br />
Differences in efficacy among FOLFOX for advanced gastric cancer involve 14-3-3 δ<br />
Bo Yi, (PR China), QY Li, OP Huang, D Liu, D Yin, M He<br />
Tuesday 20 July ■ 13:00 - 14:00 ■ Poster Area 201
FC02<br />
Transmembrane transport: Perspectives for disease<br />
and drug discovery<br />
Tue 037<br />
Tue 038<br />
Tue 039<br />
Tue 040<br />
Tue 041<br />
Tue 042<br />
Tue 043<br />
Tue 044<br />
Tue 045<br />
Tue 046<br />
Tue 047<br />
Tue 048<br />
Tue 049<br />
Tue 050<br />
Tue 051<br />
Ivermectin activates Cys-loop ligand-gated chloride channels by interacting with the third<br />
transmembrane domain<br />
Timothy Lynagh, (Australia), T Webb, J Lynch<br />
A role of α2 isoform of the Na,K-pump in mesenteric small arteries wall<br />
Vladimir Matchkov, (Denmark), NM Nielsen, C Aalkjær<br />
Expression and function of the organic cation transporter 3 (OCT3) in the human placenta<br />
Karen May, (Germany), V Rozehnal, M Grube, M Zygmunt, HK Kroemer, W Siegmund<br />
Effect of the P-glycoprotein on the intestinal absorption of herbal products associated with<br />
antiretrovirals in mice<br />
Joe Miantezila Basilua, (France), G Mamadou, N Limas Nzouzi, G Peytavin, B Eto<br />
Impact of OATP1B1, OATP1B3 and ABCC2 on the hepatic uptake and pharmacokinetics of the<br />
MRI-contrast agent Gd-EOB-DTPA in healthy volunteers<br />
A Nassif, S Oswald, J-P Kühn, C Modess, N Hosten, Werner Siegmund (Germany)<br />
Mitochondrial sodium/calcium exchanger as a new target to develop neuroprotective drugs<br />
Santos Nicolau, (Spain), J Egea, M López, A García<br />
Influence of ABCB1 C3435T polymorphism on the pharmacokinetics of ezetimibe and its glucuronide in<br />
healthy subjects<br />
Da-Hee Oh, (Republic Of South Korea), C-I Choi, J-W Bae, M-J Kim, C-G Jang, S-Y Lee<br />
The role of OATP1B1 genetic variants in the disposition of pitavastatin in healthy Koreans<br />
Da-Hee Oh, (Republic Of South Korea), C-I Choi, J-W Bae, M-J Kim, C-G Jang, S-Y Lee<br />
Influence of efavirenz on the disposition and lipid-lowering effects of ezetimibe in healthy subjects<br />
Stefan Oswald, (Germany), H Meyer zu Schwabedissen, A Nassif, C Modess, D Lütjohann, Z Desta,<br />
H Kroemer, W Siegmund<br />
SLC26 transporters are regulated via the [Cl-]i-sensitive Ste20p kinases<br />
Hyun Woo Park, (South Korea), JH Nam, MG Lee<br />
Modification of equilibrative nucleoside transporter 1 (ENT1) function by sulfhydryl reagents involves<br />
cysteine residues in transmembrane regions 6 and 7<br />
Jamie Park, (Canada), J Hammond<br />
The expression of organic cation transporter mrna in cultured adult and neonatal rat astrocytes and<br />
their possible functional role<br />
Katja Perdan-Pirkmajer, (Slovenia), S Pirkmajer, Z Grubiè, M Krzan<br />
Influence of rifampicin on pulmonary expression of ABCB1 and ABCC2 and on distribution of<br />
clarithromycin into epithelial lining fluid and broncho-alveolar cells of foals<br />
Jette Peters, (Germany), J Freyer, W Block, S Oswald, M Venner, W Siegmund<br />
Effect of viral infection on hepatic and placental drug transporters and endogenous substrates in<br />
pregnant rats<br />
Vanja Petrovic, (Canada), M Piquette-Miller<br />
Block of the IKr current by the HMG-CoA reductase inhibitor rosuvastatin is modulated by BCRP, MDR1<br />
and OATP2B1 membrane drug-transporter activites<br />
I Plante, M Frappier, F Belanger, Jacques Turgeon (Canada)<br />
202 Tuesday 20 July ■ 13:00 - 14:00 ■ Poster Area
FC02<br />
Transmembrane transport: Perspectives for disease<br />
and drug discovery<br />
Tue 052<br />
Tue 053<br />
Tue 054<br />
Tue 055<br />
Tue 056<br />
Tue 057<br />
Tue 058<br />
Tue 059<br />
Tue 060<br />
Tue 061<br />
Tue 062<br />
Tue 063<br />
Tue 064<br />
Tue 065<br />
Tue 066<br />
Tue 067<br />
A liposomal formulation of Azithromycin for treatment of cutaneous leishmania<br />
Omid Rajabi, (Iran), P Layegh, M Khoddami, R Salari<br />
Small-molecule drug design targeting PICK1 using a C-terminal dopamine transporter peptide<br />
Mette Rathje, (Denmark), MV Andersen, SE Andersen, PO Heidarsson, S Erlendsson, A Bach,<br />
FM Poulsen, K Strømgaard, U Gether<br />
The organic solute transporter OSTα-OSTβ – a potential determinant of drug absorption<br />
Ute Schwarz, (Canada), H Meyer zu Schwabedissen, B Urquhart, R Tirona, R Kim<br />
TRPC3 mediates thrombin-induced astrocyte activation and upregulates its own expression in rat<br />
cortical astrocytes<br />
H Shirakawa, T Nakagawa, Shuji Kaneko, (Japan)<br />
Transport characteristics of caffeine in human intestinal Caco-2 cell monolayer<br />
Libuse Smetanova, (Czech Republic), V Stetinova, D Kholova, J Kvetina, J Smetana, Z Svoboda<br />
MDR1 gene C3435T polymorphism is associated with the risk of threatened pregnancy interruption<br />
E Sokova, I Ignatiev, A Prilutsky, Dmitry A Sychev, (Russian Federation), V Kukes<br />
Relaxatory effect of magnesium on mesenteric vascular beds differs from normal and streptozotocin<br />
induced diabetic rats<br />
Nepton Soltani, (Iran), F Kharazmi, M Keshavarz<br />
Discovery of a monoamine transporter inhibitor via high throughput molecular model docking and<br />
pharmacophore modeling<br />
Christopher Surratt, (USA), M Indarte, Y Liu, J Madura<br />
Na + /Ca 2+ exchanger is involved in nitric oxide-mediated apoptosis in cultured astrocytes<br />
Kazuhiro Takuma, (Japan), T Kitao, T Kawasaki, Y Inoue, A Ikehara, T Nashida, Y Ago, T Matsuda<br />
Evidence for a key contribution of TMEM16A protein to the calcium-activated chloride current in rat<br />
pulmonary artery smooth muscle cells<br />
Paolo Tammaro, (UK), B Manoury, A Tamuleviciute<br />
Grapefruit juice markedly reduces the plasma concentrations of the OATP2B1 substrate aliskiren<br />
Tuija Tapaninen, (Finland), PJ Neuvonen, M Niemi<br />
Drug transporters in human mammary epithelial cells<br />
Lisa Bee-Gek Tee, (Australia), TF Sim, D Williams, A Crowe, K Ilett<br />
Pharmacokinetic analysis of irinotecan in Oatp1b2 knockout mice<br />
Wendy Teft, (Canada), S Mansell, S Welch, R Kim<br />
Molecular determinants for selective recognition of antidepressants in the human serotonin and<br />
norepinephrine transporters<br />
Mette Thomsen, (Denmark), L Sørensen, J Andersen, K Strømgaard, AK Kristensen<br />
Effect of garlic, ginkgo and St. John’s wort on the pharmacokinetics of fexofenadine in rats<br />
Jasmina Turkanovic, (Australia), MB Ward, RW Milne<br />
Highly sensitive and rapid assessment of P-glycoprotein activity in Caco-2 cells<br />
Hirkazu Wakuda, (Japan), Y Tada, N Nejime, S Kagota, K Nakamura, K Umegaki, S Yamada,<br />
K Shinozuka<br />
Tuesday 20 July ■ 13:00 - 14:00 ■ Poster Area 203
FC02<br />
Transmembrane transport: Perspectives for disease<br />
and drug discovery<br />
Tue 068<br />
Tue 069<br />
Tue 070<br />
Tue 071<br />
Tue 072<br />
Tue 073<br />
Tue 074<br />
Tue 075<br />
Tue 076<br />
Activation of M3 muscarinic acetylcholine receptors and α1-adrenoceptors induces AQP5 trafficking in<br />
rat parotid acinar cells<br />
Di Wang, (Japan), G Cho, M Shono, Y Ishikawa<br />
Interaction between troxerutin and bovine serum albumin<br />
L Wang, X Li, Y Li, Y Chen, Y Fan, Ming Xue (PR China)<br />
Structural elucidation of the metabolites of tanshinone I and its analogue dihydrotanshinone I in rats by<br />
HPLC-ESI-MSn<br />
M Wang, H Dai, X Li, Y Li, L Wang, Ming Xue (PR China)<br />
Electrophysiological properties of YM-244769, a novel and potent Na+/Ca2+ exchange inhibitor, in<br />
cardiac ventricular myocytes of guinea pig<br />
Yasuhide Watanabe, (Japan), J Kimura, K Yamashita, T Yamakawa, T Iwamoto<br />
Stimulation of noradrenalin transporter and serotonin transporter activity by soy phytoestrogen<br />
genistein<br />
Nobuyuki Yanagihara, (Japan), Y Toyohira, S Ueno, M Tsutsui, K Takahashi<br />
UDCA-induced HNF-1γα inhibition and pharmacokinetic changes of pitavastatin in relation to OATP1B1<br />
transport activity<br />
So-Jung Youn, (South Korea), C-I Choi, J-W Bae, M-J Kim, C-G Jang, S-Y Lee<br />
In vivo study of penetration of acetylcholinesterase reactivators through blood-brain barrier<br />
Jana Zdarova Karasova, (Czech Republic), K Kuca, M Pohanka, L Novotny<br />
Calcium signal passway-based on to research the neuroprotection of effective components of<br />
traditional Chinese medicine<br />
Yi Zhang, (PR China), X Lai, J Zhang<br />
Molecular mechanisms of hERG K+ channel blockade by fluoroquinolone antibiotic agent chinfloxacin<br />
hydrochloride<br />
Zhao Zhang, (PR China), X Zhang, J Guo, J Liu, Z Zhu, Z Hu, Z Zhao<br />
204 Tuesday 20 July ■ 13:00 - 14:00 ■ Poster Area
FC03<br />
Ion channels in analgesia and anaesthesia<br />
Tue 077<br />
Tue 078<br />
Tue 079<br />
Tue 080<br />
Tue 081<br />
Tue 082<br />
Tue 083<br />
Tue 084<br />
Tue 085<br />
Topical application of disodium isostearyl 2-O-l-ascorbyl phosphate, a skin-permeable amphiphilic<br />
ascorbic derivative, attenuates chemotherapy-induced neuropathic hyperalgesia in rats<br />
Kazumasa Okubo, (Japan), T Takahashi, M Matsunami, H Shibayama, A Kawabata<br />
Models for screening in rats the effects of TRPV1 receptor antagonists on thermal hyperalgesia and<br />
thermoregulation<br />
G Pethö, K Bölcskei, V Tékus, A Kis-Varga, L Dézsi, É Szentirmay, A Visegrády, C Horváth,<br />
Janos Szolcsányi, (Hungary)<br />
Local anaesthetic activity of new piperidine’s derivatives and their immobilized forms<br />
Guram Pichkhadze, (Kazakhstan), K Praliev, D Kadyrova, S Nasyrova, S Imashova, M Amyrkulova,<br />
G Muhamedzhanova, D Assylbekova<br />
Characterization of Philantotoxin analogues as subtype-selective AMPA receptor antagonists<br />
Mette Poulsen, (Denmark), S Lucas, K Strømgaard, AS Kristensen<br />
Effect of diclofenac on compound action potential<br />
Jelena Scekic, (Montenegro), M Drecun, M Bajagic<br />
Discovery and characteristics of inducible spinal D-amino acid oxidase as a novel target for the<br />
treatment of chronic pain<br />
Yong Xiang Wang, (PR China), N Gong, Z-Y Gao, J-L Huang<br />
Antinociception of synthetic ω-conotoxin SO-3, a selective N-type neuronal voltage-sensitive calcium<br />
channel blocker, and its effects on morphine analgesia in chemical stimulus tests after acute or chronic<br />
intrathecal administration in rodent<br />
Ling-Di Yan, (PR China), Y-L Liu, L Zhang, H-J Dong, P-L Zhou, R-B Su, Z-H Gong, P-T Huang<br />
Involvement of glutamate receptors existing in peripheral ending of primary afferent fibers in<br />
nociception<br />
Norifumi Yonehara, (Japan), Y Koike<br />
Regulation of NMDA receptors by copper ions<br />
Haitao You, (Canada), S Tsutsui, PK Stys, GW Zamponi<br />
Tuesday 20 July ■ 13:00 - 14:00 ■ Poster Area 205
FC04<br />
Pharmacoepidemiology, current controversies and<br />
opportunities<br />
Tue 086<br />
Tue 087<br />
Tue 088<br />
Portuguese pharmacist attitudes towards the use of herbal complementary and alternative medicines in<br />
oncology<br />
Maria T Herdeiro, (Portugal), E Mendes, A Figueiras, F Pimentel<br />
Hepatotoxicity associated with antituberculosis drugs: a cohort of incident patients receiving treatment<br />
or on chemoprophylaxis<br />
Luisa Ibáñez, (Spain), M Sabaté, E Pérez, X Vidal, Hepatox-TBC Group<br />
Analysis of suspected adverse reactions to antidiabetic drugs in Spain,2006–2008<br />
María-Isabel Jiménez-Serranía, (Spain), R Mateos-Campos<br />
Tue 089 Utilization study of antidiabetic drugs in Spain, 2006–2008<br />
María-Isabel Jiménez-Serranía, (Spain), R Mateos-Campos<br />
Tue 090<br />
Tue 091<br />
Tue 092<br />
Tue 093<br />
Tue 094<br />
Tue 095<br />
Tue 096<br />
Tue 097<br />
Tue 098<br />
Tue 099<br />
Emergence of Artemisinin resistant malaria in Western Cambodia<br />
Phisit Khemawoot, (Thailand), L Chanthap, Y Se, D Bethell, D Saunders, S Sriwichai,<br />
P Teja-isavadharm, S Tyner, D Walsh, H Noedl, D Socheat, M Fukuda<br />
Surgical site infections incidence as a quality indicator for proper antibiotic prophylactic use in tertiary<br />
health care hospital inpatients<br />
Aleksandra Kovacevic, (Republic of Serbia), V Dragojevic-Simic, V Suljagic, M Jevtic, J Vukovic,<br />
D Jandric<br />
Identification of drug-induced anaphylaxis using the French hospital administrative database<br />
L Lacoin, C Lecomte, A Kostrzewa, V Gilleron, N Moore, G Miremont-Salamé, Françoise Haramburu<br />
(France)<br />
Use of serotoninergic medications and cardiac valvulopathy: A nested case-control study in The Health<br />
Improvement Network (THIN) database<br />
Francesco Lapi, (Italy), F Nicotra, A Rubino, L Scotti, M Thomson, A Vannacci, A Zambon, G Corrao,<br />
A Mugelli<br />
Expression of adeA gene is associated with multidrug-resistance in Acinetobacter baumannii clinical<br />
isolates<br />
Baodong Ling, (PR China), G Liu, X Zhu, L Lin, Y Zeng, Y Xie<br />
Drug consumption in Croatia: The effects of pricing policy changes<br />
Tomislav Madjarevic, (Croatia), T Buble, M Gantumur, M Vitezic, B Sestan, J Mrsic Pelcic, D Vitezic<br />
Correlates of (inadequate) benzodiazepine use: The Netherlands Study of Depression and Anxiety<br />
(NESDA)<br />
Leonie Manthey, (The Netherlands), T van Veen, EJ Giltay, JE Stoop, A Knuistingh-Neven,<br />
BWJH Penninx, FG Zitman<br />
A comparative study of medicinal plants used against gastrointestinal disorders in two districts of<br />
Bangladesh<br />
Ariful Haque Mollik, (Bangladesh), R Faruque, R McField, A Chowdhury, KK Thapa, T Islam<br />
Most frequent adverse drug reactions in cardiology patients registered with intensive monitoring<br />
system<br />
Snezana Mugosa, (Montenegro), Z Todorovic<br />
Future approaches to pharmacology in context of philosophy and economics<br />
Renate Neu, (Germany), MC Michailov, M Holler, E Neu, T Senn, RK Stappen, R Schinabek, G Schulz,<br />
D Martin, S Molnar, M Schratz, G Weber<br />
206 Tuesday 20 July ■ 13:00 - 14:00 ■ Poster Area
FC04<br />
Pharmacoepidemiology, current controversies and<br />
opportunities<br />
Tue 100<br />
Tue 101<br />
Tue 102<br />
Tue 103<br />
Tue 104<br />
Tue 105<br />
Tue 106<br />
Tue 107<br />
Tue 108<br />
Tue 109<br />
Tue 110<br />
Tue 111<br />
Tue 112<br />
Tue 113<br />
Tue 114<br />
Tue 115<br />
Determinants of antibiotics prescription among doctors in a Nigerian teaching hospital<br />
Olayinka O Ogunleye, (Nigeria), SO Ogundele, AF Yinka-Ogunleye<br />
Quality of life of arthritis rheumatology patients evaluation<br />
PCR Palmiere, WA Souza, OMGC Vilas-Boas, EB Ferreira, Marcia HMC Podestá, (Brazil)<br />
A study of the longitudinal utilization of traditional non-steroidal anti-inflammatory drugs and COX-2<br />
selection inhibitors using a pharmacy based approach<br />
Emilian Damian Popovici, (Romania), MG Popovici, C Trandafirescu, M Kolliali, IM Malita, LM Baditoiu<br />
Pharmacological patterns of treatment in acute manic episode: A Spanish epidemiological multicentric<br />
study<br />
Esther Prieto, (Spain), J Galán<br />
Pharmacoepidemiology as an opportunity for prognostic studies in rare diseases: The example of giant<br />
cell arteritis and the French APOGEE cohort (Artérite en POpulation GEnérale)<br />
Gregory Pugnet, (France), L Sailler, R Bourrel, A Sommet, JL Montastruc, M Lapeyre-Mestre<br />
Effects of genetic polymorphisms of angiotensin converting enzyme in Iranian children with idiopathic<br />
nephrotic syndrome<br />
Parvaneh Rahimi-Moghaddam, (Iran)<br />
Communication of toxic effects of drugs with polymorphism genes GST and CYP450<br />
Natalya Shipovskaya, (Russian Federation), E Zaklyazminskaya, D Litvinov, L Shelihova<br />
Clinical importance of the evidentiary level basis for drug approval in oncology<br />
Gerald Sokol, (USA), L Loftus, B Djulbegovic, L Cantilena<br />
Patients’ preferences for written information about effects and undesirable side effects of drugs<br />
Petra A Thürmann, (Germany), V Mülders, D Simic, O Herber, D Schwappach, S Wilm<br />
The feasibility of monitoring paediatric adverse drug reactions via specialist clinics<br />
Mansour Tobaiqy, (UK), D Stewart, PJ Helms, CM Bond, AJ Lee, JHG Williams, JS McLay<br />
Compounding of extemporaneous items in pharmacies in South Africa<br />
Ilse Truter, (South Africa), M Lubbe, N Butler, D Nazer, A Gous, D Bayever, M Naidoo, P Naidoo,<br />
V Tlala, S Putter<br />
Antipsychotic prescribing to adults: A community pharmacy database analysis<br />
Ilse Truter, (South Africa)<br />
Prescribing for Parkinson’s disease in the private sector in South Africa<br />
Ilse Truter, (South Africa),<br />
The evaluation of quality of pharmacological treatment in elderly patients<br />
Martin Wawruch, (Slovak Republic), L Kostkova, A Macugova, K Strateny, M Kuzelova, D Jezova,<br />
A Dukat, V Kristova<br />
Psychotropic drug utilization in old-adult community<br />
N Yodu, C Peña, René Delgardo-Hernandez,(Cuba)<br />
Proton pump inhibitor (PPI) or statin associated risk for Clostridium difficile associated disease (CDAD)<br />
Anita Zachow, (Germany), S Sonnenberg, G Haase, S Koenig, B Drewelow, SC Mueller<br />
Tuesday 20 July ■ 13:00 - 14:00 ■ Poster Area 207
FC05<br />
Translational science in the metabolic syndrome:<br />
basic and clinical pharmacology<br />
Tue 116<br />
Tue 117<br />
Tue 118<br />
Tue 119<br />
Tue 120<br />
Tue 121<br />
Tue 122<br />
Tue 123<br />
Tue 124<br />
Tue 125<br />
Tue 126<br />
Tue 127<br />
Tue 128<br />
Tue 129<br />
Tue 130<br />
Level of response to antiplatelet therapy in patients with type 2 diabetes<br />
E Martin-Aurioles, F Padin, MM Arrebola, JA López-Villodres, Nuria Jebrouni, (Spain), JP de la Cruz,<br />
JA Gonzalez-Correa<br />
Five kinds of alkaloids from Rhizoma Coptis improve glucose uptake of 3T3-L1 cells without<br />
adipogenesis activity<br />
Xianli Meng, (PR China), J Li, X Fan, Y Zhang<br />
Propionyl-l-carnitine prevent metabolic and cardiovascular alterations in a model of diet-induced obesity<br />
Carmen Mingorance Gutiérrez, (Spain), M Chalopin, G Simard, PH Ducluzeau, Y Malthery, MD Herrera,<br />
M Álvarez de Sotomayor, R Andriantsitohaina<br />
Effect of genetic polymorphism on hypolipidemic response to rosuvastatin in metabolic syndrome<br />
Misbah Misbahuddin, (India), F Ahmad, S Ziaurrahman, A Khan, S Siddiqui<br />
Ethnomedicinal uses of some plant species by the traditional healers in Gaibandha district of<br />
Bangladesh<br />
Ariful Haque Mollik, (Bangladesh), R Faruque, R McField, D Sen, KK Thapa, AI Hassan<br />
Insulin resistance in the obese Zucker rat is not associated with pulmonary arterial hypertension<br />
Javier Moral-Sanz, (Spain), C Menendez, L Escolano, L Moreno, A Cogolludo, F Perez-Vizcaino<br />
Effect of Kampo, Chinese traditional medicine on clock- and metabolism-related gene expression in<br />
mice<br />
Takeshi Morishima, (Japan), G Koiwa, Y Tahara, A Hirao, S Shibata<br />
Effects of rosiglitazone on the prejunctional facilitatory actions of angiotensin II and α-2-antagonists<br />
Daniel Moura, (Portugal), H Pinheiro, F Silva, L Pereira, R Bastos<br />
Pre-emptive treatment with hemin suppresses hyperglycemia and improves glucose metabolism and<br />
diabetic nephropathy in the first generation offspring of Goto-kakizaki rats<br />
Joseph F Ndisang, (Canada), N Lane, A Jadhav<br />
Description and application of the Thrittene radioimmunoassay<br />
József Németh, (Hungary), G Fürjes, A Tóth, B Peitl, R Sári, R Pórszász, Z Szilvássy<br />
Aliskiren reduces albuminuria and affects renal TNF-α and Bcl-2 expression in a model of diabetic<br />
nephropathy in rats<br />
P Panagopoulos, Stergios Tsartsalis, (Greece), T Georgopoulou-Karanikola, C Tomos, T Mavrakanas,<br />
M Mironidou-Tzouveleki<br />
Role of AT1 receptor on the CNS insulin signalling in animal model of type 2 diabetes<br />
Mariella Pastorello, (Venezuela), A Israel<br />
The cyclic GMP-independent selective insulin sensitizing effect of oral isosorbide mononitrate in<br />
conscious rabbits<br />
Barna Peitl, (Hungary), R Sári, Z Szilvássy<br />
Protein kinase G regulates mitochondrial biogenesis and differentiation of brown adipocytes via<br />
inhibition of the RhoA/ROCK pathway<br />
Alexander Pfeifer, (Germany), B Haas, K Jennissen, P Mayer<br />
Analyzing the key enzymes of tricarboxylic acid circulation and researching metabonomics in diabetes<br />
and diabetic susceptible groups<br />
Jing Ping, (PR China), X Guan, L Wu, Y Zhao, K Bi<br />
208 Tuesday 20 July ■ 13:00 - 14:00 ■ Poster Area
FC05<br />
Translational science in the metabolic syndrome:<br />
Basic and clinical pharmacology<br />
Tue 131<br />
Tue 132<br />
Tue 133<br />
Tue 134<br />
Tue 135<br />
Tue 136<br />
Tue 137<br />
Tue 138<br />
Tue 139<br />
Tue 140<br />
Tue 141<br />
Tue 142<br />
Tue 143<br />
Tue 144<br />
Tue 145<br />
Tue 146<br />
Antidiabetic activity of biotin, sodium selenate and folic acid in diabetic rats<br />
Shweta Pitre, (India), R Ghosh, P Ganpathy, V Kadam<br />
Psammomys Obesus a promising animal model for type 2 diabetes<br />
Rasmus Pold, (Denmark), C Godfredsen, S Lund, T Bodvarsdottir<br />
Liquid fructose modifies insulin signalling pathway independently of AMPK activation in female<br />
Sprague-Dawley rats<br />
Núria Roglans, (Spain), A Rebollo, A Padrosa, L Vilà, M Alegret, JC Laguna<br />
Visfatin/PBEF/Nampt: a new therapeutical target in vascular inflammation<br />
Tanya Romacho, (Spain), V Azcutia, N Matesanz, E Cercas, R Carraro, L Rodriguez-Mañas,<br />
CF Sanchez-Ferrer, C Peiro<br />
Attenuated coronary vasodilator responses to adenosine receptor agonists in hearts from Zucker<br />
diabetic rats<br />
Roselyn Rose'Meyer, (Australia), D Wang<br />
Ca 2+ -dependent mechanism for hydrogen peroxide-induced apoptosis in pancreatic β-cells<br />
Yurie Sayama, (Japan), A Noguchi, M Takada, Y Kaneko, T Ishikawa<br />
Effect of α-lipoic acid on lipid peroxidation and microscopic structures of liver, pancreas and heart in<br />
STZ diabetic rats<br />
Manju Sharma, (India), KK Pillai, T Anwer, D Ahmad, WA Anjum, MW Siddique<br />
Ubiquitin ligase Hrd1 facilitates degradation of the Z variant α-1-antitrypsin<br />
Yuxian Shen, (PR China), H Wang, Q Li, A Sun, Y Shen, F Wang, H Fang, L Feng, X Zhu, X He, S Fang<br />
Upregulated pancreatic NF-κB/iNOS expression and impaired glucose stimulated insulin secretion in<br />
monosodium glutamate (MSG) induced obese rats after long-term fenofibrate treatment<br />
Zhufang Shen, (PR China), S Liu<br />
Fasting-induced increase in galanin mRNA expression in several hypothalamic nuclei<br />
Tomohiro Shiiya, (Japan), T Niki, H Higuchi<br />
Cardioprotective drug mildronate enhances the anti-diabetic activity of metformin in obese Zucker rats<br />
Elina Skapare, (Latvia), E Liepinsh, B Svalbe, M Dambrova<br />
Impaired neurogenic relaxation of the sphincter of Oddi of rabbits with insulin resistance<br />
Zoltán Szilvássy, (Hungary), J Németh, R Sári, B Peitl<br />
Atrial enlargement and decreased heart rate in SHRSP.Z-Leprfa/IzmDmcr rats, a model of metabolic<br />
syndrome<br />
Yukari Tada, (Japan), S Kagota, N Nejime, H Wakuda, K Nakamura, M Kunitomo, K Shinozuka<br />
Coronary artery bypass grafting surgery worsens oxidative stress among patients with coronary<br />
disease<br />
Teresa Tejerina, (Spain), MC M. Carnero, J Muñoz-Marin, JA González-Correa, E Gallardo, J Navarro-<br />
Dorado, M Ramajo, S Redondo<br />
Development and application of a quantitative LC-MS/MS method for endocannabinoids<br />
Brian Thomas, (USA), S Warren, Q Zhan, J Sasay, D Russell, A Howlett<br />
Neuronal insulin resistance in the nucleus Tractus solitarii induces hypertension in the fructose fed rats<br />
Ching-Jiunn Tseng, (Taiwan), B-R Chen, W-Y Ho, W-H Cheng, P-W Cheng<br />
Tuesday 20 July ■ 13:00 - 14:00 ■ Poster Area 209
FC05<br />
Translational science in the metabolic syndrome:<br />
Basic and clinical pharmacology<br />
Tue 147<br />
Tue 148<br />
Tue 149<br />
Tue 150<br />
Tue 151<br />
Tue 152<br />
Tue 153<br />
Tue 154<br />
Tue 155<br />
Tue 156<br />
Body temperature regulation after dietary intervention of three kinds of high-fat diets<br />
Hiromi Tsushima, (Japan), M Mori, K Yamada, H Okuyama, Y Hashimoto, T Ohkubo, H Hibino<br />
Evaluation of a glucagon challenge test as a tool in diabetes research<br />
Marloes GJ Van Dongen, (The Netherlands), BF Geerts, S Bhanot, ML de Kam, AF Cohen, JA Romijn,<br />
J Burggraaf<br />
CB1 cannabinoid receptor expression is regulated by glucose and feeding state in murine pancreatic<br />
islets<br />
Rafael Villalobos-Molina, (Mexico), A Vilches-Flores, NL Delgado-Buenrostro, G Navarrete-Vazquez<br />
Metabolic syndrome prevalence in university students of México City<br />
Rafael Villalobos-Molina, (Mexico), JR Jimenez-Flores, AR Mendez-Cruz, NY Rodríguez-Soriano,<br />
MI Mendoza-Ramos, M Murguia-Romero, SC Sigrist-Flores, M Rodriguez-Salazar, L Anguiano,<br />
E Gonzalez-Dalhaus<br />
Cell membrane crossing oligomers – a novel antisense therapy for reduction of apolipoprotein<br />
B-containing lipoproteins<br />
Georg Wietzorrek, (Austria), Y Nakada, B Werner, H Bock, T Lindhorst, H Dieplinger<br />
The role for L-carnitine in STZ-induced diabetic mice peripheral nerve injury<br />
Yunqiu Xia, (PR China), W Zhong, S Tao, C Wang, J Dong<br />
Role of heparan sulfate in glucose-induced insulin secretion in mouse pancreatic β-cell line MIN6 cells<br />
Takeo Yoshikawa, (Japan), S Takayanagi, N Noguchi, D Zhang, Y Ariyama, A Uruno, H Okamoto,<br />
A Sugawara, K Yanai<br />
Chronic hyperinsulinemia induces hypertension resulted from abnormal innervation of perivascular<br />
nerves in rat mesenteric resistance arteries<br />
Yoshito Zamami, (Japan), S Takatori, N Yabumae, M Hosoda, T Koyama, N Hobara, K Sasaki,<br />
H Kawasaki<br />
Bimodality of plasma glucose distributions in cynomolgus macaques<br />
Guodong Zhang, (PR China), D Yi, C Zhou, C Zhu, P Chan<br />
Treating diabetic complications Multitargeting effects of Scutellarein<br />
Banghao Zhu, (PR China)<br />
210 Tuesday 20 July ■ 13:00 - 14:00 ■ Poster Area
FC06<br />
The heart gone wrong; stabilization of cardiac<br />
function<br />
Tue 157<br />
Tue 158<br />
Tue 159<br />
Tue 160<br />
Tue 161<br />
Tue 162<br />
Tue 163<br />
Tue 164<br />
Tue 165<br />
Tue 166<br />
Tue 167<br />
Tue 168<br />
Tue 169<br />
Tue 170<br />
Tue 171<br />
Possible role of endocannabinoids in the cardioprotective effects of a polyunsaturated fatty acid-rich<br />
diet in rats<br />
Istvan Lepran, (Hungary), N Morvay<br />
Effects of Lenalidomide on Ob/ob mice cardiac function: The role of TNF- αinhibitors<br />
Linlin Li, (PR China), R Jun, Y Hua<br />
Role of acetylcholine in protecting H9c2 cells against oxidative stress induced by angiotensin II<br />
J-J Liu, D-L Li, L Sun, M Zhao, X-J Yu, Wei-Jin Zang (PR China)<br />
Cardiac safety assessment: Beyond QT<br />
S Lynagh, David Bunton, (UK)<br />
Cystamine and sildenafil treatment of right ventricular hypertrophy in rats with pulmonary hypertension<br />
Lars Høj Markvardsen, (Denmark), CU Andersen, M Aalling, JH Rønn, U Simonsen<br />
Neonatal hyperleptinaemia possibly modulates cardiac function<br />
E Marques, F Toste, S Marques, J Raimundo, G Sudo, R Sudo, A Vieyra,<br />
Christianne Scaramello, (Brazil)<br />
Changes in the expression of enos and nnos in human peripheral blood lymphocytes and heart failure<br />
Diana Vicente Miralles, (Spain), F Monto, E Oliver, D Barettino, J Rueda, J Aguero, L Almenar,<br />
P D'Ocon<br />
Methylsufonylmethane (MSM) treatment improves hemodynamics in monocrotaline-induced pulmonary<br />
hypertension<br />
Sadollah Mohammadi, (Iran), A Garjani, M Najafi, H Hamzeiy, N Maleki-Dizaji, M Darabi, K Hassanzadeh,<br />
M Asadi<br />
Changes in the expression of α1 and β-adrenoceptors or of GRKs in human and rat hearts induced by<br />
chronic carvedilol treatment<br />
Fermí Josep Montó Guillot, (Spain), D Vicente, E Oliver, D Barettino, J Rueda, J Agüero, L Almenar,<br />
P D´Ocon<br />
Decreased matricellular protein thrombospondin (TSP) -4 expression in human calcified aortic valves<br />
Erja Mustonen, (Finland), V Pohjolainen, P Taskinen, J Näpänkangas, T Peltonen, H Leskinen,<br />
T Juvonen, J Satta, H Ruskoaho, J Rysä<br />
Effects of administration of statins for a certain term before undergoing coronary artery bypass<br />
grafting on platelet activation and inflammatory responses<br />
Kazuo Nakamura, (Japan), H Iwase, H Kariyazono, S Oiso, R Ikeda, J Arima, K Takahama, R Sakata<br />
Effects of SERCA activators, ellagic acid and gingerol, on diabetes mellitus-induced diastolic<br />
dysfunction in isolated murine ventricular myocardia<br />
Iyuki Namekata, (Japan), M Ohhara, Y Hirota, T Kawanishi, A Takahara, H Tanaka<br />
Phenotyping of heterozygous calsequestrin targeted mice<br />
Joachim Neumann, (Germany), P Bock, M Fischer, S Hauptmann, U Gergs<br />
Acute block of Kv1.5 channels by DHA increases rabbit atrial refractory period<br />
Christophe Pignier, (France), R Letienne, N Cabriol, Y Calmettes, B Le Grand<br />
Cardioprotection against ischemia afforded by F 16916, a blocker of persistent sodium current<br />
Christophe Pignier, (France), R Letienne, P Pajeau, L Bel, A-M Bessac, B Vacher, B Le Grand<br />
Tuesday 20 July ■ 13:00 - 14:00 ■ Poster Area 211
FC06<br />
The heart gone wrong; stabilization of cardiac<br />
function<br />
Tue 172<br />
Tue 173<br />
Tue 174<br />
Tue 175<br />
Tue 176<br />
Tue 177<br />
Tue 178<br />
Tue 179<br />
Tue 180<br />
Tue 181<br />
Tue 182<br />
Tue 183<br />
Tue 184<br />
Tue 185<br />
Tue 186<br />
Tue 187<br />
Selective inhibition of persistent sodium current by F 15845 prevents ischemia-induced arrhythmias<br />
Christophe Pignier, (France), R Letienne, B Vie, C Culie, B Vacher, B Le Grand<br />
The myocardial protective and antioxidative effects of L-carnitine on patients with CHD after PCI<br />
Haijun Qu, (PR China), F Jing, Z Sui, Y Cao, Z Han, L Zhu, C Wang<br />
Targeting therapy of the systemic inflammatory response syndrome in patients with congestive heart<br />
failure<br />
Mamanti Rogava, (Georgia), T Bochorishvili, N Dolidze, M Mirziashvili<br />
State of endothelial and humoral regulation in heart failure of the aged patients on essential<br />
hypertension with combined IHD during the treatment<br />
Olesya Romashenko, (Russian Federation)<br />
Phenothiazine derivatives effects on experimental tachyarrithmias<br />
Kristina Sarkisyan, (Russian Federation), M Ivashev<br />
Elucidation of the mechanism that sulfaphenazole suppresses cardiac ischemia-reperfusion injury.<br />
Analysis using sulfaphenazole derivatives<br />
Masaya Sekine, (Japan), A Hamaguchi, Y Kobayashi, Y Ishihara, M Nakazawa, N Shimamoto<br />
Tetramethylpyrazine inhibits rat left ventricular hypertrophy induced by abdominal aorta coarctation:<br />
Involvement of calcineurin<br />
Jing-Shan Shi, (PR China), J Deng, Q Wu, Y Gao, X-N Huang<br />
Investigation of anilocain and lidocain antiarrhythmic action on the barium chloride arrhythmia model<br />
Tatjana A Skorobogatova, (Russian Federation), VI Pantsurkin, MN Ivashev,<br />
Mechanism of the anti-hypertrophic action of RGS2 in cardiomyocytes<br />
Alina J Sobiesiak, (Canada), CH Nguyen, P Chidiac<br />
Effects of reduction of sympathetic nervous tone on ventrical myocytes contraction and the response<br />
of β1 and β2 adrenoceptor to isoprenaline in the aged rats<br />
Hong Sun, (PR China), Z Zhao, L Gao, Q Wu, Y Hao, C Xu, Y Sun, C Yan<br />
The pharmacokinetics and pharmacodynamics of biomarkers in patients with left ventricular systolic<br />
dysfunction (LVSD) and CHF treated with eplerenone<br />
John Vincent, (USA), J Cumps, F Zannad, J Ketelslegers<br />
Attenuation of ischemia-induced Ca2+ overload and LV mechanical dysfunction by inhibitors of late INa<br />
Lianguo Wang, (Canada), B Vacher, B Le Grand, A Clanachan<br />
Protective effect of rutaecarpine against myocardial hypertrophy in rats<br />
Qin Wu, (PR China), L Deng, X-N Huang, J-S Shi<br />
LDL increases vascular ETB2 receptor expression via activation of ERK1/2 and p38 MAPK pathways<br />
Cang-Bao Xu, (Sweden), J-P Zheng, Y Zhang, W Zhang, L Edvinsson<br />
Mechanism of improvement in vagal activity against myocardial ischemic injury<br />
Wei-Jin Zang, (PR China), L Sun, D-L Li, S-S Kong, H-K Jiang, Y-H Wang, X-J Yu<br />
Mechanism of improvement in vagal activity against myocardial ischemic injury<br />
Wei-Jin Zang, (PR China), L Sun, D-L Li, S-S Kong, H-K Jiang, Y-H Wang, X-J Yu<br />
212 Tuesday 20 July ■ 13:00 - 14:00 ■ Poster Area
FC06<br />
The heart gone wrong; stabilization of cardiac<br />
function<br />
Tue 188<br />
Tue 189<br />
Dose-dependent drug-drug interaction between paracetamol and warfarin in adults receiving long-term<br />
oral anticoagulants<br />
Q Zhang, G Simoneau, L Drouet, C Bal-dit-Sollier, J-C Alvarez, I Mahé, J-F Bergmann,<br />
Stephane Mouly, (France)<br />
Amoxicillin/clavulanic acid did not increase INR in patients treated with warfarin<br />
Q Zhang, G Simoneau, C Verstuyft, L Drouet, C Bal-dit-Sollier, J-C Alvarez, J-F Bergmann,<br />
L Becquemont, Stephane Mouly, (France)<br />
Monday 19 July ■ 13:00 - 14:00 ■ Poster Area 213
FC07<br />
Simulation and data modelling in drug development.<br />
Better drugs faster<br />
Tue 190<br />
Tue 191<br />
Tue 192<br />
Tue 193<br />
Tue 194<br />
Tue 195<br />
Tue 196<br />
Tue 197<br />
Tue 198<br />
Infliximab pharmacokinetics in rheumatoid arthritis is influenced by body surface area, erythrocyte<br />
sedimentation rate, methotrexate and antibodies towards infliximab<br />
Gilles Paintaud, (France), E Ducourau, T David, C Anca, LG Benoît, P Aleth, D Valérie, S-G Elisabeth,<br />
G Philippe, M Denis<br />
Pharmacokinetics of florfenicol following a single SC injection in calves<br />
Ali Rassouli, (Iran), P Lees, P Sidhu<br />
New approach for fitting of data of fluorescence anisotropy and intensity for characterization of ligand<br />
binding to melanocortin 4 receptors<br />
Ago Rinken, (Estonia), S Veiksina, S Kopanchuk<br />
α2 adrenoceptor distribution in pig brain, mapped with radiolabeled yohimbine by means of positron<br />
emission tomography<br />
A Rodell, S Jakobsen, Albert Gjedde, (Denmark)<br />
Design of novel and selective HDAC8-inhibitors as anticancer agents<br />
Barij Nayan Sinha, (India), V Jayaprakash<br />
7TM-homology modelling of long form of human and rat D2 dopamine receptor and validation for<br />
evaluating ligands recognition<br />
Marvin A Soriano-Ursúa, (Mexico), JO Ocampo-López, JG Trujillo-Ferrara, J Correa-Basurto<br />
The RAAS hypertension PhysioLab platform: A systems modelling approach to hypertension<br />
Antoine Soubret, (Switzerland), A Sarkar, M Hallow, B Bieth, A Georgieva, A Lo, J Beh, S Ermakov,<br />
S Ramanujan, M Rodrigo, D Keefe, A Charney<br />
Influence of non-compliance on antimicrobial therapy with levofloxacin based on pharmacokinetic/<br />
pharmacodynamic simulation<br />
Maria Elena Suarez Gonzalez, (Spain), N Carral, R Calvo Duo, J Lukas<br />
Methotrexate influences neither pharmacokinetics nor concentration-effect relationship of infliximab in<br />
ankylosing spondylitis<br />
David Ternant, (France), F Lauferon, D Mulleman, D Wendling, E Ducourau, J-P Valat, P Goupille,<br />
G Paintaud<br />
214 Tuesday 20 July ■ 13:00 - 14:00 ■ Poster Area
FC08<br />
Developments in the treatment of sexual<br />
dysfunction and diseases of the lower urinary tract<br />
Tue 199<br />
Tue 200<br />
Tue 201<br />
Tue 202<br />
Tue 203<br />
Tue 204<br />
Tue 205<br />
Tue 206<br />
Tue 207<br />
Tue 208<br />
Tue 209<br />
Tue 210<br />
Tue 211<br />
Tue 212<br />
Tue 213<br />
Regulation of urothelial spontaneous contractile activity<br />
Christian Moro, (Australia), R Chess-Williams<br />
The relationship between hyperlipidemia-induced erectile dysfunction and serum ADMA levels in a time<br />
dependent manner<br />
N Murat, A Toylu, Atiye Sinem Evcim, (Turkey), BC Soner, O Demir, B Irer, T Demir, N Atabey,<br />
S Gidener, AA Esen<br />
Alteration of carbachol-induced prostate contraction in adiponectin transgenic mice<br />
Koji Nobe, (Japan), A Fujii, T Negoro, K Saito, Y Nakano, T Hashimoto, K Honda<br />
The effect of testosterone on intracellular calcium and cAMP in human cultured prostatic stromal cells<br />
Victoria Oliver, (Australia), C Anderson, J Haynes<br />
Comparison of the effects of AdTx1 and tamsulosin on the increase in intra-urethral and arterial<br />
pressures induced by phenylephrine in anesthetized male rats<br />
Stefano Palea, (France), N Gilles, V Guilloteau, M Guérard, P Lluel<br />
Stimulation of β3-adrenoceptors inhibits EFS-induced contractions of human isolated urinary bladder<br />
M Rekik, C Rouget, P Camparo, H Botto, P Lluel, T Westfall, Stefano Palea, (France)<br />
Involvement of both β2- and β3-adrenoceptors in the inhibition of neurogenic contractions of mouse<br />
isolated urinary bladder<br />
C Rouget, T Westfall, M Rekik, P Lluel, Stefano Palea (France)<br />
Stimulation of both both β2- and β3-adrenoceptors produces relaxation of KCl-induced contractions of<br />
mouse isolated urinary bladder<br />
C Rouget, T Westfall, M Rekik, P Lluel, Stefano Palea, (France)<br />
Effect of psychotropic drugs (Fluoxetine and Mirtazapine) on Phenylephrine-induced rat vas deferens<br />
contractility<br />
Cristina Sampayo, (Portugal), I Silva, R Pinto, B Silva-Lima<br />
Interaction between nitric oxide and dopaminergic transmission in the peripheral control of penile<br />
erection<br />
Amira Senbel, (Egypt)<br />
Acute toxicity studies and phytochemical screening of an erectile dysfunction herbal treatment;<br />
Kosteletzskya begoniifolia (Ulbr)<br />
Julius Kihdzee Tanayen, (Uganda), J Oloro, AA Ganafa<br />
Expression of phosphodiesterase (PDE) isoenzymes PDE4, PDE5 and PDE11 in the human seminal<br />
vesicles – an immunohistochemical study<br />
Stefan Ückert, (Germany), J Sonnenberg, V Steffenhagen, M Kuczyk, P Hedlund<br />
Is there a significance of the cyclic AMP specific phosphodiesterase 4 (PDE4) in the control of prostate<br />
smooth muscle A functional and biochemical approach<br />
Stefan Ückert, (Germany), D Schönfeld, G Kedia, M Kuczyk<br />
Rho-kinase related proteins in human vaginal arteries – functional and immunohistochemical studies<br />
Stefan Ückert, (Germany), E Waldkirch, M Kuczyk, P Hedlund<br />
Impaired Ca 2+ handling in penile arteries from prediabetic Zucker rats: Involvement of Rho-kinase<br />
N Villalba, A García-Sacristán, M Hernández, Dolores Prieto, (Spain)<br />
Tuesday 20 July ■ 13:00 - 14:00 ■ Poster Area 215
FC08<br />
Developments in the treatment of sexual<br />
dysfunction and diseases of the lower urinary tract<br />
Tue 214<br />
Tue 215<br />
Tue 216<br />
Tue 217<br />
Tue 218<br />
On human relevancy of pharmco-toxicological experiments on example of genito-urology<br />
Ursula Welscher, (Germany), J Stiglmayr, J Milbradt, E Neu, HW Bauer, R Wilkowski, N Moro,<br />
MC Michailov, R Schätzle, L Zebuhr, W Seidenbusch, J Foltinova<br />
Characterisation of the muscarinic receptor subtype mediating contraction in the mouse prostate gland<br />
Carl White, (Australia), J Short, S Ventura<br />
Is phytotherapy effective for the urinary dysfunction in patients with benign prostatic hypertrophy<br />
Shizuo Yamada, (Japan), M Abe, Y Ito, S Onoue<br />
Noninvasive evaluation of brain muscarinic receptor occupancy of oxybutynin, darifenacin and<br />
imidafenacin in rats by positron emission tomography<br />
Shizuo Yamada, (Japan), A Yoshida, Y Ito, H Tsukada<br />
Prostatoprotective activity of bee pollen lipophilic extract<br />
Ganna V Zaychenko, (Ukraine), S Gevoyan<br />
216 Tuesday 20 July ■ 13:00 - 14:00 ■ Poster Area
FC09<br />
Inflammation and immunopharmacology:<br />
New tools for old diseases<br />
Tue 219<br />
Tue 220<br />
Tue 221<br />
Tue 222<br />
Tue 223<br />
Tue 224<br />
Tue 225<br />
Tue 226<br />
Tue 227<br />
Tue 228<br />
Tue 229<br />
Tue 230<br />
Tue 231<br />
Tue 232<br />
Tue 233<br />
Tue 234<br />
Lipopolysaccharide induced changes of liver function in μ-opioid-receptor-wildtype and -knockout mice<br />
Amelie Lupp, (Germany), S Schulz<br />
Cerebral ischemia induces micro vascular pro-inflammatory cytokine expression via the MEK/ERK<br />
pathway<br />
Aida Maddahi, (Sweden), L Edvinsson<br />
Pharmacological evaluation of clinically active compounds in a model of cystic fibrosis related<br />
inflammation<br />
Rangan Maitra, (USA), A Giddings, J Tajuba<br />
Malnutrition and biomarkers of inflamation in elderly patients<br />
Eva Mala, (Czech Republic), E Buresova, J Novosad, I Krcmova, J Krejsek, M Pliskova, L Sobotka,<br />
I Urbanova<br />
Clavulanic acid reduces neutrophil infiltration and oedema response in carrageenan-induced acute<br />
inflammation<br />
Nasrin Maleki-Dizaji, (Iran), A Banani, A Garjani, H Hamishehkar, A Fakhrjou<br />
Association of genetic polymorphisms of eNOS and iNOS with immune sensitization in asthmatic<br />
children<br />
Vangelis G Manolopoulos, (Greece), M Iordanidou, A Tavridou, E Paraskakis, A Chatzimichael<br />
Paradoxical influences of mTOR inhibitor everolimus on progressive renal failure<br />
Satohiro Masuda, (Japan), S Nakagawa, K Nishihara, K Inui<br />
Effect of valsartan on bone loss in periodontal disease induced by lipopolysaccharides in the rat<br />
Maria Gabriela Matos, (Venezuela), L Perdomo, M Alvarez, M Varela, A Stern, M del Rosario Garrido<br />
Inhibitor of apoptosis proteins (IAPs) as novel targets in inflammatory processes of endothelial cells<br />
Bettina Mayer, (Germany), C Reichel, F Krombach, S Zahler, A Vollmar, R Fürst<br />
Administration of edoxaban, an oral factor Xa inhibitor, is safe in healthy subjects post warfarin<br />
treatment- encore abstract<br />
Jeanne Mendell, (USA), R Noveck, I Rubets, M Shi<br />
A novel mechanism for neutrophil trapping in endotoxemic hepatic microvasculature: Downregulation of<br />
β-2 integrin via IL-10<br />
Gustavo Menezes, (Brazil), W-Y Lee, H Zhou, C Waterhouse, D Cara, P Kubes<br />
Agonist-mediated changes in intracellular calcium in human bronchial epithelial cells<br />
P Menon, K Varanou, Ian McFadzean, (UK)<br />
The enhancement of pentylenetetrazole-induced seizure threshold in mice via cyclooxygenase-2<br />
inhibition by nimesulide<br />
Azam Mesdaghinia, (Iran), A Heydari, P Khazaee, H Yazdanpanah<br />
Cannabinoid receptor activation inhibits smooth muscle cell proliferation and endothelial cytokine<br />
production<br />
Lisa Michel, (UK), K Skene, S Teixeira, E Hector, H Vosper, C Wainwright<br />
Expression of 5-HT receptors by human immune cells: Impact of physiological activation<br />
Sarah Milton, (UK), A Butler, J Curnow, J Gordon, N Barnes<br />
Aqueous cigarette tar extract causes marked bronchial smooth muscle hyperresponsiveness in rats<br />
Miwa Misawa, (Japan), A Watanabe, A Fujita, H Sakai, J Kamei, Y Chiba<br />
Tuesday 20 July ■ 13:00 - 14:00 ■ Poster Area 217
FC09<br />
Inflammation and immunopharmacology:<br />
New tools for old diseases<br />
Tue 235<br />
Tue 236<br />
Tue 237<br />
Tue 238<br />
Tue 239<br />
Tue 240<br />
Tue 241<br />
Tue 242<br />
Tue 243<br />
Tue 244<br />
Tue 245<br />
Tue 246<br />
Tue 247<br />
Tue 248<br />
TRPA1 agonists iodoacetate and allyl isothiocyanate induce COX-2 expression in chondrocyte and<br />
macrophage cell lines<br />
Lauri Moilanen, (Finland), R Nieminen, E Moilanen<br />
Effect of Helicobacter pylori infection on the adherens junctions of gastric parietal cells in Mongolian<br />
gerbils<br />
Motonobu Murakami, (Japan), Y Tamura, Y Kuroda, A Sugiyama, A Nakagiri, K Tsuchida, K Amagase,<br />
K Takeuchi<br />
Up-regulation of survivin expression in simvastatin treated rats in endotoxic shock<br />
Lana Nezic, (Bosnia and Herzegovina), L Amidzic, R Skrbic, SS Satara, N Stojakovic<br />
Adenosine A2α agonist and A2β antagonist mediate an inhibition of inflammation-induced contractile<br />
disturbance of a rat gastrointestinal preparation<br />
Karen Nieber, (Germany), C Warstat, S Michael, L Yan, CE Müller<br />
Gold-containing DMARDs inhibit COX-2, MMP-3 and IL-6 expression in chondrocytes by increasing MKP-1<br />
expression and decreasing p38 phosphorylation<br />
Riina Nieminen, (Finland), R Korhonen, T Moilanen, AR Clark, E Moilanen<br />
Stimulation of macrophages by INFα in combination with LPS leads to effective elimination of<br />
F. tularensis experimental infection<br />
J Novosad, Eva Mala, (Czech Republic), M Holicka, M Novosadova, I Krcmova, J Krejsek<br />
Evaluation of antioxidant and anti-inflammatory effects of flavonoids and metal-flavonoids complexes<br />
Cristina Okuyama, (Brazil), D de Oliveira, C Miyashiro, R Pereira<br />
Epac and PKA inhibit cigarette smoke-induced production of IL-8 in airway smooth muscle cells<br />
Anouk Oldenburger, (The Netherlands), SS Roscioni, E Jansen, MH Menzen, AJ Halayko, H Meurs,<br />
M Schmidt<br />
Lipopolysaccharide stimulates diabetic gingival fibroblast to express TGF-β via MIP-2. Role of PI3K<br />
Sandra HP Oliveira, (Brazil), A Tamae, MA Machado<br />
COX imaging by PET with 11C-labeled nonsteroidal anti-inflammatory drugs (NSAIDs)<br />
Hirotaka Onoe, (Japan), M Shukuri, M Takashima-Hirano, M Goto, T Takashima, T Keiko, Y Watanabe,<br />
H Doi, M Suzuki<br />
The effect of terpenes on skin absorption of tiaprofenic acid gel Ex vivoand in vivo in rats<br />
Zeliha Pala Kara, (Turkey), A Okyar, M Nuriyev, A Yýldýz, N Öztürk<br />
Histological study of bone healing in rats after treatment with parecoxib<br />
Paraskevi Papaioannidou, (Greece), P Akritopoulos, M Dermentzopoulou, H Hatzokos, E Iosifidou,<br />
M Kotoula, V Mirtsou<br />
Anti-inflammatory properties of a dual PPAR γ/α agonist muraglitazar in in vitro and in vivo models<br />
Erja-Leena Paukkeri, (Finland), M Lindholm, T Leppänen, PH Aulaskari, MF Yam, MZ Asmawi,<br />
E Moilanen<br />
Metallic gold improves clinical outcome, induces neuroprotective astrocytosis and evokes stem cell<br />
response in an EAE rat model of multiple sclerosis<br />
Dan Sonne Pedersen, (Denmark), A Larsen, PM Fredericia, MØ Pedersen, M Stoltenberg, J Rungby,<br />
M Penkowa<br />
218 Tuesday 20 July ■ 13:00 - 14:00 ■ Poster Area
FC09<br />
Inflammation and immunopharmacology:<br />
New tools for old diseases<br />
Tue 249<br />
Tue 250<br />
Tue 251<br />
Tue 252<br />
Tue 253<br />
Tue 254<br />
Tue 255<br />
Tue 256<br />
Tue 257<br />
Tue 258<br />
In vitro and in vivo effects of WIN55,212 on exocrine pancreas in physiological condition and during<br />
acute pancreatitis<br />
Carla Petrella, (Italy), S Alemà, S Agostini, M Broccardo, P Casolini, C Giuli, F Carpino, G Improta<br />
Investigation of anti-inflammatory and anti-nociceptive effects of a non-peptide somatostatin 4 receptor<br />
agonist TEZ-321<br />
Erika Pinter, (Hungary), Z Helyes, T Szuts, G Keri, A Kemeny, K Sandor, K Elekes, E Szoke, T Bagoly,<br />
Z Hegedus, J Szolcsanyi<br />
Is severity of clinical manifestations following H lepturus envenomation relates to serum TNF-α level<br />
Mohammad Hassan Pipelzadeh, (Iran), A Jalali, A Ahmadzadehd, A Khodadadi, M Makvandi, M Taraz<br />
Dual effect of antagonist K-14585 on PAR-2 pro-inflammatory signalling<br />
Robin Plevin, (UK), F Goon Goh, PY Ng<br />
Mildronate regulates iNOS and myelin expression in the rat model of experimental autoimmune<br />
encephalomyelitis<br />
Jolanta Pupure, (Latvia), J Rumaks, N Karajeva, S Isajevs, B Jansone, S Svirskis, V Klusa<br />
Association between polymorphisms of IL-4 receptor α chain gene and plasma IgE levels in Malaysian<br />
asthmatics<br />
Vijaya Lechimi Raj, (Malaysia), R Nai, AK Radhakrishnan, CK Liam, MR Mustafa<br />
Irinotecan-induced intestinal mucositis: Role of cytokines on inducible nitric oxide synthase activation<br />
Ronaldo A Ribeiro, (Brazil), MHLP Souza, GAC Brito, RB Oriá, FQ Cunha, DVT Wong, RCP Lima-Júnior<br />
Angiotensin II promotes cytokine production in human podocytes<br />
Arianna Carolina Rosa, (Italy), L Rattazzi, G Miglio, R Fantozzi<br />
α-pinene inhibits interleukin-1-induced nitric oxide production by NF-κB-dependent and independent<br />
mechanisms in human chondrocytes<br />
Susana Rosa, (Portugal), J Goncalves, F Judas, L Salgueiro, C Cavaleiro, C Lopes, AF Mendes<br />
Preventive effect of 5-HT1A receptor agonist Buspirone on mesenteric ischemia/reperfusion-induced<br />
inflammatory injuries in mice<br />
F Saccani, L Flammini, T Gobbetti, G Vegezzi, P Ghizzardi, S Bertoni, M Tognolini, V Ballabeni,<br />
Elisabetta Barocelli, (Italy)<br />
Tue 259 Angiotensin II induces hyperresponsiveness of bronchial smooth muscle via an activation of p42/44<br />
ERK in rats<br />
Hiroyasu Sakai, (Japan), Y Chiba, M Hanazaki, M Misawa<br />
Tue 260<br />
Tue 261<br />
Tue 262<br />
Tue 263<br />
Dual roles of the PGE2-EP4 signalling in mouse experimental autoimmune encephalomyelitis<br />
Daiji Sakata, (Japan), Y Esaki, Y Li, C Yao, E Segi-Nishida, T Matsuoka, K Fukuda, S Narumiya<br />
Drug prescription after third molar removal: A retrospective study in the Faculty of Dental Medicine of<br />
the University of Porto/Portugal<br />
Carlos Santos, (Brazil), A Calvo, T Dionísio, JR Lauris, MH Fernandes, A Felino<br />
Induction of duodenal ulcers by selective cyclo- oxygenase (COX)-1 and COX-2 inhibitors in cats<br />
Hiroshi Satoh, (Japan), K Amagase, K Takeuchi<br />
Analysis of various biological responses induced by Helicobacter pylori extract: Independent of<br />
proteinase-activated receptors<br />
Fumiko Sekiguchi, (Japan), Y Maeda, Y Matsumoto, M Matsunami, H Nishikawa, A Kawabata<br />
Tuesday 20 July ■ 13:00 - 14:00 ■ Poster Area 219
FC09<br />
Inflammation and immunopharmacology:<br />
New tools for old diseases<br />
Tue 264<br />
Tue 265<br />
Tue 266<br />
Tue 267<br />
Tue 268<br />
Tue 269<br />
Tue 270<br />
Tue 271<br />
Tue 272<br />
Tue 273<br />
Tue 274<br />
Tue 275<br />
Tue 276<br />
Tue 277<br />
Tue 278<br />
Novel selective COX-2 inhibitor pyrazole derivative proven effective as anti-inflammatory and analgesic<br />
drug<br />
Amira Senbel, (Egypt), MM Mohy El-Din, AA Bistawros, A El-Mallah, NA Nour El-Din, AA Bekhit,<br />
H Abdel Razek<br />
Involvements of RhoA geranylgeranylation in the pathogenesis of allergic bronchial asthma<br />
Aya Shibuya, (Japan), S Sato, Y Chiba, M Misawa<br />
Changes of inflammatory cytokines in rats with naturally occurring gingivitis<br />
Mitsuko Shinohara, (Japan), A Hidaka, K Iwamoto, K Ohura<br />
The influence of ramipril on the inflammation markers and the immediate prognosis of myocardial<br />
infarction<br />
Anton Skotnikov, (Russian Federation), A Vertkin<br />
Sustained improvement of glycemic control reduces urinary leukotriene E4 excretion in patients with<br />
type 1 diabetes<br />
Françoise Stanke, (France), R Boizel, G Bruttmann, PY Benhamou, S Halimi<br />
Novel Pan-JAK inhibitor shows efficacy in both steroid sensitive and steroid insensitive inflammatory<br />
pathway<br />
Laurie Stevens, (UK), P Fenwick, W Liu, I Kilty, M Yeadon, L Donnelly<br />
Development of an in vitro model to investigate changes in kidney-derived exosomes with disease<br />
Jonathan M Street, (UK), M Bailey, F Frame, TS Walsh, DJ Webb, JW Dear<br />
Investigation of the role of TRPV1 capsaicin receptors and tachykinins in dextrane-sulphate induced<br />
mouse colitis model<br />
Istvan Szitter, (Hungary), E Pinter, G Pozsgai, K Sandor, A Kemeny, A Perkecz, K Elekes, Z Helyes,<br />
J Szolcsanyi, J Quinn<br />
Prostaglandin E2 inhibits advanced glycation end products-induced activation of human monocytes<br />
Hideo Takahashi, (Japan), K Liu, H Wake, S Mori, M Nishibori<br />
IL-16 accelerates cell proliferation mediated by ERK- cyclin D1 pathway in hepatocellular carcinoma<br />
Yuko Takeba, (Japan), N Matsumoto, T Kumai, M Watanabe, Y Kinoshita, S Kobayashi<br />
Roles of prostaglandins, nitric oxide and enterobacteria in pathogenesis of ischemic enteritis in rats<br />
Koji Takeuchi, (Japan), S Kojima, A Kuki, Y Nakamori, Y Komatsu, T Kotani<br />
New roles for kinin B1 receptor in the control of core temperature<br />
Sébastien Talbot, (Canada), H de Brito Gariépy, R Couture<br />
The study of effects of psychotropic drug Ladasten on LPS-induced changes cytokines profile and<br />
behavior in mice C57Bl/6<br />
Anna Tallerova, (Russian Federation), L Kovalenko, E Shipaeva, M Yarkova, A Durnev, S Seredenin<br />
Inhibitory effects of (3S)-7-(3,4-dihydroxyphenyl)-1-phenyl-(1E)-1-hepten-3-ol, a novel compound isolated<br />
from Curcuma comosa on nitric oxide and prostaglandin E2 production in lipopolysaccharide-induced<br />
microglial activation<br />
Anusorn Thampithak, (Thailand), Y Jaisin, B Meesarapee, N Poopyruchpong, Y Sanvarinda<br />
MKP-1 negatively regulates the expression of IL-8, IL-6 and COX-2 in human A549 epithelial cells<br />
Tuija Turpeinen, (Finland), R Nieminen, E Moilanen, R Korhonen<br />
220 Tuesday 20 July ■ 13:00 - 14:00 ■ Poster Area
FC09<br />
Inflammation and immunopharmacology:<br />
New tools for old diseases<br />
Tue 279<br />
Tue 280<br />
Tue 281<br />
Tue 282<br />
Tue 283<br />
Tue 284<br />
Tue 285<br />
Tue 286<br />
Tue 287<br />
Tue 288<br />
Tue 289<br />
Tue 290<br />
Tue 291<br />
Tue 292<br />
Tue 293<br />
The antimicrobial properties of 8-hydroxyquinoline derivatives and interaction with vitamin B12<br />
Robyn L van Zyl, (South Africa), M McLaverty, SF van Vuuren<br />
GLPG0259, a small molecule kinase inhibitor being developed for rheumatoid arthritis, shows good<br />
safety, tolerability and pharmacokinetics in healthy volunteers<br />
Frédéric Vanhoutte, (Belgium), J Beetens, L Gheyle, E Vets, W Haazen, F Namour, N Vandeghinste,<br />
S Blockhuys, P Wigerinck<br />
Minocycline reverses behavior and neurochemical changes in the model of global brain ischemia in rats<br />
Glauce SB Viana, (Brazil), AGG de Carvalho, AVB Peixoto, CCB Bezerra<br />
Minocycline reverts neurochemical and behavior alterations in the PD model of 6-OHDA-induced striatal<br />
lesions in rats<br />
Glauce SB Viana, (Brazil), PLF Tavares, IPP Xavier, IR Holanda, GM de Andrade<br />
Proinflammatory and catabolic role of adipokines leptin and adiponectin in arthritis<br />
Katriina Vuolteenaho, (Finland), A Koskinen, S Juslin, R Nieminen, T Moilanen, E Moilanen<br />
Identification of a selective antagonist for prostaglandin (PG) E2-glyceryl ester: AGN-217673<br />
J Wang, David Woodward, (USA), L Ford, R Ross, M Rogers<br />
Tumor necrosis factor-related apoptosis inducing ligand promotes early atherogenesis in<br />
apolipoprotein(E)-deficient mice<br />
Yan Wang, (PR China), F Jiang, Y Zhang, C Zhang, Y Zhao<br />
R-flurbiprofen reverses multidrug resistance, proliferation and metastasis in gastric cancer cells by<br />
p75NTR induction<br />
Zhipeng Wang, (PR China), H Jin, Q Mei, D Fan<br />
Possible involvement of Src family kinases in the rat bronchial smooth muscle contraction<br />
Yu Watanabe, (Japan), H Sakai, Y Chiba, M Misawa<br />
B lymphocyte stimulator receptors and autoimmune diseases<br />
Wei Wei, (PR China)<br />
Expression and functionality of leptin receptor (Ob-R) in the human near-term myometrium<br />
Maeva Wendremaire, (France), F Lirussi, M Sediki, F Goirand, C Peyronel, S Lionnais-Couvreur,<br />
M Dumas, P Sagot, M Bardou<br />
Leptin prevents LPS-induced apoptosis in an in vitro human model of myometrial inflammation<br />
Maeva Wendremaire, (France), F Lirussi, M Sediki, F Goirand, S Lionnais-Couvreur, C Peyronel,<br />
M Dumas, P Sagot, M Bardou<br />
Carnosol modulates NF-κB activity by dual mechanisms in endothelial cells<br />
Being-Sun Wung, (Taiwan)<br />
Phosphodiesterase 4 inhibition attenuates nicotine-induced airway hyperresponsiveness to kinin<br />
receptor agonists<br />
Yuan Xu, (Sweden), Y Zhang, L-O Cardell<br />
TLR4-dependent induction of VCAM-1 in rheumatoid arthritis synovial fibroblasts: roles of cPLA2/COX-2<br />
Chuen-Mao Yang, (Taiwan), H-L Hsieh<br />
Tuesday 20 July ■ 13:00 - 14:00 ■ Poster Area 221
FC09<br />
Inflammation and immunopharmacology:<br />
New tools for old diseases<br />
Tue 294<br />
Tue 295<br />
Tue 296<br />
Tue 297<br />
Tue 298<br />
Tue 299<br />
Tue 300<br />
Prostaglandin E2-EP4 signalling promotes immune inflammation through Th1 cell differentiation and<br />
Th17 cell expansion<br />
Chengcan Yao, (Japan), D Sakata, Y Esaki, Y Li, T Matsuoka, K Kuroiwa, Y Sugimoto, S Narumiya<br />
Carboxyamidotriazole inhibited the secretion of pro-inflammation cytokines and the expression of iNOS<br />
in macrophages of adjuvant arthritis rats<br />
Caiying Ye, (PR China), D Zhang, R Zheng, L Guo<br />
The effect of carboxyamidotriazole on dextran sulphate sodium induced mouse experimental ulcerative<br />
colitis<br />
Dechang Zhang, (PR China), C Ye, X Hao, R Zheng<br />
Anti-inflammatory activity of a novel natural salicylate derivative from Gaultheria yunnanensis (FRANCH.)<br />
REHDER<br />
Tiantai Zhang, (PR China), L Sun, R Liu, X Lan, JH Sun, GH Du<br />
Up-regulation of kinin receptors in rat bronchi via IκB kinase-mediated inflammatory signalling pathway<br />
Yaping Zhang, (Sweden), Y Lei, Y-X Cao, L Edvinsson, C-B Xu<br />
Artesunate potentiates antibacterial effects of antibiotics in vitro and in vivo by increased accumulation<br />
of antibiotics via an inhibition on drug efflux pumps, AcrAB-TolC and MdtABC<br />
Hong Zhou, (PR China), BL Li, Q Yao, R Zhang, X Pan, J Li, G Ding, X Liu, C Wu, J Zheng<br />
Interference of newly developed antivirals with activity of immune system<br />
Zdenek Zídek, (Czech Republic), E Kmonícková, A Holý<br />
222 Tuesday 20 July ■ 13:00 - 14:00 ■ Poster Area
FC13<br />
Maximising benefits and minimizing harms from<br />
drugs<br />
Tue 301<br />
Tue 302<br />
Tue 303<br />
Tue 304<br />
Tue 305<br />
Tue 306<br />
Tue 307<br />
Tue 308<br />
Tue 309<br />
Tue 310<br />
Tue 311<br />
Tue 312<br />
Tue 313<br />
Tue 314<br />
Tue 315<br />
Tue 316<br />
Molecular determinants of warfarin pharmacokinetics and response<br />
Inna Gong, (Canada), R Tirona, U Schwarz, N Crown, G Dresser, S LaRue, N Langlois, A Lazo-Langner,<br />
P Wells, R Kim<br />
Determination of the rate of release of ibuprofen and dexibuprofen via topical route<br />
AVM González, G Ccalleja, Liliana Bautista Chávez, (Spain), JJT Durán, PB Papantonakis, ST Durán<br />
Covariate analysis of T-wave morphology and QTc prolongation: new insights into drug-induced ECG<br />
changes<br />
Claus Graff, (Denmark), E Toft, J Matz, JK Kanters, MP Andersen, J Nielsen, JJ Struijk<br />
Imatinib determination in human serum by high-performance liquid chromatography<br />
Paula Granic, (Croatia), D Sertic, M Lovric, Z Lalic, N Bozina, B Labar, J Sertic<br />
Impact of CYP2C9, CYP2C19 and VKORC1 polymorphisms on acenocoumarol time-to-achieve stability<br />
Liliane Gschwind, (Switzerland), V Rollason Gumprecht, M Rebsamen, V Nepote, P Bonnabry,<br />
F Boehlen, C Combescure, P Francis, P Chopard, P Dayer, J Desmeules<br />
Quality-analysis of aminoglycoside therapy in children at a Belgian university hospital<br />
Evelien Haegeman, (Belgium), P De Cock, N Goerlandt, P Vanhaesebrouck, V Stove, A Verstraete,<br />
P Schelstraete, H Robays<br />
Neuroprotective and antitremor effect of Baicalein against 6-OHDA-induced experimental Parkinsonism<br />
Guorong He, (PR China), X Mu, X Li, X Yu, K Wang, G Du<br />
Fluconazole-induced intoxication with phenytoin in a patient with ultra-high activity of CYP2C9<br />
Anders Helldén, (Sweden), U Bergman, K Engström Hellgren, I Nilsson Remahl, I Odar-Cederlöf,<br />
M Ramsjö, L Bertilsson<br />
Gentamicin pharmacokinetics and dosing in older people: Is frailty a factor<br />
Sarah Hilmer, (Australia), K Tran, P Rubie, J Wright, S Matthews, D Gnjidic, P Carroll<br />
Can drug removals involving cyclooxygenase inhibitors be avoided Results from volunteer studies<br />
using ex vivo whole blood analyses<br />
Burkhard Hinz, (Germany), K Brune<br />
Association of genetic variants of UGT1A1 gene with serum bilirubin level in the Japanese<br />
Akira Hirasawa, (Japan), T Akahane, T Tsuruta, K Saito, T Zama, Y Tanigawara, N Susumu, D Aoki<br />
Pharmacokinetics, tolerability, and safety of almorexant in Japanese and Caucasian healthy male<br />
subjects<br />
Matthias Hoch, (Switzerland), P Hoever, F Alessi, J Marjason, J Dingemanse<br />
Potentially inappropriate medication in a German stroke cohort<br />
S Holt, Jacek Szymanski, (Germany), C Diederichs, PA Thürmann, K Berger<br />
A German list of potentially inappropriate medication in the elderly<br />
S Holt, Petra A Thürmann, (Germany), S Schmiedl<br />
Pharmacokinetic drug interaction of enoxacin and tizanidine via CYP1A2 inhibition<br />
Masato Homma, (Japan), K Momo, T Kobayashi, Y Kohda<br />
Strong inhibition of CYP2C8 within 1 hour after gemfibrozil dosing: Estimation of the onset of CYP2C8<br />
inactivation using repaglinide as an in vivo probe<br />
Johanna Honkalammi, (Finland), M Niemi, PJ Neuvonen, JT Backman<br />
Tuesday 20 July ■ 13:00 - 14:00 ■ Poster Area 223
FC13<br />
Maximising benefits and minimizing harms from<br />
drugs<br />
Tue 317<br />
Tue 318<br />
Tue 319<br />
Tue 320<br />
Tue 321<br />
Tue 322<br />
Tue 323<br />
Tue 324<br />
Tue 325<br />
Tue 326<br />
Tue 327<br />
Tue 328<br />
Tue 329<br />
Tue 330<br />
Tue 331<br />
Tue 332<br />
The expression of 14-3-3 subtypes in uterine leiomyoma<br />
Ouping Huang, (PR China), SF Fang, L Wang, D Yin, B Yi, L Tang, M He<br />
Effect of losartan on metabolism of arachidonic acid in human liver microsomes<br />
Nobuo Inotsume, (Japan), T Toda, K Sakamoto, S Takeuchi, T Hayakawa, B Ask, E Eliasson, A Rane<br />
Pharmacokinetics and dosage regimen of ciprofloxacin following single intramuscular administration in<br />
Sahiwal cattle<br />
Zahid Iqbal, (Pakistan), A Basit, I Javed, IU Jan, UA Khan<br />
Inhibitory effects of OTC-drugs on cytochrome P450 in human liver microsome<br />
Mariko Iwase, (Japan), Y Nishimura, N Kurata, Y Saito, N Uchida, H Yasuhara<br />
Amoxicillin pharmacokinetics in patients with aspiration pneumonia as a complication of overdosage<br />
with psychotropic drugs: a pilot study<br />
Dusan Jandric, (Republic of Serbia), V Dragojevic-Simic, B Ciric, D Jovanovic, V Kilibarda, S Vucinic,<br />
S Dobric<br />
Total and free clearance of R- and S-warfarin in elderly people<br />
Berit P Jensen, (New Zealand), P Chin, RR Roberts, J Maddison, EJ Begg<br />
CYP2C9*3 and *13 alleles significantly affected the pharmacokinetics of meloxicam in healthy subjects<br />
Kyeong-Joo Jeon, (Republic Of South Korea), C-I Choi, J-W Bae, M-J Kim, C-G Jang, S-Y Lee<br />
The role of CYP2C9 genetic variants in the disposition of glipizide in healthy subjects<br />
Kyeong-Joo Jeon, (Republic Of South Korea), C-I Choi, J-W Bae, M-J Kim, C-G Jang, S-Y Lee<br />
Pharmacokinetics of L-carnitine, acetyl-L-carnitine and propionyl-L-carnitine after multiple-dose oral<br />
administration of L-carnitine solution in healthy subjects<br />
Fanbo Jing, (PR China), H Qu, Z Sui, Y Cao, Z Han, L Zhu, C Wang<br />
Potentially inappropriate drug prescription in hospitalized geriatric patients<br />
Marcela Jirón, (Chile), P Jara, L Escobar, S Orellana, I Huala, L Arriagada, MD Castillo, VH Carrasco<br />
Cockcroft-Gault and MDRD in estimating renal function in older heart failure patients – implications for<br />
prescribing of predominantly renally cleared medications<br />
Sally Johns, (Australia), J Maddison, S Shakib<br />
Erythropoietin use in cancer-related anemia in Croatia<br />
Danica Juricic, (Croatia), S Badzek, L Bielen, V Erdeljic, K Makar-Ausperger, M Radacic-Aumiler,<br />
R Likic, I Francetic<br />
Prediction of non-compliance with antibiotic therapy in ambulatory patients<br />
Kristina Kandrotaite, (Lithuania), V Neverauskas, M Jievaltas, V Saferis, V Briedis, R Maciulaitis<br />
Gemfibrozil markedly increases the plasma concentrations of montelukast: A previously unrecognized<br />
role for CYP2C8 in the metabolism of montelukast<br />
Tiina Karonen, (Finland), J Laitila, M Niemi, P Neuvonen, J Backman<br />
CYP2D6 genetic polymorphism has an impact on the pharmacokinetics of carvedilol in Korean subjects<br />
Seul-Ki Keum, (South Korea), J-W Bae, C-G Jang, S-Y Lee<br />
Gliclazide pharmacokinetics in relation to CYP2C19 genotype in healthy Koreans<br />
Seul-Ki Keum, (South Korea), C-I Choi, J-W Bae, C-G Jang, S-Y Lee<br />
224 Tuesday 20 July ■ 13:00 - 14:00 ■ Poster Area
FC13<br />
Maximising benefits and minimizing harms from<br />
drugs<br />
Tue 333<br />
Tue 334<br />
Tue 335<br />
Tue 336<br />
Tue 337<br />
Tue 338<br />
Tue 339<br />
Tue 340<br />
Pharmacokintic and pharmacodynamic alterations of omeprazole in relation to CYP2C19 genotype<br />
Seul-Ki Keum, (South Korea), C-I Choi, J-W Bae, M-J Kim, C-G Jang, S-Y Lee<br />
Knowledge, Attitude and Perception (KAP) Study on Clinical Trial of Pharmaceuticals and Informed<br />
Consent in Korea<br />
Kyung-Soo Kim, (South Korea), SH Lee, BI Choe, CM Kim<br />
Comprehensive genotyping of drug metabolizing enzymes and transporters for the assessment of<br />
pharmacokinetics and pharmacodynamics of atorvastatin<br />
Suk-Ran Kim, (South Korea), H-H Won, J-W Kim, J-W Ko, W Huh, O-Y Bang, S-C Lee, H-G Kim, S-Y Lee<br />
Individual differences of CYP2C19 mRNA expression in the small intestine of Japanese subjects<br />
Yuichi Kinoshita, (Japan), M Hayashi, N Matsuomoto, Y Tkeba, T Kumai, S Kobayashi<br />
CYP2D6 mRNA expression and genetic polymorphism in the small intestine of Japanese<br />
Shinichi Kobayasi, (Japan), S Takenosihta-Nakaya, Y Kinoshita, N Matsumoto, Y Takeba, T Kumai<br />
Pharmacokinetic and pharmacodynamic Modelling of denopamine in patients with congestive heart<br />
failure<br />
Yuichi Koike, (Japan), N Yonehara<br />
Racemic ketoprofen induces more injection pain than dexketoprofen<br />
Hannu Kokki, (Finland), T Saarelainen, M Kokki<br />
In vitro evaluation of linezolid and novel oxazolidinone actions on central nervous system neurones<br />
Samuel Kombian, (Kuwait), O Phillips<br />
Tue 341 Bioequivalence study of two oral preparations, thyrosit (100 μg levothyroxine sodium) vs eltroxin (100<br />
μg anhydrous thyroxine sodium) in patients who have hypothyroidism with euthyroid in steady state<br />
Supornchai Kongpattanakul, (Thailand), S Vannasaeng, K Sathirakul, S Chatsiricharoenkul<br />
Tue 342<br />
Tue 343<br />
Tue 344<br />
Tue 345<br />
Tue 346<br />
Tue 347<br />
Tue 348<br />
Pharmacokinetic study of immediate and prolonged generic molsidomine formulations<br />
Jiri Kopecky, (Czech Republic), D Kholova, A Polaskova, J Zoulova, I Zubata, L Vyslouzil, K Macek,<br />
J Chladek, J Kvetina<br />
Novel candidates for replacement of standard acetylcholinesterase reactivators – antidotes in case of<br />
nerve agent and pesticide poisonings<br />
Kamil Kuca, (Czech Republic), K Musilek, D Jun, J Kassa, M Pohanka, L Novotny, J Cabal,<br />
J Zdarova-Karasova<br />
Preparation, characterization & evaluation of solvatomorphs of atorvastatin<br />
Astha Kuhad, (India), R Chadha<br />
Type and prevalence of serious adverse events in phase I trials performed in Japan<br />
Yuji Kumagai, (Japan), T Momma, I Fukazawa, H Iijima<br />
How to view JUPITER<br />
Cyrus Kumana, (PR China), HF Tse, CP Lau<br />
CYP2D6 genotype: Effect on serum levels, response and side effects of venlafaxine<br />
A Lalla, Lazara Montane Jaime, (Trinidad & Tobago)<br />
Influence of gender on clopidogrel disposition in healthy volunteers<br />
O Laosa, Alberto M Borobia, (Spain), B Mosquera, SH Lei, JL Lopez-Durán, B Duque-Bascuñana,<br />
P Guerra-López, AJ Carcas-Sansuán, J Frías-Iniesta<br />
Tuesday 20 July ■ 13:00 - 14:00 ■ Poster Area 225
FC13<br />
Maximising benefits and minimizing harms from<br />
drugs<br />
Tue 349<br />
Tue 350<br />
Tue 351<br />
Tue 352<br />
Tue 353<br />
Tue 354<br />
Tue 355<br />
Tue 356<br />
Tue 357<br />
Tue 358<br />
Tue 359<br />
Pharmacokinetic comparisons of sustained- and immediate-release oral formulations of cilostazol in<br />
healthy Koreans<br />
Donghwan Lee, (South Korea), LA Lim, SB Jang, YJ Lee, H Son, S Cho, J Chung, K Park<br />
CYP2C9*3 and *13 alleles significantly affected the pharmacokinetics of celecoxib in healthy Korean<br />
subjects<br />
Seok-Yong Lee, (South Korea), C-I Choi, J-W Bae, M-J Kim, C-G Jang<br />
Genetic polymorphisms of CYP2C9 and their influences on warfarin sensitivity in mechanical heart valve<br />
replacement patients<br />
Su-Jun Lee, (South Korea), YJ Jang, E-Y Cha, H-S Kim, M-S Hwang, SS Lee, J-G Shin<br />
Identification of CYFC19A1 single nucleotide polymorphisms in Koreans and comparative analysis of<br />
functionally important CYFC19A1 variants with different ethnic groups<br />
Su-Jun Lee, (South Korea), W-Y Kim, I-S Jung, J-Y Choi, SS Lee, J-G Shin<br />
The thiopurine methyltransferase TPMT *1/*3A genotype is associated with a better treatment<br />
outcome for children with acute lymphoblastic leukaemia<br />
Lynne Lennard, (UK), C Cartwright, R Wade, S Richards, C Mitchell, S Kinsey, T Eden, J Lilleyman,<br />
A Vora<br />
Maximising benefits and minimizing side effects of acetylsalicylic acid by using antioxidant drug<br />
thiotriazolin<br />
Anton Levykh, (Ukraine), V Mamchur<br />
The test dose – how to be a more valuable and reliable predictor<br />
Nianzhi Li, (UK), J Aronson<br />
Does definition of medication errors have any impact at prevalence A systematic review of definitions<br />
Marianne Lisby, (Denmark), LP Nielsen, B Brock, J Mainz<br />
How should medication errors be defined: A systematic approach to terminology, concepts and<br />
definitions – applied in a clinical setting<br />
Marianne Lisby, (Denmark), J Mainz, B Brock, LP Nielsen<br />
The effect of systematic medication review in patients admitted to an acute medical department<br />
Marianne Lisby, (Denmark), A Thomsen, LP Nielsen, NM Lyhne, C Breum-Leer, U Fredberg,<br />
H Jørgensen, B Brock<br />
Metallic silver ignites inflammation and causes toxic cavity formation in the brain<br />
LJ Locht, Agnete Larsen, (Denmark), MØ Pedersen, S Markholt, BM Bibby, J Rungby, M Penkowa,<br />
M Stoltenberg<br />
226 Tuesday 20 July ■ 13:00 - 14:00 ■ Poster Area
W18<br />
Synaptic events in brain function<br />
Tue 360<br />
Effects of acute and chronic treatment with attention-deficit/hyperactivity disorder drugs on<br />
monoaminergic transmission in mice<br />
Ken Koda, (Japan), Y Ago, Y Cong, K Takuma, T Matsuda<br />
Tuesday 20 July ■ 13:00 - 14:00 ■ Poster Area 227
FC19<br />
General session<br />
Tue 361 Analgesic activity of the aqueous seed extract of Hunteria umbellata (K. Schum.) Hallier f.<br />
(Apocynaceae) in rodents<br />
Olufunmilayo Adeyemi, (Nigeria), A Adeneye, T Alabi<br />
Tue 362<br />
Effect of environmental temperature on norepinephrine-induced contraction in isolated chicken cubital<br />
vein: gender variation<br />
Simon Comerma-Steffensen, (Venezuela), J Rojas, A Risso, M Rossini, V De Basilio, I Oliveros, H Zerpa<br />
Tue 363 Drugs used for the treatment of type 2 diabetes mellitus in Finland during the years 2004-2009<br />
Annikka Kalliokoski, (Finland), LK Saastamoinen, JE Martikainen<br />
Tue 364<br />
Tue 365<br />
Tue 366<br />
Tue 367<br />
Tue 368<br />
Tue 369<br />
Tue 370<br />
Tue 371<br />
Detecting stimulant and sedative properties of drugs using home cage tracking in rats<br />
John Kelly, (Ireland), F Dunne, A O'Halloran, K Lane, J Simpson, S O'Brien<br />
Two glutathione S-transferase inhibitors from Radix Angelicae Sinensis<br />
Shaojing Li, (PR China), F Huang, X Lu, A Liu, G Du<br />
The role of endogenous adenosine on mechanism of citalopram-induced cardiovascular toxic effects<br />
K Oransay, N Hocaoglu, Mujgan Buyukdeligoz, (Turkey), Y Tuncok, S Kalkan<br />
Safety of herbal products: Data from the Serbian pharmacovigilance database<br />
Marija Petronijevic, (Republic of Serbia), K Ilic, I Kovacevic<br />
Provocation-based learning (PBL) in large classes: Promising<br />
Patangi Rangachari, (Canada), S Nastos<br />
Experimental study of effects of triphasic oral contraceptive pills on fluctuations tear<br />
Khatereh Safavi Naeini, (Iran)<br />
The study of effect of iohexol on Schirmer tear test values in clinically normal cattle<br />
Aboutorab Tabatabaei Naeini, (Iran), J Ceverie<br />
Phytoestrogenic effects of catalpol in T47D and MDA-MB231 cells in culture<br />
Jifeng Wang, (PR China), J Niu, Q Hao, P Zhao<br />
228 Tuesday 20 July ■ 13:00 - 14:00 ■ Poster Area
FC19<br />
General session – Airway<br />
Tue 372<br />
Tue 373<br />
In vivo [11C]PK11195 PET imaging as a biomarker to assess lipopolysaccharide-induced lung<br />
inflammation in rat<br />
Sidath Katugampola, (UK), A Zhu, K Zasadny, M Callahan, C Proctor-Brown, M Skaddan, K Kuszpit,<br />
T Bocan<br />
The effect of inhaled KP-496, a novelantagonist for cystenyl leukotriene receptor and thromboxane A2<br />
receptor, on experimental allergic asthma in guinea pigs<br />
Hiroichi Nagai, (Japan), M Suda, T Okuda, M Ishimura, S Kurokawa, S Tokuoka, T Nakamura,<br />
Y Takahasi, H Tanaka<br />
Tuesday 20 July ■ 13:00 - 14:00 ■ Poster Area 229
FC19<br />
General session – Biologics<br />
Tue 374<br />
Tue 375<br />
Tue 376<br />
Tue 377<br />
Tue 378<br />
Effects of (-)-epigallocatechin gallate on RPE cell migration and adhesion<br />
Chi-Feng Hung, (Taiwan), C-M Chan, H-H Lin<br />
Involvement of 5’-AMP-activated protein kinase in proliferation and survival of neural stem/progenitor<br />
cells<br />
Nobuyuki Kuramoto, (Japan), S Sano, N Tanaka, M Yoneyama, R Nagashima, K Ogita<br />
Edaravone promotes the proliferation/survival of neural progenitor cells after granule cell loss in the<br />
hippocampal dentate gyrus of mice<br />
Tatsuo Shiba, (Japan), K Kawada, M Yoneyama, K Ogita<br />
Nicotinic acetylcholine receptor stimulation enhances the DNA synthesis and proliferation of mouse<br />
induced pluripotent stem cells<br />
Yasuhiro Watanabe, (Japan), T Ishizuka, T Hiramoto<br />
Structural alterations of PKC gene promoter by cytosine methylation decreases SP1 binding affinity<br />
Shumei Yang, (USA), J Tenayuca, L Zhang<br />
230 Tuesday 20 July ■ 13:00 - 14:00 ■ Poster Area
FC19<br />
General session – Cell biology<br />
Tue 379<br />
Tue 380<br />
Dual regulation of hepatocyte apoptosis by reactive oxygen species: Increased BimEL expression<br />
downstream of ERK and suppressive BimEL degradation by proteasome inhibition<br />
Yasuhiro Ishihara, (Japan), M Sekine, K Takeuchi, F Ito, N Shimamoto<br />
Analysis of gene expression in the spontaneously cartilage calcification insufficient (CCI) rat<br />
Masami Tanaka, (Japan), I Yokomi, M Watanabe, K Sudo, H Satoh, T Igarashi, A Seki, S Kobayashi<br />
Tuesday 20 July ■ 13:00 - 14:00 ■ Poster Area 231
FC19<br />
General session – Haematology<br />
Tue 381<br />
Tue 382<br />
Modulated human maternal and premature neonatal erythrocyte membrane enzyme activities: In vitro<br />
restoration by L-carnitine<br />
K Schulpis, G Vlachos, A Antsaklis, Charis Liapi, (Greece), V Stolakis, A Zarros, S Tsakiris<br />
Effect of Rhynchophylline on platelet aggregation and cytoplasmic free calcium level in rabbit platelets<br />
Jing-Shan Shi, (PR China), Z-L Xie, M Wu, Q Wu, Z-N Huang, Q-H Gong<br />
232 Tuesday 20 July ■ 13:00 - 14:00 ■ Poster Area
FC19<br />
General session – Hepatology<br />
Tue 383<br />
Tue 384<br />
Tue 385<br />
Tue 386<br />
Tue 387<br />
Tue 388<br />
Tue 389<br />
Tue 390<br />
Tue 391<br />
Tue 392<br />
Tue 393<br />
Lovastatin prevents carcinogenesis in a rat model for liver cancer. Effects of ubiquinone<br />
supplementation.<br />
Linda Björkhem-Bergman, (Sweden), J Acimovic, U-B Torndal, P Parini, L Eriksson<br />
A study on the protective mechanism of tiβn medicine potentilla anserina on experimental liver injury<br />
Guangming Cai, (PR China), Z Zhu, X Fu<br />
Effect of siRNA-mediated knockdown of ALDH2 on GTN-induced cGMP formation in PK1 cells<br />
Yohan D'Souza, (Canada), BM Bennett<br />
Potential antifibrotic effects of losartan or silymarin coadministration with praziquantel against<br />
experimental Schistosoma mansoni-induced liver fibrosis<br />
Naglaa El-Lakkany, (Egypt), W El-Maadawy, A Ain-Shoka, A Badawy, F Ebeid<br />
Congenital-neonatal hypothyroidism impacts hepatic lipid metabolism in adulthood<br />
Leandro Fernández-Pérez, (Spain), R Santana-Farré, L Henríquez-Hernández, C Bocos, N Kahlon,<br />
E Herrera, N Gunnar, P Parini, A Flores-Morales<br />
Characterization of metabolites and cytochrome P450 isoforms involved in the microsomal metabolism<br />
of aconitine<br />
Yue Gao, (China)<br />
Roles of DNA damage and inflammation in the gender-selective liver carcinogenicity of 4-aminobiphenyl<br />
in mice<br />
Denis Grant, (Canada), K Sugamori, A Emami, S Wang, D Brenneman<br />
An acyclic retinoid, NIK-333, accelerates liver regeneration and lowers serum transaminase activities in<br />
70% partially hepatectomized rats in vivo<br />
Mitsutoshi Kimura, (Japan), N Ishibashi, S Yanagida, M Ogihara<br />
Estradiol interacts with growth hormone and thyroid hormones to regulate the expression of<br />
suppressors of cytokine signalling (SOCS) in liver<br />
Ruymán Santana-Farré, (Spain), A Flores-Morales, G Norstedt, L Fernández-Pérez<br />
Influence of estradiol on growth hormone-regulated liver transcriptome in male rats<br />
Ruymán Santana-Farré, (Spain), A Flores-Morales, M Mirecki-Garrido, G Norstedt, L Fernández-Pérez<br />
Inhibitory effects of schisandrin A and schisandrin B on CYP3A activity<br />
Hua-Wen Xin, (PR China), W-L Li, M-W Su<br />
Tuesday 20 July ■ 13:00 - 14:00 ■ Poster Area 233
FC19<br />
General session – oncology<br />
Tue 394<br />
Tue 395<br />
Tue 396<br />
Tue 397<br />
Tue 398<br />
Tue 399<br />
Tue 400<br />
Tue 401<br />
Tue 402<br />
Tue 403<br />
Tue 404<br />
Tue 405<br />
Tue 406<br />
Tue 407<br />
Tue 408<br />
An increased precryopreservation time reduces the feasibility and the recount of the CD34(+) cells of<br />
the umbilical cord blood.<br />
Inmaculada Bellido, (Spain), L Ponce, MC Hernández, M Barrios, I Prat, AI Heiniger<br />
Impact of ABCB1 variants on neutrophil depression: A prospective study<br />
Troels K Bergmann, (Denmark), C Brasch-Andersen, H Gréen, M Mirza, K Skougaard, J Wihl,<br />
N Keldsen, P Damkier, C Peterson, W Vach, K Brøsen<br />
Ionizing radiation alters the bone marrow microenvironment by inducing senescence of mesenchymal<br />
stromal cells<br />
Cynthia Carbonneau, (Canada), G Despars, A Fortin, O Le, T Hoang, CM Beausejour<br />
Temozolomide induces apoptosis and autophagy in glioma cells<br />
A Carmo, H Carvalheiro, Maria Celeste Lopes, (Portugal)<br />
Indole-3-carbinol attenuates migration and invasion of breast cancer cells by blocking the ERK/<br />
Sp1-mediated MMP-2 gene transcription<br />
Hui-Chiu Chang, (Taiwan)<br />
Peptide-conjugated biodegradable nanoparticles as a carrier to target paclitaxel to tumor<br />
neovasculature<br />
Hong-Zhuan Chen, (PR China), D-H Yu, Q Lu, J Xie, C Fang<br />
Cryptotanshinone has opposite cell cycle-arresting effects on melanoma cells of different metastatic<br />
capacity<br />
L Chen, S-Z Zheng, A-Y Wang, Lu Yin, (PR China)<br />
Pulmonary toxicity of bleomycin involved in upregulation of lysyl oxidase activity in cultured human fetal<br />
lung fibroblasts<br />
Lijun Chen, (PR China), S Li, X Su, G Lin<br />
The mechanism of MNNG-induced-apoptosis: AMPK could be a transmitter from PARP activation to<br />
mitochondrial dysfunction<br />
Yi-Cheng Chen, (Taiwan), J-H Guh<br />
The relationship between MEKK1 and carcinogenesis & development of pancreatic cancer<br />
Xiaoguang Cheng, (China), F Su, K Li, Y Zhang, C Yan<br />
Novel imidazo[1,2-a]pyridines in the induction of colonic cell differentiation and apoptosis<br />
Nurit Dahan-Farkas, (South Africa), C De Koning, L Harmse, H Davids<br />
New HPLC-mass spectrometry method for the simultaneous quantification in human plasma of the<br />
antileukemia drugs Imatinib, Dasatinib, and Nilotinib<br />
Silvia De Francia, (Italy), A D'Avolio, F De Martino, E Pirro, F Piccione, S Racca, F Di Carlo<br />
Beer polyphenols against human glioblastoma: Effects of xanthohumol on T98G cell apoptosis<br />
Michela Festa, (Italy), A Capasso, L Parente, CW D'Acunto, C Pizza, S Piacente<br />
Morphological evaluation of rat liver tissue after the subcutaneous injection of 1,2-dimethylhydrazine<br />
Ana Fortuna, (Portugal), R Direito, G Alves, J Sousa, A Falcão, A Cabrita<br />
HPLC method developement for the simultaneous determination of Arabinoside-C and Doxorubicin<br />
concentrations in human serum<br />
Suew Hua Gan, (Malaysia), AF Mistiran, AD Abdullah<br />
234 Tuesday 20 July ■ 13:00 - 14:00 ■ Poster Area
FC19<br />
General session – oncology<br />
Tue 409 Cytotoxic activity of bioactive fractions of bioactive fractions of Asparagus officinalis L.<br />
Mª Dolores García-Gimenez, (Spain), R De la Puerta, MA Fernández-Arche, MT Saenz-Rodríguez<br />
Tue 410<br />
Tue 411<br />
Tue 412<br />
Tue 413<br />
Tue 414<br />
Tue 415<br />
Tue 416<br />
Tue 417<br />
Tue 418<br />
Tue 419<br />
Tue 420<br />
Tue 421<br />
Tue 422<br />
Tue 423<br />
Tue 424<br />
Characterization of a lipid kinase involved in the synthesis of alkyl lysophosphatidic acid<br />
Amanda Gellett, (USA), Y Kharel, K Lynch<br />
HGF/c-Met overexpressions, but not Met mutation, correlates with progression of non-small cell<br />
carcinomas<br />
Mukaddes Gumustekin, (Turkey), A Kargi, G Bulut, A Gozukizil, C Ulukus, I Oztop, N Atabey<br />
Haishengsu extracted from Tegillarca granosa inhibits cell growth of human hepatic cancer in nude<br />
mice<br />
Yantao Han, (PR China), X Chen, Z Han, P Li, J Tong, C Wang<br />
Arachidonic acid promotes glutamate-induced cell death associated with necrosis through<br />
12-lipoxygenase activation in glioma cells<br />
Yoshihiro Higuchi, (Japan), M Hashii, H Tanii, Y Koriyama<br />
The effects of azole-based heme oxygenase inhibitors on breast cancer growth and metastasis in vivo<br />
Maaike Hum, (Canada), RA Dercho, S Nagy, JZ Vlahakis, WA Szarek, K Nakatsu<br />
Nerve growth factor (NGF) prevents tumor growth<br />
Hiromu Kawasaki, (Japan), M Goda, S Takatori, Y Zamami, N Hobara, Y Kitamura<br />
The effect of estrogen supplementation on cell proliferation and distribution of prostatic interstitial cells<br />
in the rat prostate<br />
Snezana Kusljic, (Australia), B Exintaris<br />
Role of cortistatin in modulating the growth of colon cancer cells<br />
Francis FY Lam, (PR China), ESK Ng, CH Cho<br />
XJ-6-A inhibits tumor invasion and metastasis and its potential molecular mechanisms<br />
Xuejun Li, (PR China), Y Cao<br />
Preparation of monoclonal antibodies by in vivo electroporation-assisted HE4 gene immunization in<br />
mice<br />
H Luan, X Gao, J Fu, Z Ma, L Dong, L Fan, Haifeng Song, (PR China)<br />
Chemoenzymatic synthesis of new diazabicyclic amides of 12-phenylacetylricinoleic acid and in vitro<br />
antineoplastic activity in mouse and human leukemic cells<br />
Axel Luviano, (Mexico), R Tiburcio, I Aguiñiga, P Demare, M López, J Cardoso, I Monsalvo, I Castillo,<br />
E Santiago, I Regla<br />
Undernutrished patients with head-neck cancer and PEG in adjuvant radioterapy<br />
Eva Mala, (Czech Republic), E Buresova, I Krcmova, J Novosad, J Krejsek, M Vosmik, R Cap,<br />
L Sobotka<br />
Candida albicans induces proliferation and neurosphere formation from mouse retinal progenitor cells<br />
Victoria Maneu, (Spain), C Murciano, ML Gil, A Yáñez, D Gozalbo<br />
Anticancer effect of horse chestnut extract<br />
Gabriela Mojzisova, (Slovak Republic), J Mojzis, L Varinska, M Pilatova, A Bomba<br />
Study of noscapine-induced cell death in hepatocellular carcinoma cell line<br />
Seyed Hadi Mousavi, (Iran), H Parsaee, Z Tayarani-Najaran<br />
Tuesday 20 July ■ 13:00 - 14:00 ■ Poster Area 235
FC19<br />
General session – oncology<br />
Tue 425<br />
Tue 426<br />
Tue 427<br />
Tue 428<br />
Tue 429<br />
Tue 430<br />
Tue 431<br />
Tue 432<br />
Tue 433<br />
Tue 434<br />
Tue 435<br />
Tue 436<br />
Tue 437<br />
Tue 438<br />
Tue 439<br />
Tue 440<br />
Study on the phytoestrogenic effects of ferulic acid<br />
Jianzhao Niu, (PR China), J Wang, Q Hao, P Zhao<br />
Effect of topiramate on tumor angiogenesis and serum proteome of mice bearing Lewis lung<br />
carcinoma<br />
Yan Pan, (PR China), B Ma, X Yang, H-M Yu, X-J Li<br />
Acetylation of p53 by histone deacetylase inhibitors sensitizes lung cancer cells to ionizing radiation<br />
induced cell death<br />
In-Chul Park, (South Korea), S-K Seo, H-O Jin, T-B Choe<br />
Antitumoral and antimetastatic activities of a proteolytic fraction from Carica candamarcensis latex<br />
Miriam Teresa Paz Lopes, (Brazil), D Dittz, C Figueiredo, CTR Viana, CE Salas<br />
Novel Pim kinase inhibitor impairs Pim-dependent stimulation of cancer cell motility<br />
Niina Santio, (Finland), R Vahakoski, E Rainio, S Virtanen, J Sandholm, M Prudhomme, F Anizon,<br />
P Moreau, P Koskinen<br />
Role of cardiac mitochondrial nitric oxide-cGMP pathway on rat cardiomyocyte apoptosis<br />
Kazuhiko Seya, (Japan), K Ono, S Fujisawa, S Motomura, K-I Furukawa<br />
Study in vitro of the mechanism of action by which coumarin and 7-hydroxycoumarin promotes<br />
apoptosis in two human lung adenocarcinoma cell lines<br />
Maribel Soto-Núñez, (Mexico), P Cuautle-Rodríguez, JA Molina-Guarneros<br />
The mechanism of gingival overgrowth as a side effect of nifedipine<br />
Reiri Takeuchi, (Japan), H Matsumoto, Y Akimoto, A Fujii<br />
Isophthalic acid derivatives targeted to the C1 domain of PKC induce cell cycle arrest in HeLa cells<br />
Virpi Talman, (Finland), E Ekokoski, A Olli, G Boije af Gennäs, J Yli-Kauhaluoma, RK Tuominen<br />
HPLC method development & validation for the determination of Imatinib Mesylate in human serum<br />
Ka Liong Tan, (Malaysia), R Hassan, SH Gan<br />
Gene expression profiling of human mesenchymal stem cells for identification of surrogate markers for<br />
in vitro culture stage<br />
Shihori Tanabe, (Japan), Y Sato, T Suzuki, T Yamaguchi, K Suzuki<br />
High-throughput screening for novel prostate cancer drug targets<br />
Paula Vainio, (Finland), K Ketola, J-P Mpindi, S Kilpinen, P Kohonen, V Fey, S Gupta, M Perälä,<br />
O Kallioniemi, K Iljin<br />
Oncology clinical trials in Croatia<br />
Dinko Vitezic, (Croatia), M Lovrek, S Omic<br />
Development of an in vitro assay to evaluate sunscreen efficacy<br />
Nicole Walter, (Switzerland), C Surber, G Kunze<br />
Investigations on the antitumor effects and mechanisms of 13 compounds<br />
Juan Wang, (PR China), XH Chen<br />
Apoptosis of U937 cells induced by Brucea javanica oil emulsion<br />
Chunfu Wu, (PR China), H Zhang, J Yang, L Wang, F Zhou, W Zhang<br />
236 Tuesday 20 July ■ 13:00 - 14:00 ■ Poster Area
FC19<br />
General session – oncology<br />
Tue 441<br />
Tue 442<br />
AST1306, a novel irreversible inhibitor of the epidermal growth factor receptor 1 and 2, exhibits<br />
antitumor activity both in vitro and in vivo<br />
Hua Xie, (PR China), L Lin, Y Jiang, J Guo, J Ding<br />
Direct antiproliferative effect of novel nonsteroidal 17β-hydroxysteroid dehydrogenase type 1 inhibitors<br />
István Zupkó, (Hungary), A Berényi, S Marchais-Oberwinkler, M Frotscher<br />
Monday 19 July ■ 13:00 - 14:00 ■ Poster Area 237
FC19<br />
General session – Toxicology<br />
Tue 443<br />
Tue 444<br />
Tue 445<br />
Tue 446<br />
Tue 447<br />
Tue 448<br />
Tue 449<br />
Tue 450<br />
Tue 451<br />
Tue 452<br />
Tue 453<br />
Tue 454<br />
Tue 455<br />
Tue 456<br />
Tue 457<br />
Tue 458<br />
Ultraviolet action spectrum and effect of EPC-K1 on ultraviolet-radiation-induced injury in cultured NHEK<br />
Kayo Aoki, (Japan), T Nakanishi-Ueda, M Tsuji, T Okuno, K Oguchi, H Yasuhara<br />
Melamine migration from melamine food contact articles available on the Malaysian market<br />
Zamri Chik, (Malaysia), DEM Haron, MA Mohamad, ED Ahmad, H Taha<br />
Topotecan vitreous levels after periocular or intravitreal delivery in healthy albino rabbits: An alternative<br />
for advanced retinoblastoma chemotherapy<br />
Denisa Darsova, (Czech Republic), P Pochop, E Klapkova, D Kodetova, H Tesfaye, J Uhlik, L Vajner<br />
Oxaliplatin-dependent neuropathy in the rat: Pain behaviour and peripheral nervous system alterations<br />
Lorenzo Di Cesare Mannelli, (Italy), L Bonaccini, A Pacini, C Ghelardini, A Bartolini<br />
Role of sister chromatid exchange analysis in assessment of proguanil genotoxicity in cultured human<br />
lymphocytes<br />
Domagoj Dinter, (Croatia), G Gajski, V Garaj-Vrhovac<br />
Synthesis of new detergents derived from quaternary ammonium salts as a part of disinfection and<br />
decontamination means<br />
Daniel Jun, (Czech Republic), J Marek, K Musilek, J Cabal, O Soukup, M Hrabinova, M Pohanka,<br />
P Stodulka, K Kuca<br />
Adenosine mediated – cardiovascular toxicity in amitriptyline poisoning rats<br />
S Kalkan, Nil Hocaoglu, (Turkey), K Oransay, M Buyukdeligoz, Y Tuncok<br />
Does amitriptyline, a tricyclic antidepressant, bind to adenosine A1 or A2a receptors<br />
S Kalkan, (Turkey), H Gurdal, Nil Hocaoglu, M Buyukdeligoz<br />
Potentiating α-lipoic acid hepatoprotective effect by l-Carnitine and Methylsulfonylmethane in<br />
Bromobenzene-induced hepatotoxicity in rats<br />
Dina Mansour, (Egypt), SA Nada, ES El-denshary, AK Bahgat, EA Omara<br />
Thymoquinone from Nigella sativa induces apoptosis in SiHa cells via p53-dependent pathway<br />
Wei Keat Ng, (Malaysia), L Saiful Yazan, M Ismail<br />
Lead poisoning after gunshot injuries in lower part of body: a case report<br />
Lokendra K Sharma, (India), S Kochar, K Sharma, M Mathur, S Dutta<br />
Interaction of silymarin and doxorubicin in rat<br />
Nebojsa Stilinovic, (Republic of Serbia), R Sederino, A Raskovic, M Mikov, V Jakovljevic, S Vukmirovic<br />
Gas chromatography mass spectrometry (GC/MS) method optimization & validation for detection of<br />
Paraquat<br />
Suk Peng Tang, (Malaysia), SA Sulaiman, SH Gan<br />
The anticancer and metal chelating properties of 8-hydroxyquinoline derivatives<br />
Robyn Van Zyl, (South Africa), A Hibbins, M McLaverty<br />
Determination of pseudocholinesterase serum activity among Agrinion pesticide applicators pre- and<br />
post-exposed to organophosphates (Fenthion and Dimethoate)<br />
G Vrioni, H Souki, K Kasiotis, M Katramadou, Haris Carageorgiou, (Greece)<br />
Chemical form of metals underlying potential cytoxicity of metal-containing traditional medicines in<br />
various cell lines<br />
Qin Wu, (PR China), Y-F Lu, J-Z Shi, J Liu<br />
238 Tuesday 20 July ■ 13:00 - 14:00 ■ Poster Area
FC19<br />
General session – Toxicology<br />
Tue 459<br />
Nasal instillation of nanoparticle-rich diesel exhaust particle affects emotional behavior and learning<br />
capability in rats<br />
Syunji Yokota, (Japan), H Takashima, T Miyahara, Y Yoshida, T Negura, Y Saito, N Hirabayashi,<br />
T Watanabe, R Ohta, S Horiuchi, Y Fujitani, S Hirano, H Fujimaki<br />
Tuesday 20 July ■ 13:00 - 14:00 ■ Poster Area 239
W02<br />
Symposium on advances in GI pharmacology<br />
Tue 460<br />
Tue 461<br />
Mechanisms underlying the modulation of gut permeability by cannabinoids<br />
Abdussalam Alhamoruni, (UK), K Wright, A Lee, M Larvin, S O'Sullivan<br />
Evaluation of the proulcerogenic effect of Atorvastatin on Indomethacin induced gastric injury in rats<br />
Ilkay Alp, (Turkey), O Uyanik, H Ozyogurtcu, A Gurel, P Atukeren, K Gumustas, A Kapucu, C Demirci,<br />
O Ozdemir, BSU Dogan<br />
Tue 462 Pro-apoptotic and anti-proliferative mechanisms of STW 5<br />
G Bonaterra, S Zügel, W Hildebrandt, Olaf Kelber, (Germany), D Weiser, J Metz, R Kinscherf<br />
Tue 463<br />
Tue 464<br />
Tue 465<br />
Tue 466<br />
Tue 467<br />
Tue 468<br />
Tue 469<br />
Tue 470<br />
Tue 471<br />
Tue 472<br />
Tue 473<br />
Tue 474<br />
αL-Tryptophan rich diet improves ulcer healing via endogenous melatonin, prostaglandins and<br />
downregulation of hypoxia inducible factor 1α (HIF-1)<br />
Tomasz Brzozowski, (Poland), A Ptak-Belowska, R Pajdo, S Kwiecien, M Pawlik, I Brzozowska,<br />
PC Konturek, WW Pawlik, SJ Konturek<br />
Could vitamin K2 guard against experimentally induced gastric stress ulcers in rats<br />
Inas Darwish, (Egypt), A Mohamed, H Abdel Aziz<br />
Cannabidiol controls intestinal inflammation throught the modulation of enteric glial cell activation<br />
Daniele De Filippis, (Italy), G Esposito, M Cipriano, C Scuderi, J De Man, L Steardo, T Iuvone<br />
Protective effect of VEGF on ethanol-induced hemorrhagic gastric erosions in rats<br />
Xiaoming Deng, (USA), X Xiong, Z Sandor, S Szabo<br />
Enhancement of aspirin-induced gastric bleeding by pretreatment of clopidogrel, an anti-platelet drug, in<br />
rats: prophylactic effects of antiulcer drugs<br />
Chitose Izuhara, (Japan), K Yamazaki, H Nishio, K Amagase, K Takeuchi<br />
Tetrodotoxin induces mouse colonic contraction in vitro through blockade of enteric inhibitory<br />
innervation<br />
Takio Kitazawa, (Japan), Y Okuno<br />
Evaluation of calcium channel antagonist activity of some new 9,10 dihydro-7H,8H-chromeno [4,3-b]<br />
chromene-6,11-dione<br />
Mohammad Miri, (Iran), M Sharifi, A Bagheri, R Motamedi, A Shafiee<br />
Generation of gut-like tissue from induced pluripotent stem cells that can be applied for functional<br />
characterization<br />
Kazuhiko Oishi, (Japan), Y Ogawa<br />
The cannabinoid, WIN55,212, reduces pacemaker frequency in the gastric antrum of conscious ferrets;<br />
a potential mechanism for cannabinoid-induced gastroparesis<br />
N Percie du Sert, Wing Sze Vanessa Ho, (UK), JA Rudd, PLR Andrews<br />
Cogitum effects at the experimental gastropathy<br />
Ivan Savenko, (Russian Federation), A Sergienko<br />
Importance of acid inhibition for gastroesophageal reflux disease with low-dose aspirin<br />
Mitsushige Sugimoto, (Japan), M Nishino, C Kodaira, M Yamade, T Uotani, M Ikuma, K Umemura,<br />
H Watanabe, T Furuta<br />
Multiple effects of L-ascorbic acid on conjugation reactions in colon carcinoma cells<br />
Hiroomi Tamura, (Japan), H Tsuruta, M Shimizu<br />
240 Tuesday 20 July ■ 13:00 - 14:00 ■ Poster Area
W02<br />
Symposium on advances in GI pharmacology<br />
Tue 475<br />
Tue 476<br />
Incidence, severity and aetiology of drug-induced acute pancreatitis<br />
Karel Urbánek, (Czech Republic), I Vinklerová, D Hajdu, V Procházka<br />
Protection of cathelicidin-encoding Lactococcus lactis in murine ulcerative colitis<br />
Clover Ching Man Wong, (Hong Kong), CH Cho<br />
Tuesday 20 July ■ 13:00 - 14:00 ■ Poster Area 241
W11<br />
New opportunities in the pharmacology of<br />
neuro-immune interactions<br />
Tue 477<br />
Tue 478<br />
Expression change in nicotinic receptor according to cellular maturity of antigen presenting cell line<br />
Yukiko Kondo, (Japan), E Tachikawa, S Ohtake, K Kudo, K Mizuma, T Kashimoto, Y Irie, E Taira<br />
Candida albicans increases TLR2 mRNA expression in mouse retinal progenitor cells<br />
Victoria Maneu, (Spain), C Murciano, ML Gil, A Yáñez, D Gozalbo<br />
242 Tuesday 20 July ■ 13:00 - 14:00 ■ Poster Area
W14<br />
Translating the human genome:<br />
From orphan G-protein coupled receptors to novel<br />
therapeutic targets<br />
Tue 479<br />
The IUPHAR Database: Tools to navigate pharmacological space<br />
JL Sharman, CP Mpamhanga, WA Catterall, Anthony P Davenport, (UK), RR Neubig, E Ohlstein,<br />
JA Peters, M Spedding, A Harmar<br />
Tuesday 20 July ■ 13:00 - 14:00 ■ Poster Area 243
W23<br />
Applying pharmacogenomics (PGX) from research<br />
into clinical practice: Present and future<br />
Tue 480<br />
Tue 481<br />
Tue 482<br />
Tue 483<br />
Tue 484<br />
Tue 485<br />
Tue 486<br />
Tue 487<br />
Tue 488<br />
Tue 489<br />
Tue 490<br />
Tue 491<br />
Tue 492<br />
Tue 493<br />
Tue 494<br />
DPYD polymorphisms and adjuvant 5-FU/LV treatment outcome in colorectal cancer patients<br />
Shoaib Afzal, (Denmark), SA Jensen, B Vainer, U Vogel, JB Sørensen, HE Poulsen<br />
The study of CYP2C19 polymorphisms in Romanian epileptic patients<br />
Anca Dana Buzoianu, (Romania), IC Bocsan, FC Militaru, R Popp, A Trifa, L Perju-Dumbrava<br />
Genetic variation in the hTAS2R38 taste receptor and Brassica vegetables intake<br />
Nela Gorovic, (Denmark), S Afzal, A Tjønneland, K Overvad, U Vogel, C Albrechtsen, HE Poulsen<br />
CYP2D6 mRNA expression and genetic polymorphism in the small intestine of Japanese<br />
Shinichi Kobayashi, (Japan), S Takenoshita-Nakaya, Y Kinoshita, N Matsumoto, Y Takeba, T Kumai<br />
Impact of CYP2D6 and CYP3A5 gene polymorphisms on pharmacokinetics of oxycodone and its<br />
demethylates and dose escalation rate in cancer patients<br />
Takafumi Naito, (Japan), K Yamamoto, Y Takashina, M Tashiro, Y Kagawa, K Ohnishi, J Kawakami<br />
Distribution and genotype frequency of the SNP 45T/G polymorphism in Iranian population: progression<br />
to diabetes and response to pioglitazone<br />
Fatemeh Namvaran, (Iran), P Rahimi-Moghaddam, N Azarpira<br />
Renal secretion clearance of N1-methylnicotinamide as an endogenous biomarker for tubular organic<br />
cation transporter type 2 activity in man<br />
Ryuichi Ogawa, (Japan), Y Nobuoka, H Echizen<br />
Role of ace and MTHFR genes polymorphisms in migraine<br />
V Pizza, A Bisogno, E Lamaida, A Agresta, G Bandieramonte, A Volpe, R Galasso, L Galasso,<br />
Anna Capasso, (Italy)<br />
Polymorphism gene apolipoprotein E in migraine and cardiovascular disease<br />
V Pizza, F Infante, G Schiavo, A Agresta, C Colucci d'Amato, A Bisogno, Anna Capasso, (Italy)<br />
Interethnic and gender dependent differences in CYP2C19 activity. A comparison between Swedes and<br />
Koreans<br />
Margareta Ramsjö, (Sweden), E Aklillu, L Bohman, M Ingelman-Sundberg, H-K Roh, L Bertilsson<br />
Impact of CYP2D6 genetics on serum concentration of escitalopram in relation to CYP2C19 genotype<br />
Ida Rudberg, (Norway), M Hermann, H Refsum, E Molden<br />
Impact of CYP3A5 and ABCB1 gene polymorphisms on plasma disposition of fentanyl and its clinical<br />
responses in cancer patients with opioid switching to fentanyl transdermal system<br />
Yoshiaki Takashina, (Japan), T Naito, Y Mino, K Ohnishi, J Kawakami<br />
VKORC1 and CYP2C9 genotyping using a rapid single nucleotide polymorphism (SNP) detection system<br />
named smart amplification process (SmartAmp) method<br />
Minoru Watanabe, (Japan), N Matsumoto, T Kumai, M Tanaka, Y Mitani, Y Hayashizaki, S Kobayashi<br />
A multiplexed primer extension denaturing high performance liquid chromatography method for the<br />
identification of 3 ABCC2 (MRP2) genetic polymorphisms<br />
Ian Westley, (Australia), J Coller, M Ward, A Evans, R Morris, B Sallustio<br />
Lack of drug-drug interaction between ketoconazole and brivanib<br />
Daphne Williams, (USA), S Syed, D Lathers, G Kollia, A Gupta, J Pursley, Y-Q Xia, E Masson<br />
244 Tuesday 20 July ■ 13:00 - 14:00 ■ Poster Area
FC10<br />
Drugs for half the world: Paediatric clinical<br />
pharmacology<br />
Wed 001<br />
Wed 002<br />
Wed 003<br />
Wed 004<br />
Wed 005<br />
Wed 006<br />
Wed 007<br />
Wed 008<br />
Wed 009<br />
Wed 010<br />
Wed 011<br />
Wed 012<br />
Wed 013<br />
Wed 014<br />
Wed 015<br />
Wed 016<br />
Risk factors for abnormal newborn hearing in the era of extended dose interval amikacin administration<br />
Karel Allegaert, (Belgium), K Kneepkens, K Vandendriessche, F Debruyne, M Rayyan, G Naulaers,<br />
C Desloovere<br />
Does the need for domperidone administration shortly after delivery affect the duration breastfeeding<br />
after preterm delivery<br />
Karel Allegaert, (Belgium), G Bosmans, M Vanhaver, V Cossey, A Debeer, C Vaanhole, K Janssens<br />
Population pharmacokinetics study of benznidazole in children with Chagas disease<br />
Jaime Altcheh, (Argentina), G Moscatelli, G Mastrantonio, S Moroni, N Giglio, G Koren, H Freilij,<br />
F Garcia-Bournissen<br />
Bioavailability and bioequivalence of three different sirup formulations cefeleksine at children in therapy<br />
of severe tonsillitis<br />
Adnan Bajraktarevic, (Bosnia Herzegovina), J Musabegovic, T Frankic, H Sladic, D Abduzaimovic<br />
Graphic and pictorial tables explaining drug’s routes administration reduce the anxiety of the<br />
hospitalized children in the intensive care unit.<br />
MV Bellido, Inmaculada Bellido, (Spain), A Gomez-Luque<br />
EUROPain – European pain audit in neonates – NeoOpioid Consortium<br />
Lena Bergqvist, (Sweden), M Eriksson, KJS Anand, EM Boyle, H Lagercrantz, S Andersson, G Menon,<br />
B van Overmeire, M Keller, L Hellström-Westas, V Fellman, RHN van Schaik, J-P Osselaere, A Rane,<br />
J Schollin, R Carbajal<br />
Drugs use in paediatric population. Evaluation in two areas: Neonatology and intensive care units<br />
Encarnación Blanco, (Spain), I Bellido, EI Márquez, A Medina, JA González-Correa<br />
Documentation of recent drug history in children visiting a pediatric emergency clinic<br />
Ylva Böttiger, (Sweden), E Kimland, S Lindemalm<br />
Diagnosis and treatment of seizures in the neonatal intensive care unit<br />
N Cosic-Cerovac, Milca Prostran-Veselinovic, (Republic of Serbia), N Jovic, R Stojanovic, Z Stojanovic<br />
Therapeutic drug monitoring: hydroquinidine administration in a newborn infant with short QT syndrome.<br />
A case report<br />
Silvia De Francia, (Italy), E Pirro, E Banaudi, C Riggi, F De Martino, F Piccione, F Di Carlo<br />
Nephrotic syndrome in children: Genetic variability of the clinical presentation and therapeutic response<br />
Valery Elie, (France), M Fakhoury, Y Medard, A Rousseau, G Deschenes, E Jacqz-Aigrain<br />
CANCELLED<br />
N-acetylcysteine as a novel prophylactic treatment for ifosfamide-induced nephrotoxicity in children;<br />
translational pharmacokinetics<br />
Lauren Hanly, (Canada), N Chen, B Baw, B Malkin, M Culter, D Freeman, M Rieder, G Koren<br />
Expression of cytochrome P450 metabolizing enzymes depends on gestational age in critically ill<br />
preterm infants<br />
Betty Kalikstad, (Norway), H Göransson, T Kristoffersen, A Isaksson<br />
Modulation of gene expression in critically ill preterm infants following stress<br />
Betty Kalikstad, (Norway), H Göransson, T Kristoffersen, A Isaksson<br />
Genotype-specific pharmacodynamics in BH4 responsive phenylketonuria<br />
Florian B Lagler, (Austria), C Zsifkovits, SW Gersting, R Fingerhut, H Glossmann, C Muntau<br />
Wednesday 21 July ■ 13:00 - 14:00 ■ Poster Area 245
FC10<br />
Drugs for half the world: Paediatric clinical<br />
pharmacology<br />
Wed 017<br />
Wed 018<br />
Wed 019<br />
Pharmacokinetics and outcomes of gentamicin therapy in neonates critically ill during the first week of<br />
life: Volumes of fluid infused or retained as possible covariates<br />
Jirina Martinkova, (Czech Republic), P Pokorná, J Záhora, J Chladek, V Vobruba, I Selke-Krulichova,<br />
J Chladkova<br />
Does budesonide applied in prevention of child asthma affect variations in body weight in asthmatic<br />
children<br />
Milica Martinovic, (Republic of Serbia)<br />
Does budesonide applied in prevention of child asthma decrease height velocity of asthmatic children<br />
Milica Martinovic, (Republic of Serbia), S Pantovic<br />
246 Wednesday 21 July ■ 13:00 - 14:00 ■ Poster Area
FC11<br />
G protein-coupled 7TM receptors:<br />
From molecular to physiological function<br />
Wed 020<br />
Wed 021<br />
Wed 022<br />
Wed 023<br />
Wed 024<br />
Wed 025<br />
Wed 026<br />
Wed 027<br />
Wed 028<br />
Wed 029<br />
Wed 030<br />
Wed 031<br />
Wed 032<br />
Wed 033<br />
Wed 034<br />
Wed 035<br />
Development of a P2X7 binding and Ex vivooccupancy assay in rat brain<br />
Sarah Able, (UK), R Fish, L Booth, S Katugampola<br />
Cerebrovascular contractile receptors up-regulate via a Raf sensitive signalling pathway<br />
Hilda Ahnstedt, (Sweden), L Edvinsson<br />
Pre-versus postsynaptic α2A-adrenoceptors functions mediated via Gαi-isoforms<br />
Julian Albarran-Juarez, (Germany), R Gilsbach, R Piekorz, K Pexa, B Nürnberg, L Hein<br />
Palmitoyl CoA antagonism of ADP-induced relaxation of rat thoracic aorta<br />
Eman Alefishat, (UK), S Alexander, V Ralevic<br />
Muscarinic m3AchR is regulated by cGMP, via a PKG-II dependent phosphorylation in plasma<br />
membranes from tracheal smooth muscle<br />
Marcelo J Alfonzo, (Venezuela), M Alfonzo-Gonzalez, RG Alfonzo, A Misle, IL Becemberg<br />
Role of receptor recycling in the recovery of Ca 2+ signalling by recombinantly expressed neuromedin U<br />
2 receptors (NMU2)<br />
Khaled Al-Hosaini, (UK), RAJ Challiss, GB Willars<br />
FRET-based evidence for ligand-independent preassociation of 5-HT7 serotonin receptors with Gs<br />
Kjetil W Andressen, (Norway), L Hommers, AH Ulsund, MJ Lohse, KA Krobert, M Bünemann, FO Levy<br />
Antimitogenic and apoptotic effects of selective 5HT3 receptor antagonist on HT29 colorectal cancer<br />
cell line.<br />
Ramin Ataee, (Iran), M Zarrindast, S Ajdary, S Sharyari<br />
REEP family members modulate α2C-adrenoceptor expression by an ER interaction<br />
Susann Björk, (Finland), C Hurt, B Kobilka, T Angelotti<br />
CRIP1a regulates CB1 cannabinoid receptor internalization and signal transduction<br />
Lawrence C Blume, (USA), CC Bass, GD Dalton, DE Selley, A Howlett<br />
Protein kinase C (PKC) regulation of type 5 metabotropic glutamate (mGlu5) receptor-stimulated Ca2+<br />
oscillations in rat cerebrocortical astroglia<br />
Sophie J Bradley, (UK), JM Watson, RAJ Challiss<br />
The inverse agonist effect of rimonabant in brain membranes is not mediated by the CB1 receptor<br />
Luis F Callado, (Spain), AM Erdozain, R Diez-Alarcia, JJ Meana<br />
Modulation of ligand binding to the α1B adrenergic receptor: a potential role for the second extracellular<br />
loop<br />
Adrian Campbell, (Australia), I McDougal, R Griffith, A Finch<br />
Long-term cigarette smoke exposure induces bronchial hyperresponsiveness to G-protein coupled<br />
receptor agonists<br />
Lei Cao, (Sweden), Y Zhang, Y-X Cao, L Edvinsson, C-B Xu<br />
mmLDL upregulates endothelin type A and type B receptors in rat basilar artery<br />
Yong-Xiao Cao, (PR China), J Li, ZY Yuan, L Cao, CB Xu<br />
Activation of OX1, but not OX2, receptors in the periaqueductal gray produces antinociception via<br />
retrograde endocannabinoid-induced disinhibition<br />
Lih-Chu Chiou, (Taiwan), Y-C Ho, H-J Lee, Y-Y Liao, S-Y Fu, S-F Teng, H-T Liao<br />
Wednesday 21 July ■ 13:00 - 14:00 ■ Poster Area 247
FC11<br />
G protein-coupled 7TM receptors:<br />
From molecular to physiological function<br />
Wed 036<br />
Wed 037<br />
Wed 038<br />
Wed 039<br />
Wed 040<br />
Wed 041<br />
Wed 042<br />
Wed 043<br />
Wed 044<br />
Wed 045<br />
Wed 046<br />
Wed 047<br />
Wed 048<br />
Wed 049<br />
Wed 050<br />
Wed 051<br />
Quantitative phosphoproteomics dissection of 7TM receptor signalling using full and biased agonists<br />
Gitte Lund Christensen, (Denmark), CD Kelstrup, C Lyngsøe, U Sarwar, R Bøgebo, SP Sheikh,<br />
S Gammeltoft, JV Olsen, JL Hansen<br />
Receptor mechanisms of the long-lasting and persistent arterial contractile effects of Endothelin-1<br />
Matthijs Compeer, (The Netherlands), M Meens, C Höltke, W Neugebauer, J De Mey<br />
Behavioral effects of 5'-GNTI and 6'-GNTI in mice<br />
Alan Cowan, (USA), S Inan<br />
Selective modulation by singlet oxygen of CCK1R and other G protein-coupled receptors in live cells<br />
Zong Jie Cui, (PR China), Y Wang, TT Li, SF Zhang, B Nashun, HY Liang, ZQ Han<br />
Serotonin is involved in airway hyperreactivity at bovine tracheal smooth muscle<br />
Darwin J Da Costa-Guevara, (Venezuela), E Trejo, M Alfonzo<br />
Lack of kinin receptors affected ACE expression in mice abdominal aorta<br />
Eliete da Silva Rodrigues, (Brazil), RP Martin, JB Pesquero, SI Shimuta<br />
Role of β2-adrenoceptor on vascular inflammatory mediators and oxidative stress induced by<br />
isoproterenol treatment<br />
Ana Paula Davel, (Brazil), C Wenceslau, G Ceravolo, MH Carvalho, P Brum, L Rossoni<br />
Impact of ambient extracellular calcium on analysis and interpretation of agonism and allosteric<br />
modulation of the extracellular calcium sensing receptor (CaSR)<br />
Anna E Davey, (Australia), K Leach, AD Conigrave, PM Sexton, A Christopoulos<br />
Crosstalk between GABAB and Group III mGlu receptors following intranigral drug administration in the<br />
reserpine-treated rat<br />
Susan Duty, (UK), M Broadstock<br />
Taurine and its analogue tauropyrone: Comparative pharmacological activities<br />
Zane Dzirkale, (Latvia), J Pupure, J Rumaks, M Vanina, S Svirskis, R Mezhapuke, MA Fernandes,<br />
G Duburs, R Muceniece, V Klusa<br />
Functional expression of CB1 receptors in rat brain nuclear fractions<br />
Leire Echeazarrra, (Spain), S Barrondo, GG del Caño, M Montaña, ML de Jesús, J Sallés<br />
The scaffold protein NHERF2 determines neuronal ion channel coupling of glutamate mGluR5 and<br />
nucleotide P2Y1 receptors<br />
Alexander K Filippov, (UK), J Simon, EA Barnard, DA Brown<br />
The conserved proline of helix 6 plays a role in the folding and expression of α1B and α2 – adrenergic<br />
receptors<br />
Angela M Finch, (Australia), SJ Humphrey, AP Campbell<br />
Angiotensin II modulates α1D-adrenoceptors expression in vascular smooth muscle cells<br />
Itzell Gallardo-Ortiz, (Mexico), P López-Sánchez, JJ López-Guerrero, M Ibarra, R Villalobos-Molina<br />
The effect of nociceptin on uterine contractions in term-pregnant rats in vitro<br />
Robert Gaspar, (Hungary), A Klukovits, K Tekes, O Gunduz, S Benyhe, A Borsodi, BH Deak,<br />
J Hajagos-Tóth, J Verli, G Falkay<br />
Stereoselectivity of the recombinant and native histamine H3 receptor isoforms: The H3-autoreceptor is<br />
a short isoform<br />
Florence Gbahou, (France), A Rouleau, S Morisset, J-M Arrang<br />
248 Wednesday 21 July ■ 13:00 - 14:00 ■ Poster Area
FC11<br />
G protein-coupled 7TM receptors:<br />
From molecular to physiological function<br />
Wed 052<br />
Wed 053<br />
Wed 054<br />
Wed 055<br />
Wed 056<br />
Wed 057<br />
Wed 058<br />
Wed 059<br />
Wed 060<br />
Wed 061<br />
Wed 062<br />
Wed 063<br />
Wed 064<br />
Wed 065<br />
Wed 066<br />
Wed 067<br />
Interactions of SDF-1 and ADP in platelet activation<br />
Olof Gidlöf, (Sweden), C Högberg, B Olde, D Erlinge<br />
From phylogeny to pharmacology; chemogenomic pharmacological GPCR clustering and<br />
ligand-inference<br />
David Gloriam, (Denmark), S Garland<br />
Autocrine effects of extracellular cyclic AMP in skeletal muscle<br />
Rosely Godinho, (Brazil), E Aparecida-Santos, AL Andrade-Lopes, T Chiavegatti<br />
Pseudo-irreversible allosteric modulators – mathematical models predicting their behaviour and a<br />
putative practical example<br />
David Hall, (UK)<br />
Role of keratinocytes GPR109A and COX-2 in nicotinic acid and mono-methyl fumarate induced flushing<br />
Julien Hanson, (Belgium), A Gille, S Zwykiel, M Lukasova, BE Clausen, K Ahmed, S Tunaru, A Wirth,<br />
S Offermanns<br />
Understanding adrenomedullin binding to its receptors<br />
Debbie Hay, (New Zealand), T Qi, K Ly, D Rathbone, J Simms, D Poyner<br />
Allosteric modulation of ‘reproductive’ GPCRs – a case for the luteinizing hormone receptor<br />
Laura Heitman, (The Netherlands)<br />
The role of nitric oxide in the local antinociceptive effects and expression of cannabinoid-2 receptors<br />
during neuropathic pain in mice<br />
A Hervera, R Negrete, S Leánez, J Martín-Campos, Olga Pol, (Spain)<br />
Change in feeding behavior by siRNAs for a NPY receptor into paraventricular nuclei<br />
Hiroshi Higuchi, (Japan), T Shiiya, S-I Murase<br />
Ubiquitin/proteasome-dependent down-regulation following clathrin-mediated internalization of histamine<br />
H1-receptors in Chinese hamster ovary cells<br />
Shigeru Hishinuma, (Japan), H Komazaki, H Fukui, M Shoji<br />
The platelet activator succinate – a possibly drug candidate for the future<br />
Carl Högberg, (Sweden), O Gidlöf, B Olde, D Erlinge<br />
M3-muscarinic acetylcholine receptor stimulation of glucose uptake in L6 skeletal muscle cells:<br />
evidence for a CaMKKβ-AMPK-dependent mechanism<br />
Dana Hutchinson, (Australia), J Merlin, R Csikasz, B Evans, T Bengtsson, R Summers<br />
GPR120 mediates high-fat diet-induced adipocyte hypertrophy and obesity<br />
Atsuhiko Ichimura, (Japan), A Hirasawa, S Miyauchi, G Tsujimoto<br />
Possible involvement of β-endorphin in tolerance to fentanyl-induced anti-hyperalgesia under a pain-like<br />
state<br />
Satoshi Imai, (Japan), M Narita, N Kuzumaki, LA Devi, Y Uezono, T Suzuki<br />
5-HT2A receptor Modelling and agonist design<br />
Vignir Isberg, (Denmark), D Gloriam, T Balle, T Sander, FS Jørgensen<br />
Apelin is mainly regulated by HIF-1α in astrocytes<br />
Yuki Ishimaru, (Japan), A Kasai, Y Yoshioka, A Yamamuro, S Maeda<br />
Wednesday 21 July ■ 13:00 - 14:00 ■ Poster Area 249
FC11<br />
G protein-coupled 7TM receptors:<br />
From molecular to physiological function<br />
Wed 068<br />
Wed 069<br />
Wed 070<br />
Wed 071<br />
Wed 072<br />
Wed 073<br />
Wed 074<br />
Wed 075<br />
Wed 076<br />
Wed 077<br />
Wed 078<br />
Wed 079<br />
Wed 080<br />
Wed 081<br />
Wed 082<br />
Wed 083<br />
Role of nitric oxide/cyclic GMP and cyclic AMP in the β-adrenoceptor vasorelaxant response<br />
Maria Dolores Ivorra, (Spain), N Flacco, S Estrada, M Perez-Aso, P D'Ocon<br />
5-HT2C receptor signal peptide<br />
Jan Anker Jahnsen, (Norway), S Uhlen<br />
The angiotensin II type 1 receptor regulates microRNA expression by Gq and Erk1/2 dependent<br />
mechanisms<br />
Pia Jeppesen, (Denmark), GL Christensen, M Schneider, Y Nossent, HB Jensen, DC Andersen,<br />
S Gammeltoft, JL Hansen, SP Sheikh<br />
Inhibition of dopamine and noradrenaline transporters (DAT & NET) and monoamine oxidase (MAO) in<br />
the prefrontal cortex of COMT knock-out mice<br />
Mikko Käenmäki, (Finland), C Amberg, PT Männistö<br />
Evidence for functional heteromerization between melatonin MT1 and MT2 receptors and serotonin<br />
5-HT2C receptors<br />
Maud Kamal, (France), J-L Guillaume, A Daulat, P Chen, C Mannoury La Cour, MJ Millan, L Vincent, O<br />
Nosjean, JA Boutin, M Spedding, P Delagrange, R Jockers<br />
Regulation of GPR55 by the G protein coupled receptor associated sorting proteins<br />
Julia Kargl, (Austria), N Balenga, L Martini, J Whistler, M Waldhoer<br />
Two distinct pathways, PKA and TrkA, mediate activation of CREB during α2-AR induced neuronal<br />
differentiation<br />
G Karkoulias, P Papathanasopoulos, Christodoulos Flordellis, (Greece)<br />
Apelin is a crucial factor for hypoxia-induced retinal angiogenesis<br />
Atsushi Kasai, (Japan), Y Ishimaru, T Kinjo, Y Yoshioka, A Yamamuro, N Shintani, A Baba, S Maeda<br />
Characterization of a sphingosine 1-phosphate receptor antagonist prodrug<br />
Perry Kennedy, (USA), R Zhu, J Tomsig, T Huang, T Mathews, T Macdonald, K Lynch<br />
The GABAB dimers of heterodimers: a way to increase the functional complexity<br />
Julie Kniazeff, (France), L Comps-Agrar, D Maurel, E Trinquet, J-P Pin<br />
Physiological significance of extracellular ATP in HaCaT keratinocytes<br />
Daisaku Kobayashi, (Japan), S Ohkubo, N Nakahata<br />
Enhanced BRET technology for the monitoring of agonist-induced and agonist-independent interactions<br />
between GPCRs and β-arrestins<br />
Martina Kocan, (Australia), HB See, NG Sampaio, BJ Feldman, KA Eidne, KDG Pfleger<br />
Ligand-directed signalling at the relaxin family peptide receptor 3 (RXFP3)<br />
Martina Kocan, (Australia), ET van der Westhuizen, MA Hossain, JD Wade, RJ Summers<br />
MTα is a selective α2B-adrenoceptor antagonist<br />
Katja Koivula, (Finland), S Rondinelli, J Näsman<br />
The effects of naturally occurring single nucleotide polymorphisms (SNPs) at the glucagon-like peptide<br />
1 receptor (GLP-1R)<br />
Cassandra Koole, (Australia), J Simms, D Wootten, A Christopoulos, PM Sexton<br />
Possible regulation of GABAB receptors expression by phosphatases<br />
Akira Koutani, (Japan), H Niihara, N Kuramoto, K Ogita<br />
250 Wednesday 21 July ■ 13:00 - 14:00 ■ Poster Area
FC11<br />
G protein-coupled 7TM receptors:<br />
From molecular to physiological function<br />
Wed 084<br />
Wed 085<br />
Wed 086<br />
Wed 087<br />
Wed 088<br />
Wed 089<br />
Wed 090<br />
Wed 091<br />
Wed 092<br />
Wed 093<br />
Wed 094<br />
Wed 095<br />
Identification and electrophysiological characterization of new NR3-containing NMDA receptor<br />
modulators<br />
Trine Kvist, (Denmark), JR Greenwood, KB Hansen, RP Clausen, SF Traynelis, H Bräuner-Osborne<br />
Characterization of the binding site of low molecular weight frizzled-1/2 antagonists<br />
Hilde Laeremans, (The Netherlands), HCJ Ottenheijm, JFM Smits, MW Blankesteijn<br />
Viral chemokine receptor US28 activates β-catenin signalling pathway<br />
Ellen Langemeijer, (The Netherlands), E Slinger, D Maussang, M Siderius, R Leurs, M Smit<br />
Lack of BAMBI (BMP and Activin membrane-bound inhibitor) in mutant mice increases the analgesic<br />
effect of morphine, without favouring tolerance development or worsening withdrawal severity<br />
Aquilino Lantero, (Spain), D Merino, ML Laorden, A Díaz, MA Hurlé<br />
Involvement of the first transmembrane segment of the human 2α-adrenoceptor in the subtype<br />
selectivity of bulky antagonists<br />
Jonne M Laurila, (Finland), H Xhaard, G Wissel, JO Ruuskanen, MS Johnson, M Scheinin<br />
Probing the binding and function of orthosteric, allosteric and bitopic agonists at the M4 muscarinic<br />
acetylcholine receptor<br />
Katie Leach, (Australia), AE Davey, PM Sexton, A Christopoulos<br />
Activation of group II metabotropic glutamate receptors inhibits neuronal excitability and epilepsy in the<br />
entorhinal cortex via down-regulation of protein kinase A pathway<br />
Saobo Lei, (USA), C Yang, Z Xiao, J Pribula<br />
The ligand binding properties of human membrane estrogen receptors<br />
Amanda HY Lin, (PR China), GPH Leung, SWS Leung, RYK Man<br />
Octopamine receptors from the barnacle Balanus improvisus exhibit cAMP-mediated signalling by the<br />
antifouling substance medetomidine<br />
Ulrika Lind, (Sweden), M Rosenblad, L Frank, S Falkbring, L Brive, J Laurila, K Pohjanoksa,<br />
L Gunnarsson, M Scheinin, L Mårtensson-Lindblad, A Blomberg<br />
Lactate is the endogenous ligand for GPR81 and suppresses lipolysis in adipocytes<br />
Timothy Lovenberg, (USA), C Liu, C Kuei, T Mirzadegan, J Shelton, J Yu, J Zhu<br />
Molecular determinants of the interaction of selective negative allosteric modulators with metabotropic<br />
glutamate receptor 2<br />
Linda Lundström, (Switzerland), C Bissantz, J Beck, T Woltering, J Wichmann, JG Wettstein, S Gatti<br />
Epac induces airway smooth muscle relaxation by shifting the RhoA/Rac1 balance towards Rac1<br />
Harm Maarsingh, (The Netherlands), SS Roscioni, CRS Elzinga, LJ Schuur, MH Menzen, AJ Halayko,<br />
H Meurs, M Schmidt<br />
Wednesday 21 July ■ 13:00 - 14:00 ■ Poster Area 251
FC12<br />
Ion channelopathies: New windows on complex<br />
disease and therapy<br />
Wed 096<br />
Wed 097<br />
Wed 098<br />
Wed 099<br />
Wed 100<br />
Wed 101<br />
Non-genomic effects of oestrogen derivatives on BK channels<br />
M Allen, Jacqueline Maher, (UK), A Hunter, J Mabley<br />
The role of potassium channels in experimental sepsis<br />
Jamil Assreuy, (Brazil), R Sordi, D Fernandes<br />
Diabetogenic ABCC8/KCNJ11: Mechanisms to personalized treatment<br />
Andrey Babenko, (USA)<br />
The Kv11.1 channel opener NS1643 shortens the QT in transgenic rabbits with long QT-syndrome 1 in<br />
vivo and shortens the APD90 ex vivo, but is associated with increased risk of arrhythmias<br />
Bo Bentzen, (Denmark), S Bahrke, K Wu, AP Larsen, J Biermann, X Peng, G Koren, M Zehender,<br />
C Bode, M Grunnet, M Brunner<br />
GRP-78 is a possible target in GABAA-channelopathies<br />
Ksenia Chekina, (Russian Federation)<br />
Variable expression of ABCC8 and ABCC9 transporters in pregnant rat myometrium: influence of<br />
gestation age<br />
George Falkay, (Hungary), N Lovasz, E Ducza, R Gaspar<br />
Wed 102 Contribution of Trpc1 to the pathogenesis of dystrophic mice: analysis of double knock-out Trpc1 -/-<br />
dystrophin<br />
Chiara Gallo, (Switzerland), OM Dorchies, G Shapovalov, N Zanou, P Gailly, E Roulet, UT Ruegg<br />
Wed 103<br />
Wed 104<br />
Wed 105<br />
Wed 106<br />
Wed 107<br />
Wed 108<br />
The antivasoconstrictor effect of potassium channel opener FC1075 in the human vascular grafts<br />
Ljiljana Gojkovic-Bukarica, (Republic of Serbia), A Novakovic, B Beleslin-Cokic, M Peric,<br />
J Markovic-Lipkovski, S Cirovic, V Kanjuh<br />
Volume-regulated chloride channel mediates foam cell formation in atheroscerosis<br />
Yong-Yuan Guan, (PR China)<br />
Simulation of the effect of the phasphorylation on the gap junction channel closure by computatinal<br />
chemistry<br />
Nobuo Homma, (Japan)<br />
Minocycline inhibits d-amphetamine-elicited action potential bursts in a central snail neuron<br />
Hui-Yu Hsu, (Taiwan), Y-H Chen<br />
The regulation of melatonin release by BK channel activity in pinealocytes<br />
Yuji Imaizumi, (Japan), H Mizutani, H Yamamura, M Muramatsu, S Ohya<br />
Does iPLA2β play a role in store-operated calcium entry in Edl-mdx-2 myotubes<br />
Karin Jacobson, (Switzerland), O Petermann, E Roulet, U Rüegg<br />
252 Wednesday 21 July ■ 13:00 - 14:00 ■ Poster Area
FC13<br />
Maximising benefits and minimizing harms from<br />
drugs<br />
Wed 109<br />
Wed 110<br />
Wed 111<br />
Wed 112<br />
Wed 113<br />
Wed 114<br />
Wed 115<br />
Wed 116<br />
Wed 117<br />
Wed 118<br />
Wed 119<br />
Wed 120<br />
Wed 121<br />
Wed 122<br />
Relevance of manganese superoxide dismutase (SOD2 Val16Ala) and glutathione peroxidase1 (GPX1<br />
Pro200Leu) functional polymorphisms in patients with idiosyncratic drug-induced liver injury (DILI)<br />
Maribel Isabel Lucena, (Spain), E Garcia-Martin, RJ Andrade, C Martinez, C Stephens, JD Ruiz,<br />
E Ulzurrun, MC Fernandez, JA Duran, A Melcon de Dios, Y Borraz, JAG Agundez<br />
Introducing clinical events classification for improving antibiotic prescribing<br />
Tatyana Lugovkina, (Russian Federation), B Richards<br />
Usefulness of Bayes TDM for monitoring in immunosuppression using the Dynapred® platform:<br />
An example with tacrolimus<br />
John C Lukas, (Spain), I Oteo, R Calvo, A Valdivieso, N Leal, E Suarez<br />
Impaired function of CYP2C9 metabolic enzyme and OATP1B1 transporter as a predisposition for<br />
HMGCoA reductase inhibitors induced rhabdomyolysis:case reports<br />
V Macolic-Sarinic, N Mirosevic-Skvrce, Nada Božina, (Croatia), S Marusic, S Tomic<br />
The pharmacodynamics of single dose R- and S-warfarin when administered alone and in combination<br />
as a function of VKORC1 genotype in healthy volunteers<br />
John Maddison, (Australia), A Somogyi, B Jensen, M Gentgall, P Rolan<br />
Inhibition of basal and ultraviolet B induced melanogenesis by cannabinoid receptors CB1<br />
Sofia Magina, (Portugal), C Esteves Pinto, E Moura, MP Serrão, I Correia-de-Sá, D Moura,<br />
M-A Vieira-Coelho<br />
Protective effects of glutathione and the related thiols against hepatotoxicity of acetaminophen and<br />
furosemide in mice<br />
Yasuhiro Masubuchi, (Japan), J Nakayama, Y Sadakata<br />
On expressing drug dosage<br />
Mukul Mathur, (India), L Sharma, KK Sharma<br />
Influence of VKORC1 polymorphism on PT-INR adherence to the target therapeutic range in long-term<br />
warfarin therapy<br />
Naoki Matsumoto, (Japan), M Watanabe, T Kumai, M Tanaka, Y Takeba, Y Harimoto, S Takenoshita,<br />
Y Kinoshita, M Yamauchi, F Miyake, H Musha, S Kobayashi<br />
Influence of Escherichia coli Nissle 1917 on cytochrome P450 protein expression in the intestine of<br />
male rats<br />
Zuzana Matuskova, (Czech Republic), A Tunkova, E Anzenbacherova, R Vecera,<br />
H Tlaskalova-Hogenova, Z Zidek, P Anzenbacher<br />
Incidence, genetic and non-genetic risk factors for severe phenprocoumon associated gastrointestinal<br />
bleeding leading to hospitalisation<br />
Karen May, (Germany), K Wergin, S Müller, M Hippius, K Farker, B Drewelow, J Szymanski,<br />
D Rosskopf, PA Thürmann, W Siegmund<br />
Effect of low-dose and high-dose aspirin on the pharmacokinetics and pharmacodynamics of edoxaban<br />
Jeanne Mendell, (USA), S Chen, R Noveck, F Lee, V Petrushun, M Shi<br />
Effect of naproxen on the pharmacokinetics and pharmacodynamics of edoxaban- encore abstract<br />
Jeanne Mendell, (USA), S Chen, R Noveck, F Lee, V Petrushun, M Shi<br />
The effect of quinidine and verapamil, P glycoprotein/CYP3A4/5 inhibitors, on edoxaban<br />
pharmacokinetics and pharmacodynamics<br />
Jeanne Mendell, (USA), R Noveck, H Zahir, F Lee, V Petrushun, I Rubets, G Zhang, M Shi, S Chen<br />
Wednesday 21 July ■ 13:00 - 14:00 ■ Poster Area 253
FC13<br />
Maximising benefits and minimizing harms from<br />
drugs<br />
Wed 123<br />
Wed 124<br />
Wed 125<br />
Wed 126<br />
Wed 127<br />
Wed 128<br />
Wed 129<br />
Wed 130<br />
Wed 131<br />
Wed 132<br />
Wed 133<br />
Wed 134<br />
Wed 135<br />
Wed 136<br />
Wed 137<br />
Wed 138<br />
Effects of CYP4F2 genetic polymorphisms on warfarin dose requirements in Caucasian patients<br />
initiating therapy<br />
Veronique Michaud, (Canada), M Frappier, M Champagne, D Brouillette, D Roy, I Taillon, G O'Hara,<br />
D Gossard, M Phillips, A Ajami, J Turgeon<br />
Inhibition of human liver microsomal opioid glucuronidation by ketamine – A potential pharmacokinetic<br />
drug-drug interaction<br />
John Miners, (Australia), V Uchipichat, P Ruangrut, D Elliot, B Janchawee, A Evans<br />
Estimation of creatinine clearance and gentamicin dose using lean body weight prediction<br />
Sarah Mitchell, (Australia), S Hilmer, C Kirkpatrick, R Hansen, MF Singh<br />
Estimation of lean body weight in older black and white men and women: the Health, Aging and Body<br />
Composition Study<br />
Sarah Mitchell, (Australia), C Kirkpatrick, A Newman, S Satterfield, A Schwartz, A Simonsick, S Hilmer<br />
Influence of the VKORC1 genetic polymorphism and patient characteristics upon warfarin dose in<br />
Japanese elderly patients<br />
Jun Miura, (Japan), H Nakashima, T Tateishi<br />
Relation between ethanol-induced oxidative stress and apoptosis in human hepatoma (SK-Hep-1) cells<br />
Yoshiya Mochizuki, (Japan), M Tsuji, H Oyamada, M Ota, C Kurahashi, K Oguchi<br />
Genotypic determinants of CYP2D6 activity and its clinical implications in Indo-Trinidadians<br />
Lazara Montane Jaime, (Trinidad & Tobago), A Lalla<br />
Making therapeutic drug monitoring of efavirenz work: what is a subtherapeutic concentration<br />
Emilia C Monteiro, (Portugal), U Caixas, I Germano, S Gouveia, A Carlos, TF Lampreia, T Branco,<br />
SA Pereira<br />
Effects of the Crotalus durissus cascavella venom on renal tubular cells<br />
Janaina Monteiro, (Brazil), A Torres, R Menezes, F Monteiro, R Dantas, A Martins, H Monteiro<br />
The development of a novel system for the investigation of microvascular dysfunction<br />
E Moss, L Rankin, S Lynagh, David Bunton, (UK)<br />
Variability of tamoxifen metabolism in vivo is influenced by genotypes of drug metabolizing enzymes<br />
Thomas Mürdter, (Germany), W Schroth, H Brauch, M Eichelbaum, M Schwab<br />
Frequency of adverse drug reactions type A and type B registered with intensive monitoring system<br />
Snezana Mugosa, (Montenegro), Z Todorovic, N Duborija-Kovacevic<br />
Spontaneous reporting of adverse drug reactions and level of intervention<br />
Snezana Mugosa, (Montenegro), Z Todorovic, A Boskovic, N Duborija-Kovacevic<br />
A novel polymorphism in ABCB1 gene, CYP2B6*6 and sex predict single dose efavirenz population<br />
pharmacokinetics in Ugandans<br />
Jackson K Mukonzo, (Uganda), D Röshammar, P Waako, M Andersson, T Fukasawa, L Milani,<br />
J Ogwal-Okeng, L Gustafsson, E Aklillu<br />
Using prescribing data to determine drug persistence for the purpose of pharmacovigilance<br />
Isa Naina Mohamed, (UK), P Helms, C Simpson, J McLay<br />
Metformin and lactic acidosis: Do we pay attention to the renal function in the elderly<br />
Makiko Nakagawa, (Sweden), U Bergman<br />
254 Wednesday 21 July ■ 13:00 - 14:00 ■ Poster Area
FC13<br />
Maximising benefits and minimizing harms from<br />
drugs<br />
Wed 139<br />
Wed 140<br />
Wed 141<br />
Wed 142<br />
Wed 143<br />
Wed 144<br />
Wed 145<br />
Wed 146<br />
Wed 147<br />
Wed 148<br />
Wed 149<br />
Wed 150<br />
Wed 151<br />
Wed 152<br />
Wed 153<br />
Wed 154<br />
Outcome among head trauma patients on anticoagulants or platelet inhibitors prior to trauma<br />
Sigrid Narum, (Norway), M Kringen, O Brørs, O Stokland<br />
Gender differences in the disposition of drugs<br />
C Neta, J Silva, F Martins, A Pedroso, T Macedo, Carlso Fontes Ribeiro, (Portugal)<br />
Gas mediator hydrogen as a tool for protection of Parkinson's disease<br />
Mami Noda, (Japan), K Fujita, M Kido, T Katafuchi, Y Nakabeppu<br />
Flurbiprofen pharmacokinetics in relation to CYP2C9 genotype<br />
Da-Hee Oh, (Republic Of South Korea), J-W Bae, M-J Kim, C-G Jang, S-Y Lee<br />
Contribution of CYP2D6*10 allele to the inter-individual variability in the pharmacokinetic of metoprolol<br />
and its β-hydroxy metabolite in Koreans<br />
Da-Hee Oh, (Republic Of South Korea), C-I Choi, J-W Bae, M-J Kim, C-G Jang, S-Y Lee<br />
Use of confidence intervals in the fractional analysis of the interaction between non-depolarizing<br />
neuromuscular blockers<br />
Antonio Carlos Oliveira, (Brazil), CR Souza, WL Silva, CSM Serra<br />
Effect of lamivudine-artesunate co-administration on some hematological, hepatic and renal biomarkers<br />
in rats<br />
Temidayo Olurishe, (Nigeria), H Kwanashie, J Anuka, H Muktar<br />
Comparative study of adverse drug reactions between a public and a private specialist hospital in<br />
Lagos, South West Nigeria<br />
Ibrahim Oreagba, (Nigeria), I Ishola, A Akinyandenu<br />
The metabolism of the novel dopamine stabiliser ACR16 (Pridopidine)is mainly mediated by CYP2D6<br />
Georgios Panagiotidis, (Sweden), A Hellden, J Tedroff, N Waters, S Waters, L Bertilsson<br />
Role of genetic factors on between-subject variability in cytarabine cytotoxicity<br />
Sumit Parmar, (Germany), A Seeringer, K Pitterle, D Denich, F Gärtner, E Lebedeva, J Kirchheiner<br />
Nephrotoxic medications in acute kidney injury: Opportunities for learning<br />
Peysh Patel, (UK), A Sengupta, O Martin, F Razik, O Johnson<br />
Early postnatal ketamine anesthesia causes persistent deficits in rhesus monkey cognition<br />
Merle G Paule, (USA), M Li, X Zou, C Hotchkiss, JP Hanig, TA Patterson, W Slikker, C Wang<br />
Linkage disequilibrium between the rapid CYP2C19*17 allele and wildtype CYP2C8 and CYP2C9<br />
alleles: identification of CYP2C haplotypes in healthy Nordic populations<br />
Rasmus S Pedersen, (Denmark), C Brasch-Andersen, SC Sim, TK Bergmann, J Halling, MS Petersen,<br />
P Weihe, A-L Börresen-Dale, VN Kristensen, K Brøsen, M Ingelman-Sundberg<br />
Effects of verapamil, over materno-fetal pharmacokinetics and transplacental exchange of ivermectin,<br />
in pregnant sheep<br />
Ruben Perez, (Chile), C Palma, MJ Nuñez, P Urrutia, L Morales, D Vera, J Cox<br />
Determining toxicological parameters of atropine/scopolamine mixture as food contaminant<br />
L Perhariè, M Zidariè, Lovro Stanovnik, (Slovenia)<br />
Parenteral alanyl-glutammine in critically ill patients: a Bayesian meta-analysis of published trials<br />
Lorenzo Pradelli, (Italy), O Zaniolo, S Iannazzo, M Eandi<br />
Wednesday 21 July ■ 13:00 - 14:00 ■ Poster Area 255
FC13<br />
Maximising benefits and minimizing harms from<br />
drugs<br />
Wed 155<br />
Wed 156<br />
Wed 157<br />
Wed 158<br />
Wed 159<br />
Wed 160<br />
Wed 161<br />
Wed 162<br />
Wed 163<br />
Wed 164<br />
Wed 165<br />
Wed 166<br />
Wed 167<br />
Provocative potassium handling to predict changes in ambulatory serum potassium with dual<br />
renin-angiotensin-aldosterone (RAAS) blockade<br />
Richard Preston, (USA), D Afshartous<br />
Emotional state dependence of the pressor response in normal dogs<br />
Joseph Prinsen, (USA), NS Archambault, AJ Lange, NB Olivier<br />
Carbamazepine induced leucopenia in 20-year-old male patient<br />
Vesna Radovic, (Republic of Republic of Serbia)<br />
Fexofenadine is not a substrate for OATP2B1<br />
Gregory Reed, (USA), C Flynn, B Hagenbuch<br />
From pharmacogenetics to personalized medicine: A Cuban regulatory perspective<br />
Diadelis Remirez-Figueredo, (Cuba)<br />
Hypertension in general practice – an APO-audit<br />
Lene Reuther, (Denmark), P Schultz-Larsen, J Damsgaard, D Gilså Hansen, A Munck, J Søndergaard,<br />
M Skov Paulsen, M Andersen<br />
Rational drug use at hospitals and in the primary-secondary care interface<br />
Lene Reuther, (Denmark), H Thomsen, HR Christensen, B Kirkeby<br />
Influence of aldehyde dehydrogenase-2 gene polymorphism on vasodilatation induced by organic<br />
nitrates in healthy human subjects<br />
S Sakata, K Ichishima, H Oniki, T Miwa, H Arima, K Matsumura, T Yoshihara,<br />
F Takahashi-Yanaga, F Shiraishi, Toshiyuki Sasaguri, (Japan)<br />
Changes in drug-metabolizing enzyme activities in the multiple histamine receptor gene knockout mice<br />
Eiichi Sakurai, (Japan), E Sakurai, Y Ueda, Y Sakurai, K Yanai<br />
Medication errors in critical care unit<br />
Nicole Salazar, (Chile), L Escobar, M Jirón<br />
The effect of paraxon organophosphate insecticide on antioxidant system in rat brain tissue<br />
Maryam Salehi, (Iran), M Jafari, M Saleh Moqadam, A Asghari, M Kazemi, M Abasnejad,<br />
M Haggholamali<br />
Genetic polymorphism and drug interactions modulating CYP2D6 and CYP3A activities have a major<br />
impact on oxycodone analgesic efficacy, safety and pharmacokinetics<br />
Caroline Samer, (Switzerland), Y Daali, M Wagner, G Hopfgartner, CB Eap, MC Rebsamen, MF Rossier,<br />
D Hochstrasser, P Dayer, JA Desmeules<br />
Awareness of the risk of venous thromboembolism among users of oral contraceptives<br />
Isidora Samojlik, (Republic of Serbia), M Panduriv, B Bogdanov<br />
256 Wednesday 21 July ■ 13:00 - 14:00 ■ Poster Area
FC14<br />
Addiction and doping: Neurobiological and clinical<br />
basis of emerging treatments<br />
Wed 168<br />
Wed 169<br />
Wed 170<br />
Wed 171<br />
Wed 172<br />
Wed 173<br />
Wed 174<br />
Wed 175<br />
Wed 176<br />
Wed 177<br />
Wed 178<br />
Wed 179<br />
Wed 180<br />
Wed 181<br />
Wed 182<br />
Wed 183<br />
Neuroprotective effect of adenosine A1 and A2A receptors in chronic alcohol withdrawal syndrome in<br />
mice<br />
Kiran Kumar Akula, (India), K Chopra, SK Kulkarni<br />
Comparison of the neurochemical changes induced by acute and repeated administration of morphine,<br />
cocaine and amphetamine in the rat lateral septum<br />
Katherine A Araya, (Chile), MR Ibañez, V Noches, R Sotomayor-Zarate, K Gysling<br />
Pharmacodynamic effects of 3,4-methylenedioxyamphetamine (MDA)<br />
MJ Baggott, J Siegrist, JR Coyle, K Flower, GP Galloway, John Mendelson, (USA)<br />
Vitamins as antioxidants have important role of asthmatic additional therapy in children and protection<br />
of passive smoking<br />
Adnan Bajraktarevic, (Bosnia Herzegovina), M Miokovic, D Abduzaimovic, J Ceman Saric, T Frankic,<br />
J Musabegovic, I Tahmiscija, A Selimovic, JA Maglajlic, B Begovic<br />
Areca nut dependence among chewers in a South Indian community who do not also use tobacco<br />
Robert L Balster, (USA), SJS Bhat, MD Blank, M Nichter, M Nichter<br />
Interaction of protein kinase C and allosteric modulation at extrasynaptic GABA-A receptors following<br />
chronic ethanol treatment<br />
I Barrett, Stephen Kelley, (UK)<br />
Memantine prevents the cognitive deficits induced by methamphetamine in rats<br />
Jorge Camarasa, (Spain), T Rodrigo, D Pubill, E Escubedo<br />
Russian biosimilar epoetins and their possible use in sport<br />
Yuliya I Dykhal, (Russian Federation), GI Krotov, PV Postnikov, GM Rodchenkov<br />
Testosterone inhibits endothelial nitric oxide synthase mRNA expression and nitric oxide production<br />
Lena Ekström, (Sweden), C Skogastierna, A Rane<br />
In vitro neurochemical profile of MDMA and its metabolite α-methyldopamine<br />
Elena Escubedo, (Spain), S Abad, I Torres, J Camarasa, D Pubill<br />
Acetaldehyde stimulates IL-6 mRNA expression and IL-6 protein secretion in cultured rat astrocytes<br />
Polonca Ferk, (Slovenia), L Sarc, B Wraber, M Lipnik-Stangelj<br />
The effect of centrally injected Gly-L-Gln (Glycyl-Glutamine) on nucleus accumbens GABA output after<br />
acute morphine administration<br />
Nesrin Filiz Basaran, (Turkey), S Cavun, RL Buyukuysal, WR Millington<br />
Exercise influence on the amphetamine-dependent behaviour and dopamine in striatum, frontal cortex<br />
and hippocampus<br />
Carlos Alberto Fontes-Ribeiro, (Portugal), E Marques, F Pereira, AP Silva, T Macedo<br />
Effect of methylenedioxymethamphetamine (MDMA) on cytosolic calcium levels in PC 12 cells. Role of<br />
nicotinic receptors<br />
Sara Garcia-Rates, (Spain), E Escubedo, J Camarasa, D Pubill<br />
Intranasal administration of the dopamine D3 receptor antagonist SB-277011A inhibits cocaine<br />
self-administration and cocaine-enhanced brain-stimulation reward in rats<br />
Eliot Gardner, (USA), X-Q Peng, X Li, C Ashby, Z-X Xi<br />
Testosterone enanthate induces the expression of HMGCR and cholesterol levels<br />
Nina Gårevik, (Sweden), C Skogastierna, A Rane, L Ekström<br />
Wednesday 21 July ■ 13:00 - 14:00 ■ Poster Area 257
FC14<br />
Addiction and doping: Neurobiological and clinical<br />
basis of emerging treatments<br />
Wed 184<br />
Wed 185<br />
Wed 186<br />
Wed 187<br />
Wed 188<br />
Wed 189<br />
Wed 190<br />
Wed 191<br />
Wed 192<br />
Wed 193<br />
Enhancement of clonidine-induced analgesia by sulfisoxazole in mice<br />
Anil Gulati, (USA), G Matwyshyn, M Boxwalla, B Puppala, S Andurkar<br />
The role of D1/D2 dopamine receptors in the development and expression of nigrostratal DA<br />
sensitisation in rats<br />
Susanna Gyarmati, (Hungary), J Timar, A Horvath, A Fendt, S Fürst<br />
Toxic dose of methamphetamine induces endoplasmic reticulum stress related gene<br />
CHOP/Gadd153/ddit3 in dopaminergic neural cells<br />
Yasuyuki Irie, (Japan), M Saeki, H Tanaka, S Otake, Y Kondo, K Kudo, K Mizuma, Y Kamisaki, N Miki,<br />
E Taira<br />
Intereceptive effects of atypical anxiolytics with neuroprotective properties<br />
Tatiana S Kalinina, (Russian Federation), AV Volkova, TA Voronina, SB Seredenin<br />
Experimental study of the antinociceptive effects of GB-115, a dipeptide analogue of cholecystokinin<br />
Larisa Kolik, (Russian Federation), V Zhukov, T Gudasheva, S Seredenin<br />
Inhibition of heat shock protein 90 attenuates adenylate cyclase sensitization after chronic morphine<br />
treatment<br />
Takaaki Koshimizu, (Japan), H Tsuchiya, S Fujimura, Y Fujiwara, A Fujimura<br />
Activation of cAMP-response-binding-element protein (CREB) in the nucleus accumbens reduces relapse<br />
to methamphetamine-seeking behaviour in rats<br />
Niree Kraushaar, (Australia), L Hunt, J Cornish<br />
Predicting steady state oral methadone dosage with CYP3A4 activity Preliminary results<br />
Kamilia Ksouda, (France), F Vorspan, S Mouly, V Bloch, A Hajj, K Peoch, J-L Laplanche, P Houze,<br />
J-P Lepine<br />
Role of metabotropic glutamate receptor 5 in ethanol regulation of NMDA receptor function and in<br />
ethanol-induced change in blood pressure in rats<br />
Chih-Chia Lai, (Taiwan), W-K Hsieh<br />
Assessing potential for drug abuse in humans: Defining clinical important differences in subjective<br />
pharmacodynamic measures<br />
Naama Levy-Cooperman, (Canada), K Schoedel, N Chen, D Feltner, CB Billing Jr., E Sellers, D Milovan<br />
258 Wednesday 21 July ■ 13:00 - 14:00 ■ Poster Area
FC15<br />
Endothelium in health and disease<br />
Wed 194<br />
Wed 195<br />
Wed 196<br />
Wed 197<br />
Wed 198<br />
Wed 199<br />
Wed 200<br />
Wed 201<br />
Wed 202<br />
Wed 203<br />
Wed 204<br />
Wed 205<br />
Wed 206<br />
Wed 207<br />
Wed 208<br />
Anatomical regional differences in aortic tissue reactivity: The role of perivascular adipose tissue in<br />
normal and diabetic rats<br />
Francis I Achike, (Malaysia), CB Chua, CY Kwan<br />
Potassium channel modulation of acidosis-induced vasodilatation of normal and diabetic rat aorta.<br />
Francis I Achike, (Malaysia), JL Yeo<br />
Red wine polyphenols prevent metabolic and cardiovascular alterations associated with obesity in<br />
zucker fatty rats (Fa/Fa)<br />
A Agouni, A-H Lagrue-Lak-Hal, HA Mostefai, A Tesse, P Mulder, P Rouet, F Desmoulins, C Heymes,<br />
MC Martinez, Ramaroson Andriantsitohaina, (France)<br />
Species difference in calcium dependency of cromakalim induced relaxation in porcine and human<br />
coronary arteries<br />
Nora Ambrus, (Hungary), J Pataricza, I Krassoi, Z Marton, M Bitay, A Varro, GJ Papp<br />
Various types of potassium channels are activated by the new nitric oxide (NO) donor<br />
[Ru(terpy)(bdq)NO+]3+ (Terpy) in mesenteric resistance arteries of renal hypertensive rats<br />
Alice Araújo, (Brazil), J Vercesi, J Biazzotto, R da Silva, L Bendhack<br />
The variations in measurements of blood pressurec values obtained by the conventional method and<br />
the ambulatory blood pressure monitoring<br />
Mensura Asceric, (Bosnia Herzegovina), N Mulabegovic, E Kapic, F Becic, S Loga-Zec, J Kusturica<br />
Functional distribution of nitrergic nerve derived from pterygoparatine ganglion in monkey cerebral<br />
artery<br />
Kazuhide Ayajiki, (Japan), S Kobuchi, N Toda, M Hanamitsu, T Okamura<br />
Mast cell activation alters neuronal nitric oxide release in rat mesenteric artery<br />
Gloria Balfagón, (Spain), J Blanco-Rivero<br />
Temporal effects of ATP/ADP in a murine sepsis model<br />
Hermes Vieira Barbeiro, (Brazil), DF Barbeiro, FR Laurindo, HP Souza, IT Velasco, FG Soriano<br />
Vascular reactivity on Nagase analbuminemic rats challenged by LPS<br />
Hermes Vieira Barbeiro, (Brazil), CB Lorigados, DF Barbeiro, S Catanozi, E Nakarandake, IT Velasco,<br />
FB Fusco, A dos Santos Filho, FG Soriano<br />
Volemic reposition on vascular reactivity of endotoxemic rats.<br />
Hermes Vieira Barbeiro, (Brazil), RC Petroni, TSL Garcia, DF Barbeiro, CB Lorigados, FG Soriano,<br />
IT Velasco<br />
The peculiarities of action of pentoxifylline on rat isolated aorta in experimental hypokinesia<br />
Aram Baykov, (Armenia), A Manukyan<br />
The endothelial pathway for current spread is modulated by smooth muscle K+-channels<br />
Timea Z Beleznai, (UK), KA Dora<br />
Endothelium-derived hyperpolarizing factor and nitric oxide regulate arterial wall viscosity in vivo in<br />
humans<br />
Jeremy Bellien, (France), M Iacob, C Thuillez, R Joannides<br />
Oral sildenafil increases sodium nitroprusside iontophoresis induced skin hyperaemia in healthy<br />
volunteers<br />
S Blaise, M Hellmann, M Roustit, S Isnard, Jean-Luc Cracowski, (France)<br />
Wednesday 21 July ■ 13:00 - 14:00 ■ Poster Area 259
FC15<br />
Endothelium in health and disease<br />
Wed 209<br />
Wed 210<br />
Wed 211<br />
Wed 212<br />
Wed 213<br />
Wed 214<br />
Wed 215<br />
Wed 216<br />
Wed 217<br />
Wed 218<br />
Wed 219<br />
Wed 220<br />
Wed 221<br />
Wed 222<br />
Wed 223<br />
Wed 224<br />
CANCELLED<br />
Analysis of nitric oxide sensitive guanylyl cyclase activation by ciguates based on MANT-GTP<br />
fluorescence<br />
Mareike Busker, (Germany), JR Kraehling, M Seeanner, S Behrends<br />
PKG mediates the testosterone vasorelaxant effect in human umbilical artery without endothelium<br />
Elisa Cairrão, (Portugal), AJ Santos-Silva, I Verde<br />
Rat kidney antioxidant enzymes in an experimental model of preeclampsia<br />
Elsa Camacho, (Venezuela), J Silva, MG Matos, M Varela, MR Garrido, A Israel<br />
Increased sensitivity of cerebral and coronary arteries to GPCR agonists in spontaneously hypertensive<br />
rats<br />
Lei Cao, (Sweden), Y Zhang, Y-X Cao, L Edvinsson, C-B Xu<br />
Correlation between amine oxidases kinetic parameters and nitric oxide production in human<br />
mesenteric arteries<br />
Margarida Caramona, (Portugal), S Nunes, J Pereira, C Lopes, I Figueiredo<br />
Coronary artery bypass grafting surgery worsens oxidative stress among patients with coronary<br />
disease<br />
Manuel Carnero, (Spain), J Muñoz-Marin, JA González Correa, F Reguillo, J Navarro-Dorado, M Ramajo,<br />
JP de la Cruz, T Tejerina<br />
Estrogen receptor α as a key target of red wine polyphenols action on the endothelium<br />
M Chalopin, A Tesse, MC Martinez, D Rognan, JF Arnal, Ramaroson Andriantsitohaina, (France)<br />
The hypocholesterolemic effect of a novel series of compounds with structural properties of α-asarone<br />
and fibrates in tyloxapol treated mice.<br />
Germán Chamorro, (Mexico), C Zúñiga, L Garduño, MdC Cruz, R Pérez, F Labarrios, J Tamariz<br />
Secretoneurin induces endothelium-dependent relaxation of the porcine coronary artery<br />
Calvin KY Chan, (PR China), JCW Mak, PM Vanhoutte<br />
NADPH oxidase and TGF-β signalling in extracellular matrix production in cardiac fibroblasts<br />
Elsa Chan, (Australia), H Peshavariya, G Nancy, F Jiang, G Dusting<br />
Characterization of VIP and PACAP receptors in the human coronary and meningeal artery<br />
Kayi Chan, (The Netherlands), M Baun, J Danser, I Jansen-Olesen, AM van den Brink, S Gupta<br />
Acute effect of sulfaphenazole on isolated mesenteric small arteries from db/db mice<br />
Hua Chen, (Denmark), U Simonsen, C Aalkjaer<br />
Role of RhoA/ROK in vascular hyporeactivity induced by endotoxin in early and late sepsis<br />
Shiu-Jen Chen, (Taiwan), M-H Liao, C-C Wu<br />
High-sodium loaded in rats impairs central baroreflex and ACh-induced vasodilation<br />
Akiko Chisyaki, (Japan), M Tsuruhisa, M Miyakawa, T Masuda, Y Hirabara, K Honda, R Saito, Y Takano<br />
Increased outward currents recorded in situ from endothelial cells of rabbit coronary arteries after<br />
ischemia reperfusion<br />
Belén Climent, (Spain), AL García-Villalón, N Fernández, L Monge, G Diéguez, A García Sacristán,<br />
L Rivera<br />
260 Wednesday 21 July ■ 13:00 - 14:00 ■ Poster Area
FC15<br />
Endothelium in health and disease<br />
Wed 225<br />
Wed 226<br />
Wed 227<br />
Wed 228<br />
Wed 229<br />
Wed 230<br />
Wed 231<br />
Wed 232<br />
Wed 233<br />
Wed 234<br />
Wed 235<br />
Wed 236<br />
Wed 237<br />
Wed 238<br />
Wed 239<br />
Contribution of smooth muscle BKCa currents to outward currents recorded from endothelial cells in<br />
situ<br />
Belén Climent, (Spain), P de la Villa, U Simonsen, A García-Sacristán, L Rivera<br />
Ceramide is involved in the hypoxic vasoconstriction of chicken pulmonary and choriallantoic arteries<br />
Angel Cogolludo, (Spain), E Villamor, J Moral-Sanz, R Scheepers, B Barreira, C Menendez, L Escolano,<br />
L Moreno, F Perez-Vizcaino<br />
Epac proteins as a determinant for forskolin-induced vasorelaxant effect and cAMP-inhibition of store<br />
operated Ca 2+ entry in vascular myocytes<br />
Andrea Cuíñas, (Spain), J Elies, M Campos-Toimil<br />
A comparative study of α-adrenergic receptor mediated Ca 2+ signals and contraction in intact human<br />
and mouse vascular smooth muscle<br />
Jiazhen Minnie Dai, (Canada), H Syyong, C van Breemen, J Navarro-Dorado, S Redondo, M Alonso,<br />
T Tejerina<br />
Activators of small conductance calcium-activated potassium channels selectively enhance bradykinin<br />
NO-mediated vasodilatation in porcine retinal arterioles<br />
Thomas Dalsgaard, (Denmark), C Kroigaard, M Misfeldt, T Bek, U Simonsen<br />
Nitrite and nitroglycerin preferentially dilate large systemic arteries during hypoxia<br />
Thomas Dalsgaard, (Denmark), C Kroigaard, A Fago, U Simonsen<br />
Exposure to concentrated ambient fine particles (PM2.5) of urban Sao Paulo air pollution induces<br />
endothelial dysfunction and structural changes in rat pulmonary arteries<br />
Ana Paula Davel, (Brazil), M Lemos, L Pastro, L Rossoni, P Saldiva<br />
Changes in rats vascular reactivity in response to neonatal induced hyperleptinaemia<br />
Fernanda Carla Ferreira de Brito, (Brazil), NAV da Motta, EB Marques, CBV Scaramello, LL da Silva<br />
Role of protein disulfide Isomerase in angiotensin II induced contraction in vascular smooth muscle<br />
cells from spontaneously hypertensive rats<br />
Livia de Lucca Camargo, (Brazil), ACD Androwiki, GS Ceravolo, AZ Chignalia, Alexandre Denadai-<br />
Souza, MN Muscará, MHC de Carvalho, ZB Fortes, M Janizewski, LR Lopes<br />
Signalling via IRAG regulates NO- and ANP-mediated smooth muscle relaxation<br />
Matthias Desch, (Germany), B Hieke, D Bernhard, K Hoecherl, F Hofmann, J Schlossmann<br />
CANCELLED<br />
Thalidomide produces smooth muscle relaxation<br />
James R Docherty, (Ireland), SW Seto<br />
Protein disulfide isomerase regulates reactive oxygen species generation and angiotensin II induced<br />
contraction in aorta from wistar rats<br />
Ana Alice Dos Santos Dias, (Brazil), LL Camargo, GS Ceravold, ACD Androwiki, MHC Carvsalho,<br />
FRM Laurindo, M Janiszewski, LR Lopes<br />
Evidence for functional two-pore domain potassium channels (K2P) in rat mesenteric arteries<br />
Gillian Edwards, (UK), E Porter, N Ashton, A Gurney, A Weston, I Johnson<br />
Rho kinase-dependent calcium sensitization in the interplay between pressure- and agonist-induced<br />
constriction of cerebral artery<br />
Ahmed El-Yazbi, (Canada), RP Johnson, K Takeya, EJ Wlash, MP Walsh, WC Cole<br />
Wednesday 21 July ■ 13:00 - 14:00 ■ Poster Area 261
FC15<br />
Endothelium in health and disease<br />
Wed 240<br />
Wed 241<br />
Wed 242<br />
Wed 243<br />
Wed 244<br />
Wed 245<br />
Wed 246<br />
Wed 247<br />
Wed 248<br />
Wed 249<br />
Wed 250<br />
Wed 251<br />
Wed 252<br />
Wed 253<br />
Wed 254<br />
Pulmonary pressure reduction attenuates expression of proteins identified by lung proteomic profiling in<br />
pulmonary hypertensive rats<br />
Yvonne Eskildsen-Helmond, (Denmark), L Østergaard, B Honore, L Bech Thorsen, J Baandrup,<br />
B Elmedal Laursen, H Vorum, M Mulvany, U Simonsen<br />
Unfolded protein response involved in oxidized LDL-evoked endothelial dysfunction<br />
Yvonne Eskildsen-Helmond, (Denmark), M Jørgensen, E Stankevicius, N Christophersen, E Falk,<br />
U Simonsen<br />
Tanshinone IIA inhibits ER-α activity in MCF-7 breast cancer cell<br />
Guanwei W Fan, (China), XM Gao, H Wang, Y Zhu, J Zhang, L Hu<br />
Prostaglandin E2 promotes angiogenesis by synergizing with fibroblast growth factor receptor-1/<br />
fibroblast growth factor-2 system<br />
Federica Finetti, (Italy), S Donnini, L Morbidelli, A Giachetti, M Ziche<br />
High salt intake abolishes AT2-mediated vasodilation of pial arterioles in rats<br />
Sebastien Foulquier, (France), C Perrin-Sarrado, F Dupuis, F Soussi, P Liminana, Y-W Kwan,<br />
C Capdeville-Atkinson, I Lartaud, J Atkinson<br />
Impact of window L-type Ca 2+ influx on activity of Ca 2+ channel blockers in aortic smooth muscle cells<br />
of C57Bl6 mice<br />
Paul Fransen, (Belgium), CE Van Hove, C Michiels, J van Langen, H Bult<br />
Significance of window L-type calcium influx for contraction of C57Bl6 mouse aortic segments<br />
Paul Fransen, (Belgium), CE Van Hove, J van Langen, H Bult<br />
Role of HIF-1 β in endothelial cells in monocrotaline-induced pulmonary hypertension in mice<br />
Yayoi Fukuhara, (Japan), S Tomita, Y Imamura, Y Horinouchi, M Imanishi, T Sakurada, T Kitagawa,<br />
T Tamaki<br />
The difference in cerebrovascular effects of Afobazol and Nimodipin under the conditions of combined<br />
cardiac and cerebral vascular pathology<br />
Tamara Ganshina, (Russian Federation), R Mirzoyan, N Khaylov, S Seredenin<br />
ABCB1 C3435T genetic polymorphism alters clinical response to losartan in patients with hypertension<br />
MT Goktas, F Pepedil, G Sain-Guven, B Cakir, Melih O Babaoglu, (Turkey), U Yasar, A Bozkurt<br />
Pharmacodynamic/pharmacokinetic study of two formulation of acetylsalicylic acid in patients with<br />
chronic coronary disease<br />
Jose Antonio Gonzalez-Correa, (Spain), A Guerrero, E Rueda, MM Arrebola, JA Lopez-Villodres,<br />
JP de la Cruz<br />
Effect of sulodexide on vascular permeability in the kidney of diabetic rats<br />
Caroline González-Serryn, (Venezuela), D Fernandes, Y Mathison<br />
Alteration of the effects of growth factors by simulated microgravity<br />
Daniela Grimm, (Denmark), C Ulbrich, J Pietsch, M Infanger, G Aleshcheva, J Bauer<br />
Endothelial dysfunction of uterine artery in suramin-induced preeclampsia-like syndrome in rats<br />
Sebile Guler, (Turkey), EG Cekic, G Soydan, D Ertoy Baydar, M Tuncer<br />
Sexual dimorphism in aortic endothelial function of streptozotocin-induced diabetic rats<br />
X Han, R Zhang, L Anderson, Roshanak Rahimian, (USA)<br />
262 Wednesday 21 July ■ 13:00 - 14:00 ■ Poster Area
FC15<br />
Endothelium in health and disease<br />
Wed 255<br />
Wed 256<br />
Wed 257<br />
Wed 258<br />
Wed 259<br />
Wed 260<br />
Wed 261<br />
Wed 262<br />
Wed 263<br />
Wed 264<br />
Wed 265<br />
Wed 266<br />
Wed 267<br />
Wed 268<br />
Wed 269<br />
Is hydrogen sulfide an endothelium-derived relaxing factor<br />
Joanne Hart, (Australia), M Al-magableh<br />
Change in intracellular Ca 2+ response of middle cerebral artery of stroke-prone spontaneously<br />
hypertensive rats<br />
Terumasa Hashimoto, (Japan), H Ohata, T Miyazaki, K Shibata, K Nobe, K Honda<br />
Maternal high fat diet programmed endothelial dysfunction on juvenile offspring born to high fat diet on<br />
nonhuman primate model<br />
Guo-Wei He, (PR China), L Fan, P Sinnayah, KL Grove<br />
Synergistic effect of iron and glucose on endothelial cells is mediated by DDAH/ADMA/ROS signalling<br />
pathway<br />
Ming He, (PR China), D Liu, D Yin, Z Liao, L Tang, Q Huang<br />
Protective effect of sodium nitroprusside against in vitro ischemia-reperfusion injury of rat mesenteric<br />
artery<br />
X He, M Zhao, H-L Zhang, X-L Xu, L-Y Xie, L Sun, X-J Yu, Wei-Jin Zang, (PR China)<br />
Vascular actions of the calcimimetic, cinacalcet<br />
Vanessa W-S Ho, (UK), P Thakore<br />
Ischemic suppression of cerebral endothelial eNOS: Effects of estrogen<br />
James Horne, (USA), S Duckles, D Krause<br />
Orexins depolarize rostral ventrolateral medulla neurons and regulate cardiovascular functions in the rat<br />
mainly via orexin 2 receptor<br />
Shang-Cheng Huang, (Taiwan), Y-W Dai, Y-H Li, C-T Chen, L-L Hwang<br />
Effect of fluvastatin on cerebral salt wasting after subarachnoid hemorrhage in rats<br />
Takahiro Igarashi, (Japan), M Yoneko, J Kojima, N Moro, Y Kondo, Y Katayama<br />
NO dilates rat retinal blood vessels through the COX-1-dependent prostanoids-cAMP signalling pathway<br />
in vivo<br />
Kunio Ishii, (Japan), A Mori, K Sakamoto, T Nakahara<br />
Role of AT1 receptor and NAD(P)H oxidase in the pressor resonse and hypothalamic antioxidant<br />
enzymes activity induce by forced immobilization in rats<br />
Anita Israel, (Venezuela), J Silva, S DeJesus, I Medina, MR Garrido<br />
Involvement of early release of HMGB1 in aggravation of neuronal damage after transient focal<br />
ischemia in diabetic rat brain<br />
Naohiro Iwata, (Japan), M Okazaki, S Kamiuchi, Y Hibino<br />
The effect of connexin 43 remolding in vascular restenosis<br />
Liping Jiang, (China), L Zhu, T Hong, J Feng<br />
Evidence for a novel signalling mechanism involving NAADP in endothelium-dependent hyperpolarization<br />
of resistance arteries<br />
Francesc Jimenez-Altayo, (UK), KA Dora, P Galindo, GC Churchill, A Galione, CJ Garland<br />
Reduced two-pore domain potassium channel (K2P) function may contribute to hypertension in<br />
spontaneously-hypertensive rats<br />
Ian Johnson, (UK), E Porter, N Ashton, A Gurney, A Weston<br />
Wednesday 21 July ■ 13:00 - 14:00 ■ Poster Area 263
FC15<br />
Endothelium in health and disease<br />
Wed 270<br />
Wed 271<br />
Wed 272<br />
Wed 273<br />
Wed 274<br />
Wed 275<br />
Wed 276<br />
Wed 277<br />
Wed 278<br />
Wed 279<br />
Wed 280<br />
Wed 281<br />
Wed 282<br />
Wed 283<br />
Wed 284<br />
Wed 285<br />
Wed 286<br />
Roles of binding affinity and lipophilicity in the kinetics of prostanoid receptor ligands<br />
Robert Jones, (UK), D Woodward, J Wang, R Clark<br />
Arterial vasodilation mediated by proteinase-activated receptor-2 in obese diabetic mice<br />
Satomi Kagota, (Japan), JJ McGuire<br />
Cessation of the metabolic disturbances progressing and endothelial dysfunction in patients with<br />
ischemic heart disease<br />
Tamara Kezeli, (Georgia), N Gongadze, M Chipashvili, M Mirziashvili, K Bakuridze<br />
Chronic intake of RWPs improves EDHF-mediated relaxation in the mesenteric artery of old rats: Role of<br />
angiotensin II and AT1 receptors<br />
N Khodja, T Chataigneau, C Auger, Valerie B Schini-Kerth (France)<br />
3',4'-Dihydroxyflavonol decreases vascular contraction through inhibition of the RhoA/Rho-kinase<br />
pathway in endothelium-denuded rat aorta<br />
InKyeom Kim, (South Korea)<br />
Calcium sensitization induced by sodium fluoride in permeabilized rat mesenteric arteries<br />
InKyeom Kim, (South Korea)<br />
Protective effect of Ilex latifolia on glutamate-induced neurotoxicity in vitro and focal cerebral ischemia<br />
in vivo<br />
Joo Youn Kim, (South Korea), YH Seong<br />
Functional analysis of single nucleotide polymorphsims in NOS2A<br />
Soon Ae Kim, (South Korea), SY Yang<br />
Expression of soluble VEGF receptor-1 in human monocyte-derived mature dendritic cells<br />
Masatoshi Kishuku, (Japan), Y Nishioka, K Teraoka, K Kawazoe, H Hochi, S Sone, K Minakuchi<br />
Estrogen-induced relaxation of rat tail artery was attenuated in rats with pulmonary hypertension<br />
Ivan Kocic, (Poland), R Szczepazka, I Pawlowska<br />
Dimerization of nitric oxide sensitive guanylyl cyclase<br />
Jan Robert Kraehling, (Germany), M Busker, T Haase, M Seeanner, S Behrends<br />
Expression and functional studies of small- and intermediate conductance calcium-activated potassium<br />
channels in human small pulmonary arteries and bronchioles<br />
Christel Kroigaard, (Denmark), T Dalsgaard, B Elmedal Laursen, H Pilegaard, U Simonsen<br />
SKCa and BKCa expression is upregulated in pulmonary arteries from chronic hypoxic rats<br />
Christel Kroigaard, (Denmark), T Dalsgaard, S-P Olesen, U Simonsen<br />
Sex difference in experimental hypoxic pulmonary hypertension in rats<br />
Olga Kudryavtseva, (Denmark), N Medvedeva, V Koshelev<br />
Involvement of large-conductance Ca 2+ -activated K + channels in acetylcholine-evoked vasodilation of<br />
human penile small arteries<br />
Attila Kun, (Hungary), I Kiraly, A Varro, U Simonsen, J Pataricza, JG Papp, L Pajor<br />
Vasoconstriction in omental arteries from obese human subjects<br />
Hye Chung Kwak, (UK), M Larvin, P Leeder, J Ahmed, S O'Sullivan<br />
Methyl palmitate is the retina-derived relaxing factor<br />
Yuan-Chieh Lee, (Taiwan), H-H Chang, C-H Liu, M-F Chen, P-Y Chen, H-S Kuo, TJ-F Lee<br />
264 Wednesday 21 July ■ 13:00 - 14:00 ■ Poster Area
FC15<br />
Endothelium in health and disease<br />
Wed 287<br />
Wed 288<br />
Wed 289<br />
Wed 290<br />
Wed 291<br />
Wed 292<br />
Dual ECE/NEP inhibition and ETA/B receptor antagonists: Two ways of inhibiting endogenous ET-1<br />
effects in resistance arteries<br />
Pieter Lemkens, (The Netherlands), J Nelissen, JGPJ Bost, BJA Janssen, PMA Schiffers, JGR De Mey<br />
Impairment of both nitric oxide and endothelium-derived hyperpolarizing factor in streptozotocin-induced<br />
diabetic small mesenteric artery<br />
Chen Huei Leo, (Australia), J Ziogas, JL Favaloro, OL Woodman<br />
7 day treatment with 3’,4’-dihydroxyflavonol prevents endothelial dysfunction in mesenteric arteries<br />
from streptozotocin-induced diabetic rats<br />
Chen Huei Leo, (Australia), J Ziogas, JL Favaloro, OL Woodman<br />
Inhibition of cyclooxygenase activity improves endothelium-dependent relaxation in mesenteric arteries<br />
of ovariectomized rats following chronic inhibition of nitric oxide synthase<br />
Susan WS Leung, (PR China), MLY Chan, GSK Man, RYK Man<br />
Inhibition of Ikα kinase a/b (IKKα/β) improved insulin resistance of endothelial cells induced by high<br />
glucose in vitro<br />
ZX Li, FH Chen, LL Liu, RX Zhan, Y Gao, SR Peng, CX Chen, Qi-Ren Huang, (PR China)<br />
Characterization of the CGRP receptor antagonist telcagepant (MK0974) in human isolated coronary<br />
arteries<br />
Kayi Chan, (The Netherlands), L Edvinsson, S Eftekhari, R de Vries, S Kane, R Hargreaves, J Danser,<br />
AM van den Brink<br />
Wednesday 21 July ■ 13:00 - 14:00 ■ Poster Area 265
W30<br />
Is eNOS Still a valid therapeutic target<br />
– The era after the discovery of eNOS uncoupling<br />
Wed 293<br />
DHEA prevents pulmonary arterial hypertension in a rodent model of pulmonary hypertension in infants<br />
Jean-Pierre Savineau, (France), T Ducret, J-F Quignard, G Simon, R Marthan, E Dumas de la Roque<br />
266 Wednesday 21 July ■ 13:00 - 14:00 ■ Poster Area
FC16<br />
Natural products: Past and future<br />
Wed 294<br />
Wed 295<br />
Wed 296<br />
Wed 297<br />
Wed 298<br />
Wed 299<br />
Wed 300<br />
Wed 301<br />
Wed 302<br />
Wed 303<br />
Wed 304<br />
Wed 305<br />
Wed 306<br />
Wed 307<br />
Wed 308<br />
Wed 309<br />
Mechanism of antiproliferative action of Xylopia aethiopica (annonaceae) dried fruits extract on human<br />
cervical cancer cells<br />
Oluwatosin Adaramoye, (Nigeria), N Singh, S Meena, B Changkija, R Konwar, S Sinha, J Sarkar<br />
The analgesic and antiinflammatory activities of the aqueous leaf and stem extract of Asystasia<br />
gangetica<br />
Olufunmilayo O Adeyemi, (Nigeria), FR Aigbe, GN Uyaiabasi<br />
In vivo antioxidant activity of Byrsocarpus coccineus Schum. and Thonn. (Connaraceae) extract in<br />
carbon tetrachloride-induced hepatotoxicity in rats<br />
Olufunmilayo O Adeyemi, (Nigeria), A Akindele, K Ezenwanebe, C Anunobi<br />
Cardiac and renal effects of Tityus serrulatus venom and a new isolated peptide<br />
Renata S Alves, (Brazil), ARC Jorge, RM Ximenes, A Havt, NRF Nascimento, MGR Queiroz,<br />
AMC Martins, MH Toyama, HSA Monteiro<br />
Evaluation of the anticonvulsant activity of Zanthoxylum capense (Thunb.) Harv. (Rutaceae) leaf<br />
methanol extract in mice<br />
George Amabeoku, (South Africa), CG Kinyua<br />
Improving the antibacterial activity of lysozyme by conjugation with polysaccharides<br />
Mahmoud Aminlari, (Iran)<br />
Shikonin, a natural naphtoquinone, promotes wound healing in intestinal epithelial cells-18<br />
Isabel Andújar, (Spain), MC Recio, JL Ríos<br />
A new anticoccidial product developed from Artemisia sieberi plant<br />
Hossein Ali Arab, (Iran), A Rasouli, J Kaboutari, S Rahbari<br />
Evaluation of the gastric antiulcer activity of a proteolytic fraction from Carica candamarcensis latex<br />
Ana Cândida Araújo e Silva, (Brazil), FO Lemos, C Figueiredo, CTR Viana, CM Souza, GD Cassali,<br />
CE Salas, MTP Lopes<br />
Antinociceptive activity of fruits of methanolic extract of Capparis ovata in mice<br />
Rana Arslan, (Turkey), N Bektas<br />
Evaluation of hepatoprotective activity of Garcinia indica in rodents: Evidence of antioxidant activity<br />
Hardik D Ashar, (India), VS Panda<br />
Effects of free D-amino acids present in foods on human dermal fibroblasts<br />
Yutaka Ashida, (Japan), S Shimada, C Okamura, M Mita, K Hamase<br />
Several fruit and berry juices and purées are potent inducers of endothelium-dependent relaxations in<br />
the porcine coronary artery via activation of nitric oxide and endothelium-derived hyperpolarizing factor<br />
pathways<br />
C Auger, S Trinh, J-H Kim, T Chataigneau, Valerie B Schini-Kerth, (France)<br />
Effect of the anthraquinone compound rhein on human colon adenocarcinoma cell proliferation<br />
Gabriella Aviello, (Italy), I Rowland, C Gill, AM Acquaviva, R Capasso, AA Izzo, F Capasso, F Borrelli<br />
Inhibitory actions of carvacrol 1,4-cineole but not 1,8-cineole on field stimulation of isolated rat vas<br />
deferens: Role of isopropyl group as a pharmacophore<br />
Suleyman Aydin, (Turkey), Y Cakmakci<br />
The effects of carvacrol thymol and propofol on isolated rat atrium<br />
Yasemin Aydin, (Turkey), S Arkan, S Aydin<br />
Wednesday 21 July ■ 13:00 - 14:00 ■ Poster Area 267
FC16<br />
Natural products: Past and future<br />
Wed 310<br />
Wed 311<br />
Wed 312<br />
Wed 313<br />
Wed 314<br />
Wed 315<br />
Wed 316<br />
Wed 317<br />
Wed 318<br />
Wed 319<br />
Wed 320<br />
Wed 321<br />
Wed 322<br />
Wed 323<br />
Wed 324<br />
Wed 325<br />
Pharmacological screening of medicinal plants in Swaziland<br />
Peter Aziba, (Nigeria)<br />
Effects of surfacen in low and maintained dose in the treatment of ARDS. Preliminary results.<br />
Yinet Barrese Pérez, (Cuba), Y Avila Albuerne, E Díaz Casañas, O Fernández Lima, R Uranga Piña,<br />
CM Ballagas Flores<br />
Effects of the endemic plant, Eryngium kotschyi, on rat isolated ileum and detrussor muscle<br />
E Baydan, M Kartal, S Aslan, S Ýnce, Begum Yurdakok, (Turkey), H Ekici, H Alp<br />
Honey: the oldest modern remedies for mastitis<br />
Mokhtar El-Bachir Benhanifia, (Algeria), L Boukraâ<br />
Study of influency indol-3-carbinol, epigallocatechin-3-gallate and soy on proliferation diseases of the<br />
reproductive system in women<br />
Nadyia Berdnikova, (Russian Federation), L Zorina, S Serebrova<br />
Study of the antihypertensive potential of Indian medicinal plant, Emblica officinalis, in a rat model of<br />
hypertension<br />
Jagriti Bhatia, (India), F Tabassum, DS Arya, S Joshi, AK Shrivastava<br />
Anti-inflammatory and antiproliferative potential of extracts and purified fractions from Mediterranean<br />
marine algae<br />
Abderrahmene Bouraoui, (Tunisia), W Chaouch, L Mhadhebi, A Dellai, M Dridi, A Laroche, F Berrue,<br />
R Kerr, J Robert<br />
Today’s use of medicinal natural products by Italian women in Sicily<br />
Gioacchino Calapai, (Italy), A Pieratti, D Crupi, A De Sarro<br />
Anti-inflammatory effects of the pentacyclic triterpenes α,β-amiryns on animal models of irritative<br />
contact dermatitis induced by tetradecanoylphorbol 13-acetate<br />
Iana Calou, (Brazil), D Gonçalves, T Melo, T Olinda, GA Brito, V Rao, M Chaves, F Santos<br />
The anti-inflammatory effect of the pentacyclic triterpenes α and β amiryns on animal model of delayed<br />
hypersensitivity induced by repeated applications of oxazolone<br />
Iana Calou, (Brazil), D Gonçalves, T Olinda, T Melo, I Figueiredo, GA Brito, M Chaves, V Rao, F Santos<br />
Molecular mechanisms of Pistacia lentiscus essential oil antiproliferative activity<br />
Elisabetta Casarin, (Italy), B Barocco, A Buriani, M Carrara<br />
Effect of chromium enriched fermentation product of bareley and beer yeast and its combination with<br />
rosiglitazone on experimentally induced hyperglycemia in mice<br />
Vlada Cekic, (Republic of Serbia), V Vasovic, V Jakovljevic, D Lalosevic, M Mikov, A Sabo<br />
Inhibition of catecholamine secretion by a terpenoid extracted from Syneilesis aconitifolia (Bunge)<br />
maxim in cultured bovine adrenal chromaffin cells<br />
L Chai, H Mao, Y Su, Han Zhang, (PR China), H Guo, Y Jin, Z Zang<br />
Gastroprotective activity of Annona muricata L. on ethanol induced gastric lesions in rodents<br />
Pit Foong Chan, (Malaysia), R Abdul Hamid<br />
Pharmacological exploration of hypericum perforatum growing in India using rodent models<br />
Shyam Sunder Chatterjee, (Germany), V Kumar<br />
Structure activity relationship (SAR) of Hyperforin for its antidepressant-like activity profile<br />
Shyam Sunder Chatterjee, (Germany), O Kristhal<br />
268 Wednesday 21 July ■ 13:00 - 14:00 ■ Poster Area
FC16<br />
Natural products: Past and future<br />
Wed 326<br />
Wed 327<br />
Wed 328<br />
Wed 329<br />
Wed 330<br />
Wed 331<br />
Wed 332<br />
Wed 333<br />
Wed 334<br />
Wed 335<br />
Wed 336<br />
Wed 337<br />
Wed 338<br />
Wed 339<br />
Wed 340<br />
A novel antitussive botanical drug PDC-1427<br />
Jui-Ching Chen, (Taiwan), C-Y Lin, Y-L Ku<br />
Modulatory effects of the extract of burdock tea on hyperlipidemia rat and rice models<br />
Xiangguo Chen, (PR China), Y Xu, Y Cao, Z Han, P Li, C Wang<br />
Approach of action mechanism of TCM-98 and its active component on neuro-inflammation in in vivo<br />
and in vitro models<br />
Yuh-Fung Chen, (Taiwan), Y-W Wang, H-Y Tsai<br />
Resveratrol inhibits 8-iso-prostaglandin F2α production in young and aged rat brain<br />
Annalisa Chiavaroli, (Italy), L Brunetti, G Orlando, L Menghini, L Recinella, S Leone, C Ferrante,<br />
C Di Nisio, R Shohreh, P Di Michele, M Vacca<br />
A novel protocol for the discovery of angiogenesis-modulators<br />
Chin-wen C Cho, (UK), J-C Yeh, T-P Fan<br />
Improvement of memory in mice and increase of hippocampal excitability in rats by ginsenoside Rg1's<br />
metabolites ginsenoside Rh1 and protopanaxatriol<br />
Shifeng Chu, (PR China), J Chen, Y Wang, N Chen, J Zhang<br />
Crotoxin: a toxin from rattlesnake venom that induces a long-lasting inhibitory effect on the phagocytic<br />
activity of neutrophils<br />
Maria Cristina Cirillo, (Brazil), TS Lima, SC Cataneo, SC Sampaio, MC Della-Casa<br />
Crotoxin: a toxin from rattlesnake venom with potential anti-inflammatory properties<br />
Maria Cristina Cirillo, (Brazil), FPB Nunes, BC Zychar, MS Della-Casa, SC Sampaio, LRC Gonçalves<br />
Involvement of formyl peptide receptors on the long-lasting anti-inflammatory effect of crotoxin, a toxin<br />
from rattlesnake venom<br />
Maria Cristina Cirillo, (Brazil), FPB Nunes, BC Zychar, MS Della-Casa, SC Sampaio, LRC Gonçalves<br />
Inhibition of the 26S proteasome complex by chemical constituents of Smilax Regelii and its possible<br />
chemotherapeutic capabilities on mammary tumours in Sprague Dawley rats<br />
Damian Cohall, (Barbados), PDA Singh<br />
JNK signalling pathway involves in Aβ1-40-induced neuronal death and protective effect of extracts of<br />
ginseng and Ginkgo biloba<br />
Weihong Cong, (PR China), J Liu, L Sheng, C Lin<br />
Oxalis pes-caprae L. inhibit NA concentration-response curves in human internal mammary artery<br />
Maria Cotrim, (Portugal), M Campos, M Gaspar, D Fonseca, C Frigerio, M Antunes<br />
Comparative studies on the antimutagenicity and antioxidant activities of the fruiting body and mycelium<br />
of Thai Ganoderma lucidum<br />
Theera Dalodom, (Thailand), A Aramphongphan<br />
Heparin prevent the cardiotoxic effect of bothropstoxin I & II<br />
Miguel de Lemos Neto, (Brazil), HD Ricardo, MM Machado, VV Martins, BL Cons, A Cintra, PA Melo<br />
Hydro-alcoholic extract of açaí (an Amazon plant) prevents endothelial dysfunction, oxidative stress and<br />
development of renovascular hypertension<br />
Miguel de Lemos Neto, (Brazil), CA Costa, RS de Moura, LCRM Carvalho, PRB Oliveira, PJC Sousa,<br />
AC Resende<br />
Wednesday 21 July ■ 13:00 - 14:00 ■ Poster Area 269
FC16<br />
Natural products: Past and future<br />
Wed 341<br />
Wed 342<br />
Wed 343<br />
Wed 344<br />
Wed 345<br />
Wed 346<br />
Wed 347<br />
Wed 348<br />
Wed 349<br />
Wed 350<br />
Wed 351<br />
Wed 352<br />
Wed 353<br />
Wed 354<br />
Wed 355<br />
Protective action of hydro-alcoholic extract of açaí (an Amazon plant) on experimental metabolic<br />
syndrome in C57BL/6 mice<br />
Roberto Soares de Moura, (Brazil), PRB Oliveira, CA Costa, L Carvalho, M de Lemos Neto, PJC Sousa,<br />
AC Resende<br />
Preventive action of açai (an Amazon plant) hydroalcoholic extract on deleterious effect of cigarette<br />
smoke in mouse lungs<br />
Roberto Soares de Moura, (Brazil), AC Resende, M de Lemos Neto, MAS Silva, ETL Trajano, JN Alves,<br />
RT Nesi, PJC Sousa, LC Porto, SS Valença<br />
Gastroprotective effect of Olea europaea leaf extract in experimentaly induced gastric lesions in rats<br />
Dragana Dekanski, (Republic of Serbia), S Ristic, V Piperski, N Radonjic, N Petronijevic, D Mitrovic<br />
Pharmacological profile and therapeutic potentiality of natural product obtain from stem bark of<br />
mangifera indica l (VIMANG) and its glucosilxantona, mangiferin<br />
Rene Delgado-Hernandez, (Cuba), B Garrido Suarez, D Garcia-Rivera, GL Pardo-Andreu, P Hernandez<br />
Casaña, I Rodeiro-Guerra, I Hernandez-Balmaseda, N Merino-Garcia, MM Guevara-Garcia,<br />
A Alvarez-Leon, Y Maragiño, AJ Nuñez-Selles<br />
Mechanisms of the dilator action of a Danshen and Gegen formulation on rat basilar artery<br />
Shirlly Y Deng, (PR China), FFY Lam, ESK Ng, JHK Yeung, YW Kwan, CBS Lau, JCM Koon, PC Leung,<br />
KP Fung<br />
Vasorelaxant effects of coptisine in rat aortic rings<br />
Lian-Hua Fang, (PR China), L-L Gong, J-J Hu, H-L Qin, Y Lv, G-H Du<br />
CANCELLED<br />
Effect of Ulva lactuca in liver conservation in Wistar rat model<br />
H Ferchichi, I Salouage, S Bacha, L Ouanes, M Lakhal, Anis Klouz, (Tunisia)<br />
Asparagus officinalis regulates cholesterol metabolism and improves antioxidant status in<br />
hypercholesterolemic rats<br />
Aangeles Fernández-Arche, (Spain), D García -Gonzalez, R Saenz-Rodriguez, R Puerta-Vazquez<br />
Acute oral and acute dermal toxicity study of Dioscorea hispida (nami) aqueous plant extract in<br />
sprague-dawley rats<br />
Mona Liza Flores, (Philippines)<br />
Effects of resveratrol on learning and memory in rats<br />
Nejat Gacar, (Turkey), O Mutlu, T Utkan, I Komsuoglu Celikyurt, SS Gocmez, G Ulak<br />
A Jerte Valley cherry-based product acts as an enhancer of sleep, improves mood and possesses<br />
antioxidant properties<br />
Maria Garrido, (Spain), D Gonzalez-Gomez, M Lozano, MT Hernandez, MS Salcedo, C Barriga,<br />
SD Paredes, AB Rodriguez<br />
Pharmacological use of Borago officinalis<br />
Anwar-ul-Hassan Gilani, (Pakistan)<br />
Pharmacological basis for the medicinal use of Psyllium husk in constipation and diarrhea<br />
Anwar-ul-Hassan Gilani, (Pakistan), MH Mehmood<br />
Antidepressant activity of Orchis mascula<br />
Anwar-ul-Hassan Gilani, (Pakistan), S Khan, HS Siddiqi<br />
270 Wednesday 21 July ■ 13:00 - 14:00 ■ Poster Area
FC16<br />
Natural products: Past and future<br />
Wed 356<br />
Wed 357<br />
Wed 358<br />
Wed 359<br />
Wed 360<br />
Wed 361<br />
Wed 362<br />
Wed 363<br />
Wed 364<br />
Wed 365<br />
Wed 366<br />
Wed 367<br />
Wed 368<br />
Wed 369<br />
Pharmacological basis for the medicinal use of Origanum Vulgare Linn. in urolithiasis<br />
Anwar-ul-Hassan Gilani, (Pakistan), A Khan<br />
The effects of Lavandula stoechas extract on cholesterol levels and cardiac functions on<br />
ischemia-reperfusion model in isolated rat hearts<br />
Sule Gok, (Turkey), E Olmez, A Sonmez, K Vural, E Darýverenli, M Soylar<br />
Effect of hydroalcoholic extract of Emblica officinalis (HAEEO) against kainic acid induced seizures,<br />
oxidative stress and expression of heat shock proteins in rat brain<br />
Mahaveer Golechha, (India), J Bhatia, A Goyal<br />
Trans-resveratrol enhances eNOS expression and decreases its interaction with caveolin 1 in vascular<br />
smooth muscle and endothelial cells<br />
JE Gomez, A Cuíñas, J Leiro, F Orallo, Manuel Campos-Toimil, (Spain)<br />
Enzymatic inhibition, antioxidant and antibacterial activity of medicinal plant extracts: Potential<br />
application in the management of type 2 diabetes<br />
Vandana Gulati, (Australia), I Harding, E Palombo<br />
Effects of high-salt diet and bioactive peptides on mRNA expression of common markers of<br />
renin-angiotensin-aldosterone system in Goto-Kakizaki rat aorta<br />
Anne Hakala, (Finland), P Jäkälä, AM Turpeinen, R Korpela, H Vapaatalo<br />
Sasanquasaponin pretreatment protects cadiocytes from acute anoxia damage via a ERK1/2-HSP70<br />
pathway<br />
M He, Qingxian Zhu, (PR China), D Liu, L Tang, D Yin, Z Liao<br />
Ginkgolide B slows the cystogenesis and growth in MDCK and embryonic kidney models of polycystic<br />
kidney disease via PKA-dependent pathway<br />
Zhou Hong, (PR China), G Jinsheng, Y Baoxue<br />
Effect of Crocus sativus extract on seizure-induced extracellular changes of glutamate and aspartate in<br />
the rat hippocampus<br />
Hossein Hosseinzadeh, (Iran), H-R Sadeghnia, A Rahimi<br />
Preliminary investigation to the clinical application of phospholipase A2 inhibitor from snake serum<br />
Chunghong Huang, (PR China), X Deng, K Chen<br />
Snake venom C type lectin protein, agacutegrin, inhibits platelet aggregation and carcinoma cell<br />
migration<br />
Chunhong Huang, (PR China), S Tu, Z Liao, X Deng, K Chen<br />
Anti-hepatitis B virus activity in cultured cell line HepG2.2.15 cells of total phenolics extracted from<br />
Oenanthe javanica<br />
Zheng-Ming Huang, (PR China), X-J Wang, X-B Yang, J-G Song<br />
Mechanism of inhibition of transcription factor specificity protein 1 by betulinic acid<br />
Jan-Jong Hung, (Taiwan), W-C Chang<br />
Anti-inflammatory activity of aqueous fruit pulp extract of Hunteria umbellata K. Schum in acute and<br />
chronic inflammation<br />
Ighodaro Igbe, (Nigeria), P Ching, A Eromon<br />
Wednesday 21 July ■ 13:00 - 14:00 ■ Poster Area 271
FC16<br />
Natural products: Past and future<br />
Wed 370<br />
Wed 371<br />
Wed 372<br />
Wed 373<br />
Wed 374<br />
Wed 375<br />
Wed 376<br />
Wed 377<br />
Wed 378<br />
Wed 379<br />
Wed 380<br />
Wed 381<br />
Wed 382<br />
Wed 383<br />
Wed 384<br />
Wed 385<br />
Exploring gender differences in the relaxant effect of quercetin on phenylephrine-contracted normal and<br />
diabetic rat aorta<br />
Aloysius Iguegbe, (Malaysia), F Achike, R Mustafa<br />
Effects of A2 type botulinum toxin on spontaneous miniature and evoked transmitter release from the<br />
rat spinal excitatory and inhibitory synapses<br />
Yushi Ito, (Japan), O Akaike, MC Shin, K Nonaka, T Harakawa, A Ginnaga<br />
Tea polyphenols inhibit tube formation in cocultured endothelial cells with fibroblasts<br />
Shinichi Iwai, (Japan), A Tsuboi, C Kurahashi, A Yura, K Oguchi<br />
Inhibitory effect of piperlongumine on platelet aggregation via collagen receptor<br />
Masaya Iwashita, (Japan), Y Nasu, A Okuda, N Nakahata<br />
Effects of 3,5,7,3',4'-pentamethoxyflavone on isolated human cavernosum<br />
Chaweewan Jansakul, (Thailand), K Techanaparukse, P Sirirugsa<br />
Hypotensive constituents and their mechanisms responsible for the hypotensive activity of Phyllanthus<br />
acidus (L.) Skeels<br />
Chaweewan Jansakul, (Thailand), Y Leeya, M Mulvany, E Queiroz, A Marston, K Hostettmann<br />
Antispasmodic effect of Achillea fillipendula extract on the guinea pig ileum<br />
Katayou Javidnia, (Iran), R Miri, H Mirkhani, E Faghih mirzaei, M Sharifi<br />
Acute oral toxicity and acute dermal toxicity of the aqueous extract of Gmelina arborea Roxb. (Family<br />
Verbenaceae) leaves<br />
Maria Cesthrine Jane Javier, (Philippines)<br />
Gene expression profiling of cardioprotective effects of Qi-Shen-Yi-Qi on acute myocardial infarction<br />
M Jiang, G Wang, P Cui, Z Zhao, Xiaoying Wang, (PR China),G Luo<br />
Proteomic and metabonomic-based investigations on mechanisms of aging of senescence-accelerated<br />
mouse and actions of Liuwei and Bawei Dihuang decoctions<br />
Ning Jiang, (PR China), W-X Zhou, Y-X Zhang, X-Z Yan, Q Zhang<br />
Dyskinesia and plasma DOPA levels in hemi-Parkinsonian rats after chronic oral administration of<br />
Mucuna pruriens seed extract or L-DOPA methyl ester<br />
Monica Jørgensen, (Denmark), JB Gramsbergen, LP Christensen<br />
Evaluation of antihyperlipidemic & cardioprotective effect of methanolic extract of Lagenaria siceraria<br />
Amitesh Khare, (India), VV Khadke, AW Patil<br />
STW 5, an herbal preparation, is effective in experimental inflammatory bowel disease<br />
Mohamed T Khayyal, (Egypt), H Abdel-Aziz, W Wadie, DM Abdallah, O Kelber, B Vinson, D Weiser<br />
The protective effects by the extract from Platycodon Grandiflorum against myocardial ischemia in rats<br />
Eun-Joo Kim, (South Korea), M-H Lee, K-S Kim, B-Y Byun<br />
Effects of phytoalexin glyceollin isolated from soybean, on vascular contraction in rat aortas<br />
InKyeom Kim, (South Korea)<br />
Aronia juice, a polyphenol-rich berry juice, induces redox-sensitive activation of endothelial nitric oxide<br />
synthase and relaxation in porcine coronary arteries<br />
J-H Kim, C Auger, T Chataigneau, Valerie B Schini-Kerth, (France)<br />
272 Wednesday 21 July ■ 13:00 - 14:00 ■ Poster Area
FC16<br />
Natural products: Past and future<br />
Wed 386<br />
Wed 387<br />
Wed 388<br />
Wed 389<br />
Wed 390<br />
Wed 391<br />
Wed 392<br />
Inhibitors of Ca 2+ -ATPase thapsigargin and trilobolide possess immunostimulatory properties<br />
Eva Kmonícková, (Czech Republic), J Harmatha, K Vokác, Z Zídek<br />
Effects of antioxidant xanthones from Gentiana dinarica on Acantoscelides obtectus aging in vivo<br />
Dijana Krstic-Milosevic, (Republic of Serbia), I Spasojevic, A Nikolic-Kokic, M Spasic, D Blagojevic<br />
Modulation of vascular reactivity by kaempferol in porcine coronary arteries<br />
Yat Tin Lau, (PR China), SWS Leung, RYK Man<br />
The effect of Phela, a traditional medicine extract, on interleukin-2 in a rat model<br />
Makhotso R Lekhooa, (South Africa), A Walubo, J Du plessis, G Matsabisa<br />
A comprehensive method for identification of ‘Phela’, a traditional herbal medicine, using different<br />
chromatographic techniques<br />
Makhotso R Lekhooa, (South Africa), A Walubo, JB Du Plessis, MG Matsabis<br />
The use of metabolite peakokinetics to monitor ‘Phela’, a herbal medicine, in plasma after oral<br />
administration in a rat model<br />
Makhotso R Lekhooa, (South Africa), A Walubo, JB Du Plessis, MG Matsabisa<br />
Treatment of children’s asthma with a lipid extract of the New Zealand green lipped mussel (Perna<br />
canaliculus) (Lyprinol) – a double blind, randomised controlled trial in children with moderate to severe<br />
chronic obstructive asthma<br />
James Lello, (New Zealand), A Liang, E Robinson, D Leutenegger, A Wheat<br />
Wednesday 21 July ■ 13:00 - 14:00 ■ Poster Area 273
FC17<br />
New approaches and targets in psychiatry<br />
Wed 393<br />
Wed 394<br />
Wed 395<br />
Wed 396<br />
Wed 397<br />
Wed 398<br />
Wed 399<br />
Wed 400<br />
Wed 401<br />
Wed 402<br />
Wed 403<br />
Wed 404<br />
Wed 405<br />
Wed 406<br />
Wed 407<br />
Wed 408<br />
Wed 409<br />
Wed 410<br />
Effects of selected glutamatergic ligands on novelty-induced hyperactivity of GluA1-deficient mouse line<br />
Teemu Aitta-aho, (Finland), C Procaccini, ER Korpi, AM Linden<br />
The antipsychotic-like effect of myricitrin, a PKC inhibitor in mice<br />
Roberto Andreatini, (Brazil), M Pereira, L Pereira, MABF Vital, ARS dos Santos, MG Pizzolatti<br />
Magnesium sulphate and sodium valproate block methylphenidate-induced hyperlocomotion, an animal<br />
model of manic state<br />
Roberto Andreatini, (Brazil), FJ Barbosa, B Hesse, RB de Almeida, IP Baretta, R Boerngen-Lacerda<br />
Neuroprotective effects of the polyphenolic antioxidant agent, Curcumin, against Homocysteine-induced<br />
cognitive impairment and oxidative stress in the rat<br />
Amin Ataie, (Iran), M Sabetkasaei, A Haghparast<br />
The HPA axis, cardio-vascular system and behavior in rat CMS model of depression.<br />
Elena V Bouzinova, (Denmark), S Christiansen, K Henningsen, R Palme, O Wiborg<br />
The role of CYP2D6 and ABCB1 pharmacogenetics in the clinical efficacy of orally administered<br />
risperidone<br />
Nada Božina, (Croatia), N Jovanovic, M Lovric, V Medved, M Kudumija-Slijepèevic, J Grubišin<br />
Cholinergic and glutamate-nitric oxide signalling pathways in a genetic animal model of depression, the<br />
Flinders Sensitive Line (FSL) rat<br />
Linda Brand, (South Africa), EL Minnaar, J van Zyl, G Wegener, BH Harvey<br />
Rescue of TGF-β1 signalling as a new neuroprotective tool in Alzheimer's disease<br />
Filippo Caraci, (Italy), G Battaglia, ML Giuffrida, V Bruno, P Bosco, MA Sortino, F Drago, F Nicoletti,<br />
A Copani<br />
Neuroplastic changes precede chronic antidepressant responses of the 5-HT4 receptor agonist<br />
RS67333<br />
Elena Castro, (Spain), A Díaz, EM Valdizán, R Vidal, F Pilar-Cuellar, A Pazos<br />
Expression of VGLUTs in the process of degeneration and acquisition of learning and memory<br />
Xiaorui Cheng, (PR China), Y Zhao, W Zhou, Y Zhang<br />
Impairment of heme oxygenase-1 expression by the defect of Parkinson-related PINK1 protein<br />
Wei-Lin Chien, (Taiwan), J-R Li, M-J Li, W-M Fu<br />
Fluvoxamine pharmacokinetics in elderly subjects and patients with chronic heart failure<br />
Sara De Martin, (Italy), R Orlando, M Floreani, P Palatini<br />
Effect of GABAmimetics on the duration of immobility in behavioral despair swim test<br />
Abdalla Elhwuegi, (Libya), N Zahaf<br />
The effects of sertraline on behavioral alterations caused by environmental enrichment<br />
Kevser Erol, (Turkey), E Yildirim, E Ulupinar<br />
CANCELLED<br />
CANCELLED<br />
Oxytocin antagonist prevents pro-cognitive effect of angiotensin IV<br />
Paul Gard, (UK), C Naylor<br />
The involvement of ERK-dependent processes in antidepressant drugs effects on β-arrestins<br />
Moran Golan, (Israel), G Schreiber, S Avissar<br />
274 Wednesday 21 July ■ 13:00 - 14:00 ■ Poster Area
FC17<br />
New approaches and targets in psychiatry<br />
Wed 411<br />
Wed 412<br />
Wed 413<br />
Wed 414<br />
Wed 415<br />
Wed 416<br />
Wed 417<br />
Wed 418<br />
Wed 419<br />
Wed 420<br />
Wed 421<br />
Wed 422<br />
Wed 423<br />
Wed 424<br />
Wed 425<br />
Involvement of 5-HT1A receptors in the effects of cannabidiol injected into the bed nucleus of the stria<br />
terminalis on behavioral and cardiovascular responses induced by contextual conditioned fear<br />
Felipe V Gomes, (Brazil), DG Reis, FHF Alves, FMA Côrrea, L Resstel, FS Guimarães<br />
Effect of combined oral contraceptives on the serum concentration of olanzapine<br />
Tore Haslemo, (Norway), H Refsum, E Molden<br />
Involvement of α7 nicotinic acetylcholine receptor on the conditioned place aversion induced by naloxone<br />
in single-dose morphine-treated rats<br />
Shigeru Ishida, (Japan), Y Ikuta, I Miyazaki, M Asanuma, H Matsunaga, T Sendo, H Araki, H Kawasaki,<br />
Y Kitamura<br />
Serotonergic gene polymorphisms and drug plasma concentration influence therapeutic response to<br />
paroxetine in patients with panic disorder<br />
Shin Ishiguro, (Japan), M Ueda, T Watanabe, Y Saeki, T Ayugase, A Saito, K Akiyama, Y Inoue,<br />
S Morita, G Hirokane, N Yamada, K Shimoda<br />
Association between autonomic nervous system activity in schizophrenia and antipsychotic medication:<br />
the comparison of typical and atypical antipsychotic drugs<br />
Yohko Iwamoto, (Japan), I Kisida, M Fujibayashi, S Tanaka, C Kawanishi, N Ishii, Y Hirayasu, T Moritani<br />
Ilex latifolia protects against amyloid β protein (25-35)-induced neurotoxicity in cultured neurons and<br />
has antidementia activities in mice<br />
Ha Yeon Jeong, (South Korea), YH Seong<br />
St. John´s wort extract or fluoxetine influence gene expression of hypothalamic and hippocampal tissues<br />
in a model of stress induced depression<br />
Peggy Jungke, (USA), G Ostrow, J Li, C Kolb, O Kelber, D Weiser, K Nieber, V Butterweck<br />
Inhibition by lithium of the nitrergic relaxation of rat anococcygeus muscle<br />
Alireza Karimollah, (Iran), M Ghasemi, MH Ghahremani, AR Dehpour<br />
Effect of propranolol alone and in combination with alprazolam on elevated plus maze and forced<br />
swimming induced-stress in rats<br />
Razia Khanam, (India), F Ahmed, D Vohora, K Pillai<br />
Investigation of antidepressant and anxiolytic effects of Simvastatine in rats<br />
Fatma Sultan Kilic, (Turkey), Y Özatýk, B Kaygisiz, C Baydemýr, K Erol<br />
The atidepressant and anxiolytic activities of Gabapentine<br />
Fatma Sultan Kilic, (Turkey), S Ismailoglu, C Baydemir, K Erol<br />
Dysfunction of autonomic nervous system activity in schizophrenia and the influence of neuroleptics<br />
Ikuko Kishida, (Japan), M Fujibayashi, S Tanaka, C Kawanishi, Y Iwamoto, T Furuno, C Ishii, N Ishii,<br />
Y Hirayasu, T Moritani<br />
Effects of cariprazine on D2 and D3 dopamine receptor signalling mechanisms in vitro<br />
B Kiss, Zsolt Nemethy, (Hungary), S Peterson, K Fazekas, B Masri, M Caron<br />
Influence of the suppression of cell proliferation and neurogenesis in the ability of antidepressants in an<br />
ACTH-induced animal model of treatment-resistant<br />
Yoshihisa Kitamura, (Japan), M Doi, H Hayashi, I Miyazaki, M Asanuma, H Kawasaki<br />
Effect of temperature and glucose concentration on anoxic dopamine efflux in the mouse caudate<br />
Steve Knight, (UK), N Chauhan, A Young, C Gibson, C Davidson<br />
Wednesday 21 July ■ 13:00 - 14:00 ■ Poster Area 275
FC17<br />
New approaches and targets in psychiatry<br />
Wed 426<br />
Wed 427<br />
Wed 428<br />
Wed 429<br />
Wed 430<br />
Wed 431<br />
Wed 432<br />
Wed 433<br />
Cognitive enhancers: different targets – common objective<br />
Georgy Kovalev, (Russian Federation), J Firstova<br />
Neuroprotective effect of rice bran oil on amyloid β protein (25-35)-induced neurotixicity: In vitro and in<br />
vivo<br />
Hong-Kyu Lee, (South Korea), YH Seong<br />
Isolation rearing alters protein expression of synaptic markers, myelin markers and GABAB1 receptor in<br />
the rat brain<br />
Ann Li Lim, (Australia), DA Taylor, DT Malone<br />
Multiple therapeutical targets revealed by protein expression profiles analysis in the brains of Balb/c<br />
mice subjected to unpredictable chronic mild stress<br />
Yanyong Liu, (PR China), N Yang, C Ji, P Zuo<br />
Cytochrome P-450 enzyme genetic polymorphisms influence antidepressant escitalopram metabolism<br />
and treatment response<br />
Yu-Li Liu, (Taiwan), K-M Lin, M-H Tsai, M-C Hsiao, WW Shen, M-L Lu, H-S Tang, C-K Fang, C-S Wu,<br />
S-C Lu, SC Liu, C-Y Chen<br />
Tryptophan hydroxylase 2 (TPH2) gene is associated with major depressive disorder in the three main<br />
ethnic groups of the Malaysian population<br />
AC Loke, LH Lian, NZ Zainal, Zahurin Mohamed, (Malaysia)<br />
Antidepressant use and salivary cortisol: The Netherlands Study of Depression and Anxiety (NESDA)<br />
Leonie Manthey, (The Netherlands), C Leeds, EJ Giltay, T van Veen, SA Vreeburg, BWJH Penninx,<br />
FG Zitman<br />
Increased reuptake masks elevated sensitivity to monoamines in peripheral but not cerebral resistive<br />
arteries of rats depressed in response to the chronic mild stress (CMS)<br />
Vladimir Matchkov, (Denmark), E Bouzinova, T Brøgger, NM Nielsen, K Henningsen, O Wiborg,<br />
C Aalkjær<br />
276 Wednesday 21 July ■ 13:00 - 14:00 ■ Poster Area
W33<br />
Synaptic events in brain function<br />
Wed 434<br />
Endomorphin-1 stimulates norepinephrine release in rat hypothalamus<br />
Lucia Recinella, (Italy), L Brunetti, G Orlando, A Mollica, C Ferrante, A Chiavaroli, S Leone, C Di Nisio,<br />
R Shohreh, P Di Michele, F Pinnen, M Vacca<br />
Wednesday 21 July ■ 13:00 - 14:00 ■ Poster Area 277
W34<br />
State-of-the-art of basic and clinical pharmacology<br />
in Serbia<br />
Wed 435<br />
Wed 436<br />
The new association in clinical pharmacology: Section of Clinical Pharmacology Serbian Medical<br />
Assotiation<br />
Dragana A Kastratovic, (Republic of Serbia), MM Mikov, VV Stanimirovic, AJ Sabo, SM Jankovic,<br />
N Japundzic-Zigon, DR Milovanovic, R Lilic, MH Vukovic, VM Jugovic<br />
Influence of ticlopidine alone and in combination with aspirin on liver function test in rats<br />
Zorica Stanojevic, (Republic of Serbia), R Mitic, S Stevic, M Dejanovic, Z Bukumiric<br />
278 Wednesday 21 July ■ 13:00 - 14:00 ■ Poster Area
FC18<br />
Nuclear receptor targets for treatment of diseases<br />
Wed 437<br />
Wed 438<br />
Wed 439<br />
Wed 440<br />
Wed 441<br />
Wed 442<br />
Wed 443<br />
Wed 444<br />
Wed 445<br />
Wed 446<br />
Wed 447<br />
Wed 448<br />
Wed 449<br />
Study of 5HT3 and HT4 receptors expression in HT29 Cell line and human colon adenocarcinoma<br />
tissues<br />
Ramin Ataee, (Iran), S Ajdary, M Zarrindast, M Rezayat, MA Shokrgozar<br />
Effects of gonadectomy on hippocampal aromatase expression in both genders<br />
Nihan Burul-Bozkurt, (Turkey), P Kelicen, C Pekiner<br />
Involvement of autophagy in the sex-different brain injury caused by iron overload<br />
Tzu-Yin Chen, (Taiwan), S-I Lue, C Hsu<br />
Activation of peroxisome proliferator-activated receptor β/δ (PPAR β/δ) by gw501516 prevents fatty<br />
acid-induced NF-βB activation and insulin resistance in skeletal muscle cells<br />
T Coll, AM Gomez-Foix, Manuel Vazquez-Carrera, (Spain)<br />
Gastroprotective effect of peroxisome proliferator-activated receptor-γ (PPARγ) agonist, rosiglitazone<br />
against stress-induced gastric mucosal injury in rats<br />
Mohamed A.EL-Moselhy, (Egypt), W H. Nazmy, HM Ibrahim<br />
Synergistic interaction between PPAR agonists and albuterol on human bronchial smooth muscle cell<br />
proliferation<br />
Stefano Fogli, (Italy), L Picchianti, F Stefanelli, MC Breschi<br />
Distinct roles for the nuclear receptors Nur77 and Nor-1 in dopamine-mediated and psychostimulantinduced<br />
behaviors<br />
Céline Hodler, (Canada), B Paquet, J Baillargeon, P Seeman, D Lévesque, C Rouillard<br />
Single-label time-resolved fluorescence based estrogen receptor-ligand binding assay<br />
Roope Huttunen, (Finland), Shweta, E Martikkala, M Lahdenranta, P Hänninen, H Härmä<br />
Type II diabetes drug metformin induces transcriptional coactivator PGC-1α in liver possibly through<br />
AMPK independent mechanism<br />
Sanna-Mari Järvenpää, (Finland), J Hakkola<br />
Bi-transgenic mice expressing human hydroxysteroid (17β) dehydrogenase 1 (HSD17B1) and estrogen<br />
response element (ERE) -reporter gene provide a novel tool to monitor action of HSD17B1 inhibitors<br />
Päivi Järvensivu, (Finland), T Saloniemi, P Koskimies, P van der Saag, M Poutanen<br />
Downregulation of PPARα expression by glucose in pancreatic α-cells is mediated by ChREBP<br />
Lars La Cour Poulsen, (Denmark), M Børgesen, SF Schmidt, F Frigerio, P Maechler, S Mandrup<br />
Cytochrome P450 2A5 expression is dependent on redox-sensitive transcription factor Nrf2 in liver<br />
Virpi Lämsä, (Finland), A-L Levonen, H Hurttila, S Ylä-Herttuala, M Yamamoto, J Hakkola<br />
Progesterone receptor activation of extra-nuclear signalling pathways in regulating p53 expression in<br />
vascular endothelial cells<br />
Wen-Sen Lee, (Taiwan), S-P Hsu<br />
Wednesday 21 July ■ 13:00 - 14:00 ■ Poster Area 279
FC10<br />
Drugs for half the world: Paediatric clinical<br />
pharmacology<br />
Thu 001<br />
Thu 002<br />
Thu 003<br />
Thu 004<br />
Thu 005<br />
Thu 006<br />
Sy Cushing at the child with asthma, case report<br />
Milica Martinovic, (Republic of Serbia)<br />
Using Adapt® in paediatric patients: Pharmacokinetic modelling for lamotrigine<br />
Janet Mifsud, (Malta), D Soler, H Shabbi<br />
Effects of paracetamol during first days of life<br />
Petra Millfors, (Sweden), KJS Anand, LL Bergqvist<br />
Effect of soybean on male reproductive physiology<br />
Mehrdad Modaresi, (Iran), M Messripour, H Khorami<br />
Clinical efficacy of bovine colostrum in non-organic failure to thrive<br />
Yashar Moharamzad, (Iran), Y Panahi, G Falahi, M Falahpour<br />
Blood level of Cyclosporine-A in Iranian renal transplant patients<br />
Manijeh Motevalian, (Iran), H Otukesh, RH Shamsabadi, M Chalian<br />
Thu 007 Safety in paediatric drug trials – an update from randomised controlled trials published in 2007<br />
KNB Nor Aripin, Helen M Sammons, (UK), I Choonara<br />
Thu 008<br />
Thu 009<br />
Thu 010<br />
Thu 011<br />
Thu 012<br />
Thu 013<br />
Thu 014<br />
Thu 015<br />
Thu 016<br />
Thu 017<br />
The effect of premedication for intubation on amplitude-integrated electroencephalography in a<br />
randomized blinded intervention study of preterm infants<br />
Elisabeth Norman, (Sweden), S Wikström, I Rosén, V Fellman, L Hellstrom-Westas<br />
Pediatric outcomes following in utero exposure to psychotropic medications: An update<br />
Irena Nulman, (Canada)<br />
Pharmacokinetics, pharmacodynamics and bioequivalence of dexamethasone liquid and tablet<br />
formulations<br />
Christian Queckenberg, (Germany), B Wachall, P Di Gion, D Tomalik-Scharte, M Abdel-Tawab, U Fuhr<br />
Population pharmacokinetics of hydrocortisone in extremely premature infants<br />
Hesty Ramadaniati, (Indonesia), B Charles, H Liley<br />
Saliva efavirenz levels as a non-invasive alternative to determine adherence in children<br />
Malie Rheeders, (South Africa), M Viljoen, A Theron, T Meyers<br />
Clinical trial of epigallocatechin-3-gallate in Duchenne muscular dystrophy<br />
Urs T Ruegg, (Switzerland), A von Moers, F Paul, Y Nakae, O Dorchies<br />
Discovery of novel pharmacological chaperones for phenylketonuria<br />
S Santos Sierra, (Austria), A Perna, J Kirchmayer, K Kemter, DD Messing, SW Gersting, AC Muntau,<br />
H Glossmann, G Wolber, FB Lagler<br />
Oral antibodies to S100 protein in attention deficit and hyperactivity disorder: first clinical trial in<br />
children<br />
Svetlana Sergeeva, (Russian Federation), JL Dugina, IA Kheifets, OI Epstein<br />
Prevalence of CYP2B6-516G>T polymorphism in black South African HIV-infected children on efavirenz<br />
based antiretroviral therapy<br />
Michelle Viljoen, (South Africa), C Dandara, M Rheeders, KR Conradie, HS Kruger, H Gous, TM Meyers<br />
Population pharmacokinetics of carbamazepine and its metabolite in Chinese children with epilepsy<br />
Li Wang, (PR China), Y Liu<br />
280 Thursday 22 July ■ 13:00 - 14:00 ■ Poster Area
FC10<br />
Drugs for half the world: Paediatric clinical<br />
pharmacology<br />
Thu 018<br />
Thu 019<br />
Thu 020<br />
Evaluation of a limited sampling strategy for determination of the mycophenolic acid-AUC in different<br />
renal pediatric patients<br />
Martin Wiesen, (Germany), M Feldkötter, H Stützer, C Müller<br />
Asthma drug regimens and health service utilization: What impact do changes in the optimal use of<br />
medication have on children with asthma<br />
Tingting Zhang, (Canada), A Smith, R Prosser, B Carleton<br />
Pharmacoepidemiological studies in Chinese and Canadian children – lack of comprehensive<br />
prescription data a major limitation<br />
Tingting Zhang, (Canada), Z Li, A Smith, Y Wang, D Cao, B Carleton<br />
Thursday 22 July ■ 13:00 - 14:00 ■ Poster Area 281
FC11<br />
G protein-coupled 7TM receptors:<br />
From molecular to physiological function<br />
Thu 021<br />
Thu 022<br />
Thu 023<br />
Thu 024<br />
Thu 025<br />
Thu 026<br />
Thu 027<br />
Thu 028<br />
Thu 029<br />
Thu 030<br />
Thu 031<br />
Thu 032<br />
Thu 033<br />
Thu 034<br />
Thu 035<br />
Synthesis and characterization of peripherally selective CB1 receptor antagonists<br />
Rangan Maitra, (USA), Y Zhang, M Roche, J Tajuba, R Snyder, N Gaudette, T Fennell, B Thomas,<br />
H Seltzman<br />
The role of dopaminergic receptors in the inhibition of the vasopressor sympathetic outflow in pithed<br />
rats<br />
Guadalupe Manrique-Maldonado, (Mexico), A González-Hernández, BA Marichal-Cancino,<br />
A Sánchez-López, D Centurión, CM Villalón<br />
Association of β3-adrenergic receptor polymorphism with contractile responses in human atrium<br />
Alina Marandykina, (Lithuania), A Bogdelis, D Zablockaite, R Treinys, VA Skeberdis<br />
Brain region specificity of 5-HT1A receptor activation by selective agonists demonstrated by functional<br />
autoradiography<br />
Jean-Claude Martel, (France), N LeducC, A Newman-Tancredi<br />
Constitutive activation is responsible for the intracellular predominance of the C18S mutant AT1<br />
receptor of angiotensin II<br />
Renan Martin, (Brazil), E Rodrigues, L Oliveira, S Shimuta<br />
A novel nanoscale high throughput assay screening membrane based protein-protein interactions<br />
S Mathiasen, Vikram Kjøller Bhatia, (Denmark), S Pedersen, K Strømgaard, D Stamou<br />
Development and characterization of a β2 adrenergic receptor cAMP biosensor assay<br />
Jesper M Mathiesen, (Denmark), H Bräuner-Osborne<br />
Molecular organization and dynamics of the MT1 melatonin receptor/RGS20/Gαi protein complex<br />
reveal asymmetry of receptor dimers for RGS coupling<br />
P Maurice, AM Daulat, R Turecek, K Ivankova-Susankova, F Zamponi, JL Guillaume, B Bettler,<br />
P Delagrange, Ralf Jockers, (France)<br />
The pharmacology of GluN3 containing NMDA receptors<br />
David McClymont, (UK), I Mellor<br />
Synergy between α-1-adrenoceptor subtypes and P2X receptors in nerve induced vascular responses<br />
revealed by successive α-1-adrenoceptor knockouts and antagonists<br />
John McGrath, (UK), C Daly, P Simpson, E Wallace, L Methven<br />
Regulation of noradrenaline release by administration of stressin I into the locus coeruleus: A brain<br />
microdialysis study in awake rat<br />
J Javier Meana, (Spain), I Horrillo, JE Ortega<br />
GRK6 regulates the desensitization of 5-HT4 receptors in the rat oesophagus<br />
Teshome Nedi Megersa, (Australia), H Irving, I Coupar, P White<br />
The relationship between GRα and NFκB related proteins in children idiopathic nephrotic syndrome<br />
Ladislav Mirossay, (Slovak Republic), K Szilagyi, L Podracka, A Mirossay, J Mojzis<br />
Identification of a novel ligand for glutamate receptor β2<br />
Masayoshi Mishina, (Japan), T Uemura, S-J Lee, M Yasumura, T Yoshida<br />
New HTRF solutions for cell surface receptors study and screening. Application to GPCR dimerization<br />
and highly selective ligand binding assays<br />
Hamed Mokrane, (France), E Trinquet, T Roux, L Comps-Agrar, J-P Pin, J-L Tardieu<br />
282 Thursday 22 July ■ 13:00 - 14:00 ■ Poster Area
FC11<br />
G protein-coupled 7TM receptors:<br />
From molecular to physiological function<br />
Thu 036<br />
Thu 037<br />
Thu 038<br />
Thu 039<br />
Thu 040<br />
Thu 041<br />
Thu 042<br />
Thu 043<br />
Thu 044<br />
Thu 045<br />
Thu 046<br />
Thu 047<br />
Thu 048<br />
Thu 049<br />
Thu 050<br />
The conserved Trp IV:10 (4.50) together with Ser/Asn II:05 (2.45) are crucial for 7TM receptors<br />
activation and might be a putative cholesterol binding site<br />
Jacek Mokrosinski, (Denmark), R Nygaard, MS Engelstoft, L Valentin-Hansen, B Holst, TW Schwartz<br />
Screening and characterization of GPCR C-terminal tail interactions with the PSD-95 PDZ domains<br />
Thor Møller, (Denmark), P Jacky, A Bach, K Strømgaard, T Schwartz, K Martinez<br />
Novel pathway of smooth muscle contraction by UTP in rat aortic myocyte<br />
Hiromitsu Morita, (Japan), M Sugihara, M Matsuda, S Kajioka, Y Ito, K Abe, M Hirata<br />
β3-adrenoceptors substitute the role M2 muscarinic receptors in the heart of stressed mice<br />
Jaromir Myslivecek, (Czech Republic), M Novakova, V Farar, R Kvetnansky<br />
Presynaptic BK channels activated by IP3-induced Ca 2+ release are involved in prostanoid TP<br />
receptor-mediated inhibition of noradrenaline release from the rat gastric sympathetic nerves<br />
Kumiko Nakamura, (Japan), K Yokotani<br />
Mutational analysis of an M4 muscarinic acetylcholine receptor allosteric site<br />
Vindhya Nawaratne, (Australia), K Leach, CC Felder, PM Sexton, A Christopoulos<br />
The involvement of nitric oxide in the local antinociceptive effects of JWH-015 and expression of<br />
cannabinoid-2, μ- and δ-opioid receptors during chronic inflammatory pain in mice<br />
R Negrete, J Martín-Campos, A Hervera, S Leánez, Olga Pol (Spain)<br />
Pharmacological evaluation of new bivalent ligands aimed to interact with orthosteric and allosteric<br />
sites of mAChRs<br />
Marta Nesi, (Italy)<br />
Conditional mutant mouse with enhanced Gα-i2 signalling due to loss of regulator of G protein signalling<br />
(RGS) regulation<br />
Richard Neubig, (USA), X Huang, S Wade, R Charbeneau<br />
Pertussis toxin inhibits EP4 and IP receptor-mediated cAMP production in adult rat dorsal root ganglion<br />
cells<br />
Kai-Yu Ng, (PR China), Y-H Wong, H Wise<br />
Identification of Adrenergic Receptor Interacting Protein (ARIP), as a novel receptor-interacting protein<br />
that modulates α1A- and α1L-adrenoceptor expression<br />
Atsushi Nishimune, (Japan), F Suzuki, H Yoshiki, S Morishima, I Muramatsu<br />
G protein-coupled estrogen receptor 1 function in vivo and in vitro<br />
B Olde, C Sandén, S Broselid, U Mårtensson, Fredrik Leeb-Lundberg, (Sweden)<br />
The expression of cardiac and lymphocytic GRKs in human cardiovascular diseases correlated to the<br />
expression levels of β-ARs<br />
Eduardo Oliver, (Spain), F Monto, D Vicente, J Agüero, EE Rovira, L Almenar, P D'Ocon<br />
Conditional functional selectivity of β2-adrenoceptor ligands in stimulating adenylyl cyclase and ERK<br />
phosphorylation in HEK 293 cells<br />
Gülnihal Özcan, (Turkey), A Kaya, O Onaran, Ö Ugur<br />
The three α1-AR subtypes show different spatio-temporal patterns of ERK1/2 phosphorylation and<br />
internalization<br />
Miguel Perez-Aso, (Spain), V Segura, M-A Noguera, P D'Ocon<br />
Thursday 22 July ■ 13:00 - 14:00 ■ Poster Area 283
FC11<br />
G protein-coupled 7TM receptors:<br />
From molecular to physiological function<br />
Thu 051<br />
Thu 052<br />
Thu 053<br />
Thu 054<br />
Thu 055<br />
Thu 056<br />
Thu 057<br />
Thu 058<br />
Thu 059<br />
Thu 060<br />
Thu 061<br />
Thu 062<br />
Thu 063<br />
Thu 064<br />
Thu 065<br />
Chimaering orexin receptors reveal selectivity-conferring areas for orexins<br />
Jaana Putula, (Finland), P Turunen, L Johansson, R Ra, J Näsman, J Kukkonen<br />
Effects of route of administration on dexmedetomidine pharmacokinetics in C57Bl/6J and<br />
α2A-adrenoceptor knock-out mice<br />
Ville Ranta-Panula, (Finland), M Lahtinen, S Tikka, T Streng, M Scheinin<br />
Local enhanced contractile response of ETB, 5-HT1B and AT1 receptors following distal focal<br />
permanent occlusion<br />
Marianne NP Rasmussen, (Denmark), M Hornbak, L Edvinsson<br />
Functional and morphological characterization of presynaptic A1 and A3 adenosine receptors in the<br />
superior mesenteric artery of spontaneously hypertensive rats<br />
C Rocha-Pereira, P Fresco, S Arribas, MC González, MV Conde, J Gonçalves, Carmen Diniz, (Portugal)<br />
The orphan GPR50 receptor promotes transforming growth factor β (TGFβ) signalling by interacting<br />
with the TGFβ type I receptor<br />
A Saade, A Daulat, N Ferrand, P Delagrange, Nathalie Clement, (France), C Prunier, R Jockers<br />
DMSO-lipid soluble cigarette smoking particles upregulate contractile endothelin type B and<br />
thromboxane A2 receptors of rat middle cerebral arteries<br />
Hardip Sandhu, (Denmark), C-B Xu, L Edvinsson<br />
Involvement of H2O2 in adenosine-mediated regulation of coronary flow<br />
Maryam Sharifi Sanjani, (USA), B Teng, T Krahn, S Tilley, C Ledent, J Mustafa<br />
β-arrestin 1 and 2 stabilize the Angiotensin II type 1 receptor in distinct high-affinity conformations<br />
Samra Joke Sanni, (Denmark), JT Hansen, MM Bonde, T Speerschneider, GL Christensen, S Munk,<br />
S Gammeltoft, JL Hansen<br />
Receptor localization to caveolae regulates differential G protein coupling of mouse β3-adrenoceptor<br />
splice variants<br />
Masaaki Sato, (Australia), D Hutchinson, B Evans, R Summers<br />
Pharmacological characterisation of an allosteric small-molecule agonist for the chemokine receptor<br />
CXCR3<br />
Danny Scholten, (The Netherlands), M Canals, S de Munnik, M Wijtmans, I de Esch, M Smit, R Leurs<br />
Overexpression of kinin B1 receptor induces increased reactivity of DBK and BK in transgenic rat aorta<br />
Suma Imura Shimuta, (Brazil), RF da Silva, JB Pesquero, RP Martin, ES Rodrigues<br />
Role of the α-2 adrenoceptors subtypes in regulation of gastric motor activity in the rat and mouse<br />
Nashwan Shujaa, (Hungary), Z Zadori, M Al-khrasani, M Rossi, L Hein, K Gyires<br />
Sorting nexin-25 interacts with D1 and D2 dopamine receptors to regulate receptor expression and<br />
signaling<br />
David Sibley, (USA), R Free, Y Namkung, L Hazelwood, C Furman<br />
Crosstalk between excitatory A2A, NK1 and M3 receptors on a tripartite myenteric synapse<br />
Isabel Silva, (Portugal), D Fernandes, F Ferreirinha, C Vieira, M Duarte-Araújo, P Correia-de-Sá<br />
Cell-based screening for modulators of regulator of G protein signalling protein 9 (RGS9) – implications<br />
in Parkinson’s disease<br />
Benita Sjögren, (USA), RR Neubig<br />
284 Thursday 22 July ■ 13:00 - 14:00 ■ Poster Area
FC11<br />
G protein-coupled 7TM receptors:<br />
From molecular to physiological function<br />
Thu 066<br />
Thu 067<br />
Thu 068<br />
Thu 069<br />
Thu 070<br />
Thu 071<br />
Thu 072<br />
Thu 073<br />
Thu 074<br />
Rapid functional upregulation of ETB receptors in rat coronary arteries during myograph studies<br />
Gry Freja Skovsted, (Denmark), AF Pedersen, M Sheykhzade, L Edvinsson<br />
Identification of G protein-coupled receptor (GPCR) targets using RT-PCR array: validation of PAR1 as<br />
the most highly expressed GPCR in regulation of cardiac fibroblasts<br />
Aaron Snead, (USA), P Insel<br />
Evidence for an anti-inflammatory role of the Ang(1-7)-Mas receptor axis in LPS-induced macrophages<br />
Laura Souza, (Brazil), C Costa-Neto<br />
Characterization of bimodal multivalent interactions for the bifunctional muscarinic receptor (mAChR)<br />
antagonist and β2-adrenoceptor agonist (MABA), THRX 198321<br />
Tod Steinfeld, (USA), AD Hughes, U Klein, JAM Smith, M Mammen<br />
Expression of NMDA receptor subunits NR1 and NR2A and metabotropic mGluR1 immunoreactivity in<br />
the intertrigeminal region of the lateral pons in rats<br />
Milan Stoiljkovic, (Republic of Serbia), S Pesic, N Stojiljkovic, V Nikolic<br />
Cardiovascular effects of dexmedetomidine in awake α2A-adrenoceptor knock-out mice<br />
Tomi Streng, (Finland), V Ranta-Panula, S Tikka, M Scheinin<br />
Muscarinic acetylcholine receptor subtypes involved in carbachol-induced HCO3- secretion in mouse<br />
duodenum in vitro<br />
Koji Takeuchi, (Japan), M Koyama, K Takahashi, E Aihara, N Kurata, S Hayashi<br />
Induction of kinin B1 receptor by stimulation of TRPV1<br />
S Talbot, J Pena Dias, Réjean Couture, (Canada)<br />
ADP receptor P2Y13 induce apoptosis in pancreatic β-cells<br />
Chanyuan Tan, (Sweden), A Salehi, S Svensson, B Olde, D Erlinge<br />
Thu 075 Structural analysis of two selective inhibitors of G protein-coupled receptor kinase 2<br />
David Thal, (USA), R Yeow, J Tesmer<br />
Thu 076<br />
Thu 077<br />
Thu 078<br />
Thu 079<br />
Thu 080<br />
Thu 081<br />
a2-adrenoceptor mediated increases phosphorylation of MAP-2c in rat pheochromocytoma cells (PC12<br />
cells) via a protein kinase C- and mitogen activated protein kinase-dependent mechanism<br />
Lu Tie, (China), X-J Li<br />
Manganese enhances agonist binding to 5-HT1A receptors by inhibiting guanosine nucleotide binding to<br />
receptor-coupled G-proteins<br />
Lauri Tontson, (Estonia), S Parkel, A Rinken<br />
Heteromerization of HCMV encoded chemokine receptors<br />
Pia Tschische, (Austria), K Tadagaki, M Kamal, R Jockers, M Waldhoer<br />
TRPC2 channels modulate both calcium- and cAMP-mediated signalling in rat thyroid FRTL-5 cells<br />
Minna Vainio, (Finland), P Sukumaran, C Löf, K Törnquist<br />
Similar adenosine A1 receptor allosteric agonists require different orthosteric site conformations for<br />
stimulus transmission<br />
Celine Valant, (Australia), L Aurelio, P Scammells, P Sexton, A Christopoulos<br />
Proteinase activated receptor 2 (PAR-2) and toll like receptor 4 (TLR4) receptors cross-talk in rat<br />
vascular reactivity<br />
Valentina Vellecco, (Italy), M Bucci, V Brancaleone, F Roviezzo, R Meli, G Mattace Raso, G Cirino<br />
Thursday 22 July ■ 13:00 - 14:00 ■ Poster Area 285
FC11<br />
G protein-coupled 7TM receptors:<br />
From molecular to physiological function<br />
Thu 082<br />
Thu 083<br />
Thu 084<br />
Thu 085<br />
Thu 086<br />
Thu 087<br />
Thu 088<br />
Thu 089<br />
Thu 090<br />
Thu 091<br />
Thu 092<br />
Thu 093<br />
Thu 094<br />
Thu 095<br />
Thu 096<br />
Mutation of the S1P1 receptor differentially affects signalling by agonists<br />
Dennis Verzijl, (The Netherlands), P Van Loenen, C De Graaf, R Didier, S Peters, A Alewijnse<br />
LSP4-2022 is a new selective and potent mGlu4 agonist with antihyperalgesic effect<br />
Bruno Vilar, (France), J Busserolles, I Brabet, B Ling, F Acher, J-P Pin, A Eschalier, C Goudet<br />
Ca 2+ -signalling of α2B-adrenoceptors in A7r5 vascular smooth muscle cells<br />
Anne Vuorenpää, (Finland), A Huhtinen, M Scheinin<br />
Oligomerization of chemokine receptors CXCR3 and CXCR4<br />
Anne Watts, (The Netherlands), M van Lipzig, S Jähnichen, R Alimahomed, G Zaman, M van der Lee,<br />
N Siderius, H Vischer, M Smit, R Leurs<br />
Supported cell-membrane sheets as a model system to analyze pathways ofintracellular GPCR signaling<br />
Volker F Wirth, (Denmark), TC Møller, KL Martinez<br />
The structural and functional landscape of the ADP receptor P2Y12<br />
Doreen Wittkopf, (Germany), M Cöster, A Kreuchwig, K-U Simon, G Kleinau, D Thor, G Krause,<br />
T Schöneberg<br />
Rapid characterization of bimatoprost pharmacology in human ocular cells by using cellular dielectric<br />
specroscopy<br />
David Woodward, (USA), J Wang, D Piwnica, R Carling, C Cornell, J Martos, D Stamer<br />
Characteristics of junctophilin 3 and 4 expressions in neurons derived from mouse embryonic stem<br />
cells<br />
Jiaying Wu, (PR China), Y Gao, H Wang, X Zhang, W Zhu, J Qian, Y Shen, H Yu, Q Wang, Y Lou<br />
T-type calcium channels mediate nicotine-induced cerebral neurogenic nitrergic vasodilation<br />
Yin-Chieh Wu, (Taiwan), HC Lee, PY Chen, MH Nam, MF Chen, TJF Lee<br />
Pharmacological characterization of the first potent and selective cysteinyl leukotriene 2 receptor<br />
antagonist<br />
Frank Wunder, (Germany), H Tinel, R Kast, A Geerts, E-M Becker, P Kolkhof, J Hütter, J Ergüden,<br />
M Härter<br />
Oestrogen confers cardioprotection by up-regulating β2-AR<br />
C Xu, A Liu, Hong Sun, (PR China)<br />
Serotonin 5-HT2C receptors alters gene expression of amyloid precursor protein<br />
Ming Yin, (PR China), LC Guo, J Zhang<br />
Endomorphins are potential endogenous regulators of the gastric mucosal integrity<br />
Zoltan Zadori, (Hungary), N Shujaa, A Rónai, K Gyires<br />
Biochemical analysis of the cleaved n-terminal of the PAR1 receptor<br />
Dimitrios Zampatis, (Germany), N Tsopanoglou, R Schuelein<br />
The presence of P2X receptors in CD34-positive cells of human umbilical cord blood<br />
Airat U Ziganshin, (Russian Federation), RR Kazakova, IG Moustafin, DV Nurullina, GZ Sagdieva,<br />
FF Kazakova, LE Ziganshina<br />
286 Thursday 22 July ■ 13:00 - 14:00 ■ Poster Area
FC12<br />
Ion channelopathies: New windows on complex<br />
disease and therapy<br />
Thu 097<br />
Thu 098<br />
Thu 099<br />
Thu 100<br />
Thu 101<br />
Thu 102<br />
Thu 103<br />
Administration of clarithromycin and furosemid alters cardiac ion channel gene expression and induces<br />
β-adrenergically evoked Torsades de Pointes in rat<br />
Jan Klimas, (Slovak Republic), J Kmecova, K Mackovicova, P Vavrinec, P Krenek, J Kyselovic,<br />
P Ochodnicky<br />
Different mutations in the ABCC8 gene can either enhance or reduce sulfonylurea receptor 1 mediated<br />
apoptosis<br />
Martina Lösle, (Germany), S Ackermann, S Hiller, A Hambrock<br />
Decreased expression of connexin 26 in the cochlear spiral ligament fibrocyte following intense noise<br />
exposure<br />
Reiko Nagashima, (Japan), T Yamaguchi, H Tanaka, A Matsushita, K Ogita<br />
Effect of mebudipine and dibudipine two new calcium channel blockers in comparison to nifedipine on<br />
vascular flow of isolated kidney from diabetic rat<br />
Lili Sepehr-Ara, (Iran), M Mahmoudian<br />
Anticonvulsive evaluation of THIP in the murine pentylenetetrazole kindling model<br />
Charlotte Simonsen, (Denmark), A Kloppenburg, K Sonderskov, U Kristiansen, S Hansen<br />
Function of BK-VDCC complex in vascular smooth muscle cells<br />
Yoshiaki Suzuki, (Japan), H Yamamura, S Ohya, Y Imaizumi<br />
Assessment of salivary AQP5 as a biomarker for xerostomia<br />
Di Wang, (Japan), F Iwata, Y Pan, M Muraguchi, K Ooga, Y Ohmoto, M Takai, X-J Li, T Mori, Y Ishikawa<br />
Thu 104 Angiotensin II inhibites IKr /hERG channels through protein kinase C-<br />
Yuhong Wang, (PR China), J Xu, X Chen, Y Xu<br />
Thu 105<br />
Thu 106<br />
Thu 107<br />
Thu 108<br />
Thu 109<br />
Protein kinases modulate store-operated channels in pulmonary artery myocytes<br />
Bin-Nan Wu, (Taiwan), I-S Chen, D Welsh, Z-K Dai, I-J Chen<br />
Localization of BKCa channels and effect of BKCa channels on CGRP release in the rat trigeminal<br />
nucleus caudalis<br />
Helle Wulf-Johansson, (Denmark), DV Amrutka, A Hay-Schmidt, A Poulsen, D Klaerke, J Olesen,<br />
I Jansen-Olesen<br />
Molecular assembly in fuctional Ca 2+ microdomain in vascular smooth muscle cells<br />
Hisao Yamamura, (Japan), S Ohya, Y Imaizumi<br />
Studies on epileptic animal model bearing a genetic abnormality identified in autosomal dominant<br />
nocturnal frontal lobe epilepsy (ADNFLE) and benign familial newborn baby convulsions (BFNC) of<br />
human<br />
Sayaka Yamashita, (Japan), M Nagano, Y Tanaka, M Deshimaru, M Okada, S Kaneko, S Hirose,<br />
R Saito, K Honda, Y Takano<br />
Mechanisms of amphotericin B-induced renal tubular cell injury<br />
Takahisa Yano, (Japan), Y Itoh, E Kawamura, A Maeda, Y Arimura, N Egashira, M Nishida, H Kurose,<br />
R Oishi<br />
Thursday 22 July ■ 13:00 - 14:00 ■ Poster Area 287
FC13<br />
Maximising benefits and minimizing harms from<br />
drugs<br />
Thu 110<br />
Thu 111<br />
Thu 112<br />
Thu 113<br />
Thu 114<br />
Thu 115<br />
Thu 116<br />
Thu 117<br />
Thu 118<br />
Thu 119<br />
Thu 120<br />
Thu 121<br />
Thu 122<br />
Thu 123<br />
Thu 124<br />
Lacritin, a novel secretagogue, increases tear flow in rabbits<br />
Sandeep Samudre, (USA), J Sheppard, F Lattanzio, G Laurie, R McKown, P Williams<br />
Crono-pharmacokinetic of irinotecan after hepatic intra arterial perfusion in patients with metastatic<br />
colon carcinoma<br />
Francesco Scaglione, (Italy), S Bareggi, A Nasisi, G Bondiolotti, M Pirovano<br />
Blunted reward system activation to erotic stimuli under paroxetine as compared to bupropion or<br />
placebo in healthy subjects<br />
Angela Seeringer, (Germany), B Abler, A Hartmann, G Groen, M Walter, J Kirchheiner<br />
Transient neurological disturbance in a patient with lamotrigine overdose<br />
Anshuman Sengupta, (UK), O Martin, G Lane, P Patel, S Abbasi<br />
Plasma serotonin levels and influence of granisetron on pharmacokinetics and pharmacodynamics of<br />
omeprazole in healthy subjects and patients with peptic ulcer disease<br />
Svetlana Serebrova, (Russian Federation), A Starodubtzev, S Kondratenko, G Belyakova, N Berdnikova<br />
Amphotericin B molecular organization and the particle size as essential factors to reduce its toxicity<br />
by hemolysis<br />
Dollores R Serrano Lopez, (Spain), HKR Saldaña, JJT Durán, MP Ballesteros, ST Durán<br />
Chemical forms of mercurials differentiate the potential of mercury for toxicity from that for medicinal<br />
remedy<br />
Jing Zhen Shi, (PR China), F Kang, Q Wu, YF Lu, J Liu, YJ Kang<br />
Effect of a novel fungal triprenyl phenol metabolite (Cpd-7) on acetic acid-induced embolic cerebral<br />
infarction model in mice<br />
Keita Shibata, (Japan), T Hashimoto, K Nobe, K Hasumi, K Honda<br />
Evaluation of clinical relevance of drug interactions based on metabolism: comparison of two CDK<br />
inhibitors<br />
Michal Siller, (Czech Republic), P Anzenbacher, E Anzenbacherova, K Dolezal, M Strnad<br />
Antihypertensive treatment and blood pressure control in primary health care<br />
D Silva, Isabel Vitórial Figueiredo, (Portugal), A Figueiras, MT Herdeiro, M Caramona, J Polónia<br />
Drug use pattern in hospital outpatients and private practice in Sylhet city of Bangladesh<br />
Sharadindu Kanti Sinha, (Bangladesh), WR Choudhury, MR Choudhury<br />
SLCO1B1 and CYP2C9 genetic variants could be associated with fluvastatin induced side effects in<br />
solid organ allotransplant recipients: case series<br />
NM Skvrce, L Zibar, Nada Božina, (Croatia), VM Sarinic, S Tomic<br />
Effects of fullerenol on rat uterus contraction and antioxidative enzymes activity<br />
Marija Slavic, (Republic of Serbia), Z Orescanin-Dusic, R Radojicic, S Milovanovic, A Djordjevic,<br />
M Spasic, D Blagojevic<br />
The HLA class I B*1801 allele influences hepatocellular expression of amoxicillin-clavulanate liver<br />
damage and outcome in Spanish patients<br />
Camilla Stephens, (Spain), MA Lopez-Nevot, RJ Andrade, F Ruiz-Cabello, MC Fernandez, C Guarner,<br />
G Soriano, M Romero-Gomez, JM Navarro, JL Solís-Herruzo, J Costa, MI Lucena<br />
Antimicrobial consumption and polypharmacy in patients on immunosuppressive therapy<br />
Jan Strojil, (Czech Republic), P Langerová, K Urbánek<br />
288 Thursday 22 July ■ 13:00 - 14:00 ■ Poster Area
FC13<br />
Maximising benefits and minimizing harms from<br />
drugs<br />
Thu 125<br />
Thu 126<br />
Thu 127<br />
Thu 128<br />
Thu 129<br />
Thu 130<br />
Thu 131<br />
Thu 132<br />
Thu 133<br />
Thu 134<br />
Thu 135<br />
Thu 136<br />
Thu 137<br />
Thu 138<br />
Thu 139<br />
Gentamicin pharmacokinetics estimated using rat model of early sepsis with capillary leak syndrome<br />
Studena Studena, (Czech Republic), J Martinkova, J Chladek, D Slizova, O Krs, J Zahora<br />
Analysis of proarrhythmic effects of typical IKr blockers using human ES/iPS cell-derived<br />
cardiomyocytes<br />
Atsushi Sugiyama, (Japan), T Kitamura, F Nomura, T Kaneko, P Sartipy, K Fukuda, K Yasuda<br />
Routine use of pharmacogenetic tests for detection of CYP2C19 genetic polymorphisms in Clopidogrel<br />
non-responders in resource limited setting<br />
Chonlaphat Sukasem, (Thailand), R Tunthongb, V Pairoj, C Srichunrasamia, P Vathesatogkit, P Sritarab,<br />
W Chantratita<br />
Determination of Olanzapine in human plasma by a validated LC-MS/MS method<br />
Dobrin Svinarov, (Bulgaria), L Kasabova<br />
Reduced activity of CYP2C9 in the application of a complex pharmacotherapy at Russian patients with<br />
decompensation of chronic heart failure<br />
Dmitry A Sychev, (Russian Federation), A Levanov, A Savchenko, G Ramenckaya, V Dmitriev,<br />
S Bogoslovscaya, V Kukes<br />
Investigation of bioavailability of nanosized telmisartan in rat<br />
Anita Sztojkov-Ivanov, (Hungary), G Filipcsei, G Heltovics, F Darvas, I Zupkó<br />
Potentially inappropriate medication leading to adverse drug reactions and hospitalisation<br />
Jacek Szymanski, (Germany), S Schmiedl, S Holt, K Farker, B Drewelow, M Hippius, K May,<br />
PA Thürmann<br />
Cevimeline raises saliva volume and level of substance P in saliva<br />
Masaharu Takeyama, (Japan), K Amada, S Tsuda, Y Sato, H Itoh<br />
Lithium potentiates the effects of thiocolchicoside on neuronal excitability in rat dentate gyrus<br />
Giuseppe Talani, (Italy), N Obili, E Fadda, R Uras, G Cordeddu, C Fois, S Prinzis, A Frau, V Piras,<br />
L Siuni, P Niola, PL De Riu, GP Sechi, G Biggio, E Sanna<br />
Preliminary experimental data regarding the bioavailability and biodistribution of systemically<br />
administered 99MTC-coupled AA124 silica nanoparticle<br />
Bogdan I Tamba, (Romania), C Stefanescu, I Jaba, O Mungiu, A Wirth, U Pieles<br />
Transfection of a mutant mu-opioid receptor into mice periaqueductal gray resulted in naloxonemediated<br />
antinociception without tolerance and dependence<br />
Pao-Luh Tao, (Taiwan), SH Chou, HI Ma, PY Law, HH Loh<br />
Taste perceptions of salbutamol-containing inhalers: A randomised crossover trial<br />
Jolyn Tay, (New Zealand), TR Ingham, B Jones, N Pierse, C Burgess<br />
Delay of monitoring may add to pre-existing toxicity risk in elderly patients treated with potentially<br />
nephrotoxic antibiotics: case series study<br />
Hundie Tesfaye, (Czech Republic), R Prusa, B Jedlickova, J Lukaskova, M Palivoda, V Pavelkova<br />
Effect of losartan on metabolism of arachidonic acid using recombinant cytochrome P450 (CYP)<br />
enzymes<br />
Takaki Toda, (Japan), N Inotsume, K Sakamoto, S Takeuchi, T Hayakawa, B Ask, E Eliasson, A Rane<br />
Dose response for simvastatin in a rat model for the evaluation of myopathy<br />
Brian Tomlinson, (PR China), VWL Mak, TWC Lo, DK Rowlands, M Hu, B Chadwick, AE James<br />
Thursday 22 July ■ 13:00 - 14:00 ■ Poster Area 289
FC13<br />
Maximising benefits and minimizing harms from<br />
drugs<br />
Thu 140<br />
Thu 141<br />
Thu 142<br />
Thu 143<br />
Thu 144<br />
Thu 145<br />
Thu 146<br />
Thu 147<br />
Thu 148<br />
Thu 149<br />
Thu 150<br />
Thu 151<br />
Thu 152<br />
Thu 153<br />
Thu 154<br />
Thu 155<br />
Pharmacogenetics of laβlol are influenced by CYP2C19 rather than CYP2D6<br />
Brian Tomlinson, (PR China), BSP Fok, OQP Yin, SSW Ko, CWY Tam, TTW Chu, M Hu, VHL Lee<br />
Colloids improve morphine excretion in elderly patients after single intravenous dose<br />
Stergios Tsartsalis, (Greece), M Vasileiadis, E Flioni, M Myronidou-Tzouveleki<br />
In vitro release and permeation characteristics of three nimesulide gel products (Sulidin, Nimes and<br />
Nimelid gels) in Turkey<br />
F Cankat Tulunay, (Turkey), L Kaytanlioglu, K Embil, A Okyar, G Baktir<br />
Clinical efficacy and adverse effects of the partial dopaminergic agonist aripiprazole compared with<br />
other antipsychotics<br />
Ingunn Fride Tvete, (Norway), M Klemp, J Gaasemyr, B Natvig, T Skomedal, I Aursnes<br />
In vivo phenotyping for CYP3A4 by determination of a single-point plasma concentration and urinary<br />
excretion of midazolam and its metabolites<br />
Shinya Uchida, (Japan), M Miura, S Misaka, Y Katoh, S Yamada, K Ohashi, H Watanabe, N Namiki<br />
Effect of 2-iminobiotin and N-ω-propyl-L-arginine on learning and memory in rats<br />
T Utkan, SS Gocmez, IK Celikyurt, Oguz Mutlu, (Turkey), N Gacar, F Aricioglu<br />
Development of new Catechol-O-methyltransferase inhibitors for treatment of Parkinson’s disease<br />
Nuno Vale, (Portugal), N Micaelo<br />
The effect of 5 artificial sweeteners on Caco-2 cells<br />
Armorel Van Eyk, (South Africa)<br />
Qunidine and aspirin kinetics in blood and central nervous system of rats after intraarterial application<br />
Velibor Vasovic, (Republic of Serbia), S Vukmirovic, V Jakovljevic, M Mikov, B Milijasevic, I Mikov<br />
Gender differences in pharmacokinetics of tacrolimus in renal transplant recipients<br />
Radmila Velickovic-Radovanovic, (Republic of Serbia), M Mikov, A Catic-Djordjevic, G Paunovic,<br />
V Djordjevic<br />
Biotransformation of a new anxiolytic aphobazole in rats<br />
Anastassia Viglinskaya, (Russian Federation), S Seredenin, V Zherdev, G Kolyvanov, A Litvin,<br />
T Mozhaeva, D Bastrigin<br />
Influence of clonidine within analgesic combinations administered epiduraly on postoperative analgesia<br />
quality<br />
Jelena Vukovic, (Republic of Serbia), L Grbovic, Z Milan, V Dragojevic-Simic, D Jandric, A Kovacevic<br />
Prescriptions analysis of analgesic medicines by primary care physician<br />
Nida'a Wadi, (Oman), M Bhupathyraaj, KAI Harthy<br />
A validated stereoselective assay for 3,4-methylenedioxymethamphetamine in human urine samples<br />
Wan Raihana Wan Aasim, (Malaysia), SH Gan, SC Tan<br />
Development of a novel therapeutic system of adenovirus gene therapy in combination with<br />
macromolecular drug therapy<br />
Yoshiteru Watanabe, (Japan), N Koizumi, Y Yamagishi, E Hagiwara, H Mizuguchi, M Fujii<br />
Oxidative DNA damage induced by ethanol is associated with its ADH1B/ALDH2 metabolic pathway in<br />
human peripheral lymphocytes<br />
Chunfu Wu, (PR China), Y Yan, J Yang, Y Mou, L Wang<br />
290 Thursday 22 July ■ 13:00 - 14:00 ■ Poster Area
FC13<br />
Maximising benefits and minimizing harms from<br />
drugs<br />
Thu 156<br />
Thu 157<br />
Thu 158<br />
Thu 159<br />
Thu 160<br />
Thu 161<br />
Thu 162<br />
Thu 163<br />
Thu 164<br />
Thu 165<br />
Thu 166<br />
Thu 167<br />
Thu 168<br />
Population pharmacokinetics and pharmacogenetics of clobazam and its active metabolite in Japanese<br />
adults with refractory epilepsy<br />
Ikuko Yano, (Japan), M Shibata, S Yasuda, A Yokomasu, K Hosohata, S Masuda, A Ikeda, R Takahashi,<br />
K Inui<br />
Vascular effects of protease inhibitors and non-nucleoside reverse transcriptase inhibitors, the major<br />
components of highly active antiretroviral therapy [HAART]<br />
Yuen Ting Yeung, (PR China), SS Lee, PM Vanhoutte, SWS Leung<br />
The role of the reactive oxygen species (ROS)-induced ROS release mediated by mitochondrial<br />
permeability transition pore in iron overload resulted in hepatic damage<br />
Dong Yin, (PR China), D Liu, A Que, Q Huang, M He<br />
Urinary cortisone/cortisol ratio corrected with the cortisol concentration serves as an index for the<br />
activity of human11 β-HSD2 in vivo<br />
Akitomo Yokokawa, (Japan), H Shibasaki, T Furuta<br />
CYP2C9*3 and *13 alleles were significantly associated with the decreased metabolism of lornoxicam<br />
So-Jung Youn, (South Korea), J-W Bae, C-G Jang, S-Y Lee<br />
Impact of genetic variations in CYP450 enzymes on the pharmacokinetics of cilostazol<br />
So-Jung Youn, (South Korea), C-I Choi, J-W Bae, C-G Jang, S-Y Lee<br />
Partial effects of UGT1A1*28 allele on the pharmacokinetics of ezetimibe and its glucuronide in healthy<br />
subjects<br />
So-Jung Youn, (South Korea), C-I Choi, J-W Bae, M-J Kim, C-G Jang, S-Y Lee<br />
Polyprenols facilitate transporting of adriamycin across brain-blood barrier via anti-angiogenesis and<br />
P-gp inhibition<br />
Shenghua Yuan, (PR China), W Ge, H Li, H Zhu, C Wang<br />
The influence of CYP2A6 polymorphism on artesunate and amodiaquine tolerability<br />
Wardah Yusof, (Malaysia), SH Gan<br />
Influence of calcium antagonists on DNA-damage induced by cyclophosphamide and dioxidine<br />
Aliy K Zhanataev, (Russian Federation), AV Kulakova, EA Anisina, AD Durnev, SB Seredenin<br />
Hangover effects of orally, nocturnally administrated antihistamines: a double-blinded, placebocontrolled,<br />
crossover positron emission tomography (PET) study in healthy subjects<br />
Dongying Zhang, (Japan), M Tashiro, K Shibuya, Y Funaki, S Watanuki, M Kato, K Yanai<br />
Creation of a new class of medicinal agents on the basis of nanotechnologies<br />
Vadim Zhdanov, (Russian Federation), A Dygai, A Artamonov, A Bekarev, E Vereschagin, A Churin<br />
Gender factors in pharmacokinetics of ciprofloxacin in healthy volunteers<br />
Jana Zoulova, (Czech Republic), J Kopecky, Z Vybiralova, J Chladek, K Macek, J Kvetina<br />
Thursday 22 July ■ 13:00 - 14:00 ■ Poster Area 291
W29<br />
New horizons in therapeutic drug management<br />
(TDM)<br />
Thu 169<br />
Thu 170<br />
A rapid and sensitive high-performance liquid chromatographic method to quantify carbamazepine,<br />
oxcarbazepine, eslicarbazepine acetate and their main metabolites in human plasma<br />
Ana Fortuna, (Portugal), G Alves, L Santos, A Falcão, P Soares-da-Silva<br />
Biodistribution of 18F-labeled thermally hydrocarbonized porous silicon nanoparticles for drug delivery<br />
Mirkka Sarparanta, (Finland), E Mäkilä, T Heikkilä, J Salonen, V-P Lehto, HA Santos, J Hirvonen,<br />
AJ Airaksinen<br />
292 Thursday 22 July ■ 13:00 - 14:00 ■ Poster Area
FC14<br />
Addiction and doping: Neurobiological and clinical<br />
basis of emerging treatments<br />
Thu 171<br />
Thu 172<br />
Thu 173<br />
Thu 174<br />
Thu 175<br />
Thu 176<br />
Thu 177<br />
Thu 178<br />
Thu 179<br />
Thu 180<br />
Thu 181<br />
Thu 182<br />
Thu 183<br />
Thu 184<br />
Thu 185<br />
Aquaporin 4 deficiency modulates glutamate transporters expression and glutamate uptake in chronic<br />
morphine-treated mice<br />
Jin Li, (PR China), H-T Yan, N Wu, R-B Su, J-Q Zheng<br />
Tramadol reverses reserpine-induced hypothermia via μ opioid receptor in mice<br />
Jian-Hui Liang, (PR China), H-L Sun, M Zhang, K Wang<br />
Benzodiazepines reveals the addictive properties of buprenorphine in a conditioned place preference in<br />
mice<br />
Lin Lin Ma, (France), V Lelong-Boulouard, A Coquerel<br />
Effect of subchronic Pueraria radix extract administration on mRNA expression of POMC, PENK, PDYN,<br />
MOR, DOR and KOR genes in brain of WHP and WLP alcohol drinking rats<br />
Przemyslaw L Mikolajczak, (Poland), A Bogacz, M Karasiewicz, I Okulicz-Kozaryn, E Kaminska,<br />
M Szulc, P Figura, T Bobkiewicz-Kozlowska, W Dyr, W Kostowski, PM Mrozikiewicz<br />
The influence of magnesium, zinc and copper in reward system in rats<br />
Mihai Nechifor, (Romania), D Chelarescu, D Ciubotariu<br />
CNS effects of CB2 cannabinoid receptors<br />
Emmanuel Onaivi, (USA), H Ishiguro, Q-R Liu, J-P Gong, P Tagliaferro, A Brusco, G Uhl<br />
3,4-Methylenedioxymethamphetamine (MDMA, “ecstasy”) in humans: Gender differences in<br />
pharmacodynamics and pharmacokinetics<br />
Ricardo Pardo, (Spain), M Farre, S Yubero, B O'Mahony, M Torrens, C Mustata, C Perez-Maña,<br />
E Menoyo, M Perez, S Martin, R de la Torre<br />
Role of the dose of ethanol on the generation of endogenous hydroxytyrosol-DOPET<br />
Clara Perez-Maña, (Spain), M Farre, R Pardo, C Mustata, E Papaseit, A Pastor, E Orrtiz, E Menoyo,<br />
M Perez, S Martin, R de la Torre<br />
In vivo upregulation of central nicotinic receptors induced by methylenedioxymethamphetamine (MDMA)<br />
and its association with nicotine<br />
David Pubill, (Spain), S Garcia-Ratés, E Escubedo, J Camarasa<br />
Cannabinoid-induced tolerance reduction by lithium chloride in guinea-pig small intestine<br />
Fatemeh Rezania, (Iran), S Ejtemaei Mehr, AR Dehpour<br />
A laboratory package for personalised methadone therapy<br />
Ismail Rusli, (Malaysia), SC Tan, HL Sim, M Nurfadhlina, KC Sanjaya, MZ Iqbal, T Nazila, R Fazni,<br />
N Mohamad<br />
Icariin attenuates learning and memory deficits induced by D-galactose in rats<br />
Jing-Shan Shi, (PR China), F Li, Q-H Gong, Q Wu, Y-F Lu<br />
CANCELLED<br />
Pharmacokinetics of Dendrobine, an alkaloid from Dendrobium nobile, in rats<br />
Jing-Shan Shi, (PR China), C Liu, Q Wu, Y-F Lu, Q-H Gong<br />
Reflection of Dendrobium nobile lindl. alkaloids on lipopolysaccharide induced tau protein<br />
hyperphosphorylation in the hippocampus of rats<br />
Jing-Shan Shi, (PR China), S Yang, F Li, Q-H Gong, Q Wu, Y-F Lu<br />
Thursday 22 July ■ 13:00 - 14:00 ■ Poster Area 293
FC14<br />
Addiction and doping: Neurobiological and clinical<br />
basis of emerging treatments<br />
Thu 186<br />
Thu 187<br />
Thu 188<br />
Thu 189<br />
Thu 190<br />
Thu 191<br />
Thu 192<br />
Thu 193<br />
Thu 194<br />
Thu 195<br />
Thu 196<br />
Resveratrol prevents the inflammatory process and the dopaminergic degeneration induced by the<br />
intranigral injection of lipopolysaccharide<br />
Jing-Shan Shi, (PR China), F Jin, H Jin, Q Wu, F Zhang, Y-F Lu, Q-H Gong<br />
Activation of GABA B receptors abolishes dopamine release induced by systemic amphetamine in the<br />
rat lateral septum<br />
Ramón Sotomayor-Zárate, (Chile), K Araya, P Pereira, P Carreño, K Gysling, G Quiroz, E Blanco<br />
Molecular mechanisms underlying the lack of δ-opioids-induced rewarding effects associated with the<br />
downregulation of central dopaminergic transmission under the neuropathic pain-like state<br />
Tsutomu Suzuki, (Japan), S Imai, M Narita, K Niikura, N Kuzumaki, M Narita<br />
The antihypnotic and antihypoxic effects of mildronate<br />
Baiba Svalbe, (Latvia), R Muceniece, E Vavers, E Liepinsh, L Zvejniece<br />
Ethanol and the cannabinoid system interaction at GABAergic synapses within the basolateral amygdala<br />
Giuseppe Talani, (Italy), DM Lovinger<br />
Investigation of morphine preference in Swiss and C57BL/6J mice<br />
David Taylor, (Australia), B Bernard, D Malone<br />
Increased vulnerability of perinatally drug-exposed rats towards subsequent drug abuse<br />
Julia Timar, (Hungary), M Sobor, S Gyarmati, P Riba, M Al-Khrasani, S Fürst<br />
Negative impact of methamphetamine on glutamatergic neuron-astrocyte interaction<br />
Ana Sofia Travassos, (Portugal), T Morgadinho, J Gonçalves, AP Silva, CF Ribeiro, FC Pereira<br />
Effects of single in vivo doses of gaboxadol, a high-efficacy agonist of extrasynaptic GABA-A receptors,<br />
on glutamatergic transmission in VTA DA neurons<br />
Elena V Vashchinkina, (Finland), AE Panhelainen, OY Vekovischeva, ER Korpi<br />
The selective mGluR7 agonist AMN082 inhibits cocaine-triggered relapse by a glutamate mechanism in<br />
the nucleus accumbens in rats<br />
Zheng-Xiong Xi, (USA), X Li, J Li, E Gardner<br />
Cocaine induces nitric oxide production and apoptosis in fetal rat myocardial cells<br />
Shumei Yang, (USA), G Li, L Zhang<br />
294 Thursday 22 July ■ 13:00 - 14:00 ■ Poster Area
FC15<br />
Endothelium in health and disease<br />
Thu 197<br />
Thu 198<br />
Thu 199<br />
Thu 200<br />
Thu 201<br />
Thu 202<br />
Thu 203<br />
Thu 204<br />
Thu 205<br />
Thu 206<br />
Thu 207<br />
Thu 208<br />
Thu 209<br />
Thu 210<br />
Protective role of the adrenomedullin receptor in vascular hypertrophy<br />
Lihuan Liang, (UK), C Tam, G Pozgai, R Siow, K Husmann, W Born, J Fischer, R Poston, A Shah,<br />
S Brain<br />
Intermittent hypoxia alters the expression of NMDA receptor subunits and antioxidant enzymes in the<br />
rat rostral ventrolateral medulla<br />
Hsun-Hsun Lin, (Taiwan), C-C Lai<br />
Plasma fibrinogen mediates the binding of streptokinase to activated human platelets<br />
Chao-Zong Liu, (Taiwan), P-S Jiang, L-Y Chang<br />
COX-1 or COX-2 deletion is associated with increased nuclear NF-κB in the endothelium of the aortic<br />
arch<br />
Martina H Lundberg, (UK), LS Harrington, PDM Leadbeater, TD Warner, JA Mitchell<br />
5-Hydroxytryptamine induces cycolooxygenase-2 through mechanism involving Src, PKC and MAPK in<br />
rat vascular smooth muscle cells<br />
Takuji Machida, (Japan), K Iizuka, M Hirafuji<br />
Interactions between carbon monoxide releasing molecules and nitric oxide donors in vascular tissue<br />
Antonia Marazioti, (Greece), P Baskaran, M Bucci, C Szabo, G Cirino, C Romao, AR Marques, A Beuve,<br />
A Papapetropoulos<br />
Spinal dihydroergotamine inhibits capsaicin-induced canine external carotid vasodilatation via central<br />
5-HT1B/1D receptors and α2-adrenoceptors<br />
Bruno Marichal-Cancino, (Mexico), G Manrique-Maldonado, A González-Hernández,<br />
MT Villamil-Hernández, O Alcántara-Vázquez del Mercado, D Centurión, A Sánchez-López, C Villalón<br />
Plasma melatonin primes for a long-term endothelial cell cultures<br />
Regina Markus, (Brazil), E Tamura, P Fernandes, M Marçola, S Cruz-Machado<br />
Glycosaminoglycans and candesartan prevent renal alteration and oxidative stress in the kidney of<br />
diabetic rats<br />
Yaira Mathison, (Venezuela), C Ciangherotti, M Álvarez, H Fernández, A Israel<br />
Nitric oxide levels in the renal cortex of streptozocin-induced diabetic rats treated with ramipril and<br />
eplerenone<br />
T Mavrakanas, Constantinos Tomos, (Greece), M Mironidou-Tzouveleki<br />
Effects of cyclooxygenase inhibitors on protease-activated receptor 2 activating peptide-induced<br />
relaxations of aorta in chronic angiotensin II treated mice<br />
John J McGuire, (Canada), KH Hughes<br />
Calcitonin gene-related peptide terminates endothelin-1-induced vasoconstriction and vasopressor<br />
responses<br />
Merlijn JPMT Meens, (The Netherlands), NJA Mattheij, H van Essen, MG Compeer, BJA Janssen,<br />
JGR De Mey<br />
Aspirin may prevent preeclampsia and its complications in women with abnormal uterine artery doppler<br />
ultrasound<br />
Elaheh Mesdaghinia, (Iran), H Talari, A Zolfagharpour, M Abedzadeh, P Rezapourian<br />
Nampt/Visfatin as a novel therapeutic target for stroke<br />
Chao-Yu Miao, (PR China), P Wang, T-Y Xu, W-W Tian, Y-F Guan, D-F Su, Y-C Rui, B Viollet, Q-W Zhai<br />
Thursday 22 July ■ 13:00 - 14:00 ■ Poster Area 295
FC15<br />
Endothelium in health and disease<br />
Thu 211<br />
Thu 212<br />
Thu 213<br />
Thu 214<br />
Thu 215<br />
Thu 216<br />
Thu 217<br />
Thu 218<br />
Thu 219<br />
Thu 220<br />
Thu 221<br />
Thu 222<br />
Thu 223<br />
Thu 224<br />
Thu 225<br />
Thu 226<br />
On pharmaco-physiological problems of hypertonia idiopathica<br />
Michael C Michailov, (Germany), E Neu, U Welscher, S Ivanova, N Senn, J Foltinova, W Seidenbusch<br />
Vasodilatory activity of a new quinoxaline N-acylhydrazone derivative LASSBio-1120: The participation<br />
of NO/cGMP pathway<br />
Ana Luisa Miranda, (Brazil), L Louback, LM Lima, A Monge, EJ Barreiro<br />
Distinct effects of tissue-type plasminogen activator and Cpd-7 on cerebrovascular inflammation during<br />
thrombolysis<br />
Takuro Miyazaki, (Japan), O Hisayuki, K Hasumi, K Honda<br />
Evaluation of the EndoPAT as a tool to assess endothelial function<br />
Matthijs Moerland, (The Netherlands), A Kales, L Schrier, D Bradnock, J Burggraaf<br />
Modulation of vasoactivity and platelet aggregation by 5-HT antagonism<br />
Matthijs Moerland, (The Netherlands), M Kemme, L Bergougnan, A Cohen, J Burggraaf<br />
Antiangiogenic effect of 4-hydroxychalcone<br />
Jan Mojzis, (Slovak Republic), L Varinska, M van Wijhe, P Koolwijk, L Mirossay, G Mojzisova<br />
Neutral sphingomyelinase-NADPH oxidase as a redox amplification pathway for hypoxic pulmonary<br />
vasoconstriction<br />
Laura Moreno, (Spain), G Frazziano, C Menendez, J Moral-Sanz, E Moreno, L Escolano, C Gonzalez,<br />
E Villamor, A Cogolludo, F Perez-Vizcaino<br />
Antihypertensive efficacy of aliskiren/hydrochlorothiazide combination: a meta-analytical approach<br />
Manuel Morgado, (Portugal), S Morgado, L Castanheira, A Macedo, M Castelo-Branco<br />
Boldine protects vascular endothelial function in Spontaneously Hypertensive rats (SHR) by inhibiting<br />
free radicals<br />
Dharmani D Murugan, (Malaysia), YS Lau, MR Mustafa<br />
Kallidinogenase inhibits the retinal neovascularization via the cleavage of VEGF<br />
Shinsuke Nakamura, (Japan), H Isuta, K Tsuruma, M Shimazawa, H Hara<br />
Antihypertensive efficacy of dual ECE/NEP inhibition during the onset of spontaneous hypertension in<br />
rats<br />
Jelly Nelissen, (TheNetherlands), BFJ Heijnen, P Lemkens, H van Essen, JGR De Mey,<br />
HAJ Struijker-Boudier, BJA Janssen<br />
Endothelin receptor activation reverses hypoxic vasodilation in porcine large coronary arteries<br />
Elise Nielsen, (Denmark), E Stankevicius, U Simonsen, O Fröbert<br />
Dexamethasone-releasing biodegradable vascular stents – in vitro and in vivo results<br />
R Nieminen, A Kotsar, I Uurto, Mari Hämäläinen, (Finland), J Mikkonen, J Leppiniemi, T Isotalo, M Talja,<br />
J-P Salenius, M Kellomäki, T Tammela, E Moilanen<br />
Roles of vinculin and Rho kinase on fibroblast fiber contraction<br />
Hiromi Nobe, (Japan), K Nobe, R Paul, K Honda, Y Sakai<br />
Aging has a negative effect on estrogen modulation of nitric oxide (NO) production in mice aorta<br />
Laura Novensa, (Spain), S Novella, G Segarra, P Medina, N Castillo, C Hermenegildo, AP Dantas<br />
Inhibitory role of phosphorylation of myosin light chain at threonine-9 in the mechanical activity of<br />
canine basilar artery<br />
Kazuo Obara, (Japan), T Ishikawa, K Nakayama<br />
296 Thursday 22 July ■ 13:00 - 14:00 ■ Poster Area
FC15<br />
Endothelium in health and disease<br />
Thu 227<br />
Thu 228<br />
Thu 229<br />
Thu 230<br />
Thu 231<br />
Thu 232<br />
Thu 233<br />
Thu 234<br />
Thu 235<br />
Thu 236<br />
Thu 237<br />
Thu 238<br />
Thu 239<br />
Thu 240<br />
Intravenous administration of sodium nitrite alleviates ischemia/reperfusion-induced cerebral injury in<br />
nondiabetic rats but not in diabetic rats<br />
Mari Okazaki, (Japan), N Iwata, E Takamura, S Kamiuchi, Y Hibino<br />
UII plays a proatherogenic role in the hyperglycemic milieu characteristic of diabetes<br />
Murat Olukman, (Turkey), A Watson, TJ Allen, ME Cooper<br />
The mechanism of contractions induced by electrical field stimulation of rat mesenteric artery in<br />
calcium-free solution<br />
Melike Hacer Ozkan, (Turkey), S Uma<br />
Effects of atorvastatin and L-arginine pretreatments on electrical field stimulation-mediated relaxations<br />
in monocrotaline-induced pulmonary hypertensive rats<br />
Elif Inci Ozturk, (Turkey), S Uma<br />
Circulating molecules lipoprotein – HDL, LDL AND VLDL: possible risk factor with function of time in<br />
restenosis<br />
Snezana Pantovic, (Republic of Serbia), M Martinovic<br />
The growth factor pleiotrophin induces migration of endothelial and tumour cells that express ανβ3<br />
integrin and nucleolin on their cell surface<br />
Evangelia Papadimitriou, (Greece), M Koutsioumpa, C Mikelis<br />
The effect of rapamycin on endothelial function<br />
Ayse Parlar, (Turkey), A Erol, C Can<br />
Cystamine reduces blood pressure in SHR and attenuates inward eutrophic remodelling in vitro<br />
Morten Engholm Pedersen, (Denmark), A Eftekhari, MJ Mulvany<br />
Dual changes in pulmonary vascular reactivity in rats with ventilator-induced lung injury<br />
Francisco Perez Vizcaino, (Spain), C Menedez, L Martinez-Caro, J Moral-Sanz, E Moreno, JA Lorente,<br />
N Nin, A Esteban<br />
Participation of endothelial superoxide anion on alteration of angiotensin II-induced contraction in<br />
contralateral carotid of diabetic rats after balloon catheter injury<br />
Larissa Pernomian, (Brazil), M Santos Gomes, AM de Oliveira<br />
Endothelial TREK-1 potassium channels mediate acetylcholine-induced longitudinal hyperpolarization<br />
transfer to synchronize the diameter changes along cerebral arteries<br />
Olivier Pétrault, (France), C Widmann, C Misioreck, M De Bock, V Bérézovski, L Leybaert, R Ceccelli,<br />
C Heurteaux, M Borsotto<br />
Effect of chronic shear stress on endothelial cell morphology in vitro and in vivo: relevance to areas at<br />
risk of atherosclerosis in the aorta<br />
Claire MF Potter, (UK), MH Lundberg, HH Gashaw, J Gorelik, AV Moshkov, LS Harrington,<br />
PD Weinberg, JA Mitchell<br />
Importance of cerebrovascular vasoconstrictor receptor upregulation for the long-term outcome of<br />
experimental subarachnoid hemorrhage in rats<br />
Gro Klitgaard Povlsen, (Denmark), S Johansson, C Larsen, L Edvinsson<br />
Endothelial progenitor cell depletion in atherosclerotic patients is not related to increased apoptosis by<br />
plasmatic TGF-β<br />
Santiago Redondo, (Spain), A Gonzalez-Rocafort, J Navarro-Dorado, M Ramajo, M Hristov,<br />
A Gordillo-Moscoso, F Reguillo, M Carnero, E Rodriguez, C Weber, T Tejerina<br />
Thursday 22 July ■ 13:00 - 14:00 ■ Poster Area 297
FC15<br />
Endothelium in health and disease<br />
Thu 241<br />
Thu 242<br />
Thu 243<br />
Thu 244<br />
Thu 245<br />
Thu 246<br />
Thu 247<br />
Thu 248<br />
Thu 249<br />
Thu 250<br />
Thu 251<br />
Thu 252<br />
Thu 253<br />
Thu 254<br />
Thu 255<br />
TLR3 and TLR4 ligands induce intracellular IL-1β immunoreactivity in human aortic endothelial cells<br />
(HAEC) and lung microvascular endothelial cells (HLMVECs)<br />
Daniel M Reed, (UK), WR Wright, CMF Potter, HH Gashaw, LK Bailey, M Paul-Clark, JA Mitchell<br />
Soluble epoxide hydrolase inhibition prevents coronary endothelial dysfunction in renovascular<br />
hypertension<br />
Vincent Richard, (France), J Gao, E Gomez, B Dautreaux, F Bounoure, M Skiba, C Thuillez, J Bellien<br />
Improved vascular function and altered cardiac phenotype in mice overexpressing melanocytestimulating<br />
hormone<br />
Petteri Rinne, (Finland), I Heinonen, A Saraste, ST Ruohonen, S Ruohonen, E Savontaus<br />
Non-invasive laser speckle contrast imaging to assess skin microvascular reactivity in humans<br />
Matthieu Roustit, (France), C Millet, S Blaise, B Dufournet, J-L Cracowski<br />
Cathodal iontophoresis of treprostinil and iloprost induce a sustained increase in skin blood flow in rats<br />
Matthieu Roustit, (France), S Blaise, C Ribuot, C Millet, J-L Cracowski<br />
Differences in the in vitro antiplatelet effect of dexibuprofen, ibuprofen and flurbiprofen in human blood<br />
Maria Isabel Ruiz-Moreno, (Spain), JJ Reyes-Vega, JA Lopez-Villodres, N Jebrouni, JA Gonzalez-Correa,<br />
JP de la Cruz<br />
Effect of cinnamaldehyde (C) on vascular function in diabetic rats<br />
Ramzi Sabra, (Lebanon), M Khalaf<br />
Involvement of secretory phospholipase A2 in stretch-induced aberrant contraction in pulmonary<br />
arteries isolated from pulmonary hypertensive rats<br />
Maki Saito, (Japan), Y Tanabe, A Kamataki, T Sawai, K Nakayama<br />
Differential COX-2-mediated arachidonic acid metabolism in coronary and penile arteries from<br />
prediabetic obese Zucker rats<br />
A Sánchez, C Contreras, N Villalba, P Martínez, A García-Sacristán, M Hernández, Dolores Prieto,<br />
(Spain)<br />
Thyroid hormone up-regulates elastin and lysyl oxidase genes in rat aorta<br />
Mitsutoshi Satoh, (Japan), S Yanagino, T Nishimaki-Mogami, K Suzuki, Y Sato<br />
NO synthase and Thrombospondin-1 in the initiation of flow-related reModelling of rat mesenteric<br />
resistance arteries<br />
Paul Schiffers, (The Netherlands), P Lemkens, G Boari, G Fazzi, G Janssen, J Murphy-Ullrich, J De Mey<br />
Distinct NADPH-cytochrome P450 reductase dependence of heme oxygenase-1 and heme oxygenase-2<br />
Monika Seeanner, (Germany), JR Kraehling, M Busker, S Behrends<br />
In vitro dissolution kinetics studies of amlodipine tablets marketed in Russia under biowaiver conditions<br />
IE Shohin, GV Ramenskaya, GF Vasilenko, EA Malashenko, KS Davydova, Dmitry A Sychev, (Russian<br />
Federation), VG Kukes<br />
Role of AT1 and AT2 receptor and NAD(P)H oxidase on angiotensin II-stimulated antioxidant enzymes<br />
activity in the rat hypothalamus<br />
Jose Silva, (Venezuela), M Pastorello, S De Jesus, MG Matos, MR Garrido, A Israel<br />
Potential beneficial effect of ergothioneine in protecting endothelial dysfunction<br />
Albert SM Sit, (PR China), EYW Ho, RWS Li, YW Kwan, M Hausman, PM Vanhoutte, GPH Leung<br />
298 Thursday 22 July ■ 13:00 - 14:00 ■ Poster Area
FC15<br />
Endothelium in health and disease<br />
Thu 256<br />
Thu 257<br />
Thu 258<br />
Thu 259<br />
Thu 260<br />
Thu 261<br />
Thu 262<br />
Thu 263<br />
Thu 264<br />
Thu 265<br />
Thu 266<br />
Thu 267<br />
Thu 268<br />
Thu 269<br />
Thu 270<br />
Statin-dependent effects on vascular tone and gene expression in human endothelial cells<br />
Cristine Skogastierna, (Sweden), L Luksha, K Kublickiene, E Eliasson, A Rane, L Ekström<br />
Adding ezetimibe to statin halts progression of carotid plaque<br />
J David Spence, (Canada)<br />
Involvement of endothelial sphingolipid metabolism in release and action of endothelium-derived<br />
contracting factors<br />
Léon Spijkers, (The Netherlands), R van der Akker, A Alewijnse, S Peters<br />
Small and intermediate calcium-activated K channels are involved in release of NO and EDHF in small<br />
arteries<br />
Edgaras Stankevicius, (Denmark), C Krøjgaard, T Dalsgaard, L Beck, AD Hughes, U Simonsen<br />
Electropharmacological analysis of triggered activity in the pulmonary vein myocardium of the guinea<br />
pig<br />
Akira Takahara, (Japan), T Sugimoto, K Takeda, I Namekata, H Tanaka<br />
Proton mediates perivascular adrenergic and CGRPericg neurotransmission in the rat mesenteric artery<br />
Shingo Takatori, (Japan), K Hirai, H Fujiwara, X Jin, S Egutchi, Y Kitamura, H Kawasaki<br />
ω6-polyunsatulated fatty acids, but not other free fatty acids, evoke endothelial dysfunction by inhibiting<br />
store-operated Ca2+ entries<br />
Kazuhiko Takeuchi, (Japan), J Wei, N Inui, H Watanabe<br />
Different contributions of Rho-kinase to the vasoconstrictions caused by 5-HT and noradrenalin in the<br />
isolated human internal thoracic artery and saphenous vein<br />
Naoko Tanaka, (Japan), T Kanai, Y Matsuo, M Kuwabara, E Nakamura, K Nakamura, Y Asada, H Hisa,<br />
R Yamamoto<br />
Impaired arterial smooth muscle calcium signalling and ultrastructural deterioration appear linked in the<br />
elderly<br />
Teresa Tejerina, (Spain), J Navarro-Dorado, M Alonso, M Ramajo, S Redondo, C van Breemen,<br />
N Fameli<br />
Renovascular hypertension increases the hypothalamic content of serotonin in rats<br />
José A Terrón, (Mexico), B García-Iglesias, I López-Islas<br />
FP and TP receptors are responsible for increased vasoconstriction induced by Prostaglandin F2α in<br />
preeclamptic human umbilical vein<br />
Gokce Topal Tanyilmaz, (Turkey), SB Uydes Dogan, M Kucur, A Gezer, R Madazli, O Ozdemir, X Norel<br />
Endothelial cells during a parabolic flight – which changes appear<br />
C Ulbrich, Jessica Pietsch, (Germany), J Bauer, D Grimm<br />
Protective effect of amlodipine against the decrease in bone density in rats<br />
Kentarou Ushijima, (Japan), Y Liu, E Ishikawa, T Maekawa, Y Motosugi, H Ando, A Fujimura<br />
Sensitivity to Rho kinase inhibitor Y-27632 is increased in the mesenteric arteries of L-NAME<br />
hypertensive rats<br />
B Sonmez Uydes-Dogan, (Turkey), F Gezerler, S Takir, FI Alp, O Ozdemir<br />
Genomic changes caused by chronic exposure to high cholesterol or fish oil in native and regenerated<br />
porcine coronary endothelial cells<br />
Paul M Vanhoutte, (PR China), MYK Lee, Y Wang, HF Tse<br />
Thursday 22 July ■ 13:00 - 14:00 ■ Poster Area 299
FC15<br />
Endothelium in health and disease<br />
Thu 271<br />
Thu 272<br />
Thu 273<br />
Thu 274<br />
Thu 275<br />
Thu 276<br />
Thu 277<br />
Thu 278<br />
Thu 279<br />
Thu 280<br />
Thu 281<br />
Thu 282<br />
Thu 283<br />
Thu 284<br />
Effect of sulodexide on aortic vasodilation capacity and associated morphological changes in rats with<br />
streptozotocin-induced diabetes<br />
José Vázquez, (Venezuela), Y Mathison, E Romero, C Suárez<br />
Peroxynitrite stimulates pulmonary artery endothelial cell proliferation and may be generated in<br />
pulmonary hypertension<br />
Roger Wadsworth, (UK), EO Agbani, P Milliken, AT Demiryurek, P Coats, A Mills, A McPhaden, T Hoehn<br />
EDHF-mediated responses in the renal circulation of double transgenic hypertensive mice developing<br />
renal failure<br />
Ludovic Waeckel, (France), F Bertin, N Clavreul, R Kohler, P Sansilvestri-Morel, S Simonet,<br />
C Vayssettes-Courchay, H Wulff, TJ Verbeuren, M Félétou<br />
Endothelial dysfunction in the isolated aorta of double transgenic hypertensive mice developing aortic<br />
aneurysm<br />
Ludovic Waeckel, (France), N Clavreul, P Sansilvestri-Morel, S Simonet, C Vayssettes-Courchay,<br />
TJ Verbeuren, M Félétou<br />
Histidine-rich glycoprotein inhibits the angiogenic response induced by the combination of high mobility<br />
group box 1 and heparin in matrigel plug assay<br />
Hidenori Wake, (Japan), S Mori, HK Takahashi, K Liu, M Nishibori<br />
AGEs breakers reverse endothelial cell dysfunction and enhance the antihypertensive effect of<br />
Nifedipine in diabetic-hypertensive rats<br />
LiLi Wang, (PR China), B Zhang, G Chen, S Li<br />
Exercise improves the dilatation function of mesenteric artery in post-infarction rats: involved the<br />
mechanism of PI3K/Akt mediated eNOS cascaded<br />
Y-H Wang, (PR China), S-P Wang, H-K Jiang, S-F Chen, M Zhao, J Yang, J Zhang, Y Cai, S-J Fan,<br />
Y-L Tian, X-J Yu, W-J Zang<br />
20-HETE activation of TRPV1 in small diameter primary sensory neurons<br />
Hairuo Wen, (UK), J Östman, C Panayiotou, J Priestley, M Baker, A Ahluwalia<br />
Reduced action of sildenafil in pulmonary arteries from mice lacking the PKGI or the BKCa channel<br />
Matthias Werner, (UK), S Lia, M Nelson, A Gurney<br />
Albumin-facilitated extravasation of siRNA across vascular endothelium in vivo<br />
Paul White, (Australia), S Lau, N Cao, B Graham, C Pouton, B Boyd<br />
Both D- and L-arginine increase contractions to dexmedetomidine in the presence of L-NAME in the rat<br />
aorta with endothelium<br />
Emily SW Wong, (PR China), RYK Man, PM Vanhoutte, KFJ Ng<br />
Chronic treatment of Vitamin D derivatives reduce endothelium-dependent contractions in the aorta of<br />
the spontaneously hypertensive rat<br />
Michael SK Wong, (PR China), RYK Man, PM Vanhoutte<br />
Role of hydrogen sulfide (H2S) in conduit and resistance arteries from septic rats<br />
Chin-Chen Wu, (Taiwan), S-J Chen, C-T Chiu, M-H Liao<br />
Effects of CYP7A1 polymorphisms on the fasting plasma concentrations of bile acids, bile acid<br />
synthesis marker, and total cholesterol in humans<br />
Xiaoqiang Xiang, (Finland), PJ Neuvonen, M Niemi<br />
300 Thursday 22 July ■ 13:00 - 14:00 ■ Poster Area
FC15<br />
Endothelium in health and disease<br />
Thu 285<br />
Thu 286<br />
Radiation of electromagnetic waves to a finger using Yubi-MR reduces oxidative stress in blood by<br />
electron-transfer via negatively charged water formation<br />
Naomasa Yamamoto, (Japan), Y Koike, K Kumano, N Yonehara<br />
CNS pericytes originate from the circulating hematopoietic progenitors<br />
Seiji Yamamoto, (Japan), M Muramatsu, E Azuma, M Dohmoto, S Kita, T Iwamoto, I Komuro,<br />
K Takano, S Niida, M Shibuya, N Matsuda, Y Hattori<br />
Thu 287 AVE3085 inhibits homocysteine-induced endothelial dysfunction: role of phosphatidylinositol 3-kinase /<br />
Protein kinase Akt<br />
Qin Yang, (PR China), H-M Xue, J-H Huang, G-W He<br />
Thu 288<br />
Thu 289<br />
Thu 290<br />
Thu 291<br />
Thu 292<br />
Thu 293<br />
Thu 294<br />
Role of canonical transient receptor potential channels in endothelial function and the effect of<br />
hypoxia-reoxygenation<br />
Qin Yang, (PR China), J-H Huang, H-M Xue, X-Q Yao, G-W He<br />
Vasodilatation to NO- in rat small mesenteric arteries; a role for potassium channels<br />
Polina Yarova, (UK), C Garland, K Dora<br />
Mechanism for the differential regulation of iNOS expression in J774 macrophages and vascular<br />
smooth muscle cells by the c-Jun N-terminal kinase inhibitor SP600125<br />
Marzieh Zamani, (UK), S Thakur, A Baydoun<br />
The influence of moxonidine on plasma resistin levels in patients with essential hypertension<br />
Iwona Zaporowska-Stachowiak, (Poland), A Targonska, T Bobkiewicz-Kozowska<br />
Protective effect of celecoxib against acute myocardial ischemia on coronary artery of rabbits<br />
M Zhao, X He, H-L Zhang, X-J Yu, Wei-Jin Zang, (PR China)<br />
Generating novel hypothetical associations between statin therapy and endothelial adhesion molecules<br />
using computerized tool SemBT<br />
Lovro Ziberna, (Slovenia), M Lunder, G Drevensek, D Hristovski<br />
Vitamin D3 does not augment EDHF-mediated relaxations to bradykinin<br />
Qian Zou, (PR China), PM Vanhoutte<br />
Thursday 22 July ■ 13:00 - 14:00 ■ Poster Area 301
FC16<br />
Natural products: Past and future<br />
Thu 295<br />
Thu 296<br />
Thu 297<br />
Thu 298<br />
Thu 299<br />
Thu 300<br />
Thu 301<br />
Thu 302<br />
Thu 303<br />
Thu 304<br />
Protective effects of Ganoderma lucidum polysaccharides on intestine damage in vivo and in vitro and<br />
mechanisms approach<br />
Wei Dong Li, (PR China), LH Chen, J Ma, Y Qin, JQ Zhang, J Yang, ZB Lin<br />
Proteomic study of hepatotoxicity induced by retrorsine, a representative pyrrolizidine alkaloid<br />
Yanhong Li, (PR China), WCS Tai, N Li, WLW Hsiao, G Lin<br />
In vivo and in vitro mechanistic studies of the wound-healing effects of Radix Rehmanniae towards<br />
diabetic foot ulcer using bioassay-guided fractionation<br />
Cheuk-Lun Liu, (PR China), L Cheng, HF Kwok, KM Lau, CM Koon, CP Lau, KP Fung, BS Lau<br />
Oxidative stress-induced stimulation of AMP-activated protein kinase involves in sodium ferulate-induced<br />
cardioprotection<br />
Dan Liu, (PR China), D Yin, L Tang, B Zhong, D Sun, M He<br />
Effects and mechanism of WNK on reperfusion-induced vascular injury to cerebral microvessels after<br />
global cerebral ischemia<br />
Jianxun Liu, (PR China), Y Zheng, X Li, L Xu<br />
Antioxidant activity of oligosaccharide ester extracted from Polygala tenuifolia roots in senescenceaccelerated<br />
mice<br />
Ping Liu, (PR China), Y Hu<br />
San-Huang- Xie-Xin-Tang protects against MPTP-induced dopaminergic neurotoxicity via inhibition of<br />
oxidative stress and apoptosis<br />
Yi-Ching Lo, (Taiwan), Y-T Shih<br />
Complementary and alternative drugs use among preoperative patients: A cross-sectional study in<br />
Tuscany (Italy)<br />
Ersilia Lucenteforte, (Italy), E Gallo, A Pugi, F Giommoni, P Lupi, M La Torre, G Diddi, F Firenzuoli,<br />
A Mugelli, A Vannacci, F Lapi<br />
Investigation of the phytochemistry, antioxidant activities and anticancer effects of total extract and<br />
some of the purified compounds of Ferula szowitsiana D.C. on several human cancer cell lines<br />
Omid Mashinchian, (Iran)<br />
Role of Terminalia arjuna an Indian medicinal plant in cardiovascular diseases<br />
Subir Kumar Maulik, (India)<br />
Thu 305 The neuroprotective effects of a purified compound extracted from curcuma longa against 6-OHDA -<br />
induced dopaminergic neurotoxicity in SH-SY5Y cells<br />
Benjawan Meesarapee, (Thailand), A Thampithak, Y Jaisin, Y Sanvarinda<br />
Thu 306<br />
Thu 307<br />
Thu 308<br />
Thu 309<br />
Simultaneous determination of gallic acid and protocatechuic acid in rabbit serum by HPLC after oral<br />
administration of Fructus choerospondiatis extract<br />
Xianli Meng, (PR China), P Wang, Y Zhang, H Liu<br />
Effects of a water-soluble Cinnamomum cassia extract on isolated rat platelets<br />
Zsofia Mezei, (Hungary), G Mester, Z Mécs, A Leprán, D Rédei, G Szabó<br />
Antiproliferative activity of some solanidine analogs on HL-60 cells<br />
Renata Minorics, (Hungary), T Szekeres, G Krupitza, P Saiko, B Giessrigl, J Wölfling, E Frank, I Zupkó<br />
Synthesis and cytotoxic activity of novel benzopyrano[3,2-c]chromene-6,8-dione derivatives<br />
Ramin Miri, (Iran), O Firuzi, S Meili, AR Mehdipour, R Motamedi, A Shafiee<br />
302 Thursday 22 July ■ 13:00 - 14:00 ■ Poster Area
FC16<br />
Natural products: Past and future<br />
Thu 310<br />
Thu 311<br />
Thu 312<br />
Thu 313<br />
Thu 314<br />
Thu 315<br />
Thu 316<br />
Thu 317<br />
Thu 318<br />
Thu 319<br />
Thu 320<br />
Thu 321<br />
Thu 322<br />
Thu 323<br />
Thu 324<br />
Effect of Polygonum bistorta and tannic acid against carbon tetrachloride induced hepatic damage in<br />
albino rats<br />
Deepak Kumar Mittal, (India)<br />
Clinical efficacy of a topical herbal cream (aloe vera, geranium robertianum and lavandula stoechas) in<br />
second-degree burn wounds<br />
Yashar Moharamzad, (Iran), Y Panahi, F Beiraghdar, I Feizi<br />
Evaluation of the reproductive and developmental toxicities of the aqueous extract of Labisia pumila<br />
var. alata in female rats<br />
Wan Ezumi Mohd Fuad, (Malaysia), SS Amrah, J Hasnan, SSJ Mohsin<br />
Analyzing cytotoxic and apoptogenic properties of Scutellaria litwinowii root extract on cancer cell lines<br />
Seyed Hadi Mousavi, (Iran), SA Emami, Z Tayarani-Najaran, J Asili, A Mirzaei<br />
Baicalein protects the brain against neuron impairments induced by MPTP in C57BL/6 mice<br />
Xin Mu, (PR China), G He, X Li, G Du<br />
The effects of the aqueous extract of Asystasia gangetica on the blood pressure and heart rate in<br />
spontaneously hypertensive male wistar rats<br />
Pierre Mugabo, (South Africa), J-A Amunjela, D Hanse, G Hikumwah, F Hoedemaker, M Motsoaole,<br />
P Mwandingi, X Sambo<br />
Anti-inflammatory effects of bergamot essential oil in carrageenan-induced paw oedema in rat<br />
Michele Navarra, (Italy), C Mannucci, E Trapasso, S Pergolizzi, MR Ursino, S Micali, N Miceli,<br />
G Calapai<br />
The multi-herbal drug STW 5: potential mechanisms for the treatment of irritable bowel syndrome<br />
Karen Nieber, (Germany), M Michael, U Voss, D Weiser, O Kelber<br />
Ibogain in vitro effects on erythrocytes antioxidative enzymes activites<br />
Aleksandra Nikolic-Kokic, (Republic of Serbia), Z Orescanin-Dusic, M Slavic, P Jamnik, R Paskulin,<br />
M Spasic, D Blagojevic<br />
Possible drug interaction with Oren-gedoku-to by the inhibition of CYP2D metabolism<br />
Yuki Nishimura, (Japan), N Kurata, M Iwase, Y Saito, H Yasuhara<br />
Antitumor effect of Cordyceps sinensis via adenosine receptors<br />
Arisa Nishiuchi, (Japan), N Yoshikawa, Y Takahashi, Y Kimoto, A Sato, M Kunitomo, S Kagota,<br />
K Shinozuka, K Nakamura<br />
Biochemical and blood pressure alterations of elderly patients with colorectal cancer after of dietary<br />
supplementation with Agaricus Sylvaticus fungi<br />
Maria Rita Novaes, (Brazil), R Fortes, LC Novaes<br />
Effects of dietary supplementation with Agaricus Sylvaticus fungi on the metabolic and blood pressure<br />
evaluation of patients with colorectal cancer in the postsurgical phase<br />
Maria Rita Novaes, (Brazil), R Fortes<br />
Immunological and hematological effects of a dietary supplementation with Agaricus Sylvaticus in<br />
breast cancer patients undergoing chemotherapy<br />
Maria Rita Novaes, (Brazil), F Valadares<br />
Cardioprotective effect of resveratrol<br />
Aleksandra Novakovic, (Republic of Serbia), LG Bukarica, D Nezic, M Peric, V Kanjuh<br />
Thursday 22 July ■ 13:00 - 14:00 ■ Poster Area 303
FC16<br />
Natural products: Past and future<br />
Thu 325<br />
Thu 326<br />
Thu 327<br />
Thu 328<br />
Thu 329<br />
Thu 330<br />
Thu 331<br />
Thu 332<br />
Thu 333<br />
Thu 334<br />
Thu 335<br />
Thu 336<br />
Thu 337<br />
Thu 338<br />
Thu 339<br />
Thu 340<br />
Inhibition of prostate cell growth and angiogenesis induced by different phytosterols of marine origin<br />
Silvia Novio, (Spain), M Freire-Garabal, G Amigo, MJ Nuñez-Iglesias<br />
Evaluating the anti-diabetic properties of Paspalum vaginatum<br />
Nkechi Veronica Offiah, (Trinidad & Tobago), CD Ezeokoli<br />
The study of antidiabetic effects of partially purified extract from the roots of Thottea grandiflora Rottb<br />
Patrick Okechukwu, (Malaysia), G Marimuthu, GA Akuwoah<br />
Antimalaria and anticancer properties of Labisia pumila<br />
Maizatul Hasyima Omar, (UK), A Crozier, NR Abdullah, Z Ismail<br />
Effects of ibogaine on rat uterus contraction and antioxidative enzymes activity<br />
Zorana Orescanin-Dusic, (Republic of Serbia), M Slavic, R Paskulin, P Jamnik, S Milovanovic, M Spasic,<br />
D Blagojevic<br />
In vivo evaluation of the antitumor activity of daphnetin in murine melanoma model<br />
Fausto AJ Orozco, (Mexico), MJ García Mondragón, A Maldonado Espinza, MA Herrera Henriquez,<br />
N Mendoza Patiño, JJ Mandoki Weitzner<br />
Chinese herbal medicine ‘Wu Ling San’ had anti-inflammatory activity in crystal induced nephritis in rats<br />
Yoko Oyama, (Japan), S Tancharoen, T Ito, T Hashiguchi, T Uchimura, K Kawahara, I Maruyama<br />
Antioxidant effect of a methanol extract of Garcinia kola biflavonoid agbilu<br />
Jones Chukwudi Ozokwere, (South Africa), F Udoh, B Lawal, E Olivier<br />
Study of antidepressant activity of portulaca oleracea linn in mice<br />
Vinod Pawar, (India), S Gujar, S Rayate, RN Patil, S Hugar<br />
Acute and subacute toxicity of virgin coconut oil in rodents<br />
Ryan Pekson, (The Philippines), I Sia<br />
Optimization of aristolochic acid I detection in Aristolochia tagala Cham and Thai traditional recipe using<br />
TLC<br />
Rattana Phadungrakwittaya, (Thailand), P Akarasereenont, A Lumlerdkij, S Chaisri, S Chotewuttakorn,<br />
T Laohapand<br />
Membrane with a vegetative extract based on the collagen for tissue regeneration<br />
Guram Pichkhadze, (Kazakhstan), G Ustenova, I Kaulambaeva, D Assylbekova<br />
Cannabidiol inhibits human cancer cell invasion via upregulation of tissue inhibitor of matrix<br />
metalloproteinases-1<br />
Robert Ramer, (Germany), J Merkord, B Hinz<br />
Intraperitoneal and oral LD50 of an active principle of Nigella sativa, thymoquinone, in mice and rats<br />
Muhammad Akram Randhawa, (Saudi Arabia), A Al-Ali, AA Alkhawajah, NA Shaikh<br />
Regulatory status of herbal medicines. Considerations about Cuba<br />
Diadelis Remirez-Figueredo, (Cuba)<br />
Analysing on compatibility principle of pharmacologic action of traditional Chinese medicine formula by<br />
network approach<br />
Junguo Ren, (PR China), X Ma, C Lin, H Li, M Wang, J Li, Y Wang, J Liu<br />
304 Thursday 22 July ■ 13:00 - 14:00 ■ Poster Area
FC16<br />
Natural products: Past and future<br />
Thu 341<br />
Thu 342<br />
Thu 343<br />
Thu 344<br />
Thu 345<br />
Thu 346<br />
Thu 347<br />
Thu 348<br />
Thu 349<br />
Thu 350<br />
Thu 351<br />
Thu 352<br />
Thu 353<br />
Thu 354<br />
Bak foong pills, a traditional remedy for dysmenorrhoea, inhibits nociception via the somatostatin<br />
pathway<br />
Dewi K Rowlands, (PR China), YG Cui, SC So, LL Tsang, YW Chung, HC Chan<br />
Protective effect of Nigella sativa extract and thymoquinone on serum/glucose deprivation-induced<br />
PC12 cells death<br />
Hamid Reza Sadeghnia, (Iran), SH Mousavi, Z Tayarani-Najaran, M Asghari<br />
Effect of anchusan, Japanese traditional herbal medicine, on midazolam metabolism in rats<br />
Yusuke Saito, (Japan), Y Nishimura, N Kurata, M Iwase, H Yasuhara<br />
San'oshashinto prevents cardiac ischemia/reperfusion injury in ovariectomized rat via antioxidant<br />
properties<br />
Mayuko Sakanashi, (Japan), T Matsuzaki, K Noguchi, J Nakasone, M Sakanashi, K Chinen,<br />
M Sakanashi, M Tsutsui<br />
Effect of momordica charantia on blood glucose level in experimentally induced diabetic rats<br />
Mahmed Salahuddin, (Bangladesh)<br />
Effect of three plants: Hypericum humifusum, Crataegus L. Azarolus and Myrtus Communis L. on<br />
ischemia-reperfusion liver in Wistar male rats<br />
I Salouage, H Ferchichi, T Ayadi, S Bacha, I Ouanes, M Lakhal, Anis Klouz (Tunisia)<br />
Antioxidant activity of Rhizophora mangle (L.) bark and its effect on redox mechanisms involved in<br />
wound healing<br />
J Sánchez Calero, R Faure García, G Martínez Sánchez, O Fernández Limia, M Mitjavila Cors,<br />
E Marrero Faz, Yinet Barrese-Pérez, (Cuba)<br />
Selective detection of CYP3A4 inhibition by complementary products<br />
Danielle Sevior, (Finland), J Hokkanen, A Tolonen, K Abass, L Tursas, O Pelkonen, J Ahokas<br />
The “Zinaxin” clinical – pharmacological application aspects<br />
Evgeniya Shikh, (Russian Federation), O Shumkova<br />
Cinnamomi ramulus ethanol extract exerts vasorelaxation through inhibition of the rho-kinase signalling<br />
pathway<br />
Heung Shin, (South Korea), Y Kang<br />
Solavetivone reduces intracellular calcium in cultured myocytes isolated from guinea-pig ileum<br />
Joelmir LV Silva, (Brazil), F De Andrade Cavalcante, VLC Rigoni, TMS Silva, TL Nascimento,<br />
J Aboulafia, BA Silva, VLA Nouailhetas<br />
Trachylobane-360 decreases intracellular calcium in cultured myocytes isolated from guinea-pig ileum<br />
Joelmir LV Silva, (Brazil), RF Santos, VLS Rigoni, JJF Tavares, MS Silva, TL Nascimento, J Aboulafia,<br />
BA Silva, VLA Nouailhetas<br />
Crotalus durissus terrificus snake venom: a potential natural product in controlling inflammatory<br />
diseases<br />
Tatiane Soares de Lima, (Brazil), S Coccuzzo Sampaio, MC Cirillo<br />
On future phytopharmacology<br />
Jakob Stiglmayr, (Germany), J Milbradt, E Neu, SK Gupta, J Foltinova, M Schratz, W Seidenbusch,<br />
G Weber, N Senn, R Neu, U Welscher, M Michailov<br />
Thursday 22 July ■ 13:00 - 14:00 ■ Poster Area 305
FC16<br />
Natural products: Past and future<br />
Thu 355<br />
Thu 356<br />
Thu 357<br />
Thu 358<br />
Thu 359<br />
Thu 360<br />
Thu 361<br />
Thu 362<br />
Thu 363<br />
Thu 364<br />
Thu 365<br />
Thu 366<br />
Thu 367<br />
Thu 368<br />
Thu 369<br />
Mechanism of action of compounds isolated from Cecropia glazioui Sneth, a plant used to treat<br />
hypertension in Brazilian folk medicine<br />
Mirtes Tanae, (Brazil), MTR Lima-Landman, TMA Lima, KKY Isla, C Souccar, AJ Lapa<br />
Effects of a standardized extract of Centella asiatica ECa 233 on second degree burn wound in rats<br />
Boonyong Tantisira, (Thailand), M Tantisira, K Wannarat<br />
A randomized, single blind, placebo controlled trial on the effects of a standardized extract of Centella<br />
asiatica ECa 233 on minor aphthous ulcers<br />
Mayuree Tantisira, (Thailand), C Ruengprasertkit, B Tantisira, N Hongprasong<br />
Study of the effects of natural zeolite modified with zinc (ZZ) and its cellular signalling mechanisms in<br />
diabetes<br />
A Torres Domínguez, O León, G Rodríguez, LC de Menorval, M Casanova, L Rodriguez,<br />
René Delgardo-Hernandez, (Cuba)<br />
Non-ethanol fractions isolated from red wine have potent vasodilation activity in isolated rat aorta<br />
Milena Trandafilovic, (Republic of Serbia), M Janzek, L Ziberna, M Lunder, S Kreft, D Janes,<br />
G Drevensek<br />
Pro-apoptotic effect of ouabain in Jurkat and A549 cells<br />
Annalisa Trenti, (Italy), F Cusinato, S Luciani, L Trevisi<br />
The safety of Aristolochia tagala Cham. and Homnawakod recipe in Wistar rats: renal function study<br />
Pinpat Tripatara, (Thailand), S Booranasubkajorn, S Soukasem, W Onlamul, S Huabprasert,<br />
A Lumlerdkj<br />
Post-treatment with an active component of Scutellariae radix (TChi-2) reduces LPS-induced acute lung<br />
injuries and fatality<br />
Tzu-Ling Tseng, (Taiwan), M-F Chen, Y-H Hsu, TJF Lee<br />
Evaluation of haematinic activity of naga bhasma(NB) in phenylhydrazine induced haemolytic anaemia in<br />
rats<br />
Vaishali R Undale, (India), AV Yadav, PN Jagtap, CD Upasani, AV Bhosale<br />
Effects of bergamot essential oil and its extractive fractions on SH-SY5Y human neuroblastoma cell<br />
growth<br />
MR Ursino, E Trapasso, G Calapai, P Bramanti, Michele Navarra, (Italy)<br />
In vitro antimicrobial activity of some herbal extracts against oral pathogens<br />
Surena Vahabi, (Iran), E Najafi<br />
Sreening of Portuguese propolis and its plant sources for inhibitory activity against pathogenic<br />
protozoa<br />
Nuno Vale, (Portugal), S Falcão, V Batista, C Freire, L Maes, M Villas-Boas<br />
Effects of apple polyphenols on oxidative DNA damage induced by ethanol<br />
Fang Wang, (PR China), J Yang, J Du, C Wu<br />
The effectiveness and safety of arsenic trioxide with and without all-trans retinoic acid in the treatment<br />
of acute promyelocytic leukaemia: a meta-analysis<br />
Hao Wang, (PR China), Z-X Rong, H Qi, Y Zhang, B-S Wang, H-Z Chen<br />
Study on absorption kinetics of baicalin in extracted scutellaria affected by Rubarb anthraquinones<br />
Ping Wang, (PR China), X Meng, Y Zhang, H Liu<br />
306 Thursday 22 July ■ 13:00 - 14:00 ■ Poster Area
FC16<br />
Natural products: Past and future<br />
Thu 370<br />
Thu 371<br />
Thu 372<br />
Thu 373<br />
Thu 374<br />
Thu 375<br />
Thu 376<br />
Thu 377<br />
Thu 378<br />
Thu 379<br />
Thu 380<br />
Thu 381<br />
Thu 382<br />
Thu 383<br />
Thu 384<br />
Thu 385<br />
Neuroprotective effects of morroniside against transient forebrain ischemia in the rat cortex<br />
Wen Wang, (PR China), L Li, J Xiang, H Ai, L Zhang, P Wang, L Li<br />
Liquorice, pharmacological and clinical experiments from the traditional Chinese medicine to the<br />
modern research<br />
Xiaoying Wang, (China), H Zhang, X Gao<br />
The action mechanism and metabolism characteristics of the effective components groups of<br />
Xiaoxuming decoction for anti-ischemia<br />
Yuehua Wang, (PR China), N Zhou, X He, J Hu, H Zhang, Y Ding, H Qin, J Zhang, Z Li, G Du<br />
Lutein, a natural carotenoid, inhibits PDGF-BB and oxidative stress-induced signalling in vascular smooth<br />
muscle cells<br />
Wen-Bin Wu, (Taiwan), Y-C Lin<br />
Ellucidation of Crotalus durissus cascavella natriuretic peptide mode of action in isolated rat kidney:<br />
Expression of GC-A and GC-C receptors<br />
Rafael Matos Ximenes, (Brazil), JSAM Evangelista, RS Alves, ARC Jorge, PCP Sousa, AMC Martins,<br />
MEA Moraes, MM Rabello, MZ Hernandes, MH Toyama, A Havt, HSA Monteiro<br />
Effect of three purine alkaloids in tea on learning and memory functions of ratss exposed to restraint<br />
stress<br />
Jie-Kun Xu, (PR China), W-K Zhang, Q-G Wang, K Hiroshi, X-S Yao<br />
WNK improves learning and memory by modulating the neurotransmitter levels in rats and mice with<br />
vascular demantia<br />
Li Xu, (PR China), J-X Liu, W-H Cong<br />
Curcumin inhibits renal cyst formation and enlargement through regulating intracellular signalling<br />
pathways<br />
Baoxue Yang, (PR China), J Gao, H Zhou, T Lei, W Li, X Li<br />
Cornel iridoid glycoside promotes cell survival via the activation of PI-3K/Akt signalling pathway after<br />
stroke in the rat<br />
Ruiqin Yao, (China), X Wang, X Liu, L Zhang, C Ye, W Wang, H Ai, L Li<br />
Morinda Citrifolia leave extract prolongs human blood coagulation in vitro<br />
Peng Nam Yeoh, (Malaysia), JK Kumar, JW Mak, SK Cheong<br />
Effect of Morinda citrifolia hot water extract on platelet aggregation<br />
Peng Nam Yeoh, (Malaysia), V Ramachandran, JW Mak, SK Cheong, CF Leong<br />
Mitochondria and dihydrotanshinone-induced apoptosis in HepG2 cells<br />
JHK Yeung, WYW Lee, Peter Xuelin Zhou, (PR China), YW Kwan, SK Kong, HP Ho<br />
Gravidoprotective activity of glucosamine<br />
Ganna V Zaychenko, (Ukraine)<br />
Connection between cognition and sexual function<br />
Juntian Zhang, (PR China)<br />
Effects of Salvianolic acid A on renal injury in type 2 diabetic KKAy mice<br />
Li Zhang, (PR China), G Qiang, L Shi, H Zhang, B Chen, G Du<br />
In vitro antioxidant and in vivo anti-inflammatory and antinociceptive activities of Ophioglossum thermale<br />
Xue-Qiong Zhang, (PR China), Y-H Zhang, J-H Kim, J-T Bae, J-Y Oh, G-S Lee, H-B Pyo<br />
Thursday 22 July ■ 13:00 - 14:00 ■ Poster Area 307
FC16<br />
Natural products: Past and future<br />
Thu 386<br />
Thu 387<br />
Thu 388<br />
Thu 389<br />
Thu 390<br />
Thu 391<br />
Thu 392<br />
Thu 393<br />
Involvement of serotonergic system in Ganoderma Lucidum extraction-induced hypnosis<br />
Yong-He Zhang, (PR China), X-Y Cui<br />
Roles of antioxidants and heat shock proteins as an antifatigue effect induced by meirusenjyu on aged<br />
mice<br />
Jianrong Zhou, (Japan), K Yokomizo, T Miyata<br />
Study on anti-tumor activity and mechanism of methylacryloylshikonin in vitro and in vivo<br />
Liming Zhou, (PR China), Y Wu, X Zheng, Z Shao<br />
Protection of a water-soluble Danshen (Salvia miltiorrhiza) extract and its active ingredients on<br />
paracetamol-induced toxicity in rat hepatocytes<br />
Peter Xuelin Zhou, (PR China), WYW Lee, CM Cheung, PMY Or, JHK Yeung<br />
Higher specificity of the activity of low molecular weight fucoidan for thrombin-induced platelet<br />
aggregation<br />
Z Zhu, Q Zhang, L Chen, S Ren, Dali Luo, (PR China)<br />
In vitro antifungal activity of the essence of Thymus vulgaris and Myrtus communis L against candida<br />
albicans strains isolated from the patients with oral candidiasis in comparison with Nystatin<br />
Mohammadali Zia, (Iran), M Rouholamin, M Bayat, H Khalkhali<br />
Making cream from bee propolis for treatment of dermatophytic infections<br />
Mohammadali Zia, (Iran), M Rouholamin, R Mannani, S Gavanji<br />
Investigating potential immunomodulatory activity in native flora<br />
James Ziogas, (Australia), L Ng, L Bennett, R Williams, K Robinson, S Sudharmarajan, AG Stewart<br />
308 Thursday 22 July ■ 13:00 - 14:00 ■ Poster Area
FC17<br />
New approaches and targets in psychiatry<br />
Thu 394<br />
Thu 395<br />
Thu 396<br />
Thu 397<br />
Thu 398<br />
Thu 399<br />
Thu 400<br />
Thu 401<br />
Thu 402<br />
Thu 403<br />
Thu 404<br />
Thu 405<br />
Thu 406<br />
Thu 407<br />
A collaborative capacity building project for developing human resources in the area of clinical trials in<br />
psychiatry: a Cuban –Canadian experience<br />
Yudexi Mendoza, (Cuba), M Fors, MA Pascual, B Horner, C Cash, S Kutcher, R Valle, Y Cachimaille<br />
Placebo response in depression. Results from two clinical trials in Cuba<br />
Yudexi Mendoza, (Cuba), R Valle, MA Pascual<br />
Extinction of avoidance behavior by safety learning depends on intrahippocampal endocannabinoid<br />
signaling<br />
Vincenzo Micale, (Germany), R Marsch, F Pamplona, F Drago, CT Wotjak<br />
Prenatal stress induces anxiety-like behavior together with structural and functional disruption of central<br />
serotonin neurons in mice<br />
Kazuya Miyagawa, (Japan), M Tsuji, T Takeuchi, H Takeda<br />
α2C-adrenoceptor blockage increases DOPA uptake and dopamine synthesis in the central nervous<br />
system of mice<br />
Eduardo Moura, (Portugal), C Esteves-Pinto, MP Serrão, MA Vieira-Coelho<br />
Pharmacological evaluation of the antidepressant effects of new 2-adrenoceptor antagonists<br />
Carolina Muguruza, (Spain), F Rodriguez, JE Ortega, L Urigüen, JJ Meana, I Rozas, LF Callado<br />
Chronic antidepressants dampen the increase of depolarization-evoked glutamate release induced by<br />
acute behavioural stress in prefrontal/frontal cortex<br />
Laura Musazzi, (Italy), M Milanese, F Pasqualina, Z Simona, B Tiziana, M Alessandra, B Pietro,<br />
R Giorgio, R Maurizio, B Fabio, B Giambattista, P Maurizio<br />
Effects of clozapine and olanzapine on acquisition, consolidation and retention of memory in elevated<br />
plus maze test in mice<br />
Oguz Mutlu, (Turkey), G Ulak, I Komsuoglu Celikyurt, F Erden, F Yýldýz Akar<br />
Knockdown of DISC1 by in utero gene transfer impaired postnatal dopaminergic maturation in the<br />
frontal cortex and adult behaviors<br />
Toshitaka Nabeshima, (Japan), M Niwa, A Kamiya, K Kubo, K Kohda, P O'Donnell, Y Noda, A Sawa,<br />
K Nakajima<br />
Effects of early intervention with fluoxetine on anxiety-related behaviors induced in prenatally<br />
glucocorticoid exposed rats<br />
Masatoshi Nagano, (Japan), M Liu, H Ozawa, H Suzuki<br />
Chronic L-DOPA treatment prevents increased binding of [11C] MDL100907 to 5-HT2A receptors in a<br />
rat model of Parkinson’s disease<br />
Adjmal Nahimi, (Denmark), A Landau, M Høltzermann, S Jakobsen, S Østergaard, A Møller, D Doudet,<br />
A Gjedde<br />
Dyskinesia inducing dopamine originates in serotoninergic neurons<br />
Adjmal Nahimi, (Denmark), M Høltzermann, A Landau, K Vang, S Jacobsen, A Møller, G Wegener,<br />
D Doudet, A Gjedde<br />
Generation and characterization of conditional heparin-binding EGF-like growth factor knockout mice<br />
Atsushi Oyagi, (Japan), Y Oida, K Kakefuda, M Shimazawa, N Shioda, S Moriguchi, K Kitaichi, D Nanba,<br />
Y Furuta, K Fukunaga, S Higashiyama, H Hara<br />
Description of a new method of primary culture of bovine retinal ganglion cells<br />
Mercedes Palmero, (Spain), MA Company, V Maneu, JA Formigos<br />
Thursday 22 July ■ 13:00 - 14:00 ■ Poster Area 309
FC17<br />
New approaches and targets in psychiatry<br />
Thu 408<br />
Thu 409<br />
Thu 410<br />
Thu 411<br />
Thu 412<br />
Thu 413<br />
Thu 414<br />
Thu 415<br />
Thu 416<br />
Thu 417<br />
Thu 418<br />
Thu 419<br />
Thu 420<br />
Thu 421<br />
Thu 422<br />
Hippocampal neuroplasticity pathways in an animal model of depression: influence of chronic fluoxetine<br />
and δ-9-tetrahydrocannabinol administration<br />
Angel Pazos, (Spain), F Pilar-Cuillar, V Valdizin, R Madureira, A Diaz, A Rodriguez-Gaztelumendi,<br />
E Castro<br />
Adult neurogenesis and novelty-induced c-Fos expression in the hippocampus of GluA1 AMPA/glutamate<br />
receptor knockout mice<br />
Chiara Procaccini, (Finland), T Aitta-aho, K Jaako-Movits, A Zarkovski, A-M Linden, E Korpi<br />
Behavioral inhibition in rats: A model to examine mechanisms underlying the risk to develop anxiety and<br />
depression<br />
Chao Qi, (USA), P Roseboom, S Nanda, J Lane, J Speers, N Kalin<br />
CANCELLED<br />
The effects of URB597, fatty acid amide hydrolase (FAAH) inhibitor, in the basolateral amygdala of rats<br />
on anxiety-Like behaviors<br />
Ali Roohbakhsh, (Iran), A Hajizadeh Moghaddam, J Damchi Jelodar<br />
Effect of combined psychiatric and clinical pharmacological audit<br />
Eva Sædder, (Denmark), B Brock, B Klindt Poulsen, U Bartels<br />
The role of the histamine receptors on responses under restraint and psychological stress<br />
Eiko Sakurai, (Japan), A Oikawa, K Yanai<br />
Multitarget effects of anxiolytic afobazol<br />
S Seredenin, Mikhail Voronin, (Russian Federation), M Yarkova<br />
Effect of Yokukan-san, a kampo Chinese traditional medicine on mGlur5 knock-out mouse, a model<br />
mouse for schizophrenia<br />
Shigenobu Shibata, (Japan), A Fujimori, T Shimane, Y Nakano, K Horikawa<br />
Reversal of suppressive action of β-amyloid on long term potentiation in rat hippocampal slices by<br />
donepezil<br />
Elena Solntseva, (Russian Federation), N Kapai<br />
Effects of polymorphism of MDR1, SLCO1B1 and CYP3A4 on the pharmacokinetics of Simvastatin in<br />
healthy Koreans<br />
Hankil Son, (South Korea), SB Jang, YJ Lee, LA Lim, S Cho, J Chung, K Park<br />
Pharmacokinetic interaction between duloxetine and second-generation antipsychotics in patients with<br />
psychotic disorders<br />
Edoardo Spina, (Italy), C D'Arrigo, V Santoro, U Micograve, MR Muscatello, G Pandolfo<br />
Human cerebrospinal fluid contains exosomes that represent a novel reservoir for therapeutic<br />
biomarker discovery<br />
Jonathan M Street, (UK), RTA Chalmers, TS Walsh, DJ Webb, JW Dear<br />
Emotional behavior in pentylenetetrazol kindled mice<br />
Kenshi Takechi, (Japan), K Suemaru, H Araki<br />
Increase in hippocampal synaptosomal-associated protein 25 in mice adapted to chronic variable<br />
stress<br />
Hiroshi Takeda, (Japan), K Miyagawa, T Takeuchi, M Tsuji<br />
310 Thursday 22 July ■ 13:00 - 14:00 ■ Poster Area
FC17<br />
New approaches and targets in psychiatry<br />
Thu 423<br />
Thu 424<br />
Thu 425<br />
Thu 426<br />
Thu 427<br />
Thu 428<br />
Thu 429<br />
Thu 430<br />
Thu 431<br />
Thu 432<br />
The 5-HT7 receptor mediates fear conditioning through the amygdaloid extracellular signal-regulated<br />
kinase signalling in mice<br />
Minoru Tsuji, (Japan), K Miyagawa, T Takeuchi, H Takeda<br />
Ethic and psychiatry clinical trials’ design<br />
E Valle Cabrera, Y Mendoza Rodríguez, Yinet Barrese-Pérez, (Cuba)<br />
The impact of psychiatry clinical trials over the clinical practice. The Cuban experience<br />
R Valle Cabrera, Y Mendoza Rodríguez, Yinet Barrese-Pérez, (Cuba)<br />
A “two-step” competition binding approach to determine unlabelled ligand-receptor complex dissociation<br />
rates<br />
Georges Vauquelin, (Belgium), M Wennerberg, A Balendran, A Packeu<br />
Peripheral blood mononuclear cell gene expression profiles identify subjects with major depressive<br />
disorder (MDD) among healthy controls<br />
J Vistisen, J Tamm, R Artymyshyn, I Antonijevic, M Das, A Abdourahman, Birgitte Søgaard, (Denmark)<br />
Stereotypy in the deer mouse, correlation with cortico-striatal oxidative status and dopamine turnover,<br />
and response to combined fluoxetine/risperidone treatment<br />
De Wet Wolmarans, (South Africa), M Guldenpfennig, B Harvey, D Stein, J du Preez<br />
Erythropoietin-induced sonic hedgehog expression contributes to brain-derived neurotrophic factormediated<br />
neuroprotection against mitochondrial dysfunction<br />
Ding I Yang, (Taiwan), CL Wu<br />
Gravity-changing stress increases serotonin-related gene expression in the mouse brain<br />
Mitsuhiro Yoshioka, (Japan), T Yamaguchi, H Ohta, J Gyotoku, T Ochiai<br />
Inhibition of acetylcholinesterase activity in a rat model of Wernicke’s encephalopathy: In vivo and in<br />
vitro effects of thiamine<br />
A Zarros, Hussam Al-Humadi, (Greece), C Liapi, M Almpani, V Stolakis, N Skandali, E Katsouni,<br />
S Tsakiris<br />
Discovery and validation of the combinational therapeutic targets for Alzheimer's disease: A preliminary<br />
study<br />
Wenxia Zhou, (PR China), X-R Cheng, N Jiang, Y Zhang<br />
Thursday 22 July ■ 13:00 - 14:00 ■ Poster Area 311
FC18<br />
Nuclear receptor targets for treatment of diseases<br />
Thu 433<br />
Thu 434<br />
Thu 435<br />
Thu 436<br />
Thu 437<br />
Thu 438<br />
Thu 439<br />
Thu 440<br />
Thu 441<br />
Thu 442<br />
In silico approach to develop new selective PPARγ modulators (SPPARMs)<br />
Francesca Mancini, (Italy), M Vitiello, G Mangano, G Pochetti, MA Alisi, R Ombrato, E Fioravanzo,<br />
N Cazzolla, L Polenzani<br />
Peroxisome proliferator-activated receptor (PPAR) agonists protect podocytes from human kidney<br />
against cell death induced by oxygen/glucose deprivation-reoxygenation<br />
Gianluca Miglio, (Italy), AC Rosa, L Rattazzi, R Fantozzi<br />
Analysis of glucocorticoid receptor gene haplotype structure and its influence on disease activity and<br />
steroid therapy outcome in inflammatory bowel disease patients<br />
Jessica Mwinyi, (Switzerland), C Wenger, JJ Eloranta, GA Kullak-Ublick<br />
Influence of LHRH on sex hormone receptors in the CA3 of hippocampi of the male rat<br />
Bojana Petrovic, (Republic of Serbia), Z Zoric, D Drekic<br />
Inhibition of leukocyte endothelial cells interactions by activation of retinoid X receptor<br />
Laura Piqueras, (Spain), E Morcillo, C Company, J Cortijo, MJ Sanz<br />
Comparative analysis of gene regulation by the transcription factor PPARá between mouse and human<br />
Maryam Rakhshandehroo, (The Netherlands), G Hooiveld, M Müller, S Kersten<br />
Interaction between peroxisome proliferator-activated receptor-α and NADPH oxidases plays an<br />
important role in the development of pressure-overload cardiac hypertrophy<br />
Emma Robinson, (UK), DJ Grieve<br />
The fat-induced satiety factor OEA suppresses feeding through central release of oxytocin<br />
Adele Romano, (Italy), S Gaetani, J Fu, T Cassano, P Dipasquale, L Righetti, S Cianci, L Laconca,<br />
E Giannini, S Scaccianoce, D Piomelli, V Cuomo<br />
Renal side effects of short-term dexamethasone treatment<br />
Ita Samarzija, (Croatia)<br />
Activation of liver X receptors (α and β) by HIV protease inhibitors atazanavir and ritonavir and inhibition<br />
by non-nucleoside reverse transcriptase inhibitor efavirenz<br />
Jenny Svard, (Ireland), JP Spiers, F Mulcahy, M Hennessy<br />
Thu 443 Expression of the receptor for advanced glycation end products (RAGE) and high mobility group box 1<br />
(HMGB1) is related to human dental pulpitis progression<br />
Salunya Tancharoen, (Thailand), T Tengrungsun, T Suddhasthira<br />
Thu 444<br />
Thu 445<br />
Bag1 regulates chaperone-mediated triage decisions on degradation of chronic myelogenous leukemia<br />
oncoprtein, BCR-ABL<br />
Fujiko Tsukahara, (Japan), Y Maru<br />
Neuroprotection of ginsenoside Rg1 against Aβ25-35-induced neurotoxicity in primary cultured rat<br />
cortical neurons via nuclear steroid receptors activation<br />
Jiang Wu, (PR China), Z Wang, X Zhang, W Zhu, Y Shen, R Cui, J Lin, Y Su, Y Lou<br />
312 Thursday 22 July ■ 13:00 - 14:00 ■ Poster Area
Index<br />
The index shows the presentation reference<br />
for all authors and co-authors<br />
<strong>WorldPharma</strong><strong>2010</strong> provides a very large number of bursaries<br />
for young scientists from lesser developed countries<br />
Professor Zhi-Bin Lin (PR China)<br />
President of the 15th World Congress on Pharmacology (Beijing, 2006)<br />
Index 313
Name Paper ref. Name Paper ref.<br />
Aalkjær, C Tue 038, Wed 221, Wed 433<br />
Aalling, M Tue 161<br />
Ab Wahab, MS Mon 147, Mon 333<br />
Abacioglu, N Mon 366<br />
Abad, S Wed 177<br />
Abasnejad, M Tue 165<br />
Abass, K Thu 348<br />
Abbasi, S Thu 113<br />
Abdallah, DM Wed 382<br />
Abdel Aziz, H Tue 464<br />
Abdel Razek, H Tue 264<br />
Abdel-Aziz, H Wed 382<br />
Abdel-Maksoud, S FC06.2.6<br />
Abdel-Rahman, SM FC10.2.4<br />
Abdel-tawab, AM-D Mon 252<br />
Abdel-Tawab, M Thu 010<br />
Abdourahman, A Thu 427<br />
Abdul Hamid, R Wed 323<br />
Abdul Sattar, MZ FC05.1.5<br />
Abduljalil, K Mon 384<br />
Abdulla, MH<br />
FC05.1.5<br />
Abdullah, AD Tue 408<br />
Abdullah, N Mon 389<br />
Abdullah, NA<br />
YI.04, FC05.1.5<br />
Abdullah, NR Thu 328<br />
Abdullah, WZW Mon 361<br />
Abduzaimovic, D Wed 171, Wed 004<br />
Abe, K Thu 038<br />
Abe, M Tue 216<br />
Abe, N Mon 255<br />
Abedzadeh, M Thu 209<br />
Abel, U<br />
FC18.2.6<br />
Abernethy, D<br />
Mon 392, FC13.1.6<br />
Abid, M Tue 002<br />
Abi-Dargham, A FC17.1.3<br />
Abildstrøm, SZ FC04.2.4<br />
Able, S Mon 393, Wed 020<br />
Able, S Mon 420<br />
Abler, B Thu 112<br />
Abotaleb, N Mon 188<br />
Aboulafia, J Thu 351, Thu 352<br />
Abu Bakar, NH Mon 107<br />
Abu Bakar, R Mon 147, Mon 333<br />
Aburto-Cortes, L Tue 025<br />
Acheampong, P Mon 116,<br />
Acher, F FC11.3.6, Thu 083<br />
Achike, F Wed 370<br />
Achike, F I Wed 195, Wed 194<br />
Acimovic, J Tue 383<br />
Ackermann, S Thu 098<br />
Acosta, G Mon 040<br />
Acquaviva, AM Wed 307<br />
Adam de Beaumais, T FC10.1.5<br />
Adamicova, K Mon 293<br />
Adamu, I Tue 011<br />
Adamus, M Mon 081<br />
Adaramoye, O Wed 294<br />
Adcock, Ian M FC09.1.1<br />
Addolorato, G<br />
FC14.2.2<br />
Adeneye, A Tue 361<br />
Aderaye, G FC01.4.7, Mon 018<br />
Adeyemi, OO Wed 296, Tue 361, Wed 295<br />
Adham, N Wed 423<br />
Adler, A<br />
FC05.4.3<br />
Ado, S Tue 011<br />
Afshartous, D Wed 155<br />
Afzal, S FC13.3.6, Tue 482, Mon 119,<br />
Mon 118, Mon 406, Tue 480<br />
Agbani, EO Thu 272<br />
Agha Alaie, SY Mon 002, Mon 231<br />
Agirgol, M Mon 199<br />
Ago, Y Tue 360, Tue 060<br />
Agostini, S Tue 249<br />
Agouni, A Mon 148, Wed 196<br />
Ågren, G<br />
FC14.5.2<br />
Agresta, A Tue 487, Mon 448, Tue 488<br />
Agüero, J Tue 165, Thu 048<br />
Aguero, J Tue 163<br />
Aguiar, D<br />
FC17.5.5<br />
Aguila, JDF Mon 038<br />
Aguilera, R<br />
Mon 023, W04.1.3<br />
Aguiñiga, I Tue 420<br />
Ahluwalia, A Thu 278<br />
Ahmad, D Tue 137<br />
Ahmad, ED Tue 444<br />
Ahmad, F Tue 119<br />
Ahmad, M<br />
FC08.2.5<br />
Ahmadi, A Wed 012<br />
Ahmadzadehd, A Tue 251<br />
Ahnstedt, H Wed 021<br />
Ahokas, J Thu 348<br />
Ai, H Thu 370, Thu 378<br />
Aigbe, FR Wed 295<br />
Aihara, E Thu 072<br />
Ain-Shoka, A Tue 386<br />
Airaksinen, AJ Thu 170<br />
Aitta-aho, T Thu 409<br />
Aitta-aho, T Wed 393<br />
Ajami, A Wed 123<br />
Ajdary, S Wed 027, Wed 437<br />
Akagi, M Mon 253<br />
Akagi, R Mon 253<br />
Akahane, T Tue 311<br />
Akaike, A Mon 432, Mon 424, Mon 464<br />
Akaike, O Wed 371<br />
Akamine, EH<br />
FC06.1.5<br />
Akamine, T Mon 213<br />
Akarasereenont, P Mon 334<br />
Akarasereenont, P Thu 335<br />
Akbarali, H<br />
FC12.1.5<br />
Akdis, Cezmi A FC09.1.3<br />
Akhtar, S FC01.4.6, Mon 151<br />
Akiba, Y<br />
W02.1.5<br />
Akici, A Tue 027, Mon 117<br />
Akimoto, Y Tue 432<br />
Akindele, A Wed 296<br />
Akinyandenu, A Wed 144<br />
A, Shizuo PL14<br />
Akiyama, K Wed 414<br />
Aklillu, E FC01.4.7, Mon 018, Tue 005,<br />
Wed 136, Tue 489<br />
Akramiene, D Mon 403<br />
Akritopoulos, P Tue 246<br />
Akula, KK Wed 168<br />
Akuwoah, GA Thu 327<br />
Al, T Mon 264<br />
Alabi, T Tue 361<br />
Al-A, A Thu 338<br />
314 Index
Name Paper ref. Name Paper ref.<br />
Albarran-Juarez, J FC11.4.2, W01.2.1<br />
Albarran-Juarez, J Wed 022<br />
Albertioni, F Mon 055<br />
Albrechtsen, C Tue 482<br />
Alcántara-Vázquez<br />
del Mercado, O Thu 203<br />
Alcaraz, MJ W09.1<br />
Alderton, A<br />
FC03.2.6<br />
Alefishat, E Wed 023<br />
Alegret, M Tue 133<br />
Aviciene, C Mon 403<br />
Alemà, S Tue 249<br />
Aleshcheva, G Wed 252<br />
Alessandra, M Thu 400<br />
Alessi, F Tue 312<br />
Aleth, P Tue 190<br />
Alewijnse, A Thu 258, Thu 082<br />
Alexander, N<br />
FC11.3.2<br />
Alexander, S Mon 404, Wed 023<br />
Alexander, SPH Mon 282<br />
Alfonzo, M Wed 040<br />
Alfonzo, Marcelo J Wed 024<br />
Alfonzo, RG Wed 024<br />
Alfonzo-Gonzalez, M Wed 024<br />
Alhamoruni, A Tue 460<br />
Al-hosaini, K Wed 025<br />
Al-Humadi, H Thu 431,<br />
A Alsinde, H<br />
FC01.1.5<br />
A Arab, H Wed 301<br />
Alimahomed, R Thu 085<br />
Alisi, MA Thu 433<br />
Al-Kashi, A<br />
FC09.5.7<br />
Alkhawajah, AA Thu 338<br />
Al-khrasani, M Thu 062<br />
Al-Khrasani, M Thu 192,<br />
Allegaert, Karel FC10.4.3, Wed 001, Wed 002<br />
Allen, M Wed 096<br />
Allen, TJ Thu 228<br />
Allerheiligen, SRB FC07.3.4<br />
Alloza, JL Mon 138<br />
Al-magableh, M Wed 255<br />
Almaguer, D<br />
Mon 023, W04.1.3<br />
Almeida, OF<br />
FC18.3.1<br />
Almenar, L Tue 165, Thu 048, Tue 163<br />
Almpani, M Thu 431<br />
Alonso, M Wed 228, Thu 264<br />
Alp, FI Thu 269<br />
Alp, H Wed 312<br />
Alp, I Tue 461<br />
Al-Rasheed, NMI Mon 189<br />
Alstrup, AKO<br />
FC17.4.5<br />
Altaany, Z<br />
FC15.3.6<br />
Altcheh, J Mon 003, Wed 003<br />
Altcheh, J Mon 022<br />
Altinok, A<br />
FC07.1.3<br />
Alvarez de Mon, M Mon 254<br />
Álvarez de Sotomayor, M Tue 118<br />
Alvarez López, MC Mon 128<br />
Alvarez, J-C Tue 188, Tue 189<br />
Alvarez, M Tue 226<br />
Álvarez, M Thu 205<br />
Alvarez, S<br />
FC18.3.5<br />
Alvarez-Laviada, A FC03.2.4<br />
Alvarez-Leon, A Wed 344<br />
Alvarez-Sala, JL Mon 374<br />
Alves, FHF Wed 411<br />
Alves, G Thu 169, Mon 383, Tue 407<br />
Alves, JN Wed 342<br />
Alves, RS Thu 374<br />
Alves, RS Wed 297<br />
Alves-Filho, J Mon 275<br />
Alvey, C Mon 251<br />
Alving, Kjell<br />
FC09.3.2<br />
Amabeoku, G Wed 298<br />
Amada, K Tue 132<br />
Amadio, M Mon 152<br />
Amagase, K<br />
Tue 262, Tue 236, W02.2.3,<br />
Tue 467, Mon 335, Mon 255,<br />
Mon 405<br />
Amano, Y Mon 386<br />
Amaral, F W31.4<br />
Amberg, C Wed 071<br />
Ambrus, N Wed 197<br />
Amidzic, L Tue 237<br />
Amigo, G Thu 325<br />
Amini, M<br />
YI.07<br />
Aminlari, M Wed 299<br />
Ammendrup-Johnsen, I Mon 067, Mon 061<br />
Ammer, H<br />
FC16.1.5<br />
Amogne, W FC01.4.7, Mon 018<br />
Amrah, SS Thu 312<br />
Amrutka, DV Thu 106<br />
Amrutkar, D Mon 099<br />
Amrutkar, M Mon 336<br />
Amundsen, R Mon 041<br />
Amunjela, J-A Thu 315<br />
Amyrkulova, M Tue 079<br />
Anand, KJS Wed 006, Thu 003<br />
Ananthan, S<br />
FC14.3.5<br />
Anca, C Tue 190<br />
Ancrenaz, V Mon 337<br />
Andalib, S Mon 294<br />
Andersen, B<br />
FC05.3.5<br />
Andersen, CB Mon 050<br />
Andersen, CU Tue 161<br />
Andersen, D<br />
FC06.2.5<br />
Andersen, DC Wed 070<br />
Andersen, J FC13.3.6, Tue 065<br />
Andersen, JT Mon 118, Mon 119, Mon 406<br />
Andersen, M Wed 160<br />
Andersen, MP Tue 303<br />
Andersen, MV Tue 053<br />
Andersen, N Mon 118<br />
Andersen, NL Mon 119<br />
Andersen, SE Tue 053<br />
Anderson, C Tue 202<br />
Anderson, L Wed 254<br />
Anderson, ME<br />
FC06.4.4<br />
Andersson, J Mon 122<br />
Andersson, KE FC08.2.2<br />
Andersson, M Wed 136, Mon 371<br />
Andersson, S Wed 006<br />
Ando, H Mon 386, Thu 268<br />
Andó, R W19.2<br />
Ando, Y<br />
FC07.4.3<br />
Andrade, RJ Tue 123, Wed 109<br />
Andrade, T Mon 298<br />
Andrade-Lopes, AL Wed 054<br />
Index 315
Name Paper ref. Name Paper ref.<br />
Andre, JL<br />
FC10.5.5<br />
Atini, R Wed 394, Wed 395<br />
Andrés, V W09.4<br />
Andresen, B<br />
FC02.3.6<br />
Andresen, T W12.5<br />
Andressen, KW Wed 026<br />
As, PLR Tue 471<br />
As, W<br />
FC13.3.5<br />
Andriantsitohaina, R W08.2, Wed 216, Mon 148,<br />
Wed 196, Tue 118<br />
Androwiki, ACD Wed 233, Wed 237<br />
Andújar, Isabel Wed 300<br />
Andurkar, S Wed 184<br />
Angeles-Gamiño, M Tue 025<br />
Angelotti, T Wed 028<br />
Anggono, V<br />
YI.10<br />
Anguiano, L Tue 150<br />
Angulo, J<br />
FC08.1.4<br />
Anisina, EA Tue 165<br />
Anizon, F Tue 429<br />
Anjum, WA Tue 137<br />
Ansiau, D Mon 124<br />
Antipova, T Mon 225<br />
Antonijevic, I Thu 427<br />
Antsaklis, A Tue 381<br />
Antunes, M Wed 337<br />
Anuka, J Wed 145<br />
Anunobi, C Wed 296<br />
Anwar, EI Mon 364<br />
Anwer, T Tue 137<br />
Anzellotti, P Mon 281<br />
Anzenbacher, P Thu 118, Wed 118<br />
Anzenbacher, P Mon 081<br />
Anzenbacherova, E Thu 118, Mon 081, Wed 118<br />
Aoki, A Mon 307<br />
Aoki, D Tue 311<br />
Aoki, K Tue 443<br />
Aoki, Y<br />
FC03.2.5<br />
Aono, H Mon 402, Mon 112<br />
Aouichri, M Mon 020, Mon 021, Mon 338<br />
Aoyagi, H Mon 399<br />
Aparecida-S, E Wed 054<br />
Apicella, C Mon 296<br />
Araki, H Thu 421, Wed 413<br />
Arami, S Mon 002<br />
Aramphongphan, A Wed 338<br />
Arapovic, S Mon 342, Mon 343<br />
Araújo e Silva, AC Wed 302<br />
Araújo, A Mon 299, Wed 198<br />
Araújo, J Mon 042<br />
Araújo, JR Mon 057<br />
Araya, K Thu 187<br />
Araya, KA Wed 169<br />
Arce, MP Mon 079<br />
Archambault, NS Wed 156<br />
Arendt-Nielsen, L W12.2, W12.3, W12.5,<br />
W26.1<br />
Arici, A Mon 170<br />
Aricioglu, F Tue 145<br />
Arietti, P<br />
FC18.4.6<br />
Arima, H Tue 162<br />
Arima, J Tue 167<br />
Arimura, Y Thu 109<br />
Ariyama, Y Tue 153<br />
Arkan, S Wed 309<br />
Armor, D W03.7<br />
Arnal, JF Wed 216<br />
Aronowski, J<br />
FC18.3.2<br />
Aronson, J Tue 355<br />
Aronson, JK<br />
OL<br />
Arrang, J-M Wed 051<br />
Arrebola, MM Tue 116, Wed 250<br />
Arreto, C-D Mon 339<br />
Arriagada, L Tue 326<br />
Arribas, S Thu 054<br />
Arslan, F Mon 170<br />
Arslan, Rana Wed 303<br />
Artamonov, A Tue 167<br />
Artymyshyn, R Thu 427<br />
Arya, DS Mon 190, Mon 260, Wed 315<br />
Aryamanesh, S Mon 188<br />
Arýcý, MA Mon 043<br />
Asada, Y Thu 263<br />
Asadi, M Mon 044, Tue 164<br />
Asano, H Mon 399<br />
Asanuma, M Wed 424, Wed 413<br />
Åsberg, A Mon 041<br />
Asceric, M Wed 199<br />
Asghari, A Tue 165<br />
Asghari, M Thu 342<br />
Ashar, HD Wed 304<br />
Ashby, C Wed 182<br />
Ashcroft, FM<br />
FC12.4.2<br />
Ashida, Y Wed 305<br />
Ashna, A Mon 222<br />
Ashton, N Wed 269, Wed 238<br />
Asili, J Thu 313<br />
Ask, B Tue 318, Tue 138<br />
Asker-Hagelberg, C W35.4<br />
Aslan, S Wed 312<br />
Asmawi, MZ Tue 247, Mon 302<br />
Asmawi, Z<br />
FC16.3.4<br />
Assefa, A<br />
FC01.2.5<br />
Asslaber, M Mon 153<br />
Assreuy, J Wed 097<br />
Assunção, JPFC YI.08<br />
Assylbekova, D Thu 336, Tue 079<br />
Atabey, N Tue 200, Tue 411<br />
Ataee, R Wed 027, Wed 437<br />
Ataie, A Wed 396<br />
Ates, M Mon 043, Mon 170<br />
Atkinson, J Wed 244<br />
Attia, HA Mon 189<br />
Attia, TA Mon 340<br />
Atukeren, P Tue 461<br />
Au, CL<br />
FC15.4.7<br />
Auger, C Wed 306, Wed 273, Wed 385<br />
Aulaskari, PH Tue 247<br />
Aumiler, MR<br />
FC01.3.7<br />
Aurelio, L Thu 080<br />
Aursnes, I Tue 143<br />
Ausperger, KM FC01.3.7<br />
Autio, Anu Mon 256<br />
Aviello, G Wed 307<br />
Avila Albuerne, Y Wed 311<br />
Avissar, S Wed 410<br />
Avorn, J<br />
FC04.1.3<br />
Ayadi, T Thu 346<br />
316 Index
Name Paper ref. Name Paper ref.<br />
Ayajiki, K Wed 200<br />
Aydin, S Wed 309, Wed 308, Mon 348<br />
Aydin, Y Wed 309<br />
Ayugase, T Wed 414<br />
Azam, A Tue 002<br />
Azarpira, N Tue 485<br />
Azcutia, V Tue 134<br />
Aziba, P Wed 310<br />
Aznar, S<br />
FC11.2.6<br />
Azougagh, S<br />
FC10.1.5<br />
Azuma, E Thu 286<br />
Baandrup, J Wed 240<br />
Baba, A Wed 075, Mon 106, Mon 318<br />
Babaie, J Mon 455<br />
Babaoglu, M Wed 249,<br />
Babenko, A Wed 098<br />
Babosha, K<br />
FC01.2.5<br />
Bach, A YI.10, Tue 053, Thu 037<br />
Bach, KF Mon 345<br />
Bacha, S Thu 346, Wed 348, Mon 004<br />
Bach-Rojecky, L Mon 096<br />
Bachurin, SO Mon 422<br />
Bäck, S Mon 341<br />
Backman, JT FC05.2.4, Mon 380, Tue 316,<br />
Tue 330<br />
Badawy, A Tue 386<br />
Baditoiu, LM Tue 102<br />
Badyal, DK Mon 005<br />
Badzek, S Tue 328<br />
Bae, J-T Thu 385<br />
Bae, J-W Mon 358, Tue 350, Mon 359,<br />
Mon 049, Mon 069,<br />
Mon 066, Mon 065, Tue 043,<br />
Tue 044, Tue 073,<br />
Tue 160, Tue 161, Tue 323,<br />
Tue 162, Tue 324,<br />
Tue 331, Tue 332, Tue 333,<br />
Wed 142, Wed 143<br />
Baek, S<br />
FC18.4.2<br />
Baggott, MJ Wed 170<br />
Bagheri, A Tue 469<br />
Bagley, E<br />
FC03.3.1<br />
Bagoly, T Tue 250<br />
Baharuddin, KA Mon 107<br />
Bahgat, AK Tue 451<br />
Bahrke, S Wed 099<br />
Bai, J Mon 310<br />
Bai, X Mon 092<br />
Bai, X-Y Mon 172<br />
Baigent, C W18.4<br />
Bailey, LK Thu 241<br />
Bailey, M Tue 270<br />
Baillargeon, J Wed 443<br />
Bairy, LK<br />
FC04.3.7<br />
Bajagic, M Tue 081<br />
Bajcetic, M<br />
FC10.1.6<br />
Bajraktarevic, A Wed 171, Wed 004<br />
Baker, J<br />
FC11.1.5<br />
Baker, M Thu 278, W06.3<br />
Baktir, G Tue 142<br />
Bakuridze, K Wed 272<br />
Balaguer, P<br />
FC18.3.5<br />
Balazin, A Mon 342, Mon 343<br />
Bal-dit-Sollier, C Tue 188, Tue 189<br />
Balendran, A Thu 426<br />
Balenga, N Wed 073<br />
Balenga, NAB<br />
FC11.1.6<br />
Balfagón, Gloria Wed 201<br />
Balikuddembe, R FC01.4.5<br />
Balkau, B Mon 161<br />
Ballabeni, V Tue 258, Mon 381<br />
Ballagas Flores, CM Wed 311<br />
Balle, T Wed 066<br />
Ballesteros, MP Thu 115<br />
Balogh, A Mon 261<br />
Balster, RL Wed 172<br />
Banani, A Tue 223,<br />
Banaudi, E Wed 010<br />
Bandieramonte, G Tue 487<br />
Bang, O-Y Tue 335<br />
Banken, L Mon 259<br />
Baños, J-E Mon 137<br />
Banovac, M Mon 342, Mon 343<br />
Baoxue, Y Wed 363<br />
Barakat, W Mon 165<br />
Baranyi, M Mon 460, W19.2<br />
Barar, J Mon 044<br />
Barat, I Mon 142<br />
Barbeiro, DF<br />
Wed 202, Wed 204, Wed<br />
203, Mon 257<br />
Barbeiro, HV<br />
Wed 202, Wed 204, Wed<br />
203, Mon 257<br />
Barbosa, FJ Wed 395<br />
Bardou, M Tue 289, Tue 290<br />
Bareggi, S Thu 111<br />
Baretta, IP Wed 395<br />
Barettino, D Tue 165, Tue 163<br />
Barnard, EA Wed 047<br />
Barnes, KI<br />
FC10.1.3<br />
Barnes, N Tue 233<br />
Barnes, PJ<br />
PL19<br />
Barnett, JW W17.3<br />
Barocco, B Wed 320<br />
Barocelli, E Tue 258, Mon 381<br />
Baron, R W03.6<br />
Barranco-Garduño, M Mon 019<br />
Barreira, B Wed 226<br />
Barreiro, E Mon 398<br />
Barreiro, EJ Thu 212<br />
Barrero, P Mon 128<br />
Barrese Pérez, Y Thu 425, Thu 424, Wed 311,<br />
Thu 347, Mon 038<br />
Barrett, I Wed 173<br />
Barriga, C Wed 352<br />
Barrios, M Tue 394<br />
Barrondo, S Wed 046<br />
Barroso, I Mon 161<br />
Bartella, C Mon 296<br />
Bartels, U Thu 413<br />
Bartlett, S<br />
FC14.3.5<br />
Bartlett, SE<br />
FC14.2.3<br />
Bartolini, A Mon 113, Tue 446, Mon 391<br />
Basaran, NF Mon 156<br />
Basinoglu, F Mon 199<br />
Basir, R<br />
FC16.3.4<br />
Basit, A Tue 319<br />
Baskaran, P Thu 202<br />
Bass, CC Wed 029<br />
Index 317
Name Paper ref. Name Paper ref.<br />
Bass, R W10.3<br />
Bastholm, P Mon 371<br />
Bastien, O Mon 193<br />
Bastos, R Tue 123<br />
Bastrigin, D Tue 150<br />
Batacchi, P Mon 120<br />
Bate, A<br />
FC04.2.1<br />
Bateman, J W03.7<br />
Bathgate, R W14.2<br />
Batista, MT Mon 291<br />
Batista, V Thu 366<br />
Battaglia, G Wed 400<br />
Baudouin, V<br />
FC10.5.5<br />
Bauer, C<br />
FC03.2.4<br />
Bauer, HW Tue 214<br />
Bauer, J Thu 267, Wed 252<br />
Bauer, R FC16.2.2, Mon 153<br />
Baun, M Wed 220<br />
Baveewo, S<br />
FC01.4.5<br />
Baw, B Wed 013<br />
Bayat, M Thu 391<br />
Baydan, E Wed 312<br />
Baydemir, C Wed 421<br />
Baydemýr, C Wed 420<br />
Baydoun, A Thu 290<br />
Bayever, D Tue 110<br />
Bay-Jensen, A-C W26.2, W26.4<br />
Baykov, A Wed 205<br />
Bayliss, DA<br />
FC03.4.4<br />
Bazarbachi, A<br />
FC01.3.4<br />
Beart, P Mon 045<br />
Beauchamp, GK W02.1.1<br />
Beauchesne, M-F FC04.1.5<br />
Beausejour, CM Tue 396<br />
Beaussier, H Mon 191<br />
Becemberg, IL Wed 024<br />
Bech Thorsen, L Wed 240<br />
Becic, F Wed 199<br />
Beck, J Wed 094<br />
Beck, L Thu 259<br />
Becker, AJ Mon 247<br />
Becker, E-M Thu 091<br />
Beck-Nielsen, H FC05.4.4<br />
Becquemont, L FC13.5.5, W02.2.6, Tue 189,<br />
FC02.2.6<br />
Bedi, G<br />
FC14.3.4<br />
Beetens, J Tue 280<br />
Begg, E<br />
FC10.5.3<br />
Begg, EJ Tue 322, Mon 064<br />
Begovic, B Wed 171<br />
Beh, J Tue 196<br />
Beheshti, S Mon 455<br />
Behrends, S Wed 280, Thu 252, Wed 210<br />
Behr-Roussel, D FC08.1.1, Mon 233, Mon 232<br />
Beiraghdar, F Thu 311<br />
Beitnere, U Mon 429<br />
Bejarano, I Mon 407<br />
Bek, T Wed 229<br />
Bekarev, A Tue 167<br />
Bekhit, AA Tue 264<br />
Bekker, Z Mon 258<br />
Bektas, N Wed 303<br />
Bel, L Tue 171<br />
Belanger, F Tue 051<br />
Beleslin-Cokic, B Wed 103<br />
Beleznai, TZ Wed 206<br />
Belkhiria, M-N Mon 006<br />
Bellido, I Mon 471, Mon 149, Tue 394,<br />
Wed 005, Wed 007, Mon 123<br />
Bellido, MV Wed 005<br />
Bellien, J Thu 242<br />
Bellien, J Wed 207<br />
Belyakova, G Thu 114<br />
Benameur, T Mon 148<br />
Ben-Attia, M Mon 338<br />
Bendayan, R FC02.4.5, Mon 070<br />
Bender, B Mon 401<br />
Bendhack, L<br />
Wed 198, FC15.4.5<br />
Benedito, S Mon 239, Mon 411<br />
Benemei, S Mon 120<br />
Benetti, LR Mon 289<br />
Bengtsson, F W29.1<br />
Bengtsson, T Wed 063<br />
Benham, C Mon 086<br />
Benhamou, PY Tue 268<br />
Benhanifia, MEB Wed 313<br />
Bénichou, J FC04.2.6, Mon 145, Mon 132<br />
Benkõ, I Mon 150, Mon 167<br />
Benkõ, K Mon 150, Mon 167<br />
Bennett, BM Tue 385<br />
Bennett, L Thu 393<br />
Benoît, LG Tue 190<br />
Bensaid, D Mon 021<br />
Bensman, A<br />
FC10.5.5<br />
Benter, I Mon 151<br />
Bentley, D Mon 259<br />
Bentzen, BH FC06.1.4, Wed 099<br />
Benyhe, S Wed 050<br />
Ben-Zvi, Z Mon 054<br />
Beraud-Dufour, S FC17.2.5<br />
Berdnikova, N Mon 344, Wed 314, Thu 114<br />
Berendt, L Mon 345<br />
Berényi, A Tue 442<br />
Bérézovski, V Thu 237<br />
Berger, K Tue 313<br />
Berggren, P-O<br />
FC12.4.1<br />
Bergman, J Mon 234<br />
Bergman, P Mon 122<br />
Bergman, U W35.4, Mon 129, Tue 308,<br />
Wed 138<br />
Bergmann, JF<br />
FC01.4.4<br />
Bergmann, J-F Tue 188, Tue 189<br />
Bergmann, TK Tue 395, Wed 151<br />
Bergougnan, L Thu 215<br />
Bergquist, K<br />
FC14.3.3<br />
Bergqvist, L Wed 006, Thu 003<br />
Berisa, A Mon 254<br />
Berkman, K Mon 117<br />
Bernabé, J Mon 233<br />
Bernhard, D Wed 234<br />
Bernhard, F<br />
YI.02<br />
Berrue, F Wed 316<br />
Bertilsson, L Tue 489, Tue 308, Mon 018<br />
Wed 147<br />
Bertin, F Thu 273<br />
Bertoni, S Tue 258, Mon 381<br />
Bertran, F Mon 362<br />
Bertrand, H-O<br />
FC11.3.6<br />
318 Index
Name Paper ref. Name Paper ref.<br />
Bessac, A-M Tue 171<br />
Besson, M Mon 337<br />
Bethell, D Tue 090<br />
Bettler, B FC11.3.5, Thu 028<br />
Beubler, E Mon 369<br />
Beugels, IPE Mon 212<br />
Beukers, MW<br />
FC11.4.6<br />
Beuve, A Thu 202<br />
Bevan, S Mon 287<br />
Beyens, MN<br />
FC04.2.5<br />
Bhala, N W18.4<br />
Bhanot, S Tue 148<br />
Bharti, D Mon 336<br />
Bhat, SJS Wed 172<br />
Bhatia, J Mon 260, Wed 315, Wed 358<br />
Bhatia, VK Thu 026<br />
Bhosale, A Mon 336<br />
Bhosale, AV Thu 363<br />
Bhupathyraaj, M Tue 152<br />
Bi, K Tue 130<br />
Bi, Y-Q<br />
FC16.5.5<br />
Biazzotto, J<br />
Wed 198, FC15.4.5<br />
Bibby, BM Tue 359<br />
Biddie, SC<br />
FC18.4.2<br />
Bie, P<br />
FC06.2.5<br />
Bielen, L<br />
FC01.3.7, Mon 135, Mon<br />
373, Tue 328<br />
Biermann, J Wed 099<br />
Bieth, B Tue 196<br />
Bihari, P<br />
FC16.1.5<br />
Biliczki, P Mon 100<br />
Billesbølle, CC Mon 073<br />
Billing Jr., CB Wed 193<br />
Bilsen, M<br />
FC18.2.5<br />
Binder, A W03.6<br />
Binder, EB<br />
FC17.5.1<br />
Bindslev, N<br />
FC02.2.5, FC07.1.5,<br />
Mon 071<br />
Birk, B<br />
FC18.2.6<br />
Bischof, L Mon 045<br />
Bishnoi, M Mon 183<br />
Bisogno, A Tue 487, Mon 448, Tue 488,<br />
Mon 449<br />
Bissantz, C Wed 094<br />
Bissoli, F FC04.2.6, Mon 141<br />
Bistawros, AA Tue 264<br />
Bitay, M Wed 197<br />
Bitel, M Mon 181<br />
Bittner, RE Mon 218<br />
Bjarnason, NH Mon 346<br />
Bjerregaard, BK Mon 121<br />
Bjerrum, L<br />
FC13.1.5<br />
Bjerrum, OJ Mon 089<br />
Björk, Susann Wed 028<br />
Björkhem-Bergman, L Tue 383, Mon 122<br />
Blad, CC<br />
FC11.2.5<br />
Blagojevic, D Thu 329, Tue 122, Thu 318,<br />
Wed 387<br />
Blais, Lucie<br />
FC04.1.5<br />
Blaise, S Thu 244, Wed 208, Thu 245<br />
Blakely, R<br />
FC02.4.1<br />
Blakemore, D<br />
FC05.3.6<br />
Blalock, JE<br />
FC09.5.2, FC09.5.3<br />
Blanchard, SC FC02.1.2<br />
Blanco, E Mon 123, Mon 149, Mon 471,<br />
Wed 007, Thu 187<br />
Blanco-Rivero, J Wed 201<br />
Blank, MD Wed 172<br />
Blankesteijn, MW Wed 085<br />
Blasio, A<br />
FC18.4.6<br />
Blättermann, S FC11.1.6<br />
Blayden, C<br />
FC03.2.1<br />
Blazer, L<br />
YI.01<br />
Blazsó, G Mon 261<br />
Blin, P Mon 140<br />
Bloch, V Wed 191<br />
Block, W Tue 049<br />
Blockhuys, S Tue 280<br />
Blume, LC Wed 029<br />
Boari, G Thu 251<br />
Bobadilla, RA Wed 209<br />
Bobkiewicz-Kozlowska, T Mon 262, Thu 174, Thu 291<br />
Bocan, T Tue 372<br />
Bocca, M-L Mon 362<br />
Bochorishvili, T Mon 192, Tue 174<br />
Bock, E<br />
PL23<br />
Bock, H Tue 151<br />
Bock, P Tue 169<br />
Bocos, C Tue 387<br />
Bocsan, C Mon 438<br />
Bocsan, IC Mon 417, Tue 481<br />
Bode, C Wed 099<br />
Bodo, L P16.281<br />
Bodvarsdottir, T Tue 132<br />
Boehlen, F Tue 305<br />
Boekschoten, M FC18.2.5<br />
Boerngen-Lacerda, R Wed 395<br />
Boeuf-Cazou, O Mon 124<br />
Boeynaems, J-M W10.3<br />
Bogacz, A Thu 174<br />
Bogdanov, B Tue 167<br />
Bogdelis, A Thu 023<br />
Bøgebo, R Wed 036<br />
Bøgesø, K Mon 046<br />
Bogoslovscaya, S Tue 129<br />
Bohman, L Tue 489<br />
Bohotin, C Mon 108<br />
Boije af Gennäs, G Tue 433<br />
Boizel, R Tue 268<br />
Bölcskei, K Mon 110, Tue 078<br />
Bomba, A Tue 423<br />
Bonaccini, L Tue 446, Mon 391<br />
Bonaterra, G Mon 317, Tue 462<br />
Bonci, A<br />
FC14.3.1<br />
Bond, CM Tue 109<br />
Bonde, MM Thu 058<br />
Bondiolotti, G Thu 111<br />
Bondolfi, G Mon 160<br />
Bongue, B Mon 124<br />
Bonke, G Mon 064, Mon 047<br />
Bonnabry, P Tue 305<br />
Bonnefond, A Mon 161<br />
Bonta, P<br />
FC18.2.4<br />
Booranasubkajorn, S Thu 361<br />
Boos, J<br />
FC10.4.5<br />
Booth, L Wed 020, Mon 420<br />
Børgesen, M Wed 447<br />
Børglum, A<br />
FC13.3.6<br />
Index 319
Name Paper ref. Name Paper ref.<br />
Born, W Thu 197<br />
Borobia, AM Tue 348, Mon 451<br />
Borrelli, E<br />
FC17.4.6<br />
Borrelli, F Wed 307<br />
Börresen-Dale, A-L Wed 151<br />
Borsodi, A Wed 050<br />
Borsotto, M Thu 237<br />
Bosch, M<br />
FC10.4.6<br />
Bosco, P Wed 400<br />
Boskovic, A Wed 135<br />
Boskovic, J Mon 127<br />
Bosmans, G Wed 002<br />
Bosnjak, Z Mon 373<br />
Bossert, J<br />
FC14.3.2<br />
Bost, JGPJ Wed 287<br />
Bõsze, Z Mon 401<br />
Botros, S Mon 372<br />
Böttiger, Y Mon 371, Wed 008<br />
Botto, H Tue 204<br />
Botz, B Mon 110, Mon 106<br />
Botzenhart, E W03.7<br />
Boukraâ, L Wed 313<br />
Boulieu, R Mon 193, Mon 263<br />
Bounoure, F Thu 242<br />
Bouraoui, A Wed 316<br />
Bourinet, E<br />
FC03.2.3<br />
Bourrel, R Tue 104<br />
Boussaïd, M Mon 004<br />
Boutaud, O<br />
FC05.3.6<br />
Boutin, JA Wed 072<br />
Bouvier, M<br />
FC11.3.1<br />
Bouzinova, EV Wed 397, Wed 433<br />
Boxwalla, M Wed 184<br />
Boyd, B Thu 280<br />
Boyden, PA<br />
FC06.1.2<br />
Boyer, M<br />
FC04.2.5<br />
Boyle, EM Wed 006<br />
Bozec, E Mon 191<br />
Bozina, N Tue 304, Wed 398, Wed 112,<br />
Mon 048, Tue 121<br />
Božina, T Mon 048<br />
Bozkurt, A Wed 249,<br />
Bozkurt, TE Mon 366<br />
Bozo, T<br />
FC16.2.6<br />
Braber, S<br />
FC09.5.2<br />
Brabet, I FC11.3.6, Thu 083<br />
Bradamante, V Mon 347<br />
Bradley, SJ Wed 030<br />
Bradnock, D Thu 214<br />
Brain, S Thu 197<br />
Brain, SD Mon 287<br />
Brajovic, M<br />
FC10.1.6<br />
Bramanti, P FC18.1.5, Mon 277,<br />
FC18.3.6, Thu 364<br />
Brancaleone, V Thu 081, FC09.4.6<br />
Branco, T Wed 130<br />
Brand, L Wed 399<br />
Brandes, RP<br />
FC15.1.1<br />
Brasch-Andersen, C Mon 090, Tue 395, Wed 151<br />
Brauch, H Wed 133<br />
Bräuner-Osborne, H FC11.5.1, FC11.5.6, Wed<br />
084, Thu 027<br />
Breckenridge, A FC13.1.3<br />
Bregnedal, P Mon 046<br />
Breitkreutz, J<br />
FC10.3.2<br />
Bremner, JD<br />
FC17.5.3<br />
Brenneman, D Tue 389<br />
Brennum, LT<br />
FC17.4.2<br />
Breschi, MC Wed 442, Mon 382<br />
Breum-Leer, C Tue 358<br />
Briedis, V Tue 329<br />
Briggs, JP<br />
FC16.5.4<br />
Brink, CB W20.2, W15.3, Mon 412<br />
Brito, GAC Mon 298, Tue 255, Wed 318,<br />
Wed 319<br />
Brive, L Wed 092<br />
Briyal, S<br />
FC05.2.5<br />
Broadstock, M Wed 044<br />
Broccardo, M Tue 249,<br />
Brochard, K<br />
FC10.5.5<br />
Brock, B Tue 356, Tue 357, Tue 358,<br />
FC05.4.6, Thu 413<br />
Brock, C W12.6<br />
Brødbæk, K FC13.3.6, Mon 119,<br />
Mon 118, Mon 406<br />
Bröer, S<br />
FC02.3.4<br />
Brøgger, T Wed 433<br />
Broquères-You, D Mon 232<br />
Brørs, O Wed 139<br />
Broselid, S Thu 047<br />
Brøsen, K FC13.5.5, Mon 050,<br />
Mon 090, Wed 151<br />
Brouillette, D Wed 123<br />
Broux, F<br />
FC10.5.5<br />
Brown, DA Wed 047<br />
Brown, MJ<br />
PL17<br />
Brown, VJ<br />
FC17.3.4<br />
Brum, P Wed 042<br />
Brune, K Tue 310<br />
Brunet, A Mon 203, Mon 201, Mon 205,<br />
Mon 204, Mon 202<br />
Brunetti, L Mon 105, Wed 434, Wed 329<br />
Bruno, V Wed 400<br />
Brusco, A Thu 176<br />
Brussee, J<br />
FC11.2.5<br />
Brusselle, GG<br />
FC09.5.1<br />
Brusturean, E Mon 417, Mon 438<br />
Bruttmann, G Tue 268<br />
Bruun, J<br />
FC05.1.1<br />
Bryan, K Mon 443<br />
Bryson, P Tue 012<br />
Brzozowska, I Tue 463<br />
Brzozowski, T Tue 463<br />
Buadze, M<br />
YI.02<br />
Bubik, MF<br />
FC16.1.5<br />
Buble, T Tue 095<br />
Bucci, M Thu 081, Thu 202<br />
Bucolo, C Mon 152<br />
Bucsics, A Mon 153<br />
Buda, S Mon 120<br />
Budimir, A Mon 373<br />
Bühler, FR W10.3<br />
Bünemann, M Wed 026<br />
Buhl, CS Mon 154<br />
Buhl, ES Mon 154<br />
Bui, V Mon 285<br />
Bukarica, LG Thu 324<br />
Bukumiric, Z Wed 436<br />
320 Index
Name Paper ref. Name Paper ref.<br />
Bult, H Wed 246, Wed 245<br />
Bulut, G Tue 411<br />
Bungay, P Mon 236<br />
Buniatian, GH<br />
YI.02<br />
Bunton, D Wed 132, Tue 160<br />
Burande, DM<br />
FC01.1.6<br />
Burcher, E<br />
Mon 235, FC08.1.6<br />
Buresova, E Tue 222, Tue 421<br />
Burgess, C Tue 136<br />
Burggraaf, J Tue 148, Thu 214, Thu 215,<br />
Mon 316<br />
Burggraaf, JK<br />
FC10.4.6<br />
Burhenne, J Mon 018<br />
Buriani, A Wed 320<br />
Burk, O<br />
FC02.1.5<br />
Burkhardt, T Mon 153<br />
Burkin, DJ<br />
FC12.4.5<br />
Burnet, M<br />
FC18.2.6<br />
Burstein, S Mon 264<br />
Burul-Bozkurt, N Wed 438, Mon 155<br />
Busenlehner, LS FC11.3.2<br />
Busija, D<br />
FC05.1.6<br />
Busillo, V Mon 448<br />
Busker, M Wed 210, Wed 280, Thu 252<br />
Busserolles, J Thu 083<br />
Bustamante, S Mon 411<br />
Butler, A Tue 233<br />
Butler, N Tue 110<br />
Butterweck, V Wed 417<br />
Buus, NH Mon 200<br />
Buyukdeligoz, M Tue 366, Tue 449, Tue 450<br />
Buyukuysal, RL Wed 179<br />
Buzoianu, AD Mon 417, Mon 438, Tue 481<br />
Bylund, DB W15.1<br />
Byun, B-Y Wed 383<br />
Cabal, J Tue 343, Tue 448<br />
Cabral, A Mon 376<br />
Cabriol, N Tue 170<br />
Cabrita, A Tue 407,<br />
Cachimaille, Y Thu 394<br />
Cadete, V<br />
FC06.3.6<br />
Caduff, P W32.1<br />
Cahalan, MD<br />
FC12.5.1<br />
Cai, G Tue 384<br />
Cai, Y Mon 266, Thu 277<br />
Cailliez, M<br />
FC10.5.5<br />
Cairns, BE W12.3<br />
Cairrão, E Wed 211<br />
Caisey, A Mon 232<br />
Caixas, U Wed 130<br />
Cakir, B Wed 249<br />
Cakmak, A Mon 348<br />
Cakmakci, Y Wed 308<br />
Calapai, G Wed 317, Thu 316, Thu 364<br />
Calignano, A<br />
FC18.1.6<br />
Caliskan, F Mon 348<br />
Callado, LF Wed 031, Thu 399<br />
Callahan, M Tue 372<br />
Callegari, E Mon 236<br />
Calloe, K<br />
FC06.1.4<br />
Callreus, T Mon 345<br />
Calmettes, Y Tue 170<br />
Calou, I Mon 299, Mon 298, Wed 318,<br />
Wed 319<br />
Calvet, D Mon 191<br />
Calvo Duo, R Tue 197<br />
Calvo, A Mon 007, Tue 261<br />
Calvo, R Wed 111<br />
Camacho, E Wed 212<br />
Camarasa, J<br />
Wed 174, Wed 177, Wed<br />
181, Thu 179<br />
Camargo, LL Wed 237<br />
Camici, PG<br />
FC05.2.2<br />
Camins, A Mon 443<br />
Camm, AJ<br />
FC06.2.1<br />
Camparo, P Tue 204<br />
Campbell, A Wed 032<br />
Campbell, AP Wed 048<br />
Campbell, WB<br />
FC15.3.4<br />
Campos, A Mon 451<br />
Campos, M Wed 337<br />
Campos-Toimil, M Wed 359, Wed 227<br />
Can, C Thu 233<br />
Canals, M Thu 060<br />
Candeletti, S<br />
FC14.1.5<br />
Canet, E<br />
PL04<br />
Cantilena, L Tue 107<br />
Cao, D Thu 020<br />
Cao, G Mon 349<br />
Cao, L Wed 034<br />
Cao, Lei Wed 213, Wed 033<br />
Cao, N Thu 280<br />
Cao, Y Tue 418, Tue 173, Tue 325,<br />
Wed 327, Tue 035<br />
Cao, Y-B Mon 265<br />
Cao, Y-X Mon 266, Wed 034<br />
Cao, Y Mon 008<br />
Cao, Y-X Tue 298, Wed 213, Wed 033<br />
Cap, R Tue 421<br />
Capasso, A Tue 406, Tue 487, Mon 448,<br />
Tue 488, Mon 449<br />
Capasso, F Wed 307<br />
Capasso, R Wed 307<br />
Capdeville-Atkinson, C Wed 244<br />
Capellà, D<br />
FC14.4.5<br />
Caputi, A<br />
FC04.4.5, FC04.3.6<br />
Caputi, F<br />
FC14.1.5<br />
Cara, D Tue 229<br />
Caraci, F Wed 400<br />
Carageorgiou, H Tue 457<br />
Caramona, MM Mon 350, Mon 376, Thu 119,<br />
Wed 214<br />
Carbonell, N<br />
W02.2.6<br />
Carbonneau, C Tue 396<br />
Carcak, N Mon 418<br />
Carcas, AJ Mon 451<br />
Carcas-Sansuán, AJ Tue 348<br />
Cardell, LO Mon 266<br />
Cardell, L-O Tue 292<br />
Cardeso, ALC Mon 125<br />
Cardoso, J Tue 420<br />
Carle, F<br />
FC04.3.6<br />
Carleton, B FC10.5.2, Thu 019, Thu 020<br />
Carlier, P<br />
FC04.2.5<br />
Carling, R Thu 088<br />
Carlsson, L<br />
FC06.2.2<br />
Carmo, A Tue 397<br />
Carnero, M Thu 240, Wed 215, Mon 206<br />
Index 321
Name Paper ref. Name Paper ref.<br />
Caron, MG FC11.4.1, Wed 423<br />
Carpino, F Tue 249<br />
Carral, N Tue 197<br />
Carrara, M Wed 320<br />
Carraro, R Tue 134<br />
Carrasco, VH Tue 326<br />
Carrasco-Portugal, M Mon 009, Mon 019<br />
Carreño, P Thu 187<br />
Carroll, P Tue 309<br />
Cars, Otto<br />
PL12<br />
Cartwright, C Mon 351, Tue 353<br />
Carvajal, A Mon 129, Mon 130<br />
Carvalheiro, H Tue 397<br />
Carvalho, DM Mon 010<br />
Carvalho, L Wed 341<br />
Carvalho, LCRM Wed 340<br />
Carvalho, MH Wed 042<br />
Carvalho, MHC FC06.1.5, Wed 237<br />
Casadesus, G Mon 443<br />
Casanova, M Thu 358<br />
Casarin, E Wed 320<br />
Casarotto, P<br />
FC17.5.5<br />
Casas, M<br />
FC14.4.5<br />
Cascorbi, I FC02.4.3, Mon 059<br />
Casey-Green, K Mon 352, Mon 353<br />
Cash, C Thu 394<br />
Casolini, P Tue 249<br />
Cassali, GD Wed 302<br />
Cassano, T Thu 440<br />
Castañeda-Hernández, G Mon 011, Mon 019<br />
Castanheira, L Mon 126, Thu 218<br />
Castel-Branco, MM Mon 376<br />
Castells, X<br />
FC14.4.5<br />
Castelo-Branco, M Thu 218<br />
Castillo, I Tue 420<br />
Castillo, MD Tue 326<br />
Castillo, N Thu 225<br />
Castro, E Wed 401, Thu 408<br />
Castro, N Mon 398<br />
Cataneo, SC Wed 332<br />
Catanozi, S Wed 203, Mon 257<br />
Cathala, C Mon 084<br />
Catic-Djordjevic, A Tue 149<br />
Catterall, WA FC12.1.2, Tue 479<br />
Cavaleiro, C Tue 257<br />
Cavun, S Mon 156, Wed 179<br />
Cazzolla, N Mon 296, Thu 433<br />
Ccalleja, G Tue 302<br />
CCB Tue 281<br />
Ceccelli, R Thu 237<br />
Cekic, EG Mon 419, Wed 253<br />
Cekic, V Wed 321<br />
Celikyurt, IK Mon 387, Tue 145<br />
Cellier, C<br />
W02.2.6<br />
Ceman Saric, J Wed 171<br />
Centurión, D W13.3, Thu 022, Thu 203<br />
Ceravolo, GS FC06.1.5, Wed 042,<br />
Wed 233, Wed 237<br />
Cercas, E Tue 134<br />
Cerná, O Mon 267<br />
Cernecka, H Mon 219<br />
Cervantes-Nevárez, A Mon 019<br />
Cervenka, R Mon 217, Mon 218<br />
Ceverie, J Tue 370<br />
Cha, E-Y Tue 351<br />
Chadha, R Tue 344<br />
Chadwick, B Tue 139<br />
Chai, L Wed 322<br />
Chaisri, S Thu 335<br />
Chalian, M Thu 006<br />
Challiss, RAJ Wed 030, Wed 025<br />
Chalmers, RTA Thu 420<br />
Chalon, S Tue 012<br />
Chalopin, M Wed 216, Tue 118<br />
Chamorro, G Wed 217<br />
Champagne, M Wed 123<br />
Chan, A W10.3<br />
Chan, CKY Wed 218<br />
Chan, C-M Tue 374<br />
Chan, Elsa Mon 194, Wed 219<br />
Chan, HC Thu 341<br />
Chan, K Wed 292, Wed 220<br />
Chan, M-H FC17.1.5, Mon 354<br />
Chan, MLY Wed 290<br />
Chan, P Mon 465, Tue 155<br />
Chan, PF Wed 323<br />
Chandra, V<br />
FC18.4.1<br />
Chandranipapongse, W Mon 355<br />
Chang, C<br />
FC15.2.5<br />
Chang, C-Z Mon 319<br />
Chang, H-C Tue 398<br />
Chang, HH Mon 356<br />
Chang, H-H Wed 286<br />
Chang, J Mon 443<br />
Chang, L-Y Thu 199<br />
Chang, W-C Wed 368<br />
Changkija, B Wed 294<br />
Chanthap, L Tue 090<br />
Chantratita, W Tue 127<br />
Chao, PL Mon 325<br />
Chaouch, W Wed 316<br />
Chappell, M Mon 151<br />
Charbeneau, R Thu 044<br />
Charoin, J-E<br />
FC07.2.5<br />
Charpentier, G Mon 161<br />
Chartier-Kastler, E Mon 233, Mon 232<br />
Chataigneau, T Wed 306, Wed 273, Wed 385<br />
Chatsiricharoenkul, S Mon 334, Mon 357, Tue 007,<br />
Tue 341<br />
Chatterjee, P Mon 157<br />
Chatterjee, S<br />
FC14.2.3<br />
Chatterjee, SS Wed 324, Wed 325<br />
Chatzimichael, A Tue 224<br />
Chaudhary, J Tue 020<br />
Chauhan, NK Mon 195, Mon 237, Wed 425<br />
Chaves, M Wed 318, Wed 319<br />
Chávez, LB Tue 302<br />
Chavkin, C<br />
FC14.4.4<br />
Chefer, V<br />
FC03.3.1<br />
Chekina, K Wed 100<br />
Chelarescu, D<br />
Thu 175, FC14.2.6<br />
Chen, AF<br />
FC15.1.2, FC15.4.6, W04.2.2<br />
Chen, B Thu 384<br />
Chen, B-C Mon 326<br />
Chen, B-R Tue 146<br />
Chen, C<br />
FC05.3.6<br />
Chen, C-T Mon 012, Mon 158, Wed 262<br />
Chen, CX Wed 291<br />
322 Index
Name Paper ref. Name Paper ref.<br />
Chen, D<br />
W02.2.1<br />
Chen, FH Wed 291<br />
Chen, G Thu 276<br />
Chen, H Mon 185,<br />
Chen, H-H Mon 268, Mon 354<br />
Chen, H-Z Tue 399<br />
Chen, H Wed 221<br />
Chen, H-H<br />
FC17.1.5<br />
Chen, H-Z Thu 368<br />
Chen, I-J Mon 269, Thu 105<br />
Chen, I-S Thu 105<br />
Chen, J Wed 331,<br />
Chen, J-C Wed 326<br />
Chen, K Wed 366, Wed 365<br />
Chen, K-H<br />
FC12.3.5<br />
Chen, L Thu 390, Tue 400<br />
Chen, LH Thu 295<br />
Chen, L Tue 401<br />
Chen, M Mon 045<br />
Chen, M-F Thu 090, Thu 362, Wed 286<br />
Chen, M-S<br />
Mon 186, FC09.5.6<br />
Chen, N Wed 331, Wed 013, Wed 193<br />
Chen, P Wed 072<br />
Chen, PS Mon 356<br />
Chen, P-Y Wed 286, Thu 090<br />
Chen, S Wed 122, Wed 121, Wed 120<br />
Chen, S-F Thu 277<br />
Chen, S-H Mon 270<br />
Chen, S-J Wed 222, Thu 283<br />
Chen, S-S Mon 268<br />
Chen, T-Y Wed 439<br />
Chen, W-L<br />
FC16.4.5<br />
Chen, X Tue 412, Wed 327, Thu 104<br />
Chen, XH Tue 439<br />
Chen, Y Tue 069<br />
Chen, Y-H Wed 106<br />
Chen, Y-C Tue 402<br />
Chen, Y-F Wed 328<br />
Cheng, G Mon 310, Mon 032<br />
Cheng, J<br />
Mon 331, FC13.2.1<br />
Cheng, L Thu 297,<br />
Cheng, LS<br />
FC10.2.5<br />
Cheng, P-W Tue 146<br />
Cheng, R<br />
FC09.3.3<br />
Cheng, W-H Tue 146<br />
Cheng, X Tue 403<br />
Cheng, Wed 402<br />
Cheng, X-R Thu 432, Mon 470<br />
Cheng, Y Mon 467<br />
Cheng, Y-C<br />
FC16.5.3<br />
Cheong, SK Thu 379, Thu 380<br />
Cherny, SS Mon 271, Mon 159<br />
Chess-Williams, R Tue 199<br />
Chetan, P Mon 091<br />
Cheung, BMY Mon 271, Mon 159<br />
Cheung, CM Thu 389<br />
Cheung, N Mon 045<br />
Chevet, E<br />
FC17.2.5<br />
Chiavaroli, A Mon 105, Wed 329, Wed 434<br />
Chiavegatti, T Wed 054<br />
Chiavegatto, S FC03.1.5<br />
Chiba, Y Mon 303, Mon 304, Tue 234,<br />
Tue 259, Mon 272,<br />
Tue 265, Tue 287<br />
Chick, J W06.3<br />
Chidiac, P Tue 180<br />
Chien, C-H Mon 158<br />
Chien, W-L Wed 403<br />
Chignalia, AZ Wed 233<br />
Chik, Z Tue 444<br />
Chimienti, F<br />
FC05.1.4<br />
Chin, P Tue 322<br />
Chinen, K Thu 344<br />
Ching, P Wed 369<br />
Chiou, L-C Wed 035<br />
Chipashvili, M Wed 272<br />
Chisyaki, A Wed 223<br />
Chitaley,<br />
FC08.1.2<br />
Chiu, C-T Thu 283<br />
Chiu, P-H<br />
FC17.1.5<br />
Chiu, P-T Mon 423<br />
Chladek, J Wed 017, Tue 342, Tue 125,<br />
Thu 168<br />
Chladkova, J Wed 017<br />
Cho, CH W02.1.4, Tue 476, Tue 417<br />
Cho, CWC Wed 330<br />
Cho, G Tue 068<br />
Cho, IH Mon 427<br />
Cho, S Tue 349, Thu 418<br />
Cho, SK Mon 013<br />
Choe, BI Tue 334<br />
Choe, T-B Tue 427<br />
Choi, C-I Mon 049, Mon 065, Mon 066,<br />
Mon 069, Mon 358, Mon 359,<br />
Tue 044, Tue 043, Tue 073,<br />
Tue 350, Tue 161, Tue 162,<br />
Tue 323, Tue 324, Tue 332,<br />
Tue 333, Wed 143<br />
Choi, J-Y Tue 352<br />
Choonara, I Thu 007<br />
Choong, E Mon 160<br />
Chopard, P Tue 305<br />
Chopra, K Mon 183, Wed 168<br />
Chopra, SC<br />
FC01.3.6<br />
Chotewuttakorn, S Thu 335<br />
Chou, SH Tue 135<br />
Choudhary, S W03.2<br />
Choudhury, MR Thu 120<br />
Choudhury, WR Thu 120<br />
Chowdhury, A Tue 097<br />
Christ, G J<br />
FC08.3.1<br />
Christakidis, D Mon 187<br />
Christensen, GL Wed 036, Wed 070, Thu 058<br />
Christensen, H Mon 041<br />
Christensen, HR Wed 161, Mon 360<br />
Christensen, KL Mon 200<br />
Christensen, LP Wed 380<br />
Christensen, MMH Mon 050<br />
Christensen, T Mon 320<br />
Christians, U Mon 053<br />
Christiansen, B FC11.5.1<br />
Christiansen, C Mon 346, W26.4, W26.2<br />
Christiansen, S Wed 397<br />
Christie, MJ<br />
FC03.3.1<br />
Crsen, N Wed 241<br />
Christopoulos, A Wed 089, Wed 082,<br />
Wed 043, Thu 041, Thu 080<br />
FC11.2.2<br />
Index 323
Name Paper ref. Name Paper ref.<br />
Chu, S Wed 331<br />
Chu, TTW FC02.4.6, Tue 140<br />
Chua, CB Wed 194<br />
Chua, T Mon 238<br />
Chua, YA Mon 361<br />
Chuang, Y-F Mon 423<br />
Chumakov, D Tue 024<br />
Chung, HC Mon 029<br />
Chung, J Tue 349, Thu 418<br />
Chung, JY Mon 013, Mon 033<br />
Chung, YW Thu 341<br />
Chuppa, S Mon 280<br />
Churchill, GC Wed 268<br />
Churin, A Tue 167<br />
Ciaccioli, G<br />
FC18.4.5<br />
Cianci, S Thu 440<br />
Ciangherotti, C Thu 205<br />
Cichutek, K<br />
PL02<br />
Cifuentes, L Mon 014, Mon 015<br />
Cintra, A Wed 339<br />
Cipriano, M Tue 465<br />
Ciric, B Tue 321<br />
Cirillo, MC<br />
Thu 353, Wed 332, Wed<br />
333,Wed 334<br />
Cirino, G Thu 081, Thu 202<br />
Cirovic, S Wed 103<br />
Ciubotariu, D Thu 175<br />
Clairambault, J W07.4<br />
Clanachan, A Tue 183<br />
Clark, AR FC09.1.5, W21.5, Tue 239<br />
Clark, Nicolas C FC14.1.4<br />
Clark, R Wed 270<br />
Clarke, K<br />
FC06.3.4<br />
Clausen, BE Wed 056<br />
Clausen, RP FC11.5.6, Wed 084<br />
Clavreul, N Thu 273, Thu 274<br />
Clawson, G Mon 285<br />
Clement, N Thu 055, Mon 161<br />
Clemmensen, C FC11.2.6, FC11.5.1<br />
Climent, B Mon 239, Wed 224, Wed 225<br />
Coats, P Thu 272<br />
Cobos-Puc, LE W13.3<br />
Coccuzzo Sampaio, S Thu 353<br />
Coe, JW<br />
FC14.2.3<br />
Coelho, AL Mon 314<br />
Coelho, M Mon 095, Mon 097, Mon 094<br />
Cogolludo, A Mon 374, Tue 121, Wed 226,<br />
Thu 217<br />
Cohall, D Wed 335<br />
Cohen, A Thu 215<br />
Cohen, AF<br />
Tue 148, FC10.4.6<br />
Cole, W W03.7<br />
Cole, WC Wed 239<br />
Coll, T Wed 440<br />
Coller, J Tue 495<br />
Colli, E<br />
FC08.2.3<br />
Collis, M W15.2<br />
Coloma, P<br />
FC04.1.6<br />
Colucci d'Amato, C Tue 488, Mon 449<br />
Coman, O Mon 111<br />
Coman, OA Mon 274<br />
Combescure, C Tue 305<br />
Comerma-Steffensen, S Tue 362<br />
Compagnie, S Mon 232<br />
Company, C Thu 437<br />
Company, MA Thu 407<br />
Compeer, MG Wed 037, Thu 208<br />
Comps-Agrar, L FC11.2.1, FC11.3.5, Wed<br />
077, Thu 035<br />
Conde, MV Thu 054<br />
Conde, S Mon 079<br />
Conforti, A Mon 129<br />
Cong, W Wed 336<br />
Cong, W-H Thu 376<br />
Cong, Y Tue 360,<br />
Conigrave, AD Wed 043<br />
Conn, PJ<br />
FC11.5.2, FC17.2.3<br />
Conradie, KR Thu 016<br />
Cons, BL Wed 339<br />
Constable, T<br />
FC14.3.3<br />
Contreras, C Thu 249, Mon 239<br />
Cook, JM<br />
FC03.3.3<br />
Cooper, M<br />
FC03.3.5<br />
Cooper, ME Thu 228<br />
Copani, A Wed 400<br />
Coquerel, A Thu 173, Mon 362<br />
Corbin, JD<br />
FC08.1.5<br />
Corcostegui, R Mon 254<br />
Cordeddu, G Tue 133<br />
Cornell, C Thu 088<br />
Cornes, L W10.2<br />
Cornish, J Wed 190<br />
Corrao, G FC04.1.6, FC04.3.6, Tue 093<br />
Côrrea, FMA Wed 411<br />
Correa-Basurto, J Tue 195<br />
Correia-de-Sá, I Wed 114<br />
Correia-de-Sá, P FC08.2.6, Thu 064<br />
Cortes, L<br />
FC16.2.5<br />
Cortijo, J Thu 437<br />
Cosic-Cerovac, N Wed 009<br />
Cossey, V Wed 002<br />
Costa, CA Wed 341, Wed 340<br />
Costa, ECA Mon 010<br />
Costa, ES Mon 273<br />
Costa, TJ<br />
FC06.1.5<br />
Costa-Neto, C Thu 068<br />
Cöster, M Thu 087<br />
Costescu, M Mon 274<br />
Cotrim, M Wed 337<br />
Cots, JM<br />
FC13.1.5<br />
Coupar, I Thu 032<br />
Couture, R Tue 275, Thu 073<br />
Cowan, A Wed 038<br />
Cox, J Wed 152<br />
Coyle, JR Mon 388, Wed 170<br />
Cracowski, J-L Wed 208, Thu 244, Thu 245<br />
Cristante, E<br />
FC15.1.5<br />
Cromarty, D Mon 368<br />
Crowe, A Mon 051, Tue 063<br />
Crown, N Tue 301<br />
Crozier, A Thu 328<br />
Crupi, D Wed 317<br />
Cruz, J<br />
FC03.1.5<br />
Cruz, MDC Wed 217<br />
Cruz, MT Mon 291<br />
Cruz-Machado, S Thu 204<br />
Csajka, C<br />
FC10.5.3<br />
Cseharovszky, R Mon 318<br />
324 Index
Name Paper ref. Name Paper ref.<br />
Csikasz, R Wed 063<br />
Cuautle-Rodríguez, P Tue 431<br />
Cuciureanu, M FC14.2.6,<br />
Cui, P Wed 378<br />
Cui, R Thu 445<br />
Cui, S-Y Mon 082<br />
Cui, X-Y Thu 386<br />
Cui, Y<br />
FC13.4.3<br />
Cui, YG Thu 341<br />
Cui, Zong Jie Wed 039<br />
Cuíñas, A Wed 359<br />
Cuíñas, A Wed 227<br />
Culie, C Tue 172<br />
Culig, J Mon 127<br />
Cullen, W Mon 453<br />
Culter, M Wed 013<br />
Cumming, P<br />
FC17.1.2<br />
Cummins, TR<br />
FC12.2.2<br />
Cumps, J Tue 182<br />
Cunha, F Mon 275<br />
Cunha, FQ Tue 255<br />
Cunha, Thiago FC03.1.5<br />
Curnow, J Tue 233<br />
Cury, Y Mon 273<br />
Cury, Yara Mon 276<br />
Cusinato, F Thu 360<br />
Cussac, D Mon 084<br />
Cussonneau, X Mon 193<br />
Cuzzocrea, S<br />
FC18.1.5, FC18.3.6,<br />
Mon 277, Mon 286<br />
D´Ocon, P Tue 165<br />
Da Costa-Guevara, DJ Wed 040<br />
da Cruz e Silva, O Mon 146<br />
da Motta, NAV Wed 232<br />
da Silva Rodrigues, E Wed 041<br />
da Silva, AL<br />
FC16.2.3<br />
da Silva, LL Mon 279, Wed 232<br />
da Silva, R<br />
Wed 198, FC15.4.5<br />
da Silva, RF Thu 061<br />
Daali, Y Tue 166, Mon 337<br />
D'Acunto, CW Tue 406<br />
D'Addario, C<br />
FC14.1.5<br />
Dadgar, FN Mon 036<br />
Dadkhah, F<br />
FC01.3.5<br />
D'Agostino, G<br />
FC18.1.6<br />
Dahan, A W12.4<br />
Dahan-Farkas, N Tue 404<br />
Dai, H Tue 070<br />
Dai, JM Wed 228<br />
Dai, Y-W Wed 262<br />
Dai, Z-K Thu 105<br />
Daiber, A<br />
W30.3, W04.2.4<br />
Dalhoff, K Mon 345<br />
Dalla, C W33.4<br />
Dalli, J<br />
FC09.5.7, FC09.4.6<br />
Dalodom, T Wed 338<br />
Dalsgaard, T<br />
Wed 229, Wed 230, Wed<br />
281, Wed 282, Thu 259<br />
Dalton, GD Wed 029<br />
Daly, AK<br />
FC13.3.2<br />
Daly, C Thu 030<br />
Daly, CJ<br />
W01.2.2<br />
Dam, E W26.4<br />
Dambrova, M Tue 141<br />
Damchi Jelodar, J Thu 412<br />
Damkier, P FC04.4.2, Mon 050, Tue 395,<br />
Damsgaard, EM Mon 142<br />
Damsgaard, J Wed 160<br />
Danchin, N Mon 145, Mon 132<br />
Dandara, C Thu 016<br />
Daniel, H<br />
FC02.3.3<br />
Danielyan, L<br />
YI.02<br />
Danscher, G Mon 320<br />
Danser, J Wed 292, Wed 220<br />
Dantas, AP YI.03, Thu 225<br />
Dantas, R Wed 131<br />
Darabi, M Tue 164<br />
D'Arrigo, C Thu 419<br />
Darrouzain, F Mon 363<br />
Darsova, D Tue 445<br />
Darvas, F Tue 130<br />
Darwish, IE Mon 364, Tue 464<br />
Darwish, SA Mon 364<br />
Darýverenli, E Wed 357<br />
Das, A Mon 314<br />
Das, M Thu 427<br />
Daulat, A Thu 055, Wed 072<br />
Daulat, AM Thu 028<br />
Dautreaux, B Thu 242<br />
Davarian, A Mon 196<br />
Davel, AP Wed 042, Wed 231<br />
Davenport, AP W14.1, Tue 479<br />
Davey, AE Wed 043, Wed 089<br />
Davids, H Mon 308, Tue 404<br />
Davidson, C Wed 425, Mon 195, Mon 430<br />
Davidson, M<br />
SS01.1<br />
D'Avolio, A Tue 405<br />
Davy, J-M<br />
FC06.2.3<br />
Davydova, KS Thu 253<br />
Dawson, J<br />
FC15.1.6<br />
Dawson, N<br />
FC17.1.4<br />
Dayer, P Tue 166, Tue 305, Mon 337<br />
de Almeida, RB Wed 395<br />
de Andrade Cavalcante,<br />
F Thu 351<br />
de Andrade, GM Tue 282<br />
de Araujo, I<br />
W02.1.6<br />
de Basilio, V Tue 362<br />
de Bock, M Thu 237<br />
de Brito Gariépy, H Tue 275<br />
de Brito, FCF Wed 232<br />
de Bruin, ML<br />
FC04.3.3<br />
de Carvalho, AGG Tue 281<br />
de Carvalho, MHC Wed 233<br />
de Cock, J<br />
FC03.2.6<br />
de Cock, P Mon 365, Tue 306<br />
de Diego, AMG FC12.1.6, FC16.2.5<br />
de Esch, I Thu 060<br />
de Fátima, A Mon 097<br />
de Filippis, D FC18.4.6, Tue 465<br />
de Francia, S Tue 405, Wed 010<br />
de Franco, F<br />
FC18.4.5<br />
de Graaf, C Thu 082<br />
de Jesus Barreiro, E Mon 279<br />
de Jesús, ML Wed 046<br />
de Jesus, S Thu 254<br />
de Jong-van den Berg,<br />
LTW<br />
FC04.4.4<br />
Index 325
Name Paper ref. Name Paper ref.<br />
de Kam, ML FC17.3.5, FC10.4.6, Tue 148<br />
de Koning, C Tue 404<br />
de la Cortes, J P Mon 278<br />
de la Cruz, JP Mon 206, Tue 116, Wed 215,<br />
Wed 250, Thu 246<br />
de la Puerta, R Tue 409<br />
de la Villa, P Wed 225<br />
de Lemos Neto, M Wed 339, Wed 340, Wed 342<br />
de Leon, MW Mon 038<br />
de Lera, A<br />
FC18.3.5<br />
de Lima, CKF Mon 279<br />
de Luca, P Mon 223<br />
de Lucca Camargo, L Wed 233<br />
de Man, J Tue 465<br />
de Martin, S Wed 404<br />
de Martino, F Tue 405, Wed 010<br />
de Menorval, LC Thu 358<br />
de Mey, JGR W25.3, Wed 037, Thu 251<br />
Thu 208, Wed 287, Thu 221<br />
de Miranda, ALP Mon 279<br />
de Moura, RS Wed 341, Wed 340, Wed 342<br />
de Munnik, S Thu 060<br />
de Oliveira, AM Thu 236<br />
de Oliveira, D Tue 241<br />
de Sarro, A Wed 317<br />
de Vries, A Mon 442<br />
de Vries, C FC04.2.6, Mon 140<br />
de Vries, CJM<br />
FC18.2.4<br />
de Vries, C<br />
FC04.4.3<br />
de Vries, R Wed 292<br />
de Wit, H<br />
FC14.3.4<br />
Deak, BH Wed 050<br />
Dear, JW Thu 420, Tue 270<br />
Debeer, A Wed 002<br />
Debets, JJ Mon 212<br />
DeBold, J<br />
FC14.4.3<br />
Debruyne, F Wed 001<br />
Dechent, C Mon 136<br />
Deforges, L<br />
W02.2.6<br />
Degenhardt, T FC18.2.5<br />
Degenne, D Mon 363<br />
DeGorter, M<br />
FC02.1.6<br />
Dehpour, AR Wed 418<br />
Dehpour, AR. Thu 180<br />
Dejanovic, M Wed 436<br />
DeJesus, S Wed 265<br />
Dekanski, D FC16.3.6, Wed 343<br />
del Caño, GG Wed 046<br />
del Rosario Garrido, M Tue 226<br />
Delagrange, P Thu 028, Thu 055<br />
de-la-Hera, A Mon 254<br />
Delchier, JC<br />
W02.2.6<br />
Delgado-Buenrostro, NL Tue 149<br />
Delgado-Hernandez, R Tue 114, Wed 344, Thu 358<br />
Deli, J<br />
FC16.2.6<br />
Della-Casa, MC Wed 332<br />
Della-Casa, MS Wed 333, Wed 334<br />
Dellai, A Wed 316<br />
Delpón, E<br />
FC06.2.4<br />
Demare, P Tue 420<br />
Demir, O Mon 043, Tue 200<br />
Demir, T Tue 200<br />
Demircan, D Mon 117<br />
Demirci, C Tue 461<br />
Demiryurek, AT Thu 272<br />
Demotes, J W10.1<br />
Denadai-Souza, A Wed 233<br />
Dencker, L W10.2<br />
Deng, J Tue 178<br />
Deng, L Tue 184<br />
Deng, SY Wed 345<br />
Deng, X W02.2.7, Tue 466, Wed 366,<br />
Wed 365<br />
Denich, D Wed 148<br />
P, M Tue 190<br />
Denise, P Mon 362<br />
Denizalti, M Mon 366<br />
Denys, P Mon 233, Mon 232<br />
Dercho, RA Tue 414<br />
Dermentzopoulou, M Tue 246<br />
Desch, M Wed 234<br />
Deschenes, G Wed 011<br />
Descotes, J<br />
FC09.2.7<br />
Deshimaru, . M Thu 108<br />
Desloovere, C Wed 001<br />
Desmeules, J Mon 337<br />
Desmeules, JA Tue 166<br />
Desmoulins, F Wed 196<br />
Despars, G Tue 396<br />
Desta, Z Tue 045<br />
Desvergne, B<br />
FC18.1.2, FC18.2.5<br />
Deswal, R Mon 005<br />
Detilleux, P W10.2<br />
Deuschle, U<br />
FC18.2.6<br />
Deval, E<br />
FC17.2.5<br />
Devay, A<br />
FC16.2.6<br />
Devi, LA Wed 065<br />
Dewhurst, D W20.1<br />
Dey, A Mon 240, Mon 242, Mon 248<br />
Dézsi, L Tue 078<br />
Dhaunsi, G Mon 151<br />
di Bari, M Mon 120<br />
di C, F Tue 405, Wed 010<br />
di Cesare Mannelli, L Mon 113, Mon 391, Tue 446<br />
di Francesco, A Mon 281, Wed 235<br />
di Francesco, L Wed 235, Mon 281<br />
di Gion, P Thu 010<br />
di Lio, A<br />
FC03.3.3<br />
di Matteo, A Mon 296<br />
di Michele, P Mon 105, Wed 434, Wed 329<br />
di Nisio, C Mon 105, Wed 434, Wed 329<br />
di Paola, R FC18.1.5, Mon 277,<br />
FC18.3.6<br />
Dias, MF<br />
FC01.4.3<br />
Diaz Acedo, C FC04.4.6<br />
Díaz Casañas, E Wed 311<br />
Diaz, A Thu 408<br />
Díaz, A Wed 401, Wed 087<br />
Dib-Hajj, SD<br />
FC03.1.4<br />
Diddi, G Thu 302<br />
Didier, R Thu 082<br />
Diederichs, C Tue 313<br />
Diéguez, G Wed 224<br />
Dieleman, J<br />
FC04.4.5<br />
Dieplinger, H Tue 151<br />
Dietrich, D W10.2<br />
Diez, R Mon 128, Mon 280<br />
Diez-Alarcia, R Wed 031<br />
326 Index
Name Paper ref. Name Paper ref.<br />
Díez-Juan, A W09.4<br />
Dilley, R<br />
Mon 194, FC06.4.5<br />
Dimitri, W Mon 352, Mon 353<br />
Dimmeler, S<br />
PL05<br />
Dimosiari, G Mon 367<br />
Dinat, N Tue 001<br />
D'Incau, P Mon 129, Mon 130<br />
Diness, J<br />
FC06.3.5, FC06.1.4<br />
Ding, G Tue 299,<br />
Ding, J Tue 441<br />
Ding, Y Thu 372<br />
Dingemanse, J Tue 312<br />
Diniz, C Thu 054<br />
Dinter, D Tue 447<br />
Dionísio, T Mon 007, Tue 261<br />
Dipasquale, P Thu 440<br />
Dirach, J W10.2<br />
Direito, R Mon 383, Tue 407<br />
Disania, N Mon 131<br />
Dittz, D Tue 428<br />
Dixit, VK Mon 237<br />
Diz, D Mon 151<br />
Djordjevic, A Tue 122<br />
Djordjevic, V Tue 149<br />
Djulbegovic, B Tue 107<br />
Dlugokecka, J Mon 197<br />
Dmitriev, V Tue 129<br />
Doan, AE Mon 103<br />
Dobric, S Tue 321<br />
Docherty, JR Wed 236<br />
D’Ocon, P Thu 050, Wed 068, Thu 048,<br />
Tue 163<br />
Dodgen, T Mon 368<br />
Dodoo, A W32.4, W35.3, W27.4<br />
Doe, M Mon 404<br />
Dogan, BSU Tue 461<br />
Dohmoto, M Thu 286<br />
Doi, H Tue 244<br />
Doi, M Wed 424<br />
Doig, C Mon 116<br />
Dolezal, K Thu 118<br />
Dolidze, N Tue 174<br />
Dolphin, A<br />
FC03.2.4<br />
Dombi, G Mon 261<br />
Dominguez, H<br />
FC04.2.4<br />
Donadio, L<br />
FC18.4.5<br />
Donaldson, K W10.3<br />
Donati, M Mon 130<br />
Doncheva, N Mon 083<br />
Donertas, B Mon 117<br />
Dong, H-J Tue 083<br />
Dong, J Tue 152, Tue 419<br />
Donnelly, L Tue 269<br />
Donnerer, J Mon 369<br />
Donnini, S Wed 243<br />
Dora, KA FC15.2.2, Wed 268,<br />
Wed 206, Thu 289<br />
Dorchies, O<br />
Thu 013, W04.3.2<br />
Dorchies, OM Wed 102<br />
Doroshyenko, O Mon 315<br />
Doroszko, A<br />
FC06.3.6<br />
Doroumian, S Mon 204<br />
dos Santos Dias, AA Wed 237<br />
dos Santos Filho, A Wed 203, Mon 257<br />
dos Santos, ARS Wed 394<br />
Dosa, MD Mon 162<br />
Dosenko, V<br />
FC06.1.6<br />
Doshi, M Mon 116,<br />
Doudet, D Thu 405, Thu 404<br />
Doudet, DJ<br />
FC17.4.5<br />
Doustar, Y Mon 294,<br />
Dovizio, M Mon 281, Wed 235<br />
Draganic, P Mon 370<br />
Drago, F Thu 396, Mon 152, Wed 400<br />
Dragojevic-Simic, V Tue 091, Tue 321, Tue 151,<br />
W34.3, W34.5<br />
Drake, MJ<br />
FC08.4.4<br />
Drecun, M Tue 081<br />
Drekic, D Thu 436, Mon 446<br />
Dresser, G Tue 301<br />
Drevensek, G Thu 359, Thu 293<br />
Drewelow, B Wed 119, Tue 131, Tue 115<br />
Drewes, AM W12.1<br />
Dridi, M Wed 316<br />
Drimba, L Mon 163<br />
Drouet, L Tue 188, Tue 189<br />
Droz-Perroteau, C Mon 145, Mon 132<br />
Drummond, GR FC15.1.4, Mon 305<br />
Dsokey, N Mon 165<br />
D'Souza, Y Tue 385<br />
Du Plessis, JB Mon 258, Wed 389,<br />
Wed 390, Wed 391<br />
du Preez, J Thu 428<br />
du Souich, P W06.5<br />
Du, G Thu 314, Mon 034, Thu 384,<br />
Thu 372, Tue 307<br />
Du, GH Mon 433, Tue 297, Tue 365<br />
Du, G-H Mon 421, Wed 346<br />
Du, J Thu 367<br />
Du, L Mon 092<br />
Duan, DD<br />
FC12.4.5<br />
Duarte, C Mon 398<br />
Duarte, H<br />
FC03.1.5<br />
Duarte-Araújo, M FC08.2.6, Thu 064<br />
Duborija-Kovacevic, N Wed 135, Wed 134<br />
Duburs, G Wed 045<br />
Ducimetière, P Mon 145, Mon 132<br />
Duckles, S PL15, Wed 261<br />
Ducluzeau, PH Mon 148, Tue 118<br />
Ducourau, E Tue 198, Tue 190<br />
Ducret, T Wed 293<br />
Ducza, E Wed 101<br />
Duczynski, G Mon 251<br />
Dufournet, B Thu 244<br />
Dufton, N<br />
FC09.4.6<br />
Dugina, JL Mon 198, Mon 284, Thu 015<br />
Dukat, A Tue 113<br />
Dulak, J W24.5<br />
Dulger, GA Tue 027<br />
Dumas de la Roque, E Wed 293<br />
Dumas, M Tue 289, Tue 290<br />
Dumbrava, LP Mon 417, Mon 438<br />
Dunlop, A<br />
FC03.2.6<br />
Dunne, F Tue 364<br />
Dupuis, F Wed 244<br />
Duque-Bascuñana, B Tue 348<br />
Duran, JA Wed 109<br />
Durán, JJT Mon 288, Thu 115, Tue 302<br />
Index 327
Name Paper ref. Name Paper ref.<br />
Durán, ST Mon 288, Thu 115, Tue 302<br />
Dureau-Pournin, C Mon 145, Mon 132<br />
Duret, J-P Mon 202<br />
Durman, DK Mon 199<br />
Durnev, A Tue 276<br />
Durnev, AD Tue 165<br />
Durroux, T<br />
FC11.3.5<br />
Duruewuru, K Mon 017<br />
Dusting, G<br />
Mon 194, FC06.4.5, Wed<br />
219, FC15.2.5<br />
Dutta, S Tue 453<br />
Duty, S Wed 044<br />
Duvauchelle, T Mon 201<br />
Dygai, A Tue 167<br />
Dyhring, T<br />
YI.10<br />
Dykhal, YI Wed 175<br />
Dyr, W Thu 174<br />
Dyve, S<br />
FC17.4.5<br />
Dzirkale, Z Wed 045<br />
Eandi, M Wed 154<br />
Eandi, M Mon 223<br />
Eap, CB Tue 166, Mon 160<br />
Ebeid, F Tue 386<br />
Ebner, K W33.5<br />
Ebrahimi, R Mon 202<br />
Ebrahimi, SM Mon 188<br />
Echeazarrra, L Wed 046<br />
Echeverría, O Mon 176<br />
Echizen, H Tue 486<br />
Eden, T Tue 353<br />
Edington, A Mon 052<br />
Edlert, M Mon 371<br />
Edvinsson, L Mon 450, Tue 185, Tue 220,<br />
Thu 239, Tue 298, Wed 021,<br />
Wed 033, Wed 213,<br />
Wed 292, Thu 053, Thu 056,<br />
Thu 066<br />
Edwankar, RV<br />
FC03.3.3<br />
Edwards, B W32.3<br />
Edwards, G FC15.2.1, Wed 238<br />
Edwards, R<br />
FC02.2.4<br />
Eftekhari, A Mon 200, Thu 234<br />
Eftekhari, S Wed 292<br />
Egashira, N Mon 093, Thu 109<br />
Egea, J Tue 042<br />
Egutchi, S Thu 261<br />
Eichelbaum, M Wed 133<br />
Eidne, KA Wed 079<br />
Eiermann, B Mon 371<br />
Ejtemaei Mehr, S Thu 180<br />
Ekici, H Wed 312<br />
Ekokoski, E Tue 433<br />
Ekström, L<br />
Thu 256, Wed 183, FC14.1.6,<br />
Wed 176<br />
El Deeb, K Mon 282<br />
El jebari, H<br />
FC07.3.6<br />
El Saghir, N<br />
FC01.3.4<br />
El-Banna, H Mon 016<br />
El-Bassossy, H Mon 164, Mon 165<br />
El-denshary, ES Tue 451<br />
Elekes, K W19.3, Mon 283, Tue 271,<br />
Tue 250,<br />
Elgabarty, H<br />
FC06.2.6<br />
El-Gendy, AAM Mon 340<br />
Elgharbi, A Mon 290, Mon 377<br />
Elhwuegi, A Wed 405<br />
Eliasson, E FC13.4.5, Thu 256, Tue 318,<br />
Tue 138<br />
Elie, V<br />
FC10.5.5<br />
Elie, Valery Wed 011<br />
Elies, J Wed 227<br />
Elisabeth, S-G Tue 190<br />
Elisabetsky, E<br />
FC16.2.3<br />
Eliseeva, E Mon 133, Mon 134<br />
Elkarimi, H Mon 378<br />
El-Kiweri, I Mon 053<br />
El-Lakkany, N Tue 386, Mon 372<br />
Elliot, D Wed 124<br />
Ellis, EM Mon 413<br />
El-Maadawy, W Tue 386<br />
El-Mallah, A Tue 264<br />
Elmedal Laursen, B Wed 281, Wed 240<br />
El-Moselhy, M Mon 164, Wed 441<br />
Eloranta, JJ Thu 435<br />
El-Yacoubi, M<br />
FC17.2.5<br />
El-Yazbi, A Wed 239<br />
Elzinga, CRS Wed 095<br />
Elzorba, H Mon 016<br />
Emami, A Tue 389<br />
Emami, SA Thu 313<br />
Embil, K Tue 142<br />
Engelstoft, MS Thu 036<br />
Enggaard, TP<br />
FC13.5.5<br />
Engidawork, E FC01.2.5<br />
Engström Hellgren, K Tue 308<br />
Enwere, O Mon 017<br />
Enzaka, J Mon 304<br />
Epstein, D<br />
FC14.3.4<br />
Epstein, OI Mon 198, Mon 284, Thu 015<br />
Erb, C<br />
FC18.3.5<br />
Ercanlý, T Tue 029<br />
Erdeljic, V FC01.3.7, Mon 135,<br />
Mon 373, Tue 328<br />
Erden, F Thu 401<br />
Erdozain, AM Wed 031<br />
Erenmemisoglu, A Tue 018<br />
Ergüden, J Thu 091<br />
Eriksson, L Tue 383<br />
Eriksson, M Wed 006<br />
Erin, N Mon 285<br />
Erlendsson, S Tue 053<br />
Erlinge, D Thu 074, Wed 052, Wed 062<br />
Ermakov, S Tue 196<br />
Ernst, G Mon 245<br />
Eroglu, E Tue 031<br />
Erol, A Thu 233<br />
Erol, K Mon 103, Wed 406,<br />
Wed 420, Wed 421<br />
Eromon, A Wed 369<br />
Eromosele, S Mon 241<br />
Ertoy Baydar, D Wed 253<br />
Eruanga, V Mon 241<br />
Esaki, Y Tue 260, Tue 294<br />
Eschalier, A Thu 083<br />
Escobar, L Mon 136, Tue 164, Tue 326<br />
Escobar, T Mon 480<br />
Escolano, L Mon 374, Tue 121, Wed 226,<br />
Thu 217<br />
328 Index
Name Paper ref. Name Paper ref.<br />
Escubedo, E Wed 174, Wed 177,<br />
Wed 181, Thu 179<br />
Esen, AA Tue 200<br />
Eskildsen, T<br />
FC06.2.5<br />
Eskildsen-Helmond, Y Wed 240, Wed 241<br />
Esmaeili, J Mon 454<br />
Espino, J Mon 407<br />
Esposito, E<br />
FC18.1.5, FC18.3.6,<br />
Mon 277, Mon 286<br />
Esposito, G<br />
Tue 465, FC18.4.6<br />
Esposti, ED Mon 120<br />
Esposti, LD Mon 120<br />
Esteban, A Thu 235<br />
Esteves Pinto, C Wed 114, Thu 398<br />
Estrada, S Wed 068<br />
Estupiñan, J Mon 480<br />
Eto, B Tue 040<br />
Etter, M Mon 160<br />
Euikyung, K Tue 017<br />
Evangelista, JSAM Thu 374<br />
Evans, A Wed 124, Tue 495<br />
Evans, B Wed 063, Mon 395, Thu 059<br />
Evans, C<br />
FC14.1.3<br />
Evans, SJW<br />
FC04.2.3, FC04.3.2<br />
Evans, W E<br />
FC13.2.4<br />
Evcim, AS Tue 200<br />
Exintaris, B Mon 240, Mon 242, Mon 248,<br />
Tue 416<br />
Eyakem, AH Mon 018<br />
Eybl, V Mon 409<br />
Ezenwanebe, K Wed 296<br />
Ezeokoli, CD Thu 326<br />
Faal, M<br />
FC17.2.6<br />
Fabio, B Thu 400<br />
Fadda, E Tue 133<br />
Faddah, LM Mon 189<br />
Faghih Mirzaei, E Wed 376<br />
Fagni, L<br />
FC11.3.3<br />
Fago, A Wed 230<br />
Fagundes, C W31.4<br />
Fahmy, A Mon 165<br />
Faiad, OJ Mon 273<br />
Fakhoury, M FC10.1.5, Wed 011<br />
Fakhrjou, A Tue 223<br />
Falahi, G Thu 005<br />
Falahpour, M Thu 005<br />
Falcão, A Thu 169, Mon 383, Tue 407<br />
Falcão, S Thu 366<br />
Falk, E Wed 241<br />
Falkay, G Mon 208, Mon 261, Wed 050,<br />
Wed 101<br />
Falkbring, S Wed 092<br />
Fameli, N Thu 264<br />
Fan, D Tue 286<br />
Fan, GW Wed 242<br />
Fan, J<br />
FC15.2.5<br />
FAN, L Tue 419<br />
Fan, L Wed 257<br />
Fan, S-J Thu 277<br />
Fan, T-P FC16.4.1, Wed 330<br />
Fan, X Tue 117<br />
Fan, Y Tue 069<br />
Fang, C Tue 399<br />
Fang, C-K Wed 430<br />
Fang, H Tue 138, Mon 458<br />
Fang, L-H Wed 346<br />
Fang, S Mon 457, Mon 458<br />
Fang, SF Mon 325, Tue 317<br />
Fantozzi, R Tue 256, Thu 434<br />
Farar, V Thu 039<br />
Farker, K Wed 119, Tue 131<br />
Farooqi, S<br />
FC11.4.3<br />
Farre, M Thu 177, Thu 178, Mon 137,<br />
Mon 109, Mon 375<br />
Faruque, R Tue 097, Tue 120<br />
Fätkenheuer, G Mon 315<br />
Fauler, M<br />
FC12.2.3<br />
Faure García, R Thu 347<br />
Favaloro, JL Wed 288, Wed 289<br />
Fawcett, K Mon 161<br />
Fazekas, K Wed 423<br />
Fazni, R Thu 181<br />
Fazzi, G Thu 251<br />
Fedorenko, A Mon 431<br />
Fedotova, Y FC17.1.6, Wed 407, Wed 347<br />
Feinshtein, V Mon 054<br />
Feizi, I Thu 311<br />
Felder, CC Thu 041<br />
Feldkötter, M Thu 018<br />
Feldman, BJ Wed 079<br />
Feldman, M<br />
FC09.2.1<br />
Félétou, M Thu 273, Thu 274<br />
Félétou, Ml<br />
FC15.3.1<br />
Felino, A Tue 261<br />
Felix, AMR Mon 010<br />
Fellman, V Thu 008<br />
Feltner, D Wed 193<br />
Fendt, A Wed 185<br />
Feng, J Wed 267<br />
Feng, L Mon 457, Mon 458, Tue 138<br />
Feng, N Mon 466<br />
Fennell, T Thu 021<br />
Fenner, K Mon 236<br />
Fenwick, P Tue 269<br />
Feoktistova, Y Mon 133<br />
Ferchichi, H Thu 346, Wed 348, Mon 004<br />
Ferk, Polonca Wed 178<br />
Fernandes, AC Mon 276<br />
Fernandes, D Wed 097, Wed 251, Thu 064<br />
Fernandes, ES Mon 287<br />
Fernandes, K<br />
W01.2.4<br />
Fernandes, LGR Mon 289<br />
Fernandes, MA Wed 045<br />
Fernandes, MH Tue 261<br />
Fernandes, P Thu 204<br />
Fernández Lima, O Wed 311, Thu 347<br />
Fernández, H Thu 205<br />
Fernandez, MC Tue 123, Wed 109<br />
Fernández, N Wed 224<br />
Fernández-Arche, MA Tue 409, Wed 349<br />
Fernandez-Aviles, F W09.5<br />
Fernández-Llimós, F Mon 376<br />
Fernandez-Morales, JC FC16.2.5, FC12.1.6<br />
Fernández-Pérez, L Tue 387, Tue 391, Tue 392<br />
Fernandez-Vallin, E Wed 209<br />
Ferrand, N Thu 055<br />
Ferrante, C Mon 105, Wed 434, Wed 329<br />
Ferreira, EB Tue 101<br />
Index 329
Name Paper ref. Name Paper ref.<br />
Ferreira, HHA Mon 289<br />
Ferreira, S Mon 275<br />
Ferreira, W Mon 095, Mon 097, Mon 094<br />
Ferreirinha, F Thu 064<br />
Ferro, H Mon 280<br />
Feske, S<br />
FC12.5.3<br />
Festa, M Tue 406<br />
Fey, V Mon 410, Tue 436<br />
Fickl, H Mon 368<br />
Field, J Mon 102<br />
Figueiras, A Thu 119, Tue 086, Mon 146<br />
Figueiredo, C Wed 302, Tue 428<br />
Figueiredo, I Wed 214, Mon 299, Mon 298,<br />
Wed 319<br />
Figueiredo, IV Mon 376, Thu 119<br />
Figueirinha, A Mon 291<br />
Figueiró, M<br />
FC16.2.3<br />
Figura, P Thu 174<br />
Filali, H Mon 290, Mon 378, Mon 377<br />
Filaretova, L<br />
W02.2.5<br />
Filipcsei, G Tue 130<br />
Filipovic, B Mon 096<br />
Filippov, AK Wed 047<br />
Filiz Basaran, N Wed 179<br />
Filppula, A Mon 380<br />
Finch, AM Mon 394, Wed 032, Wed 048<br />
Finetti, F Wed 243<br />
Fingerhut, R Wed 016<br />
Fioravanzo, E Thu 433<br />
Firenzuoli, F Thu 302<br />
Firstova, J Wed 426<br />
Firuzi, O Thu 309<br />
Fischer, DF W14.4<br />
Fischer, J Thu 197<br />
Fischer, M Tue 169<br />
Fish, R Mon 393, Wed 020, Mon 420<br />
Flacco, N Wed 068<br />
Flammer, A<br />
FC16.1.2<br />
Flammini, L Tue 258, Mon 381<br />
Fleckenstein, L Tue 012<br />
Flioni, E Tue 141<br />
Flor, H W03.6<br />
Flordellis, C Wed 074<br />
Floreani, M Wed 404<br />
Flores, ML Wed 350<br />
Flores-Morales, A Tue 387, Tue 391, Tue 392<br />
Flores-Murrieta, F Mon 009, Mon 019<br />
Flores-Santana, W FC09.3.3<br />
Flower, K FC14.2.5, Mon 388, Wed 170<br />
Flower, RJ<br />
FC09.4.6<br />
Flynn, C Wed 158<br />
Fogli, S Wed 442, Mon 382<br />
Fois, C Tue 133<br />
Fok, BSP FC02.4.6, Tue 140<br />
Folarin, OA<br />
YI.09<br />
Folkerts, G<br />
FC09.5.2<br />
Folmes, CD<br />
FC05.2.6<br />
Foltin, V Mon 479<br />
Foltinova, J Thu 211, Thu 354<br />
Fonseca, D Wed 337<br />
Fontana, P Mon 337<br />
Fontes Ribeiro, C Wed 140, Wed 180<br />
Foo, Y-T<br />
FC01.3.1<br />
Ford, L Tue 284<br />
Forget, A<br />
FC04.1.5<br />
Forjasz, R Mon 262<br />
Formigos, JA Mon 138, Mon 472, Thu 407,<br />
Formigós-Bolea, J Mon 477, Mon 473, Mon 481<br />
Fors, M Thu 394<br />
Forsberg, M Mon 425<br />
Förstermann, U FC15.4.3<br />
Fortes, R Tue 008, Thu 322, Thu 321<br />
Fortes, ZB<br />
Wed 233, FC06.1.5<br />
Fortin, A Tue 396<br />
Fortuna, A Thu 169, Mon 383, Tue 407<br />
Fotoohi, A Mon 055<br />
Fotouhi, M Mon 036<br />
Fouad, M Mon 164<br />
Foulquier, S Wed 244<br />
Fourrier-Réglat, A FC04.4.6, W10.4<br />
Frade, M Mon 298<br />
Fraga, C Mon 398<br />
Fraga, CAM Mon 279<br />
Frame, F Tue 270<br />
Francetic, I<br />
FC01.3.7, Mon 135, Mon<br />
373, Tue 328<br />
Francisco, V Mon 291<br />
Franco, DW W31.3<br />
Franco, LAM Mon 292<br />
Frank, D Mon 384, Mon 315<br />
Frank, E Thu 308<br />
Frank, L Wed 092<br />
Frankic, T Wed 171, Wed 004<br />
Franks, N<br />
FC03.4.1<br />
Franova, S Mon 293<br />
Fransen, P Wed 246, Wed 245<br />
Frappier, M Wed 123, Tue 051<br />
Frau, A Tue 133<br />
Frazziano, G Thu 217<br />
Fredberg, U Tue 358<br />
Fredericia, PM Tue 248<br />
Free, R Thu 063<br />
Freeman, D Wed 013<br />
Freeman, DJ<br />
FC10.2.5<br />
Freilij, H Mon 003, Wed 003<br />
Freire, C Thu 366<br />
Freire-Garabal, M Thu 325<br />
Freissmuth, M<br />
FC11.4.5<br />
Freitas, A Mon 275<br />
Freitas, L Mon 298<br />
Fresco, P Mon 126, Thu 054<br />
Frey II, WH<br />
YI.02<br />
Frey, N<br />
FC07.2.2<br />
Freyer, J Tue 049<br />
Frias, J Mon 451<br />
Frías-Iniesta, J Tue 348<br />
Friberg, L W29.3<br />
Frigerio, C Wed 337<br />
Frigerio, F Wed 447<br />
Fröbert, O Thu 222<br />
Frølund, B<br />
FC11.5.6<br />
Fromm, MF<br />
FC02.2.6, FC02.3.2<br />
Frotscher, M Tue 442<br />
Fry, C H<br />
FC08.3.2<br />
Fu, J Tue 419, Thu 440<br />
Fu, S-Y Wed 035<br />
Fu, W-M Wed 403<br />
Fu, X Tue 384<br />
330 Index
Name Paper ref. Name Paper ref.<br />
Fuad, WEM Thu 312<br />
Füchtbauer, EM FC02.3.6<br />
Fürjes, G Tue 125<br />
Fürst, R<br />
Tue 227, FC16.1.5<br />
Fürst, S Wed 185, Thu 192<br />
Fuhr, U Mon 315, Mon 384, Thu 010<br />
Fujibayashi, M Wed 422, Wed 415<br />
Fujii, M Tue 154<br />
Fujii, A Tue 201, Tue 432<br />
Fujii, N<br />
FC05.2.6<br />
Fujimori, A Thu 416<br />
Fujimura, A Thu 268, Wed 189<br />
Fujimura, S Wed 189<br />
Fujisawa, S Tue 430<br />
Fujita, A Tue 234<br />
Fujita, K Wed 141<br />
Fujiwara, H Thu 261<br />
Fujiwara, Y Wed 189<br />
Fukami, K Mon 243<br />
Fukasawa, T Wed 136<br />
Fukazawa, I Tue 345<br />
Fukuda, K FC13.2.5, Tue 126, Tue 260<br />
Fukuhara, Y Wed 247<br />
Fukui, H Wed 061<br />
Fukuishi, N Mon 253<br />
Fukumoto, A<br />
FC16.4.6<br />
Fukunaga, K Thu 406<br />
Fukushima, T Mon 307<br />
Fulga, I Mon 111, Mon 274<br />
Fuller, PJ<br />
FC18.2.3<br />
Funaki, Y Tue 166<br />
Fung, KP Thu 297, Wed 345<br />
Funk, C Wed 235<br />
Furlan, G Mon 385<br />
Furlotti, G Mon 296<br />
Furman, C Thu 063<br />
Furuie, H Mon 386<br />
Furukawa, K-I Tue 430<br />
Furumoto, S<br />
FC17.5.6<br />
Furuno, T Wed 422<br />
Furuta, T W23.4, Tue 159, Mon 459,<br />
Tue 473<br />
Furuta, Y Thu 406<br />
Fusco, FB Wed 203, Mon 257<br />
Fuster, JJ W09.4<br />
Gaasemyr, J Tue 143<br />
Gabrielsen, M Mon 224<br />
Gacar, G Mon 387<br />
Gacar, N Wed 351, Mon 387, Tue 145<br />
Gad, M<br />
FC06.2.6<br />
Gaedigk, A Mon 384<br />
Gaetani, S Thu 440<br />
Gagiano, C<br />
FC14.5.5<br />
Gahrn-Hansen, B FC13.1.5<br />
Gaïes, E FC07.3.6, Mon 020, Mon 021<br />
Gailly, P Wed 102<br />
Gajski, G Tue 447<br />
Galán, J Tue 103<br />
Galasso, L Tue 487<br />
Galasso, R Tue 487<br />
Gales, C Mon 162<br />
Galindo, P Wed 268<br />
Galione, A Wed 268<br />
Gallardo, E Tue 144<br />
Gallardo-Ortiz, I Wed 049<br />
Galleyrand, J Mon 203, Mon 201, Mon 205,<br />
Mon 204<br />
Gallo, C W04.3.2, Wed 102<br />
Gallo, E Thu 302<br />
Galloway, GP FC14.2.5, Mon 388, Wed 170<br />
Gallwitz, B<br />
FC05.3.3<br />
Galuppo, M FC18.1.5, Mon 277,<br />
FC18.3.6<br />
Gambassi, G<br />
FC04.4.5<br />
Gammeltoft, S Wed 070, Thu 058, Wed 036<br />
Gan, SH Mon 361, Mon 389, Tue 153,<br />
Tue 164, Tue 408, Tue 434,<br />
Tue 455<br />
Ganafa, AA Tue 209<br />
Gandelman, K Mon 251<br />
Gandhi, T<br />
FC16.1.6<br />
Ganpathy, P Mon 166, Tue 131<br />
Ganshina, T Wed 248<br />
Gantumur, M Tue 095<br />
Gao, C Mon 056<br />
Gao, D-L Mon 470<br />
Gao, J Thu 377, Thu 242<br />
Gao, J-W Mon 031<br />
Gao, L Mon 434, Tue 181<br />
Gao, M Mon 421<br />
Gao, X Thu 371<br />
Gao, X Tue 419<br />
Gao, XM Wed 242<br />
Gao, Y Tue 178, Wed 291, Thu 089<br />
Gao, Y Tue 388<br />
Gao, Z Mon 331<br />
Gao, Z-Y Tue 082<br />
Garaj-Vrhovac, V Tue 447<br />
Garayt, C<br />
FC04.2.5<br />
Garcia Fuentes, JL Mon 390<br />
García -Gonzalez, D Wed 349<br />
García Mondragón, MJ Thu 330<br />
García Sacristán, A Wed 224<br />
García, A Tue 042<br />
Garcia, AG<br />
FC12.1.6<br />
García, AG FC16.2.5, Mon 079<br />
Garcia, MR Mon 038<br />
Garcia, R Mon 207<br />
Garcia, TSL Wed 204<br />
Garcia-Algar, O Mon 375<br />
Garcia-Arnes, JA Mon 471<br />
Garcia-Barreto, D Mon 207<br />
Garcia-Bournissen, F FC10.5.3, Mon 003, Mon<br />
022, Wed 003,<br />
García-Cabanes, MC Mon 472, Mon 473, Mon 477,<br />
Mon 481<br />
García-Carrascal, L Mon 149<br />
García-Gimenez, D Tue 409<br />
García-Iglesias, B Thu 265<br />
Garcia-M, E Wed 109<br />
Garcia-Ratés, S Thu 179<br />
Garcia-Rates, S Wed 181<br />
Garcia-Rivera, D Wed 344<br />
Garcia-Rodriguez, C Mon 291<br />
García-Sacristán, A Thu 249, Mon 239, Tue 213,<br />
Mon 411, Wed 225<br />
García-Villalón, AL Wed 224<br />
Gard, P Wed 409<br />
Index 331
Name Paper ref. Name Paper ref.<br />
Gardner, E Thu 195, Wed 182<br />
Garduño, L Wed 217<br />
Gårevik, N Wed 183<br />
Garg, V<br />
FC06.1.1<br />
Garibova, TL Mon 422<br />
Garjani, A Mon 294, Tue 164, Tue 223<br />
Garland, CJ FC15.2.2, Wed 268, Thu 289<br />
Garland, S Wed 053<br />
Garle, M FC14.1.6, Mon 404<br />
Garrido Suarez, B Wed 344<br />
Garrido, M Wed 352<br />
Garrido, MR<br />
Mon 295, Wed 212, Wed<br />
265, Thu 254<br />
Garrone, B Mon 296<br />
Gärtner, F Wed 148<br />
Garuoliene, K Mon 139<br />
Gashaw, HH Thu 241, Thu 238<br />
Gaspar, M Wed 337<br />
Gaspar, R Mon 208, Wed 101, Wed 050<br />
Gassmann, M<br />
FC11.3.5<br />
Gaszner, B Mon 110, Mon 106<br />
Gatti, S Wed 094<br />
Gaud, C Mon 203, Mon 201, Mon 205,<br />
Mon 204, Mon 202<br />
Gaudette, N Thu 021<br />
Gavanji, S Thu 392<br />
Gayi, E<br />
W04.3.2<br />
Gazerani, P W12.3<br />
Gbahou, F Wed 051<br />
Gbotosho, GO<br />
YI.09<br />
Ge, W Tue 163<br />
Gean, PW Mon 356<br />
Geerts, A Thu 091<br />
Geerts, BF Tue 148<br />
Gelal, A Mon 043, Mon 474<br />
Gellett, A Tue 410<br />
Genovese, T<br />
FC18.1.5, Mon 277, Mon<br />
286, FC18.3.6<br />
Gentgall, M Wed 113<br />
Gentry, C Mon 287<br />
George, AL<br />
FC12.3.2<br />
Georgiadi, A<br />
FC18.2.5<br />
Georgieva, A Tue 196<br />
Georgopoulou-<br />
Karanikola, T Mon 297, Tue 126<br />
Geppetti, P W11.2, FC04.3.6, Mon 120<br />
Gerardin, E Mon 191<br />
Géresi, K Mon 150, Mon 167<br />
Gergs, U Tue 169<br />
Germain, P<br />
FC18.3.5<br />
Germano, I Wed 130<br />
Germer, M<br />
FC09.2.6<br />
Gersting, SW Thu 014, Wed 016<br />
Geta, D Mon 108<br />
Gether, U<br />
FC02.1.1, FC02.3.5,<br />
FC02.3.6, Mon 058,<br />
Mon 061, Mon 067, Mon 073,<br />
Tue 053<br />
Getova, D Mon 083<br />
Gevoyan, S Tue 218<br />
Gezer, A Thu 266<br />
Gezerler, F Thu 269<br />
Ghahremani, MH Wed 418<br />
Ghasemi, M Wed 418<br />
Ghelardini, C Mon 113, Mon 391, Tue 446<br />
Ghersi, D<br />
FC01.3.3<br />
Gheyle, L Tue 280<br />
Ghita, I Mon 111<br />
Ghizzardi, P Tue 258<br />
Ghosh, R Tue 131, Mon 166<br />
Giachetti, A Wed 243<br />
Giannini, E Thu 440<br />
Giaquinto, C<br />
FC04.1.6<br />
Gibson, C Wed 425, Mon 430<br />
Gibson, CL Mon 195<br />
Giddings, A Tue 221<br />
Gidener, S Tue 200, Mon 474<br />
Gidlöf, O Wed 052, Wed 062<br />
Giessrigl, B Thu 308<br />
Giglio, F Mon 007<br />
Giglio, N Wed 003<br />
Gil, ML Tue 478, Tue 422<br />
Gilani, AH FC16.2.4 Wed 356, Wed 354,<br />
Wed 355, Wed 353<br />
Gilbert, A<br />
FC13.1.6<br />
Gill, C Wed 307<br />
Gill, D<br />
FC12.2.5<br />
Gill, JS<br />
FC01.2.6<br />
Gill, PK<br />
FC01.2.6<br />
Gille, A Wed 056<br />
Gilleron, V Tue 092<br />
Gilles, N Tue 203<br />
Gilles, P Mon 363<br />
Gillies, G<br />
FC15.1.5<br />
Gilligan, J<br />
FC09.5.7<br />
Gilså Hansen, D Wed 160<br />
Gilsbach, R FC11.4.2, W01.2.1, Wed 022<br />
Giltay, EJ Wed 432, Tue 096<br />
Gini, R<br />
FC04.1.6<br />
Ginnaga, A Wed 371<br />
Giommoni, F Thu 302<br />
Giorgio, C Mon 381<br />
Giorgio, R Thu 400<br />
Girgis, R<br />
FC17.1.3<br />
Gislason, GH<br />
FC04.2.4<br />
Giuffrida, ML Wed 400<br />
Giuli, C Tue 249<br />
Giuliano, F FC08.2.1, Mon 233, Mon 232<br />
Gjedde, A<br />
FC17.1.2, FC17.4.5,<br />
Tue 193, Thu 405, Thu 404<br />
Glass, C K<br />
FC18.2.1<br />
Glenthøj, B<br />
FC17.3.2<br />
Gloriam, D Wed 053, Wed 066<br />
Gloriam, DE<br />
FC11.5.1<br />
Glossmann, H Thu 014, Wed 016<br />
Glynn, RJ<br />
FC04.1.3<br />
Glynn, R J<br />
FC04.1.4<br />
Glynn, S<br />
FC09.3.3<br />
Gnjidic, D FC13.1.6, Mon 392, Tue 309<br />
Gobbetti, T Tue 258<br />
Gobburu, JVS<br />
FC07.4.1<br />
Gocmez, SS Wed 351, Mon 387, Tue 145<br />
Goda, M Tue 415<br />
Godfredsen, C Tue 132<br />
Godin, A Mon 094, Mon 095, Mon 097<br />
Godinho, R Wed 054<br />
Goel, PC<br />
FC09.5.5<br />
Goerlandt, N Mon 365, Tue 306<br />
332 Index
Name Paper ref. Name Paper ref.<br />
Goh, G<br />
FC02.2.4<br />
Goirand, F Tue 289, Tue 290<br />
Gojkovic-Bukarica, L Wed 103<br />
Gok, Sule Wed 357<br />
Goktas, MT Wed 249<br />
Golan, M Wed 410<br />
Goldbeter, A<br />
FC07.1.3<br />
Goldman, M W24.1<br />
Goldstein, DB<br />
FC13.4.1<br />
Golechha, M Mon 260<br />
Golechha, M Wed 358<br />
Golkar, M Mon 455<br />
Golocorbin-Kon, S W34.4<br />
Gomes, FV Wed 411<br />
Gomes, N Wed 337<br />
Gomes, P Tue 032<br />
Gomez, E Thu 242<br />
Gomez, JE Wed 359<br />
Gomeza, J<br />
FC02.3.6<br />
Gomez-Foix, AM Wed 440<br />
Gomez-Luque, A Mon 471, Mon 149, Wed 005<br />
Gómez-Pliego, R Mon 168<br />
Gómez-Zamudio, J Mon 168<br />
Gonçalves, D Mon 298, Mon 299, Wed 318,<br />
Wed 319<br />
Gonçalves, J Tue 257, Thu 054, Thu 193<br />
Gonçalves, LRC Wed 333, Wed 334<br />
Gonçalves, P Mon 007, Mon 042, Mon 057<br />
Gong, I Tue 301<br />
Gong, J Mon 251<br />
Gong, J-P Thu 176<br />
Gong, L-L Wed 346<br />
Gong, N Tue 082<br />
Gong, Q-H FC14.4.6, Tue 178, Tue 382,<br />
Thu 182, Thu 184,<br />
Thu 185, Thu 186<br />
Gong, Z-H Tue 083<br />
Gongadze, N Wed 272<br />
González Correa, JA Wed 215, Mon 206<br />
González, AVM Tue 302<br />
Gonzalez, C Thu 217<br />
González, D Mon 407<br />
Gonzalez, E Mon 280<br />
Gonzalez, FJ<br />
FC13.2.1<br />
Gonzalez, JC<br />
FC16.2.5<br />
González, MC Thu 054<br />
Gonzalez-Correa, JA Mon 278, Tue 116, Tue 144,<br />
Wed 007, Thu 246, Wed 250<br />
Gonzalez-Dalhaus, E Tue 150<br />
González-Flores, L Mon 011<br />
Gonzalez-Gomez, D Wed 352<br />
González-Hernández, A Thu 022, Thu 203<br />
González-Navarro, H W09.4<br />
Gonzalez-Rocafort, A Thu 240<br />
González-Serryn, C Wed 251<br />
Gonzalo, A Mon 080<br />
Goodacre, R<br />
FC13.4.2<br />
Goodyear, LJ<br />
FC05.2.6<br />
Goon Goh, F Tue 252<br />
Göransson, H Wed 014, Wed 015<br />
Gordillo-Moscoso, A Thu 240<br />
Gordon, J Tue 233<br />
Gorelik, J Thu 238<br />
Gorny, D Mon 233<br />
Gorovic, N Tue 482<br />
Gossard, D Wed 123<br />
Gossart, S Tue 012<br />
Gotfryd, K Mon 058, Mon 073<br />
Goto, M Tue 244<br />
Gottesman, MM FC02.1.3<br />
Gottwald, M W10.3<br />
Gotzsche, O Mon 200<br />
Gou, H-Y<br />
FC14.5.4<br />
Goudet, C FC11.3.6, Thu 083<br />
Goulas, A Mon 300<br />
Goulden, N Mon 351<br />
Goulding, NJ W17.2<br />
Goupille, P Tue 198<br />
Gouraud, A<br />
FC04.2.5, FC09.2.7<br />
Gourley, I Tue 012<br />
Gous, A Tue 110<br />
Gous, H Thu 016<br />
Gouveia, S Wed 130<br />
Govantes, GF Mon 288<br />
Govoni, S Mon 152<br />
Goyal, A Mon 169, Wed 358<br />
Goyal, S Mon 190<br />
Gozalbo, D Tue 478, Tue 422<br />
Gozukizil, A Tue 411<br />
Grabnar, I<br />
FC07.3.5<br />
Grace, AA<br />
FC17.1.1<br />
Graepel, R Mon 287<br />
Graff, C Tue 303<br />
Grafström, RC Mon 410<br />
Graham, B Thu 280<br />
Gramsbergen, JB Wed 380<br />
Granic, P Tue 304<br />
Grant, D Tue 389<br />
Gratzke, C<br />
FC08.2.4<br />
Graudal, N<br />
FC09.2.4<br />
Gray, A<br />
FC01.1.4<br />
Grbovic, L Tue 151,<br />
Greedy, B<br />
YI.01<br />
Gréen, H Tue 395<br />
Green, I Mon 157<br />
Green-Thompson, L Mon 478<br />
Greenwood, JR Wed 084<br />
Gregori, D<br />
FC04.3.6<br />
Gresshoff, I W03.7<br />
Gribble, Fiona M FC05.3.2<br />
Grieve, DJ Thu 439<br />
Griffith, R Wed 032, Mon 394<br />
Grigoriev, VV Mon 422<br />
Grimaldi, M<br />
FC18.3.5<br />
Grimm, D Thu 267, Wed 252<br />
Groen, G Thu 112<br />
Gronemeyer, H FC18.3.5<br />
Groning, JE Mon 207<br />
Grossberg, A Mon 280<br />
Grove, KL Wed 257<br />
Grube, M Tue 039<br />
Gruber, C<br />
FC11.4.5<br />
Grubiè, Z Tue 048<br />
Grubišin, J Wed 398<br />
Gruetzner, C<br />
FC17.2.2<br />
Grunnet, M<br />
Wed 099, FC06.3.5,<br />
FC06.1.4<br />
Grzywa-Celiñska, A Tue 022<br />
Index 333
Name Paper ref. Name Paper ref.<br />
Gschwind, L Tue 305<br />
Guan, X Tue 130<br />
Guan, Y-F Thu 210<br />
Guan, Y-Y Wed 104<br />
Guantai, A W27.3<br />
Guarner, C Tue 123<br />
Gudasheva, T Mon 225, Wed 188<br />
Guddattu, V<br />
FC04.3.7<br />
Gudi, G W03.2<br />
Guedes, PMM W31.3<br />
Guegan-Massardier, E Mon 191<br />
Güler, S Wed 253<br />
Gülhan, R Mon 418<br />
Gültekin, H Tue 030<br />
Güney, HZ W05.1, Tue 029<br />
Guénolé, E Mon 203<br />
Guentert, T W10.2<br />
Guerard, M Mon 244<br />
Guérard, M Tue 203<br />
Guerra-López, P Tue 348<br />
Guerrero, A Wed 250, Mon 278<br />
Guevara, M Tue 016<br />
Guevara-García, MM W04.1.3, Mon 023, Wed 344<br />
Guglielmotti, A Mon 296<br />
Guh, JH Mon 249<br />
Guh, J-H Tue 402<br />
Guillaume, J-L Mon 161, Wed 072, Thu 028<br />
Guillén, JE Mon 388<br />
Guilloteau, V Mon 244, Tue 203<br />
Guimaraes, FS FC17.5.5, Wed 411<br />
Guimaraes, M Mon 398<br />
Gujar, S Thu 333<br />
Gulati, A FC05.2.5, Wed 184<br />
Gulati, K<br />
FC16.4.2<br />
Gulati, V Wed 360<br />
Gulbinovic, J Mon 139<br />
Guldenpfennig, M Thu 428<br />
Gullapalli, S W03.2<br />
Gulmez, SE FC04.2.6, Mon 140, Mon 141<br />
Gultekin, H Tue 031<br />
Gumusel, B Tue 027<br />
Gumustas, K Tue 461<br />
Gumustekin, M Tue 411, Mon 170<br />
Gunduz, O Wed 050<br />
Guneli, E Mon 170<br />
Guneli, M Mon 474<br />
Gunnar, N Tue 387<br />
Gunnarsson, L Wed 092<br />
Guo, D<br />
FC11.4.6<br />
Guo, H Wed 322<br />
Guo, J Tue 441, Tue 076<br />
Guo, L Tue 295<br />
Guo, LC Thu 093<br />
Guo, N Mon 194<br />
Guo, Y-K Mon 031<br />
Gupta, A Tue 495<br />
Gupta, BM Mon 131<br />
Gupta, DD Mon 024<br />
Gupta, J Mon 171<br />
Gupta, M Mon 024<br />
Gupta, N Mon 169<br />
Gupta, S W13.2, Mon 099, Tue 436,<br />
Wed 220<br />
Gupta, SK Thu 354<br />
Gupta, YK Mon 169 Mon 452,<br />
Gurdal, H Tue 450<br />
Gurel, A Tue 461<br />
Gurianova, V<br />
FC06.1.6<br />
Gurney, A Thu 279, Wed 269, Wed 238<br />
Gustafsson, L Tue 005, Wed 136<br />
Gutierrez, V Mon 276<br />
Guven, H Mon 474<br />
Guyon, A<br />
FC17.2.5<br />
Gyarmati, S Wed 185, Thu 192<br />
Gyires, K W19.1, Thu 062, Thu 094<br />
Gylling, H Mon 215<br />
Gyotoku, J Thu 430<br />
Gysling, K Thu 187, Wed 169<br />
H. Nazmy, W Wed 441<br />
Haas, B Tue 129<br />
Haas, H W33.3<br />
Haase, G Tue 115<br />
Haase, T Wed 280<br />
Haazen, W Tue 280<br />
Habtewold, A<br />
FC01.4.7<br />
Hacker, J<br />
FC03.3.1<br />
Haddad, E<br />
FC05.3.6<br />
Haegeman, E Mon 365, Tue 306<br />
Haenisch, S Mon 059, W03.6<br />
Hafizoglu, E Mon 098<br />
Hagenbuch, B Wed 158<br />
Hager, GL<br />
FC18.4.2<br />
Haggholamali, M Tue 165<br />
Haghparast, A Wed 396<br />
Hagiwara, E Tue 154<br />
Hajagos-Tóth, J Mon 208, Wed 050<br />
Hajdu, D Tue 475<br />
Hajikhani, R Wed 012<br />
Hajizadeh Moghaddam, A Thu 412<br />
Hajj, A<br />
Wed 191, FC01.4.4<br />
Hajmohammadi, A Tue 015<br />
Hakala, Ae Wed 361<br />
Hakkola, J Wed 448, Wed 445<br />
Hakkou, F Mon 290, Mon 378, Mon 377<br />
Halayko, AJ Tue 242, Wed 095<br />
Halimi, S Tue 268<br />
Hall, D Wed 055<br />
Hall, Ian P<br />
FC13.5.2<br />
Halling, J Wed 151<br />
Halliwell, B<br />
PL09, W04.1.1<br />
Hallow, M Tue 196<br />
Halls, M W14.2<br />
Halonen, P Mon 410<br />
Hamaguchi, A Tue 177<br />
Hämäläinen, M Mon 302, Thu 223<br />
Hamase, K Wed 305<br />
Hamaue, N Mon 309<br />
Hambrock, A Thu 098<br />
Hambruch, E<br />
FC18.2.6<br />
Hamishehkar, H Tue 223<br />
Hammond, J Tue 047<br />
Hamoud, F Mon 140, Mon 141<br />
Hamza, I Mon 020, Mon 021<br />
Hamzeiy, H Mon 044, Tue 164<br />
Han, C Mon 331<br />
Han, X Wed 254<br />
Han, X Mon 209<br />
Han, Yantao Tue 412<br />
334 Index
Name Paper ref. Name Paper ref.<br />
Han, Z Mon 414, Tue 412, Tue 173,<br />
Tue 325, Wed 327<br />
Han, Zhiwu Mon 408<br />
Han, ZQ Wed 039<br />
Han, Z-W Mon 008<br />
Hanamitsu, M Wed 200<br />
Hanazaki, M Mon 303, Tue 259<br />
Hanig, JP Wed 150<br />
Hanly, L Wed 013<br />
Hänninen, P Wed 444<br />
Hannonen, P<br />
FC09.2.5<br />
Hanse, D Thu 315<br />
Hansen, BS Mon 227<br />
Hansen, BK<br />
FC11.5.1<br />
Hansen, H<br />
FC05.3.5<br />
Hansen, JL Wed 070, Thu 058, Wed 036<br />
Hansen, JT Thu 058<br />
Hansen, KB Wed 084<br />
Hansen, MB Mon 071<br />
Hansen, MP<br />
FC13.1.5<br />
Hansen, R<br />
Wed 125, FC06.3.5<br />
Hansen, RS<br />
FC06.1.4<br />
Hansen, S Thu 101<br />
Hanson, J Wed 056<br />
Hao, Q Tue 425, Tue 371<br />
Hao, X Tue 296<br />
Hao, Y Tue 181<br />
Haouari, M Mon 338<br />
Happi, CT<br />
YI.09<br />
Hara, H Thu 220<br />
Hara, T Mon 304<br />
Harakawa, T Wed 371<br />
Haramburu, F Tue 092<br />
Harbig, P Mon 142<br />
Harding, I Wed 360<br />
Hardman, M W10.3<br />
Hardman, M W10.1<br />
Hargreaves, R W10.3, Wed 292<br />
Harimoto, Y Wed 117<br />
Härlin, U Mon 245<br />
Härmä, H Wed 444<br />
Harmar, A Tue 479<br />
Harmatha, J Wed 386<br />
Harmer, C<br />
FC17.4.3<br />
Harmse, L Tue 003, Tue 404<br />
Haron, DEM Tue 444<br />
Haron, MH<br />
YI.04<br />
Haroun, F<br />
FC01.3.4<br />
Harrabi, I Mon 006<br />
Harrington, LS Thu 200, Thu 238<br />
Harris, CW<br />
FC14.2.5<br />
Harrison, C Mon 305<br />
Harrison, N L<br />
FC03.4.3<br />
Hart, J Wed 255<br />
Hartzema. AG. FC04.2.2<br />
Härter, M Thu 091<br />
Harthy, KAI Tue 152<br />
Hartmann, A W10.2, Thu 112<br />
Harvey, B FC16.3.7, Thu 428<br />
Harvey, BH Wed 399, Mon 412<br />
Hasford, J W35.2<br />
Hashemi, J Mon 055<br />
Hashiguchi, T Thu 331<br />
Hashii, M Tue 413<br />
Hashikawa, N Mon 174, Mon 306<br />
Hashimoto, H Mon 110, Mon 318<br />
Hashimoto, T Tue 201, Wed 256, Thu 117<br />
Hashimoto, Y Tue 147<br />
Hashtroodi, AA Mon 002<br />
Haslemo, T Wed 412<br />
Hasnan, J Thu 312<br />
Hassan, AI Tue 120<br />
Hassan, AM Mon 252<br />
Hassan, AN-E Mon 252<br />
Hassan, M W07.3<br />
Hassan, R Tue 434<br />
Hassan, SK Mon 389<br />
Hassanein, S<br />
FC06.2.6<br />
Hassanzadeh, K Tue 164<br />
Hasumi, K Thu 213, Thu 117<br />
Hasunuma, T Mon 307<br />
Hatazawa, R Mon 255<br />
Hatoum, H<br />
FC01.3.4<br />
Hatta, N Tue 001<br />
Hattori, Y<br />
FC09.1.6<br />
Hatzitolios, A Mon 143<br />
Hatzokos, H Tue 246<br />
Haubold, M<br />
FC11.4.2<br />
Hauptmann, S Tue 169<br />
Hausman, M Thu 255<br />
Hauta-aho, M Mon 144<br />
Havlik, I Mon 308, Tue 002<br />
Havt, A Wed 297<br />
Hay, D Wed 057<br />
Hayakawa, T Tue 318, Tue 138<br />
Hayashi, H Wed 424<br />
Hayashi, M Tue 336<br />
Hayashi, S Thu 072<br />
Hayashizaki, Y Tue 492<br />
Haynes, J Tue 202<br />
Hay-Schmidt, A Thu 106<br />
Haythornthwaite, A FC03.2.6<br />
Hazelwood, L Thu 063<br />
He, G FC12.2.5, Tue 307, Thu 314<br />
He, G-W Mon 172, Wed 257, Thu 287,<br />
Thu 288<br />
He, M FC06.4.6, Mon 210, Tue 036,<br />
Tue 158, Thu 298,<br />
Tue 317, Wed 258, Wed 362<br />
He, X Tue 138, Wed 259, Thu 292,<br />
Thu 372<br />
Hector, E Tue 232<br />
Hedlund, P FC08.3.5, Tue 212, Tue 210<br />
Heedaard, A-M Mon 089<br />
Heerdink, ER Mon 129<br />
Hegedus, Z Tue 250<br />
Hegele, R<br />
FC02.1.6<br />
Heidarsson, PO Tue 053<br />
Heijnen, BFJ Thu 221<br />
Heikkilä, T Thu 170<br />
Heikkinen, AT Mon 060<br />
Heilig, M<br />
FC14.4.2<br />
Hein, L<br />
FC11.4.2, W01.2.1, W01.2.4,<br />
Wed 022, Thu 062<br />
Hein, W Mon 315<br />
Heinemann, A<br />
FC11.1.6<br />
Heiniger, AI Tue 394<br />
Heinonen, I Thu 243<br />
Index 335
Name Paper ref. Name Paper ref.<br />
Heinrich, A W19.2<br />
Heishman, S<br />
FC14.3.4<br />
Heitman, L Wed 058<br />
Heliopoulos, I Mon 187<br />
Helldén, A W35.4, Tue 308, Wed 147<br />
Hellmann, M Wed 208<br />
Hellstrom-Westas, L FC10.4.4, Wed 006, Thu 008<br />
Helms, P Wed 137<br />
Helms, PJ Tue 109<br />
Heltovics, G Tue 130<br />
Helyes, Z W19.3, FC16.2.6, Mon 318,<br />
Tue 250, Tue 271<br />
Hempel, G<br />
FC10.4.5<br />
Hendrich, J<br />
FC03.2.4<br />
Heneka, M T<br />
FC18.3.3<br />
Hennessy, M Thu 442<br />
Henningsen, K Wed 433, Wed 397<br />
Henningsson, A FC07.4.4<br />
Henriksen, F Mon 061<br />
Henriksen, K W26.4, W26.2<br />
Henriksen, T Mon 406<br />
Henríquez-Hernández, L Tue 387<br />
Henthorn, T Mon 053<br />
Heo, DK Mon 062<br />
Hepburn, C Mon 211<br />
Heras, M<br />
YI.03<br />
Herber, O Tue 108<br />
Hercberg, S Mon 145, Mon 132<br />
Herdeiro, MT Thu 119, Tue 086, Mon 146<br />
Herings, R<br />
FC04.1.6<br />
Herman, Arnold G FC16.4.3<br />
Hermann, M Tue 490<br />
Hermans, JJR Mon 212<br />
Hermenegildo, C Thu 225<br />
Hernandes, MZ Thu 374<br />
Hernandez Casaña, P Wed 344<br />
Hernández, M Thu 249, Tue 213, Mon 411<br />
Hernández, MC Tue 394<br />
Hernandez, MT Wed 352<br />
Hernandez-Balmaseda, I Wed 344<br />
Hernandez-Cañero, A Mon 207<br />
Hernández-Guijo, J FC16.2.5<br />
Herrera Henriquez, MA Thu 330<br />
Herrera, MD Tue 118<br />
Herrera, E Tue 387<br />
Hervera, A Thu 042, Wed 059<br />
Hesse, B Wed 395<br />
Heurteaux, C FC17.2.5, Thu 237<br />
Heusler, P Mon 084<br />
Hewett, P Mon 102<br />
Heydari, A Tue 231,<br />
Heymes, C Wed 196<br />
Hibbins, A Tue 456<br />
Hibino, H Tue 147<br />
Hibino, Y Wed 266, Thu 227<br />
Hidaka, A Tue 266<br />
Hieke, B Wed 234<br />
Higa, T Mon 399<br />
Higgins, P<br />
FC15.1.6<br />
Higuchi, H Tue 140<br />
Higuchi, H Wed 060<br />
Higuchi, M Mon 213<br />
Higuchi, Y Tue 413<br />
Hikumwah, G Thu 315<br />
Hilber, K Mon 218, Mon 217<br />
Hildebrand, M<br />
FC03.2.1<br />
Hildebrandt, W Tue 462<br />
Hill, SR FC10.2.2, W36.1, W36.2<br />
Hiller, S Thu 098<br />
Hilmer, S<br />
FC13.2.6, FC13.1.6, Mon<br />
392, Tue 309,<br />
Wed 125, Wed 126<br />
Hintze, TH<br />
FC15.1.3<br />
Hinz, B Tue 310, Thu 337<br />
Hippisley-Cox, J FC04.1.6<br />
Hippius, M Wed 119, Tue 131<br />
Hirabara, Y Wed 223<br />
Hirabayashi, N Tue 459<br />
Hirafuji, M Mon 309, Thu 201<br />
Hirai, K Thu 261<br />
Hiramoto, T Tue 377<br />
Hirano, M Mon 309<br />
Hirao, A Mon 173, Tue 122<br />
Hirasawa, A Tue 311, Wed 064<br />
Hirata, M Thu 038<br />
Hirayama, Y Mon 313<br />
Hirayasu, Y Wed 422, Wed 415<br />
Hirokane, G Wed 414<br />
Hirose, S Thu 108<br />
Hiroshi, K Thu 375<br />
Hirota, Y Tue 168<br />
Hirshman, MF<br />
FC05.2.6<br />
Hirvonen, J Thu 170, Tue 032<br />
Hisa, H Thu 263<br />
Hisayuki, O Thu 213<br />
Hishinuma, S Mon 178, Wed 061<br />
Hjelvang, B FC13.3.6, Mon 118, Mon 406<br />
Hjelvang, BR Mon 119<br />
Hnasko, T<br />
FC02.2.4<br />
Ho, EYW Thu 255<br />
Ho, HP Thu 381<br />
Ho, HR Mon 327<br />
Ho, WSV Wed 260, Tue 471<br />
Ho, W-Y Tue 146<br />
Ho, Y-C Wed 035<br />
Hoang, T Tue 396<br />
Hobara, N Mon 174, Mon 306, Tue 154,<br />
Tue 415<br />
Hocaoglu, N Mon 474, Tue 366, Tue 449,<br />
Tue 450,<br />
Hoch, M Tue 312<br />
Hochi, H Wed 278<br />
Hochstrasser, D Tue 166<br />
Hodková, A Mon 409<br />
Hodler, C Wed 443<br />
Hoecherl, K Wed 234<br />
Hoeck, Hans C W26.5<br />
Hoedemaker, F Thu 315<br />
Hoehn, T Thu 272<br />
Hoever, P Tue 312<br />
Hoffmann, C<br />
W01.1.4<br />
Hofmann, F Wed 234<br />
Hofmann, KP<br />
FC11.1.3<br />
Hofstetter, A Mon 245<br />
Høg, S<br />
FC11.5.6<br />
Hogaboam, CM Mon 314<br />
Hogan, P<br />
FC12.5.4<br />
Högberg, C Wed 052<br />
336 Index
Name Paper ref. Name Paper ref.<br />
Högberg, Carl Wed 062<br />
Högestätt, E<br />
FC09.4.5<br />
Højgaard, L W24.4<br />
Hokkanen, J Thu 348<br />
Holanda, IR Tue 282<br />
Holcberg, G Mon 054<br />
Holgate, J<br />
FC14.3.5, FC14.2.3<br />
Holicka, M Tue 240<br />
Holler, M Mon 479, Tue 099<br />
Holloway, K<br />
FC01.1.4<br />
Holm, K Mon 328<br />
Holm, L W35.4<br />
Holst, B FC11.5.4, Thu 036<br />
Holt, S Tue 314, Tue 313, Tue 131<br />
Höltke, C Wed 037<br />
Høltzermann, M Thu 405, Thu 404<br />
Holý, A Tue 300<br />
Home, P<br />
FC05.4.2<br />
Homma, M Tue 315<br />
Homma, N Wed 105<br />
Hommers, L Wed 026<br />
Hompesch, M Mon 175<br />
Honda, K Tue 201, Wed 223, Wed 256,<br />
Thu 108, Thu 117, Thu 213,<br />
Thu 224<br />
Hong, E Mon 176<br />
Hong, T Wed 267<br />
Hong, Zhou Wed 363<br />
Hongprasong, N Thu 357<br />
Honkalammi, J Tue 316<br />
Honore, B Wed 240<br />
Hooiveld, G Thu 438<br />
Hopfgartner, G Tue 166<br />
Hoppu, K<br />
FC10.3.1<br />
Hoppu, Kalle<br />
FC10.2.1<br />
Horikawa, K Thu 416<br />
Horinouchi, T Mon 399<br />
Horinouchi, Y Wed 247<br />
Horiuchi, M Mon 439<br />
Horiuchi, S Tue 459<br />
Hornbak, M Thu 053<br />
Horne, J Wed 261<br />
Horner, B Thu 394<br />
Horrillo, I Thu 031<br />
Horsdal, HT<br />
FC04.2.7<br />
Horsmans, Y FC04.2.6, Mon 141<br />
Horvath, A Wed 185<br />
Horváth, C Tue 078<br />
Hosoda, M Tue 154<br />
Hosoda, T Mon 178<br />
Hosohata, K Tue 156<br />
Hossain, MA Wed 080<br />
Hosseini, R Tue 015<br />
Hosseinzadeh, H Wed 364<br />
Høst, C Mon 320<br />
Hosten, N Tue 041<br />
Hostettmann, K Wed 375<br />
Hotchkiss, C Wed 150<br />
Hotershall, J<br />
FC03.1.5<br />
Hothersall, J Mon 275<br />
Hou, H Mon 458<br />
Hou, L Tue 033<br />
Hou, N Mon 186<br />
Hou, Qi Mon 310<br />
Houze, P Wed 191<br />
Hovatta, O W21.3<br />
Howell, R Mon 265<br />
Howlett, A Tue 145, Wed 029<br />
Howng, S-L Mon 319<br />
Hrabinova, M Tue 448<br />
Hracsko, Z Mon 460<br />
Hracskó, Z W19.2<br />
Hristov, M Thu 240<br />
Hristovski, D Thu 293<br />
Hsiao, M-C Wed 430<br />
Hsiao, WLW Thu 296<br />
Hsieh, H-L Mon 311, Tue 293<br />
Hsieh, W-K Wed 192<br />
Hsu, C Wed 439<br />
Hsu, H-Y Wed 106<br />
Hsu, M-J Mon 423<br />
Hsu, S-P Wed 449<br />
Hsu, T Mon 158<br />
Hsu, Y-H Thu 362<br />
Hu, C-B Mon 158<br />
Hu, J Thu 372, Mon 323<br />
Hu, J-J Mon 421, Wed 346<br />
Hu, L Wed 242<br />
Hu, M FC02.4.6, Tue 139, Tue 140<br />
Hu, X Mon 349, Mon 032<br />
Hu, Y Mon 466, Mon 445, Thu 300<br />
Hu, Z Tue 076<br />
Hua, Y Tue 158<br />
Huabprasert, S Thu 361<br />
Huala, I Tue 326<br />
Huang, C Wed 365, Wed 366<br />
Huang, C-Y Mon 158<br />
Huang, F Tue 365<br />
Huang, HC Mon 356<br />
Huang, J-H Thu 287, Thu 288<br />
Huang, J-L Tue 082<br />
Huang, O Tue 317<br />
Huang, OP Tue 036<br />
Huang, P<br />
FC18.4.1<br />
Huang, P-T Tue 083<br />
Huang, Q Tue 158, Wed 258<br />
Huang, Q-R Wed 291<br />
Huang, S-C Wed 262<br />
Huang, T Wed 076<br />
Huang, W-T Mon 270<br />
Huang, X Thu 044<br />
Huang, X-N Tue 184, Tue 178<br />
Huang, Y<br />
FC07.2.5, FC15.3.2,<br />
FC15.4.7<br />
Huang, Y-W Mon 158<br />
Huang, Z-M Wed 367<br />
Huang, Z-N Tue 382<br />
Hüpkes, M Mon 463<br />
Hüting, D Mon 245<br />
Hütter, J Thu 091<br />
Hugar, S Thu 333<br />
Hughes, AD Thu 069, Thu 259<br />
Hughes, IE<br />
PL18<br />
Hughes, KH Thu 207<br />
Huh, W Tue 335<br />
Huhtinen, A Thu 084<br />
Huizer-Pajkos, A FC13.2.6<br />
Hum, M Tue 414<br />
Index 337
Name Paper ref. Name Paper ref.<br />
Hume, JR<br />
FC12.4.5<br />
Humphrey, SJ Wed 048<br />
Hung, C-F Tue 374<br />
Hung, J-J Wed 368<br />
Hunt, L Wed 190<br />
Hunter, A Wed 096<br />
Hurbin, F Mon 203<br />
Hurd, YL<br />
FC14.1.2<br />
Hurlé, MA Wed 087<br />
Hurst, RS<br />
FC14.2.3<br />
Hurt, C Wed 028<br />
Hurttila, H Wed 448<br />
Husbands, S<br />
YI.01<br />
Husmann, K Thu 197<br />
Hussain, M<br />
FC08.3.2<br />
Husson, J-M W10.3<br />
Hutchinson, D Thu 059, Wed 063, Mon 395<br />
Huttunen, R Wed 444<br />
Huynh, MB Mon 469<br />
Hwa, L<br />
FC14.4.3<br />
Hwang, L-L Wed 262<br />
Hwang, M-S Tue 351<br />
Iacob, M Wed 207<br />
Iacono, A<br />
FC18.1.6<br />
Iannazzo, S Wed 154, Mon 223<br />
Iaquinto, G<br />
W02.3.3<br />
Ibáñez, L Tue 087<br />
Ibañez, MR Wed 169<br />
Ibara, M A<br />
FC13.1.2<br />
Ibarra, M Wed 049<br />
Ibarra-Barajas, M Mon 168<br />
Ibrahim, M<br />
Mon 372, FC01.2.5<br />
Ichimura, A Wed 064<br />
Ichishima, K Tue 162<br />
Idriss Khodja, N Wed 273<br />
Igarashi, T Tue 380, Wed 263<br />
Igarashi, Y Mon 178<br />
Igbe, I Wed 369<br />
Ignatiev, I Tue 057<br />
Iguegbe, A Wed 370<br />
Iijima, H Tue 345, Mon 307<br />
Iino, M<br />
PL11<br />
Iizuka, K Thu 201, Mon 309<br />
Ijzerman, AP<br />
FC11.2.3, FC11.2.5,<br />
FC11.4.6, W25.1<br />
Ikarashi, N Mon 177, Mon 182<br />
Ikeda, A Tue 156<br />
Ikeda, R Tue 167<br />
Ikeda, Y Mon 180<br />
Ikeda-Matsuo, Y Mon 313<br />
Ikegami, Y Mon 093<br />
Ikehara, A Tue 060<br />
Ikesue, H Mon 093<br />
Ikuma, M Tue 473<br />
Ikuta, Y Wed 413<br />
Ilett, K<br />
FC10.5.3<br />
Ilic, K FC10.2.6, Tue 367<br />
Iljin, K Mon 410, Tue 436<br />
Iljuhhina, J<br />
FC04.3.4<br />
Imai, S Wed 065, Thu 188<br />
Imaizumi, Y Wed 107, Thu 102, Thu 107<br />
Imamoglu, S Mon 156<br />
Imamura, Y Wed 247<br />
Imanishi, M Wed 247<br />
Imashova, S Tue 079<br />
Immonen, E Mon 063<br />
Imprialos, K Mon 367<br />
Improta, G Tue 249<br />
Imreh, A Mon 110, Mon 106<br />
Inakuma, T<br />
FC16.4.6<br />
Inal, A Tue 018<br />
Inan, S Wed 038<br />
Incerti, M Mon 381<br />
Indarte, M Tue 059<br />
Infanger, M Wed 252<br />
Infante, F Tue 488, Mon 449<br />
Ingelman-Sundberg, M FC13.5.1, W23.5, Tue 489<br />
Ingham, TR Tue 136<br />
Inotsume, N Tue 138, Tue 318<br />
Inoue, H FC09.1.4, Mon 402<br />
Inoue, Y Tue 060, Wed 414<br />
Insel, P Thu 067<br />
Institoris, A<br />
FC05.1.6<br />
Inui, K Tue 225, Tue 156<br />
Inui, N Thu 262, W23.1<br />
Iordanidou, M Tue 224<br />
Iosifidou, E Tue 246<br />
Iqbal, MZ Thu 181<br />
Iqbal, Z Tue 319<br />
Irer, B Tue 200<br />
Irie, M<br />
FC16.4.6<br />
Irie, Y Wed 186, Tue 477<br />
Irs, Alar<br />
FC01.2.1, FC04.3.4<br />
Irving, H Thu 032<br />
Isabel, O Mon 376<br />
Isah, AO FC01.4.1, Tue 010<br />
Isajevs, S Mon 429, Tue 253<br />
Isaksson, A Wed 014, Wed 015<br />
Isberg, V Wed 066<br />
Ishibashi, N Tue 390<br />
Ishida, S Wed 413<br />
Ishiguro, H Thu 176<br />
Ishiguro, S Wed 414<br />
Ishihara, Y Tue 177, Tue 379<br />
Ishihata, A Mon 178<br />
Ishii, C Wed 422, Wed 415<br />
Ishii, K Wed 264<br />
Ishii, N Wed 422, Wed 415<br />
Ishii-Nozawa, R Mon 179<br />
Ishikawa, E Thu 268<br />
Ishikawa, M Mon 025<br />
Ishikawa, S<br />
FC16.4.6<br />
Ishikawa, T Thu 226, Tue 136<br />
Ishikawa, Y Tue 068, Thu 103<br />
Ishimaru, Y Wed 067, Wed 075<br />
Ishimura, M Tue 373<br />
Ishizawa, K Mon 180<br />
Ishizuka, T Tue 377<br />
Ishola, I Wed 144<br />
Isla, KKY Thu 355<br />
Islam, T Tue 097<br />
Ismail, M Tue 452<br />
Ismail, R Mon 107<br />
Ismail, Z Thu 328<br />
Ismailoglu, S Wed 421<br />
Ismailoglu, U Mon 314<br />
Isnard, S Wed 208<br />
Isotalo, T Thu 223<br />
338 Index
Name Paper ref. Name Paper ref.<br />
Israel, A Mon 295, Tue 127, Wed 212,<br />
Wed 265, Thu 205, Thu 254<br />
Isrona, L Mon 475<br />
Isuta, H Thu 220<br />
Ito, F Tue 379<br />
Ito, K Mon 177<br />
Ito, S FC10.5.3, Mon 022, Mon 101<br />
Ito, T Thu 331<br />
Ito, Y Thu 038, Tue 216, Tue 217,<br />
Wed 371<br />
Itoh, H Tue 132<br />
Itoh, Y Thu 109<br />
Itokawa, M Mon 173<br />
Iuvone, T<br />
Tue 465, FC18.4.6<br />
Ivankova-Susankova, K Thu 028<br />
Ivanova, I Mon 479<br />
Ivanova, S Thu 211<br />
Ivashev, M Tue 176<br />
Ivashev, MN Tue 179<br />
Ivorra, MD Wed 068<br />
Iwai, S Wed 372<br />
Iwamoto, K Tue 266<br />
Iwamoto, T Tue 071, Thu 286<br />
Iwamoto, Y Wed 415, Wed 422<br />
Iwanami, J Mon 439<br />
Iwase, H Tue 167<br />
Iwase, M Tue 320, Thu 319, Thu 343<br />
Iwashita, M Wed 373<br />
Iwata, F Thu 103<br />
Iwata, N Wed 266, Thu 227<br />
Iwata, R<br />
FC17.5.6<br />
Izuhara, C Mon 405, Tue 467<br />
Izumi, Y Mon 424, Mon 432, Mon 464<br />
Izushi, Y Mon 329<br />
Izzo, AA Wed 307<br />
Jaako-Movits, K Thu 409<br />
Jaba, I Mon 108, Tue 134<br />
Jaberi, E Mon 454<br />
Jackson, G<br />
FC08.1.3<br />
Jacky, P Thu 037<br />
Jacobs, GE<br />
FC17.3.5<br />
Jacobs, M<br />
FC14.1.2<br />
Jacobsen, S Thu 405<br />
Jacobson, K Wed 108<br />
Jacqz-Aigrain, E FC10.1.5, FC10.5.1,<br />
FC10.5.5, Wed 011<br />
Jadhav, A Tue 124<br />
Jaehde, U Mon 384<br />
Jafari, M Tue 165<br />
Jagtap, PN Thu 363<br />
Jähnichen, S Thu 085<br />
Jahnsen, JA Mon 397, Wed 069<br />
Jahromy, MH<br />
FC17.2.6<br />
Jaisin, Y Thu 305, Tue 277<br />
Jakab, L Mon 283<br />
Jäkälä, P W21.1, Wed 361<br />
Jakobsen, S FC17.4.5, Tue 193, Thu 404<br />
Jakobsson, P-J FC09.4.4<br />
Jakovljevic, E<br />
FC10.2.6<br />
Jakovljevic, M<br />
FC07.3.5<br />
Jakovljevic, V Tue 148, Tue 454, Wed 321<br />
Jalaei, J Tue 015<br />
Jalali, A Tue 251<br />
Jalil, ATMA Mon 001<br />
Jalkanen, Aaro Mon 425<br />
James, AE Tue 139<br />
Jamnik, P Thu 329, Thu 318<br />
Jamshidzadeh, A Mon 085, Mon 088<br />
Jan, IU Tue 319<br />
Janani, S Mon 131<br />
Janchawee, B Wed 124<br />
Jandric, D Tue 091, Tue 321, Tue 151<br />
Janes, D Thu 359<br />
Jang, C-G Mon 358, Tue 350, Mon 359,<br />
Mon 049, Mon 069, Tue 161,<br />
Tue 160, Mon 065, Tue 324,<br />
Tue 162, Wed 142, Tue 044,<br />
Tue 331, Tue 332, Tue 323,<br />
Tue 043, Tue 073, Tue 333,<br />
Mon 066, Wed 143<br />
Jang, S Mon 033<br />
Jang, SB Mon 013, Mon 226, Tue 349,<br />
Thu 418<br />
Jang, YJ Tue 351<br />
Jani, Nitya Mon 214<br />
Janiszewski, M Wed 237<br />
Janizewski, M Wed 233<br />
Jankova, L W06.3<br />
Jankovic, S FC07.3.5 Mon 039<br />
Jankovic, SM Wed 435<br />
Jankowski, J<br />
FC15.3.3<br />
Jansakul, C Wed 374, Wed 375<br />
Jansen, E Tue 242<br />
Jansen-Olesen, I Wed 220, Thu 106 Mon 099<br />
Jansone, B Mon 429, Tue 253<br />
Janssen, BJA Thu 208, Wed 287, Thu 221<br />
Janssen, G Thu 251<br />
Janssens, K Wed 002<br />
Jantaka, J Tue 007<br />
Jantschak, F W13.4<br />
Janzek, M Thu 359<br />
Japundzic-Zigon, N Wed 435<br />
Jara, P Tue 326 Mon 136<br />
Jardine, D Mon 064<br />
Jarrott, B<br />
FC03.1.6<br />
Järvenpää, S-M Wed 445<br />
Järvensivu, P Wed 446<br />
Jasna, L Mon 347<br />
Jauslin, P<br />
FC07.2.2<br />
Javed, I Tue 319<br />
Javid, FA Mon 246<br />
Javidnia, K Wed 376<br />
Javier, MCJ Wed 377<br />
Javitch, JA<br />
FC02.1.2, FC02.3.5,<br />
Mon 058, Mon 073<br />
Jayaprakash, V Tue 194<br />
Jebabli, N FC07.3.6, Mon 020, Mon 021<br />
Jebali, MA Mon 006<br />
Jebrouni, N Tue 116, Thu 246<br />
Jedlickova, B Tue 137<br />
Jedlitschky, G<br />
FC02.4.2<br />
Jennissen, K Tue 129<br />
Jensen, B FC06.2.5, Wed 113<br />
Jensen, BP Tue 322, Mon 064<br />
Jensen, BP Mon 047<br />
Jensen, GM FC02.2.5, Mon 071<br />
Jensen, H<br />
FC06.2.5<br />
Jensen, HB Wed 070<br />
Index 339
Name Paper ref. Name Paper ref.<br />
Jensen, KG<br />
FC07.4.5<br />
Jensen, SA Tue 480<br />
Jeon, K-J Mon 065, Tue 324, Tue 323,<br />
Mon 066<br />
Jeong, HY Wed 416<br />
Jeppesen, P<br />
FC06.2.5<br />
Jeppesen, P Wed 070<br />
Jespersen, T<br />
FC06.3.5<br />
Jessen, N FC05.2.6, Mon 154<br />
Jesus-Sandoval, R Tue 025<br />
Jetter, A Mon 315, Mon 384<br />
Jevtic, M Tue 091<br />
Jezova, D Tue 113<br />
Jha, S<br />
W01.2.4<br />
Jhaveri, D<br />
W01.2.4<br />
Ji, C Wed 429<br />
Ji, Y Mon 470<br />
Jiaang, W-T Mon 158<br />
Jian, Y Mon 433<br />
Jiang, F Mon 194, Wed 219, Tue 285<br />
Jiang, H-K Tue 187, Tue 186, Thu 277<br />
Jiang, L Wed 267<br />
Jiang, M Wed 378<br />
Jiang, N FC16.3.1, Wed 379, Thu 432<br />
Jiang, P-S Thu 199<br />
Jiang, T<br />
FC18.4.5<br />
Jiang, X-P Mon 470<br />
Jiang, Y Tue 441<br />
Jiang, Y-Y Mon 265<br />
Jievaltas, M Tue 329<br />
Jimenez-Altayo, F Wed 268<br />
Jimenez-Flores, JR Tue 150<br />
Jiménez-Serranía, M-I Tue 088, Tue 089<br />
Jin, F Thu 186<br />
Jin, H Tue 286, Thu 186<br />
Jin, H-O Tue 427<br />
Jin, M-W<br />
FC12.3.5<br />
Jin, X Thu 261<br />
Jin, Y Wed 322<br />
Jindal, R<br />
FC09.5.5<br />
Jing, F Tue 173, Tue 325<br />
Jing, W-B Mon 172<br />
Jingami, H<br />
FC11.1.4<br />
Jinsheng, G Wed 363<br />
Jiron, M Mon 390<br />
Jirón, M Tue 326 Mon 136, Tue 164<br />
Joannides, R Wed 207, Mon 191<br />
Jockers, R FC11.3.4, Thu 028, Thu 055,<br />
Thu 078<br />
Jõgi, K<br />
FC10.3.6<br />
Johansen, LD<br />
FC11.5.1<br />
Johansson, L Thu 051<br />
Johansson, S Thu 239<br />
Johns, EJ<br />
FC05.1.5<br />
Johns, S Tue 327<br />
Johnsen, SP<br />
FC04.2.7<br />
Johnson, I Wed 238<br />
Johnson, Ian Wed 269<br />
Johnson, MS Wed 088<br />
Johnson, O Wed 149<br />
Johnson, RP Wed 239<br />
Johnson, TA<br />
FC18.4.2<br />
Johnson, T<br />
FC10.3.5<br />
Jokela, H Mon 215<br />
Jones, B Tue 136<br />
Jones, R Wed 270<br />
Jönsson, Siv<br />
FC07.4.4<br />
Jorge, ARC Thu 374, Wed 297<br />
Jørgensen, FS Wed 066<br />
Jørgensen, H Mon 346, Tue 358<br />
Jørgensen, M Wed 241, Wed 380<br />
Joseph, J Mon 443<br />
Joshi, C<br />
FC16.1.6<br />
Joshi, S YI.05, Wed 315<br />
Joskova, M Mon 293<br />
Jost, N Mon 100<br />
Jouanjus, É<br />
FC04.3.5<br />
Jovanoviæ, N Wed 398<br />
Jovanovic, D Tue 321<br />
Jovanovic, I<br />
FC10.1.6<br />
Jové, J Mon 141<br />
Jovic, N Wed 009<br />
Judas, F Tue 257<br />
Jürgenliemk, G FC16.1.5<br />
Jürgens, G<br />
FC09.2.4<br />
Jugovic, VM Wed 435<br />
Juhl, K Mon 046<br />
Jun, D Tue 343, Tue 448<br />
Jun, R Tue 158<br />
Jung, I-S Tue 352<br />
Jung, J Mon 068<br />
Jungke, P Wed 417<br />
Juricic, D FC01.3.7, Mon 135, Tue 328<br />
Jurkat-Rott, K<br />
FC12.2.3<br />
Juslin, S Tue 283<br />
Juvonen, T Tue 166<br />
Käär, R<br />
FC10.3.6<br />
Kaboutari, J Wed 301<br />
Kacevska, M W06.3<br />
Kadam, V Tue 131, Mon 166<br />
Kadoi, H Mon 416<br />
Kadurin, I<br />
FC03.2.4<br />
Kadyrova, D Tue 079<br />
Käenmäki, M Wed 071<br />
Kagawa, Y Tue 484<br />
Kagota, S Tue 143, Tue 067, Wed 271,<br />
Thu 320<br />
Kahlon, N Tue 387<br />
Kaila, M Mon 328<br />
Kaipiainen-Seppänen, O FC09.2.5<br />
Kajioka, S Thu 038<br />
Kakefuda, K Thu 406<br />
Kalekou, H Mon 297<br />
Kalenic, S Mon 373<br />
Kales, A Thu 214<br />
Kales, AJ Mon 316<br />
Kalikstad, B Wed 014, Wed 015<br />
Kalin, N Thu 410<br />
Kalinina, TS Wed 187, Mon 422<br />
Kaliszan, R Mon 197<br />
Kalkan, S Tue 449, Tue 450, Tue 366,<br />
Mon 474<br />
Kalliokoski, A Tue 363<br />
Kallioniemi, O Mon 410, Tue 436<br />
Kalokasidis, K Mon 300<br />
Kalvinsh, I Mon 429<br />
Kamal, M Thu 078, Wed 072<br />
Kamataki, A Thu 248<br />
340 Index
Name Paper ref. Name Paper ref.<br />
Kamatani, N W23.2<br />
Kamath, S<br />
FC04.3.7<br />
Kamei, J Tue 234<br />
Kamerman, P Tue 001<br />
Kaminska, E Thu 174<br />
Kaminski, P<br />
FC08.2.5<br />
Kamisaki, Y Wed 186<br />
Kamiuchi, S Wed 266, Thu 227<br />
Kamiya, A Mon 309, Thu 402<br />
Kanai, A<br />
FC08.3.2<br />
Kanai, T Thu 263<br />
Kanaoka, D<br />
FC03.2.5<br />
Kandrotaite, K Tue 329<br />
Kane, K Mon 211<br />
Kane, S Wed 292<br />
Kaneko, S Tue 055, Thu 108<br />
Kaneko, T<br />
Tue 126, FC13.2.5<br />
Kaneko, Y Tue 136<br />
Kang, CY Mon 270<br />
Kang, F Thu 116<br />
Kang, M<br />
FC12.1.5<br />
Kang, Y Thu 350<br />
Kang, YJ Thu 116<br />
Kanjuh, V Thu 324, Wed 103<br />
Kanno, S-I Mon 025<br />
Kanters, JK Tue 303<br />
Kapai, N Thu 417<br />
Kapanadze, KT Mon 216<br />
Kapic, E Wed 199<br />
Kapitsa, I Mon 462<br />
Kaplan, T<br />
W02.2.7<br />
Kaplinskiy, S<br />
FC06.1.6<br />
Kapoor, A<br />
FC18.3.6<br />
Kapucu, A Tue 461<br />
Kapur, S<br />
FC17.3.1<br />
Karajeva, N Tue 253<br />
Karaman, M Mon 170<br />
Karasiewicz, M Thu 174<br />
Karasova, JZ Tue 074<br />
Karatassas, A Mon 102<br />
Karbwang-Laothavorn, J FC01.3.2<br />
Kargi, A Tue 411<br />
Kargl, J FC11.1.6, Wed 073<br />
Karhi, T Mon 256<br />
Karimi, G Mon 230<br />
Karimollah, A Wed 418<br />
Kariyazono, H Tue 167<br />
Karkoulias, G Wed 074<br />
Karlsson, MO<br />
FC07.2.2<br />
Karonen, T Tue 330<br />
Karsdal, MA W26.2, W26.4<br />
Kartal, M Wed 312<br />
Kasabova, L Tue 128<br />
Kasai, A Mon 416, Mon 435, Mon 440,<br />
Wed 067, Wed 075<br />
Kasamatsu, R Mon 243<br />
Kashaf, SS Mon 231<br />
Kashanian, M<br />
FC01.3.5<br />
Kashimoto, T Tue 477<br />
Kasiotis, K Tue 457<br />
Kassa, J Tue 343<br />
Kast, R Thu 091<br />
Kastratovic, DA Wed 435<br />
Katafuchi, T Wed 141<br />
Katakam, P<br />
FC05.1.6<br />
Katano, Y Mon 178<br />
Katayama, Y Wed 263<br />
Katende-Kyenda, NL Mon 026<br />
Katisart, T Mon 086<br />
Katiskalahti, T Mon 144<br />
Kato, M Tue 166<br />
Kato, S FC18.4.3, Mon 335<br />
Katoh, Y Tue 144<br />
Katramadou, M Tue 457<br />
Katryniok, C Mon 317<br />
Katsiki, N Mon 143<br />
Katsoulieris, E Mon 157<br />
Katsouni, E Thu 431<br />
Kattamuri, V Mon 264<br />
Kattige, V W03.2<br />
Katugampola, S Mon 393, Tue 372, Wed 020<br />
Kauffman, M Mon 280<br />
Kaulambaeva, I Thu 336<br />
Kaunitz, JD<br />
W02.1.5<br />
Kauppi, M<br />
FC09.2.5<br />
Kaur, H<br />
FC09.5.5<br />
Kaur, St<br />
FC01.3.6<br />
Kaushal, S<br />
FC01.3.6<br />
Kautiainen, H<br />
FC09.2.5<br />
Kawabata, A FC03.2.5, Tue 263, Tue 077,<br />
Mon 243, Mon 250<br />
Kawada, K Tue 376<br />
Kawahara, K Thu 331<br />
Kawahara, R Mon 335<br />
Kawakami, J Tue 484, Tue 491<br />
Kawamoto, E Mon 292<br />
Kawamoto, K Mon 101<br />
Kawamura, E Thu 109<br />
Kawanishi, C Wed 422, Wed 415<br />
Kawanishi, T Tue 168<br />
Kawasaki, H Mon 174, Tue 154, Thu 261,<br />
Tue 415, Wed 413, Wed 424<br />
Kawasaki, T Mon 093, Tue 060<br />
Kawazoe, K Wed 278<br />
Kaya, A FC11.3.2, Thu 049<br />
Kaya, AI<br />
FC11.3.2<br />
Kaygisiz, B Wed 420<br />
Kayiwa, J<br />
FC01.4.5<br />
Kaytanlioglu, L Tue 142<br />
Kazakova, FF Thu 096<br />
Kazakova, RR Thu 096<br />
Kazemi, M Tue 165<br />
Kearns, GL<br />
FC10.2.4, FC13.3.5<br />
Kedia, G Tue 211<br />
Keeble, J Mon 287<br />
Kegeles, L<br />
FC17.1.3<br />
Keiko, T Tue 244<br />
Kelber, O Mon 317, Tue 462, Thu 317,<br />
Wed 382, Wed 417<br />
Keldsen, N Tue 395<br />
Kelicen, P Wed 438, Mon 155<br />
Keller, M Wed 006<br />
Kelley, S Wed 173<br />
Kellomäki, M Thu 223<br />
Kelly, J Tue 364<br />
Kelstrup, CD Wed 036<br />
Kemeny, A<br />
Tue 271, Tue 250, FC16.2.6,<br />
Mon 318<br />
Index 341
Name Paper ref. Name Paper ref.<br />
Kemény, A W19.3<br />
Kemme, M Thu 215<br />
Kemter, K Thu 014<br />
Kendall, DA Mon 282<br />
Kennedy, P Wed 076<br />
Keown, O Mon 211<br />
Keres Kos, M<br />
FC07.3.5<br />
Kereskai, L Mon 283, W19.3<br />
Keri, G Tue 250<br />
Kerr, R Wed 316<br />
Kersten, S<br />
Thu 438, FC18.2.5<br />
Keshavarz, M Tue 058<br />
Ketelslegers, J Tue 182<br />
Ketola, K Mon 410, Tue 436<br />
Keum, S-K Mon 069, Tue 331, Tue 332,<br />
Tue 333<br />
Kezeli, T Wed 272<br />
Khadke, VV Wed 381<br />
Khairatkar Joshi, N W03.2<br />
Khakpour, SH<br />
FC17.2.6<br />
Khalaf, M Thu 247<br />
Khalifa, HM Mon 364<br />
Khalili-Mahani, N Mon 400<br />
Khalkhali, H Thu 391<br />
Khan, A Tue 119, Wed 356<br />
Khan, GM Tue 023<br />
Khan, MAH<br />
FC05.1.5<br />
Khan, S Wed 355<br />
Khan, UA Tue 319<br />
Khanam, R Wed 419<br />
Kharazmi, F Tue 058<br />
Khare, Ah Wed 381<br />
Kharel, Y Tue 410<br />
Khaylov, N Wed 248<br />
Khayyal, M T Wed 382<br />
Khazaee, P Tue 231,<br />
Khazali, S Mon 002<br />
Kheifets, IA Thu 015<br />
Khemawoot, P Tue 090<br />
Kheyfets, IA Mon 198<br />
Khodadadi, A Tue 251<br />
Khoddami, M Tue 052<br />
Kholova, D Tue 056, Tue 342<br />
Khorami, H Thu 004<br />
Khori, V Mon 196<br />
Khotimchenko, M Mon 426<br />
Khotimchenko, Y Mon 426<br />
Khoza, S Tue 004<br />
Kido, M Wed 141<br />
Kieffer, B L<br />
FC11.4.4<br />
Kihira, Y Mon 180<br />
Kilibarda, V Tue 321<br />
Kilic, FS Wed 420, Mon 103, Wed 421<br />
Kilinc, E Mon 043<br />
Kilpinen, S Tue 436<br />
Kilty, I Tue 269<br />
Kim, CM Tue 334<br />
Kim, E-J Wed 383<br />
Kim, H-G Tue 335<br />
Kim, H-S Tue 351<br />
Kim, IK Wed 274, Wed 384, Wed 275<br />
Kim, J-H Wed 306, Wed 385 Thu 385<br />
Kim, JY Wed 276<br />
Kim, J-W Tue 335<br />
Kim, JY Mon 062<br />
Kim, K-S Tue 334, Wed 383<br />
Kim, M-J Mon 049, Mon 065, Mon 066,<br />
Mon 069, Mon 358, Mon 359,<br />
Tue 043, Tue 044, Tue 073,<br />
Tue 162, Tue 323, Tue 324,<br />
Tue 333, Tue 350, Wed 142,<br />
Wed 143<br />
Kim, R FC02.1.6, 072, Tue 054,<br />
Tue 064, Mon Tue 301<br />
Kim, RB<br />
FC02.3.1<br />
Kim, SA Mon 428, Mon 427, Wed 277<br />
Kim, S-R Tue 335<br />
Kim, W-Y Tue 352<br />
Kimbacher, S Mon 218<br />
Kimland, E Wed 008<br />
Kimoto, Y Thu 320<br />
Kimura, J Tue 071<br />
Kimura, M Tue 390<br />
Kinjo, T Wed 075<br />
Kinoshita, Y Wed 117, Tue 273, Tue 336,<br />
Tue 337, Tue 483<br />
Kinscherf, R Mon 317, Tue 462<br />
Kinsey, S Tue 353<br />
Kinyua, CG Wed 298<br />
Kiraly, I Wed 284<br />
Kirchheiner, J Mon 384, Mon 315, Wed 148,<br />
Thu 112<br />
Kirchmayer, J Thu 014<br />
Kirkeby, B Wed 161<br />
Kirkpatrick, C Wed 125, Wed 126<br />
Kis, O Mon 070<br />
Kishida, I Wed 422<br />
Kishuku, M Wed 278<br />
Kisida, I Wed 415<br />
Kiss, B Wed 423<br />
Kis-Varga, Á Tue 078<br />
Kita, S Thu 286<br />
Kitagawa, T Wed 247<br />
Kitaichi, K Thu 406<br />
Kitamoto, T Mon 435<br />
Kitamura, T FC13.2.5, Tue 126<br />
Kitamura, Y Wed 413, Wed 424, Thu 261,<br />
Tue 415<br />
Kitano, H<br />
FC07.1.2<br />
Kitao, T Tue 060<br />
Kitazawa, T Tue 468<br />
Klaassen, T Mon 384, Mon 315<br />
Klaerke, D Thu 106<br />
Klapkova, E Tue 445<br />
Klayoncu, NI Tue 027<br />
Kleberg, K FC02.2.5, Mon 071<br />
Klein, AB<br />
FC11.2.6<br />
Klein, U Thu 069<br />
Kleinau, G Thu 087<br />
Kleinloog, HD<br />
FC17.3.5<br />
Kleinschnitz, C FC15.4.4<br />
Klemp, M Tue 143<br />
Kliewer, SA<br />
FC18.1.3<br />
Klimas, J FC05.4.5, Mon 219, Mon 221<br />
Klimas, Jan Thu 097<br />
Klindt Poulsen, B Thu 413<br />
Klitgaard, T Mon 227<br />
Kloppenburg, A Thu 101<br />
342 Index
Name Paper ref. Name Paper ref.<br />
Klouz, A W27.1, FC07.3.6, Mon 004,<br />
Mon 020, Mon 021, Mon 338,<br />
Wed 348, Thu 346<br />
Kluft, C Mon 316<br />
Klukovits, A Wed 050<br />
Klumpers, LE Mon 400<br />
Klungel, OH<br />
FC04.1.2<br />
Klusa, V Mon 429, Tue 253, Wed 045<br />
Kmecova, J Thu 097<br />
Kmonícková, E Tue 300, Wed 386<br />
Knani, J Mon 006<br />
Knapp, A Mon 229<br />
Knauer, M Mon 072<br />
Kneepkens, K Wed 001<br />
Kniazeff, J<br />
FC11.2.1, FC11.3.5, Mon<br />
058, Mon 073, Wed 077<br />
Knight, S Wed 425, Mon 430<br />
Knowles, RG<br />
FC09.3.4<br />
Knudsen, GM<br />
FC11.5.6, FC11.2.6<br />
Knudsen, LB<br />
FC05.3.4<br />
Knuhtsen, S Mon 071<br />
Knuistingh-Neven, A Tue 096<br />
Ko, J-W Tue 335<br />
Ko, SSW Tue 140<br />
Ko, YK Mon 104<br />
Kobayashi, D Wed 078<br />
Kobayashi, N Mon 307<br />
Kobayashi, S Tue 273, Tue 336, Tue 380,<br />
Tue 483, Tue 492<br />
Kobayashi, T Tue 315<br />
Kobayashi, Y Tue 177, Mon 178<br />
Kobayasi, S Tue 337<br />
Køber, L<br />
FC13.3.6, FC04.2.4<br />
Kobilka, B Wed 028<br />
Kobilka, BK<br />
PL10, W01.1.2<br />
Kobuchi, S Wed 200<br />
Kocan, M W14.2, Wed 079, Wed 080<br />
Kochar, S Tue 453<br />
Kocic, I Wed 279, Mon 181<br />
Koda, Ken Tue 360<br />
Kodaira, C W23.4, Tue 473<br />
Kodetova, D Tue 445<br />
Koenig, J<br />
FC02.2.6<br />
Koenig, S Tue 115<br />
Koenig, X Mon 217, Mon 218<br />
Koh, H-J<br />
FC05.2.6<br />
Kohda, K Thu 402<br />
Kohda, Y Tue 315<br />
Kohjitani, A Mon 303<br />
Kohler, R Thu 273<br />
Kohonen, P Mon 410, Tue 436<br />
Koike, Y Tue 084, Tue 338, Thu 285<br />
Koistinaho, J W21.3<br />
Koivula, K Wed 081<br />
Koiwa, G Tue 122<br />
Koizumi, N Tue 154<br />
Kojima, J Wed 263<br />
Kojima, S Tue 274<br />
Kojo, A Mon 255, Mon 405<br />
Kokkas, B Mon 300, Mon 297<br />
Kokki, H Tue 339<br />
Kokki, M Tue 339<br />
Kolb, C Wed 417<br />
Koley, M Mon 217<br />
Kolik, L Wed 188<br />
Kolkhof, P Thu 091<br />
Kollia, G Tue 495<br />
Kolliali, M Tue 102<br />
Kolyvanov, G Tue 150<br />
Komatsu, Y Tue 274<br />
Komazaki, H Wed 061<br />
Kombian, S Tue 340<br />
Komsuoglu Celikyurt, I Thu 401, Wed 351<br />
Komuro, I Thu 286<br />
Koncz, I Mon 100<br />
Kondo, Y Wed 186, Wed 263<br />
Kondo, Yukiko Tue 477<br />
Kondratenko, S Thu 114<br />
Kong, SK Thu 381<br />
Kong, S-S Tue 187, Tue 186<br />
Kong, WCB<br />
FC15.2.6<br />
Kongpatanakul, S Mon 334, Mon 355, Mon 357,<br />
Tue 007, Tue 341<br />
Kongsiang, A Tue 007<br />
Konhan, K Mon 357<br />
König, F<br />
FC07.4.2<br />
Konsman, J-P W11.1<br />
Konturek, PC Tue 463<br />
Konturek, SJ Tue 463<br />
Konwar, R Wed 294<br />
Koob, GF<br />
FC14.4.1<br />
Koole, C Wed 082<br />
Koolwijk, P Thu 216<br />
Koon, CM Thu 297<br />
Koon, JCM Wed 345<br />
Kopanchuk, S Tue 192<br />
Kopecky, J Tue 342, Thu 168<br />
Koponen, J W21.3<br />
Koren, G Wed 003, Wed 099, Wed 013<br />
Korhonen, R<br />
W21.5, Tue 278, FC09.5.4,<br />
FC09.1.5, Tue 239<br />
Koriyama, Y Tue 413<br />
Korjamo, T Mon 060<br />
Kormányos, Z Mon 208<br />
Kormos, V Mon 110, Mon 106<br />
Korpela, M<br />
FC09.2.5<br />
Korpela, R Wed 361<br />
Korpi, ER Wed 393, Thu 194, Thu 409<br />
Korstanje, C<br />
W01.3.2<br />
Korth-Bradley, J Tue 012<br />
Koshelev, V Wed 283<br />
Koshimizu, T Wed 189<br />
Koskimies, P Wed 446<br />
Koskinen, A Tue 283<br />
Koskinen, P Tue 429<br />
Kostantinidis, G FC10.2.6<br />
Kostenis, E<br />
FC11.1.6<br />
Kostkova, L Tue 113<br />
Kostowski, W Thu 174<br />
Kostrzewa, A Tue 092<br />
Kotani, T Tue 274<br />
Kotoula, M Tue 246<br />
Kotsar, A Thu 223<br />
Kotyzová, D Mon 409<br />
Kou, Y Mon 078<br />
Kouchi, K<br />
FC03.4.5<br />
Koutani, A Wed 083<br />
Koutsioumpa, M Thu 232<br />
Index 343
Name Paper ref. Name Paper ref.<br />
Kovacevic, A Tue 091, Tue 151<br />
Kovacevic, I Tue 367<br />
Kovacs, P Mon 027<br />
Kovalenko, L Tue 276,<br />
Kovalev, G Wed 426<br />
Koyama, M Thu 072<br />
Koyama, T Tue 154<br />
Kraahs, P Mon 229<br />
Kraehling, JR Wed 280, Thu 252, Wed 210<br />
Krahn, T Thu 057<br />
Krahtz, C Mon 247<br />
Kraneveld, AD FC09.5.2, W11.3<br />
Krassoi, I Wed 197<br />
Krause, D Wed 261<br />
Krause, G Thu 087<br />
Kraushaar, N Wed 190<br />
Krayneva, V Mon 431<br />
Krcmova, I Tue 222, Tue 421, Tue 240<br />
Kreft, S Thu 359<br />
Kreilgaard, M<br />
FC17.4.2<br />
Krejsek, J Tue 222, Tue 421, Tue 240<br />
Kremoser, C<br />
FC18.2.6<br />
Krenek, P FC05.4.5, Thu 097, Mon 221<br />
Krenek, P Mon 219<br />
Kreuchwig, A Thu 087<br />
Kringen, M Wed 139<br />
Krishnan, S Mon 102<br />
Krishnaswami, S FC07.3.3<br />
Kristensen, AK Tue 065<br />
Kristensen, AS Tue 080<br />
Kristensen, J<br />
FC10.5.3<br />
Kristensen, SD FC05.2.3<br />
Kristensen, VN Wed 151<br />
Kristhal, O Wed 325<br />
Kristiansen, K Mon 224<br />
Kristiansen, U Thu 101<br />
Kristof, A Mon 100<br />
Kristoffersen, T Wed 014, Wed 015<br />
Kristova, V Tue 113<br />
Krnic, D Mon 342, Mon 343<br />
Krobert, KA Wed 026<br />
Kroemer, H Tue 045<br />
Kroemer, HK FC02.4.2, Tue 039<br />
Kroetz, D W16.1<br />
Kroigaard, C<br />
Wed 229, Wed 230, Wed<br />
281, Wed 282<br />
Krøjgaard, C Thu 259<br />
Krombach, F<br />
Tue 227, FC16.1.5<br />
Krook, A<br />
FC05.1.2<br />
Kropotov, A Mon 426<br />
Krotov, GI Wed 175<br />
Krs, O Tue 125<br />
Krstic-Milosevic, D Wed 387<br />
Krüger, DB Mon 073<br />
Kruger, D Mon 058<br />
Kruger, HS Thu 016<br />
Krupitza, G Thu 308<br />
Krzan, M Tue 048<br />
Krzan, Mojca Mon 074<br />
Ksouda, K Wed 191<br />
Ku, DD<br />
FC16.1.3<br />
Ku, HC Mon 220<br />
Ku, Y-L Wed 326<br />
Kubes, P Tue 229<br />
Kublickiene, K Thu 256<br />
Kubo, K Thu 402<br />
Kuca, K Tue 074, Tue 448<br />
Kuca, K Tue 343, Mon 075<br />
Kucur, M Thu 266, Mon 199<br />
Kuczyk, M Tue 212, Tue 211, Tue 210<br />
Kuczyk, MA FC08.3.5, Mon 247<br />
Kudo, K Wed 186, Tue 477<br />
Kudo, T Mon 182<br />
Kudryavtseva, O Wed 283<br />
Kudumija-Slijepèevic, M Wed 398<br />
Küçük, N Tue 018<br />
Kühn, J-P Tue 041<br />
Kuei, C Wed 093<br />
Kuhad, A Mon 183, Tue 344<br />
Kukes, V Tue 129, Tue 057<br />
Kukes, VG Thu 253<br />
Kuki, A Tue 274<br />
Kukkonen, J Thu 051<br />
Kulakova, AV Tue 165<br />
Kulkarni, SK Wed 168<br />
Kullak-Ublick, GA FC02.4.4, Thu 435<br />
Kumagai, Y Tue 345<br />
Kumai, T Wed 117, Tue 492, Tue 273,<br />
Tue 337, Tue 336, Tue 483<br />
Kumakura, Y<br />
FC17.1.2<br />
Kumana, C Tue 346<br />
Kumano, K Thu 285<br />
Kumar, JK Thu 379<br />
Kumar, V Wed 324<br />
Kume, T Mon 424, Mon 432, Mon 464<br />
Kummu, M Mon 063, Mon 076<br />
Kun, A Wed 284<br />
Kunitomo, M Thu 320, Tue 143<br />
Kunze, G Tue 438<br />
Kuo, H-S Wed 286<br />
Kurahashi, C Wed 128, Wed 372<br />
Kuramoto, N Tue 375, Wed 083<br />
Kurata, N Thu 319, Tue 320, Thu 343,<br />
Thu 072<br />
Kurihara, T<br />
FC03.4.5<br />
Kuroda, Y Tue 236<br />
Kuroiwa, K Tue 294<br />
Kurokawa, S Tue 373<br />
Kurose, H Thu 109<br />
Kusljic, S Mon 240, Mon 242, Tue 416<br />
Kusturica, J Wed 199<br />
Kuszpit, K Tue 372<br />
Kutcher, S Thu 394<br />
Kuwabara, M Thu 263<br />
Kuwamata, M Mon 307<br />
Kuzelova, M Tue 113<br />
Kuzmenko, M<br />
FC06.1.6<br />
Kuzumaki, N Thu 188, Wed 065<br />
Kvell, K Mon 401<br />
Kvetina, J Tue 056, Tue 342, Thu 168<br />
Kvetnansky, R Thu 039<br />
Kvist, T Wed 084<br />
Kwak, HC Wed 285<br />
Kwan, A-L Mon 319,<br />
Kwan, CY Wed 194<br />
Kwan, YW Thu 255, Wed 345, Thu 381<br />
Kwan, Y-W Wed 244<br />
Kwanashie, H Wed 145<br />
344 Index
Name Paper ref. Name Paper ref.<br />
Kwiecien, S Tue 463<br />
Kwizera, EN Mon 037<br />
Kwok, HF Thu 297<br />
Kyselovic, J FC05.4.5, Mon 219, Thu 097,<br />
Mon 221<br />
Kýyýcý, S Mon 156<br />
la Cour Poulsen, L Wed 447<br />
La Rana, G<br />
FC18.1.6<br />
La Torre, M Thu 302<br />
Laavola, M<br />
FC16.3.4<br />
Labar, B Tue 304<br />
Labarrios, F Wed 217<br />
Lacadie, C<br />
FC14.3.3<br />
Lacerda, RB Mon 279<br />
Lachaux, A Mon 263<br />
Lächelt, S Mon 059<br />
Lackovic, Z Mon 096, W17.1<br />
Lacoin, L Tue 092<br />
Laconca, L Thu 440<br />
Ladwa, S Mon 353, Mon 352<br />
Laeremans, H Wed 085<br />
Lafuente-de-carvalho, J FC08.2.6<br />
Lagercrantz, H Wed 006<br />
Laget, M<br />
FC11.3.5<br />
Lagler, FB Thu 014, Wed 016<br />
Lagrue-Lak-Hal, A-H Wed 196<br />
Laguna, JC Tue 133<br />
Lahdenranta, M Wed 444<br />
Laher, I<br />
FC15.1.3<br />
Lahtinen, M Thu 052<br />
Lai, C-C Wed 192, Thu 198<br />
Lai, X Tue 075<br />
Laine, K Mon 144<br />
Laitila, J Mon 380, Tue 330<br />
Laitinen, J Mon 328<br />
Laius, O<br />
FC04.3.4<br />
Lakhal, M FC07.3.6, Mon 004,<br />
Mon 020, Mon 021, Mon 338,<br />
Wed 348, Thu 346<br />
Lalic, Z Tue 304<br />
Lalla, A Wed 129, Tue 347<br />
Lallemand, C<br />
FC09.2.3<br />
Lalosevic, D Wed 321<br />
Laloux, B Mon 191<br />
Lam, FFY Tue 417, Wed 345<br />
Lam, KSL Mon 271, Mon 159<br />
Lam, M Mon 242, Mon 248<br />
Lam, TH Mon 271, Mon 159<br />
Lamaida, E Tue 487, Mon 449<br />
Lamandé, S W03.7<br />
Lambert, JJ<br />
FC03.3.5<br />
Lamminen, T Mon 215<br />
Lampreia, F Wed 130<br />
Lämsä, V Wed 448<br />
Lan, X Mon 433<br />
Lan, Xi Tue 297<br />
Landau, A FC17.4.5, Thu 404, Thu 405<br />
Landreth, GE<br />
FC18.3.4<br />
Lane, G Thu 113<br />
Lane, J Thu 410<br />
Lane, JR<br />
FC11.2.5<br />
Lane, K Tue 364<br />
Lane, N Tue 124<br />
Lane, R<br />
FC03.2.6<br />
Lang, R Mon 242<br />
Lang, RJ Mon 240<br />
Lange, AJ Wed 156<br />
Langemeijer, E Wed 086<br />
Langer, SZ<br />
W01.3.1<br />
Langerová, P Tue 124<br />
Langlois, N Tue 301<br />
Lanius, R<br />
FC17.5.3<br />
Lantero, A Wed 087<br />
Lanvers-Kaminsky, C FC10.4.5<br />
Laohapand, T Thu 335<br />
Laorden, ML Wed 087<br />
Laosa, O Tue 348<br />
Lapa, AJ Thu 355<br />
LaPerle, J Mon 236<br />
Lapeyre-Mestre, M Tue 104, Mon 129, Mon 130,<br />
FC04.3.5, Mon 124<br />
Lapi, F<br />
Tue 093 FC04.3.6<br />
Lapidus, N<br />
FC13.4.6<br />
Laplanche, J-L FC01.4.4, Wed 191<br />
Larger, M Mon 193<br />
Laroche, A Wed 316<br />
Larrey, D FC04.2.6, Mon 141<br />
Larsen, A Tue 359, Tue 248, Mon 320<br />
Larsen, AM Mon 320<br />
Larsen, AP Wed 099<br />
Larsen, C Mon 450, Thu 239<br />
Larsen, F<br />
FC07.4.5<br />
Larsson, C Mon 055<br />
Lartaud, I Wed 244<br />
LaRue, S Tue 301<br />
Laruelle, M<br />
FC17.1.3<br />
Larvin, M Wed 285, Tue 460<br />
Lashkari, MH Mon 036<br />
Lass, J<br />
FC10.3.6, FC04.3.4<br />
Lassalle, R Mon 141<br />
Lasseter, K Mon 205<br />
Lathers, D Tue 495<br />
Lattanzio, F Thu 110<br />
Lau, BS Thu 297<br />
Lau, C Mon 045<br />
Lau, CBS Wed 345<br />
Lau, CP Tue 346, Thu 297<br />
Lau, CW<br />
FC15.4.7<br />
Lau, HYA Mon 321<br />
Lau, KM Thu 297<br />
Lau, S Thu 280<br />
Lau, YS Thu 219<br />
Lau, YT Wed 388<br />
Lau, YY Mon 228<br />
Laudet, V<br />
FC18.4.4<br />
Lauferon, F Tue 198<br />
Laurie, G Thu 110<br />
Laurikainen, T Mon 144<br />
Laurila, J Wed 092<br />
Laurila, Jonne M Wed 088<br />
Laurindo, FR Wed 202<br />
Laurindo, FRM Wed 237<br />
Lauris, JR Tue 261<br />
Lavhale, M<br />
FC05.2.5<br />
Law, IKM<br />
YI.06<br />
Law, PY Tue 135<br />
Lawal, B Thu 332<br />
Layegh, P Tue 052<br />
Index 345
Name Paper ref. Name Paper ref.<br />
Lazdunski, M<br />
FC03.4.2<br />
Lazo-Langner, A Tue 301<br />
Le Couteur, D FC13.2.6, Mon 392,<br />
FC13.1.6<br />
Le Gall, C Mon 263<br />
Le Grand, B Tue 183, Tue 170, Tue 171,<br />
Tue 172<br />
le Maire, A<br />
FC18.3.5<br />
Le, O Tue 396<br />
Leach, K Wed 043, Wed 089, Thu 041<br />
Leadbeater, PDM Thu 200<br />
Leal, LK Mon 299<br />
Leal, N Wed 111<br />
Leánez, S Thu 042, Wed 059<br />
Lebedeva, E Wed 148<br />
Lecomte, C Tue 092<br />
Ledent, C Thu 057<br />
Ledo, F Mon 254<br />
LeducC, N Thu 024<br />
Lee, A Tue 460<br />
Lee, AJ Tue 109<br />
Lee, DH Mon 013<br />
Lee, D Tue 349<br />
Lee, F Wed 122, Wed 121, Wed 120<br />
Lee, G-S Thu 385<br />
Lee, HC Thu 090<br />
Lee, H-J Wed 035<br />
Lee, H-K Wed 427<br />
Lee, MG Tue 046, Mon 068, Mon 062<br />
Lee, M-H Wed 383<br />
Lee, MYK Thu 270<br />
Lee, S Mon 034,<br />
Lee, S-C Tue 335<br />
Lee, S-Y Tue 350<br />
Lee, SH Tue 334<br />
Lee, S-J Thu 034<br />
Lee, SS Tue 157, Tue 352, Tue 351<br />
Lee, S-J Tue 352, Tue 351<br />
Lee, S-Y Mon 049, Mon 069, Mon 065,<br />
Mon 066, Mon 358, Mon 359,<br />
Tue 043, Tue 044, Tue 073,<br />
Tue 160, Tue 161, Tue 162,<br />
Tue 323, Tue 324, Tue 331,<br />
Tue 332, Tue 333, Tue 335,<br />
Wed 142, Wed 143<br />
Lee, TJF Wed 286, Thu 090, Thu 362<br />
Lee, VHL FC02.4.6, Tue 140<br />
Lee, W-H Mon 104<br />
Lee, W-S Wed 449<br />
Lee, W-Y Tue 229<br />
Lee, WYW Thu 389, Thu 381<br />
Lee, Y Mon 033<br />
Lee, Y-C Wed 286<br />
Lee, YJ Mon 029, Mon 226, Mon 013,<br />
Tue 349, Thu 418<br />
Leeb-Lundberg, F Thu 047<br />
Leeder, P Wed 285<br />
Leeder, SJ<br />
FC13.3.3<br />
Leeds, C Wed 432<br />
Lees, KR<br />
FC15.1.6<br />
Lees, P Tue 191<br />
Leeya, Y Wed 375<br />
Leftheriotis, G Mon 148<br />
Lehmann-Horn, F FC12.2.3<br />
Lehri, S Mon 469<br />
Lehtimäki, L Mon 328<br />
Lehto, V-P Thu 170<br />
Lei, Saobo Wed 090<br />
Lei, SH Tue 348<br />
Lei, SL Mon 451<br />
Lei, T Thu 377<br />
Lei, Y Tue 298<br />
Leirisalo-Repo, M FC09.2.5<br />
Leiro, J Wed 359<br />
Leitão, R Mon 298<br />
Lekhooa, Makhotso R Wed 389, Wed 390, Wed 391<br />
Lello, J Wed 392<br />
Lelong-Boulouard, V Thu 173, Mon 362<br />
Lemasson, I<br />
FC11.3.6<br />
Lemière, C<br />
FC04.1.5<br />
Lemkens, P Thu 251, Thu 221<br />
Lemkens, P Wed 287<br />
Lemmer, B W07.1<br />
Lemos, FO Wed 302<br />
Lemos, M Wed 231, Wed 341<br />
Lendak, D Mon 115<br />
Lennard, L Mon 351, Tue 353<br />
Leo, CH Wed 288, Wed 289<br />
León, O Thu 358<br />
Leone, S Mon 105, Wed 329, Wed 434<br />
Leong, CF Thu 380<br />
León-Molina, H Mon 019<br />
Leopardi, R<br />
FC17.5.4<br />
Lepikkö, V Mon 060<br />
Lepine, JP<br />
FC01.4.4<br />
Lepine, -J-P Wed 191<br />
Leppänen, T FC09.5.4, Tue 247<br />
Leppee, M Mon 127<br />
Leppiniemi, J Thu 223<br />
Leprán, A Thu 307<br />
Lepran, I Tue 157<br />
Lerner, F Mon 030<br />
Leskinen, H Tue 166<br />
Letienne, R Tue 170, Tue 171, Tue 172<br />
Letierce, A<br />
W02.2.6<br />
Lett, K Tue 063<br />
Lettfuss, NY Mon 463<br />
Leung, GPH Wed 091 Thu 255<br />
Leung, JYT Mon 184<br />
Leung, PC Wed 345<br />
Leung, RYH Mon 271, Mon 159<br />
Leung, SWS FC15.2.6, Tue 157, Wed 091,<br />
Wed 290, Wed 388<br />
Leurs, R Wed 086, Thu 085, Thu 060<br />
Leutenegger, D Wed 392<br />
Levälampi, T<br />
FC09.2.5<br />
Levanov, A Tue 129<br />
Lévesque, D FC17.4.6, Wed 443<br />
Lévi, F FC07.1.3, FC07.2.4, W07.2<br />
Levonen, A-L Wed 448<br />
Levy, FO FC06.3.3, Wed 026<br />
Levy-Cooperman, N Wed 193<br />
Levykh, A Tue 354<br />
Leweke, M<br />
FC17.2.2<br />
Lewis, RS<br />
FC12.5.2<br />
Leybaert, L Thu 237<br />
Leymarie, F<br />
FC04.3.5<br />
Li, BL Tue 299<br />
346 Index
Name Paper ref. Name Paper ref.<br />
Li, DJ Mon 322<br />
Li, D-L Tue 187, Tue 186, Tue 159<br />
Li, F FC14.4.6, Thu 182, Thu 185<br />
Li, G Mon 264, Thu 196<br />
Li, G-R<br />
FC12.3.5<br />
Li, H<br />
FC15.4.3, W04.3.3, W30.1,<br />
W30.4, Tue 163, Thu 340<br />
Li, J<br />
FC12.2.5, FC14.5.4,<br />
Mon 323, Mon 457, Mon 466,<br />
Tue 117, Tue 299, Wed 034,<br />
Wed 417, Thu 195, Thu 171,<br />
Thu 340<br />
Li, J-R Wed 403<br />
Li, K Tue 403<br />
Li, KX Mon 032<br />
Li, L Tue 158, Thu 370, Thu 370,<br />
Thu 378<br />
Li, M Wed 150<br />
Li, M-J Wed 403<br />
Li, N FC16.3.5, Tue 355, Thu 296<br />
Li, P Tue 412, Mon 408, Wed 327,<br />
Mon 469<br />
Li, Q Tue 138, Mon 458 Mon 330,<br />
FC16.4.5<br />
Li, QY Tue 036<br />
Li, R<br />
FC14.3.5<br />
Li, RWS Thu 255<br />
Li, S Tue 401, Thu 276, Tue 365<br />
Li, T Mon 056<br />
Li, TT Wed 039<br />
Li, W Thu 377<br />
Li, WD Thu 295<br />
Li, W-L Tue 393<br />
Li, X Mon 056, Mon 092, Mon 251,<br />
Tue 069, Tue 070, Tue 307,<br />
Wed 182, Thu 195, Thu 299,<br />
Thu 314, Thu 377<br />
Li, X-Y Mon 031<br />
Li, X-J Tue 426, Thu 076, Thu 103<br />
Li, X Tue 418<br />
Li, X-Z Mon 209<br />
Li, Y Tue 069, Tue 070, Tue 260,<br />
Tue 294, Mon 310<br />
Li, Y Mon 185<br />
Li, Y Mon 032<br />
Li, Y<br />
Thu 296, FC16.3.5<br />
Li, Y-F<br />
FC14.4.6<br />
Li, Y-H Wed 262<br />
Li, YJ Mon 469<br />
Li, Z Thu 372, Thu 020<br />
Li, ZX Wed 291<br />
Lia, S Thu 279<br />
Liam, CK Tue 254<br />
Lian, LH Wed 431<br />
Liang, A Wed 392<br />
Liang, CF YI.06, Mon 324<br />
Liang, HY Wed 039<br />
Liang, J-H Thu 172<br />
Liang, L Thu 197<br />
Liang, M Mon 228<br />
Liao, H-T Wed 035<br />
Liao, M-H Thu 283, Wed 222<br />
Liao, Y-Y Wed 035<br />
Liao, Z Mon 210, Wed 362,<br />
Wed 258, FC06.4.6, Wed 366<br />
Liapi, C Tue 381, Thu 431<br />
Lichtenstein, L FC18.2.5<br />
Liddle, C W06.3<br />
Liem-Moolenaar, M FC17.3.5<br />
Liepinsh, E Tue 141, Thu 189<br />
Lignot-Maleyran, S FC04.2.6, Mon 140, Mon 141<br />
Likic, R FC01.3.7, Mon 373 Tue 328,<br />
Mon 135<br />
Liley, H Thu 011<br />
Lilic, R Wed 435<br />
Lilleyman, J Tue 353<br />
Lim, AL Wed 428<br />
Lim, LA Mon 013, Mon 033, Mon 226,<br />
Tue 349, Thu 418<br />
Lim, SL Mon 184<br />
Lima, C Mon 398<br />
Lima, L Mon 292<br />
Lima, LM Thu 212<br />
Lima, TMA Thu 355<br />
Lima, TS Wed 332<br />
Lima-Júnior, RCP Tue 255<br />
Lima-Landman, MTR Thu 355<br />
Limas Nzouzi, N Tue 040<br />
Liminana, P Wed 244<br />
Lin, AHY Wed 091<br />
Lin, AM-Y Mon 325<br />
Lin, C Wed 336, Thu 340<br />
Lin, C-H Mon 326<br />
Lin, C-L Mon 319<br />
Lin, C-Y FC17.1.5, Wed 326<br />
Lin, G<br />
Tue 401, Thu 296, FC16.3.5<br />
Lin, H-H Tue 374<br />
Lin, H-H Thu 198<br />
Lin, J Thu 445<br />
Lin, K-M Wed 430<br />
Lin, L Tue 441, Tue 094<br />
Lin, M Mon 310<br />
Lin, W-W Mon 327<br />
Lin, Y-C Thu 373<br />
Lin, ZB FC16.2.1, Thu 295<br />
Lind, U Wed 092<br />
Lindemalm, S Wed 008<br />
Linden, AM Wed 393<br />
Linden, A-M Thu 409<br />
Linden, H W10.2<br />
Lindh, J Mon 122<br />
Lindholm, M Tue 247<br />
Lindhorst, T Tue 151<br />
Lindquist, L FC01.4.7, Mon 018<br />
Ling, B Tue 094, Thu 083<br />
Lingam, PRVS W03.2<br />
Lingueglia, E<br />
FC03.1.1<br />
Linkosalo, L Mon 328<br />
Linnet, J<br />
FC17.1.2<br />
Lionnais-Couvreur, S Tue 289, Tue 290<br />
Lipnik-Stangelj, M Wed 178<br />
Lirussi, F Tue 289, Tue 290<br />
Lisby, M Tue 356, Tue 357, Tue 358<br />
Little, C W03.7<br />
Litvin, A Tue 150<br />
Litvinov, D Tue 106<br />
Litvinova, SA Mon 422<br />
Index 347
Name Paper ref. Name Paper ref.<br />
Liu, A Thu 092<br />
Liu, Ailin Mon 034<br />
Liu, A-J PL22, Mon 330<br />
Liu, AL Tue 365<br />
Liu, C Thu 184, Wed 093<br />
Liu, C-F Mon 354<br />
Liu, C-H Wed 286<br />
Liu, C-Z Thu 199<br />
Liu, C-L Thu 297<br />
Liu, D Thu 298, Tue 158, Wed 362,<br />
Wed 258, Tue 036<br />
Liu, G Tue 094,<br />
Liu, G-L Mon 031<br />
Liu, H Thu 306, Thu 369<br />
Liu, J FC16.4.5, Mon 323, Tue 076,<br />
Tue 458, Wed 336, Thu 116,<br />
Thu 340<br />
Liu, JTC<br />
YI.06<br />
Liu, J Thu 299<br />
Liu, J-J Tue 159<br />
Liu, J-X Thu 376, Mon 209<br />
Liu, K Tue 272, Mon 077, Mon 078,<br />
Mon 329, Thu 275<br />
Liu, K Mon 035<br />
Liu, L<br />
FC12.4.5 FC08.1.6<br />
Liu, LL Wed 291<br />
Liu, M Thu 403<br />
Liu, P Mon 434<br />
Liu, P<br />
FC06.4.2<br />
Liu, P Thu 300<br />
Liu, Q Mon 434<br />
Liu, Q-C<br />
FC16.5.5<br />
Liu, Q-R Thu 176<br />
Liu, R Mon 329, Mon 433, Tue 297<br />
Liu, S Tue 139<br />
Liu, W Tue 269, Tue 035<br />
Liu, X Tue 299, Mon 468, Mon 469,<br />
Mon 330, Thu 378<br />
Liu, X-C Mon 172<br />
Liu, Y<br />
FC14.5.4, FC06.4.6,<br />
Mon 077, Mon 078, Tue 059,<br />
Wed 429, Thu 017, Thu 268,<br />
Liu, Y-L Tue 083<br />
Liu, Y Mon 331<br />
Liu, Y-L Wed 430<br />
Livesey, MR<br />
FC03.3.5<br />
Llerana, A W16.3<br />
Llor, C<br />
FC13.1.5<br />
Lloret Linares, C FC01.4.4<br />
Lluel, P Tue 205, Tue 206, Tue 204,<br />
Mon 244, Tue 203<br />
Lo, A Tue 196<br />
Lo, TWC Tue 139<br />
Lo, Y-C Thu 301<br />
Locht, LJ Tue 359<br />
Löf, Cr Thu 079<br />
Loftus, L Tue 107<br />
Loga-Zec, S Wed 199<br />
Logothetis, N W33.2<br />
Loh, HH Tue 135<br />
Lohse, MJ Wed 026<br />
Loilier, M Mon 362<br />
Loirat, C<br />
FC10.5.5<br />
Loke, AC Wed 431<br />
Loland, C Mon 058<br />
Loland, CJ FC02.3.5, Mon 073<br />
Lonka, L Mon 341<br />
Lönngren, T<br />
PL21<br />
Lopaschuk, GD FC05.2.6<br />
Lopes, C Tue 257, Wed 214<br />
Lopes, LR Wed 233, Wed 237<br />
Lopes, MC Tue 397, Mon 291<br />
Lopes, MTP Wed 302<br />
López, E Mon 128<br />
Lopez, EG Mon 038<br />
López, GJ Mon 125<br />
López, M Tue 420, Tue 042<br />
López, MG Mon 079<br />
Lopez, P Wed 209<br />
Lopez-Durán, JL Tue 348<br />
López-Guerrero, JJ Wed 049<br />
López-Islas, I Thu 265<br />
Lopez-Nevot, MA Tue 123<br />
López-Sánchez, P Wed 049<br />
Lopez-Villodres, JA Mon 278, Tue 116, Wed 250,<br />
Thu 246<br />
Lorente, JA Thu 235<br />
Lorigados, CB Wed 204, Wed 203, Mon 257<br />
Lorrio, S Mon 079<br />
Lösle, M Thu 098<br />
Lötsch, J<br />
FC13.5.3<br />
Lotufo, C<br />
FC03.1.5<br />
Lou, Y Thu 445, Thu 089<br />
Louback, L Thu 212<br />
Lovasz, N Wed 101<br />
Lovenberg, T Wed 093<br />
Lovinger, DM Thu 190<br />
Lovrek, M Tue 437<br />
Lovriæ, M Wed 398<br />
Lovric, M Tue 304<br />
Lowry, C A<br />
FC17.4.1<br />
Lozano, M Wed 352<br />
Lozinskaya, L Mon 133<br />
Lozoya-Moreno, G Mon 009<br />
Lu, H Mon 228<br />
Lu, L Mon 445<br />
Lu, M-L Wed 430<br />
Lu, P<br />
FC07.2.5<br />
Lu, PH Mon 249<br />
Lu, Q Tue 399<br />
Lu, RB Mon 356<br />
Lu, S-C Wed 430<br />
Lu, SM Mon 266<br />
Lu, XH Tue 365<br />
Lu, X-Q<br />
FC14.5.4<br />
Lu, Y Mon 092<br />
Lu, YF Thu 116<br />
Lu, Y-F Tue 458, Thu 186, Thu 184,<br />
Thu 182, Thu 185<br />
Luan, H Tue 419<br />
Lubbe, M Tue 110, Mon 026<br />
Ls, G<br />
FC17.2.5<br />
Ls, S Tue 080<br />
Lucena, MI Wed 109<br />
Lucenteforte, E Thu 302<br />
Lucero, ML Mon 080<br />
Lucero, ML Mon 254<br />
Luciani, S Thu 360<br />
348 Index
Name Paper ref. Name Paper ref.<br />
Lue, S-I Wed 439<br />
Luescher, TF<br />
FC16.1.2<br />
Lütjohann, D Tue 045<br />
Lugovkina, T Wed 110<br />
Lukacs, P Mon 218, Mon 217<br />
Lukas, J Tue 197<br />
Lukas, JC Mon 229, Wed 111<br />
Lukaskova, J Tue 137<br />
Lukasova, M Wed 056<br />
Luksha, L Thu 256<br />
Lumlerdkij, A Thu 335<br />
Lumlerdkj, A Thu 361<br />
Lund Nielsen, P Mon 142<br />
Lund, S Mon 154, Tue 132<br />
Lundberg, MH Thu 200, Thu 238<br />
Lunder, M Thu 359, Thu 293<br />
Lundmark, J<br />
FC14.1.6<br />
Lundström, L Wed 094<br />
Luo, Dali Thu 390<br />
Luo, G Wed 378<br />
Luo, G<br />
FC16.4.4<br />
Luo, J-D<br />
Mon 186, FC09.5.6<br />
Luo, Y<br />
FC06.4.6<br />
Luo, Y Mon 434<br />
Luoto, P Mon 256<br />
Lupi, P Thu 302<br />
Lupp, A Tue 219<br />
Lutsar, I<br />
FC10.3.6<br />
Luviano, A Tue 420<br />
Lv, Y Wed 346<br />
Ly, K Wed 057<br />
Lyhne, NM Tue 358<br />
Lynagh, S Wed 132, Tue 160<br />
Lynagh, T Tue 037<br />
Lynch, J Tue 037<br />
Lynch, K Tue 410, Wed 076<br />
Lyngsøe, C Wed 036<br />
Lyoussi, B W27.2<br />
M. Carnero, MC Tue 144<br />
M. I, H Wed 441<br />
Ma, B Tue 426<br />
Ma, HI Tue 135<br />
Ma, J Thu 295<br />
Ma, Lin Lin Thu 173<br />
Ma, Q Tue 004<br />
Ma, X FC13.2.1, Thu 340<br />
MA, Z Tue 419<br />
Maarsingh, H Wed 095<br />
Mabley, J Mon 157, Wed 096<br />
MacDonald, E Mon 476<br />
Macdonald, T Wed 076<br />
MacDougall, IJA Mon 394<br />
Macedo, A Thu 218,<br />
Macedo, AF Mon 126<br />
Macedo, T Wed 180, Wed 140<br />
Macek, K Tue 342, Thu 168<br />
Machado, MA Tue 243<br />
Machado, MM Wed 339<br />
Machida, T Mon 309, Thu 201<br />
Macias, D Mon 129<br />
Maciulaitis, R Tue 329<br />
Mackovicova, K Thu 097<br />
MacLeod, S W36.1<br />
Macolic-Sarinic, V Mon 342, Mon 343, Mon 370,<br />
Wed 112<br />
Macugova, A Tue 113<br />
Madazli, R Thu 266<br />
Maddahi, A Tue 220<br />
Maddison, J Tue 327, Tue 322, Wed 113<br />
Madjarevic, T Tue 095<br />
Madsen, J Mon 227<br />
Madsen, KL<br />
YI.10<br />
Madura, J Tue 059<br />
Madureira, R Thu 408<br />
Maechler, P Wed 447<br />
Maeda, A Thu 109, Mon 416<br />
Maeda, S Mon 435, Mon 440, Wed 067,<br />
Wed 075<br />
Maeda, Y Mon 250, Tue 263<br />
Maekawa, T Thu 268<br />
Maes, L Thu 366<br />
Magalhães, MH Mon 010<br />
Magalhães-Cardoso, T FC08.2.6<br />
Magina, S Wed 114<br />
Maglajlic, JA Wed 171<br />
Magour, S Mon 245<br />
Maguire, JJ W14.3<br />
Magyar, I Mon 436<br />
Mahé, I Tue 188<br />
Maher, J Wed 096<br />
Maheux, J<br />
FC17.4.6<br />
Mahmoudi, G Mon 437<br />
Mahmoudian, M Thu 100<br />
Mahmud, FH<br />
FC10.2.5<br />
Maier, C W03.6<br />
Maihöfner, C W03.6<br />
Mainz, J Tue 356, Tue 357<br />
Maitra, R Thu 021, Tue 221<br />
Maïzi, H Mon 132<br />
Majzoob Zanjani, S Mon 455<br />
Mak, JCW Wed 218<br />
Mak, JW Thu 379, Thu 380<br />
Mak, TW<br />
YI.06<br />
Mak, VWL Tue 139<br />
Makar-Ausperger, K Mon 373, Tue 328, Mon 135<br />
Makarenko, O Mon 087<br />
Mäkilä, E Thu 170, Tue 032<br />
Makonnen, E FC01.4.7, Mon 018<br />
Maksimovic-Ivanic, D FC16.3.6<br />
Makvandi, M Tue 251<br />
Mala, E Tue 222, Tue 421, Tue 240<br />
Malan, SF Mon 442<br />
Malashenko, EA Thu 253<br />
Maldonado Espinza, A Thu 330<br />
Maleki-Dizaji, N Mon 294 Tue 164<br />
Maleki-Dizaji, N Tue 223<br />
Malhotra, B Mon 236, Mon 251<br />
Mali, A Mon 256<br />
Malita, IM Tue 102<br />
Malkin, B Wed 013<br />
Mallal, S<br />
FC13.3.1<br />
Mallayasamy, SR FC04.3.7<br />
Malm, T W21.3<br />
Malone, D Thu 191<br />
Malone, DT Wed 428<br />
Malthery, Y Tue 118<br />
Mamadou, G Tue 040<br />
Index 349
Name Paper ref. Name Paper ref.<br />
Mamchur, V Tue 354<br />
Mammen, M Thu 069<br />
Man, GSK Wed 290<br />
Man, RYK FC15.2.6, YI.06, Thu 281,<br />
Wed 091,<br />
Mancini, F Thu 433<br />
Mandia, R Tue 020<br />
Mandoki Weitzner, JJ Thu 330<br />
Mandrup, S FC18.1.4, Wed 447<br />
Maneu, V Mon 472, Mon 473, Mon 477,<br />
Mon 481, Tue 478, Tue 422,<br />
Thu 407<br />
Mangano, G Thu 433<br />
Mangelsdorf, DJ FC18.1.3<br />
Manjunatha, N FC01.4.6<br />
Mann, D L<br />
FC06.4.1<br />
Mannani, R Thu 392<br />
Männistö, PT Wed 071, Mon 444, Mon 447,<br />
Mon 341<br />
Mannoury La Cour, C Wed 072<br />
Mannucci, C Thu 316<br />
Manolopoulos, VG Tue 224, Mon 187<br />
Manoury, B Tue 061<br />
Manrique-Maldonado, G Thu 022, Thu 203<br />
Mansell, S Tue 064<br />
Mansoori, SD Mon 002<br />
Mansour, D Tue 451<br />
Mantegazza, M FC12.1.3<br />
Manthey, L Wed 432, Tue 096<br />
Manukyan, A Wed 205<br />
Mao, H Wed 322<br />
Maponga, C Tue 004<br />
Marandykina, A Thu 023<br />
Marathe, S<br />
W01.2.4<br />
Marazioti, A<br />
FC15.3.6<br />
Marazioti, Antonia Thu 202<br />
Marbury, T Mon 205,<br />
Marchais-Oberwinkler, S Tue 442<br />
Marchei, E Mon 375<br />
Marchionni, N Mon 120<br />
Marçola, M Thu 204<br />
Mardirosian, Artin Mon 036<br />
Marek, J Tue 448<br />
Marichal-Cancino, BA Thu 022, Thu 203<br />
Marie, S Mon 362<br />
Marija, M Mon 347<br />
Marijan, K Mon 347<br />
Marimuthu, G Thu 327<br />
Marinda, E Tue 001<br />
Marjason, J Tue 312<br />
Markholt, S Tue 359<br />
Márki, A Mon 261<br />
Markovic-Lipkovski, J Wed 103<br />
Markovics, A W19.3, Mon 106, Mon 283<br />
Marks, AR<br />
FC12.3.3<br />
Markvardsen, LH Tue 161<br />
Marques, AR Thu 202<br />
Marques, E Wed 180, Tue 162<br />
Marques, EB Wed 232<br />
Marques, S Tue 162<br />
Marquez, E-I Mon 471, Mon 149<br />
Márquez, EI Wed 007, Mon 123<br />
Marquié, J-C Mon 124<br />
Marre, M Mon 161<br />
Marrero Faz, E Thu 347<br />
Marsch, R Thu 396<br />
Marsh, A Mon 353, Mon 352<br />
Marston, A Wed 375<br />
Martel, F Mon 042, Mon 057<br />
Martel, J-C Thu 024<br />
Mårtensson, U Thu 047<br />
Mårtensson-Lindblad, L Wed 092<br />
Marthan, R Wed 293<br />
Martikainen, JE Tue 363<br />
Martikkala, E Wed 444<br />
M, Roland FC09.2.2<br />
M-Aurioles, E Tue 116<br />
Martín-Campos, J Thu 042, Wed 059<br />
Martínez Sánchez, G Thu 347<br />
Martinez, C Mon 148, Wed 109<br />
Martinez, G Mon 136<br />
Martinez, GS Mon 038<br />
Martinez, K Thu 037<br />
Martinez, KL Thu 086<br />
Martinez, MC Wed 216, Wed 196<br />
Martínez, P Thu 249<br />
Martinez-Caro, L Thu 235<br />
Martínez-González, J W09.4<br />
Martínez-Saénz, A Mon 411<br />
Martini, L Wed 073<br />
Martinkova, J Tue 125, Wed 017<br />
Martinovic, M Thu 231, Wed 019, Wed 018,<br />
Thu 001<br />
Martins, A Wed 131<br />
Martins, AMC Thu 374, Wed 297<br />
Martins, F Wed 140<br />
Martins, VV Wed 339<br />
Martiny, L<br />
FC11.5.6<br />
Marton, Z Wed 197<br />
Martos, J Thu 088<br />
Maru, Y Thu 444<br />
Maruo, T Mon 035<br />
Marusic, S Wed 112<br />
Maruyama, A Mon 253<br />
Maruyama, I Thu 331<br />
Mashinchian, O Thu 303<br />
Mason, BJ<br />
FC14.2.4<br />
Masri, B Wed 423<br />
Massard, J<br />
W02.2.6<br />
Masson, E Tue 495<br />
Masson, I Mon 191<br />
Mastrantonio, G Wed 003<br />
Masubuchi, Y Wed 115<br />
Masuda, S Tue 156, Tue 225<br />
Masuda, T Wed 223<br />
Mataji, A Mon 099<br />
Matak, I Mon 096<br />
Matchkov, V Tue 038, Wed 433<br />
Mateos-Campos, R Tue 088, Tue 089<br />
Matesanz, N Tue 134<br />
Mathews, T Wed 076<br />
Mathiasen, S Thu 026<br />
Mathiassen, ON Mon 200<br />
Mathie, AA<br />
FC03.3.6<br />
Mathiesen, JM Thu 027<br />
Mathison, Y Thu 205<br />
Mathison, Y Mon 295, Wed 251, Thu 271<br />
Mathur, M Tue 453, Tue 020, Wed 116<br />
350 Index
Name Paper ref. Name Paper ref.<br />
Mato, ID Mon 125<br />
Matos, MG Mon 295, Tue 226, Wed 212,<br />
Thu 254<br />
Matreja, P Mon 005<br />
Matsabisa, G Wed 389<br />
Matsabisa, MG Wed 390, Wed 391<br />
Matschke, K Tue 012<br />
Matsuda, M Thu 038<br />
Matsuda, T Tue 360, Tue 060<br />
Matsui, N Mon 253<br />
Matsumoto, H Tue 432<br />
Matsumoto, K FC16.3.3, Mon 386<br />
Matsumoto, N Tue 273, Tue 337, Tue 483,<br />
Tue 492, Wed 117<br />
Matsumoto, Y Tue 263<br />
Matsumura, K Tue 162<br />
Matsunaga, H Wed 413<br />
Matsunami, M Tue 263, Tue 077<br />
Matsuo, Y Thu 263<br />
Matsuoka, T Tue 260, Tue 294<br />
Matsuomoto, N Tue 336<br />
Matsushima, S Mon 424<br />
Matsushita, A Thu 099, Mon 461<br />
Matsushita, K<br />
PL14<br />
Matsuzaki, T Thu 344<br />
Mattace Raso, G Thu 081<br />
Mattheij, NJA Thu 208<br />
Matthews, S Tue 309<br />
Matuskova, Z Wed 118<br />
Matwyshyn, G FC05.2.5, Wed 184<br />
Matz, J Tue 303<br />
Maulik, SK Thu 304<br />
Maurel, D Wed 077<br />
Maurice, P Thu 028<br />
Maurizio, R Thu 400<br />
Maussang, D Wed 086<br />
Mavrakanas, T Tue 126, Thu 206<br />
Mavri, J Mon 074<br />
Maxwell, S<br />
FC01.3.7,<br />
Maxwell, SRJ FC01.1.3, W20.4<br />
May, D W03.6<br />
May, K Tue 039, Tue 131, Wed 119<br />
Mayer, B PL24, Tue 227<br />
Mayer, ME Mon 247<br />
Mayer, P Tue 129<br />
Mazella, J<br />
FC17.2.5<br />
Mazzaglia, G<br />
FC04.1.6<br />
Mazzon, E FC18.1.5, Mon 277,<br />
Mon 286, FC18.3.6<br />
McArthur, K<br />
FC15.1.6<br />
McArthur, S<br />
FC15.1.5<br />
McCarthy, C<br />
FC08.3.2<br />
McClymont, D Thu 029<br />
McDougal, I Wed 032<br />
McFadzean, I Tue 230<br />
McField, R Tue 097, Tue 120<br />
McGarth, J C<br />
W01.2.2<br />
McGrath, J Thu 030<br />
McGuire, JJ Wed 271<br />
McGuire, J J Thu 207<br />
McIntyre, P W03.7<br />
McKown, R Thu 110<br />
McLachlan, A<br />
FC13.2.6<br />
McLaverty, M Tue 456, Tue 279<br />
McLay, J Wed 137<br />
McLay, JS Tue 109<br />
McNally, G<br />
FC03.3.1<br />
McNaughton, PA FC03.1.3<br />
McPhaden, A Thu 272<br />
McQuain, C Mon 264<br />
Meana, JJ Wed 031, Thu 031, Thu 399<br />
Mécs, Z Thu 307<br />
Medard, Y<br />
Wed 011, FC10.1.5<br />
Medina, A Wed 007<br />
Medina, I Wed 265<br />
Medina, P Thu 225<br />
Medved, V Wed 398<br />
Medvedeva, N Wed 283<br />
Meena, S Wed 294<br />
Meens, M Wed 037<br />
Meens, MJPMT Thu 208<br />
Meesarapee, B Tue 277, Thu 305<br />
Megersa, TN Thu 032<br />
Megson, I Mon 211<br />
Megyeri, A Mon 150, Mon 167<br />
Mehdipour, AR Thu 309<br />
Mehla, J Mon 452,<br />
Mehmood, MH Wed 354<br />
Mehnert, F<br />
FC04.2.7<br />
Mehta, N<br />
FC09.5.7<br />
Mei, Q Tue 286<br />
Meier, SM<br />
FC11.3.2<br />
Meiler, J<br />
FC11.3.2<br />
Meili, S Thu 309<br />
Meissner-Kirch, O Mon 037<br />
Mejyr, S W35.4<br />
Melcon de Dios, A Wed 109<br />
Meli, R FC18.1.6, Thu 081<br />
Mellor, I Thu 029<br />
Melo, PA Wed 339<br />
Melo, T Wed 318, Wed 319<br />
Mendell, J Tue 228, Wed 122, Wed 121,<br />
Wed 120<br />
Mendelson, J FC14.2.5, Mon 388, Wed 170<br />
Mendes, AF Tue 257<br />
Mendes, E Tue 086<br />
Mendez-Cruz, AR Tue 150<br />
Mendoza Hernandez, IC Mon 038<br />
Mendoza Patiño, N Thu 330<br />
Mendoza Rodríguez, Y Thu 425, Thu 424<br />
Mendoza, Y Thu 394, Thu 395<br />
Mendoza-Ramos, MI Tue 150<br />
Menendez, C Tue 121, Wed 226, Thu 217,<br />
Thu 235<br />
Menezes, G Tue 229<br />
Menezes, R Wed 131<br />
Meng, X Tue 117, Thu 306, Thu 369<br />
Meng, Y Tue 035<br />
Menghini, L Wed 329<br />
Menna, A<br />
FC04.3.6<br />
Menon, G Wed 006<br />
Menon, P Tue 230<br />
Menoyo, E Thu 177, Thu 178<br />
Menzen, MH Tue 242, Wed 095<br />
Mer, M Mon 308<br />
Meræep, I Mon 048<br />
Meraner, P<br />
FC12.5.4<br />
Merino -Garcia, N Wed 344<br />
Index 351
Name Paper ref. Name Paper ref.<br />
Merino, D Wed 087<br />
Merkord, J Thu 337<br />
Merlin, J Wed 063<br />
Mesarosova, L FC05.4.5, Mon 219<br />
Mesdaghinia, A Tue 231<br />
Mesdaghinia, Eh Thu 209<br />
Mesquita, C Mon 398<br />
Messing, DD Thu 014<br />
Messlinger, K Mon 099<br />
Messripour, M Thu 004<br />
Mester, G Thu 307<br />
Mester, M W19.3<br />
Methven, L W01.2.2, Thu 030<br />
Metsvaht, T<br />
FC10.3.6<br />
Metz, J Tue 462<br />
Meurs, H Tue 242, Wed 095<br />
Meyer zu<br />
Schwabedissen, H Tue 045, Tue 054<br />
Meyer, J<br />
FC02.2.5<br />
Meyer, JG Mon 071<br />
Meyer-Lindenberg, As FC17.3.3<br />
Meyers, T Thu 012<br />
Meyers, TM Thu 016<br />
Mezei, Zsofia Thu 307<br />
Mezhapuke, R Wed 045<br />
Mhadhebi, L Wed 316<br />
Miantezila Basilua, J Tue 040<br />
Miao, Chao-Yu Thu 210<br />
Micaelo, N Tue 146<br />
Micale, V Thu 396<br />
Micali, S Thu 316<br />
Miceli, N Thu 316<br />
MIchael, M Tue 238, Thu 317<br />
Michailov, MC Mon 479, Thu 211, Tue 214,<br />
Mon 245, Tue 099<br />
Michaud, V Wed 123<br />
Michel, Lisa Tue 232<br />
Michelon, H<br />
FC02.2.6<br />
Michiels, C Wed 245<br />
Micograve, U Thu 419<br />
Micon, S Mon 140, Mon 141<br />
Miczek, K<br />
FC14.4.3<br />
Miettinen, T Mon 215<br />
Mifsud, J Thu 002<br />
Miftah, A Mon 378<br />
Miglio, G Tue 256, Thu 434<br />
Mihovilovic, MD Mon 217<br />
Mijatovic, S<br />
FC16.3.6<br />
Mikelis, C Thu 232<br />
Miki, N Wed 186<br />
Mikkelsen, S<br />
FC13.5.5<br />
Mikkonen, J Thu 223<br />
Mikolajczak, PL Thu 174<br />
Mikov, I Tue 148<br />
Mikov, M Mon 115, Tue 148, Tue 149,<br />
Tue 454, Wed 321<br />
Mikov, MM W34.4, Wed 435<br />
Milan, Z Tue 151<br />
Milanese, M Thu 400<br />
Milani, L Wed 136<br />
Milbradt, J Tue 214, Thu 354<br />
Milijasevic, B Tue 148,<br />
Militaru, FC Mon 417, Mon 438, Tue 481<br />
Miljkovic, D<br />
FC16.3.6<br />
Millan, MJ Wed 072<br />
Millard, R<br />
FC08.1.6<br />
Mille, M Mon 217, Mon 218<br />
Millet, C Thu 244, Thu 245<br />
Millfors, P Thu 003<br />
Milliken, P Thu 272<br />
Millington, WR Wed 179<br />
Mills, A Thu 272<br />
Milne, RW Tue 066<br />
Milovan, D Wed 193<br />
Milovanovic, D Mon 039,<br />
Milovanovic, DR Wed 435<br />
Milovanovic, M Mon 114<br />
Milovanovic, S Thu 329, Tue 122<br />
Milton, S Tue 233<br />
Milusheva, E Mon 460<br />
Minakuchi, K Wed 278<br />
Miners, J Wed 124<br />
Mingorance Gutiérrez, C Tue 118<br />
Minnaar, EL Wed 399<br />
Minnaard-Huiban, M Mon 212<br />
Mino, Y Tue 491<br />
Minorics, R Thu 308<br />
Miokovic, M Wed 171<br />
Miralles, Diana V Tue 163<br />
Miranda, AL Thu 212<br />
Mirecki-Garrido, M Tue 392<br />
Miremont, G<br />
FC09.2.7<br />
Miremont-Salamé, G Tue 092<br />
Miri, M Tue 469<br />
Miri, R Wed 376<br />
Miri, Ramin Thu 309<br />
Mirkhani, H Wed 376<br />
Mirmohammad<br />
Sadeghi, H<br />
YI.07<br />
Mironidou-Tzouveleki, M Mon 367, Thu 206, Mon 297,<br />
Tue 126<br />
Miroševic, V Mon 048<br />
Mirosevic-Skvrce, N Wed 112<br />
Mirossay, A Thu 033<br />
Mirossay, L Thu 033, Thu 216<br />
Mirtsou, V Tue 246<br />
Mirtsou-Fidani, V Mon 143<br />
Mirza, M Tue 395<br />
Mirzadegan, T Wed 093<br />
Mirzaei, A Thu 313<br />
Mirziashvili, M Wed 272, Tue 174<br />
Mirzoyan, R Wed 248<br />
Misaka, S Tue 144<br />
Misawa, M Mon 303, Mon 304, Mon 272,<br />
Tue 259, Tue 234, Tue 265,<br />
Tue 287<br />
Misbahuddin, M Tue 119<br />
Misfeldt, M Wed 229<br />
Mishina, M Thu 034<br />
Misioreck, C Thu 237<br />
Misle, A Wed 024<br />
Mistchenko, AS Mon 128<br />
Mistiran, AF Tue 408<br />
Mita, M Mon 179, Wed 305<br />
Mitani, Y Tue 492<br />
Mitchell, C Tue 353, Mon 351<br />
Mitchell, JA FC09.4.1, Thu 200, Thu 238,<br />
Thu 241<br />
352 Index
Name Paper ref. Name Paper ref.<br />
Mitchell, S FC13.2.6, Wed 125, Wed 126<br />
Mitic, R Wed 436<br />
Mitjavila Cors, M Thu 347<br />
Mitrovic, D Wed 343<br />
Mittal, DK Thu 310<br />
Miura, Jun Wed 127<br />
Miura, M Tue 144<br />
Miwa, S Mon 399<br />
Miwa, T Tue 162<br />
Miyagawa, K Thu 397, Thu 423, Thu 422<br />
Miyahara, T Tue 459<br />
Miyakawa, M Wed 223<br />
Miyake, F Wed 117<br />
Miyashiro, C Tue 241<br />
Miyata, T Thu 387<br />
Miyauchi, S Wed 064<br />
Miyazaki, I Wed 424, Wed 413<br />
Miyazaki, T Wed 256, Thu 213<br />
Mizobuchi, S Mon 303<br />
Mizuguchi, H Tue 154<br />
Mizuma, K Wed 186, Tue 477<br />
Mizutani, H Wed 107<br />
Moachon, L<br />
FC09.2.7<br />
Moazen, F<br />
YI.07<br />
Mobasher, MA Mon 085, Mon 088<br />
Mobini, H<br />
FC14.5.2<br />
Moch, S Mon 478, Tue 001<br />
Mochizuki, Y Wed 128<br />
Modaresi, M Thu 004<br />
Modess, C Tue 041, Tue 045<br />
Moerland, M Mon 316, Thu 214, Thu 215<br />
Mogi, M Mon 439<br />
Mohajeri, SA Mon 230<br />
Mohamad, MA Tue 444<br />
Mohamad, N Mon 107, Thu 181<br />
Mohammadi, S Mon 044, Tue 164<br />
Moharamzad, Y Thu 005, Thu 311<br />
Mohr Drewes, A W12.5<br />
Mohsin, SSJ Thu 312<br />
Mohy El-Din, MM Tue 264<br />
Moibenko, A<br />
FC06.1.6<br />
Moilanan, E<br />
FC09.1.5, FC09.3.1,<br />
FC09.5.4, FC16.3.4, W21.5,<br />
Mon 302, Mon 328, Tue 278,<br />
Tue 235, Tue 239, Tue 247,<br />
Tue 283<br />
Moilanen, L Tue 235<br />
Moilanen, T W21.5, Tue 283, Tue 239<br />
Mojic, M<br />
FC16.3.6<br />
Mojzis, J Thu 033, Tue 423<br />
Mojzis, Jan Thu 216<br />
Mojzisova, G Tue 423, Thu 216<br />
Mokhtari, F<br />
FC01.3.5<br />
Mokoena, M Mon 412<br />
Mokrane, H Thu 035<br />
Mokrosinski, Thu 036<br />
Molana, H Mon 036<br />
Molden, E Tue 490, Wed 412<br />
Molero, E<br />
FC04.4.6<br />
Molina-Guarneros, JA Tue 431<br />
Mollentze, W<br />
FC14.5.5<br />
Møller, A<br />
Thu 405, Thu 404, FC17.1.2<br />
Møller, LB Mon 089<br />
Möller, M<br />
FC18.2.5<br />
Møller, MU Mon 090<br />
Møller, TC Thu 086<br />
Møller, T Thu 037<br />
Mollica, A Mon 105, Wed 434<br />
Mollik, AH Tue 097, Tue 120<br />
Molloy, M W06.3<br />
Molnar, P<br />
FC16.2.6<br />
Molnar, S Tue 099<br />
Molyva, D Mon 300<br />
Momma, T Tue 345<br />
Momo, K Tue 315<br />
Moncada, S<br />
PL01, FC09.3.5<br />
Monge, A Thu 212<br />
Monge, L Wed 224<br />
Mönkkönen, J Mon 060<br />
Monnier, C<br />
FC11.2.1<br />
Monopoli, A Mon 281<br />
Monsalvo, I Tue 420<br />
Montagnani, M W08.4<br />
Montaña, M Wed 046<br />
Montanaro, N<br />
FC04.3.6<br />
Montane Jaime, L Wed 129, Tue 347<br />
Montastruc, JL Tue 104<br />
Monteiro, EC Wed 130<br />
Monteiro, F Wed 131<br />
Monteiro, H Wed 131<br />
Monteiro, HSA Wed 297<br />
Monteiro, J Wed 131<br />
Montó Guillot, FJ Tue 165<br />
Monto, F Thu 048, Tue 163<br />
Monuki, Y Mon 307<br />
Moon, S-M, Mon 049, Mon 359<br />
Moore, N W32.2, Mon 140, Tue 092<br />
Moradi, N<br />
FC09.5.7<br />
Moraes, MEA Thu 374<br />
Morales, C Tue 016<br />
Morales, L Wed 152<br />
Moral-Sanz, J Tue 121, Wed 226, Thu 217,<br />
Thu 235<br />
Morbidelli, L Wed 243<br />
Morcillo, E Thu 437<br />
Moreau, P Tue 429<br />
Moreira, A-P Mon 314<br />
Moreira, F<br />
FC17.5.5<br />
Moreira, IS<br />
YI.10<br />
Moreno, E Thu 235, Thu 217<br />
Moreno, L Tue 121, Mon 374, Wed 226<br />
Moreno, L Thu 217<br />
Morgadinho, T Thu 193<br />
Morgado, M Thu 218<br />
Morgado, S Thu 218<br />
Morgan, ET W06.1<br />
Mori, A Wed 264<br />
Mori, H<br />
FC16.4.6<br />
Mori, M Tue 147<br />
Mori, S Tue 272, Mon 035, Mon 329,<br />
Thu 275<br />
Mori, T Thu 103<br />
Moriguchi, S Thu 406<br />
Morikawa, M Mon 307<br />
Morin, C Mon 469<br />
Morini, G Mon 381<br />
Morishima, S Thu 046<br />
Morishima, T Tue 122<br />
Index 353
Name Paper ref. Name Paper ref.<br />
Morisset, S Wed 051<br />
Morita, H Thu 038<br />
Morita, K Mon 303<br />
Morita, S Wed 414<br />
Moritani, T Wed 422, Wed 415<br />
Mørk, A<br />
FC17.4.2<br />
Moro, C Tue 199<br />
Moro, N Wed 263, Tue 214<br />
Moroni, S Mon 003, Wed 003<br />
Morris, B<br />
FC17.1.4<br />
Morris, R Mon 102, Tue 495<br />
Morrow, L Mon 175<br />
Morvay, N Tue 157<br />
Moscatelli, G Mon 003, Wed 003<br />
Mosekilde, E<br />
FC07.1.1<br />
Moseley, E Tue 002<br />
Moshfegh, A Mon 055<br />
Moshkov, AV Thu 238<br />
Mosquera, B Tue 348<br />
Moss, E Wed 132<br />
Mostefai, HA Wed 196<br />
Motamedi, R Thu 309, Tue 469<br />
Motau, Harold Tue 003<br />
Motavallian Naeini, A YI.07<br />
Motegi, T Mon 440<br />
Motevalian, M Thu 006<br />
Motomura, S Tue 430<br />
Motosugi, Y Thu 268<br />
Motsoaole, M Thu 315<br />
Möttönen, T<br />
FC09.2.5<br />
Mou, Y Tue 155<br />
Mouly, S Tue 188, Tue 189, Wed 191,<br />
FC01.4.4<br />
Moura, D Wed 114<br />
Moura, D Tue 123<br />
Moura, E Wed 114, Thu 398<br />
Mousavi, SH Thu 313, Thu 342, Tue 424<br />
Moustafin, IG Thu 096<br />
Moutin, E<br />
FC11.3.3<br />
Mozhaeva, T Tue 150<br />
Mpamhanga, CP Tue 479<br />
Mpindi, J-P Tue 436<br />
Mrhar, A<br />
FC07.3.5<br />
Mrsic Pelcic, J Tue 095<br />
Mu, X Tue 307, Thu 314<br />
Muceniece, R Thu 189, Wed 045<br />
Mudzviti, T Tue 004<br />
Mülders, V Tue 108<br />
Müller, C Thu 018<br />
Müller, CE Tue 238<br />
Müller, M Thu 438<br />
Müller, S Wed 119<br />
Mueller, SC Tue 115<br />
Mürdter, T Wed 133<br />
Mugabo, P Thu 315<br />
Mugelli, A Thu 302, Tue 093<br />
Mugosa, S Tue 098, Wed 135, Wed 134<br />
Muguruza, C Thu 399<br />
Muhamedzhanova, G Tue 079<br />
Mukonzo, JK Tue 005, Wed 136<br />
Muktar, H Wed 145<br />
Mulabegovic, N Wed 199<br />
Mulcahy, F Thu 442<br />
Mulder, P Wed 196<br />
Mulleman, D Tue 198<br />
Mulvany, M Wed 375, Wed 240<br />
Mulvany, M W17.1<br />
Mulvany, MJ Thu 234, Mon 200<br />
Munck, A<br />
Wed 160, FC13.1.5<br />
Mungiu, O Mon 108, Tue 134<br />
Munhoz, C Mon 292<br />
Munk, S Thu 058<br />
Muñoz, A Mon 123, Mon 254<br />
Muñoz, R Mon 451<br />
Muñoz-Marin, J Mon 206, Mon 278, Tue 144,<br />
Wed 215<br />
Muntau, AC Wed 016, Thu 014<br />
Muona, A W21.3<br />
Muraguchi, M Thu 103<br />
Murai, M Mon 402<br />
Murakami, M Tue 236<br />
Muramatsu, I W01.2.3, Thu 046<br />
Muramatsu, M Wed 107, Thu 286<br />
Murase, S-I Wed 060<br />
Murat, N Tue 200<br />
Murciano, C Tue 478, Tue 422<br />
Murguia-Romero, M Tue 150<br />
Murphy, SE<br />
FC17.4.3<br />
Murphy-Ullrich, J Thu 251<br />
Murugan, DD Thu 219<br />
Musabegovic, J Wed 004, Wed 171<br />
Musavi, P Mon 231<br />
Musazzi, L Thu 400<br />
Muscará, MN Wed 233<br />
Muscatello, MR Thu 419<br />
Musgrave, U<br />
FC16.3.7<br />
Musil, P Mon 219<br />
Musilek, K Tue 343, Mon 075, Tue 448<br />
Mustafa, J Thu 057<br />
Mustafa, MR Thu 219, Tue 254<br />
Mustafa, R Wed 370<br />
Mustata, C Thu 177, Thu 178, Mon 109<br />
Mustonen, E Tue 166<br />
Muthig, V<br />
W01.2.4<br />
Mutka, A-L Mon 215<br />
Mutlu, O Mon 387, Tue 145, Wed 351,<br />
Thu 401<br />
Mwandingi, P Thu 315<br />
Mwinyi, J Thu 435<br />
Myllynen, P Mon 063, Mon 076<br />
Myöhänen, TT Mon 444<br />
Myronidou-Tzouveleki, M Tue 141<br />
Myslivecek, J Thu 039<br />
Mzah, D Mon 378<br />
Nabeshima, T Thu 402<br />
Nabipoor, I Tue 014<br />
Nada, SA Tue 451<br />
Naeini, KS Tue 369<br />
Nafrialdi, Tue 009<br />
Nagahama, H Mon 173<br />
Nagai, H Tue 373<br />
Nagano, M Thu 108<br />
Nagano, M Thu 403<br />
Nagashima, R Mon 461, Tue 375, Thu 099<br />
Naggara, O Mon 191<br />
Nagy, S Tue 414,<br />
Nahimi, A Thu 405, Thu 404<br />
Naidoo, D Mon 478<br />
354 Index
Name Paper ref. Name Paper ref.<br />
Naidoo, M Tue 110<br />
Naidoo, P Tue 110<br />
Naidu, R Tue 254<br />
Naim Abu Nabah, Y W09.4<br />
Naina, MI Wed 137<br />
Naito, T Tue 484, Tue 491<br />
Najafi, E Thu 365<br />
Najafi, M Tue 164<br />
Najafian, B Mon 231<br />
Najafzadeh, H Mon 222<br />
Nakabeppu, Y Wed 141<br />
Nakada, Y Tue 151<br />
Nakae, Y Thu 013<br />
Nakagawa, M FC03.2.5, Wed 138<br />
Nakagawa, S Tue 225<br />
Nakagawa, T Tue 055<br />
Nakagiri, A Tue 236<br />
Nakahara, T Wed 264<br />
Nakahata, N Wed 373, Wed 078<br />
Nakajima, K Thu 402<br />
Nakamori, Y Tue 274<br />
Nakamura, E W02.1.3, Thu 263<br />
Nakamura, K Tue 067, Tue 143, Tue 167,<br />
Thu 040, Thu 263, Thu 320<br />
Nakamura, M Mon 112<br />
Nakamura, S Thu 220<br />
Nakamura, T Tue 373<br />
Nakamura, Y Mon 441<br />
Nakanishi-Ueda, T Tue 443<br />
Nakano, Y Tue 201, Thu 416<br />
Nakarandake, E Wed 203, Mon 257<br />
Nakashima, H Wed 127<br />
Nakasone, J Thu 344<br />
Nakatsu, K Tue 414<br />
Nakayama, J Wed 115<br />
Nakayama, K Thu 226, Thu 248, W09.4<br />
Nakayama, KI W09.4<br />
Nakazawa, M Tue 177<br />
Nam, JH Tue 046, Mon 068<br />
Nam, MH Thu 090<br />
Namekata, I Tue 168, Thu 260<br />
Namiki, N Tue 144<br />
Namkung, Y Thu 063<br />
Namour, F Tue 280<br />
Namvaran, F Tue 485<br />
Namvaran, MM Mon 088<br />
Nanba, D Thu 406<br />
Nancy, G Wed 219<br />
Nanda, S Thu 410<br />
Näpänkangas, J Tue 166<br />
Narita, M Thu 188, Thu 188, Wed 065<br />
Narum, S Wed 139<br />
Narumiya, S Mon 194, Tue 260, Tue 294<br />
Nasal, A Mon 197<br />
Nascimento, E Mon 094, Mon 095, Mon 097<br />
Nascimento, NRF Wed 297<br />
Nascimento, TL Thu 351, Thu 352<br />
Nashida, T Tue 060<br />
Nashun, B Wed 039<br />
Nasisi, A Thu 111<br />
Näsman, J Wed 081, Thu 051<br />
Nasser, A Mon 089<br />
Nassif, A Tue 045, Tue 041<br />
Nastos, S Tue 368<br />
Nasu, Y Wed 373<br />
Nasyrova, S Tue 079<br />
Natvig, B Tue 143<br />
Naulaers, G Wed 001<br />
Navarra, Michele Thu 316, Thu 364<br />
Navarrete-Vazquez, G Tue 149<br />
Navarro, JM Tue 123<br />
Navarro-Dorado, J Mon 206, Tue 144, Wed 215,<br />
Wed 228, Thu 264, Thu 240<br />
Nawaratne, V Thu 041<br />
Nayeri, K Tue 015<br />
Naylor, C Wed 409<br />
Nazer, D Tue 110<br />
Nazifi, S Tue 015<br />
Nazila, T Thu 181<br />
Ndisang, JF Tue 124<br />
Nechifor, M FC14.2.6, Mon 162, Thu 175<br />
Neef, CK W29.4<br />
Negoro, T Tue 201<br />
Negredo, P Mon 079<br />
Negrete, R Thu 042, Wed 059<br />
Negura, T Tue 459<br />
Nejime, N Tue 143, Tue 067<br />
Nelissen, J Wed 287<br />
Nelissen, Jelly Thu 221<br />
Nelson, M<br />
Thu 279, YI.05<br />
Nelson, MT<br />
FC08.3.3, FC15.2.4<br />
Németh, J Tue 125, Tue 142<br />
Nemethy, Z Wed 423<br />
Nepote, V Tue 305<br />
Nerobkova, L Mon 462<br />
Nesi, M Thu 043<br />
Nesi, RT Wed 342<br />
Nesic, Z Mon 114<br />
Neta, C Wed 140<br />
Neu, E Mon 245, Mon 479, Tue 099,<br />
Tue 214, Thu 211, Thu 354<br />
Neu, R Thu 354, Tue 099<br />
Neubig, R YI.01, Thu 044, Tue 479,<br />
Thu 065<br />
Neugebauer, W Wed 037<br />
Neumann, J Tue 169<br />
Neuvonen, PJ Mon 380, Tue 062, Thu 284,<br />
Tue 316, Tue 330<br />
Neverauskas, V Tue 329<br />
Neves, BM Mon 291<br />
Neville, K<br />
FC13.3.5<br />
Newall, DR W10.2<br />
Newman, A Wed 126<br />
Newman, AH<br />
FC02.3.5<br />
Newman-Tancredi, A Thu 024<br />
Nezic, D Thu 324<br />
Nezic, L Tue 237<br />
Neznamov, G Tue 024<br />
Ng, ESK Tue 417, Wed 345<br />
Ng, K-Y Thu 045<br />
Ng, KFJ Thu 281<br />
Ng, L Thu 393<br />
Ng, PY Tue 252<br />
Ng, WK Tue 452<br />
Ngokpol, S Mon 355, Tue 006, Tue 007<br />
Nguyen, CH Tue 180<br />
Nguyen, D-T Mon 242<br />
Nguyen, TMH Mon 263<br />
Index 355
Name Paper ref. Name Paper ref.<br />
Nichols, CG<br />
FC12.4.3<br />
Nichter, M Wed 172, Wed 172<br />
Nicolau, S Tue 042<br />
Nicoletti, F Wed 400<br />
Nicolucci, A W18.2<br />
Nicotra, F Tue 093<br />
Nie, L-Y Mon 470<br />
Nie, YL Mon 032<br />
Nieber, K Wed 417<br />
Nieber, K Thu 317, Tue 238<br />
Nielsen, C<br />
FC14.3.5<br />
Nielsen, E W29.3, Thu 222<br />
Nielsen, HB Mon 050<br />
Nielsen, J Tue 303<br />
Nielsen, LP Tue 356, Tue 357, Tue 358<br />
Nielsen, NM Tue 038, Wed 433<br />
Nielsen, S<br />
FC02.2.2<br />
Niemi, M Tue 062, Tue 330, Tue 316,<br />
Thu 284<br />
Nieminen, R<br />
FC09.1.5, FC09.2.5,<br />
FC16.3.4, W21.5, Mon 302,<br />
Tue 235, Tue 239, Tue 278,<br />
Tue 283, Thu 223,<br />
Niesters, M W12.4<br />
Nieto, MA Mon 374<br />
Niida, S Thu 286<br />
Niihara, H Wed 083<br />
Niikura, K Thu 188<br />
Nijkamp, F<br />
FC09.5.2<br />
Niki, T Tue 140<br />
Nikitina, T Wed 347<br />
Nikolic, D W34.3<br />
Nikolic, V Thu 070,<br />
Nikolic-Kokic, A Wed 387, Thu 318<br />
Nilsson Remahl, I Tue 308<br />
Nin, N Thu 235<br />
Nishibori, M Tue 272, Mon 035, Mon 329,<br />
Thu 275<br />
Nishida, M Thu 109<br />
Nishida, Y Mon 272<br />
Nishihara, K Tue 225<br />
Nishikawa, H Tue 263<br />
Nishimaki-Mogami, T Thu 250<br />
Nishimoto, A W01.2.3, Mon 399, Thu 046<br />
Nishimura, Y Tue 320, Thu 319, Thu 343<br />
Nishino, M W23.4, Tue 473<br />
Nishio, H Tue 467<br />
Nishioka, Y Wed 278<br />
Nishiuchi, A Thu 320<br />
Nishiwaki, M Mon 307<br />
Nishiya, T Mon 399<br />
Niu, J Tue 371, Tue 425<br />
Niwa, M Mon 112, Thu 402<br />
Nobakht, M Mon 188<br />
Nobe, H Thu 224<br />
Nobe, K Tue 201, Wed 256, Thu 117,<br />
Thu 224<br />
Nobuoka, Y Tue 486<br />
Noches, V Wed 169<br />
Noda, M Wed 141<br />
Noda, Y Thu 402<br />
Noe, CR W24.2<br />
Noedl, H Tue 090<br />
Noehr-Jensen, L FC13.5.5<br />
Noguchi, A Tue 136<br />
Noguchi, K Thu 344<br />
Noguchi, N Tue 153<br />
Noguera, M-A Thu 050<br />
Nolasco-Velazquez, XE Tue 025<br />
Noll, G<br />
FC16.1.2<br />
Nomura, F<br />
Tue 126, FC13.2.5<br />
Nonaka, K Wed 371<br />
Nor Aripin, KNB Thu 007<br />
Norel, X Thu 266<br />
Nørgaard, ML<br />
FC04.2.4<br />
Nørgaard-Strandfelt, K FC02.3.6<br />
Norman, E Thu 008<br />
Norstedt, G Tue 391, Tue 392<br />
Nosalova, G Mon 293<br />
Nosjean, O Wed 072<br />
Nossent, AY<br />
FC06.2.5<br />
Nossent, Y Wed 070<br />
Nouailhetas, VLA Thu 351, Thu 352<br />
Nour El-Din, NA Tue 264<br />
Novaes, LC Thu 321<br />
Novaes, MR Tue 008, Thu 323, Thu 322,<br />
Thu 321<br />
Novakova, E Mon 293<br />
Novakova, M Thu 039<br />
Novakovic, A Wed 103, Thu 324<br />
Noveck, R Tue 228, Wed 122, Wed 121,<br />
Wed 120<br />
Novella, S Thu 225<br />
Novensa, L<br />
YI.03<br />
Novensa, L Thu 225<br />
Novio, S Thu 325<br />
Novosad, J Tue 222, Tue 421, Tue 240<br />
Novosadova, M Tue 240<br />
Novotny, L Tue 343, Tue 074<br />
Nowaczyk, M Mon 262<br />
Ntaios, G Mon 143<br />
Ntale, M<br />
FC01.4.5<br />
Nürnberg, B Wed 022<br />
Nugroho, AW Tue 009<br />
Nukui, K Mon 405<br />
Nulman, I Thu 009<br />
Nunes, FPB Wed 333, Wed 334<br />
Nunes, S Wed 214<br />
Nuñez, MJ Wed 152<br />
Nuñez-Iglesias, MJ Thu 325<br />
Nunn, A J<br />
FC10.3.3<br />
Nurfadhlina, M Thu 181<br />
Nuriyev, M Tue 245<br />
Nurullina, DV Thu 096<br />
Nutt, D J<br />
FC17.4.4<br />
Nuutinen, S<br />
FC14.3.6<br />
Nyegaard, M<br />
FC13.3.6<br />
Nygaard Jørgensen, T Mon 067<br />
Nygaard, EB<br />
FC05.3.5<br />
Nygaard, R Thu 036<br />
Oates, J<br />
FC05.3.6<br />
Obando, EP Mon 480<br />
Obara, K Thu 226<br />
Obili, N Tue 133<br />
O'Brien, S Tue 364<br />
Obua, C<br />
FC01.4.5<br />
Ocampo-López, JO Tue 195<br />
Ochi, A Mon 335<br />
356 Index
Name Paper ref. Name Paper ref.<br />
Ochiai, T Thu 430<br />
Ochiai, W Mon 177, Mon 182<br />
Ochodnicky, P FC05.4.5, Mon 219, Thu 097,<br />
Mon 221<br />
Odar-Cederlöf, I Tue 308, W35.4<br />
Odenholt, I W29.2<br />
Odeon, MM Mon 040<br />
Odlind, V<br />
FC10.1.4<br />
O'Donnell, P Thu 402<br />
Odoriz, B Mon 280<br />
Oduola, MJ<br />
YI.09<br />
Offermanns, S FC11.5.3, Wed 056<br />
Offiah, NV Thu 326<br />
Offringa, M W36.1, W36.3<br />
Ofori-Adjei, D W36.1, W36.5<br />
Ogawa, R Tue 486<br />
Ogawa, Y Tue 470<br />
Oger, S Mon 233, Mon 232<br />
Ogihara, M Tue 390<br />
Ogita, K Thu 099, Tue 376, Mon 461,<br />
Wed 083, Tue 375<br />
Oguchi, K Wed 128, Wed 372, Tue 443<br />
Ogundele, SO Tue 100<br />
Ogunleye, OO Tue 100<br />
Ogwal-Okeng, J Tue 005, Wed 136<br />
Oh, D-H Wed 142, Tue 044, Tue 043,<br />
Wed 143<br />
Oh, J-Y Thu 385<br />
O'Halloran, A Tue 364<br />
O'Hara, G Wed 123<br />
Ohashi, K Tue 144<br />
Ohata, H Wed 256<br />
Ohhara, M Tue 168<br />
Ohi, K Mon 182<br />
Ohkubo, S Wed 078<br />
Ohkubo, T Tue 147<br />
Ohlstein, E Tue 479<br />
Ohmoto, Y Thu 103<br />
Ohnishi, K Tue 484, Tue 491<br />
Ohta, H Thu 430<br />
Ohta, R Tue 459<br />
Ohtake, S Tue 477<br />
Ohura, K Tue 266<br />
Ohya, S Wed 107, Thu 102, Thu 107<br />
Oida, Y Thu 406<br />
Oikawa, A Thu 414<br />
Oikonen, V Mon 256<br />
Oishi, K Tue 470<br />
Oishi, R Mon 093, Thu 109<br />
Oiso, S Tue 167<br />
Ojala, Y<br />
FC14.3.6<br />
Ojoo, A<br />
FC10.3.1<br />
Okada, M Thu 108<br />
Okamoto, H Tue 153<br />
Okamoto, S Mon 459<br />
Okamura, C Wed 305<br />
Okamura, M Mon 329<br />
Okamura, N<br />
FC17.5.6<br />
Okamura, T Wed 200<br />
Okaniwa, T Mon 177<br />
Okazaki, M Wed 266, Thu 227<br />
Okechukwu, P Thu 327<br />
Oki, K Mon 402<br />
Okubo, K Tue 077<br />
Okuda, A Wed 373<br />
Okuda, T Tue 373<br />
Okulicz-Kozaryn, I Thu 174<br />
Okuno, T Tue 443<br />
Okuno, Y Tue 468<br />
Okuyama, C Tue 241<br />
Okuyama, H Tue 147<br />
Okwara, V Mon 017<br />
Okyar, A Tue 245, Tue 142<br />
Ola, R Mon 215<br />
Olazabal, EV Mon 038<br />
Olde, B Thu 074, Thu 047, Wed 052,<br />
Wed 062<br />
Oldenburger, A Tue 242<br />
Olesen, J PL13, Thu 106, Mon 099<br />
Olesen, S-P FC06.1.4, Wed 282<br />
Olinda, T Wed 318, Mon 299, Wed 319<br />
Oliveira, A C Wed 144<br />
Oliveira, F Mon 097<br />
Oliveira, JL<br />
FC04.4.6<br />
Oliveira, L Thu 025<br />
Oliveira, MFSC YI.08<br />
Oliveira, PRB Wed 341, Wed 340<br />
Oliveira, R Mon 298<br />
Oliveira, SHP Tue 243<br />
Oliveiros, B Mon 350<br />
Oliver, DW Mon 442<br />
Oliver, DW Mon 412<br />
Oliver, E Tue 165, Thu 048, Tue 163<br />
Oliver, V Tue 202<br />
Oliveros, I Tue 362<br />
Olivier, E Thu 332<br />
Olivier, NB Wed 156<br />
Olli, A Tue 433<br />
Olmez, E Wed 357<br />
Oloro, J Tue 209<br />
Olowofela, A Tue 010<br />
Olsen, JV Wed 036<br />
Olukman, M Thu 228<br />
Olurishe, T Tue 011, Wed 145<br />
O'Mahony, B Thu 177<br />
Omar, MH Thu 328<br />
Omara, EA Tue 451<br />
Ombrato, R Thu 433<br />
Omic, S Tue 437<br />
Omidi, Y Mon 044,<br />
Onaivi, E Thu 176<br />
Onaran, O Thu 049<br />
Onat, F Mon 418<br />
Oneda, B Mon 160<br />
Ong, KL Mon 271, Mon 159<br />
Oniki, H Tue 162<br />
Onlamul, W Thu 361<br />
Ono, K Tue 430<br />
Onoe, H Tue 244<br />
Onoue, S Tue 216<br />
Ooga, K Thu 103<br />
Opie, L<br />
FC06.3.1<br />
Oppenheim, C Mon 191<br />
Or, PMY Thu 389<br />
Orallo, F FC16.2.5, Wed 359<br />
Oram, D<br />
FC05.3.6<br />
Oransay, K Tue 449, Tue 366<br />
Ordyan, N<br />
FC17.1.6<br />
Index 357
Name Paper ref. Name Paper ref.<br />
Oreagba, I Wed 144<br />
Orellana, S Tue 326<br />
Orensanz, LM Mon 411<br />
Orer, SH W17.4<br />
Orescanin-Dusic, Z Thu 329, Tue 122, Thu 318<br />
Oriá, RB Tue 255<br />
Orlandi, S<br />
FC18.4.5<br />
Orlando, G Mon 105, Wed 434, Wed 329<br />
Orlando, R Wed 404<br />
Orozco, FAJ Thu 330<br />
Orrenius, S<br />
FC13.2.3<br />
Orrico, M Mon 275<br />
Orrtiz, E Thu 178<br />
Ørskov, C<br />
FC05.3.5<br />
Orta, IA Mon 125<br />
Orta, ML Mon 040<br />
Ortega, JE Thu 031, Thu 399<br />
O'Shea, R Mon 045<br />
Ospina, DA Mon 480<br />
Østergaard, L Wed 240<br />
Østergaard, S Thu 404<br />
Östervall, J<br />
FC13.4.5<br />
Östman, J Thu 278<br />
Ostrow, G Wed 417<br />
O'Sullivan, S Wed 285, Tue 460<br />
Oswald, S Tue 049, Tue 041<br />
Oswald, S Tue 045<br />
Ota, M Wed 128<br />
Otake, S Wed 186<br />
Oteo, I Wed 111<br />
Otsu, K<br />
FC06.4.3<br />
Otsuguro, K Mon 101<br />
Otsuka, A Mon 035<br />
Ottenheijm, HCJ Wed 085<br />
Otto, M Mon 090<br />
Otto, S<br />
FC13.4.5<br />
O'Tuathaigh, C FC17.2.1<br />
Otukesh, H Thu 006<br />
Ouanes, I Thu 346<br />
Ouanes, L Wed 348, Mon 004<br />
Oueslati, N<br />
FC11.3.6<br />
Overvad, K Tue 482<br />
Ovesjö, M-L Mon 371<br />
Oyagi, A Thu 406<br />
Oyama, Y Thu 331<br />
Oyamada, H Wed 128<br />
Özatýk, Y Wed 420<br />
Ozawa, H Thu 403<br />
Özcan, G Thu 049<br />
Ozdemir, O Thu 266, Mon 199, Tue 461,<br />
Thu 269<br />
Özdemir, V W16.6<br />
Ozkan, MH Thu 229<br />
Özkutlu, U W05.2<br />
Ozokwere, JJC Thu 332<br />
Oztop, I Tue 411<br />
Öztürk, N Tue 245<br />
Ozturk, EI Thu 230<br />
Ozyogurtcu, H Tue 461<br />
Pacifici, R Mon 375<br />
Pacini, A Tue 446, Mon 391<br />
Packeu, A Thu 426<br />
Padin, F Tue 116<br />
Padrosa, A Tue 133<br />
Pageaux, GP FC04.2.6, Mon 141<br />
Pai, H-C Mon 326<br />
Paillard, F Mon 145, Mon 132<br />
Paintaud, G Tue 198, Tue 190<br />
Painter, A W06.3<br />
Pairoj, V Tue 127<br />
Pajdo, R Tue 463<br />
Pajeau, P Tue 171<br />
Pajor, L Wed 284<br />
Pajouhesh, H<br />
FC03.2.1<br />
Pakarinen, P Mon 215<br />
Pal, A<br />
FC16.2.6<br />
Pala Kara, Z Tue 245<br />
Palatini, P Wed 404<br />
Palea, S Tue 205, Tue 206, Tue 204,<br />
Mon 244, Tue 203<br />
Palivoda, M Tue 137<br />
Pallas, M Mon 443<br />
Palma, C Wed 152<br />
Palme, R Wed 397<br />
Palmero, M Mon 138 Mon 477, Mon 472,<br />
Mon 481, Thu 407<br />
Palmero, MM Mon 473<br />
Palmiere, PCR Tue 101<br />
Palombo, E Wed 360<br />
Pamplona, F Thu 396<br />
Pan, X Tue 299<br />
Pan, Y FC14.1.2, Thu 103, Tue 426<br />
Panagiotidis, G Wed 147<br />
Panagopoulos, P Tue 126<br />
Panahi, Y Thu 005, Thu 311<br />
Panayiotou, C Thu 278<br />
Panchaud, A<br />
Mon 022, FC10.5.3<br />
Panda, VS Wed 304<br />
Pandolfo, G Thu 419<br />
Panduriv, M Tue 167<br />
Pang, CCY Mon 184<br />
Panhelainen, AE Thu 194<br />
Pani, L<br />
SS01.4<br />
Panich, U Tue 007<br />
Pantovic, S Thu 231, Wed 019<br />
Pantsurkin, VI Tue 179<br />
Panula, P<br />
FC14.3.6<br />
Papadimitriou, E Thu 232<br />
Papadopoulos, C Mon 143<br />
Papadopoulou-Daifoti, Z W33.4<br />
Papaioannidou, P Tue 246<br />
Papakosta, M<br />
FC03.2.6<br />
Papantonakis, PB Tue 302<br />
Papapetropoulos, A Thu 202<br />
Papapetropoulos, As FC15.3.6<br />
Papaseit, E Thu 178, Mon 109<br />
Papathanasopoulos, P Wed 074<br />
Papouchado, M Mon 280<br />
Papp, GJ Wed 197<br />
Papp, J Mon 100<br />
Papp, JG Wed 284<br />
Paquet, B Wed 443<br />
Parada, C Mon 276<br />
Paraskakis, E Tue 224<br />
Pardo, L<br />
W01.1.3<br />
Pardo, R Mon 109, Mon 375, Thu 177,<br />
Thu 178<br />
Pardo-Andreu, GL Wed 344<br />
358 Index
Name Paper ref. Name Paper ref.<br />
Paredes, SD Wed 352, Mon 407<br />
Parente, L Tue 406<br />
Pariente, JA Mon 407<br />
Parini, P Tue 387, Tue 383<br />
Park, BK<br />
FC13.2.2<br />
Park, HW Tue 046<br />
Park, I-C Tue 427<br />
Park, J Tue 047<br />
Park, K Mon 226, Mon 013, Tue 349,<br />
Mon 029, Thu 418, Mon 033<br />
Park, M Mon 427<br />
Parkel, S Thu 077<br />
Parks, V Tue 012<br />
Parlar, A Thu 233<br />
Parmar, S Wed 148<br />
Parsaee, H Tue 424<br />
Parsons, M Mon 086<br />
Pascale, A Mon 152<br />
Pascual, MA Thu 394, Thu 395<br />
Pascual-Brazo, J Wed 401<br />
Pasko, K Mon 347<br />
Paskulin, R Thu 329, Thu 318<br />
Pasqualina, F Thu 400<br />
Passeri, D<br />
FC18.4.5<br />
Pastor, A Thu 178<br />
Pastor, M<br />
YI.03<br />
Pastor, MJ<br />
FC09.2.7<br />
Pastorello, M Tue 127, Thu 254<br />
Pastro, L Wed 231<br />
Pásztor, M Mon 261<br />
Patacchini, R W03.4<br />
Patapoutian, A FC03.1.2<br />
Pataricza, J Wed 197, Wed 284<br />
Patel, K<br />
FC16.1.6<br />
Patel, P Wed 149, Thu 113<br />
Paterniti, I<br />
FC18.1.5, FC18.3.6,<br />
Mon 286<br />
Patil, AW Wed 381<br />
Patil, RN Thu 333<br />
Patiño-Camacho, S Mon 009<br />
Patonay, T Mon 163<br />
Patras, X Mon 108<br />
Patrignani, P FC09.4.2, W18.3, Mon 281,<br />
Wed 235<br />
Patrikainen, S Mon 447<br />
Patrono, C W18.1, W18.4<br />
Patte-Reutenauer, J W04.3.2<br />
Patterson, TA Wed 150<br />
Paukkeri, E-L Tue 247<br />
Paul, F Thu 013<br />
Paul, R Thu 224<br />
Paul-Clark, M Thu 241<br />
Paule, MG Wed 150<br />
Paules, RS<br />
FC13.4.3<br />
Paulo, M<br />
FC15.4.5<br />
Paunescu, H Mon 274<br />
Paunovic, B<br />
W02.2.7<br />
Paunovic, G Tue 149<br />
Pavelkova, V Tue 137<br />
Pavlyuchenko, V FC06.1.6<br />
Pawar, V Thu 333<br />
Pawlik, M Tue 463<br />
Pawlik, WW Tue 463<br />
Pawlowska, I Wed 279, Mon 181<br />
Paz Lopes, MT Tue 428<br />
Pazos, A Wed 401, Thu 408<br />
Pechanova, O Mon 148, Mon 293<br />
Pedersen, A<br />
FC05.4.6<br />
Pedersen, AF Thu 066<br />
Pedersen, DS FC11.5.1, Tue 248<br />
Pedersen, L<br />
FC04.1.6<br />
Pedersen, MFH FC11.5.6<br />
Pedersen, MØ Tue 359, Tue 248<br />
Pedersen, ME Thu 234<br />
Pedersen, RS Wed 151<br />
Pedersen, S FC05.1.1, Thu 026<br />
Pedroso, A Wed 140<br />
Peeters, M<br />
FC11.4.6<br />
Peiro, C W08.1, Tue 134<br />
Peitl, B Tue 142, Mon 163, Tue 125<br />
Mon 150, Mon 167, Tue 128<br />
Peixoto, AVB Tue 281<br />
Pekiner, C Wed 438, Mon 155<br />
Pekson, R Thu 334<br />
Pelkonen, O PL16, Thu 348<br />
Pellaquini, EH Mon 289<br />
Pellegrini, M Mon 375<br />
Peltonen, I Mon 444<br />
Peltonen, T Tue 166<br />
Pena Dias, J Thu 073<br />
Peña, C Tue 114<br />
Pendek, R<br />
YI.04<br />
Peng, M Mon 331<br />
Peng, SR Wed 291<br />
Peng, X Wed 099<br />
Peng, X-Q Wed 182<br />
Peng, Y Mon 445, Mon 466<br />
Penkowa, M Tue 359 Tue 248<br />
Penninx, BWJH Wed 432, Tue 096<br />
Peoch, K Wed 191<br />
Peoc'h, K<br />
FC01.4.4<br />
Pepedil, F Wed 249<br />
Pepper, M Mon 368<br />
Perälä, M Mon 410, Tue 436<br />
Peränen, J Mon 341<br />
Percie du Sert, N Tue 471<br />
Perdan-Pirkmajer, K Mon 074, Tue 048<br />
Perdomo, L Tue 226<br />
Pereira do Vale, AC YI.08<br />
Pereira, F Wed 180<br />
Pereira, FC YI.08, Thu 193<br />
Pereira, J Wed 214<br />
Pereira, JCM W31.3<br />
Pereira, L Wed 394, Tue 123<br />
Pereira, M Wed 394<br />
Pereira, P Thu 187<br />
Pereira, R Tue 241<br />
Pereira, SA Wed 130<br />
Perez Vizcaino, F Thu 235<br />
Pérez, E Tue 087<br />
Pérez, JA Mon 125<br />
Perez, M Thu 177, Thu 178<br />
Pérez, R Wed 152, Wed 217<br />
Pérez, T Tue 016<br />
Perez-Aso, M Thu 050, Wed 068<br />
Perez-Gutthann, S FC04.2.6<br />
Perez-Maña, C FC14.4.5, Thu 178, Thu 177<br />
Index 359
Name Paper ref. Name Paper ref.<br />
Perez-Vizcaino, F Tue 121, Mon 374, Wed 226,<br />
Thu 217<br />
Pergolizzi, S Thu 316<br />
Perhariè, L Wed 153<br />
Peric, M Thu 324, Wed 103<br />
Perju-Dumbrava, L Tue 481<br />
Perkecz, A Tue 271<br />
Perna, A Thu 014<br />
Pernas, S Mon 146<br />
Pernomian, L Thu 236<br />
Perreau, V Mon 045<br />
Perretti, M<br />
FC09.5.7, FC09.4.6<br />
Perrin-Sarrado, C Wed 244<br />
Perroy, J<br />
FC11.3.3<br />
Perry, M<br />
FC06.1.1<br />
Pertz, HH W13.4<br />
Peshavariya, H Mon 194, FC06.4.5,<br />
Wed 219, FC15.2.5<br />
Pesic, S Thu 070<br />
Pesquero, JB Thu 061, Wed 041<br />
Petcu, LC Mon 162<br />
Petermann, O Wed 108<br />
Peters, D<br />
YI.10<br />
Peters, JA<br />
Tue 479, FC03.3.5<br />
Peters, J Tue 049<br />
Peters, S Thu 258, Thu 082<br />
Petersen, CN Mon 154<br />
Petersen, KB<br />
FC07.4.5<br />
Petersen, L J W26.3<br />
Petersen, LG Mon 345<br />
Petersen, M FC13.3.6, Mon 119,<br />
Mon 118, Mon 406<br />
Petersen, MS Wed 151<br />
Peterson, C Tue 395<br />
Peterson, S Wed 423<br />
Pethö, G Tue 078<br />
Pétrault, O Thu 237<br />
Petrella, C Tue 249,<br />
Petridis, I Mon 187<br />
Petroni, RC Wed 204<br />
Petronijevic, M Tue 367<br />
Petronijevic, N Wed 343<br />
Petrovic, B Thu 436, Mon 446<br />
Petrovic, V Tue 050<br />
Petrrault, O<br />
FC17.2.5<br />
Petrushun, V Wed 122, Wed 121, Wed 120<br />
Petsalo, A Mon 063<br />
Pexa, K Wed 022<br />
Peyronel, C Tue 289, Tue 290<br />
Peytavin, G Tue 040<br />
Pfeifer, A Tue 129<br />
Pfister, M<br />
FC07.3.2<br />
Pfleger, KDG Wed 079<br />
Phadungrakwittaya, R Thu 335<br />
Philippu, A W33.1<br />
Phillips, M Wed 123<br />
Phillips, O Tue 340<br />
Piacente, S Tue 406<br />
Picchianti, L Wed 442, Mon 382<br />
Piccione, F Tue 405, Wed 010<br />
Pichette, V W06.4<br />
Pichini, S Mon 375<br />
Pichkhadze, G Thu 336 Tue 079<br />
Piekorz, R Wed 022<br />
Pieles, U Tue 134<br />
Pieratti, A Wed 317<br />
Pierse, N Tue 136<br />
Pietro, B Thu 400<br />
Pietrobon, D<br />
FC12.1.4<br />
Pietsch, J Thu 267, Wed 252<br />
Pignier, C Tue 170, Tue 171, Tue 172<br />
Pihlaja, T Mon 063<br />
Pilar-Cuellar, F Wed 401<br />
Pilar-Cuillar, F Thu 408<br />
Pilatova, M Tue 423<br />
Pilegaard, H Wed 281<br />
Pillai, K Wed 419<br />
Pillai, KK Tue 137,<br />
Piltonen, M Mon 447<br />
Pimentel, F Tue 086<br />
Pin, J-P<br />
FC11.2.1, FC11.3.5,<br />
FC11.3.6, Wed 077, Thu 035,<br />
Thu 083<br />
Ping, J Tue 130<br />
Pinheiro, H Tue 123<br />
Pinheiro, R Mon 298<br />
Pinho, MJ Mon 057<br />
Pintér, E W19.3, Mon 318, Tue 271,<br />
Tue 250<br />
Pinto, R Tue 207<br />
Pipelzadeh, MH Tue 251<br />
Piperski, V Wed 343<br />
Piqueras, L Thu 437<br />
Piquette-Miller, M W06.2, Tue 050<br />
Piras, V Tue 133<br />
Pirkmajer, S Tue 048<br />
Pirmohamed, M FC13.3.4<br />
Pirovano, M Thu 111<br />
Pirro, E Tue 405, Wed 010<br />
Pistritto, G Mon 281<br />
Pitre, S Mon 166<br />
Pitre, Shweta Tue 131<br />
Pitterle, K Wed 148<br />
Pitychoutis, P W33.4<br />
Piwnica, D Thu 088<br />
Pizza, C Tue 406<br />
Pizza, V Tue 487, Mon 448, Tue 488,<br />
Mon 449<br />
Pizzolatti, MG Wed 394<br />
Plante, I Tue 051<br />
Plath, N<br />
FC17.4.2<br />
Platzer, W<br />
FC11.1.6<br />
Plenge, P<br />
FC02.3.5<br />
Plevin, R Tue 252<br />
Pliskova, M Tue 222<br />
Pochetti, G Thu 433<br />
Pochop, P Tue 445<br />
Podestá, MHMC Tue 101, Mon 010<br />
Podracka, L Thu 033<br />
Pogantsch, M Mon 153<br />
Pogge, T<br />
PL08<br />
Pohanka, M Tue 343, Mon 075, Tue 074,<br />
Tue 448<br />
Pohjanoksa, K Wed 092<br />
Pohjolainen, V Tue 166<br />
Poitou, C<br />
FC01.4.4<br />
Pokorná, P Wed 017, Mon 267<br />
Pol, O Thu 042, Wed 059<br />
360 Index
Name Paper ref. Name Paper ref.<br />
Polaskova, A Tue 342<br />
Pold, R Tue 132<br />
Polenzani, L Thu 433<br />
Polewicz, D<br />
FC06.3.6<br />
Polónia, J Thu 119<br />
Pols, T<br />
FC18.2.4<br />
Ponce, L Tue 394<br />
Ponciano, E Mon 350<br />
Pongnarin, P Tue 007, Mon 357, Mon 355,<br />
Mon 334<br />
Pons, G<br />
FC10.1.1<br />
Poopyruchpong, N Tue 277<br />
Pope, HG<br />
FC14.5.1<br />
Popova, O Mon 462<br />
Popovici, ED Tue 102<br />
Popovici, MG Tue 102<br />
Popp, R Mon 417, Mon 438, Tue 481<br />
Porreca, F<br />
FC03.2.1<br />
Pórszász, R Tue 125<br />
Porter, E Wed 269, Wed 238<br />
Porto, LC Wed 342<br />
Postnikov, PV Wed 175<br />
Poston, R Thu 197<br />
Potschka, H<br />
FC02.2.3<br />
Potter, CMF Thu 241, Thu 238<br />
Poulsen, A Thu 106<br />
Poulsen, FM Tue 053<br />
Poulsen, H Mon 118<br />
Poulsen, HE FC04.2.4, Mon 345, Tue 480,<br />
Tue 482, Mon 119<br />
Poulsen, M Tue 080<br />
Poulsen, P Mon 406<br />
Pourcel, L Mon 129<br />
Pourmotabbed, A Mon 437<br />
Poutanen, M Wed 446<br />
Pouton, C Thu 280<br />
Povarnina, P Mon 225<br />
Povlsen, GK Mon 450, Thu 239<br />
Powell, C Mon 393, Mon 420<br />
Poyner, D Wed 057<br />
Pozgai, G Thu 197<br />
Pozsgai, G Tue 271<br />
Pradelli, L Mon 223<br />
Pradelli, L Wed 154<br />
Praliev, K Tue 079<br />
Prasad, AN<br />
FC10.2.5<br />
Prasad, R Mon 028<br />
Prat, I Tue 394<br />
Pratt, J<br />
FC17.1.4<br />
Preininger, A<br />
FC11.3.2<br />
Preston, K<br />
FC14.3.4<br />
Preston, R Wed 155<br />
Prezeau, L<br />
FC11.2.1<br />
Pribula, J Wed 090<br />
Priestley, J Thu 278<br />
Prieto, D FC08.2.5, Thu 249, Mon 239,<br />
Tue 213, Mon 411<br />
Prieto, E Tue 103<br />
Prilutsky, A Tue 057<br />
Prinsen, J Wed 156<br />
Prinzis, S Tue 133<br />
Pritchard, D Mon 282<br />
Procaccini, C Wed 393, Thu 409<br />
Procházka, V Tue 475<br />
Proctor-Brown, C Tue 372<br />
Proksch, B<br />
YI.02<br />
Prosser, R Thu 019<br />
Prostran-Veselinovic, M Tue 013, Mon 114, Wed 009,<br />
Tue 026, W34.1, W34.2<br />
Prudhomme, M Tue 429<br />
Prunier, C Thu 055<br />
Prusa, R Tue 137<br />
Ptacek, LJ<br />
FC12.4.4<br />
Ptak-Belowska, A Tue 463<br />
Pubill, D Wed 177, Wed 174, Thu 179,<br />
Wed 181<br />
Puerta-Vazquez, R Wed 349<br />
Pugi, A Thu 302,<br />
Pugnet, G Tue 104<br />
Puppala, B Wed 184<br />
Pupure, J Mon 429, Tue 253, Wed 045<br />
Pursley, J Tue 495<br />
Putter, S Tue 110<br />
Puttonen, KA W21.3<br />
Putula, J Thu 051<br />
Pyo, H-B Thu 385<br />
Pyriochou, A<br />
FC15.3.6<br />
Qi, C Mon 032, Thu 410<br />
Qi, H Thu 368<br />
Qi, T Wed 057<br />
Qian, G Mon 031<br />
Qian, J Thu 089<br />
Qiang, G Thu 384<br />
Qiang, GF Mon 433<br />
Qin, H Thu 372<br />
Qin, H-L Wed 346<br />
Qin, Y Thu 295<br />
Qiu, H<br />
FC02.1.5<br />
Qu, H Tue 173, Tue 325<br />
Qu, HJ Mon 008<br />
Quadros, I<br />
FC14.4.3<br />
Que, A Tue 158<br />
Queckenberg, C Thu 010<br />
Queiroz, E Wed 375<br />
Queiroz, MGR Wed 297<br />
Quick, M<br />
FC02.1.2<br />
Quignard, J-F Wed 293<br />
Quinn, J Tue 271<br />
Quinn, JP W19.3<br />
Quinn, TJ<br />
FC15.1.6<br />
Quiroz, G Thu 187<br />
Ra, R Thu 051<br />
Raasmaja, A Mon 341<br />
Rabello, MM Thu 374<br />
Racca, S Tue 405<br />
Racek-Król, B Mon 181<br />
Radacic-Aumiler, M Tue 328, Mon 135<br />
Radhakrishnan, AK Tue 254<br />
Radojicic, R Tue 122<br />
Radonjic, N Wed 343<br />
Radovic, J<br />
FC16.3.6<br />
Radovic, V Wed 157<br />
Radwanska, A Mon 197<br />
Ragia, G Mon 187<br />
Rägo, L<br />
FC01.4.3<br />
Rahbar, A Tue 014<br />
Rahbari, S Wed 301<br />
Rahimi, A Wed 364<br />
Index 361
Name Paper ref. Name Paper ref.<br />
Rahimian, R Wed 254<br />
Rahimi-Moghaddam, P Tue 105, Tue 485<br />
Rahmoun, I Mon 290<br />
Rai, J<br />
FC01.2.6<br />
Raimundo, J Tue 162<br />
Rain, M Mon 136<br />
Raine, JM<br />
FC04.3.1<br />
Rainio, E Tue 429<br />
Raisman, R Mon 469<br />
Raj, VL YI.04, Tue 254<br />
Rajabi, O Tue 052<br />
Rajabnia, M Mon 230<br />
Rajaian, H Tue 015<br />
Rajakannan, T<br />
FC04.3.7<br />
Rajbanshi, S Mon 091<br />
Rakhshandehroo, M Thu 438<br />
Ralevic, V Wed 023<br />
Ram, Birendra Mon 028<br />
Ram, M Mon 028<br />
Rama, AC Mon 376<br />
Ramachandran, V Thu 380<br />
Ramadaniati, H Thu 011<br />
Ramajo, M Thu 264, Thu 240, Wed 215,<br />
Mon 206, Tue 144<br />
Ramanujan, S Tue 196<br />
Ramaswamy, M Mon 070<br />
Ramenckaya, G Tue 129<br />
Ramenskaya, GV Thu 253,<br />
Ramer, R Thu 337<br />
Ramirez, E Mon 451<br />
Ramírez, O<br />
Mon 023, W04.1.3<br />
Ramírez-Rosas, MB W13.3<br />
Ramsjö, M Tue 489, Tue 308<br />
Randhawa, MA Thu 338<br />
Rane, A Thu 256, Tue 318, Tue 138,<br />
FC14.1.6, Wed 183, Wed 176<br />
Rangachari, PK W20.3, Tue 368<br />
Rankin, L Wed 132<br />
Rantakari, P Mon 215<br />
Ranta-Panula, V Thu 052, Thu 071<br />
Rao, A<br />
FC12.5.4<br />
Rao, PGM<br />
FC04.3.7<br />
Rao, V Wed 318, Wed 319<br />
Raskovic, A Tue 454,<br />
Rasmussen, M Mon 450<br />
Rasmussen, MH Mon 227<br />
Rasmussen, MNP Thu 053<br />
Rasouli, A Wed 301<br />
Rassouli, A Tue 191<br />
Rastinejad, F<br />
FC18.4.1<br />
Rathbone, D Wed 057<br />
Rathje, MA YI.10, Tue 053<br />
Rattazzi, L Tue 256, Thu 434<br />
Rauch, A W33.2<br />
Raunsø, J<br />
FC04.2.4<br />
Rautio, A Mon 076<br />
Ravna, AW Mon 224<br />
Ray, A<br />
FC16.4.2<br />
Rayate, S Thu 333<br />
Raynaud, F<br />
FC11.3.3<br />
Rayyan, M Wed 001<br />
Razik, F Wed 149<br />
Rebola, N<br />
YI.10<br />
Rebollo, A Tue 133<br />
Rebsamen, M Tue 305<br />
Rebsamen, MC Tue 166<br />
Recinella, L Mon 105, Wed 329, Wed 434<br />
Recio, MC Wed 300<br />
Recio, P Mon 411<br />
Rédei, D Thu 307<br />
Redondo, S W09.3, Mon 206, Tue 144,<br />
Wed 228, Thu 240, Thu 264<br />
Reed, DM Thu 241<br />
Reed, G Wed 158<br />
Rees, K<br />
FC03.3.6<br />
Reeta, KH Mon 452,<br />
Reeves, J Mon 443<br />
Refsum, H Tue 490, Wed 412<br />
Regla, I Tue 420<br />
Reglodi, D Mon 110, Mon 106, Mon 318<br />
Reguillo, F Thu 240, Wed 215, Mon 206<br />
Reichel, C Tue 227<br />
Reiner, Z Mon 048<br />
Reis, DG Wed 411<br />
Reiter, RJ Mon 407<br />
Rekik, M Tue 205, Tue 206, Tue 204<br />
Rembold, CM<br />
W04.3.4<br />
Remirez-Figueredo, D Wed 159, Thu 339<br />
Ren, Junguo Thu 340<br />
Ren, S Thu 390<br />
Ren, X<br />
W02.1.6<br />
Resende, AC Wed 341, Wed 340, Wed 342<br />
Resstel, L Wed 411<br />
Reul, J<br />
FC17.5.2<br />
Reuther, L Wed 160, Wed 161<br />
Reyes-Vega, JJ Thu 246<br />
Reynolds, RF<br />
FC04.2.1<br />
Rezania, F Thu 180<br />
Rezapourian, P Thu 209<br />
Rezayat, M Wed 437<br />
Rezazadeh, H Mon 294<br />
Rheeders, M Thu 016, Thu 012<br />
Riba, P Thu 192<br />
Ribeiro, CF YI.08, Thu 193<br />
Ribeiro, RA Tue 255<br />
Ribel-Madsen, R Mon 406<br />
Ribuot, C Thu 245<br />
Ricciotti, E Mon 281<br />
Richards, B Wed 110<br />
Richards, J<br />
FC14.3.5<br />
Richards, S Tue 353<br />
Richelsen, B<br />
FC05.1.1<br />
Rickhag, M<br />
FC02.3.6<br />
Rieder, M Wed 013<br />
Rieder, MJ<br />
FC10.2.5<br />
Riegel, C Mon 463<br />
Riggi, C Wed 010<br />
Righetti, L Thu 440<br />
Rigoni, VLC Thu 351, Thu 352<br />
Rimando, A Mon 443<br />
Rimondini, R<br />
FC14.1.5<br />
Rinken, A Tue 192, Thu 077<br />
Rinne, P Thu 243<br />
Ríos, JL Wed 300<br />
Risso, A Tue 362<br />
Ristic, S Wed 343<br />
Ristimäki, A<br />
FC09.4.3<br />
Riva, MA<br />
SS01.3<br />
362 Index
Name Paper ref. Name Paper ref.<br />
Rivera, L Wed 225, Wed 224<br />
Rizzo, G<br />
FC18.4.5<br />
Robays, H Mon 365, Tue 306<br />
Roberts, RR Tue 322, Mon 064<br />
Robertson, G W06.3<br />
Robillard, K FC02.4.5, Mon 070<br />
Robinson, E Wed 392, Thu 439<br />
Robinson, K Thu 393<br />
Robson, R Mon 259<br />
Rocha, L Mon 095, Mon 097, Mon 094<br />
Rocha, M Mon 383<br />
Rocha-Pereira, C Thu 054<br />
Roche, M Thu 021<br />
Roda, JM Mon 079<br />
Rodchenkov, GM Wed 175<br />
Rodeiro-Guerra, I Wed 344<br />
Rodell, A Tue 193<br />
Roden, DM W23.3<br />
Roden, M<br />
FC05.4.1<br />
Rodrigo, M Tue 196<br />
Rodrigo, T Wed 174<br />
Rodrigues, E Thu 025<br />
Rodrigues, ES Thu 061<br />
Rodriguez, AB Mon 407, Wed 352<br />
Rodriguez, B<br />
FC07.2.3<br />
Rodríguez, C W09.4<br />
Rodriguez, E Thu 240, Thu 399<br />
Rodríguez, G Thu 358<br />
Rodríguez, JC<br />
Mon 023, W04.1.3<br />
Rodriguez, L Thu 358<br />
Rodriguez, M Mon 229, Mon 080<br />
Rodríguez, R<br />
Mon 023, W04.1.3<br />
Rodríguez-Franco, MI Mon 079<br />
Rodriguez-<br />
Gaztelumendi, A Thu 408<br />
Rodriguez-Mañas, L Tue 134<br />
Rodriguez-Salazar, M Tue 150<br />
Rodríguez-Soriano, NY Tue 150<br />
Rogava, MA Mon 192, Mon 216<br />
Rogava, M Tue 174<br />
Rogers, M Tue 284<br />
Roglans, N Tue 133<br />
Rognan, D Wed 216<br />
Roh, H-K Tue 489<br />
Roivainen, A Mon 256<br />
Rojas, J Tue 362<br />
Rolan, P Wed 113<br />
Rollason Gumprecht, V Tue 305<br />
Rollema, H<br />
FC14.2.3<br />
Romacho, T Tue 134<br />
Roman, A Mon 374<br />
Roman-Campos, D FC03.1.5<br />
Romano, Adele Thu 440<br />
Romao, C Thu 202<br />
Romashenko, O Tue 175<br />
Rombouts, SARB Mon 400<br />
Romero, E Thu 271<br />
Romero-Gomez, M Tue 123<br />
Romijn, JA Tue 148<br />
Rommelfanger, K W01.2.4<br />
Rompré, P-P<br />
FC17.4.6<br />
Romualdi, P<br />
FC14.1.5<br />
Rónai, A Thu 094<br />
Rondard, P<br />
FC11.2.1<br />
Rondinelli, S Wed 081<br />
Rong, Z-X Thu 368<br />
Rønn, JH Tue 161<br />
Roohbakhsh, A Thu 412<br />
Rosa, AC Thu 434<br />
Rosa, AC Tue 256<br />
Rosa, S Tue 257<br />
Roschin, V Wed 347<br />
Roscioni, SS Tue 242, Wed 095<br />
Roseboom, P Thu 410<br />
Rose'Meyer, R Tue 135<br />
Rosén, I Thu 008<br />
Rosenbaum, D S FC06.1.3<br />
Rosenblad, M Wed 092<br />
Rosenborg, S<br />
FC13.4.5<br />
Rosenkilde, MM FC11.2.4, FC11.5.5<br />
Röshammar, D Wed 136<br />
Roskos, L Mon 228<br />
Ross, G<br />
FC12.1.5<br />
Ross, R Tue 284<br />
Rossi, M Thu 062<br />
Rossier, BC<br />
FC12.3.4<br />
Rossier, MF Tue 166<br />
Rossini, M Tue 362<br />
Rosskopf, D Wed 119<br />
Rossoni, L Wed 231, Wed 042<br />
Rostami-Hodjegan, A FC07.2.1, FC10.3.5<br />
Rothman, KJ<br />
FC04.1.3<br />
Rouet, P Wed 196<br />
Rouget, C Tue 205, Tue 206, Tue 204<br />
Roughead, E<br />
FC13.1.6<br />
Rouholamin, M Thu 391, Thu 392<br />
Rouillard, C FC17.4.6, Wed 443<br />
Rouleau, A Wed 051<br />
Roulet, E Wed 108, Wed 102<br />
Rousseau, A Wed 011<br />
Roustit, M Wed 208, Thu 244, Thu 245<br />
Roux, T Thu 035<br />
Roviezzo, F Thu 081<br />
Rovira, EE Thu 048<br />
Rowan, M Mon 453<br />
Rowland, I Wed 307<br />
Rowlands, DK Tue 139, Thu 341<br />
Royer, C<br />
FC18.3.5<br />
Röyttä, M W21.4<br />
Rozas, I Thu 399<br />
Rozehnal, V Tue 039<br />
Ruan, J Mon 077, Mon 078<br />
Ruangnapa, T Mon 355<br />
Ruangrut, P Wed 124<br />
Rubets, I Tue 228, Wed 122<br />
Rubie, P Tue 309<br />
Rubino, A Tue 093<br />
Rubio, V Mon 254<br />
Rucman, R<br />
W02.3.1<br />
Rudberg, I Tue 490<br />
Rudd, JA Tue 471<br />
Rueda, E Wed 250, Mon 278<br />
Rueda, J Tue 165, Tue 163<br />
Rüegg, UT W04.3.2, Wed 102, Wed 108,<br />
Thu 013<br />
Ruengprasertkit, C Thu 357<br />
Rui, Y-C Thu 210<br />
Ruiz- Moreno, MI Thu 246<br />
Index 363
Name Paper ref. Name Paper ref.<br />
Ruiz, I Mon 390<br />
Ruiz, JD Wed 109<br />
Ruiz-Cabello, F Tue 123<br />
Rumaks, J Mon 429, Tue 253, Wed 045<br />
Rungby, J<br />
FC04.2.7, FC05.4.6,<br />
Tue 359, Tue 248<br />
Ruohonen, ST W21.4, Thu 243<br />
Ruohonen, S W21.4<br />
Ruponen, M W21.3<br />
Ruschitzka, FT FC16.1.2<br />
Rusiecka, I Mon 181<br />
Ruskoaho, H Tue 166<br />
Rusli, I Thu 181<br />
Russell, D Tue 145<br />
Russell, FA Mon 287<br />
Russell, R<br />
FC03.2.6<br />
Russo, R<br />
FC18.1.6<br />
Ruuskanen, JO Wed 088<br />
Ruzic Zecevic, D Mon 039<br />
Ryan, B Mon 453<br />
Ryan, M Mon 314<br />
Ryan, R Mon 052<br />
Rysä, J W21.2, Tue 166<br />
Saade, A Thu 055<br />
Saarelainen, T Tue 339<br />
Saarma, M Mon 341<br />
Saastamoinen, LK Tue 363<br />
Sabaté, M Tue 087<br />
Sabbatini, P<br />
FC11.5.6<br />
Sabetkasaei, M Wed 396<br />
Sabo, AJ W34.4, Wed 321, Wed 435<br />
Saboori, Mon 454<br />
Sabra, AN Mon 372<br />
Sabra, R Thu 247<br />
Saccani, F Tue 258<br />
Sadakata, Y Wed 115<br />
Sadananda, P Mon 235<br />
Saddichha, S<br />
FC01.4.6<br />
Sadee, W<br />
FC14.2.5<br />
Sadeghnia, HR Wed 364, Thu 342<br />
Sadeghpour, B FC18.4.5<br />
Sadikun, A<br />
FC16.3.4<br />
Sædder, E Thu 413<br />
Saegusa, H<br />
FC03.4.5<br />
Saeki, M Wed 186<br />
Saeki, Y Wed 414<br />
Saenz-Rodríguez, MT Tue 409<br />
Saenz-Rodriguez, R Wed 349<br />
Saferis, V Tue 329<br />
Safonts, L Tue 016<br />
Sagdieva, GZ Thu 096<br />
Sagot, P Tue 289, Tue 290<br />
Sahebgharani, M Mon 454<br />
Sahiner, M Mon 418<br />
Sahin-Erdemli, I Mon 366<br />
Sahnoun, R Mon 021<br />
Saiful Yazan, L Tue 452<br />
Saiko, P Thu 308<br />
Sailler, L Tue 104<br />
Saim, AH Mon 107<br />
Sain-Guven, G Wed 249<br />
Sainio, K Mon 215<br />
Saint Raymond, A W36.1, W36.4<br />
Sáinz, M Mon 130<br />
Saito, A Wed 414<br />
Saito, K Tue 201, Tue 311<br />
Saito, M Thu 248<br />
Saito, R Thu 108, Wed 223<br />
Saito, Y Thu 319, Tue 320, Tue 459<br />
Saito, Yusuke Thu 343<br />
Sajedianfard, J Mon 085, Mon 088<br />
Sakai, H Tue 234, Tue 259, Mon 304,<br />
Tue 287, Mon 303<br />
Sakai, Y Thu 224<br />
Sakai-Oshita, M Mon 304<br />
Sakallý, E Mon 418<br />
Sakamoto, K Tue 318, Tue 138, Wed 264<br />
Sakanashi, M Thu 344, Thu 344<br />
Sakata, D Tue 260, Tue 294<br />
Sakata, R Tue 167<br />
Sakata, S Tue 162<br />
Sakoda, N Mon 386<br />
Sakurada, T Wed 247<br />
Sakurai, E<br />
Tue 163, FC03.4.5<br />
Sakurai, E Thu 414<br />
Sakurai, T Mon 386<br />
Sakurai, Y Tue 163<br />
Salahuddin, M Thu 345<br />
Salari, A-A Wed 012<br />
Salari, R Tue 052<br />
Salas, CE Wed 302, Tue 428<br />
Salatino, A Mon 040<br />
Salazar, M Mon 123<br />
Salazar, N Tue 164<br />
Salcedo, MS Wed 352<br />
Saldaña, HKR Thu 115<br />
Saldiva, P Wed 231<br />
Saleh Moqadam, M Tue 165<br />
Salehi, A Thu 074<br />
Salehi, M Tue 165<br />
Salem, Z<br />
FC01.3.4<br />
Salenius, J-P Thu 223<br />
Salgueiro, L Tue 257<br />
Saliba, F<br />
W02.2.6<br />
Sallés, J Wed 046<br />
Sallinen, J<br />
W01.3.3<br />
Sallustio, B Tue 495<br />
Salmasi, H Mon 099<br />
Salmonsen, R Mon 264<br />
Salonen, J Thu 170, Tue 032<br />
Saloniemi, T Wed 446<br />
Salouage, I FC07.3.6, Mon 020, Thu 346,<br />
Wed 348, Mon 021, Mon 004<br />
Salter, M<br />
FC03.3.2<br />
Salvesen Blix, H Mon 234<br />
Salvicchi, A Mon 113<br />
Samai, M Mon 157<br />
Samarzija, I Thu 441<br />
Sambo, X Thu 315<br />
Samer, C Mon 337, Tue 166<br />
Sammons, HM Thu 007<br />
Samojlik, I Tue 167<br />
Sampaio, C<br />
SS01.2<br />
Sampaio, NG Wed 079<br />
Sampaio, SC Mon 273, Wed 332,<br />
Wed 333, Wed 334<br />
Sampayo, C Tue 207<br />
Samper, S W16.6<br />
364 Index
Name Paper ref. Name Paper ref.<br />
Samudre, S Thu 110<br />
SanAntonio, E Mon 254<br />
Sánchez Calero, J Thu 347<br />
Sánchez, A Thu 249, Mon 239<br />
Sánchez, G<br />
W04.1.3<br />
Sánchez-Ferrer, CF W08.3, Tue 134<br />
Sánchez-López, A W13.3, Thu 022, Thu 203<br />
Sanchez-Luque, JJ Mon 149<br />
Sandberg, K<br />
YI.03<br />
Sandberg, M<br />
FC06.2.5<br />
Sandén, C Thu 047<br />
Sander, T Wed 066<br />
Sandholm, J Tue 429<br />
Sandhu, H Thu 056<br />
Sandor, K Tue 271, Tue 250, Mon 283<br />
Sándor, K W19.3, Mon 106, Mon 110<br />
Sandor, Z W02.2.7, Tue 466<br />
Sándor, Z Mon 401<br />
Sandow, S Mon 235<br />
Sanguinetti, MC FC12.3.1, FC06.1.1<br />
Sanjani, MS Thu 057<br />
Sanjaya, KC Thu 181<br />
Sanni, SJ Thu 058<br />
Sano, S Tue 375<br />
Sansilvestri-Morel, P Thu 273, Thu 274<br />
Santana da Silva, J W31.3<br />
Santana-Farré, R Tue 387, Tue 391, Tue 392<br />
Santiago, E Tue 420<br />
Santibañez, M Mon 390<br />
Santio, N Tue 429<br />
Santoro, V Thu 419<br />
Santos Gomes, M Thu 236<br />
Santos Sierra, S Thu 014<br />
Santos-Silva, AJ Wed 211<br />
Sanvarinda, Y Thu 305 Tue 277<br />
Sanz, E FC10.1.2, Mon 254<br />
Sanz, F<br />
FC04.4.6<br />
Sanz, MJ W08.5, Thu 437<br />
Saragoni, S Mon 120<br />
Saraste, A Thu 243<br />
Sarc, L Wed 178<br />
Sári, R Tue 142, Tue 128, Tue 125<br />
Sarinic, VM Tue 121<br />
Sarkar, A Tue 196<br />
Sarkar, J Wed 294<br />
Sarkisyan, K Tue 176<br />
Sarparanta, M Thu 170<br />
Sartipy, P FC13.2.5, Tue 126<br />
Sarwar, M Mon 395<br />
Sarwar, U Wed 036<br />
Sasaguri, T Tue 162<br />
Sasaki, K Tue 154<br />
Sasaki, Y Mon 313<br />
Sasano, M Mon 402, Mon 112<br />
Sasay, J Tue 145<br />
Sasso, O<br />
FC18.1.6<br />
Satara, SS Tue 237<br />
Sathirakul, K Mon 357, Mon 355, Tue 341,<br />
Mon 334<br />
Sato, A Thu 320<br />
Sato, M Mon 395<br />
Sato, M Thu 059<br />
Sato, S Tue 265<br />
Sato, Y Tue 435, Thu 250, Tue 132<br />
Satoh, H W02.2.3, Tue 262, Tue 380<br />
Satoh, M Thu 250<br />
Satta, J Tue 166<br />
Satterfield, S Wed 126<br />
Saunders, D Tue 090<br />
Savarirayan, R W03.7<br />
Savchenko, A Tue 129<br />
Savci, V Mon 156<br />
Savenko, I Tue 472<br />
Savic Vujovic, K Mon 114<br />
Savineau, J-P Wed 293<br />
Savolainen, K W21.3, Mon 425<br />
Savontaus, E Thu 243, W21.4<br />
Savopoulos, C Mon 143<br />
Sawa, A Thu 402<br />
Sawada, H Mon 424, Mon 464<br />
Sawai, T Thu 248<br />
Sawicka, J<br />
FC06.3.6<br />
Sawicki, G<br />
FC06.3.6<br />
Sayama, Y Tue 136<br />
Sayyah, M Mon 455<br />
Scaccianoce, S Thu 440<br />
Scaglione, F W07.5, Thu 111<br />
Scammells, P Thu 080<br />
Scaramello, CBV Wed 232<br />
Scaramello, C Tue 162<br />
Scavone, C Mon 292<br />
Scekic, J Tue 081<br />
Schäfer, H-G<br />
FC07.3.1<br />
Schäfer, R<br />
YI.02<br />
Schaffer, C<br />
FC14.2.3<br />
Schätzle, R Tue 214<br />
Schautzer, A Mon 153<br />
Scheepers, R Wed 226<br />
Scheffer, I<br />
FC12.1.1<br />
Schegg, K<br />
FC12.4.5<br />
Scheinin, M W01.3.4, Wed 088, Thu 052,<br />
Wed 092, Thu 071, Thu 084,<br />
Schelstraete, P Mon 365, Tue 306<br />
Schetler, GFX<br />
FC11.1.1<br />
Scheuer, T<br />
FC12.2.4<br />
Schiavo, G Tue 488, Mon 449<br />
Schiesser, C Mon 214<br />
Schiffers, P Thu 251<br />
Schiffers, PMA Wed 287<br />
Schiffrin, E<br />
PL20, W04.2.1<br />
Schiltz, RL<br />
FC18.4.2<br />
Schinabek, R Tue 099<br />
Schini-Kerth, VB FC16.1.1, W04.2.3, W30.4,<br />
Wed 306, Wed 273, Wed 385<br />
Schjøtt, J Mon 234<br />
Schlossmann, J Wed 234<br />
Schlueter, T<br />
FC18.2.6<br />
Schmall, A Mon 059<br />
Schmidt, H<br />
FC15.4.4<br />
Schmidt, M Tue 242, Wed 095<br />
Schmidt, SF Wed 447<br />
Schmidt, WE<br />
FC05.3.1<br />
Schmiedl, S Tue 314, Tue 131<br />
Schmitz, O Mon 154<br />
Schneeweiss, S FC04.1.4<br />
Schneider, J<br />
FC11.4.2, W01.2.1<br />
Schneider, M<br />
Wed 070, FC06.2.5<br />
Schnuerch, M Mon 217<br />
Index 365
Name Paper ref. Name Paper ref.<br />
Schoeberl, B<br />
FC07.1.4<br />
Schoedel, K Wed 193<br />
Scholten, D Thu 060<br />
Schömig, E Mon 315<br />
Schöneberg, T Thu 087<br />
Schönfeld, D Tue 211<br />
Schramm, TK<br />
FC04.2.4<br />
Schratz, M Mon 479, Thu 354<br />
Schreiber, G Wed 410<br />
Schrey, D<br />
FC10.4.5<br />
Schrier, L<br />
Thu 214, FC10.4.6<br />
Schröder, R<br />
FC11.1.6<br />
Schroth, W Wed 133<br />
Schubert, B Mon 479<br />
Schuelein, R Thu 095<br />
Schuemie, M<br />
FC04.1.6<br />
Schul, W W31.2<br />
Schulpis, K Tue 381<br />
Schultz-Larsen, P Wed 160<br />
Schulz, A<br />
FC18.2.6<br />
Schulz, G Tue 099<br />
Schulz, R<br />
W22<br />
Schulz, S Tue 219<br />
Schuur, LJ Wed 095<br />
Schwab, M YI.02, FC02.1.5, Wed 133<br />
Schwab, M<br />
PL07<br />
Schwappach, D Tue 108<br />
Schwartz, A Wed 126<br />
Schwartz, T Thu 037<br />
Schwartz, TW FC11.1.2, Thu 036<br />
Schwarz, U<br />
Tue 301, FC02.1.6<br />
Schwarz, Ute Tue 054<br />
Sciulli, MG Mon 281<br />
Scotti, L Tue 093<br />
Scuderi, C<br />
Tue 465, FC18.4.6<br />
Se, Y Tue 090<br />
Sederino, R Tue 454<br />
Sediki, M Tue 289, Tue 290<br />
Sedivý, J Mon 267<br />
See, HB Wed 079<br />
Seeanner, M Wed 280, Wed 210, Thu 252<br />
Seeger-Armbruster, S Mon 463<br />
Seeman, P Wed 443<br />
Seeringer, A W16.5, Mon 315, Wed 148,<br />
Thu 112<br />
Segarceanu, A Mon 111<br />
Segarra, G Thu 225<br />
Segi-Nishida, E Tue 260<br />
Segura, V Thu 050<br />
Seidenbusch, W Mon 479, Thu 211, Thu 354,<br />
Mon 245<br />
Seif el-Din, S Mon 372<br />
Seiwerth, S<br />
W02.3.1<br />
Seki, A Tue 380<br />
Sekiguchi, F FC03.2.5, Mon 243,<br />
Mon 250, Tue 263<br />
Sekijima, M<br />
FC13.2.5<br />
Sekine, M Tue 379, Tue 177<br />
Selbach, O W33.3<br />
Selemidis, S<br />
Mon 305, FC15.1.4<br />
Selent, J<br />
YI.03<br />
Selimovic, A Wed 171<br />
Selke-Krulichova, I Wed 017<br />
Sellers, E Wed 193<br />
Selley, DE Wed 029<br />
Seltzman, H Thu 021<br />
Selvam, C<br />
FC11.3.6<br />
Sen, D Tue 120<br />
Senbel, A Tue 208, Tue 264<br />
Sendo, T Wed 413<br />
Sengupta, A Wed 149, Thu 113<br />
Seniuk, J Mon 095, Mon 097, Mon 094<br />
Senn, N Thu 211, Thu 354<br />
Senn, T Tue 099<br />
Seo, D<br />
FC14.3.3<br />
Seo, S-K Tue 427<br />
Seong, YH Wed 276, Wed 416, Wed 427<br />
Sepehr- Ara, L Thu 100<br />
Sepehri, H Mon 455<br />
Sepehrizadeh, Z Mon 454<br />
Serebrova, S Thu 114, Wed 314<br />
Seredenin, SB Mon 431, Thu 415, Wed 248,<br />
Mon 225, Wed 188, Tue 276<br />
Tue 150, Tue 165, Wed 187<br />
Serfontein, J Mon 026<br />
Sergeeva, O W33.3<br />
Sergeeva, SA Mon 198, Mon 284, Thu 015<br />
Sergienko, A Tue 472<br />
Serra, CSM Wed 144<br />
Serrano Lopez, DR Thu 115<br />
Serrão, MP Thu 398, Wed 114<br />
Sertiæ, J Mon 048<br />
Sertic, D Tue 304<br />
Sertic, J Tue 304<br />
Sestan, B Tue 095<br />
Sesti-Costa, R W31.3<br />
Seta, F Wed 235<br />
Seto, SW Wed 236<br />
Sevior, D Thu 348<br />
Sexton, P Thu 080<br />
Sexton, PM Wed 089, Wed 082, Wed 043<br />
Thu 041<br />
Seya, K Tue 430<br />
Seyedian, R Tue 017,<br />
Sezer, Zafer Tue 018<br />
Sfaxi, L Mon 338<br />
Shaban, G<br />
FC06.2.6<br />
Shabbi, H Thu 002<br />
Shafiee, A Thu 309 Tue 469<br />
Shah, A Thu 197<br />
Shah, T<br />
FC16.1.6<br />
Shaham, Y<br />
FC14.3.2, FC14.3.4<br />
Shaikh, NA Thu 338<br />
Shakib, S Tue 327<br />
Shalamai, A<br />
FC06.1.6<br />
Sham, PC Mon 271, Mon 159<br />
Shamsabadi, RH Thu 006<br />
Shamseddin, A FC01.3.4<br />
Shang, F<br />
FC08.1.6<br />
Shao, Z Thu 388<br />
Shapovalov, G Wed 102<br />
Sharifi, M Wed 376, Tue 469<br />
Sharma, K Tue 453, Tue 019, Tue 019<br />
Sharma, KK Tue 020, Wed 116<br />
Sharma, L Mon 131, Wed 116<br />
Sharma, LK Tue 453, Tue 020, Tue 019<br />
Sharma, M Tue 137<br />
Sharma, P<br />
FC09.5.5<br />
366 Index
Name Paper ref. Name Paper ref.<br />
Sharma, S<br />
FC09.5.5, FC05.2.5<br />
Sharman, JL Tue 479<br />
Sharp, T<br />
PL03<br />
Sharyari, S Wed 027<br />
Shaw, F-Z Mon 456<br />
Sheikh, S<br />
FC06.2.5<br />
Sheikh, SP Wed 070, Wed 036<br />
Shelihova, L Tue 106<br />
Shelton, J Wed 093<br />
Shen, F-M Mon 322<br />
Shen, WW Wed 430<br />
Shen, Y Tue 138, Mon 457, Thu 445,<br />
Thu 089<br />
Shen, Y Tue 138, Mon 457, Mon 458<br />
Shen, Z Tue 139<br />
Sheng, L Wed 336<br />
Sheppard, J Thu 110<br />
Sheu, J-R Mon 423<br />
Shevtsov, V Mon 134<br />
Sheykhzade, M Thu 066, Mon 099<br />
Shi, J-S FC14.4.6, Tue 182, Thu 184,<br />
Tue 382, Tue 178, Thu 185,<br />
Thu 186<br />
Shi, J-Z Thu 116, Tue 458<br />
Shi, L<br />
FC02.1.2 Thu 384, FC02.3.5,<br />
Mon 073<br />
Shi, M Tue 228, Wed 122, Wed 121,<br />
Wed 120<br />
Shiba, T Tue 376<br />
Shibasaki, H Tue 159<br />
Shibasaki-Hirano, H Mon 459<br />
Shibata, K Wed 256, Thu 117<br />
Shibata, M Tue 156<br />
Shibata, S Mon 173, Tue 122, Thu 416<br />
Shibayama, H Tue 077<br />
Shibuya, A Tue 265<br />
Shibuya, K Tue 166<br />
Shibuya, M Thu 286<br />
Shih, Y-T Thu 301<br />
Shiiya, T Wed 060<br />
Shiiya, T Tue 140<br />
Shikh, E Thu 349<br />
Shimada, S Wed 305<br />
Shimamoto, N Tue 379, Tue 177<br />
Shimane, T Thu 416<br />
Shimazawa, M Thu 220, Thu 406<br />
Shimizu, M Tue 474<br />
Shimizu, Y Mon 178<br />
Shimoda, M Mon 173<br />
Shimokawa, H FC16.1.4<br />
Shimuta, S Thu 025<br />
Shimuta, SI Wed 041, Thu 061<br />
Shin, Heung Thu 350<br />
Shin, J-G Tue 352, Tue 351<br />
Shin, MC Wed 371<br />
Shin, S Mon 029<br />
Shinohara, M Tue 266<br />
Shinozuka, K Thu 320, Tue 143, Tue 067<br />
Shintani, N Wed 075, Mon 110, Mon 318<br />
Shioda, N Thu 406<br />
Shipaeva, E Tue 276,<br />
Shipovskaya, N Tue 106<br />
Shippenberg, T FC03.3.1<br />
Shiraishi, F Tue 162<br />
Shirakawa, H Tue 055<br />
Shirinbeik Mohajer, O Mon 196<br />
Shohin, IE Thu 253<br />
Shohreh, R Mon 105, Wed 434, Wed 329<br />
Shoji, M Wed 061, Mon 179<br />
Shokrgozar, MA Wed 437<br />
Shono, M Tue 068<br />
Short, J Tue 215<br />
Shrivastava, AK Wed 315<br />
Shujaa, N W19.1, Thu 062, Thu 094<br />
Shukitt-Hale, B Mon 443<br />
Shukuri, M Tue 244<br />
Shumkova, O Thu 349<br />
Shweta, Wed 444<br />
Sia, I Thu 334<br />
Sibley, D Thu 063<br />
Siddika, MM Mon 001<br />
Siddiqi, HS Wed 355<br />
Siddique, MW Tue 137<br />
Siddiqui, S Tue 119<br />
Siderius, M Wed 086<br />
Siderius, N Thu 085<br />
Sidhu, P Tue 191<br />
Siegmund, W Tue 045, Tue 049, Tue 039,<br />
Wed 119, Tue 041<br />
Siegrist, J Wed 170<br />
Sierra, PP Mon 038<br />
Siest, J-P Mon 369<br />
Siew Hua, G Mon 147, Mon 333<br />
Sigrist-Flores, SC Tue 150<br />
Sikiric, P<br />
W02.3.1<br />
Silber, H<br />
FC07.2.2<br />
Siller, M Thu 118<br />
Silva, AP Wed 180, Thu 193<br />
Silva, BA Thu 351, Thu 352<br />
Silva, D Thu 119<br />
Silva, E Mon 350<br />
Silva, F Tue 123<br />
Silva, I FC08.2.6, Thu 064, Tue 207<br />
Silva, J Wed 212, Wed 265, Wed 140<br />
Silva, JA Mon 295<br />
Silva, JJN W31.3<br />
Silva, JLV Thu 351, Thu 352<br />
Silva, J Thu 254<br />
Silva, L Mon 398<br />
Silva, MAS Wed 342<br />
Silva, MS Thu 352<br />
Silva, TMS Thu 351<br />
Silva, WL Wed 144<br />
Silva-Lima, B Tue 207<br />
Silva-Ramos, M FC08.2.6<br />
Sim, HL Thu 181<br />
Sim, SC Wed 151<br />
Sim, TF Tue 063<br />
Simaan, J Mon 396<br />
Simard, G Tue 118<br />
Simatupang, A Tue 009, Tue 021<br />
Simic, D Tue 108<br />
Simmonds, M<br />
FC16.5.2<br />
Simms, J FC14.3.5, Wed 057,<br />
Wed 082, FC14.2.3<br />
Sa, Z Thu 400<br />
Seau, G Tue 188, Tue 189<br />
Set, S Thu 273, Thu 274<br />
Index 367
Name Paper ref. Name Paper ref.<br />
Ssen, C Thu 101<br />
Ssen, U<br />
Wed 229, Wed 230, Wed<br />
282, Wed 281, Thu 222,<br />
Wed 221, Wed 240, Wed<br />
284, Wed 225, Mon 403,<br />
Wed 241, Tue 161, Thu 259<br />
Ssick, A Wed 126<br />
Syi, M<br />
FC16.2.6<br />
Simpson, C Wed 137<br />
Simpson, J Mon 238, Tue 364<br />
Simpson, P Thu 030<br />
Sindrup, S<br />
FC13.5.5<br />
Sindrup, SH Mon 090<br />
Singer, D Mon 353, Mon 352<br />
Singer, W<br />
FC17.2.2<br />
Singewald, N W33.5<br />
Singh, G<br />
FC01.3.6<br />
Singh, KK Mon 028<br />
Singh, MF Wed 125<br />
Singh, N Wed 294<br />
Singh, PDA Wed 335<br />
Singh, S FC01.2.6, Mon 169<br />
Singh, TG<br />
FC09.5.5<br />
Singh, V Mon 028<br />
Sinha, BN Tue 194<br />
Sinha, RR<br />
FC14.3.3<br />
Sinha, S Wed 294<br />
Sinha, SK Thu 120<br />
Sinnayah, P Wed 257<br />
Siow, R Thu 197<br />
Sipetic, T W34.3<br />
Sirirugsa, P Wed 374<br />
Sissoeff, L Mon 469<br />
Sit, A SM Thu 255<br />
Siuni, L Tue 133<br />
Sizova, Z<br />
FC13.4.6<br />
Sjögren, B Thu 065<br />
Sjöqvist, F<br />
FC01.1.2<br />
Skaddan, M Tue 372<br />
Skandali, N Thu 431<br />
Skapare, Elina Tue 141<br />
Skeberdis, VA Thu 023<br />
Skene, K Tue 232<br />
Skiba, M Thu 242<br />
Skogastierna, C Wed 183, Wed 176, Thu 256<br />
Skomedal, T Tue 143<br />
Skorobogatova, TA Tue 179<br />
Skotnikov, A Tue 267<br />
Skougaard, K Tue 395<br />
Skov Paulsen, M Wed 160<br />
Skovsted, GF Thu 066<br />
Skrbic, R Tue 237<br />
Skvrce, NM Tue 121<br />
Sladic, H Wed 004<br />
Sladkova, M Mon 148<br />
Slavic, M Thu 329, Thu 318, Tue 122<br />
Slifstein, M<br />
FC17.1.3<br />
Slikker, W Wed 150<br />
Slinger, E Wed 086<br />
Slizova, D Tue 125<br />
Smajilovic, S<br />
FC11.5.1<br />
Smetana, J Tue 056<br />
Smetanova, L Tue 056<br />
Smid, S<br />
FC16.3.7<br />
Smidt, K<br />
FC05.4.6<br />
Smit, M Wed 086, Thu 085, Thu 060<br />
Smith, A Thu 019, Thu 020<br />
Smith, J<br />
FC05.3.6<br />
Smith, JAM Thu 069<br />
Smith, MA Mon 443<br />
Smits, JFM Mon 212, Wed 085<br />
Snape, W<br />
FC14.2.5<br />
Snead, A Thu 067<br />
Snopkova, M Mon 219<br />
Snutch, TP<br />
FC03.2.1<br />
Snyder, R Thu 021<br />
Snyman, J<br />
FC14.5.5<br />
So, SC Thu 341<br />
Soares de Lima, T Thu 353<br />
Soares-da-Silva, P Thu 169, Mon 383<br />
Sobey, CG Mon 305<br />
Sobey, C<br />
FC15.1.4<br />
Sobiesiak, AJ Tue 180<br />
Soboloff, J<br />
FC12.2.5<br />
Sobor, M Thu 192<br />
Sobotka, L Tue 222, Tue 421<br />
Soengas, I Mon 080<br />
Soeter, RP Mon 400<br />
Søgaard, B Thu 427<br />
Sokol, G Tue 107<br />
Sokova, E Tue 057<br />
Solati, J Wed 012<br />
Soler, D Thu 002<br />
Solís-Herruzo, JL Tue 123<br />
Solito, E<br />
FC15.1.5<br />
Solntseva, E Thu 417<br />
Soltani, N Tue 058<br />
Sommet, A Tue 104<br />
Somogyi, A Wed 113<br />
Somogyi, A W16.4<br />
Son, H Tue 349, Mon 033, Thu 418<br />
Son, HK Mon 013<br />
Søndergaard, J Wed 160<br />
Sonderskov, K Thu 101<br />
Sone, S Wed 278<br />
Soner, BC Tue 200<br />
Song, H Tue 419<br />
Song, J Mon 434<br />
Song, J-G Wed 367<br />
Song, J-S Mon 158<br />
Song, R<br />
FC14.5.4<br />
Sonmez, A Wed 357<br />
Sonnenberg, J Tue 210<br />
Sonnenberg, S Tue 115<br />
Sordi, R Wed 097<br />
Sørensen, G<br />
FC02.3.6<br />
Sørensen, JB Tue 480<br />
Sørensen, L Tue 065<br />
Sørensen, U<br />
FC06.3.5<br />
Soriano, FG Wed 202, Wed 204,<br />
Wed 203, Mon 257<br />
Soriano, G Tue 123<br />
Soriano-Ursúa, MA. Tue 195<br />
Sortino, MA Wed 400<br />
Sotomayor-Zarate, R Wed 169, Thu 187<br />
Soto-Núñez, M Tue 431<br />
Soubret, A Tue 196<br />
Souccar, C Thu 355<br />
368 Index
Name Paper ref. Name Paper ref.<br />
Soukasem, S Thu 361<br />
Souki, H Tue 457<br />
Soukup, O Tue 448<br />
Soultanov, V Wed 347<br />
Sousa, J Mon 383, Tue 407<br />
Sousa, PCP Thu 374<br />
Sousa, PJC Wed 341, Wed 340, Wed 342<br />
Soussi, F Wed 244<br />
Souto, F Mon 275<br />
Souza, CM Wed 302<br />
Souza, CR Wed 144<br />
Souza, D W31.4<br />
Souza, G<br />
FC03.1.5<br />
Souza, HP Wed 202<br />
Souza, L Thu 068<br />
Souza, MHLP Tue 255<br />
Souza, WA Tue 101, Mon 010<br />
Sowunmi, A<br />
YI.09<br />
Soydan, G Wed 253<br />
Soydan, Ö Tue 018<br />
Soylar, M Wed 357<br />
Spanagel, R<br />
FC14.2.1<br />
Spasic, M Thu 329, Tue 122, Thu 318,<br />
Wed 387<br />
Spasojevic, I Wed 387<br />
Spedding, M Tue 479, Wed 072<br />
Speers, J Thu 410<br />
Speerschneider, T Thu 058<br />
Spence, JD Thu 257<br />
Sperlagh, B Mon 460<br />
Sperlágh, B W19.2<br />
Spiers, JP Thu 442<br />
Spijkers, L Thu 258<br />
Spila, B Tue 022<br />
Spiliopoulos, A Mon 143<br />
Spiller, F Mon 275<br />
Spina, D Mon 287<br />
Spina, E Thu 419<br />
Sri Ranganathan, S FC10.2.3<br />
Srichunrasamia, C Tue 127<br />
Sritarab, P Tue 127<br />
Sriwichai, S Tue 090<br />
Staab, A<br />
FC07.3.1<br />
Staahl, C W12.5<br />
Staehler, G Mon 245<br />
Staels, B<br />
FC18.2.2<br />
Stamer, D Thu 088<br />
Stamou, D Thu 026<br />
Stancic, E Mon 395<br />
Stang, P<br />
FC04.2.2<br />
Stanimirovic, B W34.3<br />
Stanimirovic, V W34.3, W34.5<br />
Stanimirovic, VV Wed 435<br />
Stanke, F Tue 268<br />
Stankevicius, E Thu 222, Mon 403, Wed 241,<br />
Thu 259<br />
Stanojevic, Z Wed 436<br />
Stanovnik, L Wed 153<br />
Stappen, RK Tue 099<br />
Starodubtzev, A Thu 114<br />
Stasch, J-P<br />
FC15.4.1<br />
Stavreva, D<br />
FC18.4.2<br />
Steardo, L<br />
Tue 465, FC18.4.6<br />
Steensland, P<br />
FC14.2.3<br />
Selli, F Wed 442, Mon 382<br />
Sescu, C Tue 134<br />
Steffenhagen, V Tue 210<br />
Stein, D Thu 428<br />
Steinfeld, T Thu 069<br />
Stender, S<br />
FC13.3.6<br />
Steneker, I W10.1<br />
Stephens, C Tue 123, Wed 109<br />
Stephens, TD<br />
FC04.4.1<br />
Sterin-Prync, A Mon 280<br />
Stern, A Tue 226<br />
Stetinova, V Tue 056<br />
Stevens, L Tue 269<br />
Stevic, S Wed 436<br />
Stewart, D Tue 109<br />
Stewart, AG Thu 393<br />
Stichele, RV Mon 129<br />
Stief, CG FC08.3.5, Mon 247<br />
Stiglmayr, J Tue 214, Thu 354<br />
Stilinovic, N Mon 115<br />
Stilinovic, N Tue 454<br />
Stiller, C-O W05.4<br />
Stoddart, ES Mon 394<br />
Stodulka, P Mon 075, Tue 448<br />
Stoiljkovic, M Thu 070,<br />
Stojakovic, N Tue 237<br />
Stojanovic, R Tue 013, Wed 009<br />
Stojanovic, Z Wed 009<br />
Stojiljkovic, M<br />
W34.3,<br />
Stojiljkovic, MP W34.5<br />
Stojiljkovic, N Thu 070<br />
Stokland, O Wed 139<br />
Stolakis, V Thu 431 Tue 381<br />
Stoltenberg, M Tue 359, Tue 248, Mon 320<br />
Stoop, JE Tue 096<br />
Stosic-Grujicic, S FC16.3.6<br />
Stove, V Mon 365, Tue 306<br />
Strateny, K Tue 113<br />
Strauss, L Mon 215<br />
Street, JM Thu 420, Tue 270<br />
Streng, T Thu 052, Thu 071<br />
Strnad, M Thu 118<br />
Strojil, Jan Tue 124<br />
Strømgaard, K Tue 053, Thu 037, Tue 080,<br />
Thu 026, Tue 065<br />
Struijk, JJ Tue 303<br />
Struijker-Boudier, H AJ Mon 212, Thu 221<br />
Stubbs, S<br />
FC06.4.5<br />
Studena, S Tue 125<br />
Stürmer, Til<br />
FC04.1.3<br />
Stützer, H Thu 018<br />
Stuhr-Hansen, N YI.10<br />
Sturkenboom, M FC04.4.5, FC04.2.6,<br />
FC04.4.6, Mon 140,<br />
FC04.3.6<br />
Sturmer, T<br />
FC04.1.4<br />
Stys, PK Tue 085<br />
Su, D-F PL22, Mon 330, Thu 210,<br />
W04.1.2<br />
Su, F Tue 403<br />
Su, MJ Mon 220<br />
Su, M-W Tue 393<br />
Su, R-B<br />
Tue 083, Thu 171, FC14.5.4<br />
Su, X Tue 401<br />
Index 369
Name Paper ref. Name Paper ref.<br />
Su, Y Wed 322, Thu 445<br />
Suarez Gonzalez, ME Tue 197<br />
Suárez, C Thu 271<br />
Suarez, E Wed 111<br />
Suarez-Kurtz, G W16.2<br />
Subedi, GP Tue 023<br />
Subramaniam, SR Mon 413<br />
Suda, M Tue 373<br />
Sudano, I<br />
FC16.1.2<br />
Suddhasthira, T Thu 443<br />
Sudharmarajan, S Thu 393<br />
Sudo, G Tue 162<br />
Sudo, K Tue 380<br />
Sudo, R Tue 162<br />
Suemaru, K Thu 421<br />
Süverkrüp, R Mon 384<br />
Sugamori, K Tue 389<br />
Sugawara, A Tue 153<br />
Sugihara, M Thu 038<br />
Sugihara, T Mon 335<br />
Sugimoto, M W23.4, Tue 473<br />
Sugimoto, T Thu 260<br />
Sugimoto, Y Tue 294<br />
Sugiyama, A<br />
Tue 126, Tue 236, FC13.2.5<br />
Sugiyama, K Mon 177, Mon 182<br />
Sui, Z Tue 173, Tue 325<br />
Suilamo, S Mon 256<br />
Suissa, S<br />
FC04.1.1<br />
Sukasem, C Tue 127<br />
Sukoyan, GV Mon 216<br />
Sukumaran, P Thu 079<br />
Sulaiman, SA Tue 455<br />
Sulayman, D-HD FC12.2.1<br />
Suling, F Tue 021<br />
Suljagic, V Tue 091<br />
Sultan, E Mon 203, Mon 201, Mon 205,<br />
Mon 204, Mon 202<br />
Sumak, T Tue 030, Tue 031<br />
Summers, RJ W01.1.1, Wed 063, Mon 395,<br />
Thu 059, Wed 080, W14.2<br />
Sun, A Tue 138, Mon 457, Mon 458<br />
Sun, B Mon 031<br />
Sun, D Thu 298<br />
Sun, H FC16.3.2, Thu 092, Tue 181<br />
Sun, H-L Thu 172<br />
Sun, H-S W28.1<br />
Sun, JH Tue 297<br />
Sun, L Tue 187, Tue 186 Tue 159,<br />
Tue 297, Wed 259<br />
Sun, Y Tue 181<br />
Sung, M-H<br />
FC18.4.2<br />
Surber, C Tue 438<br />
Surratt, C Tue 059<br />
Susumu, N Tue 311<br />
Suziedelis, K Mon 403<br />
Suzuki, F Thu 046<br />
Suzuki, H Thu 403<br />
Suzuki, K Tue 435, Thu 250<br />
Suzuki, M Tue 244<br />
Suzuki, T Tue 435, Wed 065, Thu 188<br />
Suzuki, Y Thu 102<br />
Svalbe, B Tue 141, Thu 189<br />
Svard, J Thu 442<br />
Svensson, S Thu 074<br />
Svensson, TH<br />
FC17.2.4<br />
Svinarov, D Tue 128<br />
Svirina, D Mon 429<br />
Svirskis, S Mon 429, Wed 045, Tue 253<br />
Svoboda, Z Tue 056<br />
Switzer, C<br />
FC09.3.3<br />
Sy, GY W27.5<br />
Sychev, DA Tue 129, Tue 057, Thu 253<br />
Syed, S Tue 495<br />
Sylte, I Mon 224<br />
Syunyakov, S Tue 024<br />
Syyong, H Wed 228<br />
Szabó, B Mon 150, Mon 167<br />
Szabo, C FC15.3.6, FC15.4.2, Thu 202<br />
Szabó, G Thu 307<br />
Szabo, S W02.2.2, W02.2.7, Tue 466<br />
Szafir, D W10.4<br />
Szakacs, B Mon 283<br />
Szarek, WA Tue 414,<br />
Szczepazka, R Wed 279<br />
Szekeres, T Thu 308<br />
Szell, T Mon 100<br />
Szente, L<br />
FC16.2.6<br />
Szentirmay, É Tue 078<br />
Szilagyi, K Thu 033<br />
Szilvássy, Z Mon 163, Tue 128, Tue 125,<br />
Mon 150, Mon 167, Tue 142<br />
Szitter, I Tue 271, Mon 283<br />
Szõke, E FC16.2.6, W19.3, Tue 250,<br />
Mon 283, Mon 106, Mon 401<br />
Szolcsányi, J Tue 271, Mon 283Mon 110,<br />
Tue 078, Mon 401, Mon 318<br />
Sztojkov-Ivanov, A Tue 130<br />
Szulc, M Thu 174<br />
Szuts, T Tue 250<br />
Szymanski, J Tue 313, Tue 131, Wed 119<br />
Tabassum, F Mon 260, Wed 315<br />
Tabatabaei Naeini, A Tue 370<br />
Taché, Y<br />
W02.3.2<br />
Tachikawa, E Tue 477<br />
Tada, Y Tue 067, Tue 143<br />
Tadagaki, K Thu 078<br />
Taddio, A<br />
FC10.5.3<br />
Taegtmeyer, H FC05.2.1<br />
Tagliaferro, P Thu 176<br />
Tagwireyi, D Tue 004<br />
Taha, H Tue 444<br />
Tahara, Y Mon 173, Tue 122<br />
Taher, A<br />
FC01.3.4<br />
Tahmiscija, I Wed 171<br />
Tai, WCS Thu 296<br />
Taillon, I Wed 123<br />
Taimi, V<br />
FC09.1.5<br />
Taira, E Wed 186, Tue 477<br />
Tajti, J Mon 106<br />
Tajuba, J Thu 021, Tue 221<br />
Takada, M Tue 136<br />
Takahama, K Tue 167<br />
Takahara, A Tue 168<br />
Takahara, A Thu 260<br />
Takahashi, H Tue 272<br />
Takahashi, HK Mon 035, Mon 329, Thu 275<br />
Takahashi, K Tue 072, Thu 072<br />
Takahashi, R Tue 156<br />
370 Index
Name Paper ref. Name Paper ref.<br />
Takahashi, T Tue 077<br />
Takahashi, Y Thu 320<br />
Takahashi-Yanaga, F Tue 162<br />
Takahasi, Y Tue 373<br />
Takai, M Thu 103<br />
Takamura, E Thu 227<br />
Takano, K<br />
Thu 286, FC09.1.6<br />
Takano, Y Thu 108, Wed 223, Mon 309,<br />
FC09.1.6<br />
Takarada, T Mon 441<br />
Takashima, H Tue 459<br />
Takashima, T Tue 244<br />
Takashima-Hirano, M Tue 244<br />
Takashina, Y Tue 484, Tue 491<br />
Takatori, S Tue 154, Thu 261, Tue 415<br />
Takatsuki, M Mon 307<br />
Takayama, S Mon 335<br />
Takayanagi, S Tue 153<br />
Takeba, Y Wed 117, Tue 273, Tue 337,<br />
Tue 483<br />
Takechi, K Thu 421<br />
Takeda, H Thu 422, Thu 423, Thu 397<br />
Takeda, K Thu 260<br />
Takenoshita, S Wed 117<br />
Takenoshita-Nakaya, S Tue 337, Tue 483<br />
Takeuchi, K<br />
Tue 379, Mon 179, W23.1,<br />
Tue 262, Mon 335, Mon 255,<br />
Mon 405, Tue 236,<br />
W02.2.3, Tue 467, Thu 262<br />
Takeuchi, K<br />
Thu 072, Tue 274, W02.2.4<br />
Takeuchi, O<br />
PL14<br />
Takeuchi, Reiri Tue 432<br />
Takeuchi, S Tue 318, Tue 138<br />
Takeuchi, T Thu 423, Thu 422, Thu 397<br />
Takeya, K Wed 239<br />
Takeyama, M Tue 132<br />
Takir, S Thu 269<br />
Takuma, K Tue 060, Tue 360<br />
Talani, G Thu 190, Tue 133<br />
Talari, H Thu 209<br />
Talbot, S Thu 073<br />
Talbot, S Tue 275<br />
Talebi, M Mon 454<br />
Talja, M Thu 223<br />
Tallerova, A Tue 276<br />
Talman, V Tue 433<br />
Tam, C Thu 197<br />
Tam, CWY Tue 140<br />
Tamae, A Tue 243<br />
Tamaki, T Mon 180, Wed 247<br />
Tamargo, J<br />
FC06.3.2<br />
Tamariz, J Wed 217<br />
Tamashiro, WMSC Mon 289<br />
Tamba, B Mon 108<br />
Tamba, BI Tue 134<br />
Tambo, Ernest YI.09<br />
Tamm, J Thu 427<br />
Tammaro, P Tue 061<br />
Tamminen, T Mon 341<br />
Tampé, R<br />
FC02.2.1<br />
Tamuleviciute, A Tue 061<br />
Tamura, E Thu 204<br />
Tamura, H Tue 474<br />
Tamura, Y Tue 236<br />
Tan, C Thu 074<br />
Tan, H-M<br />
FC16.4.5<br />
Tan, KL Tue 434<br />
Tan, PCS Mon 389<br />
Tan, SC Tue 153, Thu 181<br />
Tanabe, M Mon 272<br />
Tanabe, S Tue 435<br />
Tanabe, T<br />
FC03.4.5<br />
Tanabe, Y Thu 248<br />
Tanae, M Thu 355<br />
Tanaka, A Mon 405<br />
Tanaka, H Wed 186, Tue 168, Thu 099,<br />
Thu 260, Tue 373, Mon 461<br />
Tanaka, M Tue 380, Tue 492, Wed 117<br />
Tanaka, N Thu 263, Tue 375<br />
Tanaka, S Wed 422, Wed 415<br />
Tanaka, Y Thu 108,<br />
Tanayen, JK Tue 209<br />
Tancharoen, S Thu 331, Thu 443<br />
Tandon, N Mon 169<br />
Tandon, S<br />
FC01.3.6<br />
Tang, H-S Wed 430<br />
Tang, L FC06.4.6, Mon 210,<br />
Wed 362, Wed 258, Tue 317,<br />
Thu 298<br />
Tang, SP Tue 455<br />
Tang, X<br />
FC12.2.5<br />
Tanigami, M Mon 255<br />
Tanigawara, Y Tue 311<br />
Tanii, H Tue 413<br />
Tanji, H Mon 313<br />
Tantisira, B Thu 356, Thu 357<br />
Tantisira, M Thu 356, Thu 357<br />
Tao, P-L Tue 135<br />
Tao, S Tue 152<br />
Tapaninen, T Tue 062<br />
Tapia-Pancardo, DC Tue 025<br />
Tarasov, SA Mon 284<br />
Taraz, M Tue 251<br />
Tardieu, J-L Thu 035<br />
Targonska, A Thu 291<br />
Tashiro, M<br />
Tue 166, Tue 484, FC17.5.6<br />
Taskinen, P Tue 166<br />
Tateishi, T Wed 127<br />
Taube, C<br />
FC09.1.2<br />
Tavares, F Mon 376<br />
Tavares, JJF Thu 352<br />
Tavares, PLF Tue 282<br />
Tavridou, A Tue 224, Mon 187<br />
Tay, Jolyn Tue 136<br />
Tayarani-Najaran, Z Thu 313, Tue 424, Thu 342<br />
Tayebi, H Mon 160<br />
Taylor, DA Wed 428<br />
Taylor, D Thu 191<br />
Taylor, M<br />
FC05.3.6<br />
Taylor, P Mon 353, Mon 352<br />
Taylor, R W06.3<br />
Techanaparukse, K Wed 374,<br />
Tedroff, J Wed 147<br />
Tee, LBG Tue 063<br />
Teft, W Tue 064<br />
Teixeira, M FC03.1.5, W31.4<br />
Teixeira, S Tue 232<br />
Teja-Isavadharm, P Tue 090<br />
Index 371
Name Paper ref. Name Paper ref.<br />
Tejerina, T Wed 228, Wed 215, Mon 206<br />
Tejerina, Teresa Thu 264, Tue 144<br />
Tekes, K Wed 050<br />
Tékus, V Tue 078<br />
Teleshova, E Tue 024<br />
Tenayuca, J Tue 378<br />
Teng, B Thu 057<br />
Teng, S-F Wed 035<br />
Tengrungsun, T Thu 443<br />
Teraoka, K Wed 278<br />
Teräs, M Mon 256<br />
Ternant, D Tue 198<br />
Ternant, T Mon 363<br />
Terrón, JA Thu 265<br />
Terry, D<br />
FC02.1.2<br />
Terzian, A<br />
FC17.5.5<br />
Tesfaye, H Tue 137, Tue 445<br />
Tesmer, J Thu 075<br />
Tesse, A Wed 216, Wed 196<br />
Teulon, I Mon 363<br />
Teyssier, C<br />
FC18.3.5<br />
Tezcan, K Mon 418<br />
Tfayli, A<br />
FC01.3.4<br />
Tfelt-Hansen, J FC15.2.3<br />
Thacker, T<br />
FC11.3.2<br />
Þahin, S Tue 030<br />
Thakore, P Wed 260<br />
Thakur, S Thu 290<br />
Thal, D Thu 075<br />
Thampithak, A Tue 277, Thu 305<br />
Thangboonjit, W Mon 357<br />
Thapa, KK Tue 097, Tue 120<br />
Theron, A Thu 012<br />
Thiblin, I<br />
FC14.5.2<br />
Thiele, Sie<br />
FC11.5.5<br />
Thiemermann, C FC18.3.6<br />
Thompson, J<br />
FC17.1.3<br />
Thompson, MA FC04.2.5<br />
Thomsen, A Tue 358<br />
Thomsen, H Wed 161, Mon 360<br />
Thomsen, M Tue 065<br />
Thomson, M Tue 093<br />
Thor, D Thu 087<br />
Thorneloe, KS W03.5<br />
Thörngren, J-O FC14.1.6<br />
Thorsen, TS<br />
YI.10<br />
Thürmann, PA W35.1, Tue 313, Wed 119,<br />
Tue 131, Tue 314, Tue 108<br />
Thuillez, C Wed 207, Thu 242<br />
Tian, W-W Thu 210<br />
Tian, Y-L Thu 277<br />
Tian, Y-P Mon 265<br />
Tibboel, D<br />
FC10.4.1<br />
Tiburcio, R Tue 420<br />
Tie, Lu Thu 076<br />
Tikka, S Thu 052, Thu 071<br />
Tikoo, K Mon 171<br />
Tilley, S Thu 057<br />
Tilton, R<br />
FC16.5.3<br />
Timar, J Wed 185<br />
Timar, J Thu 192<br />
Timotijevic, G<br />
FC16.3.6<br />
Tinel, H Thu 091<br />
Tirkkonen, T Mon 144<br />
Tirona, R Tue 054, Mon 072, Tue 301,<br />
FC02.1.6<br />
Tirotta, E<br />
FC17.4.6<br />
Tiwari, V Mon 183<br />
Tiziana, B Thu 400<br />
Tjønneland, A Tue 482<br />
Tkeba, Y Tue 336<br />
Tlala, V Tue 110<br />
Tlaskalova-Hogenova, H Wed 118<br />
Tobaiqy, M Tue 109<br />
Toda, N Wed 200<br />
Toda, T Mon 177, Mon 182, Tue 318,<br />
Tue 138<br />
Todoroki, M Mon 272<br />
Todorovic, S<br />
FC03.2.2<br />
Todorovic, Z Tue 098, Tue 013, Tue 026,<br />
Wed 135, Wed 134<br />
W34.1, W34.2<br />
Todt, H Mon 218, Mon 217<br />
Toft, E Tue 303<br />
Tognolini, M Tue 258, Mon 381<br />
Tohamy, MA Mon 340<br />
Toklu, HZ Tue 027<br />
Tokuoka, S Tue 373<br />
Tölle, TR W03.6<br />
Tolonen, A Thu 348<br />
Tolstanova, G<br />
W02.2.7<br />
Tomalik-Scharte, D Mon 384, Thu 010<br />
Tomic, S Mon 342, Mon 343, Mon 370,<br />
Wed 112, Tue 121<br />
Tomic, Z W34.4<br />
Tomita, K<br />
FC09.1.6<br />
Tomita, S Mon 180, Wed 247<br />
Tomlinson, B Tue 139, FC02.4.6, Tue 140<br />
Tomlinson, G<br />
FC10.5.3<br />
Tomono, Y Mon 035<br />
Tomos, C Tue 126, Thu 206<br />
Tomsig, J Wed 076<br />
Tong, J Mon 468, Mon 414, Tue 412,<br />
Mon 408<br />
Tong, X Tue 028<br />
Tonkin, J Mon 102<br />
Tontonoz, P<br />
FC18.1.1<br />
Tontson, L Thu 077<br />
Topal Tanyilmaz, G Thu 266<br />
Topcu, I Mon 117<br />
Torii, K<br />
W02.1.7<br />
Torndal, U-B Tue 383<br />
Törnquist, K Thu 079<br />
Torp-Pedersen, C FC13.3.6, FC04.2.4,<br />
Mon 119, Mon 118<br />
Torrens, M Thu 177<br />
Torres Domínguez, A Thu 358<br />
Torres, A Wed 131<br />
Torres, I Wed 177<br />
Toste, F Tue 162<br />
Tostes, R<br />
FC06.1.5<br />
Tóth, A Tue 125<br />
Toth, D Mon 283<br />
Tóth, DM Mon 401<br />
Toufiño, C Wed 209<br />
Toukola, L W21.4<br />
Tourette, A Mon 084<br />
Touw, DJ W28.5, W29.4<br />
372 Index
Name Paper ref. Name Paper ref.<br />
Touyz, R<br />
W04.3.1<br />
Tovey, MG<br />
FC09.2.3<br />
Toyama, MH Thu 374, Wed 297<br />
Toylu, A Tue 200<br />
Toyohira, Y Tue 072<br />
Tozawa, A Mon 435<br />
Trabelsi, S FC07.3.6, Mon 020, Mon 021<br />
Trajano, ETL Wed 342<br />
Tran, K Tue 309<br />
Trandafilovic, M Thu 359<br />
Trandafirescu, C Tue 102<br />
Tran-Van-Minh, A FC03.2.4<br />
Trapasso, E Thu 316, Thu 364<br />
Travassos, AS Thu 193<br />
Traynelis, SF Wed 084<br />
Treede, R-D W03.6<br />
Treinys, R Thu 023<br />
Trejo, E Wed 040<br />
Trenti, A Thu 360<br />
Trevisani, M W03.1<br />
Trevisi, L Thu 360<br />
Tributino, J Mon 398<br />
Tricoire, J Mon 145, Mon 132<br />
Trifa, A Mon 417, Mon 438, Tue 481<br />
Trifirò, G<br />
FC04.1.6, FC04.4.5,<br />
FC04.4.6<br />
Tringham, E<br />
FC03.2.1<br />
Trinh, S Wed 306<br />
Trinquet, E Thu 035, FC11.2.1, Wed 077,<br />
FC11.3.5<br />
Tripatara, P Thu 361<br />
Trujillo-Ferrara, JG Tue 195<br />
Truter, I Mon 026<br />
Truter, Ilse Tue 110, Tue 111, Tue 112<br />
Tsai, H-Y Wed 328<br />
Tsai, M-H Wed 430<br />
Tsakiris, S Thu 431 Tue 381<br />
Tsang, LL Thu 341<br />
Tsartsalis, S Tue 141, Mon 297, Tue 126<br />
Tschische, P Thu 078<br />
Tse, HF Tue 346, Thu 270<br />
Tseng, C-J Tue 146<br />
Tseng, T-L Thu 362<br />
Tsirlis, AT Mon 297<br />
Tsiwtsiwadze, ET Mon 192<br />
Tso, AWK Mon 271, Mon 159<br />
Tsoli, M W06.3<br />
Tsopanoglou, N Thu 095<br />
Tsuboi, A Wed 372<br />
Tsuchida, K Tue 236<br />
Tsuchiya, H Wed 189<br />
Tsuchiya, K Mon 180<br />
Tsuda, S Tue 132<br />
Tsuji, F Mon 402, Mon 112<br />
Tsuji, M Thu 422, Thu 397, Wed 128,<br />
Tue 443, Thu 423<br />
Tsujimoto, G Wed 064<br />
Tsukada, H Tue 217<br />
Tsukahara, F Thu 444<br />
Tsukahara, Y Mon 112<br />
Tsukuda, K Mon 439<br />
Tsuruhisa, M Wed 223<br />
Tsuruma, K Thu 220<br />
Tsuruta, H Tue 474<br />
Tsuruta, T Tue 311<br />
Tsushima, H Tue 147<br />
Tsutsui, M Tue 072, Thu 344<br />
Tsutsui, S Tue 085<br />
Tu, S Wed 366<br />
Tubéry, M<br />
FC04.3.5<br />
Tuleu, C<br />
FC10.3.4<br />
Tulunay, FC Tue 142<br />
Tumanovskaya, L FC06.1.6<br />
Tunaru, S Wed 056<br />
Tuncer, M Mon 419, Wed 253<br />
Tuncok, Y Tue 449, Tue 366, Mon 474<br />
Tunkova, A Mon 081, Wed 118<br />
Tunthong, R Tue 127<br />
Tuominen, RK Tue 433, FC09.5.4, Mon 341<br />
Turcekova, K Mon 219<br />
Turecek, R Thu 028<br />
Turgeon, J Tue 051<br />
Turkanovic, J Tue 066<br />
Turkoviæ, B<br />
W02.3.1<br />
Turpeinen, AM Wed 361<br />
Turpeinen, T FC09.1.5, Tue 278<br />
Tursas, L Thu 348<br />
Turunen, P Thu 051<br />
Tvete, IF Tue 143<br />
Tyner, S Tue 090<br />
Uchida, N Tue 320<br />
Uchida, S Tue 144<br />
Uchimura, T Thu 331<br />
Uchipichat, V Wed 124<br />
Uckert, S<br />
FC08.3.5<br />
Udoh, F Thu 332<br />
Ückert, S Tue 212, Tue 211, Tue 210<br />
Ueda, M Wed 414<br />
Ueda, Y Tue 163<br />
Uematsu, S Mon 313<br />
Uemura, T Thu 034<br />
Ueno, S Tue 072<br />
Uezono, Y Wed 065<br />
Ugur, Ö Thu 049<br />
Uhl, G Thu 176<br />
Uhlen, S Mon 397, Wed 069<br />
Uhlhaas, P<br />
FC17.2.2<br />
Uhlik, J Tue 445<br />
Ulak, G Thu 401, Wed 351<br />
Ulbrich, C Thu 267, Wed 252<br />
Ulsund, AH Wed 026<br />
Ulugol, A Mon 098<br />
Ulukus, C Tue 411<br />
Uluoglu, C Tue 029<br />
Ulupinar, E Wed 406<br />
Ulusoy, HB Tue 030, Tue 031<br />
Ulzurrun, E Wed 109<br />
Uma, S Thu 229, Thu 230<br />
Umegaki, K Tue 067<br />
Umemura, K W23.4, Tue 473<br />
Undale, V Mon 336<br />
Undale, VR Thu 363<br />
Ungvári, E Mon 150<br />
Uotani, T W23.4, Tue 473<br />
Upasani, CD Thu 363<br />
Uranga Piña, R Wed 311<br />
Uras, R Tue 133<br />
Urban, N<br />
FC17.1.3<br />
Index 373
Name Paper ref. Name Paper ref.<br />
Urbánek, K Tue 124, Tue 475<br />
Urbanova, I Tue 222<br />
Urbañska, A Tue 022<br />
Urigüen, L Thu 399<br />
Urquhart, B Tue 054<br />
Urrutia, P Wed 152<br />
Ursino, MR Thu 316, Thu 364<br />
Uruno, A Tue 153<br />
Ushijima, K Thu 268<br />
Ushiki, T Mon 182<br />
Usta, MP Mon 480<br />
Ustenova, G Thu 336<br />
Utkan, T Wed 351, Mon 387, Tue 145<br />
Uurto, I Thu 223<br />
Uyaiabasi, GN Wed 295<br />
Uyanik, O Tue 461<br />
Uydes Dogan, SB Thu 266<br />
Uydes-Dogan, BS Mon 199<br />
Uydes-Dogan, S Thu 269<br />
Vaag, A Mon 406<br />
Vaanhole, C Wed 002<br />
Vach, W Tue 395<br />
Vacher, B Tue 183, Tue 171, Tue 172<br />
Vadodaria, K<br />
W01.2.4<br />
Vahabi, S Thu 365<br />
Vàhàkangas, K Mon 063<br />
Vähäkangas, K Mon 076<br />
Vahakoski, R Tue 429<br />
Vaidya, VA<br />
W01.2.4<br />
Vaillant, E Mon 161<br />
Vainer, B Tue 480<br />
Vainio, J Mon 256<br />
Vainio, M Thu 079<br />
Vainio, P Mon 410<br />
Vainio, P Tue 436<br />
Vainio, PJ Mon 256<br />
Vaja, V Mon 221<br />
Vajner, L Tue 445<br />
Valadares, F Thu 323<br />
Valant, C Thu 080<br />
Valat, J-P Tue 198<br />
Valdés, MA Mon 011<br />
Valdivieso, A Wed 111<br />
Valdizán, EM Wed 401<br />
Valdizin, V Thu 408<br />
Valdman, E Mon 462<br />
Vale, N Thu 366, Tue 146, Tue 032<br />
Valença, SS Wed 342<br />
Valentin-Hansen, L Thu 036<br />
Valenza, M<br />
FC18.4.6<br />
Valera-Mota, MM Tue 025<br />
Valérie, D Tue 190<br />
Valinotto, ML Mon 128<br />
Valle Cabrera, R Thu 424, Thu 425, Thu 394,<br />
Thu 395<br />
van Breemen, C Wed 228, Thu 264<br />
van Buchem, MA Mon 400<br />
van den Anker, JN FC10.1.6, FC10.4.2<br />
van denBrink, AM W13.1, Wed 292, Wed 220<br />
van der Akker, R Thu 258<br />
van der Lee, M Thu 085<br />
van der Lei, J<br />
FC04.4.6<br />
van der Saag, P Wed 446<br />
van der Westhuizen, E W14.2<br />
van der Westhuizen, ET Wed 080<br />
van Dongen, Marloes GJ Tue 148<br />
van Eps, N<br />
FC11.3.2<br />
van Es, W<br />
FC10.4.6<br />
van Essen, H Mon 212, Thu 208, Thu 221<br />
van Eyk, A Tue 147<br />
van Gerven, JMA FC17.3.5, Mon 400,<br />
FC10.4.6<br />
van Grootheest, K FC13.1.1<br />
van Hove, CE Wed 246, Wed 245<br />
van Langen, J Wed 246, Wed 245<br />
van Lipzig, M Thu 085<br />
van Loenen, P Thu 082<br />
van Overmeire, B Wed 006<br />
van Patot, MT Mon 053<br />
van Ree, JM W25.2<br />
van Tiel, C<br />
FC18.2.4<br />
van Veen, HW<br />
FC02.1.4<br />
van Veen, T Wed 432, Tue 096<br />
van Veldhoven, JP FC11.2.5<br />
van Vuuren, SF Tue 279<br />
van Westen, GJP FC11.4.6<br />
van Wijhe, M Thu 216<br />
van Winsen, MR FC11.2.5<br />
van Zyl, J Wed 399<br />
van Zyl, RL FC14.5.5. Mon 012, Tue 002,<br />
Tue 003, Tue 456, Tue 279<br />
Vandeghinste, N Tue 280<br />
Vandenberg, R Mon 052<br />
Vandendriessche, K Wed 001<br />
Vang, K Thu 405<br />
Vanhaesebrouck, P Mon 365, Tue 306<br />
Vanhanen, J<br />
FC14.3.6<br />
Vanhaver, M Wed 002<br />
Vanhoutte, F Tue 280<br />
Vanhoutte, PMV IUL, FC15.2.6, YI.06,<br />
Thu 294, Thu 282, Thu 255,<br />
Tue 157, Thu 281, Wed 218,<br />
Thu 270, Mon 324<br />
Vanina, M Wed 045<br />
Vannacci, A Thu 302, Tue 093<br />
Vannasaeng, S Tue 341<br />
Vapaatalo, H Wed 361, FC16.3.4, Mon 302<br />
Varanou, K Tue 230<br />
Varela, M Wed 212, Tue 226<br />
Varendi, H<br />
FC10.3.6<br />
Varinska, L Thu 216, Tue 423<br />
Varro, A W19.4, Wed 197, Wed 284,<br />
Mon 100<br />
Varsamidis, K Mon 300<br />
Varsamidou, E Mon 300<br />
Vas, A Mon 027<br />
Vas, Adam W24.2<br />
Vasconcelos, V W31.4<br />
Vashchinkina, EV Thu 194<br />
Vasileiadis, M Tue 141<br />
Vasilenko, GF Thu 253<br />
Vasovic, V Mon 115, Tue 148, Wed 321<br />
Vassileiadis, M Mon 187<br />
Vathesatogkit, P Tue 127<br />
Vauquelin, G Thu 426<br />
Vaux, K<br />
FC08.1.6<br />
Vavers, E Thu 189<br />
Vavrinec, P Thu 097<br />
374 Index
Name Paper ref. Name Paper ref.<br />
Vaxillaire, M Mon 161<br />
Vayssettes-Courchay, C Thu 273, Thu 274<br />
Vaziri, B Mon 455<br />
Vázquez, J Thu 271<br />
Vazquez-Carrera, M Wed 440<br />
Veale, E<br />
FC03.3.6<br />
Vecera, R Wed 118<br />
Veg, A Mon 371<br />
Vegezzi, G Tue 258<br />
Veiksina, S Tue 192<br />
Veis, AA Mon 297<br />
Veitia, AM Mon 038<br />
Vekovischeva, OY Thu 194<br />
Velasco, IT<br />
Wed 202, Wed 204, Wed<br />
203, Mon 257<br />
Velasco-Bejarano, B Mon 168<br />
Velázquez, L<br />
Mon 023, W04.1.3<br />
Velickovic-Radovanovic, R Tue 149<br />
Vellecco, V Thu 081<br />
Velo, G W32.5<br />
Venner, M Tue 049<br />
Ventura, S Mon 238, Tue 215<br />
Vera, D Wed 152<br />
Verbeuren, TJ Thu 273, Thu 274<br />
Vercesi, J FC15.4.5, Wed 198<br />
Verde, I Wed 211<br />
Vereschagin, E Tue 167<br />
Verleysdonk, S YI.02<br />
Verli, J Wed 050<br />
Vermetten, E<br />
FC17.5.3<br />
Vermeulen, N W10.2<br />
Verri Jr, W<br />
FC03.1.5<br />
Verstraete, . A Tue 306<br />
Verstraete, A Mon 365<br />
Verstuyft, C W02.2.6, FC13.5.5, Tue 189<br />
Vertkin, A Tue 267<br />
Verzijl, D Thu 082<br />
Vestri, A<br />
FC04.3.6<br />
Vets, E Tue 280<br />
Vey, JL<br />
FC11.3.2<br />
Vial, T<br />
FC09.2.7, FC04.2.5<br />
Viana, CTR Wed 302, Tue 428<br />
Viana, G Mon 299<br />
Viana, GSB Tue 281, Tue 282<br />
Vidal, R Wed 401<br />
Vidal, X FC14.4.5, Tue 087<br />
Vie, B Tue 172<br />
Viegas, M Mon 128<br />
Vieira, C Thu 064<br />
Vieira, R Mon 095, Mon 097, Mon 094<br />
Vieira-Coelho, MA Wed 114, Thu 398<br />
Vienberg, S<br />
FC05.3.5<br />
Vieyra, A Tue 162<br />
Viglinskaya, A Tue 150<br />
Vilà, L Tue 133<br />
Vilakkthala, R<br />
FC04.3.7<br />
Vilar, B FC11.3.6, Thu 083<br />
Vilas-Boas, OMGC Tue 101, Mon 010<br />
Vilches-Flores, A Tue 149<br />
Viljoen, M Thu 012, Thu 016<br />
Villafaña-Godínez, L Mon 011<br />
Villalba, N Thu 249, Tue 213<br />
Villalobos-Molina, R Mon 168, Wed 049, Tue 025,<br />
Tue 150, Tue 149<br />
Villalón, CM PL06, W13.3, Thu 022,<br />
Thu 203<br />
Villamil-Hernández, MT Thu 203<br />
Villamor, E Wed 226, Thu 217<br />
Villarroya, M Mon 079<br />
Villas-Boas, M Thu 366<br />
Villier, C<br />
FC09.2.7<br />
Vilskersts, R Mon 429<br />
Vincent, F W03.3<br />
Vinklerová, I Tue 475<br />
Vinson, B Wed 382<br />
Vinué, A W09.4<br />
Viollet, B Thu 210<br />
Virag, L Mon 100<br />
Virtanen, S Tue 429<br />
Vischer, H Thu 085<br />
Visegrády, A Tue 078<br />
Vistisen, J Thu 427<br />
Vital, MABF Wed 394<br />
Vitezic, D Tue 095, Tue 437<br />
Vitezic, M Tue 095<br />
Vitiello, M Thu 433<br />
Vivoli, E Mon 113<br />
Vizi, S Mon 460<br />
Vlachos, G Tue 381<br />
Vlahakis, JZ Tue 414,<br />
Vlahovic-Palèevski, V FC01.2.3<br />
Vobruba, V Wed 017<br />
Vogel, U Tue 480, Tue 482<br />
Vohora, D Wed 419<br />
Vohra, K<br />
FC09.5.5<br />
Vokác, K Wed 386<br />
Volkova, AV Wed 187<br />
Vollmar, A Tue 227<br />
Vollmar, AM<br />
FC16.1.5<br />
Volpe, A Tue 487<br />
von Ameln-Mayerhofer, A YI.02, Mon 463<br />
von Moers, A Thu 013<br />
Vora, A Tue 353, Mon 351<br />
Voronin, M Thu 415<br />
Voronina, TA Mon 422, Mon 462, Wed 187<br />
Vorspan, F Wed 191<br />
Vorum, H Wed 240<br />
Vosmik, M Tue 421<br />
Vosper, H Tue 232<br />
Voss, TC<br />
FC18.4.2<br />
Voss, U Thu 317<br />
Voutilainen, MH Mon 341<br />
Vovk, T<br />
FC07.3.5<br />
Vrech, C Mon 280<br />
Vreeburg, SA Wed 432<br />
Vrioni, G Tue 457<br />
Vucinic, S Tue 321<br />
Vuckovic, S Mon 114<br />
Vukmirovic Papuga, M Mon 115<br />
Vukmirovic, S Mon 115, Tue 148, Tue 454<br />
Vukovic, J Tue 091, Tue 151<br />
Vukovic, MH Wed 435<br />
Vuolteenaho, K FC09.2.5, Tue 283<br />
Vuorela, P Mon 302<br />
Vuorenpää, Ae Thu 084<br />
Vural, K Wed 357<br />
Vyas, R Mon 064<br />
Vybiralova, Z Thu 168<br />
Index 375
Name Paper ref. Name Paper ref.<br />
Vyslouzil, L Tue 342<br />
Waako, P<br />
Tue 005, Wed 136, FC01.4.5<br />
Wachall, B Thu 010<br />
Wacheck, V W05.3<br />
Waddington, J L FC17.2.1<br />
Wade, JD Wed 080<br />
Wade, R Tue 353<br />
Wade, S Thu 044<br />
Wadi, N Tue 152<br />
Wadie, W Wed 382<br />
Wadsworth, R Thu 272<br />
Waeckel, L Thu 273, Thu 274<br />
Wagg, C<br />
FC05.2.6<br />
Wagner, M Tue 166<br />
Wainwright, C Tue 232, Mon 211<br />
Wake, H Tue 272, Mon 035, Mon 329,<br />
Thu 275<br />
Wakita, S Mon 464<br />
Wakuda, H Tue 067, Tue 143<br />
Waldhoer, M FC11.1.6, Wed 073, Thu 078<br />
Waldkirch, E FC08.3.5, Tue 212<br />
Wallace, E Thu 030<br />
Walsh, D Tue 090<br />
Walsh, MP Wed 239<br />
Walsh, S<br />
FC14.1.1<br />
Walsh, TS Thu 420, Tue 270<br />
Walter, M Thu 112<br />
Walter, Nicole Tue 438<br />
Walters, MR<br />
FC15.1.6<br />
Walubo, A<br />
FC01.1.1<br />
Walubo, A Mon 258, Wed 389,<br />
Wed 390, Wed 391<br />
Wan Aasim, WR Tue 153<br />
Wang, C Tue 325<br />
Wang, A-Y Tue 400<br />
Wang, B Mon 228<br />
Wang, B-S Thu 368<br />
Wang, C Tue 163, Mon 468, Tue 412,<br />
Tue 173, Mon 467, Mon 408,<br />
Wed 327, Wed 150, Tue 152<br />
Wang, C-B Mon 008<br />
Wang, C Mon 414<br />
Wang, C Tue 033<br />
Wang, C-Y Mon 423<br />
Wang, D Tue 135<br />
Wang, D Thu 103, Tue 068<br />
Wang, F Tue 138, Thu 367<br />
Wang, G FC12.4.5, Wed 378, Mon 092<br />
Wang, G-L<br />
FC16.4.5,<br />
Wang, H Wed 242, Tue 138, Mon 458<br />
Thu 089, Thu 368<br />
Wang, HC Mon 356<br />
Wang, J<br />
Tue 425, Wed 270, FC15.4.6,<br />
Thu 088, Tue 284, Tue 371<br />
Wang, J Tue 439<br />
Wang, K Thu 172, Tue 307<br />
Wang, L Thu 017, Mon 056, Tue 069,<br />
Tue 070, Mon 466, Mon 445,<br />
Tue 440, Tue 155, Tue 317,<br />
Tue 183<br />
Wang, LL Thu 276<br />
Wang, M Tue 070 Thu 340<br />
Wang, P Thu 370, Thu 306, Thu 210,<br />
Thu 369<br />
Wang, Q Mon 331, Thu 089<br />
Wang, Q-G Thu 375<br />
Wang, R<br />
FC15.3.6<br />
Wang, S Tue 389<br />
Wang, S Tue 034<br />
Wang, S-P Thu 277<br />
Wang, T<br />
FC12.2.5<br />
Wang, Tao Mon 465<br />
Wang, W Thu 378<br />
Wang, W Thu 370<br />
Wang, X Thu 371, Wed 378, Mon 445<br />
Thu 378<br />
Wang, X Mon 466<br />
Wang, X-J Wed 367<br />
Wang, XX<br />
FC18.4.5<br />
Wang, Y YI.06 , FC12.2.5, Wed 331,<br />
Mon 034, Thu 372, Thu 020,<br />
Thu 270, Tue 035, Wed 039,<br />
Thu 340<br />
Wang, Yn Tue 285<br />
Wang, Y-H Tue 187, Tue 186 Thu 277<br />
Wang, Y Thu 104<br />
Wang, Y-W Wed 328<br />
Wang, YX Tue 082<br />
Wang, Z Tue 286, Thu 445<br />
Wang, Z-J<br />
FC03.3.3<br />
Wannarat, K Thu 356<br />
Ward, M Tue 495<br />
Ward, MB Tue 066<br />
Ward, R<br />
FC03.2.6<br />
Warner, T<br />
FC09.4.1<br />
Warner, TD Thu 200<br />
Warren, S Tue 145<br />
Warstat, C Tue 238<br />
Wasilewski, R Mon 181<br />
Wasner, G W03.6<br />
Watanabe, A Tue 234<br />
Watanabe, H W23.1, W23.4, Mon 093,<br />
Tue 144, Tue 473, Thu 262<br />
Watanabe, M Mon 253, Wed 117, Tue 273,<br />
Tue 380, Tue 492<br />
Watanabe, T Tue 459, Wed 414<br />
Watanabe, Y Tue 071, Tue 244<br />
Watanabe, Y Tue 377<br />
Watanabe, Y Tue 154<br />
Watanabe, Y Tue 287<br />
Watanuki, S Tue 166<br />
Waterhouse, C Tue 229<br />
Waters, N Wed 147<br />
Waters, S Wed 147<br />
Watier, H Mon 363<br />
Watson, A Thu 228<br />
Watson, JM Wed 030<br />
Watt, S Mon 211<br />
Watts, A Thu 085<br />
Wawruch, M Tue 113<br />
Waxman, SG<br />
FC03.1.4, FC12.2.1<br />
Webb, DJ FC15.3.5, Thu 420, Tue 270<br />
Webb, T Tue 037<br />
Weber, C W09.2, Thu 240<br />
Weber, G Mon 479, Thu 354<br />
Weber, M-A<br />
FC12.2.3<br />
Webster, R Mon 236<br />
Weerasuriya, K FC01.2.2, W36.1, W36.6<br />
376 Index
Name Paper ref. Name Paper ref.<br />
Wegener, G Wed 399, Thu 405<br />
Wei, J Thu 262<br />
Wei, W Tue 288<br />
Weihe, P Wed 151<br />
Weikop, P<br />
FC02.3.6<br />
Weimann, A Mon 406<br />
Weinberg, PD Thu 238<br />
Weinshilboum, RM FC13.5.4<br />
Weinstein, H<br />
FC02.1.2, FC02.3.5, Mon<br />
073<br />
Weiser, D Wed 382, Mon 317, Thu 317,<br />
Wed 417, Tue 462<br />
Welch, S Tue 064<br />
Wellendorph, P FC11.5.1, FC11.5.6<br />
Welling, J<br />
FC16.3.4<br />
Wells, P Tue 301<br />
Wells, TNC W31.1<br />
Welscher, U Mon 479, Thu 211, Tue 214,<br />
Mon 245<br />
Welsh, D Thu 105<br />
Wen, H Thu 278<br />
Wen, M Mon 310<br />
Wenceslau, C Wed 042<br />
Wendling, D Tue 198<br />
Wendremaire, M Tue 289, Tue 290<br />
Wenger, C Thu 435<br />
Wennerberg, M Thu 426<br />
Wergin, K Wed 119<br />
Werner, B Tue 151<br />
Werner, M<br />
YI.05<br />
Werner, M Thu 279<br />
Westfall, T Tue 205, Tue 206, Tue 204,<br />
Mon 244<br />
Westley, I Tue 495<br />
Weston, AH FC15.2.1, Wed 269, Wed 238<br />
Weston, R<br />
FC03.1.6<br />
Wettstein, JG Wed 094<br />
Wheat, A Wed 392<br />
Whistler, J Wed 073<br />
White, C Tue 215<br />
White, P Thu 032<br />
White, P W20.1, Thu 280<br />
Whittard, J<br />
FC14.1.2<br />
Wiborg, O Mon 046, Wed 433, Wed 397<br />
Wibral, M<br />
FC17.2.2<br />
Wichmann, J Wed 094<br />
Wicklund, B<br />
FC13.3.5<br />
Widmann, C FC17.2.5, Thu 237<br />
Wiench, M<br />
FC18.4.2<br />
Wieninger, PR Mon 153<br />
Wiesen, M Thu 018<br />
Wietzorrek, G Tue 151<br />
Wigerinck, P Tue 280<br />
Wihl, J Tue 395<br />
Wijtmans, M Thu 060<br />
Wikström, S Thu 008<br />
Wilding, JPH<br />
FC05.1.3<br />
Wilkes, DK Mon 442<br />
Wilkowski, R Tue 214<br />
Willars, GB Wed 025<br />
Williams, D Tue 063, Tue 495<br />
Williams, JHG Tue 109<br />
Williams, P Thu 110<br />
Williams, R Thu 393<br />
Wilm, S Tue 108<br />
Wilson, C Mon 339<br />
Wilson, J X<br />
W04.1.4<br />
Wingler, K<br />
FC15.4.4<br />
Wink, D<br />
FC09.3.3<br />
Winkelmayer, WC Mon 153<br />
Wirth, A Wed 056, Tue 134<br />
Wirth, VF Thu 086<br />
Wise, H Mon 321, Thu 045<br />
Wissel, G Wed 088<br />
Witschi, R<br />
FC03.3.3<br />
Wittkopf, D Thu 087<br />
Wlash, EJ Wed 239<br />
Wojnowski, L<br />
FC02.1.5<br />
Wolber, G Thu 014<br />
Woldbye, D<br />
FC02.3.6<br />
Wölfling, J Thu 308<br />
Wolin, MS<br />
FC08.2.5<br />
Wolmarans, DW Thu 428<br />
Woltering, T Wed 094<br />
Wolzt, M W10.1<br />
Won, H-H Tue 335<br />
Wong, CCM W02.1.4, Tue 476<br />
Wong, DVT Tue 255<br />
Wong, ESW Thu 281<br />
Wong, M SK Thu 282<br />
Wong, SL<br />
FC15.4.7<br />
Wong, WT<br />
FC15.4.7<br />
Wong, Y-H Thu 045<br />
Wongkajornsilp, A Mon 334<br />
Wood, Ruth I<br />
FC14.5.3<br />
Woodman, OL Wed 288, Wed 289<br />
Woodward, D Wed 270<br />
Woodward, D Thu 088, Tue 284<br />
Woolf, CJ<br />
FC03.3.4<br />
Wootten, D Wed 082<br />
Worku, A FC01.4.7, Mon 018<br />
Wörtwein, G<br />
FC02.3.6<br />
Wotjak, C<br />
FC17.5.5<br />
Wotjak, CT Thu 396<br />
Wraber, B Wed 178<br />
Wright, C Mon 214<br />
Wright, J Tue 309<br />
Wright, K Tue 460<br />
Wright, WR Thu 241<br />
Wu, B-N Thu 105<br />
Wu, C Tue 299, Thu 367, Tue 440,<br />
Tue 155<br />
Wu, C-C Wed 222, Thu 283<br />
Wu, CL Thu 429<br />
Wu, C-S Wed 430<br />
Wu, J Thu 445<br />
Wu, J Thu 089<br />
Wu, JY Mon 032<br />
Wu, K Wed 099<br />
Wu, L Tue 130<br />
Wu, M Tue 382<br />
Wu, N<br />
Thu 171, FC14.5.4<br />
Wu, Q Tue 184, Tue 458, Thu 186,<br />
Tue 178, FC14.4.6, Tue 382,<br />
Tue 181, Thu 116, Thu 184,<br />
Thu 182, Thu 185<br />
Wu, W-B Thu 373<br />
Wu, Y Thu 388<br />
Index 377
Name Paper ref. Name Paper ref.<br />
Wu, Y-C Thu 090<br />
Wu, Z Mon 310<br />
Wudayagiri, R Mon 091<br />
Wulff, H Thu 273<br />
Wulf-Johansson, H Thu 106<br />
Wunder, F Thu 091<br />
Wung, B-S Tue 291<br />
Xavier, IPP Tue 282<br />
Xhaard, H Wed 088<br />
Xi, Z-X Wed 182, Thu 195<br />
Xia, X-D Mon 470<br />
Xia, Y W30.2<br />
Xia, Y-Q Tue 495<br />
Xia, Y Tue 152<br />
Xiang, J Thu 370<br />
Xiang, X Thu 284<br />
Xiao, Y<br />
FC12.2.2<br />
Xiao, Z Wed 090<br />
Xie, H Tue 441<br />
Xie, J Tue 399<br />
Xie, L-Y Wed 259<br />
Xie, Y Tue 094,<br />
Xie, Z-L Tue 382<br />
Ximenes, RM Thu 374, Wed 297<br />
Xin, H-W Tue 393<br />
Xiong, X Tue 466<br />
Xu, C-B Wed 213<br />
Xu, A FC15.4.7, YI.06, Mon 324<br />
Xu, C Thu 092, Tue 181<br />
Xu, C-B Tue 185<br />
Xu, CB Mon 266, Wed 034<br />
Xu, C-B Thu 056, Tue 298, Wed 033<br />
Xu, J Thu 104<br />
Xu, J Mon 467<br />
Xu, J-K Thu 375<br />
Xu, L Thu 299,<br />
Xu, Li Thu 376<br />
Xu, S Mon 466, Mon 445<br />
Xu, T-Y Thu 210<br />
Xu, X-H<br />
FC12.3.5<br />
Xu, X-L Wed 259<br />
Xu, Y Wed 327, Mon 077, Mon 078,<br />
Thu 104, Tue 028<br />
Xu, Y Tue 292<br />
Xue, H-M Thu 287, Thu 288<br />
Xue, M Mon 056, Mon 077, Tue 069,<br />
Tue 070, Mon 078<br />
Yabumae, N Tue 154<br />
Yadav, AV Thu 363<br />
Yagi, M Mon 386<br />
Yajima, T Mon 386<br />
Yakouben, K<br />
FC10.1.5<br />
Yam, MF FC16.3.4, Tue 247<br />
Yamada, A Mon 178<br />
Yamada, K Tue 147<br />
Yamada, S Tue 217, Tue 067, Tue 216,<br />
Tue 144<br />
Yamade, M W23.4, Tue 473<br />
Yamagishi, Y Tue 154<br />
Yamaguchi, T Tue 435, Thu 099, Mon 461,<br />
Thu 430<br />
Yamakawa, T Tue 071<br />
Yamamoto, K Tue 484<br />
Yamamoto, M Wed 448<br />
Yamamoto, N Mon 424, Thu 285<br />
Yamamoto, R Thu 263<br />
Yamamoto, S FC09.1.6, Thu 286<br />
Yamamura, H Wed 107, Thu 102, Thu 107<br />
Yamamuro, A Wed 075, Mon 416, Mon 435,<br />
Mon 440, Wed 067<br />
Yamanaka, R Mon 250<br />
Yamashita, K Tue 071<br />
Yamashita, S Thu 108<br />
Yamauchi, M Wed 117<br />
Yamazaki, H<br />
FC09.1.6<br />
Yamazaki, K Tue 467<br />
Yan, C Tue 181, Tue 403<br />
Yan, H-T Thu 171<br />
Yan, L Mon 408, Tue 238<br />
Yan, L-C<br />
FC16.5.5<br />
Yan, L-D Tue 083<br />
Yan, T-T<br />
FC16.4.5<br />
Yan, X-Z FC16.3.1, Wed 379<br />
Yan, Y Tue 155<br />
Yanagida, S Tue 390<br />
Yanagihara, N Tue 072<br />
Yanagino, S Thu 250<br />
Yanai, K FC17.1.6, Tue 163, Thu 414,<br />
Tue 166, Tue 153<br />
Yanaka, A<br />
FC16.4.6<br />
Yáñez, A Tue 478, Tue 422<br />
Yañez, M<br />
FC16.2.5<br />
Yang, B Thu 377<br />
Yang, C Wed 090<br />
Yang, C-M Mon 311, Tue 293<br />
Yang, DI Thu 429<br />
Yang, G<br />
FC15.3.6<br />
Yang, HG Mon 433<br />
Yang, J Thu 295, Thu 367, Tue 440,<br />
Tue 155, Thu 277<br />
Yang, L Mon 310<br />
Yang, N Wed 429<br />
Yang, N-S Mon 268<br />
Yang, Q Mon 172<br />
Yang, Qin Thu 287, Thu 288<br />
Yang, R-F<br />
FC14.5.4<br />
Yang, S Thu 185, Mon 092<br />
Yang, S Thu 196, Tue 378<br />
Yang, S-M Mon 265<br />
Yang, S-N<br />
FC12.4.1<br />
Yang, SY Mon 428, Wed 277<br />
Yang, X Tue 426<br />
Yang, X-B Wed 367<br />
Yang, YK Mon 356<br />
Yano, I Tue 156<br />
Yano, T Mon 093, Thu 109<br />
Yanpallewar, S W01.2.4<br />
Yao, C Mon 310, Tue 260, Tue 294<br />
Yao, Q Tue 299<br />
Yao, R Thu 378<br />
Yao, X<br />
FC15.4.7<br />
Yao, X-Q Thu 288<br />
Yao, X-S Thu 375<br />
Yaris, E Tue 027<br />
Yarkova, M Thu 415, Tue 276<br />
Yarova, P Thu 289<br />
Yasar, U Wed 249,<br />
Yasuda, K<br />
Tue 126, FC13.2.5<br />
378 Index
Name Paper ref. Name Paper ref.<br />
Yasuda, S Tue 156<br />
Yasuhara, H Thu 319, Tue 320, Thu 343,<br />
Tue 443<br />
Yasui, Y Mon 253<br />
Yasumura, M Thu 034<br />
Yazdanpanah, H Tue 231<br />
Ye, C Tue 295, Tue 296, Thu 378<br />
Ye, J Mon 468, Mon 414<br />
Ye, L<br />
FC12.4.5<br />
Yeadon, M Tue 269<br />
Yeh, J-C Wed 330<br />
Yeh, K-C Mon 158<br />
Yeh, K-H Mon 456<br />
Yeh, T-K Mon 158<br />
Yeo, JL Wed 195<br />
Yeoh, PN Thu 379, Thu 380<br />
Yeow, R Thu 075<br />
Yesilyurt, A Mon 043<br />
Yeung, JHK Wed 345, Thu 389, Thu 381<br />
Yeung, YT Tue 157<br />
Yi, B Tue 317, Tue 036<br />
Yi, D Tue 155<br />
Yi, J-H<br />
FC16.5.5<br />
Yildirim, E Wed 406<br />
Yilmaz, H Mon 117<br />
Yimer, G<br />
FC01.2.5, FC01.4.7,<br />
Mon 018<br />
Yin, D FC06.4.6, Mon 210, Tue 158,<br />
Wed 362, Wed 258, Tue 317,<br />
Tue 036, Thu 298<br />
Yin, L-J Mon 265<br />
Yin, L Tue 400<br />
Yin, M Thu 093<br />
Yin, OQP FC02.4.6, Tue 140<br />
Yin, S Mon 210<br />
Ying, J Mon 092<br />
Yinka-Ogunleye, AF Tue 100<br />
Yip, KH Mon 321<br />
Ylä-Herttuala, S W21.3, Wed 448<br />
Yli-Kauhaluoma, J Tue 433<br />
Ýnce, S Wed 312<br />
Yodu, N Tue 114<br />
Yokokawa, A Tue 159<br />
Yokomasu, A Tue 156<br />
Yokomi, I Tue 380<br />
Yokomizo, K Thu 387<br />
Yokoo, H<br />
FC09.1.6<br />
Yokota, S<br />
FC10.5.4<br />
Yokota, S Tue 459<br />
Yokotani, K Thu 040<br />
Yoneda, Y Mon 441<br />
Yonehara, N Tue 084, Tue 338, Thu 285<br />
Yoneko, M Wed 263<br />
Yoneyama, M Tue 376, Tue 375<br />
Yoo, HJ Mon 427<br />
Yoon, JS Mon 068<br />
Yoshida, A Tue 217<br />
Yoshida, S FC03.2.5, Mon 243<br />
Yoshida, T Thu 034<br />
Yoshida, Y Tue 459<br />
Yoshihara, T Tue 162<br />
Yoshikawa, N Thu 320<br />
Yoshikawa, T FC17.5.6, Tue 153<br />
Yoshiki, H Thu 046<br />
Yoshioka, M Thu 430<br />
Yoshioka, Y Wed 075, Mon 416, Mon 435,<br />
Mon 440, Wed 067<br />
You, H Tue 085<br />
Youn, S-J Tue 161, Tue 160, Tue 162,<br />
Tue 073<br />
Young, A Wed 425, Mon 430<br />
Young, AMJ Mon 195<br />
Yousif, M Mon 151<br />
Yshii, L Mon 292<br />
Yu, D-H Tue 399<br />
Yu, H Mon 185, Thu 089<br />
Yu, HJ Mon 325<br />
Yu, H-M Tue 426<br />
Yu, J Mon 468, Mon 414, Wed 093,<br />
Yu, X Tue 307<br />
Yu, X-J Tue 187, Tue 186 Tue 159,<br />
Thu 292, Wed 259<br />
Yu, Y<br />
FC12.2.5<br />
Yuan, S Mon 310, Tue 163<br />
Yuan, Y W03.7<br />
Yuan, ZY Wed 034<br />
Yubero, S Thu 177<br />
Yue, Q-Y<br />
FC13.4.5<br />
Yura, A Wed 372<br />
Yurdakok, B Wed 312<br />
Yusof, W Tue 164<br />
Yutani, C Mon 306, Mon 174<br />
Yýldýz Akar, F Thu 401<br />
Yýldýz, A Tue 245<br />
Zabihyan, B Mon 041<br />
Zablockaite, D Thu 023<br />
Zachow, A Tue 115<br />
Zadori, Z Thu 062<br />
Zadori, Z Thu 094<br />
Zádori, Z W19.1<br />
Zahaf, N Wed 405<br />
Zahir, H Wed 122<br />
Zahler, S<br />
Tue 227, FC16.1.5<br />
Zahora, J Tue 125<br />
Záhora, J Wed 017<br />
Zainal, NZ Wed 431<br />
Zaklyazminskaya, E Tue 106<br />
Zama, T Tue 311<br />
Zamami, Y Mon 174, Tue 154, Tue 415<br />
Zaman, G Thu 085<br />
Zamani, M Thu 290<br />
Zambelli, V Mon 276<br />
Zambon, A Tue 093<br />
Zampatis, D Thu 095<br />
Zamponi, F Thu 028<br />
Zamponi, G<br />
FC03.2.1<br />
Zamponi, GW Tue 085<br />
Zang, W-J Tue 187, Tue 186, Thu 292,<br />
Wed 259<br />
Zang, W-J Tue 159<br />
Zang, Z Wed 322<br />
Zanger, UM<br />
FC13.4.4<br />
Zangrossi, H<br />
FC17.5.5<br />
Zaniolo, O Wed 154<br />
Zannad, F Tue 182<br />
Zanou, N Wed 102<br />
Zaporowska-Stachowiak, IThu 291<br />
Zarate, V<br />
FC01.2.4<br />
Index 379
Name Paper ref. Name Paper ref.<br />
Zare, A Tue 017<br />
Zarkovski, A Thu 409<br />
Zarrindast, M Wed 027, Wed 437<br />
Zarrindast, M-R Mon 437<br />
Zarros, A Thu 431, Tue 381<br />
Zasadny, K Tue 372<br />
Zastre, J Mon 070<br />
Zaychenko, GV Tue 218, Thu 382<br />
Zdarova-Karasova, J Tue 343, Mon 075<br />
Zebedin-Brandl, E Mon 217<br />
Zebuhr, L Tue 214<br />
Zegarra, C Mon 451<br />
Zehender, M Wed 099<br />
Zeilhofer, HU<br />
FC03.3.3<br />
Zeng, Y Tue 094<br />
Zermani, R Mon 338<br />
Zerpa, H Tue 362<br />
Zezelic, S Mon 370<br />
Zgheib, N<br />
FC01.3.4<br />
Zhai, Q-W Thu 210<br />
Zhan, Q Tue 145<br />
Zhan, RX Wed 291<br />
Zhanataev, AK Tue 165<br />
Zhang, B Thu 276<br />
Zhang, B-R Mon 265<br />
Zhang, C Tue 285<br />
Zhang, D<br />
Tue 295, Tue 153, FC10.1.5<br />
Zhang, D Tue 296<br />
Zhang, D Tue 166<br />
Zhang, F Thu 186<br />
Zhang, G Mon 469, Wed 122<br />
Zhang, G-R Mon 470<br />
Zhang, G Tue 155<br />
Zhang, H Thu 371, Mon 467, Mon 092,<br />
Thu 384, Tue 440, Thu 372,<br />
Wed 322<br />
Zhang, H-L Thu 292, Wed 259<br />
Zhang, H-N<br />
FC09.5.6<br />
Zhang, J Wed 331, Wed 242, Thu 383,<br />
Mon 035, Mon 329, Mon 352,<br />
Tue 075, Thu 372, Thu 277,<br />
Thu 093<br />
Zhang, JQ Thu 295<br />
Zhang, K-Z Mon 265<br />
Zhang, L Thu 370, Mon 265, Tue 083,<br />
Thu 196, Tue 378,<br />
Thu 378, Thu 384<br />
Zhang, M FC12.4.5, Mon 265, Thu 172<br />
Zhang, P<br />
FC02.3.5<br />
Zhang, Q FC16.3.1, Tue 188, Tue 189,<br />
Thu 390, Wed 379<br />
Zhang, R Tue 299, Wed 254<br />
Zhang, SF Wed 039<br />
Zhang, S-Q<br />
FC14.5.4<br />
Zhang, T Tue 297<br />
Zhang, T Thu 019, Thu 020<br />
Zhang, W Tue 185, Tue 440<br />
Zhang, W-C Mon 421<br />
Zhang, W-K Thu 375<br />
Zhang, X<br />
Thu 445, Thu 089, W33.2,<br />
Tue 076<br />
Zhang, X-H<br />
W04.1.2<br />
Zhang, X-Q Mon 082, Thu 385<br />
Zhang, Y Wed 402, Thu 432, Tue 117,<br />
Thu 369, Thu 306, Tue 285,<br />
Thu 021, Tue 185, Tue 292,<br />
Thu 368, Wed 213, Wed 033,<br />
Tue 403, Tue 298<br />
Zhang, Y-H Mon 082, Thu 385<br />
Zhang, Y Tue 075<br />
Zhang, YL Mon 053<br />
Zhang, Y-H Thu 386<br />
Zhang, Y-X FC16.3.1, Wed 379, Mon 470<br />
Zhang, Z Tue 076<br />
Zhang, Z-Q<br />
FC14.5.4<br />
Zhao, J-N<br />
FC16.5.5<br />
Zhao, M Tue 159, Thu 277, Thu 292,<br />
Wed 259<br />
Zhao, P Tue 425, Tue 371<br />
Zhao, W<br />
FC10.5.5<br />
Zhao, X Mon 082<br />
Zhao, Y FC02.1.2, Wed 402, Tue 130,<br />
Tue 285<br />
Zhao, YB Mon 032<br />
Zhao, Z Wed 378, Tue 181, Tue 076<br />
Zhdanov, V Tue 167<br />
Zheng, J Tue 299,<br />
Zheng, J-P Tue 185<br />
Zheng, J-Q Thu 171<br />
Zheng, R Tue 296, Tue 295<br />
Zheng, S-Z Tue 400<br />
Zheng, X<br />
Thu 388, FC12.2.5<br />
Zheng, Y Thu 299<br />
Zherdev, V Tue 150<br />
Zhong, B Thu 298<br />
Zhong, H Mon 046<br />
Zhong, W Tue 152<br />
Zhorov, BS<br />
FC12.5.5<br />
Zhou, C Tue 155<br />
Zhou, F Tue 440<br />
Zhou, H Tue 229, Tue 299, Thu 377<br />
Zhou, J-C Mon 031<br />
Zhou, J Thu 387<br />
Zhou, L Thu 388<br />
Zhou, N Thu 372<br />
Zhou, PXL Thu 381, Thu 389<br />
Zhou, P-L Tue 083<br />
Zhou, S-P Mon 470<br />
Zhou, W Wed 402<br />
Zhou, W Thu 432<br />
Zhou, W-X FC16.3.1, Wed 379, Mon 470<br />
Zhou, Y<br />
FC12.5.4<br />
Zhu, A Tue 372<br />
Zhu, B Tue 156<br />
Zhu, C Tue 155<br />
Zhu, H Tue 163<br />
Zhu, J Wed 093<br />
Zhu, L Mon 414, Tue 173, Tue 325,<br />
Mon 408, Wed 267<br />
Zhu, Q Wed 362, Mon 323<br />
Zhu, R Wed 076<br />
Zhu, W Thu 445, Thu 089<br />
Zhu, X Tue 138, Tue 094<br />
Zhu, XX Mon 469<br />
Zhu, Y Wed 242<br />
Zhu, Z Tue 384, Thu 390, Tue 076<br />
Zhukov, V Wed 188<br />
380 Index
Name Paper ref. Name Paper ref.<br />
Zhuravlev, YN<br />
FC16.5.1<br />
Zia, M Thu 391, Thu 392<br />
Ziaurrahman, S Tue 119<br />
Zibar, L Tue 121<br />
Ziberna, L Thu 293, Thu 359<br />
Ziche, M Wed 243<br />
Zidariè, M Wed 153<br />
Zidek, Z Wed 118<br />
Zídek, Z Wed 386, Tue 300<br />
Ziganshin, AU Thu 096<br />
Ziganshina, LE Thu 096<br />
Ziogas, J Wed 288, Wed 289,<br />
Mon 214, Thu 393<br />
Zitman, FG Wed 432, Tue 096<br />
Zolfagharpour, A Thu 209<br />
Zolotarev, V<br />
W02.1.2<br />
Zolotov, N Mon 462<br />
Zong, S<br />
FC03.4.5<br />
Zoric, Z Thu 436, Mon 446<br />
Zorina, L Wed 314<br />
Zou, F Mon 210<br />
Zou, Q Thu 294<br />
Zou, X Wed 150<br />
Zoulova, J Tue 342, Thu 168<br />
Zsifkovits, C Wed 016<br />
Zubata, I Tue 342<br />
Zügel, S Tue 462<br />
Zúñiga, C Wed 217<br />
Zuo, P Mon 465, Wed 429<br />
Zupkó, I Tue 130, Tue 442, Thu 308<br />
Zusmanovich, M Mon 228<br />
Zvejniece, L Thu 189<br />
Zwane, N Tue 001<br />
Zwisler, ST<br />
FC13.5.5<br />
Zwykiel, S Wed 056<br />
Zychar, BC Wed 333, Wed 334<br />
Zygmunt, M Tue 039<br />
Zygmunt, P<br />
FC09.4.5<br />
Index 381
382 Notes<br />
Notes
Notes 383
<strong>Final</strong> <strong>Programme</strong> printed in Singapore by C.O.S. Printers Pte Ltd . 06.<strong>2010</strong> . Layout: Christen Tofte . Photos: Wonderful Copenhagen, Bella Center, Øresundsbron
Impact<br />
factor for<br />
2008:<br />
2.073<br />
Basic & Clinical<br />
Pharmacology & Toxicology<br />
Official journal of<br />
<strong>WorldPharma</strong> <strong>2010</strong><br />
17–23 July <strong>2010</strong><br />
Copenhagen<br />
Denmark<br />
Preferred journal of<br />
The European Association for<br />
Clinical Pharmacology and Therapeutics